data_2vil_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2vil _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 11.0 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.473 ' HA ' ' CE1' ' A' ' 80' ' ' TYR . 1.9 mt-10 64.64 66.08 0.61 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.347 -0.846 . . . . 0.0 109.521 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.631 ' CD2' ' CD1' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -44.83 -41.16 6.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 3.2 t -42.54 150.56 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.378 -0.826 . . . . 0.0 109.616 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 4' ' ' SER . 14.1 ttpt 80.49 -72.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.586 -0.697 . . . . 0.0 109.775 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.483 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 70.2 mmtt -88.33 14.53 9.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.079 -1.013 . . . . 0.0 109.851 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 6' ' ' LYS . 21.8 t -157.2 -74.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.058 -1.026 . . . . 0.0 109.618 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.517 ' CB ' ' HA ' ' A' ' 4' ' ' SER . 2.3 m -49.3 -23.16 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 0.0 109.476 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 10' ' ' LYS . . . -89.38 32.89 4.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER 164.12 47.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -1.135 . . . . 0.0 109.464 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.518 HD11 ' CD2' ' A' ' 88' ' ' LEU . 38.2 mt -68.96 -147.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 0.0 109.208 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -83.84 119.6 25.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.961 . . . . 0.0 109.385 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.517 ' O ' ' CG2' ' A' ' 14' ' ' THR . 5.1 mmmt -122.97 -11.99 8.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 0.0 109.62 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.56 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 18.4 p -160.8 69.99 0.38 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 109.544 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 15' ' ' THR . 5.9 t -175.33 124.2 0.35 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.371 -0.831 . . . . 0.0 109.176 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.7 105.99 2.12 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.25 1.967 . . . . 0.0 110.514 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 173.33 176.76 42.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.652 ' CD1' ' CE1' ' A' ' 110' ' ' PHE . 3.9 pt -124.49 134.45 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -1.208 . . . . 0.0 109.922 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.446 ' NE2' ' CH2' ' A' ' 21' ' ' TRP . 1.5 tt0 -112.93 140.77 47.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.311 -0.868 . . . . 0.0 108.732 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 47' ' ' LEU . 2.2 mt -115.06 -178.91 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.803 -1.186 . . . . 0.0 109.679 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.595 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 10.6 m-90 -141.45 119.39 11.93 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.534 ' CG ' ' HB ' ' A' ' 29' ' ' VAL . 2.5 ptt180 -78.9 128.07 32.84 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.122 -0.986 . . . . 0.0 110.147 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.529 HG13 ' CB ' ' A' ' 44' ' ' CYS . 5.8 mm -96.49 43.89 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.529 ' CG ' ' N ' ' A' ' 25' ' ' ASN . 31.1 tt0 -70.29 168.04 16.75 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.335 0.588 . . . . 0.0 110.108 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.529 ' N ' ' CG ' ' A' ' 24' ' ' GLU . 8.2 p30 47.18 24.6 0.43 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -0.796 . . . . 0.0 109.141 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.497 ' CE ' ' HG2' ' A' ' 73' ' ' GLU . 24.4 mmm 57.75 50.54 10.52 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.413 -0.805 . . . . 0.0 109.491 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.514 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 53.8 mm-40 -148.24 -111.22 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.316 -0.865 . . . . 0.0 109.108 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.57 ' SD ' ' CD2' ' A' ' 80' ' ' TYR . 2.8 ttt 178.88 153.91 0.4 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.787 -1.196 . . . . 0.0 109.861 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -160.26 147.57 12.52 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.595 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 33.4 Cg_endo -74.04 94.73 0.89 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.563 2.175 . . . . 0.0 111.869 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.509 HG22 ' N ' ' A' ' 22' ' ' ARG . 60.0 t -76.58 112.75 23.64 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 36.3 Cg_endo -78.78 -161.8 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.448 2.099 . . . . 0.0 110.601 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.48 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -88.28 -3.72 58.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.315 -0.865 . . . . 0.0 109.054 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -87.52 8.29 25.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 109.74 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.4 m -159.99 21.07 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.157 -0.964 . . . . 0.0 110.076 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.564 ' CD2' ' O ' ' A' ' 36' ' ' TYR . 19.4 p90 -90.0 32.64 0.9 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.015 -1.053 . . . . 0.0 109.334 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.31 -10.07 5.73 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.466 ' CB ' ' HB ' ' A' ' 115' ' ' ILE . 5.5 m-80 -148.02 100.92 3.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.192 -1.181 . . . . 0.0 109.889 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.585 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -115.19 131.57 56.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.305 -0.872 . . . . 0.0 109.06 179.633 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.635 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 6.7 m-30 -39.42 155.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.451 -0.781 . . . . 0.0 109.943 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.557 ' CG ' ' N ' ' A' ' 42' ' ' GLY . 10.4 pt-20 -91.0 -46.32 8.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.474 -0.766 . . . . 0.0 110.161 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.586 ' CA ' ' CB ' ' A' ' 68' ' ' ASN . . . -83.01 67.38 3.76 Favored Glycine 0 N--CA 1.483 1.793 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.057 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.514 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -162.92 -148.11 0.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.916 -1.344 . . . . 0.0 110.299 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.529 ' CB ' HG13 ' A' ' 23' ' ' ILE . 14.2 m -144.28 139.8 28.82 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 30.1 m-85 -137.18 109.64 7.41 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.983 -1.073 . . . . 0.0 109.878 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.521 ' CG2' ' HE2' ' A' ' 28' ' ' MET . 25.0 t -78.5 131.21 34.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.176 -0.953 . . . . 0.0 108.462 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 62' ' ' HIS . 8.3 tt -111.57 163.43 14.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.15 -0.968 . . . . 0.0 109.469 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 20.3 tp -153.65 92.11 1.54 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.978 -1.077 . . . . 0.0 109.263 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.533 ' CB ' HG23 ' A' ' 18' ' ' ILE . 5.3 t -81.26 148.82 29.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.904 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 m -140.23 117.05 10.98 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -112.91 175.44 5.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.514 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.96 157.31 18.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.908 . . . . 0.0 109.429 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.1 p -146.8 -170.39 3.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.449 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.96 10.17 61.12 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 p -133.73 -54.69 0.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -1.111 . . . . 0.0 109.422 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.53 -135.11 1.85 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.56 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 88.2 m-85 -120.24 144.32 47.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -1.1 . . . . 0.0 109.66 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 68.8 m -101.09 106.82 18.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.282 -0.886 . . . . 0.0 108.705 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.57 ' CD2' ' CG2' ' A' ' 91' ' ' VAL . 6.3 m-85 -84.64 156.36 21.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.205 -0.935 . . . . 0.0 110.339 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.476 ' OD1' ' CG2' ' A' ' 93' ' ' VAL . 5.8 m-20 -143.68 102.61 3.95 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.542 ' CG2' ' CG2' ' A' ' 81' ' ' THR . 7.7 mt -92.36 112.3 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.255 -0.903 . . . . 0.0 110.461 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.708 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 15.1 m-70 -105.1 166.98 10.01 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.607 -0.683 . . . . 0.0 109.534 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.583 ' CZ ' ' HA ' ' A' ' 96' ' ' ARG . 43.5 p90 -138.04 106.62 5.87 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.401 -1.32 . . . . 0.0 109.856 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.57 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 4.8 t90 -82.38 131.57 35.22 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -119.28 65.21 0.79 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.357 -0.839 . . . . 0.0 110.753 -178.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 68' ' ' ASN . . . -49.53 91.08 0.01 OUTLIER Glycine 0 N--CA 1.498 2.796 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -37.74 88.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 122.081 0.943 . . . . 0.0 112.414 -177.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.586 ' CB ' ' CA ' ' A' ' 42' ' ' GLY . 2.7 m-80 -162.75 -43.65 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.538 ' HB2' ' CB ' ' A' ' 73' ' ' GLU . 14.1 p -60.32 168.64 1.95 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.632 -0.667 . . . . 0.0 109.458 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.453 ' OG ' ' OE1' ' A' ' 73' ' ' GLU . 1.5 p -73.87 168.89 18.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.939 . . . . 0.0 109.445 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.3 -51.22 63.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.546 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 2.1 p30 -55.3 -39.32 69.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.127 -0.983 . . . . 0.0 109.511 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.538 ' CB ' ' HB2' ' A' ' 69' ' ' SER . 3.0 mp0 -56.5 -38.66 72.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 108.656 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.508 ' HB3' ' CD1' ' A' ' 65' ' ' LEU . 53.6 mt-30 -64.17 -33.52 75.97 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.511 ' O ' HD11 ' A' ' 79' ' ' ILE . . . -83.05 -10.91 82.1 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.73 -44.36 13.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.999 -1.295 . . . . 0.0 108.939 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.45 -45.41 59.69 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.328 -0.858 . . . . 0.0 109.029 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.16 93.29 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.533 ' N ' HD11 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -65.53 -41.35 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.198 -0.939 . . . . 0.0 108.994 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.631 ' CD1' ' CD2' ' A' ' 3' ' ' LEU . 11.3 m-85 -61.45 -29.43 69.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.973 -1.079 . . . . 0.0 108.53 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.542 ' CG2' ' CG2' ' A' ' 61' ' ' ILE . 2.6 m -75.52 -25.5 57.28 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.0 m -81.16 -27.14 35.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.532 -0.73 . . . . 0.0 109.22 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 0.9 OUTLIER -78.04 -36.57 48.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.608 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.504 ' HG3' ' CD1' ' A' ' 61' ' ' ILE . 5.4 ptm -82.23 -8.14 59.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 109.593 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.531 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -75.48 -41.57 55.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.381 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -90.03 -29.25 18.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.313 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.514 ' CB ' HG23 ' A' ' 8' ' ' THR . 0.3 OUTLIER -70.22 -32.26 70.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 109.55 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.518 ' CD2' HD11 ' A' ' 11' ' ' LEU . 14.7 mt -66.19 -22.4 66.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.601 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 90' ' ' SER . . . 121.12 14.61 4.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 89' ' ' GLY . 6.3 t 72.19 3.95 4.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -1.188 . . . . 0.0 109.588 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.57 ' CG2' ' CD2' ' A' ' 59' ' ' TYR . 17.9 m -87.7 -19.73 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.521 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -77.15 170.13 17.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.237 -0.914 . . . . 0.0 109.608 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.487 ' HB ' ' NE2' ' A' ' 95' ' ' HIS . 2.9 t -121.94 -177.36 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.089 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.465 ' HG2' ' OD1' ' A' ' 85' ' ' ASP . 16.0 mt-30 -128.22 140.07 52.11 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.007 -1.058 . . . . 0.0 108.864 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.708 ' CD2' ' CD2' ' A' ' 62' ' ' HIS . 7.0 m-70 -141.63 151.08 42.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.029 -1.044 . . . . 0.0 109.69 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -109.67 140.95 42.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.341 -0.849 . . . . 0.0 110.362 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.491 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 60.5 mm-40 -148.41 163.68 36.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.407 -0.808 . . . . 0.0 109.122 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.544 ' N ' ' HB2' ' A' ' 101' ' ' HIS . 2.7 t -155.38 -175.17 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.098 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.46 ' CG ' ' O ' ' A' ' 99' ' ' GLN . 38.5 tt0 -69.75 -1.99 10.74 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.934 -1.103 . . . . 0.0 110.195 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.53 16.12 2.04 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.544 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 39.4 m-70 -122.45 -16.42 7.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.484 -1.01 . . . . 0.0 109.591 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.57 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.1 24.29 2.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.905 . . . . 0.0 109.363 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 102' ' ' GLU . 3.5 p -48.63 -107.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.417 -0.802 . . . . 0.0 111.459 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 22.4 mt-10 -67.2 -17.45 64.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.916 -1.115 . . . . 0.0 110.909 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.484 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 4.3 m -72.17 -54.95 8.15 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.937 -1.102 . . . . 0.0 109.756 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.542 ' HB2' ' HB2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -63.63 -57.5 9.88 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.27 -30.15 36.89 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.228 -0.92 . . . . 0.0 108.806 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -58.1 -45.0 87.95 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -0.828 . . . . 0.0 108.809 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.473 ' CE2' ' CE1' ' A' ' 62' ' ' HIS . 34.2 m-85 -76.7 -14.16 59.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -0.816 . . . . 0.0 109.41 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.652 ' CE1' ' CD1' ' A' ' 18' ' ' ILE . 2.3 m-85 -117.03 96.99 5.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.408 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 111' ' ' LYS . 23.0 ttpt -83.75 73.1 10.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.135 -0.978 . . . . 0.0 109.415 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 111' ' ' LYS . 4.8 mt-30 -171.33 -80.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.129 -0.982 . . . . 0.0 109.804 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 179.95 131.49 1.65 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.589 HD23 ' CG ' ' A' ' 110' ' ' PHE . 10.5 mt -103.49 135.75 44.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -1.107 . . . . 0.0 110.007 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.562 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 2.6 mt -107.57 165.42 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 108.836 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.562 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -141.45 102.42 4.2 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.367 -0.833 . . . . 0.0 109.147 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.635 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 5.1 mmmt -82.28 -155.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 109.664 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.585 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -92.18 -179.9 5.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.551 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 120' ' ' GLY . . . -113.19 -169.67 17.38 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 119' ' ' GLY . . . 43.23 84.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.536 ' O ' ' CG1' ' A' ' 121' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.147 -1.208 . . . . 0.0 109.222 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.478 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 65.1 t . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 173.87 60.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.191 -0.943 . . . . 0.0 109.484 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.563 ' CD1' ' CD2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -63.48 -11.3 22.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.519 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.538 ' N ' ' CD1' ' A' ' 3' ' ' LEU . 0.3 OUTLIER -74.73 151.18 39.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.962 . . . . 0.0 109.587 -179.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 4' ' ' SER . 17.7 tttm 80.2 -72.57 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.471 -0.768 . . . . 0.0 109.764 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.77 -10.73 29.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 109.757 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.576 HG12 ' CZ2' ' A' ' 21' ' ' TRP . 5.2 t -123.93 -71.23 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.101 -0.999 . . . . 0.0 109.519 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.526 ' HB ' ' CB ' ' A' ' 87' ' ' TYR . 19.2 p -50.23 -21.89 1.53 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.668 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 10' ' ' LYS . . . -42.75 -42.05 4.65 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 12.6 mttt -155.29 -37.96 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.138 -1.213 . . . . 0.0 109.805 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.507 ' CD1' ' CD2' ' A' ' 88' ' ' LEU . 51.0 mt 64.2 -144.84 0.28 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.123 -0.986 . . . . 0.0 109.138 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.505 ' O ' ' CE2' ' A' ' 59' ' ' TYR . 2.3 m-20 -88.21 97.81 11.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.113 -0.992 . . . . 0.0 109.549 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.524 ' O ' ' CG2' ' A' ' 14' ' ' THR . 10.5 mttt -100.83 -4.71 27.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.945 . . . . 0.0 109.641 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 19.9 p -160.15 49.59 0.28 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.94 . . . . 0.0 109.499 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.3 m -151.01 105.41 3.0 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.379 -0.826 . . . . 0.0 109.116 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.35 86.76 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.402 2.068 . . . . 0.0 110.343 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.466 ' O ' HG21 ' A' ' 18' ' ' ILE . . . -170.29 -132.76 1.5 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.498 HD13 ' CE1' ' A' ' 110' ' ' PHE . 18.3 pt -156.81 137.83 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.078 -1.248 . . . . 0.0 110.119 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.58 ' O ' ' CZ3' ' A' ' 21' ' ' TRP . 1.4 tt0 -119.62 113.9 21.4 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 47' ' ' LEU . 3.8 mt -90.03 175.88 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.799 -1.188 . . . . 0.0 109.942 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.6 ' CG ' ' HE2' ' A' ' 28' ' ' MET . 10.7 m-90 -137.04 119.18 15.49 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.585 ' HG3' ' CZ ' ' A' ' 45' ' ' TYR . 8.0 ttp180 -79.15 130.23 35.28 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.14 -0.975 . . . . 0.0 110.921 -177.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.536 HG13 ' CB ' ' A' ' 44' ' ' CYS . 3.3 mm -95.08 37.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.515 ' HG2' ' N ' ' A' ' 25' ' ' ASN . 1.3 tt0 -47.31 149.45 1.04 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.395 0.617 . . . . 0.0 110.703 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.515 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 2.4 p-10 44.33 27.47 0.22 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.445 -0.785 . . . . 0.0 109.072 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.538 ' HE2' ' CB ' ' A' ' 69' ' ' SER . 3.4 mmm 64.1 51.55 2.19 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.464 -0.773 . . . . 0.0 109.322 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.418 ' CD ' HG21 ' A' ' 1' ' ' VAL . 9.7 mt-10 -153.73 122.65 6.41 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.6 ' HE2' ' CG ' ' A' ' 21' ' ' TRP . 2.1 mtp -56.63 145.06 29.74 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.177 -0.952 . . . . 0.0 110.339 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -149.64 149.98 29.71 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 32.3 Cg_endo -72.98 113.86 3.89 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.229 1.953 . . . . 0.0 111.857 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 22' ' ' ARG . 41.4 t -111.3 92.28 15.6 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.5 ' HG2' ' CD ' ' A' ' 34' ' ' LYS . 35.0 Cg_endo -77.12 -156.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.717 2.278 . . . . 0.0 110.202 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.574 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -75.83 -23.53 55.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.094 -1.004 . . . . 0.0 108.945 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.5 ' CD ' ' HG2' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -81.85 8.01 11.36 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.206 -0.934 . . . . 0.0 109.613 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.456 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 2.5 m -128.25 -45.36 1.38 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.745 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -45.05 158.31 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.438 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.466 ' O ' ' HB ' ' A' ' 115' ' ' ILE . . . 112.88 -47.84 1.0 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.43 94.15 4.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -1.209 . . . . 0.0 109.885 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.574 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -113.04 121.03 43.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.302 -0.874 . . . . 0.0 109.797 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.569 ' CG ' ' O ' ' A' ' 118' ' ' GLN . 7.0 m-30 -39.33 131.9 1.53 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 110.607 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.525 ' HG2' ' CB ' ' A' ' 116' ' ' TYR . 2.9 pt-20 -90.66 56.68 3.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.217 -0.927 . . . . 0.0 109.01 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.575 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -176.89 47.92 0.11 Allowed Glycine 0 N--CA 1.484 1.876 0 N-CA-C 108.914 -1.675 . . . . 0.0 108.914 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.468 ' CG ' ' O ' ' A' ' 42' ' ' GLY . 2.4 m-20 -162.16 -129.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.654 -0.909 . . . . 0.0 109.608 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.536 ' CB ' HG13 ' A' ' 23' ' ' ILE . 1.8 m -149.14 144.7 26.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.05 -1.031 . . . . 0.0 108.927 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CZ ' ' HG3' ' A' ' 22' ' ' ARG . 26.0 m-85 -142.65 111.25 6.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.097 -1.002 . . . . 0.0 109.727 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.53 ' CG1' ' OG1' ' A' ' 81' ' ' THR . 11.3 t -79.73 123.03 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.958 -1.089 . . . . 0.0 108.961 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.579 HD11 ' CE1' ' A' ' 106' ' ' PHE . 8.2 tt -112.94 122.24 47.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.956 -1.09 . . . . 0.0 110.061 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.45 HD12 ' HB3' ' A' ' 59' ' ' TYR . 23.2 tp -107.13 109.86 21.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.069 -1.02 . . . . 0.0 109.705 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.472 ' OG ' HG21 ' A' ' 18' ' ' ILE . 3.2 t -98.19 133.9 41.98 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.18 -0.95 . . . . 0.0 109.272 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.2 m -129.21 142.57 50.82 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.507 ' HG2' ' N ' ' A' ' 52' ' ' LYS . 9.1 ttp180 -140.14 157.12 46.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.892 . . . . 0.0 109.534 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.507 ' N ' ' HG2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -74.12 159.92 31.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -154.37 -172.74 4.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 109.463 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.73 -35.97 8.13 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t -82.74 -25.24 33.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -1.146 . . . . 0.0 109.488 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 53' ' ' THR . . . 165.67 -117.61 0.76 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.578 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 2.2 m-30 -115.07 169.08 9.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -1.116 . . . . 0.0 109.579 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -133.87 107.85 8.09 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.531 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 23.2 m-85 -92.55 169.01 10.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.104 -0.997 . . . . 0.0 110.374 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.52 ' HB3' ' NE2' ' A' ' 95' ' ' HIS . 14.2 m120 -158.89 88.25 0.89 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.517 HG23 ' CG2' ' A' ' 81' ' ' THR . 21.0 mt -76.67 137.12 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.203 -0.936 . . . . 0.0 110.264 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.686 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 53.3 m-70 -123.79 159.39 29.62 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 95' ' ' HIS . 37.4 p90 -133.38 98.64 4.29 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.345 -1.342 . . . . 0.0 109.196 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.579 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 5.6 t90 -77.07 132.77 39.07 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.076 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -116.83 65.01 0.72 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.456 -0.778 . . . . 0.0 110.844 -178.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -45.24 91.42 0.01 OUTLIER Glycine 0 N--CA 1.5 2.94 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.611 ' N ' ' O ' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -39.44 91.38 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.928 0.87 . . . . 0.0 113.204 -177.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.575 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 3.1 m-20 -162.66 -44.22 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.538 ' CB ' ' HE2' ' A' ' 26' ' ' MET . 25.2 p -63.93 -153.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.481 -0.762 . . . . 0.0 109.499 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.453 ' OG ' ' OD1' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -123.08 -173.88 2.82 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.302 -0.873 . . . . 0.0 109.428 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -61.01 -32.0 71.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.886 . . . . 0.0 109.604 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.453 ' OD1' ' OG ' ' A' ' 70' ' ' SER . 7.0 p-10 -68.09 -44.09 77.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 0.0 109.556 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.535 ' CG ' ' HB2' ' A' ' 69' ' ' SER . 0.8 OUTLIER -57.98 -36.94 73.34 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.953 -1.092 . . . . 0.0 108.395 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.458 ' HA ' HD12 ' A' ' 65' ' ' LEU . 4.5 tt0 -64.82 -32.55 74.3 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.525 ' O ' ' CG1' ' A' ' 79' ' ' ILE . . . -83.64 -10.92 80.76 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.85 -52.53 5.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.84 -1.388 . . . . 0.0 109.295 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.83 -36.53 70.23 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.183 -0.948 . . . . 0.0 108.807 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.14 -38.52 75.52 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.398 -0.814 . . . . 0.0 109.368 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.543 ' N ' HD11 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -66.89 -45.21 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 109.072 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.563 ' CD2' ' CD1' ' A' ' 3' ' ' LEU . 3.2 m-85 -59.93 -31.71 70.1 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.839 -1.163 . . . . 0.0 108.471 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.53 ' OG1' ' CG1' ' A' ' 46' ' ' VAL . 3.1 m -74.29 -27.04 60.54 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 79' ' ' ILE . 4.5 m -63.88 -50.94 66.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.5 -0.75 . . . . 0.0 109.374 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -64.86 -39.23 93.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.554 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.49 ' CB ' HD12 ' A' ' 61' ' ' ILE . 1.5 mtm -56.79 -28.13 60.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.602 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -81.37 -36.09 30.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.599 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.01 -1.12 51.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.912 . . . . 0.0 109.676 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.526 ' CB ' ' HB ' ' A' ' 8' ' ' THR . 4.1 m-85 -108.93 -29.81 8.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.146 -0.971 . . . . 0.0 109.546 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.507 ' CD2' ' CD1' ' A' ' 11' ' ' LEU . 46.9 mt -71.84 -3.94 25.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.614 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 90' ' ' SER . . . 99.0 21.82 14.78 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 90' ' ' SER . 0.3 OUTLIER 64.73 10.69 6.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -1.119 . . . . 0.0 109.484 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.8 m -86.11 -27.95 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.0 109.406 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -73.19 172.34 11.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.577 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 t -124.73 178.3 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.39 -0.818 . . . . 0.0 109.112 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -124.91 131.7 53.4 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.016 -1.052 . . . . 0.0 109.075 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.686 ' CD2' ' CE1' ' A' ' 62' ' ' HIS . 28.9 m-70 -125.98 152.1 46.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.97 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -109.71 130.53 55.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 110.242 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.492 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 15.8 mp0 -142.12 163.98 31.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 109.333 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.509 ' N ' ' HB2' ' A' ' 101' ' ' HIS . 2.2 t -153.66 -160.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 108.972 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 40.7 tp60 -78.66 4.53 13.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.718 -1.239 . . . . 0.0 109.772 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.19 22.24 0.58 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.509 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 14.9 m-70 -124.68 -17.07 6.04 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.735 -0.862 . . . . 0.0 109.664 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.579 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.09 30.26 1.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.259 -0.901 . . . . 0.0 109.369 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 105' ' ' THR . 89.1 p -57.3 -127.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.066 -1.021 . . . . 0.0 111.189 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 41.0 mt-10 -39.92 -24.62 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.9 -1.125 . . . . 0.0 111.469 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.492 ' N ' ' O ' ' A' ' 103' ' ' SER . 0.2 OUTLIER -71.99 -65.03 0.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.768 -1.208 . . . . 0.0 110.43 -179.104 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CE1' HD11 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -56.4 -50.25 72.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.969 -1.082 . . . . 0.0 108.34 -179.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.465 ' HA ' HD22 ' A' ' 114' ' ' LEU . 1.3 ttp85 -61.41 -29.78 70.15 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.491 -0.755 . . . . 0.0 108.979 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -59.05 -36.08 74.42 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.468 ' HB3' HG23 ' A' ' 18' ' ' ILE . 67.1 m-85 -88.13 -13.06 42.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.549 -0.72 . . . . 0.0 109.089 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.527 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 60.3 m-85 -113.26 96.9 6.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.472 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -74.05 83.02 1.76 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.925 . . . . 0.0 109.54 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.519 ' CB ' ' O ' ' A' ' 111' ' ' LYS . 3.0 tt0 78.48 78.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.397 -0.814 . . . . 0.0 109.715 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.44 ' C ' HD21 ' A' ' 114' ' ' LEU . . . 168.61 70.77 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.573 ' O ' ' CZ ' ' A' ' 116' ' ' TYR . 4.1 mm? -126.37 56.03 1.47 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -1.164 . . . . 0.0 109.841 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 2.3 mt -81.42 165.67 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.052 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.577 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 2.2 m-85 -145.49 107.86 4.41 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.373 -0.829 . . . . 0.0 109.211 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.558 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 26.9 mmtt -79.69 -165.79 0.87 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 108.929 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.569 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 33.3 mm-40 -87.15 158.11 19.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.962 -1.086 . . . . 0.0 109.865 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.541 ' HA2' ' CD2' ' A' ' 40' ' ' TYR . . . -95.34 -165.51 35.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 119' ' ' GLY . . . 43.48 74.32 0.2 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.452 HG11 ' O ' ' A' ' 121' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.246 -1.15 . . . . 0.0 109.751 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 2' ' ' GLU . 9.9 p . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 1' ' ' VAL . 0.0 OUTLIER 79.77 118.21 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.453 -0.779 . . . . 0.0 109.234 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.617 ' CD2' ' CD2' ' A' ' 80' ' ' TYR . 0.5 OUTLIER -90.05 -21.33 22.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.508 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 1.2 p -59.84 -12.67 7.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 110.029 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -109.4 -47.79 3.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.977 -1.077 . . . . 0.0 109.827 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.468 ' O ' HG21 ' A' ' 7' ' ' VAL . 53.2 mmtt -90.32 22.01 3.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 110.094 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.538 ' CG2' ' HB2' ' A' ' 3' ' ' LEU . 10.3 t -145.38 -63.18 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.089 -1.007 . . . . 0.0 109.823 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.553 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 23.1 p -67.81 -12.9 61.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 109.506 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 10' ' ' LYS . . . -74.24 -19.7 79.77 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 1.6 tptm 175.2 55.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.449 -1.03 . . . . 0.0 109.371 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.553 ' CD1' ' HA ' ' A' ' 8' ' ' THR . 0.6 OUTLIER -43.85 -60.29 1.89 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.43 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -161.63 -91.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.43 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER 74.48 125.98 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.502 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 23.7 p 48.05 54.35 10.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.362 -0.836 . . . . 0.0 109.631 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 14' ' ' THR . 4.0 m -168.43 101.85 0.53 Allowed Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.416 -0.803 . . . . 0.0 109.324 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.04 109.47 2.84 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.413 2.075 . . . . 0.0 110.433 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.461 ' O ' HG21 ' A' ' 18' ' ' ILE . . . 178.87 -143.81 5.99 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.551 HD13 ' CE1' ' A' ' 110' ' ' PHE . 14.3 pt -157.44 140.6 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -1.172 . . . . 0.0 109.829 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.557 ' NE2' ' CZ2' ' A' ' 21' ' ' TRP . 2.0 tt0 -122.01 109.19 14.28 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 41.9 mt -85.03 166.73 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.145 -0.972 . . . . 0.0 109.84 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.57 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 6.8 m-90 -130.26 121.95 27.1 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.591 ' HA ' ' CD1' ' A' ' 45' ' ' TYR . 8.7 mtm180 -79.26 132.54 36.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 110.888 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.623 ' CG2' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -116.8 23.11 5.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.662 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.497 ' CG ' ' HB ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -54.92 171.07 0.15 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.848 . . . . 0.0 110.193 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' CG ' ' A' ' 27' ' ' GLU . 0.7 OUTLIER 42.22 26.86 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.536 ' HE2' ' CB ' ' A' ' 70' ' ' SER . 0.0 OUTLIER 59.28 56.69 3.71 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.45 -0.781 . . . . 0.0 110.256 179.336 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.534 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 73.5 mm-40 -146.72 -144.05 0.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.925 -1.109 . . . . 0.0 109.655 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.583 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -156.04 146.44 21.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.009 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -160.37 148.77 13.27 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.086 -1.009 . . . . 0.0 109.604 -179.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.57 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 36.0 Cg_endo -78.53 125.17 6.74 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.548 2.165 . . . . 0.0 111.174 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.539 ' CG2' ' HG3' ' A' ' 22' ' ' ARG . 2.9 t -114.69 94.51 37.38 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.524 ' HD2' ' CB ' ' A' ' 35' ' ' SER . 34.7 Cg_endo -76.49 -159.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.598 2.198 . . . . 0.0 110.765 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.578 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -76.07 -34.5 59.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.368 -0.832 . . . . 0.0 110.551 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.96 32.86 0.73 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.077 -1.015 . . . . 0.0 109.932 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.524 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 74.8 m -139.66 -37.58 0.49 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.077 -1.014 . . . . 0.0 109.749 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 33' ' ' THR . 11.0 p90 -55.79 173.16 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.584 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.59 -94.93 0.66 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -90.61 113.13 25.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.358 -1.083 . . . . 0.0 109.414 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.612 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -140.77 143.46 34.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 109.983 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.586 ' CD1' ' O ' ' A' ' 118' ' ' GLN . 19.0 m-85 -42.34 144.75 0.46 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.884 . . . . 0.0 110.415 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.546 ' O ' ' CH2' ' A' ' 64' ' ' TRP . 2.0 pt-20 -90.85 -46.72 8.04 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.301 -0.874 . . . . 0.0 109.626 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.604 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -81.86 72.48 2.78 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.522 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -161.28 -145.01 0.11 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.152 -1.205 . . . . 0.0 109.837 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.56 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 23.7 m -138.61 162.1 35.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.333 -0.854 . . . . 0.0 108.811 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.612 ' CE2' ' HB2' ' A' ' 39' ' ' PHE . 11.3 m-85 -160.28 105.31 1.49 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.927 -1.108 . . . . 0.0 110.357 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 57.3 t -78.95 115.19 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.91 -1.119 . . . . 0.0 108.342 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.517 ' CD1' HD13 ' A' ' 18' ' ' ILE . 2.1 tt -104.59 116.08 31.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.31 -0.869 . . . . 0.0 110.721 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.522 ' CD2' HD22 ' A' ' 11' ' ' LEU . 19.5 tp -98.68 109.05 21.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.015 -1.053 . . . . 0.0 109.433 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.6 t -99.91 128.86 45.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.172 -0.955 . . . . 0.0 109.631 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.43 ' OG1' ' OD2' ' A' ' 12' ' ' ASP . 1.2 m -113.64 150.46 33.13 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.54 ' CG ' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -135.93 166.28 23.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.885 . . . . 0.0 109.479 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.54 ' N ' ' CG ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -104.86 147.51 27.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.425 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.9 p -142.18 -172.71 3.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.485 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.3 -10.42 71.12 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 56' ' ' GLY . 1.2 p -107.5 -53.52 2.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -1.172 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.425 ' N ' ' OG ' ' A' ' 55' ' ' SER . . . -157.32 -122.72 0.72 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 16.5 m-85 -129.32 156.24 44.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -1.092 . . . . 0.0 109.516 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.1 t -117.07 117.58 30.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.848 . . . . 0.0 108.941 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.526 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 26.2 m-85 -97.59 159.52 14.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.974 . . . . 0.0 110.166 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.549 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 9.3 m-80 -150.06 90.85 1.71 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.536 ' CG2' ' CG2' ' A' ' 81' ' ' THR . 5.9 mt -77.72 135.21 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 110.415 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.642 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 41.7 m-70 -122.0 161.95 22.02 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 53.7 p90 -138.95 96.02 3.05 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 118.4 -1.32 . . . . 0.0 109.387 176.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.567 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 14.8 t90 -69.61 139.9 53.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.554 ' CD1' ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -123.01 61.84 1.01 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.239 -0.913 . . . . 0.0 111.014 -178.253 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -53.07 89.72 0.01 OUTLIER Glycine 0 N--CA 1.5 2.967 0 N-CA-C 107.967 -2.053 . . . . 0.0 107.967 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 65' ' ' LEU . 5.2 ttmm -49.5 91.9 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.604 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 12.6 m120 -161.65 -42.05 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.534 ' OG ' ' CG ' ' A' ' 73' ' ' GLU . 24.4 p -65.57 -145.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.456 -0.777 . . . . 0.0 109.299 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.536 ' CB ' ' HE2' ' A' ' 26' ' ' MET . 3.9 p -116.11 170.74 8.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.072 -1.017 . . . . 0.0 109.847 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.479 ' HA ' ' HG2' ' A' ' 74' ' ' GLN . 7.3 tt0 -70.51 -11.58 61.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.412 -0.805 . . . . 0.0 110.403 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -82.34 -51.45 7.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.744 -1.223 . . . . 0.0 109.634 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' CG ' ' OG ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -63.69 -30.08 71.23 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.065 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.554 ' HB2' ' CD1' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -70.23 -33.32 71.51 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.187 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.526 ' N ' ' HG3' ' A' ' 74' ' ' GLN . . . -79.65 -17.19 76.03 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.56 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -82.23 -36.32 27.3 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.385 -1.068 . . . . 0.0 108.706 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.522 ' CB ' HD11 ' A' ' 23' ' ' ILE . . . -69.53 -51.95 30.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.364 -0.835 . . . . 0.0 108.989 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.35 79.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.296 -0.877 . . . . 0.0 109.224 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.463 HD11 ' O ' ' A' ' 75' ' ' GLY . 74.2 mt -56.58 -42.49 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.264 -0.898 . . . . 0.0 109.309 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.617 ' CD2' ' CD2' ' A' ' 3' ' ' LEU . 3.5 m-85 -63.57 -29.68 70.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.227 -0.921 . . . . 0.0 108.661 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.536 ' CG2' ' CG2' ' A' ' 61' ' ' ILE . 15.9 m -71.49 -23.58 61.83 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 m -86.87 -29.04 22.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.567 -0.708 . . . . 0.0 109.229 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.494 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -73.21 -39.87 65.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.297 -0.877 . . . . 0.0 109.493 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.565 ' HE3' ' CZ3' ' A' ' 21' ' ' TRP . 4.8 ptm -77.06 -27.74 54.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.453 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.454 ' HA ' HD12 ' A' ' 61' ' ' ILE . 7.8 t70 -66.72 -35.17 79.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.195 -0.94 . . . . 0.0 109.372 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -86.65 -23.33 25.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 0.0 109.393 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.494 ' CD1' ' O ' ' A' ' 83' ' ' GLN . 5.0 m-85 -87.3 -12.96 44.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -0.967 . . . . 0.0 109.448 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.1 mt -89.66 10.72 22.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.566 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 97.25 1.54 59.35 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 1.8 m 75.78 3.06 3.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -1.186 . . . . 0.0 109.629 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.2 m -83.94 -16.5 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.397 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.526 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -70.57 172.75 8.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.553 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.463 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 3.5 t -124.97 176.91 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.315 -0.865 . . . . 0.0 109.267 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.18 132.47 53.03 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.082 -1.011 . . . . 0.0 109.161 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.642 ' CD2' ' CE1' ' A' ' 62' ' ' HIS . 19.3 m-70 -130.25 153.49 48.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.652 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.533 ' HG3' ' CZ ' ' A' ' 63' ' ' TYR . 23.9 ttp180 -118.06 129.67 55.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 110.153 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.503 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 32.8 mp0 -134.01 164.45 27.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.503 ' CG2' ' C ' ' A' ' 97' ' ' GLU . 2.0 t -157.49 -172.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.282 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.78 78.46 2.72 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 134.7 -16.71 4.26 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.476 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 37.9 m-70 -99.94 -16.05 18.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.704 -0.88 . . . . 0.0 108.822 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.571 ' OE1' ' CG ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -90.12 22.76 3.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.549 -0.719 . . . . 0.0 109.366 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 105' ' ' THR . 90.9 p -57.99 -130.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.511 -0.743 . . . . 0.0 110.993 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 49.0 mt-10 -39.82 -24.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.07 -1.019 . . . . 0.0 111.271 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.491 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 7.6 m -70.62 -60.92 1.98 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.853 -1.154 . . . . 0.0 110.354 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.571 ' CG ' ' OE1' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -61.7 -50.2 73.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.805 -1.184 . . . . 0.0 108.582 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -61.95 -26.74 68.38 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.36 -0.837 . . . . 0.0 108.828 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -57.67 -51.74 68.29 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -70.98 -17.1 62.67 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.583 ' CG ' HD23 ' A' ' 114' ' ' LEU . 24.6 m-85 -108.17 93.88 4.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.467 -0.77 . . . . 0.0 109.538 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.499 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -86.17 61.81 7.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.971 . . . . 0.0 109.361 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 111' ' ' LYS . 11.8 mt-30 -163.6 -78.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.775 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 179.82 130.88 1.54 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.583 HD23 ' CG ' ' A' ' 110' ' ' PHE . 44.8 mt -96.56 107.75 20.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 109.977 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.511 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 1.3 mm -79.84 164.9 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.521 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 71.1 m-85 -137.35 133.12 34.51 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.039 -1.038 . . . . 0.0 110.055 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 2.7 mmpt? -117.28 -171.81 2.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.099 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.586 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 8.1 mm100 -90.7 128.64 36.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.073 -1.017 . . . . 0.0 110.145 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.574 ' HA2' ' CG ' ' A' ' 40' ' ' TYR . . . -58.62 -154.96 0.01 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 55.54 79.58 0.09 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.497 ' HB ' ' CG ' ' A' ' 24' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.324 -1.103 . . . . 0.0 109.52 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.523 ' O ' ' CG ' ' A' ' 2' ' ' GLU . 2.1 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 1' ' ' VAL . 9.8 pt-20 40.25 50.1 2.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.571 -0.705 . . . . 0.0 109.758 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.598 ' CD2' ' CD2' ' A' ' 80' ' ' TYR . 1.4 pp -43.07 -28.3 0.27 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 109.443 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.506 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 6.9 p -57.03 143.06 39.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 109.947 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 4' ' ' SER . 4.1 ttmt 73.41 -79.5 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.508 -0.745 . . . . 0.0 109.69 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 5' ' ' LYS . 7.8 mttm -45.4 -27.04 0.63 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.931 -1.105 . . . . 0.0 108.952 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.579 HG11 ' CZ2' ' A' ' 21' ' ' TRP . 41.5 t -106.86 -33.97 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.529 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 8.0 p -87.28 -153.19 0.21 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.392 -0.817 . . . . 0.0 109.124 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.41 ' O ' ' HD2' ' A' ' 10' ' ' LYS . . . 84.15 -44.83 3.39 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -167.67 61.18 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.219 -1.166 . . . . 0.0 109.125 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.529 ' CD1' ' HA ' ' A' ' 8' ' ' THR . 3.0 mp -41.81 -71.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.416 -0.802 . . . . 0.0 109.661 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.503 ' HB3' ' CB ' ' A' ' 50' ' ' THR . 14.4 m-20 -145.88 75.9 1.44 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.469 ' O ' ' OG1' ' A' ' 14' ' ' THR . 17.0 mmtt -91.47 125.51 36.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.515 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 23.4 p 48.6 57.3 6.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.389 -0.82 . . . . 0.0 109.535 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.3 m -162.64 104.76 1.06 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.46 -0.775 . . . . 0.0 109.243 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.94 130.76 11.59 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.312 2.008 . . . . 0.0 110.377 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.1 172.98 12.8 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.598 HG13 ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -125.91 145.04 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.853 -1.381 . . . . 0.0 110.488 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -112.42 167.17 10.66 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 26.1 mt -132.25 161.13 41.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.333 -1.479 . . . . 0.0 110.242 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.579 ' CZ2' HG11 ' A' ' 7' ' ' VAL . 7.7 m-90 -120.87 122.77 40.96 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.588 ' CG ' ' CG1' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -79.84 130.26 35.16 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.922 -1.111 . . . . 0.0 110.755 -178.463 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.525 HD13 ' CE ' ' A' ' 28' ' ' MET . 7.9 mm -94.2 25.48 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.518 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 19.6 pt-20 -57.19 166.81 1.02 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.709 -0.619 . . . . 0.0 109.861 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.519 ' OD1' ' CB ' ' A' ' 27' ' ' GLU . 14.0 p30 42.66 27.67 0.1 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.466 ' HA ' ' OE2' ' A' ' 73' ' ' GLU . 3.8 mmt 53.64 55.23 8.81 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.499 -0.751 . . . . 0.0 109.622 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.519 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -160.33 144.88 14.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 0.0 109.445 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.545 ' CB ' ' CD2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -76.54 136.36 39.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.051 -1.031 . . . . 0.0 109.788 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.588 ' CG1' ' CG ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -147.12 151.76 41.77 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.532 ' HD2' HG12 ' A' ' 29' ' ' VAL . 31.9 Cg_endo -72.99 134.27 21.21 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.362 2.041 . . . . 0.0 111.747 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.545 ' CG2' ' O ' ' A' ' 20' ' ' ILE . 2.5 t -120.43 104.9 42.32 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.97 -157.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.557 2.171 . . . . 0.0 110.551 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.561 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -78.55 -25.97 45.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.171 -0.956 . . . . 0.0 109.101 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.36 32.47 0.77 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.275 -0.891 . . . . 0.0 109.854 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.48 ' HB2' ' CG1' ' A' ' 31' ' ' VAL . 17.3 m -155.07 -35.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 0.0 110.011 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.579 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 11.9 p90 -60.06 -41.22 91.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.011 -1.056 . . . . 0.0 109.768 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.51 ' N ' ' CG ' ' A' ' 36' ' ' TYR . . . -51.7 -24.29 12.24 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.546 ' HA ' HG21 ' A' ' 115' ' ' ILE . 0.9 OUTLIER -131.87 129.85 40.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.088 -1.242 . . . . 0.0 110.158 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -148.56 128.48 13.5 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.291 -0.881 . . . . 0.0 109.671 179.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.604 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 8.5 m-30 -47.55 140.1 6.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.489 -0.757 . . . . 0.0 110.6 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 1.6 pt-20 -91.3 29.12 1.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -0.864 . . . . 0.0 109.588 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.587 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -146.21 54.62 0.54 Allowed Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.467 ' CG ' ' O ' ' A' ' 42' ' ' GLY . 1.4 m-20 -162.94 -139.47 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.502 -0.999 . . . . 0.0 109.754 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.583 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 53.7 m -147.44 158.83 44.14 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.583 ' CD1' ' O ' ' A' ' 44' ' ' CYS . 31.4 m-85 -149.48 169.5 20.76 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.075 -1.016 . . . . 0.0 108.982 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 44.3 t -132.25 113.08 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.598 ' CD1' HG13 ' A' ' 18' ' ' ILE . 3.8 tt -103.65 106.37 16.86 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.861 -1.149 . . . . 0.0 110.981 -178.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.523 HD23 ' CD2' ' A' ' 11' ' ' LEU . 19.2 tp -94.37 124.92 38.68 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.535 ' OG ' ' CG2' ' A' ' 18' ' ' ILE . 8.5 t -115.18 136.22 53.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.096 -1.003 . . . . 0.0 109.788 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.514 ' OG1' ' CD1' ' A' ' 59' ' ' TYR . 1.2 m -130.56 124.26 31.41 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.83 137.59 52.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.525 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.443 ' HA ' ' CD1' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -54.91 163.85 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.893 . . . . 0.0 109.437 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.4 -172.87 2.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.445 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.79 -29.16 39.75 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.68 -17.7 43.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -1.114 . . . . 0.0 109.42 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.8 -69.06 0.45 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.578 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 14.5 m-85 -160.09 157.16 28.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -1.139 . . . . 0.0 109.528 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.66 112.21 15.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 109.114 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.528 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 6.6 m-30 -91.93 153.93 19.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.245 -0.909 . . . . 0.0 109.929 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.504 ' ND2' ' CE1' ' A' ' 95' ' ' HIS . 1.9 m-20 -147.7 95.25 2.48 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.514 ' CG2' HG21 ' A' ' 81' ' ' THR . 15.3 mt -83.39 130.36 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.172 -0.955 . . . . 0.0 110.519 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.595 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 28.3 m-70 -115.39 164.17 14.65 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.603 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 48.1 p90 -137.87 96.78 3.28 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.611 -1.236 . . . . 0.0 109.792 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.576 ' CE2' ' OE1' ' A' ' 102' ' ' GLU . 6.7 t90 -72.62 141.41 48.34 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -125.57 65.3 1.17 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.069 -1.019 . . . . 0.0 110.865 -178.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -49.49 90.46 0.01 OUTLIER Glycine 0 N--CA 1.499 2.834 0 N-CA-C 108.414 -1.874 . . . . 0.0 108.414 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -39.15 91.48 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.927 0.87 . . . . 0.0 112.683 -177.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.587 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 1.2 m120 -162.65 -42.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.488 ' HB2' ' CB ' ' A' ' 73' ' ' GLU . 95.9 p -63.9 -151.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.582 -0.699 . . . . 0.0 109.343 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.432 ' OG ' ' OD1' ' A' ' 72' ' ' ASP . 80.1 p -121.2 176.57 5.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 109.62 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.408 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 12.0 tt0 -55.12 -41.39 71.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.549 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.432 ' OD1' ' OG ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -60.29 -43.24 96.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.159 -0.963 . . . . 0.0 109.551 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.488 ' CB ' ' HB2' ' A' ' 69' ' ' SER . 2.7 tp10 -56.33 -36.6 68.92 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.022 -1.049 . . . . 0.0 108.353 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.408 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 6.6 tt0 -62.7 -36.16 82.06 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.533 ' O ' ' CD1' ' A' ' 79' ' ' ILE . . . -80.06 -13.82 81.51 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.577 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -78.72 -54.02 6.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.234 -1.157 . . . . 0.0 109.156 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.45 -26.43 61.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.398 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.3 -48.38 20.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.25 -0.906 . . . . 0.0 109.564 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 75' ' ' GLY . 1.5 mp -65.54 -39.2 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -0.901 . . . . 0.0 108.994 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.598 ' CD2' ' CD2' ' A' ' 3' ' ' LEU . 3.8 m-85 -61.45 -39.46 90.92 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.053 -1.029 . . . . 0.0 108.331 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.514 HG21 ' CG2' ' A' ' 61' ' ' ILE . 3.0 m -67.12 -24.78 65.96 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.4 m -76.82 -37.02 56.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.454 -0.779 . . . . 0.0 109.379 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 24.2 mm100 -66.76 -36.66 82.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 109.585 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.51 ' SD ' ' CG1' ' A' ' 7' ' ' VAL . 73.3 mtm -71.72 -34.86 69.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.953 . . . . 0.0 109.602 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.55 -58.64 7.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 109.738 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -64.95 -33.33 75.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.672 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 3.1 m-85 -73.2 -10.49 59.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -1.0 . . . . 0.0 109.692 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.528 ' CD2' HD21 ' A' ' 11' ' ' LEU . 20.1 mt -89.43 -32.19 17.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 109.545 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 121.93 15.55 4.3 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 0.9 OUTLIER 75.8 -0.29 3.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -1.149 . . . . 0.0 109.683 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.458 HG21 ' CD2' ' A' ' 59' ' ' TYR . 15.6 m -83.42 -9.47 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.411 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -90.81 176.72 6.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 0.0 109.548 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.7 t -133.47 177.45 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.365 -0.835 . . . . 0.0 109.156 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -125.71 135.18 51.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.986 -1.071 . . . . 0.0 108.972 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.595 ' CD2' ' CD2' ' A' ' 62' ' ' HIS . 12.6 m-70 -132.96 149.0 52.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.128 -0.982 . . . . 0.0 109.379 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.586 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -110.77 136.94 49.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 110.384 -179.378 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.515 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 49.8 mm-40 -142.23 164.41 30.23 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.436 -0.79 . . . . 0.0 108.93 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.515 ' CG2' ' C ' ' A' ' 97' ' ' GLU . 1.8 t -157.78 -165.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.132 -0.98 . . . . 0.0 109.02 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.36 75.96 4.87 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.94 -12.17 4.78 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.483 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 10.8 m-70 -98.25 -13.21 20.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.667 -0.902 . . . . 0.0 109.107 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.578 ' OE1' ' CD2' ' A' ' 106' ' ' PHE . 2.0 pt-20 -90.05 30.17 1.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.418 -0.801 . . . . 0.0 109.031 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 102' ' ' GLU . 63.5 p -52.45 -141.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.751 0.786 . . . . 0.0 112.126 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -38.99 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.915 -1.116 . . . . 0.0 111.057 -178.435 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 103' ' ' SER . 0.8 OUTLIER -67.02 -57.47 6.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.811 -1.181 . . . . 0.0 110.138 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.582 ' CE1' HD11 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -66.64 -44.33 82.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.959 -1.088 . . . . 0.0 108.309 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.486 ' HA ' HD22 ' A' ' 114' ' ' LEU . 0.7 OUTLIER -66.82 -17.54 64.93 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -71.02 -45.4 63.99 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.471 ' CD2' HD23 ' A' ' 47' ' ' LEU . 18.3 m-85 -76.37 -17.88 59.16 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.462 -0.774 . . . . 0.0 109.466 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.589 ' CZ ' ' CD1' ' A' ' 47' ' ' LEU . 6.9 m-30 -112.07 96.5 6.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.115 -0.991 . . . . 0.0 109.316 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -67.78 86.28 0.22 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.48 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 111' ' ' LYS . 7.3 mm100 72.65 74.82 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.867 . . . . 0.0 109.586 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.463 ' C ' ' CD2' ' A' ' 114' ' ' LEU . . . -178.73 62.87 0.08 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.543 ' O ' ' CZ ' ' A' ' 116' ' ' TYR . 3.8 mm? -120.9 63.01 0.87 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -1.14 . . . . 0.0 109.336 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.546 HG21 ' HA ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -85.85 160.96 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.104 -0.998 . . . . 0.0 109.351 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.543 ' CZ ' ' O ' ' A' ' 114' ' ' LEU . 2.0 m-85 -139.75 165.0 28.46 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.604 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -146.98 -156.29 0.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.591 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -91.48 169.41 10.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.968 . . . . 0.0 109.819 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 120' ' ' GLY . . . -99.13 -169.86 30.75 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 47.37 95.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.514 ' CG2' ' HB2' ' A' ' 24' ' ' GLU . 1.3 t . . . . . 0 C--N 1.305 -1.347 0 O-C-N 121.205 -1.173 . . . . 0.0 109.297 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.435 ' O ' HG22 ' A' ' 7' ' ' VAL . 5.4 pt-20 175.54 94.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.43 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.559 HD13 ' CD2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -74.19 3.32 7.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.216 -0.927 . . . . 0.0 110.484 -179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.55 ' N ' HD11 ' A' ' 3' ' ' LEU . 1.7 p -92.74 150.9 20.36 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.811 -1.18 . . . . 0.0 110.34 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.495 ' N ' ' OG1' ' A' ' 8' ' ' THR . 12.0 ttmt 47.19 -86.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.429 0.633 . . . . 0.0 110.917 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 4' ' ' SER . 5.8 mmtt -40.54 -27.51 0.05 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.492 -0.755 . . . . 0.0 110.227 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.537 ' CG2' ' HA ' ' A' ' 3' ' ' LEU . 70.4 t -109.16 -31.85 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.097 -1.002 . . . . 0.0 109.607 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.528 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 18.2 p -72.22 -3.52 23.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.883 . . . . 0.0 109.473 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 10' ' ' LYS . . . -70.45 85.03 0.34 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 9' ' ' GLY . 5.3 mtmm 80.65 74.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.677 -0.896 . . . . 0.0 109.601 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.528 ' CD1' ' HA ' ' A' ' 8' ' ' THR . 4.7 mt -89.35 32.65 0.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 0.0 109.124 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER 78.31 61.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.438 -0.789 . . . . 0.0 109.357 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.443 ' O ' ' CG2' ' A' ' 14' ' ' THR . 4.2 mttm -81.6 -10.39 59.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 109.524 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.57 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 27.0 p -157.36 67.45 0.52 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.59 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.404 ' O ' ' OD2' ' A' ' 12' ' ' ASP . 99.2 m -161.9 118.5 1.32 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.384 -0.822 . . . . 0.0 109.169 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.84 87.84 1.44 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.255 1.97 . . . . 0.0 110.206 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.463 ' O ' HG21 ' A' ' 18' ' ' ILE . . . -170.48 -145.08 4.58 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.518 HD13 ' CD1' ' A' ' 47' ' ' LEU . 14.2 pt -157.24 142.21 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.013 -1.287 . . . . 0.0 110.202 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.61 ' NE2' ' CH2' ' A' ' 21' ' ' TRP . 0.4 OUTLIER -121.78 117.25 26.12 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.485 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 1.6 mt -90.88 178.16 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.659 -1.276 . . . . 0.0 110.733 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.629 ' CD1' ' CE ' ' A' ' 28' ' ' MET . 9.5 m-90 -137.38 121.18 17.5 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.517 ' N ' HG22 ' A' ' 31' ' ' VAL . 3.7 ptp180 -83.75 128.68 34.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.097 . . . . 0.0 111.908 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' A' ' 44' ' ' CYS . 1.8 mm -111.45 50.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.607 ' HB2' ' CE2' ' A' ' 40' ' ' TYR . 4.7 pt-20 -92.78 -39.06 11.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.372 -0.83 . . . . 0.0 110.295 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.529 ' OD1' ' CG ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -88.35 43.77 1.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 108.517 179.32 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.544 ' CE ' ' CG ' ' A' ' 73' ' ' GLU . 0.9 OUTLIER 50.22 24.48 1.48 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.529 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 3.6 pt-20 -151.94 153.74 34.7 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.629 ' CE ' ' CD1' ' A' ' 21' ' ' TRP . 15.5 ptm -97.41 133.69 41.67 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.744 -1.222 . . . . 0.0 110.746 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -120.73 149.33 50.28 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.573 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 32.0 Cg_endo -71.94 87.77 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.272 1.981 . . . . 0.0 112.217 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 22' ' ' ARG . 8.6 t -72.99 112.65 16.26 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.537 -0.727 . . . . 0.0 109.473 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 35.9 Cg_endo -78.41 -159.31 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.396 2.064 . . . . 0.0 110.149 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.576 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -88.14 -21.37 24.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 108.909 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -78.91 4.43 14.18 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.291 -0.881 . . . . 0.0 109.661 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 36' ' ' TYR . 38.7 m -128.18 -37.01 1.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.953 . . . . 0.0 109.787 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -42.81 161.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -0.894 . . . . 0.0 109.718 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.535 ' O ' ' CE1' ' A' ' 39' ' ' PHE . . . 110.82 -62.19 0.29 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.552 ' ND2' ' N ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -103.75 106.97 17.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -1.152 . . . . 0.0 109.264 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.562 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -130.93 132.47 45.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.124 -0.985 . . . . 0.0 109.989 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.607 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 9.7 m-30 -40.13 131.2 2.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.591 -0.693 . . . . 0.0 111.445 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 41' ' ' GLU . 0.8 OUTLIER -90.86 112.09 23.78 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.594 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . 115.22 45.57 0.62 Allowed Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -155.78 -134.29 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.536 -0.979 . . . . 0.0 108.678 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.528 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 60.8 m -146.18 137.27 24.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.865 -1.147 . . . . 0.0 109.437 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.562 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 26.5 m-85 -140.49 108.13 5.62 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.261 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 8.2 t -78.86 126.73 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 108.551 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.518 ' CD1' HD13 ' A' ' 18' ' ' ILE . 7.4 tt -116.65 117.96 31.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.077 -1.015 . . . . 0.0 110.112 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 22.2 tp -100.44 113.82 26.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.935 . . . . 0.0 109.333 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 t -102.4 130.73 49.25 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.225 -0.922 . . . . 0.0 109.538 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 m -121.2 142.82 49.53 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.09 -173.28 3.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.46 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.498 ' O ' ' CG2' ' A' ' 53' ' ' THR . 1.0 OUTLIER -109.96 168.87 9.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.487 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 52' ' ' LYS . 5.4 p -162.72 -170.9 2.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.06 -17.85 66.34 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.1 m -102.39 -43.74 5.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -1.153 . . . . 0.0 109.478 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.455 ' O ' ' OG1' ' A' ' 53' ' ' THR . . . -175.36 -128.34 1.1 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.57 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 42.1 m-85 -111.23 150.66 29.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -1.125 . . . . 0.0 109.516 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.419 ' OG ' HG22 ' A' ' 53' ' ' THR . 0.4 OUTLIER -111.55 114.33 27.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.0 109.001 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.512 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 12.7 m-85 -91.09 155.63 18.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.164 -0.96 . . . . 0.0 109.841 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.59 ' ND2' ' CE1' ' A' ' 95' ' ' HIS . 1.8 m-20 -147.25 92.64 2.13 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.532 ' CG2' HG21 ' A' ' 81' ' ' THR . 21.5 mt -77.64 134.38 28.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 110.374 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.616 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 42.9 m-70 -120.82 162.53 19.64 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 95' ' ' HIS . 45.9 p90 -137.05 97.69 3.57 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 118.605 -1.238 . . . . 0.0 109.298 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.577 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 7.7 t90 -74.33 137.23 42.7 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -126.53 64.62 1.26 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -0.885 . . . . 0.0 111.095 -178.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.459 ' O ' ' HA2' ' A' ' 42' ' ' GLY . . . -49.48 97.38 0.01 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 107.173 -2.371 . . . . 0.0 107.173 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 65' ' ' LEU . 2.2 tptt -55.27 89.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -176.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.594 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 12.0 m120 -160.98 -37.99 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.8 p -67.43 -146.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 109.432 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.459 ' HB2' ' OD2' ' A' ' 72' ' ' ASP . 3.0 p -114.27 158.67 21.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 109.891 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -50.99 -34.89 31.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.459 ' OD2' ' HB2' ' A' ' 70' ' ' SER . 1.6 p30 -58.18 -46.13 86.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.147 -0.971 . . . . 0.0 109.077 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.544 ' CG ' ' CE ' ' A' ' 26' ' ' MET . 59.7 mm-40 -57.09 -36.17 70.29 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.53 ' CG ' HD12 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -63.03 -35.92 81.85 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.531 ' O ' ' CG1' ' A' ' 79' ' ' ILE . . . -81.79 -12.08 81.91 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.19 -54.14 6.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.15 -1.206 . . . . 0.0 109.286 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.465 ' HB3' HD13 ' A' ' 23' ' ' ILE . . . -73.09 -34.02 65.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -0.905 . . . . 0.0 109.376 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.62 -41.76 65.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 109.776 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.531 ' CG1' ' O ' ' A' ' 75' ' ' GLY . 73.0 mt -69.24 -44.87 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.054 -1.029 . . . . 0.0 109.886 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.559 ' CD2' HD13 ' A' ' 3' ' ' LEU . 2.9 m-85 -68.38 -29.5 68.21 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.532 HG21 ' CG2' ' A' ' 61' ' ' ILE . 13.8 m -69.67 -24.17 63.57 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 79' ' ' ILE . 2.1 m -72.62 -49.01 34.86 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 9.3 mt-30 -59.28 -43.38 92.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.368 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.437 ' SD ' ' CD2' ' A' ' 11' ' ' LEU . 0.9 OUTLIER -55.06 -37.9 67.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.593 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.98 -41.59 99.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.12 4.58 49.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.196 -0.94 . . . . 0.0 109.704 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.504 ' CD1' HG23 ' A' ' 8' ' ' THR . 0.6 OUTLIER -107.97 -13.98 14.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 0.0 109.581 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.505 HD22 ' CB ' ' A' ' 11' ' ' LEU . 20.5 mt -87.13 -66.54 0.9 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 109.589 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.39 37.27 0.03 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.4 m 49.58 22.42 0.76 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -1.15 . . . . 0.0 109.552 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.475 HG22 ' CE1' ' A' ' 59' ' ' TYR . 31.1 m -110.86 -25.96 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.198 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.512 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -65.46 172.42 3.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 109.515 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.46 ' CG2' ' OD1' ' A' ' 60' ' ' ASN . 3.4 t -126.53 177.76 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.347 -0.846 . . . . 0.0 109.318 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.33 131.77 52.96 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.067 -1.021 . . . . 0.0 109.036 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.616 ' CD2' ' CE1' ' A' ' 62' ' ' HIS . 22.1 m-70 -128.52 152.68 48.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.938 . . . . 0.0 109.522 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.578 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 11.7 ttt-85 -114.62 133.23 56.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.365 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.501 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 50.2 mt-10 -140.33 165.11 28.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.108 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.501 ' CG2' ' C ' ' A' ' 97' ' ' GLU . 1.7 t -155.42 -161.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.085 -1.009 . . . . 0.0 109.319 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.497 ' OE1' ' N ' ' A' ' 67' ' ' LYS . 8.9 pt20 -82.09 72.78 9.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.086 -1.009 . . . . 0.0 108.552 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 137.07 -19.6 3.45 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.468 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 19.0 m-70 -87.19 -21.96 25.57 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.702 -0.881 . . . . 0.0 108.789 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.577 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.27 22.4 3.35 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.742 0.782 . . . . 0.0 109.124 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.9 p -57.51 -99.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.283 -0.886 . . . . 0.0 111.336 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 19.1 pt-20 -62.97 -18.32 63.09 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.092 -1.005 . . . . 0.0 111.103 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.497 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 1.6 m -79.63 -61.48 1.98 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.805 -1.185 . . . . 0.0 110.166 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.555 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -58.68 -56.45 22.03 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.954 -1.091 . . . . 0.0 108.173 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -57.2 -31.33 65.35 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.455 -0.778 . . . . 0.0 109.18 179.18 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -51.79 -54.15 31.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.022 -1.049 . . . . 0.0 108.249 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.437 ' CD2' HD23 ' A' ' 47' ' ' LEU . 19.5 m-85 -64.88 -23.95 67.39 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.57 ' CD2' HD23 ' A' ' 114' ' ' LEU . 9.2 m-85 -102.89 92.53 4.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.518 -0.739 . . . . 0.0 109.312 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 112' ' ' GLN . 28.9 mtmm -82.23 89.69 6.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.522 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER 168.58 -74.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 108.761 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 114' ' ' LEU . . . -159.78 -142.12 3.31 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.57 HD23 ' CD2' ' A' ' 110' ' ' PHE . 0.5 OUTLIER 174.94 108.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.504 -0.998 . . . . 0.0 108.921 179.433 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.574 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 5.0 mt -93.69 165.04 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 109.374 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.574 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 4.1 m-85 -142.05 113.13 7.5 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.526 ' HD2' ' N ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -79.39 -169.24 1.81 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.294 -0.879 . . . . 0.0 109.662 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.583 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 35.5 tp60 -92.64 148.4 22.1 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.751 -1.218 . . . . 0.0 110.73 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.588 ' HA2' ' CD2' ' A' ' 40' ' ' TYR . . . -66.38 -173.73 5.42 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 59.32 117.35 0.01 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.528 HG23 ' CB ' ' A' ' 25' ' ' ASN . 1.5 t . . . . . 0 C--N 1.303 -1.422 0 O-C-N 121.181 -1.187 . . . . 0.0 109.049 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.522 ' CG2' ' HG2' ' A' ' 27' ' ' GLU . 16.5 t . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 1' ' ' VAL . 7.5 pt-20 39.15 83.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.646 -0.658 . . . . 0.0 109.959 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.621 ' CD2' ' CG ' ' A' ' 80' ' ' TYR . 2.4 pt? -85.23 14.28 5.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.456 ' HA ' HG22 ' A' ' 8' ' ' THR . 1.2 p -90.83 5.21 49.34 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.675 -1.266 . . . . 0.0 110.088 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -134.26 -48.12 0.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.061 -1.024 . . . . 0.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 8.9 mmtt -89.69 35.48 0.83 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.905 . . . . 0.0 109.024 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' A' ' 3' ' ' LEU . 60.6 t -159.3 -49.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.39 -0.819 . . . . 0.0 109.751 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.574 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 44.5 p -61.89 -31.3 71.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.325 -0.86 . . . . 0.0 110.137 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' A' ' 10' ' ' LYS . . . -45.03 -26.62 1.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.489 ' CG ' ' HE3' ' A' ' 13' ' ' LYS . 0.3 OUTLIER 175.87 70.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.505 -0.997 . . . . 0.0 108.622 179.611 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.574 ' CD2' ' HA ' ' A' ' 8' ' ' THR . 0.7 OUTLIER -86.92 19.81 2.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.335 -0.853 . . . . 0.0 110.206 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 11' ' ' LEU . 3.8 p30 157.7 106.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.621 -0.675 . . . . 0.0 109.287 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HE3' ' CG ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -157.94 123.18 4.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 109.644 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.58 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 22.1 p 48.34 56.5 7.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.0 109.628 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.5 m -166.41 106.66 0.68 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.392 -0.817 . . . . 0.0 109.27 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.96 128.07 9.75 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.347 2.032 . . . . 0.0 110.263 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 144.73 167.91 12.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.577 HG13 ' CD2' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -123.64 143.11 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.075 -1.25 . . . . 0.0 109.764 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.463 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 1.7 pm0 -120.15 -170.39 1.96 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 47' ' ' LEU . 2.0 mt -147.37 178.65 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.822 -1.174 . . . . 0.0 110.156 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.59 ' HA ' ' O ' ' A' ' 29' ' ' VAL . 7.1 m-90 -134.67 122.24 21.96 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.514 ' NE ' HG13 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -82.6 130.02 35.04 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.118 -0.989 . . . . 0.0 112.293 -176.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.639 ' CG2' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -121.18 24.68 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 177.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.527 ' HB2' ' CG2' ' A' ' 121' ' ' VAL . 10.6 pt-20 -63.42 -49.57 73.21 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.223 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.405 ' N ' ' CG ' ' A' ' 24' ' ' GLU . 21.3 p-10 -85.33 42.86 0.97 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.118 -0.989 . . . . 0.0 108.336 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.487 ' CE ' ' CD ' ' A' ' 73' ' ' GLU . 79.4 mmm 48.42 34.63 4.9 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.522 ' HG2' ' CG2' ' A' ' 1' ' ' VAL . 3.2 tt0 -151.57 131.37 13.24 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.584 ' CE ' ' CB ' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -81.42 139.17 35.41 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.089 -1.007 . . . . 0.0 110.237 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -144.0 147.67 38.94 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 32.0 Cg_endo -72.29 88.32 0.86 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.292 1.995 . . . . 0.0 111.618 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 22' ' ' ARG . 20.7 t -66.91 111.97 8.45 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 36.2 Cg_endo -78.89 -159.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.408 2.072 . . . . 0.0 110.414 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.459 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -87.55 -12.67 45.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.876 . . . . 0.0 109.085 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.07 26.76 1.12 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.29 -0.881 . . . . 0.0 109.918 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 36' ' ' TYR . 1.1 m -160.08 -37.35 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.046 -1.034 . . . . 0.0 109.823 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.469 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 1.1 p90 -43.42 130.78 5.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.569 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.2 -72.51 0.44 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.511 ' ND2' HD13 ' A' ' 115' ' ' ILE . 13.6 m-20 -94.09 96.85 9.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -1.188 . . . . 0.0 109.518 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.582 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -117.33 129.53 55.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.248 -0.908 . . . . 0.0 109.187 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.603 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 84.6 m-85 -39.75 153.13 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.453 -0.779 . . . . 0.0 110.174 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 9.5 pt-20 -90.84 -32.93 15.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.392 -0.818 . . . . 0.0 110.197 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.583 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -91.69 64.49 2.47 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.047 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.484 ' CG ' ' O ' ' A' ' 42' ' ' GLY . 3.2 m-20 -162.83 -144.89 0.09 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.405 -1.056 . . . . 0.0 109.963 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.494 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 84.4 m -149.54 143.36 25.56 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.582 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 29.0 m-85 -140.35 112.39 7.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.367 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.479 ' O ' HG21 ' A' ' 20' ' ' ILE . 90.6 t -79.2 127.13 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.932 -1.105 . . . . 0.0 108.59 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.577 ' CD2' HG13 ' A' ' 18' ' ' ILE . 8.9 tt -107.69 162.81 13.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.9 -1.125 . . . . 0.0 109.901 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.563 ' CD2' ' CD1' ' A' ' 11' ' ' LEU . 13.8 tp -151.32 115.15 4.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.073 -1.017 . . . . 0.0 108.997 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.495 ' CA ' ' HB ' ' A' ' 18' ' ' ILE . 3.5 t -109.78 132.14 54.42 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.007 -1.058 . . . . 0.0 110.319 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 m -125.95 120.87 31.5 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -125.92 157.67 37.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 109.556 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.03 151.76 40.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.458 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -137.51 -171.97 3.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.209 -0.932 . . . . 0.0 109.523 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.0 -12.32 77.1 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 p -108.17 -36.42 6.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -1.107 . . . . 0.0 109.461 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.95 -100.88 0.15 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 5.9 m-85 -131.53 154.54 48.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -1.171 . . . . 0.0 109.515 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 52.5 m -126.42 112.87 16.13 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.576 ' CE2' HG22 ' A' ' 91' ' ' VAL . 2.8 m-85 -92.62 154.43 18.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.176 -0.953 . . . . 0.0 110.421 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.467 ' OD1' ' CG2' ' A' ' 93' ' ' VAL . 6.5 m-20 -140.16 98.68 3.5 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.517 ' CG2' HG21 ' A' ' 81' ' ' THR . 37.2 mt -89.38 119.25 36.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 110.79 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.69 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 21.1 m-70 -109.01 164.44 12.41 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.588 ' CE1' ' HA ' ' A' ' 96' ' ' ARG . 39.4 p90 -138.67 103.73 4.92 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.114 -1.435 . . . . 0.0 109.702 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.578 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 2.4 t90 -78.97 130.25 35.35 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.047 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -122.36 65.8 0.94 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.496 -0.753 . . . . 0.0 110.706 -178.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 99' ' ' GLN . . . -51.29 89.63 0.01 OUTLIER Glycine 0 N--CA 1.497 2.746 0 N-CA-C 108.304 -1.918 . . . . 0.0 108.304 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -39.1 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 122.076 0.941 . . . . 0.0 112.255 -177.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.583 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 2.4 m-80 -162.1 -45.2 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 73' ' ' GLU . 88.5 p -62.86 -148.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.354 -0.841 . . . . 0.0 109.199 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.46 ' OG ' ' OD2' ' A' ' 72' ' ' ASP . 2.5 p -121.86 168.54 11.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -48.46 -29.11 3.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.351 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.46 ' OD2' ' OG ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -68.24 -44.49 75.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.446 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.523 ' CB ' ' OG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -57.16 -36.53 70.88 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.468 ' HG3' HD13 ' A' ' 65' ' ' LEU . 3.8 tt0 -64.09 -34.96 79.23 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.506 ' O ' ' CG1' ' A' ' 79' ' ' ILE . . . -79.83 -13.46 82.24 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.401 ' HB1' ' HA ' ' A' ' 73' ' ' GLU . . . -80.38 -54.02 6.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -1.124 . . . . 0.0 109.248 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.442 ' HB3' HG22 ' A' ' 46' ' ' VAL . . . -75.15 -39.66 60.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.163 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 74' ' ' GLN . . . -63.1 -49.36 74.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.355 -0.84 . . . . 0.0 109.306 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' A' ' 75' ' ' GLY . 70.5 mt -63.57 -44.13 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.211 -0.931 . . . . 0.0 109.414 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.621 ' CG ' ' CD2' ' A' ' 3' ' ' LEU . 14.5 m-30 -62.98 -25.36 68.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.245 -0.909 . . . . 0.0 109.033 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.517 HG21 ' CG2' ' A' ' 61' ' ' ILE . 5.9 m -79.14 -23.41 44.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.3 m -88.79 -21.82 23.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.638 -0.664 . . . . 0.0 109.352 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 6.8 mt-30 -83.19 -37.87 23.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.497 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.507 ' HG3' ' CD1' ' A' ' 61' ' ' ILE . 5.3 ptm -75.75 -29.24 58.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.334 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.499 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 67.2 t0 -61.64 -59.64 4.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -0.944 . . . . 0.0 109.698 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.58 -33.8 76.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.136 -0.977 . . . . 0.0 109.476 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 0.5 OUTLIER -69.91 -16.11 63.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 109.59 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.532 ' CD1' HD13 ' A' ' 11' ' ' LEU . 66.7 mt -94.06 22.61 5.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.678 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 86.2 0.59 86.86 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 1.4 p 75.86 7.52 3.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -1.165 . . . . 0.0 109.616 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.576 HG22 ' CE2' ' A' ' 59' ' ' TYR . 15.7 m -83.3 -19.5 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 109.285 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.53 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -68.38 165.61 18.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.581 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.467 ' CG2' ' OD1' ' A' ' 60' ' ' ASN . 2.5 t -115.86 -177.08 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.376 -0.827 . . . . 0.0 109.125 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -131.01 138.43 49.66 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.092 -1.005 . . . . 0.0 108.674 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.69 ' CD2' ' CD2' ' A' ' 62' ' ' HIS . 19.0 m-70 -135.0 142.77 46.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.088 -1.007 . . . . 0.0 110.179 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.588 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -94.17 117.3 29.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 110.148 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.499 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 44.5 mm-40 -127.98 158.83 36.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.107 -0.996 . . . . 0.0 109.354 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.581 ' HB ' ' CD2' ' A' ' 101' ' ' HIS . 2.6 t -155.75 -175.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.27 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.455 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 0.4 OUTLIER -69.77 -1.97 10.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.924 -1.11 . . . . 0.0 110.258 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.69 16.11 1.8 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.581 ' CD2' ' HB ' ' A' ' 98' ' ' VAL . 13.1 m-70 -120.88 -15.73 8.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.487 -1.008 . . . . 0.0 109.373 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.578 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.37 21.59 3.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 0.0 109.169 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 102' ' ' GLU . 4.3 p -41.75 -106.03 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.545 -0.722 . . . . 0.0 112.177 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.482 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 1.3 pt-20 -67.97 -31.67 71.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.84 -1.163 . . . . 0.0 111.245 -177.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -58.82 -59.73 4.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.011 -1.056 . . . . 0.0 110.197 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.536 ' HB2' ' HB2' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -58.71 -55.62 32.75 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.006 -1.059 . . . . 0.0 108.467 -179.252 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -54.48 -20.64 8.03 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 104' ' ' GLU . . . -65.22 -51.99 57.43 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.568 ' CD1' HG23 ' A' ' 18' ' ' ILE . 29.4 m-85 -65.46 -17.19 64.36 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.597 ' CG ' HD23 ' A' ' 114' ' ' LEU . 4.2 m-85 -121.4 100.79 7.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 109.684 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.518 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 2.8 pttt -81.27 73.55 8.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.222 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.43 -54.93 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 109.731 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 114' ' ' LEU . . . 156.5 -20.08 0.46 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.597 HD23 ' CG ' ' A' ' 110' ' ' PHE . 23.0 mt 62.77 133.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.295 -1.121 . . . . 0.0 109.895 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.562 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 3.2 mt -116.39 164.9 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 0.0 108.978 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.562 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -141.07 102.28 4.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.36 -0.837 . . . . 0.0 109.151 179.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.603 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 3.2 mmtt -79.89 -167.97 1.45 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.893 . . . . 0.0 109.587 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.582 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -91.1 124.4 35.29 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.909 -1.119 . . . . 0.0 110.369 -179.451 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 118' ' ' GLN . . . -56.53 -161.61 0.02 OUTLIER Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 67.04 67.38 2.01 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 24' ' ' GLU . 1.4 t . . . . . 0 C--N 1.303 -1.447 0 O-C-N 121.316 -1.108 . . . . 0.0 109.648 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.495 ' N ' ' HB3' ' A' ' 28' ' ' MET . 1.5 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 1' ' ' VAL . 15.4 pm0 36.83 51.47 0.94 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.778 -0.576 . . . . 0.0 110.326 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.598 ' CD2' ' CD2' ' A' ' 80' ' ' TYR . 2.1 pt? -43.33 -31.31 0.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.877 . . . . 0.0 109.412 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.523 ' HA ' ' CG2' ' A' ' 8' ' ' THR . 4.1 t -62.31 87.22 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -0.849 . . . . 0.0 109.935 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.528 ' HG2' ' N ' ' A' ' 6' ' ' LYS . 5.2 ttmm 168.81 -90.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.528 ' N ' ' HG2' ' A' ' 5' ' ' LYS . 1.0 OUTLIER -74.83 -6.62 50.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.202 -0.936 . . . . 0.0 108.94 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.533 ' CG1' ' CD2' ' A' ' 11' ' ' LEU . 37.4 t -106.9 -72.59 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.833 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.523 ' CG2' ' HA ' ' A' ' 4' ' ' SER . 66.6 p -47.98 -29.66 3.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.678 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 8' ' ' THR . . . -41.81 -47.71 5.06 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.554 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 4.0 mtmt -141.61 -54.39 0.46 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -1.162 . . . . 0.0 109.586 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.567 ' CD1' ' CD2' ' A' ' 88' ' ' LEU . 55.2 mt 82.22 -42.55 0.13 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.756 -0.59 . . . . 0.0 109.955 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.491 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -170.98 -83.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.939 -1.1 . . . . 0.0 109.605 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER 73.87 124.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.925 . . . . 0.0 109.358 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 22.5 p 48.45 57.02 6.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.442 -0.786 . . . . 0.0 109.521 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.5 m -157.13 101.58 1.92 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.522 -0.736 . . . . 0.0 109.232 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.04 83.66 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.398 2.065 . . . . 0.0 110.502 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.424 ' C ' HG21 ' A' ' 18' ' ' ILE . . . -167.47 -146.3 4.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.561 ' HB ' ' CB ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -159.24 145.69 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.051 -1.264 . . . . 0.0 109.674 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.633 ' NE2' ' CH2' ' A' ' 21' ' ' TRP . 1.6 tt0 -122.76 143.58 49.73 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.552 HD12 ' CZ ' ' A' ' 110' ' ' PHE . 1.5 mt -114.76 175.28 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.745 -1.222 . . . . 0.0 109.537 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.633 ' CH2' ' NE2' ' A' ' 19' ' ' GLN . 7.3 m-90 -134.81 117.47 15.97 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.532 ' HD3' ' CG1' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -79.51 128.37 33.28 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 -178.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.652 ' CG2' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -101.56 31.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-O 123.075 1.417 . . . . 0.0 107.325 179.098 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.508 ' O ' ' ND2' ' A' ' 25' ' ' ASN . 1.5 pt-20 -54.96 168.44 0.3 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.647 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' CG ' ' A' ' 27' ' ' GLU . 8.0 p30 42.68 27.68 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.517 ' HE2' ' CA ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER 50.2 56.8 7.36 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.639 -0.663 . . . . 0.0 109.749 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 28' ' ' MET . 10.0 mm-40 -139.51 -99.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.982 -1.074 . . . . 0.0 110.111 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.593 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 4.1 mmm 163.04 140.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.099 -1.001 . . . . 0.0 109.205 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 1.0 OUTLIER -158.95 146.75 13.47 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.125 -0.984 . . . . 0.0 109.488 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.6 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 35.5 Cg_endo -77.45 87.45 1.51 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.842 2.361 . . . . 0.0 111.658 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 20' ' ' ILE . 42.3 t -69.92 113.08 14.86 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 34.9 Cg_endo -76.67 -159.91 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.481 2.121 . . . . 0.0 110.827 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -88.61 -16.46 32.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.322 -0.862 . . . . 0.0 109.261 -179.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.446 ' HG2' ' HG2' ' A' ' 32' ' ' PRO . 8.9 ptmt -90.38 17.66 7.02 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 110.052 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.1 m -143.2 5.27 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.936 -1.103 . . . . 0.0 110.566 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.567 ' CD1' ' O ' ' A' ' 33' ' ' THR . 30.1 p90 -90.45 146.59 24.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.784 -1.197 . . . . 0.0 109.646 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.424 ' C ' ' OD1' ' A' ' 38' ' ' ASN . . . 136.33 -27.42 2.99 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -139.47 106.4 5.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -1.159 . . . . 0.0 109.491 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.55 ' CZ ' HD13 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -119.83 126.89 52.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.108 -0.995 . . . . 0.0 109.67 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.598 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 6.9 m-30 -48.56 121.81 4.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.432 -0.792 . . . . 0.0 109.563 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.578 ' HA ' ' CH2' ' A' ' 64' ' ' TRP . 1.7 pt-20 -64.17 -7.81 10.3 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.104 -0.998 . . . . 0.0 110.297 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.621 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -111.43 57.23 0.43 Allowed Glycine 0 N--CA 1.485 1.901 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.498 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.494 ' CG ' ' O ' ' A' ' 42' ' ' GLY . 4.3 m-20 -162.34 -143.96 0.09 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.299 -1.118 . . . . 0.0 109.99 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.464 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 6.3 m -145.54 139.12 26.53 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.491 ' HB3' ' CG2' ' A' ' 20' ' ' ILE . 21.2 m-85 -137.04 106.94 6.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.054 -1.029 . . . . 0.0 110.04 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 87.5 t -78.83 128.54 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.102 -0.999 . . . . 0.0 108.857 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.587 ' HB3' ' HB2' ' A' ' 62' ' ' HIS . 3.7 tt -107.33 160.88 15.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.019 -1.05 . . . . 0.0 109.895 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 11' ' ' LEU . 20.3 tp -151.18 92.48 1.8 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.999 -1.063 . . . . 0.0 109.519 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.561 ' CB ' ' HB ' ' A' ' 18' ' ' ILE . 3.0 t -96.3 131.0 43.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 110.126 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.468 ' OG1' ' CD2' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -107.07 152.69 23.67 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.01 137.58 38.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.106 -0.996 . . . . 0.0 109.642 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.466 ' O ' ' CG2' ' A' ' 53' ' ' THR . 0.0 OUTLIER -76.98 163.64 26.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.368 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.466 ' CG2' ' O ' ' A' ' 52' ' ' LYS . 23.6 p -158.55 -177.77 6.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.538 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.36 19.29 36.58 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.7 t -140.91 -50.39 0.44 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -1.145 . . . . 0.0 109.559 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.37 -102.17 0.19 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.569 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 3.4 m-85 -152.43 -172.19 4.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -1.15 . . . . 0.0 109.5 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.6 t -149.03 102.92 3.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.844 . . . . 0.0 108.99 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.525 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 52.9 m-85 -85.23 159.34 20.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 0.0 110.181 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.469 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 6.2 m-20 -141.36 100.18 3.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.548 ' CG2' ' CG2' ' A' ' 81' ' ' THR . 47.5 mt -92.51 114.26 29.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.091 -1.005 . . . . 0.0 110.419 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.698 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 13.8 m-70 -107.91 170.1 8.2 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.545 -0.722 . . . . 0.0 109.272 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 95' ' ' HIS . 53.4 p90 -141.41 107.1 5.09 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.4 -1.32 . . . . 0.0 109.923 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.578 ' CH2' ' HA ' ' A' ' 41' ' ' GLU . 3.0 t90 -82.28 136.46 35.04 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -124.05 63.47 1.07 Allowed 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.329 -178.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 68' ' ' ASN . . . -46.49 93.68 0.01 OUTLIER Glycine 0 N--CA 1.498 2.768 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.586 ' N ' ' O ' ' A' ' 65' ' ' LEU . 7.3 tppt? -39.47 84.56 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.621 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 7.7 m120 -163.0 -43.21 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.536 ' HB2' ' CB ' ' A' ' 73' ' ' GLU . 1.4 p -50.29 -178.84 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.755 -0.591 . . . . 0.0 109.483 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.464 ' OG ' ' OD1' ' A' ' 72' ' ' ASP . 1.0 OUTLIER -95.72 -169.0 1.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.553 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.522 ' O ' ' CG ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -70.72 -39.86 73.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 9.3 p-10 -74.34 -24.57 59.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.004 -1.06 . . . . 0.0 109.298 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.536 ' CB ' ' HB2' ' A' ' 69' ' ' SER . 29.5 mt-10 -69.03 -43.03 75.57 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.579 ' CB ' ' CD1' ' A' ' 65' ' ' LEU . 4.0 pt20 -66.19 -30.35 70.8 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.509 ' O ' HD11 ' A' ' 79' ' ' ILE . . . -83.7 -12.42 77.68 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -83.8 -41.67 17.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.16 -1.2 . . . . 0.0 108.718 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.66 -50.74 22.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.855 . . . . 0.0 108.774 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.53 86.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 109.039 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.54 ' N ' HD11 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -63.52 -42.62 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.303 -0.873 . . . . 0.0 108.647 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.598 ' CD2' ' CD2' ' A' ' 3' ' ' LEU . 5.0 m-85 -62.08 -24.23 66.98 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.548 ' CG2' ' CG2' ' A' ' 61' ' ' ILE . 1.8 m -82.38 -26.31 32.99 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.1 m -70.54 -46.14 64.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.504 -0.747 . . . . 0.0 109.081 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 1.8 mt-30 -68.94 -42.56 76.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.345 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.558 ' HE2' ' CZ3' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -55.35 -36.0 65.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 109.404 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.487 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.9 t0 -77.4 -36.86 52.96 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.0 109.507 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -86.44 6.21 31.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.57 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.463 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 1.9 m-85 -121.0 -17.09 7.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 109.582 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.567 ' CD2' ' CD1' ' A' ' 11' ' ' LEU . 7.0 mt -87.58 4.93 41.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 109.598 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.73 33.63 6.04 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 p 47.02 24.25 0.36 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 0.0 109.627 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 88' ' ' LEU . 14.8 m -100.98 -15.78 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 0.0 109.282 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -79.98 167.85 19.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.274 -0.891 . . . . 0.0 109.626 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.405 ' CG1' ' H ' ' A' ' 94' ' ' GLN . 2.8 t -116.16 -176.92 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.452 -0.78 . . . . 0.0 109.099 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.405 ' H ' ' CG1' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -129.62 142.09 50.81 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.896 -1.127 . . . . 0.0 109.013 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.698 ' CD2' ' CD2' ' A' ' 62' ' ' HIS . 9.0 m-70 -143.32 150.19 38.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.067 -1.02 . . . . 0.0 109.882 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.576 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 3.4 ttp180 -108.13 138.3 44.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 110.201 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.512 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 10.5 mm-40 -145.66 161.75 39.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.36 -0.838 . . . . 0.0 109.188 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.54 ' N ' ' HB2' ' A' ' 101' ' ' HIS . 2.2 t -156.58 -166.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 108.873 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.404 ' H ' ' CG1' ' A' ' 98' ' ' VAL . 14.2 pt20 -74.12 1.82 10.3 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.837 -1.164 . . . . 0.0 110.127 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.78 19.49 1.27 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.54 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 11.9 m-70 -123.93 -9.88 7.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.571 -0.959 . . . . 0.0 109.398 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.616 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 1.2 pp20? -90.39 15.19 11.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.392 -0.817 . . . . 0.0 109.726 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 102' ' ' GLU . 24.5 p -39.72 -109.53 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.43 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 3.0 pt-20 -75.52 -25.66 57.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.719 -1.238 . . . . 0.0 111.152 -177.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.6 m -64.16 -48.83 74.46 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.823 -1.173 . . . . 0.0 109.501 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.616 ' HB2' ' HB2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -67.56 -57.29 6.73 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.548 ' N ' HD23 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -45.91 -28.04 1.03 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 104' ' ' GLU . . . -60.66 -55.22 35.87 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.651 ' CE2' ' CE1' ' A' ' 62' ' ' HIS . 69.6 m-85 -74.33 -3.65 31.53 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.605 ' CG ' HD12 ' A' ' 114' ' ' LEU . 44.9 m-85 -119.15 91.34 3.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.711 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.57 34.17 0.9 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.642 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.31 -71.78 0.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.114 -0.991 . . . . 0.0 109.696 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -173.0 125.85 1.19 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.605 HD12 ' CG ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -90.78 125.09 35.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.381 -1.07 . . . . 0.0 110.121 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.558 ' O ' ' CD1' ' A' ' 116' ' ' TYR . 0.1 OUTLIER -129.35 166.99 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.558 ' CD1' ' O ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -149.65 112.4 4.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.084 -1.01 . . . . 0.0 109.56 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -96.15 -159.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.424 -0.797 . . . . 0.0 109.801 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.47 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -91.07 167.19 12.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.248 -0.907 . . . . 0.0 109.607 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.474 ' HA2' ' OD1' ' A' ' 43' ' ' ASP . . . -80.5 -163.89 29.83 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 62.19 139.52 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 C--N 1.305 -1.344 0 O-C-N 121.219 -1.165 . . . . 0.0 108.673 179.897 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 2' ' ' GLU . 1.3 t . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 1' ' ' VAL . 1.5 pt-20 -44.41 126.25 5.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.479 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.609 ' O ' ' HB ' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -85.06 14.71 4.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.575 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 5.9 p -92.51 152.22 19.77 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.668 -1.27 . . . . 0.0 109.902 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 4' ' ' SER . 0.1 OUTLIER 80.5 -69.69 0.09 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.71 . . . . 0.0 110.742 178.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.522 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 13.8 ttmt -81.98 16.44 1.9 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.05 -1.031 . . . . 0.0 110.663 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.609 ' HB ' ' O ' ' A' ' 3' ' ' LEU . 51.6 t -158.69 -59.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.917 -1.115 . . . . 0.0 109.825 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.528 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 77.4 p -60.55 -13.32 13.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 109.813 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.79 -20.45 6.03 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 1.7 pttm -170.99 -33.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -1.141 . . . . 0.0 109.772 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.572 ' CD2' ' CD2' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 69.56 -0.4 2.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.39 -0.819 . . . . 0.0 110.093 -179.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 11' ' ' LEU . 32.3 m-20 58.63 135.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.109 -0.994 . . . . 0.0 110.201 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.563 ' O ' ' CG2' ' A' ' 14' ' ' THR . 0.0 OUTLIER -56.59 -19.27 15.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.044 -1.035 . . . . 0.0 108.587 179.235 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.563 ' CG2' ' O ' ' A' ' 13' ' ' LYS . 13.8 t 44.99 18.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.916 -0.49 . . . . 0.0 111.925 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.572 HG21 ' N ' ' A' ' 16' ' ' PRO . 0.5 OUTLIER 47.62 -177.17 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.015 -1.053 . . . . 0.0 108.599 179.435 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.572 ' N ' HG21 ' A' ' 15' ' ' THR . 34.9 Cg_endo -80.32 90.11 1.26 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.908 1.739 . . . . 0.0 110.32 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.528 ' O ' ' CG2' ' A' ' 18' ' ' ILE . . . -164.3 -120.89 0.54 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.528 ' CG2' ' O ' ' A' ' 17' ' ' GLY . 19.9 pt -160.5 -165.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -1.188 . . . . 0.0 110.232 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.485 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 2.5 mt-30 -170.78 172.95 5.48 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 18.5 mt -145.88 168.15 7.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.401 -1.437 . . . . 0.0 110.352 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.59 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 7.4 m-90 -133.97 118.83 18.31 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.531 ' CG ' HG23 ' A' ' 31' ' ' VAL . 14.4 mtm180 -79.15 121.2 24.72 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.219 -0.926 . . . . 0.0 110.921 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.636 ' CG2' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -101.98 27.48 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.123 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.536 ' HB2' ' CG2' ' A' ' 121' ' ' VAL . 1.3 pt-20 -58.62 179.13 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.375 -0.828 . . . . 0.0 109.421 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' CG ' ' A' ' 27' ' ' GLU . 8.4 p30 42.14 27.47 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.463 ' N ' ' O ' ' A' ' 24' ' ' GLU . 26.9 mmm 54.71 55.27 8.08 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.489 -0.757 . . . . 0.0 109.765 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 70.1 mm-40 -153.47 -134.36 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.117 -0.99 . . . . 0.0 109.356 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.577 ' HE1' ' CD1' ' A' ' 21' ' ' TRP . 3.1 ttt -160.04 149.74 18.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.898 -1.126 . . . . 0.0 109.316 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -160.16 149.36 14.07 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.099 -1.0 . . . . 0.0 109.587 -179.559 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.59 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 34.6 Cg_endo -76.43 125.88 8.67 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.534 2.156 . . . . 0.0 111.109 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.538 HG22 ' CA ' ' A' ' 21' ' ' TRP . 5.8 t -111.24 105.61 57.02 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.63 -158.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.44 2.093 . . . . 0.0 110.4 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.561 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -81.86 -18.91 42.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 108.952 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.16 32.33 0.76 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.345 -0.847 . . . . 0.0 109.706 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.415 ' CB ' HG11 ' A' ' 31' ' ' VAL . 1.7 m -155.07 -38.8 0.09 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.95 . . . . 0.0 109.624 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.563 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -45.55 129.47 8.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.469 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.34 -77.09 0.39 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.491 ' HB3' ' CG2' ' A' ' 115' ' ' ILE . 4.4 m-80 -89.1 106.79 18.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -1.165 . . . . 0.0 109.673 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.582 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -135.92 137.08 41.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.233 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.667 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 7.2 m-30 -42.33 151.95 0.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.285 -0.885 . . . . 0.0 109.508 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 12.1 pt-20 -90.93 -37.98 13.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.171 -0.956 . . . . 0.0 109.784 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.598 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -85.69 66.46 3.75 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.193 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -162.91 -150.28 0.16 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.025 -1.28 . . . . 0.0 110.31 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.497 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 34.6 m -139.0 148.1 43.01 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.582 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 28.2 m-85 -145.36 109.23 4.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.015 -1.053 . . . . 0.0 109.717 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 98.8 t -79.37 122.6 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.999 -1.063 . . . . 0.0 108.549 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.53 HD11 ' CE1' ' A' ' 106' ' ' PHE . 6.6 tt -108.1 123.5 48.8 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.256 -0.903 . . . . 0.0 110.168 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.572 ' CD2' ' CD2' ' A' ' 11' ' ' LEU . 24.0 tp -104.55 100.24 9.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.846 -1.159 . . . . 0.0 109.864 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.466 ' OG ' HG21 ' A' ' 18' ' ' ILE . 10.8 t -83.41 127.21 33.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 108.757 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.655 ' CG2' ' CE1' ' A' ' 57' ' ' PHE . 1.2 m -123.02 114.32 20.24 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -116.6 126.59 53.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.269 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.522 ' O ' ' CG2' ' A' ' 53' ' ' THR . 11.4 pttm -51.52 -176.86 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.329 -0.857 . . . . 0.0 109.325 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.522 ' CG2' ' O ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -178.72 153.47 0.68 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.444 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 53' ' ' THR . . . -44.2 -26.83 0.99 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.17 -40.49 14.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -1.092 . . . . 0.0 109.41 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.72 -70.29 0.2 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.655 ' CE1' ' CG2' ' A' ' 50' ' ' THR . 0.1 OUTLIER -139.81 175.63 9.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -1.138 . . . . 0.0 111.196 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.66 89.34 1.68 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.576 ' CE1' ' HB3' ' A' ' 57' ' ' PHE . 6.5 m-85 -78.74 157.2 28.57 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.135 0.969 . . . . 0.0 111.32 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.572 ' O ' ' CD2' ' A' ' 62' ' ' HIS . 7.7 m-80 -151.54 87.6 1.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.571 ' CG2' ' CG2' ' A' ' 81' ' ' THR . 10.3 mt -71.2 140.71 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.295 -0.878 . . . . 0.0 110.4 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.648 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 55.4 m-70 -125.99 160.18 30.72 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 95' ' ' HIS . 50.6 p90 -134.85 96.18 3.48 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 117.979 -1.489 . . . . 0.0 109.887 177.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.576 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 6.0 t90 -74.18 131.74 41.54 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -121.55 60.96 0.94 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.287 -0.883 . . . . 0.0 111.039 -178.078 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -49.07 90.46 0.01 OUTLIER Glycine 0 N--CA 1.498 2.786 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.59 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -38.43 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.13 0.967 . . . . 0.0 112.61 -177.432 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.598 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 2.7 m-80 -162.61 -45.73 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.47 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 96.3 p -59.34 -156.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.517 -0.739 . . . . 0.0 109.276 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 p -109.34 160.7 15.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -45.44 19.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 109.381 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -57.92 -41.74 83.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.141 -0.974 . . . . 0.0 109.361 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HG2' ' HB2' ' A' ' 69' ' ' SER . 3.9 tp10 -54.54 -39.77 68.01 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.525 ' CG ' HD12 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -60.43 -37.69 81.71 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.513 ' O ' ' CD1' ' A' ' 79' ' ' ILE . . . -70.67 -23.57 77.65 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.467 ' HA ' HD11 ' A' ' 79' ' ' ILE . . . -75.71 -67.21 0.69 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.313 -1.11 . . . . 0.0 109.192 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.407 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -45.35 -38.09 5.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 0.0 109.301 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.64 -39.91 73.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.665 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.513 ' CD1' ' O ' ' A' ' 75' ' ' GLY . 17.9 mt -60.83 -48.69 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 0.0 109.5 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.568 ' CD2' ' SD ' ' A' ' 28' ' ' MET . 25.5 m-85 -56.92 -42.46 80.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.042 -1.036 . . . . 0.0 108.968 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.571 ' CG2' ' CG2' ' A' ' 61' ' ' ILE . 6.4 m -68.72 -23.65 64.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.485 -0.76 . . . . 0.0 109.141 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.3 m -78.57 -23.59 45.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.452 -0.78 . . . . 0.0 109.46 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 5.1 mt-30 -89.91 -34.5 16.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.671 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.566 ' HE2' ' CE3' ' A' ' 21' ' ' TRP . 2.4 mtt -63.14 -47.05 84.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.696 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.565 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 3.1 t70 -50.73 -54.98 18.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.721 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.69 -12.21 59.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.717 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 4.1 m-30 -97.23 -2.92 41.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.609 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.571 ' HB3' ' CD2' ' A' ' 59' ' ' TYR . 3.9 mt -108.43 8.23 27.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.55 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 105.59 3.1 40.52 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 1.3 p 75.38 -0.09 3.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -1.174 . . . . 0.0 109.644 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.548 HG21 ' CD2' ' A' ' 59' ' ' TYR . 4.7 m -87.23 15.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.114 -0.991 . . . . 0.0 109.389 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.521 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -100.03 179.33 4.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.586 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.461 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 4.6 t -135.24 175.86 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.12 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -124.91 131.04 53.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.972 -1.08 . . . . 0.0 109.504 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.648 ' CD2' ' CE1' ' A' ' 62' ' ' HIS . 20.2 m-70 -130.21 150.02 51.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.8 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.576 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 8.6 ptm180 -109.79 136.02 49.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.369 -0.832 . . . . 0.0 109.801 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.497 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 7.4 mm-40 -139.77 166.21 25.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.263 -0.898 . . . . 0.0 109.595 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.52 ' N ' ' HB2' ' A' ' 101' ' ' HIS . 2.7 t -155.58 -176.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.354 -0.841 . . . . 0.0 109.2 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -4.52 12.18 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.966 -1.084 . . . . 0.0 110.335 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.08 14.38 3.06 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.52 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 51.8 m-70 -123.01 -20.96 5.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.57 -0.959 . . . . 0.0 109.725 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.576 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.1 OUTLIER -90.28 8.85 31.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.341 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 107' ' ' ARG . 1.0 OUTLIER -56.79 -63.03 1.34 Allowed 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.162 -0.961 . . . . 0.0 111.225 -178.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.508 ' N ' ' OG ' ' A' ' 103' ' ' SER . 3.6 mt-10 -76.5 -55.6 5.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.967 -1.083 . . . . 0.0 111.748 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.466 ' HB ' ' OE1' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -61.26 -52.64 63.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.97 -1.082 . . . . 0.0 111.113 -178.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.547 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -64.98 -55.0 21.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.968 -1.082 . . . . 0.0 108.914 -178.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' A' ' 103' ' ' SER . 2.3 ttm180 -61.51 -17.26 53.9 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.179 -0.951 . . . . 0.0 108.661 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 104' ' ' GLU . . . -66.14 -59.81 3.41 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.471 ' HB3' HG23 ' A' ' 18' ' ' ILE . 9.2 m-85 -63.43 -16.19 59.83 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.645 ' CG ' ' CD2' ' A' ' 114' ' ' LEU . 43.7 m-85 -108.22 99.51 8.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.474 -0.766 . . . . 0.0 109.536 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -74.77 1.59 12.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.286 -0.883 . . . . 0.0 109.702 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.78 -81.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.066 -1.021 . . . . 0.0 109.822 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 114' ' ' LEU . . . 178.04 -29.99 0.07 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.645 ' CD2' ' CG ' ' A' ' 110' ' ' PHE . 33.3 mt 81.75 109.33 0.07 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.589 -0.948 . . . . 0.0 110.284 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.491 ' CG2' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -91.03 172.15 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.654 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.555 ' CZ ' ' O ' ' A' ' 114' ' ' LEU . 1.4 m-85 -150.04 124.88 9.85 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.024 -1.047 . . . . 0.0 109.981 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.667 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -106.4 -164.89 1.04 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.471 -0.768 . . . . 0.0 109.31 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.579 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 1.6 tp60 -91.56 163.03 14.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.879 -1.138 . . . . 0.0 110.165 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 120' ' ' GLY . . . -76.56 -153.68 5.16 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 52.69 101.46 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.536 ' CG2' ' HB2' ' A' ' 24' ' ' GLU . 1.5 t . . . . . 0 C--N 1.304 -1.384 0 O-C-N 121.17 -1.194 . . . . 0.0 109.253 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.483 ' O ' ' C ' ' A' ' 2' ' ' GLU . 29.1 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 2' ' ' GLU . 18.0 pt-20 32.98 93.99 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.428 0.632 . . . . 0.0 110.462 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.567 HD21 ' CD2' ' A' ' 80' ' ' TYR . 2.6 pt? -53.8 -33.25 55.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 109.505 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 10.7 t -44.53 146.08 0.77 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 4' ' ' SER . 10.9 tttt 80.24 -71.84 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.63 -0.669 . . . . 0.0 109.96 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -84.73 15.76 3.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 109.985 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.526 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 12.0 t -150.56 -65.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.016 -1.052 . . . . 0.0 109.716 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.53 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 70.3 p -50.01 -23.19 1.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.4 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 10' ' ' LYS . . . -89.58 33.11 4.49 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 10' ' ' LYS . 2.4 tttm 169.28 70.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -1.069 . . . . 0.0 109.17 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.53 ' CD2' ' HA ' ' A' ' 8' ' ' THR . 4.3 mm? -94.47 74.0 3.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.375 -0.828 . . . . 0.0 109.414 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 13' ' ' LYS . 6.2 t70 62.16 -91.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 109.376 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER 62.37 124.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.954 . . . . 0.0 109.631 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 22.4 p 48.36 56.99 6.67 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.349 -0.844 . . . . 0.0 109.604 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.425 ' HB ' ' CG ' ' A' ' 12' ' ' ASP . 21.1 m -167.48 102.34 0.6 Allowed Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.417 -0.802 . . . . 0.0 109.414 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.95 99.8 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.423 2.082 . . . . 0.0 110.277 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.462 ' O ' HG21 ' A' ' 18' ' ' ILE . . . 179.54 -139.14 3.73 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.49 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 12.3 pt -157.41 142.46 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.049 -1.265 . . . . 0.0 110.1 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.447 ' NE2' ' CZ2' ' A' ' 21' ' ' TRP . 1.1 tt0 -122.24 114.44 20.83 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.576 HD13 ' CE1' ' A' ' 110' ' ' PHE . 2.9 mt -92.49 164.04 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.757 -1.214 . . . . 0.0 109.67 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.597 ' HA ' ' O ' ' A' ' 29' ' ' VAL . 8.3 m-90 -122.01 126.42 48.48 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.584 ' HA ' ' CD1' ' A' ' 45' ' ' TYR . 0.9 OUTLIER -79.23 132.66 36.57 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.177 0.989 . . . . 0.0 111.74 -176.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 44' ' ' CYS . 2.2 mm -127.27 44.26 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.534 ' HB2' ' CD2' ' A' ' 40' ' ' TYR . 3.2 pm0 -99.81 -40.12 7.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 0.0 110.049 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.526 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 3.0 p30 -81.97 10.08 7.15 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.132 -0.98 . . . . 0.0 108.677 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.517 ' CE ' ' OG ' ' A' ' 70' ' ' SER . 53.9 mmm 73.08 29.0 1.83 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.521 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 47.6 mt-10 -150.79 103.02 3.04 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.568 ' SD ' ' CD2' ' A' ' 80' ' ' TYR . 0.9 OUTLIER -42.29 138.02 1.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 110.173 -179.219 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -139.71 149.37 59.26 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.526 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 35.7 Cg_endo -78.68 82.61 2.44 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.225 1.95 . . . . 0.0 111.737 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.572 ' CG2' ' N ' ' A' ' 22' ' ' ARG . 2.8 t -69.9 112.93 14.01 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.18 -0.95 . . . . 0.0 109.887 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 36.2 Cg_endo -78.7 -158.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.486 2.124 . . . . 0.0 110.044 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.572 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -90.0 -16.29 30.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.083 -1.01 . . . . 0.0 109.152 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HG3' ' HG2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -75.39 -20.31 59.02 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -0.873 . . . . 0.0 109.874 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.0 m -122.96 13.12 9.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.12 -0.988 . . . . 0.0 109.734 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.58 ' CG ' ' O ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -85.05 49.88 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.985 . . . . 0.0 109.914 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.568 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . -137.65 -82.71 0.11 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.516 ' HB3' ' CG2' ' A' ' 115' ' ' ILE . 4.2 m-80 -81.46 123.96 29.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -1.135 . . . . 0.0 109.58 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.631 ' HB2' ' CZ ' ' A' ' 45' ' ' TYR . 2.7 p90 -160.24 141.08 12.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.013 . . . . 0.0 110.087 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.621 ' CD2' ' HA2' ' A' ' 119' ' ' GLY . 5.4 m-30 -39.6 142.9 0.26 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.355 -0.841 . . . . 0.0 110.767 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 15.7 pt-20 -90.66 -38.86 12.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 109.363 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.574 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -83.43 70.97 3.08 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.459 ' OD1' ' HB3' ' A' ' 40' ' ' TYR . 4.9 m-20 -160.66 -132.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.719 -0.871 . . . . 0.0 109.122 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.58 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 57.9 m -156.66 148.77 23.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.988 -1.07 . . . . 0.0 108.599 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.631 ' CZ ' ' HB2' ' A' ' 39' ' ' PHE . 17.2 m-85 -147.57 111.06 4.94 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.353 -0.842 . . . . 0.0 109.575 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.554 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 4.0 t -79.59 112.21 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.994 -1.066 . . . . 0.0 108.152 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.592 HD11 ' CE1' ' A' ' 106' ' ' PHE . 7.3 tt -102.97 114.59 29.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.83 -1.168 . . . . 0.0 110.331 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.405 HD12 ' HB3' ' A' ' 59' ' ' TYR . 16.5 tp -99.99 109.89 22.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.237 -0.914 . . . . 0.0 109.195 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 t -97.12 134.28 40.67 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.39 -0.819 . . . . 0.0 109.641 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.532 ' OG1' ' CD1' ' A' ' 59' ' ' TYR . 1.2 m -120.52 135.95 54.92 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.14 155.42 37.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.627 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.511 ' O ' ' CG2' ' A' ' 53' ' ' THR . 0.0 OUTLIER -91.42 155.63 18.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 109.458 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 52' ' ' LYS . 68.9 p -158.83 175.61 13.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 0.0 109.449 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.38 -22.01 71.48 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.13 -52.99 5.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -1.173 . . . . 0.0 109.477 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.06 -97.28 0.11 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.588 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 18.2 m-85 -145.35 156.23 43.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -1.143 . . . . 0.0 109.526 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.0 m -121.89 99.53 6.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.871 . . . . 0.0 108.914 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.532 ' CD1' ' OG1' ' A' ' 50' ' ' THR . 17.3 m-30 -81.77 158.23 24.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 110.209 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.558 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 8.0 m-20 -150.43 90.38 1.65 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 85' ' ' ASP . 11.7 mt -77.51 135.52 26.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.231 -0.918 . . . . 0.0 110.291 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.682 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 55.9 m-70 -122.48 159.56 27.39 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.612 ' CZ ' ' HA ' ' A' ' 96' ' ' ARG . 49.4 p90 -135.52 93.26 2.94 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.92 -1.512 . . . . 0.0 110.099 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.593 ' HA ' ' HB2' ' A' ' 97' ' ' GLU . 5.7 t90 -73.91 119.17 17.75 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.572 ' CD1' ' HB2' ' A' ' 74' ' ' GLN . 0.2 OUTLIER -110.33 77.41 1.05 Allowed 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.568 -0.707 . . . . 0.0 111.158 -177.284 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 41' ' ' GLU . . . -65.7 86.88 0.1 OUTLIER Glycine 0 N--CA 1.494 2.559 0 N-CA-C 107.751 -2.14 . . . . 0.0 107.751 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.478 ' O ' ' OD1' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -52.68 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.798 0.808 . . . . 0.0 112.617 -177.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.574 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 10.1 m120 -160.29 -39.1 0.05 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 70' ' ' SER . 11.7 p -71.72 -145.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 109.297 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.517 ' OG ' ' CE ' ' A' ' 26' ' ' MET . 16.8 p -88.62 142.41 27.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 0.0 109.956 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.505 ' CG ' ' OE1' ' A' ' 74' ' ' GLN . 5.5 tt0 -50.78 -46.92 59.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.299 -0.875 . . . . 0.0 109.018 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.93 -38.5 67.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.217 -0.927 . . . . 0.0 109.026 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.517 ' CG ' ' HE2' ' A' ' 26' ' ' MET . 1.4 tp10 -56.84 -38.58 72.85 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.572 ' HB2' ' CD1' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -62.45 -35.89 80.7 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.533 ' N ' ' HG2' ' A' ' 74' ' ' GLN . . . -80.19 -13.64 81.63 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -79.86 -44.25 20.83 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.299 -1.118 . . . . 0.0 108.706 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.12 -44.52 75.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 108.979 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.2 -48.94 71.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.424 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 75' ' ' GLY . 64.6 mt -55.5 -43.97 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.96 . . . . 0.0 109.474 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.568 ' CD2' ' SD ' ' A' ' 28' ' ' MET . 4.5 m-85 -63.35 -32.09 73.42 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.102 -0.999 . . . . 0.0 108.731 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.524 ' OG1' ' CG1' ' A' ' 46' ' ' VAL . 8.7 m -66.92 -24.8 66.13 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.5 m -84.48 -29.96 25.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.531 -0.73 . . . . 0.0 109.166 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.509 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 1.9 mt-30 -71.45 -38.03 71.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 109.514 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.565 ' HE2' ' CH2' ' A' ' 21' ' ' TRP . 4.2 ptm -82.38 -33.11 28.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.46 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.527 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 9.2 t0 -59.7 -28.89 67.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 0.0 109.299 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -90.08 -36.83 14.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.872 . . . . 0.0 109.454 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.509 ' CD1' ' O ' ' A' ' 83' ' ' GLN . 5.6 m-85 -71.33 -8.45 53.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 109.565 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.517 HD21 ' CD2' ' A' ' 59' ' ' TYR . 20.3 mt -84.98 -14.17 48.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.539 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 100.67 18.22 21.36 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 0.3 OUTLIER 73.29 6.77 5.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -1.108 . . . . 0.0 109.606 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.4 m -85.07 -14.95 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.122 -0.986 . . . . 0.0 109.464 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -90.14 172.87 8.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 109.546 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.466 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 3.5 t -128.38 176.14 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 109.312 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -122.82 133.48 54.44 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.096 -1.002 . . . . 0.0 109.006 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.682 ' CD2' ' CE1' ' A' ' 62' ' ' HIS . 29.1 m-70 -126.83 141.74 51.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.125 -0.984 . . . . 0.0 110.145 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.612 ' HA ' ' CZ ' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -89.34 120.02 30.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 109.792 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 64' ' ' TRP . 26.9 mt-10 -127.74 156.72 41.98 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.276 -0.89 . . . . 0.0 108.845 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.629 ' CG2' ' CG ' ' A' ' 101' ' ' HIS . 3.0 t -160.11 -179.27 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.301 -0.875 . . . . 0.0 108.874 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.467 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 28.8 tt0 -73.69 -3.27 27.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.938 -1.101 . . . . 0.0 109.198 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.56 6.21 3.85 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.629 ' CG ' ' CG2' ' A' ' 98' ' ' VAL . 10.9 m170 -109.45 -89.97 0.47 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.397 -1.061 . . . . 0.0 108.766 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.594 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -83.5 44.44 0.97 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.446 -0.784 . . . . 0.0 110.269 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -80.62 -61.5 1.95 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 108.698 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.516 ' N ' ' OG ' ' A' ' 103' ' ' SER . 28.2 tt0 -64.46 -47.27 79.67 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.486 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 40.8 m -49.57 -46.51 48.98 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.594 ' HB2' ' O ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -49.73 -65.14 0.61 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.54 ' HA ' ' CD1' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -42.51 -35.01 0.94 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.486 ' CB ' ' O ' ' A' ' 105' ' ' THR . . . -52.13 -56.51 14.02 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.49 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 97.1 m-85 -56.41 -28.34 59.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.902 . . . . 0.0 108.576 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.584 ' CD2' HD13 ' A' ' 114' ' ' LEU . 87.6 m-85 -88.02 90.38 8.36 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -74.06 -0.14 15.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.438 -0.789 . . . . 0.0 109.923 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -96.85 -85.46 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.109 -0.994 . . . . 0.0 109.594 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -164.22 123.07 1.14 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.584 HD13 ' CD2' ' A' ' 110' ' ' PHE . 4.4 mt -92.15 145.28 24.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -1.159 . . . . 0.0 110.067 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.533 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -140.29 169.79 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.533 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 1.0 OUTLIER -147.45 139.34 24.19 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.926 -1.109 . . . . 0.0 110.137 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -114.71 -168.25 1.35 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.512 -0.742 . . . . 0.0 109.235 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.583 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 1.1 pm0 -90.92 163.41 14.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.015 -1.053 . . . . 0.0 110.561 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.621 ' HA2' ' CD2' ' A' ' 40' ' ' TYR . . . -93.28 178.67 38.75 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.22 52.8 1.55 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.563 ' O ' ' CG1' ' A' ' 121' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.132 -1.216 . . . . 0.0 109.103 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 2' ' ' GLU . 9.7 p . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.589 ' HA ' ' CZ ' ' A' ' 80' ' ' TYR . 14.6 pt-20 -43.28 123.21 2.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.349 -0.844 . . . . 0.0 109.639 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.58 ' N ' ' CD2' ' A' ' 3' ' ' LEU . 1.7 pt? -43.78 133.78 4.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.102 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.4 m -89.23 -176.26 5.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 110.146 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.548 ' CB ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -72.2 -31.26 65.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.372 -0.83 . . . . 0.0 109.147 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -76.93 -28.68 55.33 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.512 ' CG1' ' HB2' ' A' ' 3' ' ' LEU . 1.8 t -70.8 -62.29 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.531 ' O ' ' CD1' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -90.32 12.56 17.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.275 -0.891 . . . . 0.0 109.494 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 5' ' ' LYS . . . -70.56 -105.29 0.04 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 11' ' ' LEU . 10.6 mttm -65.23 -29.28 70.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -1.098 . . . . 0.0 109.431 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.542 ' CD1' ' CD2' ' A' ' 88' ' ' LEU . 4.0 mt 44.34 57.13 4.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.403 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.467 ' HB2' ' NE2' ' A' ' 19' ' ' GLN . 0.3 OUTLIER 68.15 137.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.297 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.46 ' O ' ' OG1' ' A' ' 14' ' ' THR . 26.1 mmtt -142.04 149.7 40.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.659 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.556 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 80.5 p 50.09 58.04 5.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.476 -0.765 . . . . 0.0 109.768 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 14' ' ' THR . 18.7 m -171.64 120.82 0.47 Allowed Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.468 -0.77 . . . . 0.0 109.092 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.0 128.18 9.79 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.31 2.007 . . . . 0.0 110.348 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 147.19 169.5 14.71 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.57 HG13 ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -123.8 155.47 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.011 -1.287 . . . . 0.0 110.159 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 16.5 mt-30 -115.17 158.3 22.43 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.554 ' O ' ' CB ' ' A' ' 31' ' ' VAL . 4.0 mt -129.02 153.52 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.763 -1.21 . . . . 0.0 110.369 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.568 ' CD1' ' SD ' ' A' ' 28' ' ' MET . 9.2 m-90 -115.42 132.54 56.59 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.61 ' HA ' ' CD2' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -90.22 128.03 36.28 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.832 -1.167 . . . . 0.0 111.84 -177.351 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.54 HG13 ' CB ' ' A' ' 44' ' ' CYS . 5.0 mm -99.69 56.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 177.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.504 ' O ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -48.44 -106.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.347 -177.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.568 ' O ' ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -45.43 -77.69 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.917 -1.114 . . . . 0.0 108.3 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.587 ' CE ' ' CB ' ' A' ' 69' ' ' SER . 13.2 mmt -163.29 36.85 0.09 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 74.8 mt-10 -141.4 145.42 35.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.343 -0.848 . . . . 0.0 109.367 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.638 ' CB ' ' CD2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -73.46 139.01 45.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.253 -0.904 . . . . 0.0 110.238 -179.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.543 ' O ' ' CA ' ' A' ' 21' ' ' TRP . 1.9 t -138.43 154.96 74.0 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.544 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 35.1 Cg_endo -77.37 125.52 7.79 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.316 2.011 . . . . 0.0 111.668 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.576 ' CG2' ' N ' ' A' ' 22' ' ' ARG . 1.4 t -118.33 97.8 50.97 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.6 -154.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.676 2.25 . . . . 0.0 110.113 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.592 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -77.51 2.88 14.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.104 -0.997 . . . . 0.0 109.322 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -66.0 -35.44 80.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.142 -0.973 . . . . 0.0 110.307 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.13 68.39 0.38 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.945 -1.097 . . . . 0.0 110.38 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.592 ' CD2' ' HA ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -90.47 39.57 0.98 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.046 -1.034 . . . . 0.0 109.86 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.502 ' HA2' ' CE2' ' A' ' 39' ' ' PHE . . . -144.6 -50.48 0.03 OUTLIER Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.206 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.463 ' HA ' HG21 ' A' ' 115' ' ' ILE . 1.7 m-80 -79.73 93.92 5.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.093 -1.239 . . . . 0.0 109.57 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.627 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -129.76 128.83 43.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.508 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.625 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 64.5 m-85 -39.14 124.78 1.52 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.56 -0.713 . . . . 0.0 110.613 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.6 ' HA ' ' CH2' ' A' ' 64' ' ' TRP . 2.7 pt-20 -80.63 -0.14 36.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.281 -0.887 . . . . 0.0 109.303 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.568 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -124.61 54.97 0.72 Allowed Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.467 ' HA ' ' OE1' ' A' ' 73' ' ' GLU . 7.9 m-20 -160.15 -123.99 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.296 -1.12 . . . . 0.0 109.186 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.614 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 92.0 m -153.28 155.42 36.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.88 -1.137 . . . . 0.0 109.568 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.627 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 31.0 m-85 -155.03 116.62 4.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.359 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.543 ' O ' ' CG2' ' A' ' 20' ' ' ILE . 47.9 t -78.08 160.44 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.695 -1.253 . . . . 0.0 108.141 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.573 HD21 ' CD2' ' A' ' 62' ' ' HIS . 7.2 tt -153.76 106.48 2.88 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.496 -1.378 . . . . 0.0 110.12 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.532 ' CD2' ' HB3' ' A' ' 11' ' ' LEU . 13.1 tp -95.99 109.15 21.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.597 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.532 ' OG ' ' CG2' ' A' ' 18' ' ' ILE . 12.9 t -98.89 133.5 43.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.334 -0.854 . . . . 0.0 109.644 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.2 m -122.17 142.31 50.54 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.508 ' HG2' ' N ' ' A' ' 52' ' ' LYS . 7.6 ttt180 -142.82 147.78 36.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 109.494 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.508 ' N ' ' HG2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -80.99 163.41 23.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.979 . . . . 0.0 109.608 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 56' ' ' GLY . 1.5 p -157.97 -168.58 2.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.293 -0.879 . . . . 0.0 109.489 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.22 -41.0 32.53 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 56' ' ' GLY . 1.1 p -79.84 -59.15 2.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -1.184 . . . . 0.0 109.469 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.513 ' N ' ' OG ' ' A' ' 55' ' ' SER . . . -157.09 -129.2 1.11 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.556 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 5.0 m-30 -103.31 -169.72 1.69 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -1.159 . . . . 0.0 109.243 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.477 ' HA ' ' CG2' ' A' ' 91' ' ' VAL . 69.5 m -149.94 107.38 3.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.192 -0.943 . . . . 0.0 109.295 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.507 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 48.1 m-85 -89.16 158.09 18.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.207 -0.933 . . . . 0.0 109.805 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.577 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 6.8 m-20 -154.85 92.73 1.49 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.52 ' CG2' HG21 ' A' ' 81' ' ' THR . 9.9 mt -80.83 132.26 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.164 -0.96 . . . . 0.0 110.642 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.573 ' CD2' HD21 ' A' ' 47' ' ' LEU . 42.7 m-70 -119.57 162.35 19.08 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 95' ' ' HIS . 49.5 p90 -136.7 94.08 2.94 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.339 -1.345 . . . . 0.0 109.674 176.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.605 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 3.4 t90 -70.2 140.52 52.52 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.571 ' CD2' ' O ' ' A' ' 64' ' ' TRP . 8.1 mt -138.77 77.32 1.62 Allowed 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 118.532 -1.267 . . . . 0.0 111.144 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 41' ' ' GLU . . . -54.81 90.04 0.01 OUTLIER Glycine 0 C--N 1.275 -2.85 0 N-CA-C 106.9 -2.48 . . . . 0.0 106.9 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.546 ' HE3' ' CG1' ' A' ' 98' ' ' VAL . 9.5 ptpt -51.45 98.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.379 1.085 . . . . 0.0 112.185 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.568 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 13.7 m120 -160.15 -41.22 0.05 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.587 ' CB ' ' CE ' ' A' ' 26' ' ' MET . 81.9 p -67.22 -144.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.522 -0.736 . . . . 0.0 109.036 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.462 ' OG ' ' OD2' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -115.74 163.0 16.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.024 -1.048 . . . . 0.0 109.777 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -49.83 -32.07 13.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.25 -0.906 . . . . 0.0 109.156 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 3.0 p30 -60.35 -45.53 93.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.144 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 15.2 tt0 -56.91 -37.11 70.98 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.499 ' CG ' HD11 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -62.24 -35.85 80.21 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.529 ' O ' ' CG1' ' A' ' 79' ' ' ILE . . . -81.65 -12.98 80.87 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.58 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -77.5 -52.6 8.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.294 -1.121 . . . . 0.0 108.955 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.546 ' CB ' ' HB3' ' A' ' 44' ' ' CYS . . . -75.88 -38.82 57.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.913 . . . . 0.0 109.1 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.83 94.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.301 -0.874 . . . . 0.0 109.229 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.529 ' CG1' ' O ' ' A' ' 75' ' ' GLY . 65.4 mt -71.6 -43.67 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.248 -0.908 . . . . 0.0 109.266 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.638 ' CD2' ' CB ' ' A' ' 28' ' ' MET . 3.4 m-85 -57.97 -35.47 71.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.122 -0.986 . . . . 0.0 108.867 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.52 HG21 ' CG2' ' A' ' 61' ' ' ILE . 18.1 m -67.51 -38.77 84.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.403 -0.811 . . . . 0.0 108.856 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.9 m -59.83 -42.86 94.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.844 . . . . 0.0 109.06 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -67.16 -28.47 68.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.264 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.514 ' HG2' ' CD1' ' A' ' 61' ' ' ILE . 17.8 ttm -63.08 -45.39 92.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.201 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.54 -15.28 25.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 108.994 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.18 -63.66 1.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.327 -0.858 . . . . 0.0 109.066 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.548 ' CE1' ' CB ' ' A' ' 5' ' ' LYS . 4.7 m-85 -53.93 -20.35 5.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 108.969 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.542 ' CD2' ' CD1' ' A' ' 11' ' ' LEU . 51.7 mt -90.15 -62.64 1.42 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -0.842 . . . . 0.0 109.196 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 57.22 62.3 6.51 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.3 p -143.64 -143.14 0.14 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.259 -1.142 . . . . 0.0 109.297 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.477 ' CG2' ' HA ' ' A' ' 58' ' ' SER . 11.6 m -92.18 15.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.507 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -52.23 173.01 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.693 -0.63 . . . . 0.0 109.826 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.464 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 3.9 t -147.63 177.09 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.524 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -124.43 136.16 53.83 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.111 -0.993 . . . . 0.0 108.877 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.59 ' O ' ' CD1' ' A' ' 63' ' ' TYR . 18.0 m-70 -131.96 150.75 52.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.978 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.571 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 8.6 ttm180 -108.78 124.66 50.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.311 -0.868 . . . . 0.0 109.8 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.492 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 66.6 mm-40 -131.97 163.66 27.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.139 -0.975 . . . . 0.0 109.709 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.546 ' CG1' ' HE3' ' A' ' 67' ' ' LYS . 2.9 t -156.14 -176.95 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 108.977 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -66.23 -5.8 11.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.929 -1.107 . . . . 0.0 110.266 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.88 15.46 3.54 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.538 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 20.5 m-70 -122.57 -19.32 6.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.575 -0.956 . . . . 0.0 109.638 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.605 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.27 24.05 2.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.89 . . . . 0.0 109.508 -179.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 102' ' ' GLU . 6.1 p -45.01 -106.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.494 -0.754 . . . . 0.0 111.863 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 40.6 mt-10 -71.39 -19.05 62.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.843 -1.16 . . . . 0.0 110.948 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.483 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 3.6 m -69.6 -50.9 40.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.897 -1.127 . . . . 0.0 109.605 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.544 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.3 OUTLIER -67.85 -57.26 6.56 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.89 -24.87 25.45 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.17 -0.956 . . . . 0.0 108.628 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -61.26 -58.36 8.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.38 -0.825 . . . . 0.0 108.823 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.407 ' HB3' HG22 ' A' ' 18' ' ' ILE . 16.6 m-85 -68.33 -8.65 41.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -0.892 . . . . 0.0 109.236 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.597 ' CB ' HD22 ' A' ' 114' ' ' LEU . 1.1 m-85 -113.47 96.73 6.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -88.56 60.39 5.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 109.697 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 111' ' ' LYS . 28.2 mm100 -153.34 -87.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.181 -0.949 . . . . 0.0 109.553 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.613 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -139.16 -113.47 1.12 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.613 ' CB ' ' O ' ' A' ' 113' ' ' GLY . 0.1 OUTLIER 141.72 86.46 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.576 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -95.04 171.05 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 0.0 108.964 179.772 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.576 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -151.89 129.77 11.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.265 -0.897 . . . . 0.0 109.602 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.625 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -100.17 168.03 10.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.712 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 119' ' ' GLY . 10.6 pt20 -92.52 153.39 19.1 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.769 -1.207 . . . . 0.0 111.372 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.599 ' O ' ' CD1' ' A' ' 40' ' ' TYR . . . 52.1 164.62 0.01 OUTLIER Glycine 0 N--CA 1.498 2.807 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.57 ' O ' ' CE1' ' A' ' 40' ' ' TYR . . . -60.91 -123.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.52 ' O ' ' CG1' ' A' ' 121' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.263 -1.139 . . . . 0.0 109.253 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.513 ' CG1' ' HB3' ' A' ' 27' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 1' ' ' VAL . 1.5 mm-40 43.48 59.13 3.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.304 -0.872 . . . . 0.0 109.519 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.585 ' CD1' ' N ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -64.15 -13.89 51.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 109.695 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.585 ' N ' ' CD1' ' A' ' 3' ' ' LEU . 0.4 OUTLIER -78.21 168.33 20.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 109.791 -179.581 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 4' ' ' SER . 3.8 ttmm 81.39 -69.43 0.08 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.76 -0.588 . . . . 0.0 109.896 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -83.83 12.51 5.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.083 -1.011 . . . . 0.0 110.115 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.572 HG12 ' CZ2' ' A' ' 21' ' ' TRP . 35.0 t -145.52 -77.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.014 -1.054 . . . . 0.0 109.696 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.55 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 77.0 p -39.96 -28.08 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.471 -0.768 . . . . 0.0 109.952 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 7' ' ' VAL . . . -41.98 -59.64 2.84 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 3.3 mtmt -132.58 -29.08 1.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.178 -1.189 . . . . 0.0 110.218 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.551 ' CD2' ' CD2' ' A' ' 88' ' ' LEU . 3.1 mp 65.61 9.84 6.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.098 -1.001 . . . . 0.0 109.17 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 62.65 128.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.872 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.492 ' C ' ' CG2' ' A' ' 14' ' ' THR . 6.0 mmtt -96.43 169.02 10.2 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.492 ' CG2' ' C ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER 173.96 -83.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.592 -1.317 . . . . 0.0 111.218 -178.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.581 ' OG1' ' HD2' ' A' ' 16' ' ' PRO . 0.6 OUTLIER -161.97 -175.08 0.45 Allowed Pre-proline 0 C--N 1.284 -2.244 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.364 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.581 ' HD2' ' OG1' ' A' ' 15' ' ' THR . 33.3 Cg_endo -76.91 110.3 3.01 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.677 1.585 . . . . 0.0 111.28 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 49' ' ' SER . . . -161.47 -155.68 7.99 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.558 HD13 ' CE1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -160.92 154.56 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.734 -1.451 . . . . 0.0 110.523 179.489 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.519 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -133.82 -168.01 2.04 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.57 HD13 ' CZ ' ' A' ' 110' ' ' PHE . 55.9 mt -156.07 164.73 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.621 -1.3 . . . . 0.0 110.318 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.581 ' CG ' ' HE2' ' A' ' 28' ' ' MET . 15.0 m-90 -124.48 119.0 27.9 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.582 ' HA ' ' CD2' ' A' ' 45' ' ' TYR . 29.8 ttp-105 -80.78 108.85 14.78 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.169 -0.957 . . . . 0.0 112.189 -176.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -86.57 93.45 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 176.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 26' ' ' MET . 1.4 pm0 -56.62 80.02 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.6 ' C ' ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER 41.22 13.64 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.694 -0.629 . . . . 0.0 111.415 -179.149 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.626 ' HA ' ' CE ' ' A' ' 26' ' ' MET . 0.0 OUTLIER -157.75 -76.72 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.271 -1.518 . . . . 0.0 111.142 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.537 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -89.53 -147.06 0.17 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.167 -0.958 . . . . 0.0 110.776 -177.725 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.581 ' HE2' ' CG ' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -144.14 146.62 32.88 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.559 0.695 . . . . 0.0 109.913 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.524 ' N ' ' HG3' ' A' ' 28' ' ' MET . 0.9 OUTLIER -140.45 158.82 65.37 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.579 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 33.7 Cg_endo -75.33 137.9 21.59 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.32 2.014 . . . . 0.0 111.165 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.53 ' CB ' ' O ' ' A' ' 20' ' ' ILE . 2.5 t -123.62 98.44 40.47 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 35' ' ' SER . 34.7 Cg_endo -76.57 -157.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.441 2.094 . . . . 0.0 110.177 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.522 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -83.06 -22.41 33.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.096 -1.002 . . . . 0.0 109.111 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -86.35 1.17 52.1 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.338 -0.851 . . . . 0.0 109.879 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.47 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -131.22 -25.53 2.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.153 -0.967 . . . . 0.0 110.373 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.683 ' CD2' ' CE2' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -68.95 -5.84 23.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.946 -1.096 . . . . 0.0 109.81 -179.57 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.512 ' N ' ' CD1' ' A' ' 36' ' ' TYR . . . -85.67 -4.46 85.27 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.525 ' HB3' ' CG2' ' A' ' 115' ' ' ILE . 17.0 m-80 -153.59 103.06 2.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.133 -1.216 . . . . 0.0 109.57 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.592 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -123.46 131.73 53.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.059 -1.026 . . . . 0.0 109.598 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.6 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 6.6 m-30 -39.53 152.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.544 -0.723 . . . . 0.0 110.148 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.531 ' CG ' ' N ' ' A' ' 42' ' ' GLY . 12.4 pt-20 -89.67 -45.09 9.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 109.237 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.603 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -82.58 69.93 3.26 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 25' ' ' ASN . 10.9 m-20 -164.97 -166.39 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.91 -1.347 . . . . 0.0 111.1 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.563 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 1.7 m -127.37 156.87 41.34 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.592 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 30.9 m-85 -147.26 167.97 22.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.172 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 99.3 t -132.45 113.31 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.622 ' HB3' ' HB2' ' A' ' 62' ' ' HIS . 0.6 OUTLIER -90.13 155.15 19.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.174 -178.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.527 HD23 ' CD2' ' A' ' 11' ' ' LEU . 27.4 tp -146.5 85.9 1.66 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.553 ' CB ' ' HB ' ' A' ' 18' ' ' ILE . 1.0 OUTLIER -87.5 117.38 26.26 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 122.173 0.987 . . . . 0.0 109.872 -179.216 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.627 HG23 ' CE2' ' A' ' 57' ' ' PHE . 1.4 m -98.04 158.41 15.56 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.524 ' HG3' ' CB ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -160.56 117.62 2.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.915 -1.116 . . . . 0.0 109.867 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.528 ' O ' ' CG2' ' A' ' 53' ' ' THR . 3.0 pttm -46.78 172.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 0.0 109.268 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' A' ' 52' ' ' LYS . 1.4 p -167.69 172.95 8.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.44 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.9 -18.8 41.48 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 m -99.5 -52.23 3.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -1.111 . . . . 0.0 109.365 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 52' ' ' LYS . . . -176.08 -100.35 0.13 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.627 ' CE2' HG23 ' A' ' 50' ' ' THR . 0.9 OUTLIER -117.93 158.63 24.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -1.114 . . . . 0.0 110.033 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.524 ' CB ' ' HG3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -130.89 123.58 29.29 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.166 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.583 ' CE2' HD21 ' A' ' 88' ' ' LEU . 7.3 m-85 -105.04 153.52 21.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.856 -1.153 . . . . 0.0 111.753 -177.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.501 ' OD1' ' CG2' ' A' ' 93' ' ' VAL . 6.2 m-20 -137.6 95.41 3.06 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.539 ' CG2' ' CG2' ' A' ' 81' ' ' THR . 10.9 mt -87.75 122.71 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 111.156 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.706 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 16.4 m-70 -110.47 169.17 8.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.514 -0.741 . . . . 0.0 109.168 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 95' ' ' HIS . 50.2 p90 -139.23 109.4 6.44 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.817 -1.153 . . . . 0.0 109.044 176.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.532 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 7.0 t90 -86.05 135.72 33.52 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.279 0.561 . . . . 0.0 109.612 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.574 ' CD1' ' CG ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -120.02 61.57 0.85 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.93 -178.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -51.69 89.81 0.01 OUTLIER Glycine 0 N--CA 1.498 2.767 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 178.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 65' ' ' LEU . 1.5 tppt? -39.02 91.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.091 0.948 . . . . 0.0 112.611 -177.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.603 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 2.7 m-80 -162.76 -45.69 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 73' ' ' GLU . 14.2 p -61.21 -157.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.507 -0.745 . . . . 0.0 109.272 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.4 p -106.39 161.83 14.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.419 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 0.2 OUTLIER -50.32 -49.98 52.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.879 . . . . 0.0 109.43 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -54.45 -39.65 67.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.123 -0.986 . . . . 0.0 108.913 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.456 ' CD ' ' CE ' ' A' ' 26' ' ' MET . 0.1 OUTLIER -55.52 -39.25 70.29 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.238 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.574 ' CG ' ' CD1' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -59.78 -38.02 80.67 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 79' ' ' ILE . . . -69.55 -25.2 75.75 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.454 ' HA ' HD11 ' A' ' 79' ' ' ILE . . . -73.19 -59.38 2.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -1.129 . . . . 0.0 109.229 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 44' ' ' CYS . . . -49.45 -37.53 26.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 0.0 108.945 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.33 -34.68 68.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.334 -0.854 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 75' ' ' GLY . 15.4 mt -63.44 -49.12 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.867 . . . . 0.0 109.425 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.558 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 27.2 m-85 -58.47 -41.09 84.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.053 -1.029 . . . . 0.0 108.639 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.539 ' CG2' ' CG2' ' A' ' 61' ' ' ILE . 8.9 m -69.6 -22.34 63.51 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.431 -0.793 . . . . 0.0 108.897 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.8 m -86.44 -18.39 31.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.631 -0.668 . . . . 0.0 109.317 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 1.0 OUTLIER -89.85 -35.48 15.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.554 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.517 ' HE3' ' CZ3' ' A' ' 21' ' ' TRP . 5.2 ptm -82.32 -12.26 58.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.952 . . . . 0.0 109.482 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.408 ' HA ' ' HB1' ' A' ' 92' ' ' ALA . 9.4 t0 -79.91 -37.24 35.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.328 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -89.77 -29.04 18.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 109.257 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.471 ' HB3' ' HB ' ' A' ' 8' ' ' THR . 1.9 m-85 -76.21 -29.67 57.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.237 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.583 HD21 ' CE2' ' A' ' 59' ' ' TYR . 6.6 mt -72.06 -3.05 20.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.428 -0.795 . . . . 0.0 109.785 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.81 24.73 7.97 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 56.35 17.75 3.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -1.149 . . . . 0.0 109.322 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.7 m -96.64 -14.64 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.896 . . . . 0.0 109.255 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -77.04 164.53 25.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.316 -0.865 . . . . 0.0 109.427 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.501 ' CG2' ' OD1' ' A' ' 60' ' ' ASN . 2.5 t -113.5 -178.53 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.494 -0.754 . . . . 0.0 109.176 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 10.8 tt0 -132.64 136.41 46.47 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.135 -0.978 . . . . 0.0 109.054 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.706 ' CD2' ' CD2' ' A' ' 62' ' ' HIS . 10.1 m-70 -137.84 153.6 49.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.405 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.575 ' HA ' ' CE2' ' A' ' 63' ' ' TYR . 16.1 ptm180 -111.78 143.97 41.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.671 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.495 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 40.2 mm-40 -150.68 164.19 36.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.408 -0.808 . . . . 0.0 109.05 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.524 ' N ' ' HB2' ' A' ' 101' ' ' HIS . 2.3 t -154.52 -169.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 0.0 109.012 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -72.76 0.92 9.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.844 -1.16 . . . . 0.0 110.282 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.6 19.57 1.15 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.244 -1.943 . . . . 0.0 108.244 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.524 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 46.0 m-70 -125.09 -14.78 6.5 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.715 -0.873 . . . . 0.0 109.789 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.532 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.25 29.34 1.26 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.727 -179.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 102' ' ' GLU . 77.6 p -55.99 -131.63 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.368 -0.832 . . . . 0.0 111.138 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.466 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 0.1 OUTLIER -40.01 -24.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.769 -1.207 . . . . 0.0 111.068 -178.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 103' ' ' SER . 1.8 m -66.94 -63.78 0.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.843 -1.161 . . . . 0.0 110.592 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.52 ' HB2' ' HB2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -57.14 -47.16 81.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.756 -1.215 . . . . 0.0 108.227 -179.13 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 110' ' ' PHE . 10.6 mtm180 -59.46 -28.06 66.64 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 105' ' ' THR . . . -59.84 -44.47 94.07 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.571 ' OH ' ' CE1' ' A' ' 62' ' ' HIS . 63.6 m-85 -76.53 -12.79 60.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.683 ' CE2' ' CD2' ' A' ' 36' ' ' TYR . 20.4 m-85 -126.09 105.65 9.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.648 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 112' ' ' GLN . 5.1 ptmt -90.13 26.4 1.89 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 110.112 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.485 ' CB ' ' O ' ' A' ' 111' ' ' LYS . 1.1 pt20 165.2 83.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.892 -1.13 . . . . 0.0 110.469 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 114' ' ' LEU . . . 167.03 -122.89 1.09 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.607 ' CD2' ' CB ' ' A' ' 110' ' ' PHE . 0.2 OUTLIER 65.76 49.8 1.66 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.557 -0.966 . . . . 0.0 110.888 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.525 ' CG2' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -87.5 167.18 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 177.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.578 ' CZ ' ' O ' ' A' ' 114' ' ' LEU . 2.9 m-85 -143.66 122.73 12.86 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.823 -1.173 . . . . 0.0 110.353 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.6 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 1.9 mttm -102.62 -163.94 1.04 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.462 -0.773 . . . . 0.0 108.972 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.578 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -90.26 161.47 15.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.92 -1.112 . . . . 0.0 110.14 -179.658 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 120' ' ' GLY . . . -67.88 -161.88 1.9 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 58.73 112.5 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.519 ' HB ' ' CB ' ' A' ' 24' ' ' GLU . 4.2 p . . . . . 0 C--N 1.303 -1.431 0 O-C-N 121.265 -1.138 . . . . 0.0 108.676 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 11.0 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.473 ' HA ' ' CE1' ' A' ' 80' ' ' TYR . 1.9 mt-10 64.64 66.08 0.61 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.347 -0.846 . . . . 0.0 109.521 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.631 ' CD2' ' CD1' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -44.83 -41.16 6.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 3.2 t -42.54 150.56 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.378 -0.826 . . . . 0.0 109.616 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 4' ' ' SER . 14.1 ttpt 80.49 -72.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.586 -0.697 . . . . 0.0 109.775 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.483 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 70.2 mmtt -88.33 14.53 9.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.079 -1.013 . . . . 0.0 109.851 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 6' ' ' LYS . 21.8 t -157.2 -74.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.058 -1.026 . . . . 0.0 109.618 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.517 ' CB ' ' HA ' ' A' ' 4' ' ' SER . 2.3 m -49.3 -23.16 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 0.0 109.476 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 10' ' ' LYS . . . -89.38 32.89 4.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER 164.12 47.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -1.135 . . . . 0.0 109.464 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.518 HD11 ' CD2' ' A' ' 88' ' ' LEU . 38.2 mt -68.96 -147.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 0.0 109.208 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -83.84 119.6 25.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.961 . . . . 0.0 109.385 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.517 ' O ' ' CG2' ' A' ' 14' ' ' THR . 5.1 mmmt -122.97 -11.99 8.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 0.0 109.62 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.56 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 18.4 p -160.8 69.99 0.38 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 109.544 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 15' ' ' THR . 5.9 t -175.33 124.2 0.35 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.371 -0.831 . . . . 0.0 109.176 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.7 105.99 2.12 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.25 1.967 . . . . 0.0 110.514 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 173.33 176.76 42.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.652 ' CD1' ' CE1' ' A' ' 110' ' ' PHE . 3.9 pt -124.49 134.45 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -1.208 . . . . 0.0 109.922 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.446 ' NE2' ' CH2' ' A' ' 21' ' ' TRP . 1.5 tt0 -112.93 140.77 47.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.311 -0.868 . . . . 0.0 108.732 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 47' ' ' LEU . 2.2 mt -115.06 -178.91 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.803 -1.186 . . . . 0.0 109.679 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.595 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 10.6 m-90 -141.45 119.39 11.93 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.534 ' CG ' ' HB ' ' A' ' 29' ' ' VAL . 2.5 ptt180 -78.9 128.07 32.84 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.122 -0.986 . . . . 0.0 110.147 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.529 HG13 ' CB ' ' A' ' 44' ' ' CYS . 5.8 mm -96.49 43.89 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.529 ' CG ' ' N ' ' A' ' 25' ' ' ASN . 31.1 tt0 -70.29 168.04 16.75 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.335 0.588 . . . . 0.0 110.108 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.529 ' N ' ' CG ' ' A' ' 24' ' ' GLU . 8.2 p30 47.18 24.6 0.43 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -0.796 . . . . 0.0 109.141 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.497 ' CE ' ' HG2' ' A' ' 73' ' ' GLU . 24.4 mmm 57.75 50.54 10.52 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.413 -0.805 . . . . 0.0 109.491 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.514 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 53.8 mm-40 -148.24 -111.22 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.316 -0.865 . . . . 0.0 109.108 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.57 ' SD ' ' CD2' ' A' ' 80' ' ' TYR . 2.8 ttt 178.88 153.91 0.4 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.787 -1.196 . . . . 0.0 109.861 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -160.26 147.57 12.52 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.595 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 33.4 Cg_endo -74.04 94.73 0.89 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.563 2.175 . . . . 0.0 111.869 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.509 HG22 ' N ' ' A' ' 22' ' ' ARG . 60.0 t -76.58 112.75 23.64 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 36.3 Cg_endo -78.78 -161.8 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.448 2.099 . . . . 0.0 110.601 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.48 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -88.28 -3.72 58.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.315 -0.865 . . . . 0.0 109.054 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -87.52 8.29 25.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 109.74 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.4 m -159.99 21.07 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.157 -0.964 . . . . 0.0 110.076 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.564 ' CD2' ' O ' ' A' ' 36' ' ' TYR . 19.4 p90 -90.0 32.64 0.9 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.015 -1.053 . . . . 0.0 109.334 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.31 -10.07 5.73 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.466 ' CB ' ' HB ' ' A' ' 115' ' ' ILE . 5.5 m-80 -148.02 100.92 3.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.192 -1.181 . . . . 0.0 109.889 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.585 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -115.19 131.57 56.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.305 -0.872 . . . . 0.0 109.06 179.633 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.635 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 6.7 m-30 -39.42 155.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.451 -0.781 . . . . 0.0 109.943 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.557 ' CG ' ' N ' ' A' ' 42' ' ' GLY . 10.4 pt-20 -91.0 -46.32 8.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.474 -0.766 . . . . 0.0 110.161 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.586 ' CA ' ' CB ' ' A' ' 68' ' ' ASN . . . -83.01 67.38 3.76 Favored Glycine 0 N--CA 1.483 1.793 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.057 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.514 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -162.92 -148.11 0.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.916 -1.344 . . . . 0.0 110.299 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.529 ' CB ' HG13 ' A' ' 23' ' ' ILE . 14.2 m -144.28 139.8 28.82 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 30.1 m-85 -137.18 109.64 7.41 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.983 -1.073 . . . . 0.0 109.878 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.521 ' CG2' ' HE2' ' A' ' 28' ' ' MET . 25.0 t -78.5 131.21 34.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.176 -0.953 . . . . 0.0 108.462 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 62' ' ' HIS . 8.3 tt -111.57 163.43 14.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.15 -0.968 . . . . 0.0 109.469 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 20.3 tp -153.65 92.11 1.54 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.978 -1.077 . . . . 0.0 109.263 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.533 ' CB ' HG23 ' A' ' 18' ' ' ILE . 5.3 t -81.26 148.82 29.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.904 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 m -140.23 117.05 10.98 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -112.91 175.44 5.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.514 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.96 157.31 18.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.908 . . . . 0.0 109.429 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.1 p -146.8 -170.39 3.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.449 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.96 10.17 61.12 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 p -133.73 -54.69 0.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -1.111 . . . . 0.0 109.422 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.53 -135.11 1.85 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.56 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 88.2 m-85 -120.24 144.32 47.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -1.1 . . . . 0.0 109.66 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 68.8 m -101.09 106.82 18.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.282 -0.886 . . . . 0.0 108.705 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.57 ' CD2' ' CG2' ' A' ' 91' ' ' VAL . 6.3 m-85 -84.64 156.36 21.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.205 -0.935 . . . . 0.0 110.339 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.476 ' OD1' ' CG2' ' A' ' 93' ' ' VAL . 5.8 m-20 -143.68 102.61 3.95 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.542 ' CG2' ' CG2' ' A' ' 81' ' ' THR . 7.7 mt -92.36 112.3 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.255 -0.903 . . . . 0.0 110.461 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.708 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 15.1 m-70 -105.1 166.98 10.01 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.607 -0.683 . . . . 0.0 109.534 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.583 ' CZ ' ' HA ' ' A' ' 96' ' ' ARG . 43.5 p90 -138.04 106.62 5.87 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.401 -1.32 . . . . 0.0 109.856 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.57 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 4.8 t90 -82.38 131.57 35.22 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -119.28 65.21 0.79 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.357 -0.839 . . . . 0.0 110.753 -178.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 68' ' ' ASN . . . -49.53 91.08 0.01 OUTLIER Glycine 0 N--CA 1.498 2.796 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -37.74 88.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 122.081 0.943 . . . . 0.0 112.414 -177.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.586 ' CB ' ' CA ' ' A' ' 42' ' ' GLY . 2.7 m-80 -162.75 -43.65 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.538 ' HB2' ' CB ' ' A' ' 73' ' ' GLU . 14.1 p -60.32 168.64 1.95 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.632 -0.667 . . . . 0.0 109.458 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.453 ' OG ' ' OE1' ' A' ' 73' ' ' GLU . 1.5 p -73.87 168.89 18.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.939 . . . . 0.0 109.445 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.3 -51.22 63.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.546 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 2.1 p30 -55.3 -39.32 69.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.127 -0.983 . . . . 0.0 109.511 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.538 ' CB ' ' HB2' ' A' ' 69' ' ' SER . 3.0 mp0 -56.5 -38.66 72.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 108.656 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.508 ' HB3' ' CD1' ' A' ' 65' ' ' LEU . 53.6 mt-30 -64.17 -33.52 75.97 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.511 ' O ' HD11 ' A' ' 79' ' ' ILE . . . -83.05 -10.91 82.1 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.73 -44.36 13.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.999 -1.295 . . . . 0.0 108.939 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.45 -45.41 59.69 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.328 -0.858 . . . . 0.0 109.029 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.16 93.29 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.533 ' N ' HD11 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -65.53 -41.35 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.198 -0.939 . . . . 0.0 108.994 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.631 ' CD1' ' CD2' ' A' ' 3' ' ' LEU . 11.3 m-85 -61.45 -29.43 69.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.973 -1.079 . . . . 0.0 108.53 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.542 ' CG2' ' CG2' ' A' ' 61' ' ' ILE . 2.6 m -75.52 -25.5 57.28 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.0 m -81.16 -27.14 35.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.532 -0.73 . . . . 0.0 109.22 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 0.9 OUTLIER -78.04 -36.57 48.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.608 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.504 ' HG3' ' CD1' ' A' ' 61' ' ' ILE . 5.4 ptm -82.23 -8.14 59.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 109.593 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.531 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -75.48 -41.57 55.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.381 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -90.03 -29.25 18.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.313 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.514 ' CB ' HG23 ' A' ' 8' ' ' THR . 0.3 OUTLIER -70.22 -32.26 70.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 109.55 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.518 ' CD2' HD11 ' A' ' 11' ' ' LEU . 14.7 mt -66.19 -22.4 66.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.601 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 90' ' ' SER . . . 121.12 14.61 4.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 89' ' ' GLY . 6.3 t 72.19 3.95 4.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -1.188 . . . . 0.0 109.588 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.57 ' CG2' ' CD2' ' A' ' 59' ' ' TYR . 17.9 m -87.7 -19.73 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.521 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -77.15 170.13 17.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.237 -0.914 . . . . 0.0 109.608 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.487 ' HB ' ' NE2' ' A' ' 95' ' ' HIS . 2.9 t -121.94 -177.36 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.089 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.465 ' HG2' ' OD1' ' A' ' 85' ' ' ASP . 16.0 mt-30 -128.22 140.07 52.11 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.007 -1.058 . . . . 0.0 108.864 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.708 ' CD2' ' CD2' ' A' ' 62' ' ' HIS . 7.0 m-70 -141.63 151.08 42.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.029 -1.044 . . . . 0.0 109.69 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -109.67 140.95 42.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.341 -0.849 . . . . 0.0 110.362 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.491 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 60.5 mm-40 -148.41 163.68 36.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.407 -0.808 . . . . 0.0 109.122 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.544 ' N ' ' HB2' ' A' ' 101' ' ' HIS . 2.7 t -155.38 -175.17 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.098 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.46 ' CG ' ' O ' ' A' ' 99' ' ' GLN . 38.5 tt0 -69.75 -1.99 10.74 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.934 -1.103 . . . . 0.0 110.195 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.53 16.12 2.04 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.544 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 39.4 m-70 -122.45 -16.42 7.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.484 -1.01 . . . . 0.0 109.591 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.57 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.1 24.29 2.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.905 . . . . 0.0 109.363 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 102' ' ' GLU . 3.5 p -48.63 -107.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.417 -0.802 . . . . 0.0 111.459 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 22.4 mt-10 -67.2 -17.45 64.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.916 -1.115 . . . . 0.0 110.909 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.484 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 4.3 m -72.17 -54.95 8.15 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.937 -1.102 . . . . 0.0 109.756 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.542 ' HB2' ' HB2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -63.63 -57.5 9.88 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.27 -30.15 36.89 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.228 -0.92 . . . . 0.0 108.806 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -58.1 -45.0 87.95 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -0.828 . . . . 0.0 108.809 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.473 ' CE2' ' CE1' ' A' ' 62' ' ' HIS . 34.2 m-85 -76.7 -14.16 59.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -0.816 . . . . 0.0 109.41 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.652 ' CE1' ' CD1' ' A' ' 18' ' ' ILE . 2.3 m-85 -117.03 96.99 5.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.408 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 111' ' ' LYS . 23.0 ttpt -83.75 73.1 10.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.135 -0.978 . . . . 0.0 109.415 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 111' ' ' LYS . 4.8 mt-30 -171.33 -80.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.129 -0.982 . . . . 0.0 109.804 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 179.95 131.49 1.65 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.589 HD23 ' CG ' ' A' ' 110' ' ' PHE . 10.5 mt -103.49 135.75 44.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -1.107 . . . . 0.0 110.007 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.562 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 2.6 mt -107.57 165.42 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 108.836 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.562 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -141.45 102.42 4.2 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.367 -0.833 . . . . 0.0 109.147 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.635 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 5.1 mmmt -82.28 -155.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 109.664 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.585 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -92.18 -179.9 5.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.551 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 120' ' ' GLY . . . -113.19 -169.67 17.38 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 119' ' ' GLY . . . 43.23 84.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.536 ' O ' ' CG1' ' A' ' 121' ' ' VAL . 0.6 OUTLIER -88.62 12.98 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -1.208 . . . . 0.0 109.222 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.39 -23.34 40.51 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.49 -0.756 . . . . 0.0 109.434 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.7 m 45.85 25.48 0.3 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -0.872 . . . . 0.0 109.489 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -121.57 12.36 9.51 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.0 mmt -112.18 -154.37 0.54 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.404 -1.056 . . . . 0.0 109.407 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.9 mttt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.433 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.478 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 65.1 t . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 173.87 60.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.191 -0.943 . . . . 0.0 109.484 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.563 ' CD1' ' CD2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -63.48 -11.3 22.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.519 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.538 ' N ' ' CD1' ' A' ' 3' ' ' LEU . 0.3 OUTLIER -74.73 151.18 39.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.962 . . . . 0.0 109.587 -179.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 4' ' ' SER . 17.7 tttm 80.2 -72.57 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.471 -0.768 . . . . 0.0 109.764 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.77 -10.73 29.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 109.757 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.576 HG12 ' CZ2' ' A' ' 21' ' ' TRP . 5.2 t -123.93 -71.23 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.101 -0.999 . . . . 0.0 109.519 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.526 ' HB ' ' CB ' ' A' ' 87' ' ' TYR . 19.2 p -50.23 -21.89 1.53 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.668 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 10' ' ' LYS . . . -42.75 -42.05 4.65 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 12.6 mttt -155.29 -37.96 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.138 -1.213 . . . . 0.0 109.805 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.507 ' CD1' ' CD2' ' A' ' 88' ' ' LEU . 51.0 mt 64.2 -144.84 0.28 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.123 -0.986 . . . . 0.0 109.138 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.505 ' O ' ' CE2' ' A' ' 59' ' ' TYR . 2.3 m-20 -88.21 97.81 11.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.113 -0.992 . . . . 0.0 109.549 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.524 ' O ' ' CG2' ' A' ' 14' ' ' THR . 10.5 mttt -100.83 -4.71 27.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.945 . . . . 0.0 109.641 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 19.9 p -160.15 49.59 0.28 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.94 . . . . 0.0 109.499 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.3 m -151.01 105.41 3.0 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.379 -0.826 . . . . 0.0 109.116 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.35 86.76 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.402 2.068 . . . . 0.0 110.343 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.466 ' O ' HG21 ' A' ' 18' ' ' ILE . . . -170.29 -132.76 1.5 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.498 HD13 ' CE1' ' A' ' 110' ' ' PHE . 18.3 pt -156.81 137.83 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.078 -1.248 . . . . 0.0 110.119 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.58 ' O ' ' CZ3' ' A' ' 21' ' ' TRP . 1.4 tt0 -119.62 113.9 21.4 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 47' ' ' LEU . 3.8 mt -90.03 175.88 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.799 -1.188 . . . . 0.0 109.942 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.6 ' CG ' ' HE2' ' A' ' 28' ' ' MET . 10.7 m-90 -137.04 119.18 15.49 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.585 ' HG3' ' CZ ' ' A' ' 45' ' ' TYR . 8.0 ttp180 -79.15 130.23 35.28 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.14 -0.975 . . . . 0.0 110.921 -177.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.536 HG13 ' CB ' ' A' ' 44' ' ' CYS . 3.3 mm -95.08 37.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.515 ' HG2' ' N ' ' A' ' 25' ' ' ASN . 1.3 tt0 -47.31 149.45 1.04 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.395 0.617 . . . . 0.0 110.703 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.515 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 2.4 p-10 44.33 27.47 0.22 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.445 -0.785 . . . . 0.0 109.072 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.538 ' HE2' ' CB ' ' A' ' 69' ' ' SER . 3.4 mmm 64.1 51.55 2.19 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.464 -0.773 . . . . 0.0 109.322 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.418 ' CD ' HG21 ' A' ' 1' ' ' VAL . 9.7 mt-10 -153.73 122.65 6.41 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.6 ' HE2' ' CG ' ' A' ' 21' ' ' TRP . 2.1 mtp -56.63 145.06 29.74 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.177 -0.952 . . . . 0.0 110.339 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -149.64 149.98 29.71 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 32.3 Cg_endo -72.98 113.86 3.89 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.229 1.953 . . . . 0.0 111.857 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 22' ' ' ARG . 41.4 t -111.3 92.28 15.6 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.5 ' HG2' ' CD ' ' A' ' 34' ' ' LYS . 35.0 Cg_endo -77.12 -156.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.717 2.278 . . . . 0.0 110.202 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.574 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -75.83 -23.53 55.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.094 -1.004 . . . . 0.0 108.945 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.5 ' CD ' ' HG2' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -81.85 8.01 11.36 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.206 -0.934 . . . . 0.0 109.613 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.456 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 2.5 m -128.25 -45.36 1.38 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.745 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -45.05 158.31 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.438 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.466 ' O ' ' HB ' ' A' ' 115' ' ' ILE . . . 112.88 -47.84 1.0 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.43 94.15 4.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -1.209 . . . . 0.0 109.885 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.574 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -113.04 121.03 43.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.302 -0.874 . . . . 0.0 109.797 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.569 ' CG ' ' O ' ' A' ' 118' ' ' GLN . 7.0 m-30 -39.33 131.9 1.53 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 110.607 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.525 ' HG2' ' CB ' ' A' ' 116' ' ' TYR . 2.9 pt-20 -90.66 56.68 3.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.217 -0.927 . . . . 0.0 109.01 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.575 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -176.89 47.92 0.11 Allowed Glycine 0 N--CA 1.484 1.876 0 N-CA-C 108.914 -1.675 . . . . 0.0 108.914 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.468 ' CG ' ' O ' ' A' ' 42' ' ' GLY . 2.4 m-20 -162.16 -129.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.654 -0.909 . . . . 0.0 109.608 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.536 ' CB ' HG13 ' A' ' 23' ' ' ILE . 1.8 m -149.14 144.7 26.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.05 -1.031 . . . . 0.0 108.927 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CZ ' ' HG3' ' A' ' 22' ' ' ARG . 26.0 m-85 -142.65 111.25 6.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.097 -1.002 . . . . 0.0 109.727 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.53 ' CG1' ' OG1' ' A' ' 81' ' ' THR . 11.3 t -79.73 123.03 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.958 -1.089 . . . . 0.0 108.961 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.579 HD11 ' CE1' ' A' ' 106' ' ' PHE . 8.2 tt -112.94 122.24 47.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.956 -1.09 . . . . 0.0 110.061 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.45 HD12 ' HB3' ' A' ' 59' ' ' TYR . 23.2 tp -107.13 109.86 21.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.069 -1.02 . . . . 0.0 109.705 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.472 ' OG ' HG21 ' A' ' 18' ' ' ILE . 3.2 t -98.19 133.9 41.98 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.18 -0.95 . . . . 0.0 109.272 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.2 m -129.21 142.57 50.82 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.507 ' HG2' ' N ' ' A' ' 52' ' ' LYS . 9.1 ttp180 -140.14 157.12 46.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.892 . . . . 0.0 109.534 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.507 ' N ' ' HG2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -74.12 159.92 31.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -154.37 -172.74 4.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 109.463 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.73 -35.97 8.13 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t -82.74 -25.24 33.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -1.146 . . . . 0.0 109.488 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 53' ' ' THR . . . 165.67 -117.61 0.76 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.578 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 2.2 m-30 -115.07 169.08 9.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -1.116 . . . . 0.0 109.579 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -133.87 107.85 8.09 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.531 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 23.2 m-85 -92.55 169.01 10.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.104 -0.997 . . . . 0.0 110.374 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.52 ' HB3' ' NE2' ' A' ' 95' ' ' HIS . 14.2 m120 -158.89 88.25 0.89 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.517 HG23 ' CG2' ' A' ' 81' ' ' THR . 21.0 mt -76.67 137.12 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.203 -0.936 . . . . 0.0 110.264 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.686 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 53.3 m-70 -123.79 159.39 29.62 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 95' ' ' HIS . 37.4 p90 -133.38 98.64 4.29 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.345 -1.342 . . . . 0.0 109.196 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.579 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 5.6 t90 -77.07 132.77 39.07 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.076 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -116.83 65.01 0.72 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.456 -0.778 . . . . 0.0 110.844 -178.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -45.24 91.42 0.01 OUTLIER Glycine 0 N--CA 1.5 2.94 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.611 ' N ' ' O ' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -39.44 91.38 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.928 0.87 . . . . 0.0 113.204 -177.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.575 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 3.1 m-20 -162.66 -44.22 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.538 ' CB ' ' HE2' ' A' ' 26' ' ' MET . 25.2 p -63.93 -153.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.481 -0.762 . . . . 0.0 109.499 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.453 ' OG ' ' OD1' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -123.08 -173.88 2.82 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.302 -0.873 . . . . 0.0 109.428 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -61.01 -32.0 71.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.886 . . . . 0.0 109.604 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.453 ' OD1' ' OG ' ' A' ' 70' ' ' SER . 7.0 p-10 -68.09 -44.09 77.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 0.0 109.556 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.535 ' CG ' ' HB2' ' A' ' 69' ' ' SER . 0.8 OUTLIER -57.98 -36.94 73.34 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.953 -1.092 . . . . 0.0 108.395 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.458 ' HA ' HD12 ' A' ' 65' ' ' LEU . 4.5 tt0 -64.82 -32.55 74.3 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.525 ' O ' ' CG1' ' A' ' 79' ' ' ILE . . . -83.64 -10.92 80.76 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.85 -52.53 5.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.84 -1.388 . . . . 0.0 109.295 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.83 -36.53 70.23 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.183 -0.948 . . . . 0.0 108.807 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.14 -38.52 75.52 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.398 -0.814 . . . . 0.0 109.368 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.543 ' N ' HD11 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -66.89 -45.21 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 109.072 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.563 ' CD2' ' CD1' ' A' ' 3' ' ' LEU . 3.2 m-85 -59.93 -31.71 70.1 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.839 -1.163 . . . . 0.0 108.471 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.53 ' OG1' ' CG1' ' A' ' 46' ' ' VAL . 3.1 m -74.29 -27.04 60.54 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 79' ' ' ILE . 4.5 m -63.88 -50.94 66.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.5 -0.75 . . . . 0.0 109.374 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -64.86 -39.23 93.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.554 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.49 ' CB ' HD12 ' A' ' 61' ' ' ILE . 1.5 mtm -56.79 -28.13 60.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.602 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -81.37 -36.09 30.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.599 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.01 -1.12 51.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.912 . . . . 0.0 109.676 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.526 ' CB ' ' HB ' ' A' ' 8' ' ' THR . 4.1 m-85 -108.93 -29.81 8.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.146 -0.971 . . . . 0.0 109.546 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.507 ' CD2' ' CD1' ' A' ' 11' ' ' LEU . 46.9 mt -71.84 -3.94 25.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.614 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 90' ' ' SER . . . 99.0 21.82 14.78 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 90' ' ' SER . 0.3 OUTLIER 64.73 10.69 6.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -1.119 . . . . 0.0 109.484 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.8 m -86.11 -27.95 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.0 109.406 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -73.19 172.34 11.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.577 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 t -124.73 178.3 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.39 -0.818 . . . . 0.0 109.112 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -124.91 131.7 53.4 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.016 -1.052 . . . . 0.0 109.075 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.686 ' CD2' ' CE1' ' A' ' 62' ' ' HIS . 28.9 m-70 -125.98 152.1 46.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.97 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -109.71 130.53 55.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 110.242 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.492 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 15.8 mp0 -142.12 163.98 31.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 109.333 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.509 ' N ' ' HB2' ' A' ' 101' ' ' HIS . 2.2 t -153.66 -160.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 108.972 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 40.7 tp60 -78.66 4.53 13.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.718 -1.239 . . . . 0.0 109.772 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.19 22.24 0.58 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.509 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 14.9 m-70 -124.68 -17.07 6.04 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.735 -0.862 . . . . 0.0 109.664 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.579 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.09 30.26 1.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.259 -0.901 . . . . 0.0 109.369 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 105' ' ' THR . 89.1 p -57.3 -127.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.066 -1.021 . . . . 0.0 111.189 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 41.0 mt-10 -39.92 -24.62 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.9 -1.125 . . . . 0.0 111.469 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.492 ' N ' ' O ' ' A' ' 103' ' ' SER . 0.2 OUTLIER -71.99 -65.03 0.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.768 -1.208 . . . . 0.0 110.43 -179.104 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CE1' HD11 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -56.4 -50.25 72.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.969 -1.082 . . . . 0.0 108.34 -179.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.465 ' HA ' HD22 ' A' ' 114' ' ' LEU . 1.3 ttp85 -61.41 -29.78 70.15 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.491 -0.755 . . . . 0.0 108.979 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -59.05 -36.08 74.42 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.468 ' HB3' HG23 ' A' ' 18' ' ' ILE . 67.1 m-85 -88.13 -13.06 42.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.549 -0.72 . . . . 0.0 109.089 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.527 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 60.3 m-85 -113.26 96.9 6.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.472 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -74.05 83.02 1.76 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.925 . . . . 0.0 109.54 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.519 ' CB ' ' O ' ' A' ' 111' ' ' LYS . 3.0 tt0 78.48 78.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.397 -0.814 . . . . 0.0 109.715 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.44 ' C ' HD21 ' A' ' 114' ' ' LEU . . . 168.61 70.77 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.573 ' O ' ' CZ ' ' A' ' 116' ' ' TYR . 4.1 mm? -126.37 56.03 1.47 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -1.164 . . . . 0.0 109.841 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 2.3 mt -81.42 165.67 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.052 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.577 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 2.2 m-85 -145.49 107.86 4.41 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.373 -0.829 . . . . 0.0 109.211 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.558 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 26.9 mmtt -79.69 -165.79 0.87 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 108.929 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.569 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 33.3 mm-40 -87.15 158.11 19.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.962 -1.086 . . . . 0.0 109.865 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.541 ' HA2' ' CD2' ' A' ' 40' ' ' TYR . . . -95.34 -165.51 35.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 119' ' ' GLY . . . 43.48 74.32 0.2 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.452 HG11 ' O ' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -84.17 7.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -1.15 . . . . 0.0 109.751 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 123' ' ' SER . . . -74.56 -71.09 0.36 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.651 -0.656 . . . . 0.0 109.583 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER 68.58 9.36 7.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.367 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -167.33 26.84 0.15 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.413 ' O ' ' HB3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -150.23 -68.04 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -1.155 . . . . 0.0 109.408 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 125' ' ' MET . 20.1 pttt . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.441 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 2' ' ' GLU . 9.9 p . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 1' ' ' VAL . 0.0 OUTLIER 79.77 118.21 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.453 -0.779 . . . . 0.0 109.234 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.617 ' CD2' ' CD2' ' A' ' 80' ' ' TYR . 0.5 OUTLIER -90.05 -21.33 22.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.508 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 1.2 p -59.84 -12.67 7.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 110.029 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -109.4 -47.79 3.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.977 -1.077 . . . . 0.0 109.827 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.468 ' O ' HG21 ' A' ' 7' ' ' VAL . 53.2 mmtt -90.32 22.01 3.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 110.094 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.538 ' CG2' ' HB2' ' A' ' 3' ' ' LEU . 10.3 t -145.38 -63.18 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.089 -1.007 . . . . 0.0 109.823 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.553 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 23.1 p -67.81 -12.9 61.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 109.506 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 10' ' ' LYS . . . -74.24 -19.7 79.77 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 1.6 tptm 175.2 55.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.449 -1.03 . . . . 0.0 109.371 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.553 ' CD1' ' HA ' ' A' ' 8' ' ' THR . 0.6 OUTLIER -43.85 -60.29 1.89 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.43 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -161.63 -91.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.43 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER 74.48 125.98 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.502 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 23.7 p 48.05 54.35 10.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.362 -0.836 . . . . 0.0 109.631 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 14' ' ' THR . 4.0 m -168.43 101.85 0.53 Allowed Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.416 -0.803 . . . . 0.0 109.324 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.04 109.47 2.84 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.413 2.075 . . . . 0.0 110.433 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.461 ' O ' HG21 ' A' ' 18' ' ' ILE . . . 178.87 -143.81 5.99 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.551 HD13 ' CE1' ' A' ' 110' ' ' PHE . 14.3 pt -157.44 140.6 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -1.172 . . . . 0.0 109.829 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.557 ' NE2' ' CZ2' ' A' ' 21' ' ' TRP . 2.0 tt0 -122.01 109.19 14.28 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 41.9 mt -85.03 166.73 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.145 -0.972 . . . . 0.0 109.84 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.57 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 6.8 m-90 -130.26 121.95 27.1 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.591 ' HA ' ' CD1' ' A' ' 45' ' ' TYR . 8.7 mtm180 -79.26 132.54 36.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 110.888 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.623 ' CG2' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -116.8 23.11 5.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.662 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.497 ' CG ' ' HB ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -54.92 171.07 0.15 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.848 . . . . 0.0 110.193 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' CG ' ' A' ' 27' ' ' GLU . 0.7 OUTLIER 42.22 26.86 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.536 ' HE2' ' CB ' ' A' ' 70' ' ' SER . 0.0 OUTLIER 59.28 56.69 3.71 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.45 -0.781 . . . . 0.0 110.256 179.336 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.534 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 73.5 mm-40 -146.72 -144.05 0.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.925 -1.109 . . . . 0.0 109.655 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.583 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -156.04 146.44 21.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.009 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -160.37 148.77 13.27 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.086 -1.009 . . . . 0.0 109.604 -179.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.57 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 36.0 Cg_endo -78.53 125.17 6.74 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.548 2.165 . . . . 0.0 111.174 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.539 ' CG2' ' HG3' ' A' ' 22' ' ' ARG . 2.9 t -114.69 94.51 37.38 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.524 ' HD2' ' CB ' ' A' ' 35' ' ' SER . 34.7 Cg_endo -76.49 -159.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.598 2.198 . . . . 0.0 110.765 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.578 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -76.07 -34.5 59.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.368 -0.832 . . . . 0.0 110.551 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.96 32.86 0.73 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.077 -1.015 . . . . 0.0 109.932 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.524 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 74.8 m -139.66 -37.58 0.49 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.077 -1.014 . . . . 0.0 109.749 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 33' ' ' THR . 11.0 p90 -55.79 173.16 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.584 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.59 -94.93 0.66 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -90.61 113.13 25.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.358 -1.083 . . . . 0.0 109.414 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.612 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -140.77 143.46 34.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 109.983 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.586 ' CD1' ' O ' ' A' ' 118' ' ' GLN . 19.0 m-85 -42.34 144.75 0.46 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.884 . . . . 0.0 110.415 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.546 ' O ' ' CH2' ' A' ' 64' ' ' TRP . 2.0 pt-20 -90.85 -46.72 8.04 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.301 -0.874 . . . . 0.0 109.626 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.604 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -81.86 72.48 2.78 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.522 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -161.28 -145.01 0.11 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.152 -1.205 . . . . 0.0 109.837 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.56 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 23.7 m -138.61 162.1 35.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.333 -0.854 . . . . 0.0 108.811 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.612 ' CE2' ' HB2' ' A' ' 39' ' ' PHE . 11.3 m-85 -160.28 105.31 1.49 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.927 -1.108 . . . . 0.0 110.357 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 57.3 t -78.95 115.19 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.91 -1.119 . . . . 0.0 108.342 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.517 ' CD1' HD13 ' A' ' 18' ' ' ILE . 2.1 tt -104.59 116.08 31.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.31 -0.869 . . . . 0.0 110.721 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.522 ' CD2' HD22 ' A' ' 11' ' ' LEU . 19.5 tp -98.68 109.05 21.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.015 -1.053 . . . . 0.0 109.433 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.6 t -99.91 128.86 45.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.172 -0.955 . . . . 0.0 109.631 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.43 ' OG1' ' OD2' ' A' ' 12' ' ' ASP . 1.2 m -113.64 150.46 33.13 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.54 ' CG ' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -135.93 166.28 23.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.885 . . . . 0.0 109.479 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.54 ' N ' ' CG ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -104.86 147.51 27.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.425 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.9 p -142.18 -172.71 3.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.485 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.3 -10.42 71.12 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 56' ' ' GLY . 1.2 p -107.5 -53.52 2.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -1.172 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.425 ' N ' ' OG ' ' A' ' 55' ' ' SER . . . -157.32 -122.72 0.72 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 16.5 m-85 -129.32 156.24 44.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -1.092 . . . . 0.0 109.516 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.1 t -117.07 117.58 30.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.848 . . . . 0.0 108.941 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.526 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 26.2 m-85 -97.59 159.52 14.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.974 . . . . 0.0 110.166 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.549 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 9.3 m-80 -150.06 90.85 1.71 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.536 ' CG2' ' CG2' ' A' ' 81' ' ' THR . 5.9 mt -77.72 135.21 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 110.415 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.642 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 41.7 m-70 -122.0 161.95 22.02 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 53.7 p90 -138.95 96.02 3.05 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 118.4 -1.32 . . . . 0.0 109.387 176.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.567 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 14.8 t90 -69.61 139.9 53.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.554 ' CD1' ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -123.01 61.84 1.01 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.239 -0.913 . . . . 0.0 111.014 -178.253 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -53.07 89.72 0.01 OUTLIER Glycine 0 N--CA 1.5 2.967 0 N-CA-C 107.967 -2.053 . . . . 0.0 107.967 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 65' ' ' LEU . 5.2 ttmm -49.5 91.9 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.604 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 12.6 m120 -161.65 -42.05 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.534 ' OG ' ' CG ' ' A' ' 73' ' ' GLU . 24.4 p -65.57 -145.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.456 -0.777 . . . . 0.0 109.299 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.536 ' CB ' ' HE2' ' A' ' 26' ' ' MET . 3.9 p -116.11 170.74 8.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.072 -1.017 . . . . 0.0 109.847 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.479 ' HA ' ' HG2' ' A' ' 74' ' ' GLN . 7.3 tt0 -70.51 -11.58 61.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.412 -0.805 . . . . 0.0 110.403 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -82.34 -51.45 7.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.744 -1.223 . . . . 0.0 109.634 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' CG ' ' OG ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -63.69 -30.08 71.23 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.065 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.554 ' HB2' ' CD1' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -70.23 -33.32 71.51 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.187 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.526 ' N ' ' HG3' ' A' ' 74' ' ' GLN . . . -79.65 -17.19 76.03 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.56 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -82.23 -36.32 27.3 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.385 -1.068 . . . . 0.0 108.706 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.522 ' CB ' HD11 ' A' ' 23' ' ' ILE . . . -69.53 -51.95 30.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.364 -0.835 . . . . 0.0 108.989 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.35 79.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.296 -0.877 . . . . 0.0 109.224 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.463 HD11 ' O ' ' A' ' 75' ' ' GLY . 74.2 mt -56.58 -42.49 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.264 -0.898 . . . . 0.0 109.309 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.617 ' CD2' ' CD2' ' A' ' 3' ' ' LEU . 3.5 m-85 -63.57 -29.68 70.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.227 -0.921 . . . . 0.0 108.661 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.536 ' CG2' ' CG2' ' A' ' 61' ' ' ILE . 15.9 m -71.49 -23.58 61.83 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 m -86.87 -29.04 22.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.567 -0.708 . . . . 0.0 109.229 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.494 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -73.21 -39.87 65.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.297 -0.877 . . . . 0.0 109.493 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.565 ' HE3' ' CZ3' ' A' ' 21' ' ' TRP . 4.8 ptm -77.06 -27.74 54.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.453 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.454 ' HA ' HD12 ' A' ' 61' ' ' ILE . 7.8 t70 -66.72 -35.17 79.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.195 -0.94 . . . . 0.0 109.372 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -86.65 -23.33 25.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 0.0 109.393 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.494 ' CD1' ' O ' ' A' ' 83' ' ' GLN . 5.0 m-85 -87.3 -12.96 44.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -0.967 . . . . 0.0 109.448 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.1 mt -89.66 10.72 22.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.566 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 97.25 1.54 59.35 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 1.8 m 75.78 3.06 3.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -1.186 . . . . 0.0 109.629 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.2 m -83.94 -16.5 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.397 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.526 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -70.57 172.75 8.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.553 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.463 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 3.5 t -124.97 176.91 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.315 -0.865 . . . . 0.0 109.267 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.18 132.47 53.03 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.082 -1.011 . . . . 0.0 109.161 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.642 ' CD2' ' CE1' ' A' ' 62' ' ' HIS . 19.3 m-70 -130.25 153.49 48.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.652 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.533 ' HG3' ' CZ ' ' A' ' 63' ' ' TYR . 23.9 ttp180 -118.06 129.67 55.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 110.153 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.503 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 32.8 mp0 -134.01 164.45 27.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.503 ' CG2' ' C ' ' A' ' 97' ' ' GLU . 2.0 t -157.49 -172.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.282 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.78 78.46 2.72 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 134.7 -16.71 4.26 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.476 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 37.9 m-70 -99.94 -16.05 18.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.704 -0.88 . . . . 0.0 108.822 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.571 ' OE1' ' CG ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -90.12 22.76 3.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.549 -0.719 . . . . 0.0 109.366 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 105' ' ' THR . 90.9 p -57.99 -130.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.511 -0.743 . . . . 0.0 110.993 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 49.0 mt-10 -39.82 -24.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.07 -1.019 . . . . 0.0 111.271 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.491 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 7.6 m -70.62 -60.92 1.98 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.853 -1.154 . . . . 0.0 110.354 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.571 ' CG ' ' OE1' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -61.7 -50.2 73.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.805 -1.184 . . . . 0.0 108.582 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -61.95 -26.74 68.38 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.36 -0.837 . . . . 0.0 108.828 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -57.67 -51.74 68.29 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -70.98 -17.1 62.67 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.583 ' CG ' HD23 ' A' ' 114' ' ' LEU . 24.6 m-85 -108.17 93.88 4.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.467 -0.77 . . . . 0.0 109.538 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.499 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -86.17 61.81 7.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.971 . . . . 0.0 109.361 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 111' ' ' LYS . 11.8 mt-30 -163.6 -78.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.775 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 179.82 130.88 1.54 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.583 HD23 ' CG ' ' A' ' 110' ' ' PHE . 44.8 mt -96.56 107.75 20.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 109.977 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.511 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 1.3 mm -79.84 164.9 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.521 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 71.1 m-85 -137.35 133.12 34.51 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.039 -1.038 . . . . 0.0 110.055 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 2.7 mmpt? -117.28 -171.81 2.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.099 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.586 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 8.1 mm100 -90.7 128.64 36.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.073 -1.017 . . . . 0.0 110.145 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.574 ' HA2' ' CG ' ' A' ' 40' ' ' TYR . . . -58.62 -154.96 0.01 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 55.54 79.58 0.09 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.497 ' HB ' ' CG ' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -86.21 10.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.324 -1.103 . . . . 0.0 109.52 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 123' ' ' SER . . . -79.12 -76.72 0.19 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.7 -0.625 . . . . 0.0 109.535 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER 167.67 -29.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.39 -69.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.405 ' O ' ' C ' ' A' ' 126' ' ' LYS . 5.5 mmt -121.59 -150.49 0.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -1.144 . . . . 0.0 109.462 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 126' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.491 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.523 ' O ' ' CG ' ' A' ' 2' ' ' GLU . 2.1 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 1' ' ' VAL . 9.8 pt-20 40.25 50.1 2.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.571 -0.705 . . . . 0.0 109.758 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.598 ' CD2' ' CD2' ' A' ' 80' ' ' TYR . 1.4 pp -43.07 -28.3 0.27 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 109.443 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.506 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 6.9 p -57.03 143.06 39.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 109.947 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 4' ' ' SER . 4.1 ttmt 73.41 -79.5 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.508 -0.745 . . . . 0.0 109.69 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 5' ' ' LYS . 7.8 mttm -45.4 -27.04 0.63 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.931 -1.105 . . . . 0.0 108.952 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.579 HG11 ' CZ2' ' A' ' 21' ' ' TRP . 41.5 t -106.86 -33.97 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.529 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 8.0 p -87.28 -153.19 0.21 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.392 -0.817 . . . . 0.0 109.124 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.41 ' O ' ' HD2' ' A' ' 10' ' ' LYS . . . 84.15 -44.83 3.39 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -167.67 61.18 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.219 -1.166 . . . . 0.0 109.125 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.529 ' CD1' ' HA ' ' A' ' 8' ' ' THR . 3.0 mp -41.81 -71.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.416 -0.802 . . . . 0.0 109.661 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.503 ' HB3' ' CB ' ' A' ' 50' ' ' THR . 14.4 m-20 -145.88 75.9 1.44 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.469 ' O ' ' OG1' ' A' ' 14' ' ' THR . 17.0 mmtt -91.47 125.51 36.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.515 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 23.4 p 48.6 57.3 6.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.389 -0.82 . . . . 0.0 109.535 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.3 m -162.64 104.76 1.06 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.46 -0.775 . . . . 0.0 109.243 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.94 130.76 11.59 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.312 2.008 . . . . 0.0 110.377 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.1 172.98 12.8 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.598 HG13 ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -125.91 145.04 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.853 -1.381 . . . . 0.0 110.488 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -112.42 167.17 10.66 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 26.1 mt -132.25 161.13 41.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.333 -1.479 . . . . 0.0 110.242 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.579 ' CZ2' HG11 ' A' ' 7' ' ' VAL . 7.7 m-90 -120.87 122.77 40.96 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.588 ' CG ' ' CG1' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -79.84 130.26 35.16 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.922 -1.111 . . . . 0.0 110.755 -178.463 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.525 HD13 ' CE ' ' A' ' 28' ' ' MET . 7.9 mm -94.2 25.48 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.518 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 19.6 pt-20 -57.19 166.81 1.02 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.709 -0.619 . . . . 0.0 109.861 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.519 ' OD1' ' CB ' ' A' ' 27' ' ' GLU . 14.0 p30 42.66 27.67 0.1 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.466 ' HA ' ' OE2' ' A' ' 73' ' ' GLU . 3.8 mmt 53.64 55.23 8.81 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.499 -0.751 . . . . 0.0 109.622 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.519 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -160.33 144.88 14.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 0.0 109.445 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.545 ' CB ' ' CD2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -76.54 136.36 39.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.051 -1.031 . . . . 0.0 109.788 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.588 ' CG1' ' CG ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -147.12 151.76 41.77 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.532 ' HD2' HG12 ' A' ' 29' ' ' VAL . 31.9 Cg_endo -72.99 134.27 21.21 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.362 2.041 . . . . 0.0 111.747 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.545 ' CG2' ' O ' ' A' ' 20' ' ' ILE . 2.5 t -120.43 104.9 42.32 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.97 -157.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.557 2.171 . . . . 0.0 110.551 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.561 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -78.55 -25.97 45.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.171 -0.956 . . . . 0.0 109.101 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.36 32.47 0.77 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.275 -0.891 . . . . 0.0 109.854 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.48 ' HB2' ' CG1' ' A' ' 31' ' ' VAL . 17.3 m -155.07 -35.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 0.0 110.011 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.579 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 11.9 p90 -60.06 -41.22 91.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.011 -1.056 . . . . 0.0 109.768 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.51 ' N ' ' CG ' ' A' ' 36' ' ' TYR . . . -51.7 -24.29 12.24 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.546 ' HA ' HG21 ' A' ' 115' ' ' ILE . 0.9 OUTLIER -131.87 129.85 40.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.088 -1.242 . . . . 0.0 110.158 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -148.56 128.48 13.5 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.291 -0.881 . . . . 0.0 109.671 179.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.604 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 8.5 m-30 -47.55 140.1 6.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.489 -0.757 . . . . 0.0 110.6 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 1.6 pt-20 -91.3 29.12 1.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -0.864 . . . . 0.0 109.588 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.587 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -146.21 54.62 0.54 Allowed Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.467 ' CG ' ' O ' ' A' ' 42' ' ' GLY . 1.4 m-20 -162.94 -139.47 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.502 -0.999 . . . . 0.0 109.754 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.583 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 53.7 m -147.44 158.83 44.14 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.583 ' CD1' ' O ' ' A' ' 44' ' ' CYS . 31.4 m-85 -149.48 169.5 20.76 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.075 -1.016 . . . . 0.0 108.982 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 44.3 t -132.25 113.08 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.598 ' CD1' HG13 ' A' ' 18' ' ' ILE . 3.8 tt -103.65 106.37 16.86 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.861 -1.149 . . . . 0.0 110.981 -178.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.523 HD23 ' CD2' ' A' ' 11' ' ' LEU . 19.2 tp -94.37 124.92 38.68 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.535 ' OG ' ' CG2' ' A' ' 18' ' ' ILE . 8.5 t -115.18 136.22 53.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.096 -1.003 . . . . 0.0 109.788 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.514 ' OG1' ' CD1' ' A' ' 59' ' ' TYR . 1.2 m -130.56 124.26 31.41 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.83 137.59 52.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.525 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.443 ' HA ' ' CD1' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -54.91 163.85 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.893 . . . . 0.0 109.437 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.4 -172.87 2.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.445 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.79 -29.16 39.75 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.68 -17.7 43.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -1.114 . . . . 0.0 109.42 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.8 -69.06 0.45 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.578 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 14.5 m-85 -160.09 157.16 28.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -1.139 . . . . 0.0 109.528 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.66 112.21 15.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 109.114 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.528 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 6.6 m-30 -91.93 153.93 19.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.245 -0.909 . . . . 0.0 109.929 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.504 ' ND2' ' CE1' ' A' ' 95' ' ' HIS . 1.9 m-20 -147.7 95.25 2.48 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.514 ' CG2' HG21 ' A' ' 81' ' ' THR . 15.3 mt -83.39 130.36 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.172 -0.955 . . . . 0.0 110.519 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.595 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 28.3 m-70 -115.39 164.17 14.65 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.603 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 48.1 p90 -137.87 96.78 3.28 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.611 -1.236 . . . . 0.0 109.792 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.576 ' CE2' ' OE1' ' A' ' 102' ' ' GLU . 6.7 t90 -72.62 141.41 48.34 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -125.57 65.3 1.17 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.069 -1.019 . . . . 0.0 110.865 -178.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -49.49 90.46 0.01 OUTLIER Glycine 0 N--CA 1.499 2.834 0 N-CA-C 108.414 -1.874 . . . . 0.0 108.414 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -39.15 91.48 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.927 0.87 . . . . 0.0 112.683 -177.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.587 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 1.2 m120 -162.65 -42.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.488 ' HB2' ' CB ' ' A' ' 73' ' ' GLU . 95.9 p -63.9 -151.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.582 -0.699 . . . . 0.0 109.343 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.432 ' OG ' ' OD1' ' A' ' 72' ' ' ASP . 80.1 p -121.2 176.57 5.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 109.62 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.408 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 12.0 tt0 -55.12 -41.39 71.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.549 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.432 ' OD1' ' OG ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -60.29 -43.24 96.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.159 -0.963 . . . . 0.0 109.551 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.488 ' CB ' ' HB2' ' A' ' 69' ' ' SER . 2.7 tp10 -56.33 -36.6 68.92 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.022 -1.049 . . . . 0.0 108.353 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.408 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 6.6 tt0 -62.7 -36.16 82.06 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.533 ' O ' ' CD1' ' A' ' 79' ' ' ILE . . . -80.06 -13.82 81.51 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.577 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -78.72 -54.02 6.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.234 -1.157 . . . . 0.0 109.156 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.45 -26.43 61.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.398 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.3 -48.38 20.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.25 -0.906 . . . . 0.0 109.564 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 75' ' ' GLY . 1.5 mp -65.54 -39.2 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -0.901 . . . . 0.0 108.994 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.598 ' CD2' ' CD2' ' A' ' 3' ' ' LEU . 3.8 m-85 -61.45 -39.46 90.92 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.053 -1.029 . . . . 0.0 108.331 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.514 HG21 ' CG2' ' A' ' 61' ' ' ILE . 3.0 m -67.12 -24.78 65.96 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.4 m -76.82 -37.02 56.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.454 -0.779 . . . . 0.0 109.379 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 24.2 mm100 -66.76 -36.66 82.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 109.585 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.51 ' SD ' ' CG1' ' A' ' 7' ' ' VAL . 73.3 mtm -71.72 -34.86 69.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.953 . . . . 0.0 109.602 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.55 -58.64 7.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 109.738 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -64.95 -33.33 75.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.672 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 3.1 m-85 -73.2 -10.49 59.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -1.0 . . . . 0.0 109.692 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.528 ' CD2' HD21 ' A' ' 11' ' ' LEU . 20.1 mt -89.43 -32.19 17.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 109.545 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 121.93 15.55 4.3 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 0.9 OUTLIER 75.8 -0.29 3.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -1.149 . . . . 0.0 109.683 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.458 HG21 ' CD2' ' A' ' 59' ' ' TYR . 15.6 m -83.42 -9.47 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.411 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -90.81 176.72 6.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 0.0 109.548 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.7 t -133.47 177.45 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.365 -0.835 . . . . 0.0 109.156 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -125.71 135.18 51.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.986 -1.071 . . . . 0.0 108.972 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.595 ' CD2' ' CD2' ' A' ' 62' ' ' HIS . 12.6 m-70 -132.96 149.0 52.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.128 -0.982 . . . . 0.0 109.379 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.586 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -110.77 136.94 49.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 110.384 -179.378 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.515 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 49.8 mm-40 -142.23 164.41 30.23 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.436 -0.79 . . . . 0.0 108.93 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.515 ' CG2' ' C ' ' A' ' 97' ' ' GLU . 1.8 t -157.78 -165.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.132 -0.98 . . . . 0.0 109.02 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.36 75.96 4.87 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.94 -12.17 4.78 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.483 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 10.8 m-70 -98.25 -13.21 20.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.667 -0.902 . . . . 0.0 109.107 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.578 ' OE1' ' CD2' ' A' ' 106' ' ' PHE . 2.0 pt-20 -90.05 30.17 1.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.418 -0.801 . . . . 0.0 109.031 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 102' ' ' GLU . 63.5 p -52.45 -141.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.751 0.786 . . . . 0.0 112.126 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -38.99 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.915 -1.116 . . . . 0.0 111.057 -178.435 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 103' ' ' SER . 0.8 OUTLIER -67.02 -57.47 6.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.811 -1.181 . . . . 0.0 110.138 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.582 ' CE1' HD11 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -66.64 -44.33 82.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.959 -1.088 . . . . 0.0 108.309 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.486 ' HA ' HD22 ' A' ' 114' ' ' LEU . 0.7 OUTLIER -66.82 -17.54 64.93 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -71.02 -45.4 63.99 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.471 ' CD2' HD23 ' A' ' 47' ' ' LEU . 18.3 m-85 -76.37 -17.88 59.16 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.462 -0.774 . . . . 0.0 109.466 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.589 ' CZ ' ' CD1' ' A' ' 47' ' ' LEU . 6.9 m-30 -112.07 96.5 6.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.115 -0.991 . . . . 0.0 109.316 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -67.78 86.28 0.22 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.48 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 111' ' ' LYS . 7.3 mm100 72.65 74.82 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.867 . . . . 0.0 109.586 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.463 ' C ' ' CD2' ' A' ' 114' ' ' LEU . . . -178.73 62.87 0.08 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.543 ' O ' ' CZ ' ' A' ' 116' ' ' TYR . 3.8 mm? -120.9 63.01 0.87 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -1.14 . . . . 0.0 109.336 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.546 HG21 ' HA ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -85.85 160.96 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.104 -0.998 . . . . 0.0 109.351 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.543 ' CZ ' ' O ' ' A' ' 114' ' ' LEU . 2.0 m-85 -139.75 165.0 28.46 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.604 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -146.98 -156.29 0.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.591 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -91.48 169.41 10.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.968 . . . . 0.0 109.819 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 120' ' ' GLY . . . -99.13 -169.86 30.75 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 47.37 95.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.514 ' CG2' ' HB2' ' A' ' 24' ' ' GLU . 1.3 t -90.45 103.93 14.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.205 -1.173 . . . . 0.0 109.297 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.428 ' O ' ' OG ' ' A' ' 123' ' ' SER . . . -39.82 -81.37 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.693 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 122' ' ' ALA . 72.2 p 46.1 25.82 0.37 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.502 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.07 -82.69 1.47 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.37 154.61 17.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -1.167 . . . . 0.0 109.432 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.8 mttt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.489 179.899 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.435 ' O ' HG22 ' A' ' 7' ' ' VAL . 5.4 pt-20 175.54 94.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.43 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.559 HD13 ' CD2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -74.19 3.32 7.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.216 -0.927 . . . . 0.0 110.484 -179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.55 ' N ' HD11 ' A' ' 3' ' ' LEU . 1.7 p -92.74 150.9 20.36 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.811 -1.18 . . . . 0.0 110.34 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.495 ' N ' ' OG1' ' A' ' 8' ' ' THR . 12.0 ttmt 47.19 -86.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.429 0.633 . . . . 0.0 110.917 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 4' ' ' SER . 5.8 mmtt -40.54 -27.51 0.05 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.492 -0.755 . . . . 0.0 110.227 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.537 ' CG2' ' HA ' ' A' ' 3' ' ' LEU . 70.4 t -109.16 -31.85 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.097 -1.002 . . . . 0.0 109.607 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.528 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 18.2 p -72.22 -3.52 23.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.883 . . . . 0.0 109.473 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 10' ' ' LYS . . . -70.45 85.03 0.34 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 9' ' ' GLY . 5.3 mtmm 80.65 74.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.677 -0.896 . . . . 0.0 109.601 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.528 ' CD1' ' HA ' ' A' ' 8' ' ' THR . 4.7 mt -89.35 32.65 0.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 0.0 109.124 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER 78.31 61.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.438 -0.789 . . . . 0.0 109.357 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.443 ' O ' ' CG2' ' A' ' 14' ' ' THR . 4.2 mttm -81.6 -10.39 59.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 109.524 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.57 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 27.0 p -157.36 67.45 0.52 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.59 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.404 ' O ' ' OD2' ' A' ' 12' ' ' ASP . 99.2 m -161.9 118.5 1.32 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.384 -0.822 . . . . 0.0 109.169 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.84 87.84 1.44 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.255 1.97 . . . . 0.0 110.206 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.463 ' O ' HG21 ' A' ' 18' ' ' ILE . . . -170.48 -145.08 4.58 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.518 HD13 ' CD1' ' A' ' 47' ' ' LEU . 14.2 pt -157.24 142.21 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.013 -1.287 . . . . 0.0 110.202 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.61 ' NE2' ' CH2' ' A' ' 21' ' ' TRP . 0.4 OUTLIER -121.78 117.25 26.12 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.485 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 1.6 mt -90.88 178.16 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.659 -1.276 . . . . 0.0 110.733 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.629 ' CD1' ' CE ' ' A' ' 28' ' ' MET . 9.5 m-90 -137.38 121.18 17.5 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.517 ' N ' HG22 ' A' ' 31' ' ' VAL . 3.7 ptp180 -83.75 128.68 34.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.097 . . . . 0.0 111.908 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' A' ' 44' ' ' CYS . 1.8 mm -111.45 50.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.607 ' HB2' ' CE2' ' A' ' 40' ' ' TYR . 4.7 pt-20 -92.78 -39.06 11.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.372 -0.83 . . . . 0.0 110.295 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.529 ' OD1' ' CG ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -88.35 43.77 1.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 108.517 179.32 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.544 ' CE ' ' CG ' ' A' ' 73' ' ' GLU . 0.9 OUTLIER 50.22 24.48 1.48 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.529 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 3.6 pt-20 -151.94 153.74 34.7 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.629 ' CE ' ' CD1' ' A' ' 21' ' ' TRP . 15.5 ptm -97.41 133.69 41.67 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.744 -1.222 . . . . 0.0 110.746 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -120.73 149.33 50.28 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.573 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 32.0 Cg_endo -71.94 87.77 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.272 1.981 . . . . 0.0 112.217 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 22' ' ' ARG . 8.6 t -72.99 112.65 16.26 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.537 -0.727 . . . . 0.0 109.473 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 35.9 Cg_endo -78.41 -159.31 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.396 2.064 . . . . 0.0 110.149 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.576 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -88.14 -21.37 24.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 108.909 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -78.91 4.43 14.18 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.291 -0.881 . . . . 0.0 109.661 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 36' ' ' TYR . 38.7 m -128.18 -37.01 1.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.953 . . . . 0.0 109.787 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -42.81 161.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -0.894 . . . . 0.0 109.718 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.535 ' O ' ' CE1' ' A' ' 39' ' ' PHE . . . 110.82 -62.19 0.29 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.552 ' ND2' ' N ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -103.75 106.97 17.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -1.152 . . . . 0.0 109.264 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.562 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -130.93 132.47 45.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.124 -0.985 . . . . 0.0 109.989 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.607 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 9.7 m-30 -40.13 131.2 2.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.591 -0.693 . . . . 0.0 111.445 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 41' ' ' GLU . 0.8 OUTLIER -90.86 112.09 23.78 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.594 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . 115.22 45.57 0.62 Allowed Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -155.78 -134.29 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.536 -0.979 . . . . 0.0 108.678 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.528 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 60.8 m -146.18 137.27 24.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.865 -1.147 . . . . 0.0 109.437 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.562 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 26.5 m-85 -140.49 108.13 5.62 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.261 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 8.2 t -78.86 126.73 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 108.551 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.518 ' CD1' HD13 ' A' ' 18' ' ' ILE . 7.4 tt -116.65 117.96 31.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.077 -1.015 . . . . 0.0 110.112 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 22.2 tp -100.44 113.82 26.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.935 . . . . 0.0 109.333 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 t -102.4 130.73 49.25 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.225 -0.922 . . . . 0.0 109.538 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 m -121.2 142.82 49.53 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.09 -173.28 3.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.46 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.498 ' O ' ' CG2' ' A' ' 53' ' ' THR . 1.0 OUTLIER -109.96 168.87 9.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.487 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 52' ' ' LYS . 5.4 p -162.72 -170.9 2.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.06 -17.85 66.34 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.1 m -102.39 -43.74 5.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -1.153 . . . . 0.0 109.478 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.455 ' O ' ' OG1' ' A' ' 53' ' ' THR . . . -175.36 -128.34 1.1 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.57 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 42.1 m-85 -111.23 150.66 29.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -1.125 . . . . 0.0 109.516 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.419 ' OG ' HG22 ' A' ' 53' ' ' THR . 0.4 OUTLIER -111.55 114.33 27.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.0 109.001 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.512 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 12.7 m-85 -91.09 155.63 18.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.164 -0.96 . . . . 0.0 109.841 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.59 ' ND2' ' CE1' ' A' ' 95' ' ' HIS . 1.8 m-20 -147.25 92.64 2.13 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.532 ' CG2' HG21 ' A' ' 81' ' ' THR . 21.5 mt -77.64 134.38 28.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 110.374 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.616 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 42.9 m-70 -120.82 162.53 19.64 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 95' ' ' HIS . 45.9 p90 -137.05 97.69 3.57 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 118.605 -1.238 . . . . 0.0 109.298 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.577 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 7.7 t90 -74.33 137.23 42.7 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -126.53 64.62 1.26 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -0.885 . . . . 0.0 111.095 -178.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.459 ' O ' ' HA2' ' A' ' 42' ' ' GLY . . . -49.48 97.38 0.01 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 107.173 -2.371 . . . . 0.0 107.173 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 65' ' ' LEU . 2.2 tptt -55.27 89.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -176.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.594 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 12.0 m120 -160.98 -37.99 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.8 p -67.43 -146.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 109.432 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.459 ' HB2' ' OD2' ' A' ' 72' ' ' ASP . 3.0 p -114.27 158.67 21.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 109.891 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -50.99 -34.89 31.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.459 ' OD2' ' HB2' ' A' ' 70' ' ' SER . 1.6 p30 -58.18 -46.13 86.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.147 -0.971 . . . . 0.0 109.077 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.544 ' CG ' ' CE ' ' A' ' 26' ' ' MET . 59.7 mm-40 -57.09 -36.17 70.29 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.53 ' CG ' HD12 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -63.03 -35.92 81.85 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.531 ' O ' ' CG1' ' A' ' 79' ' ' ILE . . . -81.79 -12.08 81.91 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.19 -54.14 6.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.15 -1.206 . . . . 0.0 109.286 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.465 ' HB3' HD13 ' A' ' 23' ' ' ILE . . . -73.09 -34.02 65.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -0.905 . . . . 0.0 109.376 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.62 -41.76 65.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 109.776 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.531 ' CG1' ' O ' ' A' ' 75' ' ' GLY . 73.0 mt -69.24 -44.87 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.054 -1.029 . . . . 0.0 109.886 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.559 ' CD2' HD13 ' A' ' 3' ' ' LEU . 2.9 m-85 -68.38 -29.5 68.21 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.532 HG21 ' CG2' ' A' ' 61' ' ' ILE . 13.8 m -69.67 -24.17 63.57 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 79' ' ' ILE . 2.1 m -72.62 -49.01 34.86 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 9.3 mt-30 -59.28 -43.38 92.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.368 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.437 ' SD ' ' CD2' ' A' ' 11' ' ' LEU . 0.9 OUTLIER -55.06 -37.9 67.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.593 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.98 -41.59 99.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.12 4.58 49.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.196 -0.94 . . . . 0.0 109.704 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.504 ' CD1' HG23 ' A' ' 8' ' ' THR . 0.6 OUTLIER -107.97 -13.98 14.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 0.0 109.581 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.505 HD22 ' CB ' ' A' ' 11' ' ' LEU . 20.5 mt -87.13 -66.54 0.9 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 109.589 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.39 37.27 0.03 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.4 m 49.58 22.42 0.76 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -1.15 . . . . 0.0 109.552 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.475 HG22 ' CE1' ' A' ' 59' ' ' TYR . 31.1 m -110.86 -25.96 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.198 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.512 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -65.46 172.42 3.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 109.515 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.46 ' CG2' ' OD1' ' A' ' 60' ' ' ASN . 3.4 t -126.53 177.76 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.347 -0.846 . . . . 0.0 109.318 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.33 131.77 52.96 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.067 -1.021 . . . . 0.0 109.036 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.616 ' CD2' ' CE1' ' A' ' 62' ' ' HIS . 22.1 m-70 -128.52 152.68 48.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.938 . . . . 0.0 109.522 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.578 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 11.7 ttt-85 -114.62 133.23 56.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.365 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.501 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 50.2 mt-10 -140.33 165.11 28.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.108 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.501 ' CG2' ' C ' ' A' ' 97' ' ' GLU . 1.7 t -155.42 -161.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.085 -1.009 . . . . 0.0 109.319 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.497 ' OE1' ' N ' ' A' ' 67' ' ' LYS . 8.9 pt20 -82.09 72.78 9.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.086 -1.009 . . . . 0.0 108.552 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 137.07 -19.6 3.45 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.468 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 19.0 m-70 -87.19 -21.96 25.57 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.702 -0.881 . . . . 0.0 108.789 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.577 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.27 22.4 3.35 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.742 0.782 . . . . 0.0 109.124 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.9 p -57.51 -99.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.283 -0.886 . . . . 0.0 111.336 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 19.1 pt-20 -62.97 -18.32 63.09 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.092 -1.005 . . . . 0.0 111.103 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.497 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 1.6 m -79.63 -61.48 1.98 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.805 -1.185 . . . . 0.0 110.166 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.555 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -58.68 -56.45 22.03 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.954 -1.091 . . . . 0.0 108.173 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -57.2 -31.33 65.35 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.455 -0.778 . . . . 0.0 109.18 179.18 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -51.79 -54.15 31.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.022 -1.049 . . . . 0.0 108.249 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.437 ' CD2' HD23 ' A' ' 47' ' ' LEU . 19.5 m-85 -64.88 -23.95 67.39 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.57 ' CD2' HD23 ' A' ' 114' ' ' LEU . 9.2 m-85 -102.89 92.53 4.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.518 -0.739 . . . . 0.0 109.312 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 112' ' ' GLN . 28.9 mtmm -82.23 89.69 6.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.522 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER 168.58 -74.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 108.761 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 114' ' ' LEU . . . -159.78 -142.12 3.31 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.57 HD23 ' CD2' ' A' ' 110' ' ' PHE . 0.5 OUTLIER 174.94 108.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.504 -0.998 . . . . 0.0 108.921 179.433 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.574 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 5.0 mt -93.69 165.04 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 109.374 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.574 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 4.1 m-85 -142.05 113.13 7.5 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.526 ' HD2' ' N ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -79.39 -169.24 1.81 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.294 -0.879 . . . . 0.0 109.662 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.583 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 35.5 tp60 -92.64 148.4 22.1 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.751 -1.218 . . . . 0.0 110.73 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.588 ' HA2' ' CD2' ' A' ' 40' ' ' TYR . . . -66.38 -173.73 5.42 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 59.32 117.35 0.01 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.528 HG23 ' CB ' ' A' ' 25' ' ' ASN . 1.5 t -90.75 -141.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.181 -1.187 . . . . 0.0 109.049 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 123' ' ' SER . . . -84.23 -71.86 0.49 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.95 . . . . 0.0 109.386 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 122' ' ' ALA . 1.0 OUTLIER 75.89 14.48 2.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 109.424 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 53.73 55.07 27.23 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -135.48 -69.31 0.5 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -1.139 . . . . 0.0 109.416 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tttm . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.465 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.522 ' CG2' ' HG2' ' A' ' 27' ' ' GLU . 16.5 t . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 1' ' ' VAL . 7.5 pt-20 39.15 83.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.646 -0.658 . . . . 0.0 109.959 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.621 ' CD2' ' CG ' ' A' ' 80' ' ' TYR . 2.4 pt? -85.23 14.28 5.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.456 ' HA ' HG22 ' A' ' 8' ' ' THR . 1.2 p -90.83 5.21 49.34 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.675 -1.266 . . . . 0.0 110.088 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -134.26 -48.12 0.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.061 -1.024 . . . . 0.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 8.9 mmtt -89.69 35.48 0.83 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.905 . . . . 0.0 109.024 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' A' ' 3' ' ' LEU . 60.6 t -159.3 -49.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.39 -0.819 . . . . 0.0 109.751 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.574 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 44.5 p -61.89 -31.3 71.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.325 -0.86 . . . . 0.0 110.137 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' A' ' 10' ' ' LYS . . . -45.03 -26.62 1.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.489 ' CG ' ' HE3' ' A' ' 13' ' ' LYS . 0.3 OUTLIER 175.87 70.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.505 -0.997 . . . . 0.0 108.622 179.611 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.574 ' CD2' ' HA ' ' A' ' 8' ' ' THR . 0.7 OUTLIER -86.92 19.81 2.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.335 -0.853 . . . . 0.0 110.206 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 11' ' ' LEU . 3.8 p30 157.7 106.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.621 -0.675 . . . . 0.0 109.287 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HE3' ' CG ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -157.94 123.18 4.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 109.644 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.58 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 22.1 p 48.34 56.5 7.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.0 109.628 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.5 m -166.41 106.66 0.68 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.392 -0.817 . . . . 0.0 109.27 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.96 128.07 9.75 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.347 2.032 . . . . 0.0 110.263 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 144.73 167.91 12.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.577 HG13 ' CD2' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -123.64 143.11 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.075 -1.25 . . . . 0.0 109.764 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.463 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 1.7 pm0 -120.15 -170.39 1.96 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 47' ' ' LEU . 2.0 mt -147.37 178.65 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.822 -1.174 . . . . 0.0 110.156 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.59 ' HA ' ' O ' ' A' ' 29' ' ' VAL . 7.1 m-90 -134.67 122.24 21.96 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.514 ' NE ' HG13 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -82.6 130.02 35.04 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.118 -0.989 . . . . 0.0 112.293 -176.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.639 ' CG2' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -121.18 24.68 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 177.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.527 ' HB2' ' CG2' ' A' ' 121' ' ' VAL . 10.6 pt-20 -63.42 -49.57 73.21 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.223 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.405 ' N ' ' CG ' ' A' ' 24' ' ' GLU . 21.3 p-10 -85.33 42.86 0.97 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.118 -0.989 . . . . 0.0 108.336 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.487 ' CE ' ' CD ' ' A' ' 73' ' ' GLU . 79.4 mmm 48.42 34.63 4.9 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.522 ' HG2' ' CG2' ' A' ' 1' ' ' VAL . 3.2 tt0 -151.57 131.37 13.24 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.584 ' CE ' ' CB ' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -81.42 139.17 35.41 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.089 -1.007 . . . . 0.0 110.237 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -144.0 147.67 38.94 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 32.0 Cg_endo -72.29 88.32 0.86 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.292 1.995 . . . . 0.0 111.618 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 22' ' ' ARG . 20.7 t -66.91 111.97 8.45 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 36.2 Cg_endo -78.89 -159.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.408 2.072 . . . . 0.0 110.414 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.459 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -87.55 -12.67 45.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.876 . . . . 0.0 109.085 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.07 26.76 1.12 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.29 -0.881 . . . . 0.0 109.918 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 36' ' ' TYR . 1.1 m -160.08 -37.35 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.046 -1.034 . . . . 0.0 109.823 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.469 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 1.1 p90 -43.42 130.78 5.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.569 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.2 -72.51 0.44 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.511 ' ND2' HD13 ' A' ' 115' ' ' ILE . 13.6 m-20 -94.09 96.85 9.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -1.188 . . . . 0.0 109.518 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.582 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -117.33 129.53 55.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.248 -0.908 . . . . 0.0 109.187 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.603 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 84.6 m-85 -39.75 153.13 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.453 -0.779 . . . . 0.0 110.174 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 9.5 pt-20 -90.84 -32.93 15.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.392 -0.818 . . . . 0.0 110.197 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.583 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -91.69 64.49 2.47 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.047 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.484 ' CG ' ' O ' ' A' ' 42' ' ' GLY . 3.2 m-20 -162.83 -144.89 0.09 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.405 -1.056 . . . . 0.0 109.963 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.494 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 84.4 m -149.54 143.36 25.56 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.582 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 29.0 m-85 -140.35 112.39 7.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.367 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.479 ' O ' HG21 ' A' ' 20' ' ' ILE . 90.6 t -79.2 127.13 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.932 -1.105 . . . . 0.0 108.59 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.577 ' CD2' HG13 ' A' ' 18' ' ' ILE . 8.9 tt -107.69 162.81 13.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.9 -1.125 . . . . 0.0 109.901 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.563 ' CD2' ' CD1' ' A' ' 11' ' ' LEU . 13.8 tp -151.32 115.15 4.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.073 -1.017 . . . . 0.0 108.997 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.495 ' CA ' ' HB ' ' A' ' 18' ' ' ILE . 3.5 t -109.78 132.14 54.42 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.007 -1.058 . . . . 0.0 110.319 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 m -125.95 120.87 31.5 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -125.92 157.67 37.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 109.556 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.03 151.76 40.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.458 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -137.51 -171.97 3.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.209 -0.932 . . . . 0.0 109.523 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.0 -12.32 77.1 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 p -108.17 -36.42 6.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -1.107 . . . . 0.0 109.461 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.95 -100.88 0.15 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 5.9 m-85 -131.53 154.54 48.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -1.171 . . . . 0.0 109.515 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 52.5 m -126.42 112.87 16.13 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.576 ' CE2' HG22 ' A' ' 91' ' ' VAL . 2.8 m-85 -92.62 154.43 18.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.176 -0.953 . . . . 0.0 110.421 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.467 ' OD1' ' CG2' ' A' ' 93' ' ' VAL . 6.5 m-20 -140.16 98.68 3.5 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.517 ' CG2' HG21 ' A' ' 81' ' ' THR . 37.2 mt -89.38 119.25 36.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 110.79 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.69 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 21.1 m-70 -109.01 164.44 12.41 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.588 ' CE1' ' HA ' ' A' ' 96' ' ' ARG . 39.4 p90 -138.67 103.73 4.92 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.114 -1.435 . . . . 0.0 109.702 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.578 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 2.4 t90 -78.97 130.25 35.35 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.047 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -122.36 65.8 0.94 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.496 -0.753 . . . . 0.0 110.706 -178.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 99' ' ' GLN . . . -51.29 89.63 0.01 OUTLIER Glycine 0 N--CA 1.497 2.746 0 N-CA-C 108.304 -1.918 . . . . 0.0 108.304 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -39.1 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 122.076 0.941 . . . . 0.0 112.255 -177.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.583 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 2.4 m-80 -162.1 -45.2 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 73' ' ' GLU . 88.5 p -62.86 -148.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.354 -0.841 . . . . 0.0 109.199 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.46 ' OG ' ' OD2' ' A' ' 72' ' ' ASP . 2.5 p -121.86 168.54 11.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -48.46 -29.11 3.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.351 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.46 ' OD2' ' OG ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -68.24 -44.49 75.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.446 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.523 ' CB ' ' OG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -57.16 -36.53 70.88 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.468 ' HG3' HD13 ' A' ' 65' ' ' LEU . 3.8 tt0 -64.09 -34.96 79.23 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.506 ' O ' ' CG1' ' A' ' 79' ' ' ILE . . . -79.83 -13.46 82.24 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.401 ' HB1' ' HA ' ' A' ' 73' ' ' GLU . . . -80.38 -54.02 6.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -1.124 . . . . 0.0 109.248 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.442 ' HB3' HG22 ' A' ' 46' ' ' VAL . . . -75.15 -39.66 60.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.163 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 74' ' ' GLN . . . -63.1 -49.36 74.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.355 -0.84 . . . . 0.0 109.306 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' A' ' 75' ' ' GLY . 70.5 mt -63.57 -44.13 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.211 -0.931 . . . . 0.0 109.414 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.621 ' CG ' ' CD2' ' A' ' 3' ' ' LEU . 14.5 m-30 -62.98 -25.36 68.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.245 -0.909 . . . . 0.0 109.033 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.517 HG21 ' CG2' ' A' ' 61' ' ' ILE . 5.9 m -79.14 -23.41 44.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.3 m -88.79 -21.82 23.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.638 -0.664 . . . . 0.0 109.352 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 6.8 mt-30 -83.19 -37.87 23.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.497 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.507 ' HG3' ' CD1' ' A' ' 61' ' ' ILE . 5.3 ptm -75.75 -29.24 58.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.334 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.499 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 67.2 t0 -61.64 -59.64 4.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -0.944 . . . . 0.0 109.698 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.58 -33.8 76.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.136 -0.977 . . . . 0.0 109.476 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 0.5 OUTLIER -69.91 -16.11 63.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 109.59 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.532 ' CD1' HD13 ' A' ' 11' ' ' LEU . 66.7 mt -94.06 22.61 5.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.678 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 86.2 0.59 86.86 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 1.4 p 75.86 7.52 3.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -1.165 . . . . 0.0 109.616 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.576 HG22 ' CE2' ' A' ' 59' ' ' TYR . 15.7 m -83.3 -19.5 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 109.285 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.53 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -68.38 165.61 18.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.581 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.467 ' CG2' ' OD1' ' A' ' 60' ' ' ASN . 2.5 t -115.86 -177.08 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.376 -0.827 . . . . 0.0 109.125 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -131.01 138.43 49.66 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.092 -1.005 . . . . 0.0 108.674 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.69 ' CD2' ' CD2' ' A' ' 62' ' ' HIS . 19.0 m-70 -135.0 142.77 46.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.088 -1.007 . . . . 0.0 110.179 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.588 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -94.17 117.3 29.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 110.148 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.499 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 44.5 mm-40 -127.98 158.83 36.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.107 -0.996 . . . . 0.0 109.354 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.581 ' HB ' ' CD2' ' A' ' 101' ' ' HIS . 2.6 t -155.75 -175.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.27 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.455 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 0.4 OUTLIER -69.77 -1.97 10.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.924 -1.11 . . . . 0.0 110.258 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.69 16.11 1.8 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.581 ' CD2' ' HB ' ' A' ' 98' ' ' VAL . 13.1 m-70 -120.88 -15.73 8.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.487 -1.008 . . . . 0.0 109.373 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.578 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.37 21.59 3.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 0.0 109.169 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 102' ' ' GLU . 4.3 p -41.75 -106.03 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.545 -0.722 . . . . 0.0 112.177 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.482 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 1.3 pt-20 -67.97 -31.67 71.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.84 -1.163 . . . . 0.0 111.245 -177.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -58.82 -59.73 4.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.011 -1.056 . . . . 0.0 110.197 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.536 ' HB2' ' HB2' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -58.71 -55.62 32.75 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.006 -1.059 . . . . 0.0 108.467 -179.252 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -54.48 -20.64 8.03 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 104' ' ' GLU . . . -65.22 -51.99 57.43 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.568 ' CD1' HG23 ' A' ' 18' ' ' ILE . 29.4 m-85 -65.46 -17.19 64.36 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.597 ' CG ' HD23 ' A' ' 114' ' ' LEU . 4.2 m-85 -121.4 100.79 7.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 109.684 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.518 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 2.8 pttt -81.27 73.55 8.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.222 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.43 -54.93 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 109.731 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 114' ' ' LEU . . . 156.5 -20.08 0.46 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.597 HD23 ' CG ' ' A' ' 110' ' ' PHE . 23.0 mt 62.77 133.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.295 -1.121 . . . . 0.0 109.895 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.562 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 3.2 mt -116.39 164.9 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 0.0 108.978 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.562 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -141.07 102.28 4.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.36 -0.837 . . . . 0.0 109.151 179.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.603 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 3.2 mmtt -79.89 -167.97 1.45 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.893 . . . . 0.0 109.587 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.582 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -91.1 124.4 35.29 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.909 -1.119 . . . . 0.0 110.369 -179.451 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 118' ' ' GLN . . . -56.53 -161.61 0.02 OUTLIER Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 67.04 67.38 2.01 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 24' ' ' GLU . 1.4 t -90.79 102.72 13.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.316 -1.108 . . . . 0.0 109.648 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 121' ' ' VAL . . . -40.98 -79.49 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.321 0.581 . . . . 0.0 109.798 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 172.65 -29.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.335 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' A' ' 125' ' ' MET . . . 103.82 -38.9 3.01 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.529 ' CG ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER 172.59 -79.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -1.112 . . . . 0.0 109.402 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 125' ' ' MET . 8.9 mttp . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.453 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.495 ' N ' ' HB3' ' A' ' 28' ' ' MET . 1.5 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 1' ' ' VAL . 15.4 pm0 36.83 51.47 0.94 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.778 -0.576 . . . . 0.0 110.326 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.598 ' CD2' ' CD2' ' A' ' 80' ' ' TYR . 2.1 pt? -43.33 -31.31 0.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.877 . . . . 0.0 109.412 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.523 ' HA ' ' CG2' ' A' ' 8' ' ' THR . 4.1 t -62.31 87.22 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -0.849 . . . . 0.0 109.935 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.528 ' HG2' ' N ' ' A' ' 6' ' ' LYS . 5.2 ttmm 168.81 -90.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.528 ' N ' ' HG2' ' A' ' 5' ' ' LYS . 1.0 OUTLIER -74.83 -6.62 50.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.202 -0.936 . . . . 0.0 108.94 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.533 ' CG1' ' CD2' ' A' ' 11' ' ' LEU . 37.4 t -106.9 -72.59 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.833 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.523 ' CG2' ' HA ' ' A' ' 4' ' ' SER . 66.6 p -47.98 -29.66 3.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.678 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 8' ' ' THR . . . -41.81 -47.71 5.06 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.554 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 4.0 mtmt -141.61 -54.39 0.46 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -1.162 . . . . 0.0 109.586 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.567 ' CD1' ' CD2' ' A' ' 88' ' ' LEU . 55.2 mt 82.22 -42.55 0.13 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.756 -0.59 . . . . 0.0 109.955 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.491 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -170.98 -83.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.939 -1.1 . . . . 0.0 109.605 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER 73.87 124.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.925 . . . . 0.0 109.358 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 22.5 p 48.45 57.02 6.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.442 -0.786 . . . . 0.0 109.521 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.5 m -157.13 101.58 1.92 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.522 -0.736 . . . . 0.0 109.232 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.04 83.66 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.398 2.065 . . . . 0.0 110.502 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.424 ' C ' HG21 ' A' ' 18' ' ' ILE . . . -167.47 -146.3 4.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.561 ' HB ' ' CB ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -159.24 145.69 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.051 -1.264 . . . . 0.0 109.674 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.633 ' NE2' ' CH2' ' A' ' 21' ' ' TRP . 1.6 tt0 -122.76 143.58 49.73 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.552 HD12 ' CZ ' ' A' ' 110' ' ' PHE . 1.5 mt -114.76 175.28 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.745 -1.222 . . . . 0.0 109.537 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.633 ' CH2' ' NE2' ' A' ' 19' ' ' GLN . 7.3 m-90 -134.81 117.47 15.97 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.532 ' HD3' ' CG1' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -79.51 128.37 33.28 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 -178.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.652 ' CG2' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -101.56 31.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-O 123.075 1.417 . . . . 0.0 107.325 179.098 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.508 ' O ' ' ND2' ' A' ' 25' ' ' ASN . 1.5 pt-20 -54.96 168.44 0.3 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.647 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' CG ' ' A' ' 27' ' ' GLU . 8.0 p30 42.68 27.68 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.517 ' HE2' ' CA ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER 50.2 56.8 7.36 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.639 -0.663 . . . . 0.0 109.749 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 28' ' ' MET . 10.0 mm-40 -139.51 -99.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.982 -1.074 . . . . 0.0 110.111 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.593 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 4.1 mmm 163.04 140.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.099 -1.001 . . . . 0.0 109.205 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 1.0 OUTLIER -158.95 146.75 13.47 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.125 -0.984 . . . . 0.0 109.488 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.6 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 35.5 Cg_endo -77.45 87.45 1.51 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.842 2.361 . . . . 0.0 111.658 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 20' ' ' ILE . 42.3 t -69.92 113.08 14.86 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 34.9 Cg_endo -76.67 -159.91 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.481 2.121 . . . . 0.0 110.827 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -88.61 -16.46 32.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.322 -0.862 . . . . 0.0 109.261 -179.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.446 ' HG2' ' HG2' ' A' ' 32' ' ' PRO . 8.9 ptmt -90.38 17.66 7.02 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 110.052 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.1 m -143.2 5.27 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.936 -1.103 . . . . 0.0 110.566 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.567 ' CD1' ' O ' ' A' ' 33' ' ' THR . 30.1 p90 -90.45 146.59 24.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.784 -1.197 . . . . 0.0 109.646 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.424 ' C ' ' OD1' ' A' ' 38' ' ' ASN . . . 136.33 -27.42 2.99 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -139.47 106.4 5.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -1.159 . . . . 0.0 109.491 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.55 ' CZ ' HD13 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -119.83 126.89 52.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.108 -0.995 . . . . 0.0 109.67 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.598 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 6.9 m-30 -48.56 121.81 4.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.432 -0.792 . . . . 0.0 109.563 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.578 ' HA ' ' CH2' ' A' ' 64' ' ' TRP . 1.7 pt-20 -64.17 -7.81 10.3 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.104 -0.998 . . . . 0.0 110.297 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.621 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -111.43 57.23 0.43 Allowed Glycine 0 N--CA 1.485 1.901 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.498 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.494 ' CG ' ' O ' ' A' ' 42' ' ' GLY . 4.3 m-20 -162.34 -143.96 0.09 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.299 -1.118 . . . . 0.0 109.99 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.464 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 6.3 m -145.54 139.12 26.53 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.491 ' HB3' ' CG2' ' A' ' 20' ' ' ILE . 21.2 m-85 -137.04 106.94 6.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.054 -1.029 . . . . 0.0 110.04 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 87.5 t -78.83 128.54 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.102 -0.999 . . . . 0.0 108.857 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.587 ' HB3' ' HB2' ' A' ' 62' ' ' HIS . 3.7 tt -107.33 160.88 15.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.019 -1.05 . . . . 0.0 109.895 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 11' ' ' LEU . 20.3 tp -151.18 92.48 1.8 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.999 -1.063 . . . . 0.0 109.519 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.561 ' CB ' ' HB ' ' A' ' 18' ' ' ILE . 3.0 t -96.3 131.0 43.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 110.126 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.468 ' OG1' ' CD2' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -107.07 152.69 23.67 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.01 137.58 38.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.106 -0.996 . . . . 0.0 109.642 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.466 ' O ' ' CG2' ' A' ' 53' ' ' THR . 0.0 OUTLIER -76.98 163.64 26.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.368 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.466 ' CG2' ' O ' ' A' ' 52' ' ' LYS . 23.6 p -158.55 -177.77 6.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.538 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.36 19.29 36.58 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.7 t -140.91 -50.39 0.44 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -1.145 . . . . 0.0 109.559 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.37 -102.17 0.19 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.569 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 3.4 m-85 -152.43 -172.19 4.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -1.15 . . . . 0.0 109.5 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.6 t -149.03 102.92 3.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.844 . . . . 0.0 108.99 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.525 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 52.9 m-85 -85.23 159.34 20.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 0.0 110.181 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.469 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 6.2 m-20 -141.36 100.18 3.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.548 ' CG2' ' CG2' ' A' ' 81' ' ' THR . 47.5 mt -92.51 114.26 29.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.091 -1.005 . . . . 0.0 110.419 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.698 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 13.8 m-70 -107.91 170.1 8.2 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.545 -0.722 . . . . 0.0 109.272 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 95' ' ' HIS . 53.4 p90 -141.41 107.1 5.09 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.4 -1.32 . . . . 0.0 109.923 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.578 ' CH2' ' HA ' ' A' ' 41' ' ' GLU . 3.0 t90 -82.28 136.46 35.04 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -124.05 63.47 1.07 Allowed 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.329 -178.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 68' ' ' ASN . . . -46.49 93.68 0.01 OUTLIER Glycine 0 N--CA 1.498 2.768 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.586 ' N ' ' O ' ' A' ' 65' ' ' LEU . 7.3 tppt? -39.47 84.56 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.621 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 7.7 m120 -163.0 -43.21 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.536 ' HB2' ' CB ' ' A' ' 73' ' ' GLU . 1.4 p -50.29 -178.84 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.755 -0.591 . . . . 0.0 109.483 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.464 ' OG ' ' OD1' ' A' ' 72' ' ' ASP . 1.0 OUTLIER -95.72 -169.0 1.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.553 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.522 ' O ' ' CG ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -70.72 -39.86 73.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 9.3 p-10 -74.34 -24.57 59.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.004 -1.06 . . . . 0.0 109.298 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.536 ' CB ' ' HB2' ' A' ' 69' ' ' SER . 29.5 mt-10 -69.03 -43.03 75.57 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.579 ' CB ' ' CD1' ' A' ' 65' ' ' LEU . 4.0 pt20 -66.19 -30.35 70.8 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.509 ' O ' HD11 ' A' ' 79' ' ' ILE . . . -83.7 -12.42 77.68 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -83.8 -41.67 17.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.16 -1.2 . . . . 0.0 108.718 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.66 -50.74 22.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.855 . . . . 0.0 108.774 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.53 86.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 109.039 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.54 ' N ' HD11 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -63.52 -42.62 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.303 -0.873 . . . . 0.0 108.647 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.598 ' CD2' ' CD2' ' A' ' 3' ' ' LEU . 5.0 m-85 -62.08 -24.23 66.98 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.548 ' CG2' ' CG2' ' A' ' 61' ' ' ILE . 1.8 m -82.38 -26.31 32.99 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.1 m -70.54 -46.14 64.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.504 -0.747 . . . . 0.0 109.081 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 1.8 mt-30 -68.94 -42.56 76.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.345 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.558 ' HE2' ' CZ3' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -55.35 -36.0 65.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 109.404 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.487 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.9 t0 -77.4 -36.86 52.96 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.0 109.507 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -86.44 6.21 31.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.57 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.463 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 1.9 m-85 -121.0 -17.09 7.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 109.582 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.567 ' CD2' ' CD1' ' A' ' 11' ' ' LEU . 7.0 mt -87.58 4.93 41.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 109.598 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.73 33.63 6.04 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 p 47.02 24.25 0.36 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 0.0 109.627 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 88' ' ' LEU . 14.8 m -100.98 -15.78 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 0.0 109.282 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -79.98 167.85 19.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.274 -0.891 . . . . 0.0 109.626 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.405 ' CG1' ' H ' ' A' ' 94' ' ' GLN . 2.8 t -116.16 -176.92 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.452 -0.78 . . . . 0.0 109.099 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.405 ' H ' ' CG1' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -129.62 142.09 50.81 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.896 -1.127 . . . . 0.0 109.013 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.698 ' CD2' ' CD2' ' A' ' 62' ' ' HIS . 9.0 m-70 -143.32 150.19 38.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.067 -1.02 . . . . 0.0 109.882 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.576 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 3.4 ttp180 -108.13 138.3 44.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 110.201 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.512 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 10.5 mm-40 -145.66 161.75 39.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.36 -0.838 . . . . 0.0 109.188 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.54 ' N ' ' HB2' ' A' ' 101' ' ' HIS . 2.2 t -156.58 -166.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 108.873 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.404 ' H ' ' CG1' ' A' ' 98' ' ' VAL . 14.2 pt20 -74.12 1.82 10.3 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.837 -1.164 . . . . 0.0 110.127 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.78 19.49 1.27 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.54 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 11.9 m-70 -123.93 -9.88 7.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.571 -0.959 . . . . 0.0 109.398 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.616 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 1.2 pp20? -90.39 15.19 11.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.392 -0.817 . . . . 0.0 109.726 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 102' ' ' GLU . 24.5 p -39.72 -109.53 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.43 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 3.0 pt-20 -75.52 -25.66 57.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.719 -1.238 . . . . 0.0 111.152 -177.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.6 m -64.16 -48.83 74.46 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.823 -1.173 . . . . 0.0 109.501 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.616 ' HB2' ' HB2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -67.56 -57.29 6.73 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.548 ' N ' HD23 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -45.91 -28.04 1.03 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 104' ' ' GLU . . . -60.66 -55.22 35.87 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.651 ' CE2' ' CE1' ' A' ' 62' ' ' HIS . 69.6 m-85 -74.33 -3.65 31.53 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.605 ' CG ' HD12 ' A' ' 114' ' ' LEU . 44.9 m-85 -119.15 91.34 3.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.711 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.57 34.17 0.9 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.642 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.31 -71.78 0.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.114 -0.991 . . . . 0.0 109.696 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -173.0 125.85 1.19 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.605 HD12 ' CG ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -90.78 125.09 35.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.381 -1.07 . . . . 0.0 110.121 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.558 ' O ' ' CD1' ' A' ' 116' ' ' TYR . 0.1 OUTLIER -129.35 166.99 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.558 ' CD1' ' O ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -149.65 112.4 4.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.084 -1.01 . . . . 0.0 109.56 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -96.15 -159.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.424 -0.797 . . . . 0.0 109.801 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.47 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -91.07 167.19 12.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.248 -0.907 . . . . 0.0 109.607 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.474 ' HA2' ' OD1' ' A' ' 43' ' ' ASP . . . -80.5 -163.89 29.83 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 62.19 139.52 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 122' ' ' ALA . 2.9 p -90.44 -145.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.219 -1.165 . . . . 0.0 108.673 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.567 ' N ' ' CG1' ' A' ' 121' ' ' VAL . . . -46.3 -86.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 0.0 109.537 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 122' ' ' ALA . 1.0 OUTLIER 165.04 -41.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.935 . . . . 0.0 109.539 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 126' ' ' LYS . . . -112.15 -57.52 0.45 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 39.5 mmm -49.53 144.51 5.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -1.123 . . . . 0.0 109.549 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.484 ' OXT' ' CG ' ' A' ' 126' ' ' LYS . 2.2 ptmt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.497 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 2' ' ' GLU . 1.3 t . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 1' ' ' VAL . 1.5 pt-20 -44.41 126.25 5.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.479 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.609 ' O ' ' HB ' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -85.06 14.71 4.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.575 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 5.9 p -92.51 152.22 19.77 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.668 -1.27 . . . . 0.0 109.902 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 4' ' ' SER . 0.1 OUTLIER 80.5 -69.69 0.09 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.71 . . . . 0.0 110.742 178.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.522 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 13.8 ttmt -81.98 16.44 1.9 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.05 -1.031 . . . . 0.0 110.663 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.609 ' HB ' ' O ' ' A' ' 3' ' ' LEU . 51.6 t -158.69 -59.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.917 -1.115 . . . . 0.0 109.825 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.528 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 77.4 p -60.55 -13.32 13.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 109.813 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.79 -20.45 6.03 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 1.7 pttm -170.99 -33.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -1.141 . . . . 0.0 109.772 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.572 ' CD2' ' CD2' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 69.56 -0.4 2.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.39 -0.819 . . . . 0.0 110.093 -179.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 11' ' ' LEU . 32.3 m-20 58.63 135.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.109 -0.994 . . . . 0.0 110.201 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.563 ' O ' ' CG2' ' A' ' 14' ' ' THR . 0.0 OUTLIER -56.59 -19.27 15.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.044 -1.035 . . . . 0.0 108.587 179.235 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.563 ' CG2' ' O ' ' A' ' 13' ' ' LYS . 13.8 t 44.99 18.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.916 -0.49 . . . . 0.0 111.925 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.572 HG21 ' N ' ' A' ' 16' ' ' PRO . 0.5 OUTLIER 47.62 -177.17 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.015 -1.053 . . . . 0.0 108.599 179.435 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.572 ' N ' HG21 ' A' ' 15' ' ' THR . 34.9 Cg_endo -80.32 90.11 1.26 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.908 1.739 . . . . 0.0 110.32 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.528 ' O ' ' CG2' ' A' ' 18' ' ' ILE . . . -164.3 -120.89 0.54 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.528 ' CG2' ' O ' ' A' ' 17' ' ' GLY . 19.9 pt -160.5 -165.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -1.188 . . . . 0.0 110.232 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.485 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 2.5 mt-30 -170.78 172.95 5.48 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 18.5 mt -145.88 168.15 7.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.401 -1.437 . . . . 0.0 110.352 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.59 ' CD1' ' HA ' ' A' ' 30' ' ' PRO . 7.4 m-90 -133.97 118.83 18.31 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.531 ' CG ' HG23 ' A' ' 31' ' ' VAL . 14.4 mtm180 -79.15 121.2 24.72 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.219 -0.926 . . . . 0.0 110.921 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.636 ' CG2' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -101.98 27.48 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.123 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.536 ' HB2' ' CG2' ' A' ' 121' ' ' VAL . 1.3 pt-20 -58.62 179.13 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.375 -0.828 . . . . 0.0 109.421 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' CG ' ' A' ' 27' ' ' GLU . 8.4 p30 42.14 27.47 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.463 ' N ' ' O ' ' A' ' 24' ' ' GLU . 26.9 mmm 54.71 55.27 8.08 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.489 -0.757 . . . . 0.0 109.765 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 70.1 mm-40 -153.47 -134.36 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.117 -0.99 . . . . 0.0 109.356 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.577 ' HE1' ' CD1' ' A' ' 21' ' ' TRP . 3.1 ttt -160.04 149.74 18.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.898 -1.126 . . . . 0.0 109.316 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -160.16 149.36 14.07 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.099 -1.0 . . . . 0.0 109.587 -179.559 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.59 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 34.6 Cg_endo -76.43 125.88 8.67 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.534 2.156 . . . . 0.0 111.109 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.538 HG22 ' CA ' ' A' ' 21' ' ' TRP . 5.8 t -111.24 105.61 57.02 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.63 -158.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.44 2.093 . . . . 0.0 110.4 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.561 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -81.86 -18.91 42.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 108.952 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.16 32.33 0.76 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.345 -0.847 . . . . 0.0 109.706 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.415 ' CB ' HG11 ' A' ' 31' ' ' VAL . 1.7 m -155.07 -38.8 0.09 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.95 . . . . 0.0 109.624 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.563 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -45.55 129.47 8.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.469 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.34 -77.09 0.39 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.491 ' HB3' ' CG2' ' A' ' 115' ' ' ILE . 4.4 m-80 -89.1 106.79 18.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -1.165 . . . . 0.0 109.673 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.582 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -135.92 137.08 41.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.233 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.667 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 7.2 m-30 -42.33 151.95 0.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.285 -0.885 . . . . 0.0 109.508 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 12.1 pt-20 -90.93 -37.98 13.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.171 -0.956 . . . . 0.0 109.784 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.598 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -85.69 66.46 3.75 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.193 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -162.91 -150.28 0.16 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.025 -1.28 . . . . 0.0 110.31 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.497 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 34.6 m -139.0 148.1 43.01 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.582 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 28.2 m-85 -145.36 109.23 4.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.015 -1.053 . . . . 0.0 109.717 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 98.8 t -79.37 122.6 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.999 -1.063 . . . . 0.0 108.549 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.53 HD11 ' CE1' ' A' ' 106' ' ' PHE . 6.6 tt -108.1 123.5 48.8 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.256 -0.903 . . . . 0.0 110.168 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.572 ' CD2' ' CD2' ' A' ' 11' ' ' LEU . 24.0 tp -104.55 100.24 9.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.846 -1.159 . . . . 0.0 109.864 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.466 ' OG ' HG21 ' A' ' 18' ' ' ILE . 10.8 t -83.41 127.21 33.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 108.757 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.655 ' CG2' ' CE1' ' A' ' 57' ' ' PHE . 1.2 m -123.02 114.32 20.24 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -116.6 126.59 53.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.269 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.522 ' O ' ' CG2' ' A' ' 53' ' ' THR . 11.4 pttm -51.52 -176.86 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.329 -0.857 . . . . 0.0 109.325 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.522 ' CG2' ' O ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -178.72 153.47 0.68 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.444 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 53' ' ' THR . . . -44.2 -26.83 0.99 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.17 -40.49 14.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -1.092 . . . . 0.0 109.41 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.72 -70.29 0.2 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.655 ' CE1' ' CG2' ' A' ' 50' ' ' THR . 0.1 OUTLIER -139.81 175.63 9.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -1.138 . . . . 0.0 111.196 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.66 89.34 1.68 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.576 ' CE1' ' HB3' ' A' ' 57' ' ' PHE . 6.5 m-85 -78.74 157.2 28.57 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.135 0.969 . . . . 0.0 111.32 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.572 ' O ' ' CD2' ' A' ' 62' ' ' HIS . 7.7 m-80 -151.54 87.6 1.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.571 ' CG2' ' CG2' ' A' ' 81' ' ' THR . 10.3 mt -71.2 140.71 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.295 -0.878 . . . . 0.0 110.4 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.648 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 55.4 m-70 -125.99 160.18 30.72 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 95' ' ' HIS . 50.6 p90 -134.85 96.18 3.48 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 117.979 -1.489 . . . . 0.0 109.887 177.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.576 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 6.0 t90 -74.18 131.74 41.54 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -121.55 60.96 0.94 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.287 -0.883 . . . . 0.0 111.039 -178.078 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -49.07 90.46 0.01 OUTLIER Glycine 0 N--CA 1.498 2.786 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.59 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -38.43 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.13 0.967 . . . . 0.0 112.61 -177.432 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.598 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 2.7 m-80 -162.61 -45.73 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.47 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 96.3 p -59.34 -156.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.517 -0.739 . . . . 0.0 109.276 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 p -109.34 160.7 15.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -45.44 19.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 109.381 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -57.92 -41.74 83.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.141 -0.974 . . . . 0.0 109.361 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HG2' ' HB2' ' A' ' 69' ' ' SER . 3.9 tp10 -54.54 -39.77 68.01 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.525 ' CG ' HD12 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -60.43 -37.69 81.71 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.513 ' O ' ' CD1' ' A' ' 79' ' ' ILE . . . -70.67 -23.57 77.65 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.467 ' HA ' HD11 ' A' ' 79' ' ' ILE . . . -75.71 -67.21 0.69 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.313 -1.11 . . . . 0.0 109.192 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.407 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -45.35 -38.09 5.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 0.0 109.301 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.64 -39.91 73.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.665 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.513 ' CD1' ' O ' ' A' ' 75' ' ' GLY . 17.9 mt -60.83 -48.69 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 0.0 109.5 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.568 ' CD2' ' SD ' ' A' ' 28' ' ' MET . 25.5 m-85 -56.92 -42.46 80.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.042 -1.036 . . . . 0.0 108.968 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.571 ' CG2' ' CG2' ' A' ' 61' ' ' ILE . 6.4 m -68.72 -23.65 64.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.485 -0.76 . . . . 0.0 109.141 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.3 m -78.57 -23.59 45.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.452 -0.78 . . . . 0.0 109.46 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 5.1 mt-30 -89.91 -34.5 16.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.671 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.566 ' HE2' ' CE3' ' A' ' 21' ' ' TRP . 2.4 mtt -63.14 -47.05 84.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.696 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.565 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 3.1 t70 -50.73 -54.98 18.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.721 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.69 -12.21 59.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.717 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 4.1 m-30 -97.23 -2.92 41.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.609 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.571 ' HB3' ' CD2' ' A' ' 59' ' ' TYR . 3.9 mt -108.43 8.23 27.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.55 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 105.59 3.1 40.52 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 1.3 p 75.38 -0.09 3.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -1.174 . . . . 0.0 109.644 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.548 HG21 ' CD2' ' A' ' 59' ' ' TYR . 4.7 m -87.23 15.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.114 -0.991 . . . . 0.0 109.389 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.521 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -100.03 179.33 4.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.586 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.461 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 4.6 t -135.24 175.86 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.12 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -124.91 131.04 53.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.972 -1.08 . . . . 0.0 109.504 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.648 ' CD2' ' CE1' ' A' ' 62' ' ' HIS . 20.2 m-70 -130.21 150.02 51.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.8 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.576 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 8.6 ptm180 -109.79 136.02 49.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.369 -0.832 . . . . 0.0 109.801 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.497 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 7.4 mm-40 -139.77 166.21 25.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.263 -0.898 . . . . 0.0 109.595 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.52 ' N ' ' HB2' ' A' ' 101' ' ' HIS . 2.7 t -155.58 -176.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.354 -0.841 . . . . 0.0 109.2 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -4.52 12.18 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.966 -1.084 . . . . 0.0 110.335 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.08 14.38 3.06 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.52 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 51.8 m-70 -123.01 -20.96 5.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.57 -0.959 . . . . 0.0 109.725 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.576 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.1 OUTLIER -90.28 8.85 31.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.341 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 107' ' ' ARG . 1.0 OUTLIER -56.79 -63.03 1.34 Allowed 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.162 -0.961 . . . . 0.0 111.225 -178.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.508 ' N ' ' OG ' ' A' ' 103' ' ' SER . 3.6 mt-10 -76.5 -55.6 5.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.967 -1.083 . . . . 0.0 111.748 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.466 ' HB ' ' OE1' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -61.26 -52.64 63.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.97 -1.082 . . . . 0.0 111.113 -178.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.547 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -64.98 -55.0 21.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.968 -1.082 . . . . 0.0 108.914 -178.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' A' ' 103' ' ' SER . 2.3 ttm180 -61.51 -17.26 53.9 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.179 -0.951 . . . . 0.0 108.661 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 104' ' ' GLU . . . -66.14 -59.81 3.41 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.471 ' HB3' HG23 ' A' ' 18' ' ' ILE . 9.2 m-85 -63.43 -16.19 59.83 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.645 ' CG ' ' CD2' ' A' ' 114' ' ' LEU . 43.7 m-85 -108.22 99.51 8.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.474 -0.766 . . . . 0.0 109.536 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -74.77 1.59 12.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.286 -0.883 . . . . 0.0 109.702 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.78 -81.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.066 -1.021 . . . . 0.0 109.822 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 114' ' ' LEU . . . 178.04 -29.99 0.07 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.645 ' CD2' ' CG ' ' A' ' 110' ' ' PHE . 33.3 mt 81.75 109.33 0.07 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.589 -0.948 . . . . 0.0 110.284 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.491 ' CG2' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -91.03 172.15 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.654 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.555 ' CZ ' ' O ' ' A' ' 114' ' ' LEU . 1.4 m-85 -150.04 124.88 9.85 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.024 -1.047 . . . . 0.0 109.981 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.667 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -106.4 -164.89 1.04 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.471 -0.768 . . . . 0.0 109.31 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.579 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 1.6 tp60 -91.56 163.03 14.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.879 -1.138 . . . . 0.0 110.165 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 120' ' ' GLY . . . -76.56 -153.68 5.16 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 52.69 101.46 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.536 ' CG2' ' HB2' ' A' ' 24' ' ' GLU . 1.5 t -90.27 -141.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.17 -1.194 . . . . 0.0 109.253 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.39 -33.21 73.84 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.334 -0.854 . . . . 0.0 109.52 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.9 m -104.02 36.85 2.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.86 . . . . 0.0 109.402 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -107.87 -54.66 0.63 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.26 167.63 19.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -1.151 . . . . 0.0 109.49 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.6 mttm . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.416 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.483 ' O ' ' C ' ' A' ' 2' ' ' GLU . 29.1 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 2' ' ' GLU . 18.0 pt-20 32.98 93.99 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.428 0.632 . . . . 0.0 110.462 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.567 HD21 ' CD2' ' A' ' 80' ' ' TYR . 2.6 pt? -53.8 -33.25 55.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 109.505 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 10.7 t -44.53 146.08 0.77 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 4' ' ' SER . 10.9 tttt 80.24 -71.84 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.63 -0.669 . . . . 0.0 109.96 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -84.73 15.76 3.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 109.985 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.526 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 12.0 t -150.56 -65.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.016 -1.052 . . . . 0.0 109.716 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.53 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 70.3 p -50.01 -23.19 1.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.4 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 10' ' ' LYS . . . -89.58 33.11 4.49 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 10' ' ' LYS . 2.4 tttm 169.28 70.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -1.069 . . . . 0.0 109.17 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.53 ' CD2' ' HA ' ' A' ' 8' ' ' THR . 4.3 mm? -94.47 74.0 3.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.375 -0.828 . . . . 0.0 109.414 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 13' ' ' LYS . 6.2 t70 62.16 -91.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 109.376 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER 62.37 124.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.954 . . . . 0.0 109.631 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 22.4 p 48.36 56.99 6.67 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.349 -0.844 . . . . 0.0 109.604 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.425 ' HB ' ' CG ' ' A' ' 12' ' ' ASP . 21.1 m -167.48 102.34 0.6 Allowed Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.417 -0.802 . . . . 0.0 109.414 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.95 99.8 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.423 2.082 . . . . 0.0 110.277 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.462 ' O ' HG21 ' A' ' 18' ' ' ILE . . . 179.54 -139.14 3.73 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.49 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 12.3 pt -157.41 142.46 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.049 -1.265 . . . . 0.0 110.1 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.447 ' NE2' ' CZ2' ' A' ' 21' ' ' TRP . 1.1 tt0 -122.24 114.44 20.83 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.576 HD13 ' CE1' ' A' ' 110' ' ' PHE . 2.9 mt -92.49 164.04 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.757 -1.214 . . . . 0.0 109.67 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.597 ' HA ' ' O ' ' A' ' 29' ' ' VAL . 8.3 m-90 -122.01 126.42 48.48 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.584 ' HA ' ' CD1' ' A' ' 45' ' ' TYR . 0.9 OUTLIER -79.23 132.66 36.57 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.177 0.989 . . . . 0.0 111.74 -176.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 44' ' ' CYS . 2.2 mm -127.27 44.26 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.534 ' HB2' ' CD2' ' A' ' 40' ' ' TYR . 3.2 pm0 -99.81 -40.12 7.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 0.0 110.049 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.526 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 3.0 p30 -81.97 10.08 7.15 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.132 -0.98 . . . . 0.0 108.677 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.517 ' CE ' ' OG ' ' A' ' 70' ' ' SER . 53.9 mmm 73.08 29.0 1.83 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.521 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 47.6 mt-10 -150.79 103.02 3.04 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.568 ' SD ' ' CD2' ' A' ' 80' ' ' TYR . 0.9 OUTLIER -42.29 138.02 1.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 110.173 -179.219 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -139.71 149.37 59.26 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.526 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 35.7 Cg_endo -78.68 82.61 2.44 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.225 1.95 . . . . 0.0 111.737 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.572 ' CG2' ' N ' ' A' ' 22' ' ' ARG . 2.8 t -69.9 112.93 14.01 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.18 -0.95 . . . . 0.0 109.887 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 36.2 Cg_endo -78.7 -158.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.486 2.124 . . . . 0.0 110.044 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.572 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -90.0 -16.29 30.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.083 -1.01 . . . . 0.0 109.152 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HG3' ' HG2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -75.39 -20.31 59.02 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -0.873 . . . . 0.0 109.874 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.0 m -122.96 13.12 9.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.12 -0.988 . . . . 0.0 109.734 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.58 ' CG ' ' O ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -85.05 49.88 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.985 . . . . 0.0 109.914 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.568 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . -137.65 -82.71 0.11 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.516 ' HB3' ' CG2' ' A' ' 115' ' ' ILE . 4.2 m-80 -81.46 123.96 29.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -1.135 . . . . 0.0 109.58 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.631 ' HB2' ' CZ ' ' A' ' 45' ' ' TYR . 2.7 p90 -160.24 141.08 12.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.013 . . . . 0.0 110.087 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.621 ' CD2' ' HA2' ' A' ' 119' ' ' GLY . 5.4 m-30 -39.6 142.9 0.26 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.355 -0.841 . . . . 0.0 110.767 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 15.7 pt-20 -90.66 -38.86 12.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 109.363 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.574 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -83.43 70.97 3.08 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.459 ' OD1' ' HB3' ' A' ' 40' ' ' TYR . 4.9 m-20 -160.66 -132.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.719 -0.871 . . . . 0.0 109.122 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.58 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 57.9 m -156.66 148.77 23.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.988 -1.07 . . . . 0.0 108.599 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.631 ' CZ ' ' HB2' ' A' ' 39' ' ' PHE . 17.2 m-85 -147.57 111.06 4.94 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.353 -0.842 . . . . 0.0 109.575 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.554 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 4.0 t -79.59 112.21 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.994 -1.066 . . . . 0.0 108.152 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.592 HD11 ' CE1' ' A' ' 106' ' ' PHE . 7.3 tt -102.97 114.59 29.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.83 -1.168 . . . . 0.0 110.331 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.405 HD12 ' HB3' ' A' ' 59' ' ' TYR . 16.5 tp -99.99 109.89 22.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.237 -0.914 . . . . 0.0 109.195 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 t -97.12 134.28 40.67 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.39 -0.819 . . . . 0.0 109.641 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.532 ' OG1' ' CD1' ' A' ' 59' ' ' TYR . 1.2 m -120.52 135.95 54.92 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.14 155.42 37.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.627 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.511 ' O ' ' CG2' ' A' ' 53' ' ' THR . 0.0 OUTLIER -91.42 155.63 18.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 109.458 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 52' ' ' LYS . 68.9 p -158.83 175.61 13.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 0.0 109.449 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.38 -22.01 71.48 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.13 -52.99 5.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -1.173 . . . . 0.0 109.477 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.06 -97.28 0.11 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.588 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 18.2 m-85 -145.35 156.23 43.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -1.143 . . . . 0.0 109.526 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.0 m -121.89 99.53 6.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.871 . . . . 0.0 108.914 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.532 ' CD1' ' OG1' ' A' ' 50' ' ' THR . 17.3 m-30 -81.77 158.23 24.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 110.209 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.558 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 8.0 m-20 -150.43 90.38 1.65 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 85' ' ' ASP . 11.7 mt -77.51 135.52 26.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.231 -0.918 . . . . 0.0 110.291 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.682 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 55.9 m-70 -122.48 159.56 27.39 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.612 ' CZ ' ' HA ' ' A' ' 96' ' ' ARG . 49.4 p90 -135.52 93.26 2.94 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.92 -1.512 . . . . 0.0 110.099 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.593 ' HA ' ' HB2' ' A' ' 97' ' ' GLU . 5.7 t90 -73.91 119.17 17.75 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.572 ' CD1' ' HB2' ' A' ' 74' ' ' GLN . 0.2 OUTLIER -110.33 77.41 1.05 Allowed 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.568 -0.707 . . . . 0.0 111.158 -177.284 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 41' ' ' GLU . . . -65.7 86.88 0.1 OUTLIER Glycine 0 N--CA 1.494 2.559 0 N-CA-C 107.751 -2.14 . . . . 0.0 107.751 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.478 ' O ' ' OD1' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -52.68 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.798 0.808 . . . . 0.0 112.617 -177.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.574 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 10.1 m120 -160.29 -39.1 0.05 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 70' ' ' SER . 11.7 p -71.72 -145.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 109.297 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.517 ' OG ' ' CE ' ' A' ' 26' ' ' MET . 16.8 p -88.62 142.41 27.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 0.0 109.956 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.505 ' CG ' ' OE1' ' A' ' 74' ' ' GLN . 5.5 tt0 -50.78 -46.92 59.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.299 -0.875 . . . . 0.0 109.018 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.93 -38.5 67.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.217 -0.927 . . . . 0.0 109.026 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.517 ' CG ' ' HE2' ' A' ' 26' ' ' MET . 1.4 tp10 -56.84 -38.58 72.85 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.572 ' HB2' ' CD1' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -62.45 -35.89 80.7 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.533 ' N ' ' HG2' ' A' ' 74' ' ' GLN . . . -80.19 -13.64 81.63 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -79.86 -44.25 20.83 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.299 -1.118 . . . . 0.0 108.706 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.12 -44.52 75.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 108.979 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.2 -48.94 71.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.424 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 75' ' ' GLY . 64.6 mt -55.5 -43.97 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.96 . . . . 0.0 109.474 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.568 ' CD2' ' SD ' ' A' ' 28' ' ' MET . 4.5 m-85 -63.35 -32.09 73.42 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.102 -0.999 . . . . 0.0 108.731 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.524 ' OG1' ' CG1' ' A' ' 46' ' ' VAL . 8.7 m -66.92 -24.8 66.13 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.5 m -84.48 -29.96 25.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.531 -0.73 . . . . 0.0 109.166 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.509 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 1.9 mt-30 -71.45 -38.03 71.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 109.514 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.565 ' HE2' ' CH2' ' A' ' 21' ' ' TRP . 4.2 ptm -82.38 -33.11 28.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.46 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.527 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 9.2 t0 -59.7 -28.89 67.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 0.0 109.299 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -90.08 -36.83 14.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.872 . . . . 0.0 109.454 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.509 ' CD1' ' O ' ' A' ' 83' ' ' GLN . 5.6 m-85 -71.33 -8.45 53.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 109.565 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.517 HD21 ' CD2' ' A' ' 59' ' ' TYR . 20.3 mt -84.98 -14.17 48.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.539 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 100.67 18.22 21.36 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 0.3 OUTLIER 73.29 6.77 5.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -1.108 . . . . 0.0 109.606 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.4 m -85.07 -14.95 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.122 -0.986 . . . . 0.0 109.464 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -90.14 172.87 8.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 109.546 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.466 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 3.5 t -128.38 176.14 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 109.312 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -122.82 133.48 54.44 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.096 -1.002 . . . . 0.0 109.006 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.682 ' CD2' ' CE1' ' A' ' 62' ' ' HIS . 29.1 m-70 -126.83 141.74 51.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.125 -0.984 . . . . 0.0 110.145 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.612 ' HA ' ' CZ ' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -89.34 120.02 30.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 109.792 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 64' ' ' TRP . 26.9 mt-10 -127.74 156.72 41.98 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.276 -0.89 . . . . 0.0 108.845 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.629 ' CG2' ' CG ' ' A' ' 101' ' ' HIS . 3.0 t -160.11 -179.27 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.301 -0.875 . . . . 0.0 108.874 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.467 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 28.8 tt0 -73.69 -3.27 27.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.938 -1.101 . . . . 0.0 109.198 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.56 6.21 3.85 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.629 ' CG ' ' CG2' ' A' ' 98' ' ' VAL . 10.9 m170 -109.45 -89.97 0.47 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.397 -1.061 . . . . 0.0 108.766 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.594 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -83.5 44.44 0.97 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.446 -0.784 . . . . 0.0 110.269 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -80.62 -61.5 1.95 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 108.698 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.516 ' N ' ' OG ' ' A' ' 103' ' ' SER . 28.2 tt0 -64.46 -47.27 79.67 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.486 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 40.8 m -49.57 -46.51 48.98 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.594 ' HB2' ' O ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -49.73 -65.14 0.61 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.54 ' HA ' ' CD1' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -42.51 -35.01 0.94 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.486 ' CB ' ' O ' ' A' ' 105' ' ' THR . . . -52.13 -56.51 14.02 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.49 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 97.1 m-85 -56.41 -28.34 59.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.902 . . . . 0.0 108.576 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.584 ' CD2' HD13 ' A' ' 114' ' ' LEU . 87.6 m-85 -88.02 90.38 8.36 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -74.06 -0.14 15.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.438 -0.789 . . . . 0.0 109.923 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -96.85 -85.46 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.109 -0.994 . . . . 0.0 109.594 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -164.22 123.07 1.14 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.584 HD13 ' CD2' ' A' ' 110' ' ' PHE . 4.4 mt -92.15 145.28 24.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -1.159 . . . . 0.0 110.067 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.533 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -140.29 169.79 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.533 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 1.0 OUTLIER -147.45 139.34 24.19 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.926 -1.109 . . . . 0.0 110.137 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -114.71 -168.25 1.35 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.512 -0.742 . . . . 0.0 109.235 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.583 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 1.1 pm0 -90.92 163.41 14.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.015 -1.053 . . . . 0.0 110.561 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.621 ' HA2' ' CD2' ' A' ' 40' ' ' TYR . . . -93.28 178.67 38.75 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.22 52.8 1.55 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.563 ' O ' ' CG1' ' A' ' 121' ' ' VAL . 1.0 OUTLIER -90.01 10.08 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.132 -1.216 . . . . 0.0 109.103 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.24 -23.42 21.24 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.179 -0.95 . . . . 0.0 109.484 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 86.6 p -119.93 32.02 6.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.325 -0.859 . . . . 0.0 109.507 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.22 -80.38 1.46 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.5 mtt -84.48 144.51 28.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -1.137 . . . . 0.0 109.471 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.51 -179.958 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 2' ' ' GLU . 9.7 p . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.589 ' HA ' ' CZ ' ' A' ' 80' ' ' TYR . 14.6 pt-20 -43.28 123.21 2.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.349 -0.844 . . . . 0.0 109.639 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.58 ' N ' ' CD2' ' A' ' 3' ' ' LEU . 1.7 pt? -43.78 133.78 4.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.102 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.4 m -89.23 -176.26 5.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 110.146 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.548 ' CB ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -72.2 -31.26 65.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.372 -0.83 . . . . 0.0 109.147 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -76.93 -28.68 55.33 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.512 ' CG1' ' HB2' ' A' ' 3' ' ' LEU . 1.8 t -70.8 -62.29 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.531 ' O ' ' CD1' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -90.32 12.56 17.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.275 -0.891 . . . . 0.0 109.494 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 5' ' ' LYS . . . -70.56 -105.29 0.04 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 11' ' ' LEU . 10.6 mttm -65.23 -29.28 70.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -1.098 . . . . 0.0 109.431 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.542 ' CD1' ' CD2' ' A' ' 88' ' ' LEU . 4.0 mt 44.34 57.13 4.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.403 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.467 ' HB2' ' NE2' ' A' ' 19' ' ' GLN . 0.3 OUTLIER 68.15 137.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.297 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.46 ' O ' ' OG1' ' A' ' 14' ' ' THR . 26.1 mmtt -142.04 149.7 40.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.659 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.556 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 80.5 p 50.09 58.04 5.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.476 -0.765 . . . . 0.0 109.768 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 14' ' ' THR . 18.7 m -171.64 120.82 0.47 Allowed Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.468 -0.77 . . . . 0.0 109.092 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.0 128.18 9.79 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.31 2.007 . . . . 0.0 110.348 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 147.19 169.5 14.71 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.57 HG13 ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -123.8 155.47 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.011 -1.287 . . . . 0.0 110.159 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 16.5 mt-30 -115.17 158.3 22.43 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.554 ' O ' ' CB ' ' A' ' 31' ' ' VAL . 4.0 mt -129.02 153.52 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.763 -1.21 . . . . 0.0 110.369 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.568 ' CD1' ' SD ' ' A' ' 28' ' ' MET . 9.2 m-90 -115.42 132.54 56.59 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.61 ' HA ' ' CD2' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -90.22 128.03 36.28 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.832 -1.167 . . . . 0.0 111.84 -177.351 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.54 HG13 ' CB ' ' A' ' 44' ' ' CYS . 5.0 mm -99.69 56.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 177.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.504 ' O ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -48.44 -106.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.347 -177.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.568 ' O ' ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -45.43 -77.69 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.917 -1.114 . . . . 0.0 108.3 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.587 ' CE ' ' CB ' ' A' ' 69' ' ' SER . 13.2 mmt -163.29 36.85 0.09 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 74.8 mt-10 -141.4 145.42 35.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.343 -0.848 . . . . 0.0 109.367 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.638 ' CB ' ' CD2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -73.46 139.01 45.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.253 -0.904 . . . . 0.0 110.238 -179.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.543 ' O ' ' CA ' ' A' ' 21' ' ' TRP . 1.9 t -138.43 154.96 74.0 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.544 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 35.1 Cg_endo -77.37 125.52 7.79 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.316 2.011 . . . . 0.0 111.668 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.576 ' CG2' ' N ' ' A' ' 22' ' ' ARG . 1.4 t -118.33 97.8 50.97 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.6 -154.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.676 2.25 . . . . 0.0 110.113 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.592 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -77.51 2.88 14.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.104 -0.997 . . . . 0.0 109.322 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -66.0 -35.44 80.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.142 -0.973 . . . . 0.0 110.307 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.13 68.39 0.38 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.945 -1.097 . . . . 0.0 110.38 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.592 ' CD2' ' HA ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -90.47 39.57 0.98 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.046 -1.034 . . . . 0.0 109.86 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.502 ' HA2' ' CE2' ' A' ' 39' ' ' PHE . . . -144.6 -50.48 0.03 OUTLIER Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.206 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.463 ' HA ' HG21 ' A' ' 115' ' ' ILE . 1.7 m-80 -79.73 93.92 5.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.093 -1.239 . . . . 0.0 109.57 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.627 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -129.76 128.83 43.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.508 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.625 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 64.5 m-85 -39.14 124.78 1.52 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.56 -0.713 . . . . 0.0 110.613 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.6 ' HA ' ' CH2' ' A' ' 64' ' ' TRP . 2.7 pt-20 -80.63 -0.14 36.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.281 -0.887 . . . . 0.0 109.303 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.568 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -124.61 54.97 0.72 Allowed Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.467 ' HA ' ' OE1' ' A' ' 73' ' ' GLU . 7.9 m-20 -160.15 -123.99 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.296 -1.12 . . . . 0.0 109.186 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.614 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 92.0 m -153.28 155.42 36.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.88 -1.137 . . . . 0.0 109.568 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.627 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 31.0 m-85 -155.03 116.62 4.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.359 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.543 ' O ' ' CG2' ' A' ' 20' ' ' ILE . 47.9 t -78.08 160.44 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.695 -1.253 . . . . 0.0 108.141 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.573 HD21 ' CD2' ' A' ' 62' ' ' HIS . 7.2 tt -153.76 106.48 2.88 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.496 -1.378 . . . . 0.0 110.12 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.532 ' CD2' ' HB3' ' A' ' 11' ' ' LEU . 13.1 tp -95.99 109.15 21.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.597 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.532 ' OG ' ' CG2' ' A' ' 18' ' ' ILE . 12.9 t -98.89 133.5 43.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.334 -0.854 . . . . 0.0 109.644 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.2 m -122.17 142.31 50.54 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.508 ' HG2' ' N ' ' A' ' 52' ' ' LYS . 7.6 ttt180 -142.82 147.78 36.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 109.494 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.508 ' N ' ' HG2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -80.99 163.41 23.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.979 . . . . 0.0 109.608 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 56' ' ' GLY . 1.5 p -157.97 -168.58 2.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.293 -0.879 . . . . 0.0 109.489 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.22 -41.0 32.53 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 56' ' ' GLY . 1.1 p -79.84 -59.15 2.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -1.184 . . . . 0.0 109.469 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.513 ' N ' ' OG ' ' A' ' 55' ' ' SER . . . -157.09 -129.2 1.11 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.556 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 5.0 m-30 -103.31 -169.72 1.69 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -1.159 . . . . 0.0 109.243 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.477 ' HA ' ' CG2' ' A' ' 91' ' ' VAL . 69.5 m -149.94 107.38 3.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.192 -0.943 . . . . 0.0 109.295 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.507 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 48.1 m-85 -89.16 158.09 18.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.207 -0.933 . . . . 0.0 109.805 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.577 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 6.8 m-20 -154.85 92.73 1.49 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.52 ' CG2' HG21 ' A' ' 81' ' ' THR . 9.9 mt -80.83 132.26 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.164 -0.96 . . . . 0.0 110.642 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.573 ' CD2' HD21 ' A' ' 47' ' ' LEU . 42.7 m-70 -119.57 162.35 19.08 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 95' ' ' HIS . 49.5 p90 -136.7 94.08 2.94 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.339 -1.345 . . . . 0.0 109.674 176.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.605 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 3.4 t90 -70.2 140.52 52.52 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.571 ' CD2' ' O ' ' A' ' 64' ' ' TRP . 8.1 mt -138.77 77.32 1.62 Allowed 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 118.532 -1.267 . . . . 0.0 111.144 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 41' ' ' GLU . . . -54.81 90.04 0.01 OUTLIER Glycine 0 C--N 1.275 -2.85 0 N-CA-C 106.9 -2.48 . . . . 0.0 106.9 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.546 ' HE3' ' CG1' ' A' ' 98' ' ' VAL . 9.5 ptpt -51.45 98.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.379 1.085 . . . . 0.0 112.185 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.568 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 13.7 m120 -160.15 -41.22 0.05 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.587 ' CB ' ' CE ' ' A' ' 26' ' ' MET . 81.9 p -67.22 -144.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.522 -0.736 . . . . 0.0 109.036 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.462 ' OG ' ' OD2' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -115.74 163.0 16.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.024 -1.048 . . . . 0.0 109.777 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -49.83 -32.07 13.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.25 -0.906 . . . . 0.0 109.156 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 3.0 p30 -60.35 -45.53 93.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.144 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 15.2 tt0 -56.91 -37.11 70.98 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.499 ' CG ' HD11 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -62.24 -35.85 80.21 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.529 ' O ' ' CG1' ' A' ' 79' ' ' ILE . . . -81.65 -12.98 80.87 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.58 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -77.5 -52.6 8.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.294 -1.121 . . . . 0.0 108.955 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.546 ' CB ' ' HB3' ' A' ' 44' ' ' CYS . . . -75.88 -38.82 57.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.913 . . . . 0.0 109.1 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.83 94.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.301 -0.874 . . . . 0.0 109.229 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.529 ' CG1' ' O ' ' A' ' 75' ' ' GLY . 65.4 mt -71.6 -43.67 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.248 -0.908 . . . . 0.0 109.266 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.638 ' CD2' ' CB ' ' A' ' 28' ' ' MET . 3.4 m-85 -57.97 -35.47 71.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.122 -0.986 . . . . 0.0 108.867 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.52 HG21 ' CG2' ' A' ' 61' ' ' ILE . 18.1 m -67.51 -38.77 84.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.403 -0.811 . . . . 0.0 108.856 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.9 m -59.83 -42.86 94.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.844 . . . . 0.0 109.06 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -67.16 -28.47 68.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.264 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.514 ' HG2' ' CD1' ' A' ' 61' ' ' ILE . 17.8 ttm -63.08 -45.39 92.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.201 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.54 -15.28 25.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 108.994 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.18 -63.66 1.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.327 -0.858 . . . . 0.0 109.066 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.548 ' CE1' ' CB ' ' A' ' 5' ' ' LYS . 4.7 m-85 -53.93 -20.35 5.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 108.969 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.542 ' CD2' ' CD1' ' A' ' 11' ' ' LEU . 51.7 mt -90.15 -62.64 1.42 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -0.842 . . . . 0.0 109.196 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 57.22 62.3 6.51 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.3 p -143.64 -143.14 0.14 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.259 -1.142 . . . . 0.0 109.297 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.477 ' CG2' ' HA ' ' A' ' 58' ' ' SER . 11.6 m -92.18 15.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.507 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -52.23 173.01 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.693 -0.63 . . . . 0.0 109.826 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.464 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 3.9 t -147.63 177.09 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.524 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -124.43 136.16 53.83 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.111 -0.993 . . . . 0.0 108.877 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.59 ' O ' ' CD1' ' A' ' 63' ' ' TYR . 18.0 m-70 -131.96 150.75 52.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.978 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.571 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 8.6 ttm180 -108.78 124.66 50.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.311 -0.868 . . . . 0.0 109.8 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.492 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 66.6 mm-40 -131.97 163.66 27.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.139 -0.975 . . . . 0.0 109.709 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.546 ' CG1' ' HE3' ' A' ' 67' ' ' LYS . 2.9 t -156.14 -176.95 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 108.977 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -66.23 -5.8 11.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.929 -1.107 . . . . 0.0 110.266 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.88 15.46 3.54 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.538 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 20.5 m-70 -122.57 -19.32 6.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.575 -0.956 . . . . 0.0 109.638 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.605 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.27 24.05 2.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.89 . . . . 0.0 109.508 -179.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 102' ' ' GLU . 6.1 p -45.01 -106.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.494 -0.754 . . . . 0.0 111.863 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 40.6 mt-10 -71.39 -19.05 62.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.843 -1.16 . . . . 0.0 110.948 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.483 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 3.6 m -69.6 -50.9 40.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.897 -1.127 . . . . 0.0 109.605 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.544 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.3 OUTLIER -67.85 -57.26 6.56 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.89 -24.87 25.45 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.17 -0.956 . . . . 0.0 108.628 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -61.26 -58.36 8.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.38 -0.825 . . . . 0.0 108.823 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.407 ' HB3' HG22 ' A' ' 18' ' ' ILE . 16.6 m-85 -68.33 -8.65 41.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -0.892 . . . . 0.0 109.236 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.597 ' CB ' HD22 ' A' ' 114' ' ' LEU . 1.1 m-85 -113.47 96.73 6.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -88.56 60.39 5.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 109.697 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 111' ' ' LYS . 28.2 mm100 -153.34 -87.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.181 -0.949 . . . . 0.0 109.553 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.613 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -139.16 -113.47 1.12 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.613 ' CB ' ' O ' ' A' ' 113' ' ' GLY . 0.1 OUTLIER 141.72 86.46 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.576 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -95.04 171.05 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 0.0 108.964 179.772 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.576 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -151.89 129.77 11.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.265 -0.897 . . . . 0.0 109.602 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.625 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -100.17 168.03 10.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.712 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 119' ' ' GLY . 10.6 pt20 -92.52 153.39 19.1 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.769 -1.207 . . . . 0.0 111.372 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.599 ' O ' ' CD1' ' A' ' 40' ' ' TYR . . . 52.1 164.62 0.01 OUTLIER Glycine 0 N--CA 1.498 2.807 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.57 ' O ' ' CE1' ' A' ' 40' ' ' TYR . . . -60.91 -123.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.52 ' O ' ' CG1' ' A' ' 121' ' ' VAL . 0.5 OUTLIER -90.28 12.99 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -1.139 . . . . 0.0 109.253 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.11 0.6 18.25 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.556 -0.715 . . . . 0.0 109.607 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.64 -21.24 2.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -0.952 . . . . 0.0 109.516 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -43.78 -43.38 6.62 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.89 -173.9 3.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -1.158 . . . . 0.0 109.436 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.1 pttm . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.448 180.0 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.513 ' CG1' ' HB3' ' A' ' 27' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 1' ' ' VAL . 1.5 mm-40 43.48 59.13 3.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.304 -0.872 . . . . 0.0 109.519 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.585 ' CD1' ' N ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -64.15 -13.89 51.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 109.695 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.585 ' N ' ' CD1' ' A' ' 3' ' ' LEU . 0.4 OUTLIER -78.21 168.33 20.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 109.791 -179.581 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 4' ' ' SER . 3.8 ttmm 81.39 -69.43 0.08 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.76 -0.588 . . . . 0.0 109.896 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -83.83 12.51 5.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.083 -1.011 . . . . 0.0 110.115 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.572 HG12 ' CZ2' ' A' ' 21' ' ' TRP . 35.0 t -145.52 -77.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.014 -1.054 . . . . 0.0 109.696 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.55 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 77.0 p -39.96 -28.08 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.471 -0.768 . . . . 0.0 109.952 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 7' ' ' VAL . . . -41.98 -59.64 2.84 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 3.3 mtmt -132.58 -29.08 1.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.178 -1.189 . . . . 0.0 110.218 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.551 ' CD2' ' CD2' ' A' ' 88' ' ' LEU . 3.1 mp 65.61 9.84 6.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.098 -1.001 . . . . 0.0 109.17 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 62.65 128.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.872 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.492 ' C ' ' CG2' ' A' ' 14' ' ' THR . 6.0 mmtt -96.43 169.02 10.2 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.492 ' CG2' ' C ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER 173.96 -83.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.592 -1.317 . . . . 0.0 111.218 -178.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.581 ' OG1' ' HD2' ' A' ' 16' ' ' PRO . 0.6 OUTLIER -161.97 -175.08 0.45 Allowed Pre-proline 0 C--N 1.284 -2.244 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.364 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.581 ' HD2' ' OG1' ' A' ' 15' ' ' THR . 33.3 Cg_endo -76.91 110.3 3.01 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.677 1.585 . . . . 0.0 111.28 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 49' ' ' SER . . . -161.47 -155.68 7.99 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.558 HD13 ' CE1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -160.92 154.56 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.734 -1.451 . . . . 0.0 110.523 179.489 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.519 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -133.82 -168.01 2.04 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.57 HD13 ' CZ ' ' A' ' 110' ' ' PHE . 55.9 mt -156.07 164.73 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.621 -1.3 . . . . 0.0 110.318 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.581 ' CG ' ' HE2' ' A' ' 28' ' ' MET . 15.0 m-90 -124.48 119.0 27.9 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.582 ' HA ' ' CD2' ' A' ' 45' ' ' TYR . 29.8 ttp-105 -80.78 108.85 14.78 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.169 -0.957 . . . . 0.0 112.189 -176.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -86.57 93.45 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 176.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 26' ' ' MET . 1.4 pm0 -56.62 80.02 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.6 ' C ' ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER 41.22 13.64 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.694 -0.629 . . . . 0.0 111.415 -179.149 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.626 ' HA ' ' CE ' ' A' ' 26' ' ' MET . 0.0 OUTLIER -157.75 -76.72 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.271 -1.518 . . . . 0.0 111.142 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.537 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -89.53 -147.06 0.17 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.167 -0.958 . . . . 0.0 110.776 -177.725 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.581 ' HE2' ' CG ' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -144.14 146.62 32.88 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.559 0.695 . . . . 0.0 109.913 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.524 ' N ' ' HG3' ' A' ' 28' ' ' MET . 0.9 OUTLIER -140.45 158.82 65.37 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.579 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 33.7 Cg_endo -75.33 137.9 21.59 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.32 2.014 . . . . 0.0 111.165 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.53 ' CB ' ' O ' ' A' ' 20' ' ' ILE . 2.5 t -123.62 98.44 40.47 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 35' ' ' SER . 34.7 Cg_endo -76.57 -157.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.441 2.094 . . . . 0.0 110.177 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.522 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -83.06 -22.41 33.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.096 -1.002 . . . . 0.0 109.111 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -86.35 1.17 52.1 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.338 -0.851 . . . . 0.0 109.879 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.47 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -131.22 -25.53 2.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.153 -0.967 . . . . 0.0 110.373 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.683 ' CD2' ' CE2' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -68.95 -5.84 23.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.946 -1.096 . . . . 0.0 109.81 -179.57 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.512 ' N ' ' CD1' ' A' ' 36' ' ' TYR . . . -85.67 -4.46 85.27 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.525 ' HB3' ' CG2' ' A' ' 115' ' ' ILE . 17.0 m-80 -153.59 103.06 2.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.133 -1.216 . . . . 0.0 109.57 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.592 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -123.46 131.73 53.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.059 -1.026 . . . . 0.0 109.598 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.6 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 6.6 m-30 -39.53 152.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.544 -0.723 . . . . 0.0 110.148 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.531 ' CG ' ' N ' ' A' ' 42' ' ' GLY . 12.4 pt-20 -89.67 -45.09 9.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 109.237 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.603 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -82.58 69.93 3.26 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 25' ' ' ASN . 10.9 m-20 -164.97 -166.39 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.91 -1.347 . . . . 0.0 111.1 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.563 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 1.7 m -127.37 156.87 41.34 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.592 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 30.9 m-85 -147.26 167.97 22.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.172 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 99.3 t -132.45 113.31 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.622 ' HB3' ' HB2' ' A' ' 62' ' ' HIS . 0.6 OUTLIER -90.13 155.15 19.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.174 -178.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.527 HD23 ' CD2' ' A' ' 11' ' ' LEU . 27.4 tp -146.5 85.9 1.66 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.553 ' CB ' ' HB ' ' A' ' 18' ' ' ILE . 1.0 OUTLIER -87.5 117.38 26.26 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 122.173 0.987 . . . . 0.0 109.872 -179.216 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.627 HG23 ' CE2' ' A' ' 57' ' ' PHE . 1.4 m -98.04 158.41 15.56 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.524 ' HG3' ' CB ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -160.56 117.62 2.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.915 -1.116 . . . . 0.0 109.867 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.528 ' O ' ' CG2' ' A' ' 53' ' ' THR . 3.0 pttm -46.78 172.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 0.0 109.268 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' A' ' 52' ' ' LYS . 1.4 p -167.69 172.95 8.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.44 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.9 -18.8 41.48 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 m -99.5 -52.23 3.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -1.111 . . . . 0.0 109.365 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 52' ' ' LYS . . . -176.08 -100.35 0.13 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.627 ' CE2' HG23 ' A' ' 50' ' ' THR . 0.9 OUTLIER -117.93 158.63 24.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -1.114 . . . . 0.0 110.033 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.524 ' CB ' ' HG3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -130.89 123.58 29.29 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.166 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.583 ' CE2' HD21 ' A' ' 88' ' ' LEU . 7.3 m-85 -105.04 153.52 21.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.856 -1.153 . . . . 0.0 111.753 -177.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.501 ' OD1' ' CG2' ' A' ' 93' ' ' VAL . 6.2 m-20 -137.6 95.41 3.06 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.539 ' CG2' ' CG2' ' A' ' 81' ' ' THR . 10.9 mt -87.75 122.71 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 111.156 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.706 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 16.4 m-70 -110.47 169.17 8.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.514 -0.741 . . . . 0.0 109.168 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 95' ' ' HIS . 50.2 p90 -139.23 109.4 6.44 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.817 -1.153 . . . . 0.0 109.044 176.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.532 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 7.0 t90 -86.05 135.72 33.52 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.279 0.561 . . . . 0.0 109.612 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.574 ' CD1' ' CG ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -120.02 61.57 0.85 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.93 -178.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -51.69 89.81 0.01 OUTLIER Glycine 0 N--CA 1.498 2.767 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 178.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 65' ' ' LEU . 1.5 tppt? -39.02 91.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.091 0.948 . . . . 0.0 112.611 -177.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.603 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 2.7 m-80 -162.76 -45.69 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 73' ' ' GLU . 14.2 p -61.21 -157.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.507 -0.745 . . . . 0.0 109.272 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.4 p -106.39 161.83 14.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.419 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 0.2 OUTLIER -50.32 -49.98 52.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.879 . . . . 0.0 109.43 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -54.45 -39.65 67.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.123 -0.986 . . . . 0.0 108.913 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.456 ' CD ' ' CE ' ' A' ' 26' ' ' MET . 0.1 OUTLIER -55.52 -39.25 70.29 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.238 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.574 ' CG ' ' CD1' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -59.78 -38.02 80.67 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 79' ' ' ILE . . . -69.55 -25.2 75.75 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.454 ' HA ' HD11 ' A' ' 79' ' ' ILE . . . -73.19 -59.38 2.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -1.129 . . . . 0.0 109.229 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 44' ' ' CYS . . . -49.45 -37.53 26.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 0.0 108.945 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.33 -34.68 68.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.334 -0.854 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 75' ' ' GLY . 15.4 mt -63.44 -49.12 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.867 . . . . 0.0 109.425 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.558 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 27.2 m-85 -58.47 -41.09 84.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.053 -1.029 . . . . 0.0 108.639 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.539 ' CG2' ' CG2' ' A' ' 61' ' ' ILE . 8.9 m -69.6 -22.34 63.51 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.431 -0.793 . . . . 0.0 108.897 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.8 m -86.44 -18.39 31.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.631 -0.668 . . . . 0.0 109.317 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 1.0 OUTLIER -89.85 -35.48 15.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.554 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.517 ' HE3' ' CZ3' ' A' ' 21' ' ' TRP . 5.2 ptm -82.32 -12.26 58.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.952 . . . . 0.0 109.482 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.408 ' HA ' ' HB1' ' A' ' 92' ' ' ALA . 9.4 t0 -79.91 -37.24 35.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.328 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -89.77 -29.04 18.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 109.257 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.471 ' HB3' ' HB ' ' A' ' 8' ' ' THR . 1.9 m-85 -76.21 -29.67 57.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.237 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.583 HD21 ' CE2' ' A' ' 59' ' ' TYR . 6.6 mt -72.06 -3.05 20.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.428 -0.795 . . . . 0.0 109.785 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.81 24.73 7.97 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 56.35 17.75 3.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -1.149 . . . . 0.0 109.322 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.7 m -96.64 -14.64 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.896 . . . . 0.0 109.255 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -77.04 164.53 25.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.316 -0.865 . . . . 0.0 109.427 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.501 ' CG2' ' OD1' ' A' ' 60' ' ' ASN . 2.5 t -113.5 -178.53 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.494 -0.754 . . . . 0.0 109.176 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 10.8 tt0 -132.64 136.41 46.47 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.135 -0.978 . . . . 0.0 109.054 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.706 ' CD2' ' CD2' ' A' ' 62' ' ' HIS . 10.1 m-70 -137.84 153.6 49.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.405 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.575 ' HA ' ' CE2' ' A' ' 63' ' ' TYR . 16.1 ptm180 -111.78 143.97 41.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.671 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.495 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 40.2 mm-40 -150.68 164.19 36.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.408 -0.808 . . . . 0.0 109.05 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.524 ' N ' ' HB2' ' A' ' 101' ' ' HIS . 2.3 t -154.52 -169.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 0.0 109.012 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -72.76 0.92 9.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.844 -1.16 . . . . 0.0 110.282 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.6 19.57 1.15 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.244 -1.943 . . . . 0.0 108.244 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.524 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 46.0 m-70 -125.09 -14.78 6.5 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.715 -0.873 . . . . 0.0 109.789 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.532 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.25 29.34 1.26 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.727 -179.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 102' ' ' GLU . 77.6 p -55.99 -131.63 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.368 -0.832 . . . . 0.0 111.138 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.466 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 0.1 OUTLIER -40.01 -24.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.769 -1.207 . . . . 0.0 111.068 -178.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 103' ' ' SER . 1.8 m -66.94 -63.78 0.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.843 -1.161 . . . . 0.0 110.592 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.52 ' HB2' ' HB2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -57.14 -47.16 81.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.756 -1.215 . . . . 0.0 108.227 -179.13 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 110' ' ' PHE . 10.6 mtm180 -59.46 -28.06 66.64 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 105' ' ' THR . . . -59.84 -44.47 94.07 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.571 ' OH ' ' CE1' ' A' ' 62' ' ' HIS . 63.6 m-85 -76.53 -12.79 60.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.683 ' CE2' ' CD2' ' A' ' 36' ' ' TYR . 20.4 m-85 -126.09 105.65 9.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.648 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 112' ' ' GLN . 5.1 ptmt -90.13 26.4 1.89 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 110.112 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.485 ' CB ' ' O ' ' A' ' 111' ' ' LYS . 1.1 pt20 165.2 83.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.892 -1.13 . . . . 0.0 110.469 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 114' ' ' LEU . . . 167.03 -122.89 1.09 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.607 ' CD2' ' CB ' ' A' ' 110' ' ' PHE . 0.2 OUTLIER 65.76 49.8 1.66 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.557 -0.966 . . . . 0.0 110.888 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.525 ' CG2' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -87.5 167.18 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 177.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.578 ' CZ ' ' O ' ' A' ' 114' ' ' LEU . 2.9 m-85 -143.66 122.73 12.86 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.823 -1.173 . . . . 0.0 110.353 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.6 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 1.9 mttm -102.62 -163.94 1.04 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.462 -0.773 . . . . 0.0 108.972 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.578 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -90.26 161.47 15.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.92 -1.112 . . . . 0.0 110.14 -179.658 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 120' ' ' GLY . . . -67.88 -161.88 1.9 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 58.73 112.5 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.519 ' HB ' ' CB ' ' A' ' 24' ' ' GLU . 4.2 p -90.46 -147.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.265 -1.138 . . . . 0.0 108.676 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.476 ' N ' ' CG1' ' A' ' 121' ' ' VAL . . . -77.88 4.01 13.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.87 -1.144 . . . . 0.0 109.963 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -44.92 -49.63 10.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 0.0 109.474 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 126' ' ' LYS . . . 142.81 -60.91 0.53 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.14 -90.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -1.159 . . . . 0.0 109.45 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.508 ' N ' ' O ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.507 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 11.0 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.483 ' HA ' ' CE1' ' A' ' 80' ' ' TYR . 1.9 mt-10 64.64 66.08 0.61 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.347 -0.846 . . . . 0.0 109.521 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.113 HD21 ' CG ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -44.83 -41.16 6.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 3.2 t -42.54 150.56 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.378 -0.826 . . . . 0.0 109.616 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 4' ' ' SER . 14.1 ttpt 80.49 -72.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.586 -0.697 . . . . 0.0 109.775 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.495 ' C ' HG23 ' A' ' 7' ' ' VAL . 70.2 mmtt -88.33 14.53 9.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.079 -1.013 . . . . 0.0 109.851 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.686 HG11 ' HE1' ' A' ' 21' ' ' TRP . 21.8 t -157.2 -74.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.058 -1.026 . . . . 0.0 109.618 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.657 ' HA ' HD21 ' A' ' 11' ' ' LEU . 2.3 m -49.3 -23.16 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 0.0 109.476 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 10' ' ' LYS . . . -89.38 32.89 4.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER 164.12 47.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -1.135 . . . . 0.0 109.464 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.762 HD12 ' HG ' ' A' ' 88' ' ' LEU . 38.2 mt -68.96 -147.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 0.0 109.208 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -83.84 119.6 25.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.961 . . . . 0.0 109.385 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.672 ' O ' HG23 ' A' ' 14' ' ' THR . 5.1 mmmt -122.97 -11.99 8.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 0.0 109.62 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 13' ' ' LYS . 18.4 p -160.8 69.99 0.38 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 109.544 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 15' ' ' THR . 5.9 t -175.33 124.2 0.35 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.371 -0.831 . . . . 0.0 109.176 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.7 105.99 2.12 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.25 1.967 . . . . 0.0 110.514 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 173.33 176.76 42.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.859 HG22 ' HA ' ' A' ' 49' ' ' SER . 3.9 pt -124.49 134.45 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -1.208 . . . . 0.0 109.922 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 5.8 tt0 -112.93 140.77 47.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.311 -0.868 . . . . 0.0 108.732 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.665 HD11 ' CZ ' ' A' ' 110' ' ' PHE . 2.2 mt -115.06 -178.91 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.803 -1.186 . . . . 0.0 109.679 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.686 ' HE1' HG11 ' A' ' 7' ' ' VAL . 10.6 m-90 -141.45 119.39 11.93 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.649 ' H ' HG23 ' A' ' 31' ' ' VAL . 2.5 ptt180 -78.9 128.07 32.84 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.122 -0.986 . . . . 0.0 110.147 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 23' ' ' ILE . 5.8 mm -96.49 43.89 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.54 ' HG2' ' N ' ' A' ' 25' ' ' ASN . 31.1 tt0 -70.29 168.04 16.75 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.335 0.588 . . . . 0.0 110.108 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.54 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 8.2 p30 47.18 24.6 0.43 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -0.796 . . . . 0.0 109.141 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.736 ' HE3' ' HG2' ' A' ' 73' ' ' GLU . 24.4 mmm 57.75 50.54 10.52 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.413 -0.805 . . . . 0.0 109.491 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.514 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 53.8 mm-40 -148.24 -111.22 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.316 -0.865 . . . . 0.0 109.108 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.725 ' HE2' HD22 ' A' ' 3' ' ' LEU . 2.8 ttt 178.88 153.91 0.4 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.787 -1.196 . . . . 0.0 109.861 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -160.26 147.57 12.52 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.559 ' HD2' HG13 ' A' ' 29' ' ' VAL . 33.4 Cg_endo -74.04 94.73 0.89 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.563 2.175 . . . . 0.0 111.869 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.649 HG23 ' H ' ' A' ' 22' ' ' ARG . 60.0 t -76.58 112.75 23.64 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 36.3 Cg_endo -78.78 -161.8 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.448 2.099 . . . . 0.0 110.601 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.475 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -88.28 -3.72 58.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.315 -0.865 . . . . 0.0 109.054 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -87.52 8.29 25.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 109.74 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.4 m -159.99 21.07 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.157 -0.964 . . . . 0.0 110.076 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.564 ' CD2' ' O ' ' A' ' 36' ' ' TYR . 19.4 p90 -90.0 32.64 0.9 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.015 -1.053 . . . . 0.0 109.334 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.31 -10.07 5.73 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.475 ' CB ' ' HB ' ' A' ' 115' ' ' ILE . 5.5 m-80 -148.02 100.92 3.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.192 -1.181 . . . . 0.0 109.889 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.689 ' HZ ' HD13 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -115.19 131.57 56.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.305 -0.872 . . . . 0.0 109.06 179.633 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.638 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 6.7 m-30 -39.42 155.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.451 -0.781 . . . . 0.0 109.943 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 10.4 pt-20 -91.0 -46.32 8.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.474 -0.766 . . . . 0.0 110.161 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.606 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -83.01 67.38 3.76 Favored Glycine 0 N--CA 1.483 1.793 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.057 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.514 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -162.92 -148.11 0.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.916 -1.344 . . . . 0.0 110.299 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.531 ' CB ' HG13 ' A' ' 23' ' ' ILE . 14.2 m -144.28 139.8 28.82 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.609 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 30.1 m-85 -137.18 109.64 7.41 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.983 -1.073 . . . . 0.0 109.878 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.698 HG13 ' OG1' ' A' ' 81' ' ' THR . 25.0 t -78.5 131.21 34.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.176 -0.953 . . . . 0.0 108.462 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.787 HD23 ' N ' ' A' ' 48' ' ' LEU . 8.3 tt -111.57 163.43 14.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.15 -0.968 . . . . 0.0 109.469 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.787 ' N ' HD23 ' A' ' 47' ' ' LEU . 20.3 tp -153.65 92.11 1.54 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.978 -1.077 . . . . 0.0 109.263 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.859 ' HA ' HG22 ' A' ' 18' ' ' ILE . 5.3 t -81.26 148.82 29.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.904 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 m -140.23 117.05 10.98 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -112.91 175.44 5.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.514 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.96 157.31 18.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.908 . . . . 0.0 109.429 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.1 p -146.8 -170.39 3.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.449 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.96 10.17 61.12 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 p -133.73 -54.69 0.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -1.111 . . . . 0.0 109.422 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.53 -135.11 1.85 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.57 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 88.2 m-85 -120.24 144.32 47.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -1.1 . . . . 0.0 109.66 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 68.8 m -101.09 106.82 18.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.282 -0.886 . . . . 0.0 108.705 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.643 ' CD2' HG23 ' A' ' 91' ' ' VAL . 6.3 m-85 -84.64 156.36 21.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.205 -0.935 . . . . 0.0 110.339 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.624 ' HB3' ' HE1' ' A' ' 62' ' ' HIS . 5.8 m-20 -143.68 102.61 3.95 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 1.017 ' CG2' HG23 ' A' ' 81' ' ' THR . 7.7 mt -92.36 112.3 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.255 -0.903 . . . . 0.0 110.461 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.738 ' CD2' ' HB2' ' A' ' 95' ' ' HIS . 11.4 m80 -105.1 166.98 10.01 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.607 -0.683 . . . . 0.0 109.534 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.575 ' CZ ' ' HA ' ' A' ' 96' ' ' ARG . 43.5 p90 -138.04 106.62 5.87 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.401 -1.32 . . . . 0.0 109.856 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.591 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 4.8 t90 -82.38 131.57 35.22 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -119.28 65.21 0.79 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.357 -0.839 . . . . 0.0 110.753 -178.492 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 68' ' ' ASN . . . -49.53 91.08 0.01 OUTLIER Glycine 0 N--CA 1.498 2.796 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -37.74 88.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 122.081 0.943 . . . . 0.0 112.414 -177.362 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.606 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 1.5 m120 -162.75 -43.65 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.549 ' HB2' ' HE3' ' A' ' 26' ' ' MET . 14.1 p -60.32 168.64 1.95 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.632 -0.667 . . . . 0.0 109.458 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.452 ' OG ' ' OE1' ' A' ' 73' ' ' GLU . 1.5 p -73.87 168.89 18.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.939 . . . . 0.0 109.445 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.3 -51.22 63.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.546 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 2.1 p30 -55.3 -39.32 69.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.127 -0.983 . . . . 0.0 109.511 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.736 ' HG2' ' HE3' ' A' ' 26' ' ' MET . 3.0 mp0 -56.5 -38.66 72.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 108.656 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.496 ' OE1' HD12 ' A' ' 65' ' ' LEU . 53.6 mt-30 -64.17 -33.52 75.97 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.629 ' O ' HD13 ' A' ' 79' ' ' ILE . . . -83.05 -10.91 82.1 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.73 -44.36 13.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.999 -1.295 . . . . 0.0 108.939 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.45 -45.41 59.69 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.328 -0.858 . . . . 0.0 109.029 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.16 93.29 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.629 HD13 ' O ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -65.53 -41.35 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.198 -0.939 . . . . 0.0 108.994 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 1.113 ' CG ' HD21 ' A' ' 3' ' ' LEU . 11.3 m-85 -61.45 -29.43 69.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.973 -1.079 . . . . 0.0 108.53 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 1.017 HG23 ' CG2' ' A' ' 61' ' ' ILE . 2.6 m -75.52 -25.5 57.28 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.0 m -81.16 -27.14 35.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.532 -0.73 . . . . 0.0 109.22 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 0.9 OUTLIER -78.04 -36.57 48.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.608 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.522 ' HG3' ' CD1' ' A' ' 61' ' ' ILE . 5.4 ptm -82.23 -8.14 59.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 109.593 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.604 ' OD1' HD12 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -75.48 -41.57 55.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.381 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -90.03 -29.25 18.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.313 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.507 ' HB3' HG22 ' A' ' 8' ' ' THR . 0.3 OUTLIER -70.22 -32.26 70.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 109.55 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.784 HD12 HD11 ' A' ' 61' ' ' ILE . 14.7 mt -66.19 -22.4 66.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.601 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 90' ' ' SER . . . 121.12 14.61 4.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 89' ' ' GLY . 6.3 t 72.19 3.95 4.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -1.188 . . . . 0.0 109.588 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.643 HG23 ' CD2' ' A' ' 59' ' ' TYR . 17.9 m -87.7 -19.73 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.541 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -77.15 170.13 17.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.237 -0.914 . . . . 0.0 109.608 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.764 HG12 ' H ' ' A' ' 94' ' ' GLN . 2.9 t -121.94 -177.36 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.089 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.764 ' H ' HG12 ' A' ' 93' ' ' VAL . 73.1 mt-30 -128.22 140.07 52.11 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.007 -1.058 . . . . 0.0 108.864 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.738 ' HB2' ' CD2' ' A' ' 62' ' ' HIS . 4.7 m80 -141.63 151.08 42.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.029 -1.044 . . . . 0.0 109.69 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.575 ' HA ' ' CZ ' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -109.67 140.95 42.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.341 -0.849 . . . . 0.0 110.362 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.491 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 60.5 mm-40 -148.41 163.68 36.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.407 -0.808 . . . . 0.0 109.122 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.736 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.7 t -155.38 -175.17 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.098 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.736 ' H ' HG12 ' A' ' 98' ' ' VAL . 38.5 tt0 -69.75 -1.99 10.74 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.934 -1.103 . . . . 0.0 110.195 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.53 16.12 2.04 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.561 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 57.5 m80 -122.45 -16.42 7.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.484 -1.01 . . . . 0.0 109.591 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.591 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.1 24.29 2.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.905 . . . . 0.0 109.363 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 102' ' ' GLU . 3.5 p -48.63 -107.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.417 -0.802 . . . . 0.0 111.459 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.818 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 22.4 mt-10 -67.2 -17.45 64.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.916 -1.115 . . . . 0.0 110.909 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.505 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 4.3 m -72.17 -54.95 8.15 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.937 -1.102 . . . . 0.0 109.756 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.546 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -63.63 -57.5 9.88 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.27 -30.15 36.89 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.228 -0.92 . . . . 0.0 108.806 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.818 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -58.1 -45.0 87.95 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -0.828 . . . . 0.0 108.809 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.471 ' HB3' HD13 ' A' ' 18' ' ' ILE . 34.2 m-85 -76.7 -14.16 59.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -0.816 . . . . 0.0 109.41 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.842 ' CB ' HD21 ' A' ' 114' ' ' LEU . 2.3 m-85 -117.03 96.99 5.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.408 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 23.0 ttpt -83.75 73.1 10.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.135 -0.978 . . . . 0.0 109.415 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 111' ' ' LYS . 4.8 mt-30 -171.33 -80.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.129 -0.982 . . . . 0.0 109.804 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.403 ' C ' HD23 ' A' ' 114' ' ' LEU . . . 179.95 131.49 1.65 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.842 HD21 ' CB ' ' A' ' 110' ' ' PHE . 10.5 mt -103.49 135.75 44.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -1.107 . . . . 0.0 110.007 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.562 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 2.6 mt -107.57 165.42 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 108.836 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.564 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -141.45 102.42 4.2 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.367 -0.833 . . . . 0.0 109.147 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.638 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 5.1 mmmt -82.28 -155.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 109.664 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.585 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -92.18 -179.9 5.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.551 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 120' ' ' GLY . . . -113.19 -169.67 17.38 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 119' ' ' GLY . . . 43.23 84.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.607 ' O ' HG13 ' A' ' 121' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.147 -1.208 . . . . 0.0 109.222 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.755 ' O ' HG12 ' A' ' 1' ' ' VAL . 65.1 t . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 173.87 60.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.191 -0.943 . . . . 0.0 109.484 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.074 HD13 ' N ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -63.48 -11.3 22.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.519 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . 1.074 ' N ' HD13 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -74.73 151.18 39.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.962 . . . . 0.0 109.587 -179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 4' ' ' SER . 17.7 tttm 80.2 -72.57 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.471 -0.768 . . . . 0.0 109.764 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.77 -10.73 29.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 109.757 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.97 HG12 ' CD2' ' A' ' 11' ' ' LEU . 5.2 t -123.93 -71.23 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.101 -0.999 . . . . 0.0 109.519 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.75 HG22 ' HG2' ' A' ' 84' ' ' MET . 19.2 p -50.23 -21.89 1.53 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.668 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.468 ' O ' ' HG2' ' A' ' 10' ' ' LYS . . . -42.75 -42.05 4.65 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 9' ' ' GLY . 12.6 mttt -155.29 -37.96 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.138 -1.213 . . . . 0.0 109.805 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.12 HD12 HD21 ' A' ' 88' ' ' LEU . 51.0 mt 64.2 -144.84 0.28 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.123 -0.986 . . . . 0.0 109.138 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.505 ' O ' ' CE2' ' A' ' 59' ' ' TYR . 2.3 m-20 -88.21 97.81 11.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.113 -0.992 . . . . 0.0 109.549 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.672 ' O ' HG23 ' A' ' 14' ' ' THR . 10.5 mttt -100.83 -4.71 27.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.945 . . . . 0.0 109.641 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 13' ' ' LYS . 19.9 p -160.15 49.59 0.28 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.94 . . . . 0.0 109.499 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.3 m -151.01 105.41 3.0 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.379 -0.826 . . . . 0.0 109.116 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.35 86.76 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.402 2.068 . . . . 0.0 110.343 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.457 ' C ' HG23 ' A' ' 18' ' ' ILE . . . -170.29 -132.76 1.5 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.034 HD12 HD11 ' A' ' 47' ' ' LEU . 18.3 pt -156.81 137.83 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.078 -1.248 . . . . 0.0 110.119 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.705 ' NE2' ' CZ2' ' A' ' 21' ' ' TRP . 6.9 tt0 -119.62 113.9 21.4 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.685 HG22 ' H ' ' A' ' 21' ' ' TRP . 3.8 mt -90.03 175.88 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.799 -1.188 . . . . 0.0 109.942 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.861 ' HB3' ' HE3' ' A' ' 28' ' ' MET . 10.7 m-90 -137.04 119.18 15.49 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.699 ' H ' HG23 ' A' ' 31' ' ' VAL . 8.0 ttp180 -79.15 130.23 35.28 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.14 -0.975 . . . . 0.0 110.921 -177.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 23' ' ' ILE . 3.3 mm -95.08 37.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.612 ' O ' ' ND2' ' A' ' 25' ' ' ASN . 1.3 tt0 -47.31 149.45 1.04 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.395 0.617 . . . . 0.0 110.703 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.612 ' ND2' ' O ' ' A' ' 24' ' ' GLU . 7.5 p30 44.33 27.47 0.22 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.445 -0.785 . . . . 0.0 109.072 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.726 ' HE3' ' HB2' ' A' ' 69' ' ' SER . 3.4 mmm 64.1 51.55 2.19 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.464 -0.773 . . . . 0.0 109.322 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 9.7 mt-10 -153.73 122.65 6.41 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.861 ' HE3' ' HB3' ' A' ' 21' ' ' TRP . 2.1 mtp -56.63 145.06 29.74 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.177 -0.952 . . . . 0.0 110.339 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.598 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -149.64 149.98 29.71 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HD2' HG13 ' A' ' 29' ' ' VAL . 32.3 Cg_endo -72.98 113.86 3.89 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.229 1.953 . . . . 0.0 111.857 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.703 HG13 ' HB3' ' A' ' 35' ' ' SER . 41.4 t -111.3 92.28 15.6 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.521 ' HG2' ' CD ' ' A' ' 34' ' ' LYS . 35.0 Cg_endo -77.12 -156.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.717 2.278 . . . . 0.0 110.202 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.574 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -75.83 -23.53 55.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.094 -1.004 . . . . 0.0 108.945 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.521 ' CD ' ' HG2' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -81.85 8.01 11.36 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.206 -0.934 . . . . 0.0 109.613 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.703 ' HB3' HG13 ' A' ' 31' ' ' VAL . 2.5 m -128.25 -45.36 1.38 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.745 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -45.05 158.31 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.438 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 115' ' ' ILE . . . 112.88 -47.84 1.0 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.43 94.15 4.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -1.209 . . . . 0.0 109.885 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.901 ' HZ ' HD13 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -113.04 121.03 43.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.302 -0.874 . . . . 0.0 109.797 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.581 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 7.0 m-30 -39.33 131.9 1.53 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 110.607 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 2.9 pt-20 -90.66 56.68 3.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.217 -0.927 . . . . 0.0 109.01 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.603 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -176.89 47.92 0.11 Allowed Glycine 0 N--CA 1.484 1.876 0 N-CA-C 108.914 -1.675 . . . . 0.0 108.914 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.468 ' CG ' ' O ' ' A' ' 42' ' ' GLY . 2.4 m-20 -162.16 -129.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.654 -0.909 . . . . 0.0 109.608 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.536 ' CB ' HG13 ' A' ' 23' ' ' ILE . 1.8 m -149.14 144.7 26.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.05 -1.031 . . . . 0.0 108.927 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.592 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 26.0 m-85 -142.65 111.25 6.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.097 -1.002 . . . . 0.0 109.727 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.677 HG13 ' OG1' ' A' ' 81' ' ' THR . 11.3 t -79.73 123.03 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.958 -1.089 . . . . 0.0 108.961 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.034 HD11 HD12 ' A' ' 18' ' ' ILE . 8.2 tt -112.94 122.24 47.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.956 -1.09 . . . . 0.0 110.061 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 59' ' ' TYR . 23.2 tp -107.13 109.86 21.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.069 -1.02 . . . . 0.0 109.705 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.505 ' OG ' HG22 ' A' ' 18' ' ' ILE . 3.2 t -98.19 133.9 41.98 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.18 -0.95 . . . . 0.0 109.272 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.2 m -129.21 142.57 50.82 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.519 ' HG2' ' N ' ' A' ' 52' ' ' LYS . 9.1 ttp180 -140.14 157.12 46.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.892 . . . . 0.0 109.534 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.519 ' N ' ' HG2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -74.12 159.92 31.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.37 -172.74 4.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 109.463 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.73 -35.97 8.13 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t -82.74 -25.24 33.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -1.146 . . . . 0.0 109.488 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.67 -117.61 0.76 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 2.2 m-30 -115.07 169.08 9.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -1.116 . . . . 0.0 109.579 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -133.87 107.85 8.09 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.59 ' HB3' HD11 ' A' ' 48' ' ' LEU . 23.2 m-85 -92.55 169.01 10.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.104 -0.997 . . . . 0.0 110.374 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.713 ' HB3' ' CE1' ' A' ' 95' ' ' HIS . 46.9 m-80 -158.89 88.25 0.89 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.961 ' CG2' HG23 ' A' ' 81' ' ' THR . 21.0 mt -76.67 137.12 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.203 -0.936 . . . . 0.0 110.264 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.749 ' CD2' ' HB2' ' A' ' 95' ' ' HIS . 67.1 m80 -123.79 159.39 29.62 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 95' ' ' HIS . 37.4 p90 -133.38 98.64 4.29 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.345 -1.342 . . . . 0.0 109.196 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.6 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 5.6 t90 -77.07 132.77 39.07 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.076 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -116.83 65.01 0.72 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.456 -0.778 . . . . 0.0 110.844 -178.56 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -45.24 91.42 0.01 OUTLIER Glycine 0 N--CA 1.5 2.94 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.615 ' O ' ' ND2' ' A' ' 68' ' ' ASN . 1.0 OUTLIER -39.44 91.38 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.928 0.87 . . . . 0.0 113.204 -177.376 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 67' ' ' LYS . 0.3 OUTLIER -162.66 -44.22 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.549 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.726 ' HB2' ' HE3' ' A' ' 26' ' ' MET . 25.2 p -63.93 -153.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.481 -0.762 . . . . 0.0 109.499 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.08 -173.88 2.82 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.302 -0.873 . . . . 0.0 109.428 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -61.01 -32.0 71.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.886 . . . . 0.0 109.604 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -68.09 -44.09 77.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 0.0 109.556 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.712 ' HG2' ' HE3' ' A' ' 26' ' ' MET . 0.8 OUTLIER -57.98 -36.94 73.34 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.953 -1.092 . . . . 0.0 108.395 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.528 ' CG ' HD11 ' A' ' 65' ' ' LEU . 4.5 tt0 -64.82 -32.55 74.3 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.653 ' O ' HD13 ' A' ' 79' ' ' ILE . . . -83.64 -10.92 80.76 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.85 -52.53 5.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.84 -1.388 . . . . 0.0 109.295 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 23' ' ' ILE . . . -71.83 -36.53 70.23 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.183 -0.948 . . . . 0.0 108.807 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.14 -38.52 75.52 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.398 -0.814 . . . . 0.0 109.368 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.653 HD13 ' O ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -66.89 -45.21 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 109.072 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.867 ' CD2' HD12 ' A' ' 3' ' ' LEU . 3.2 m-85 -59.93 -31.71 70.1 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.839 -1.163 . . . . 0.0 108.471 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.961 HG23 ' CG2' ' A' ' 61' ' ' ILE . 3.1 m -74.29 -27.04 60.54 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 79' ' ' ILE . 4.5 m -63.88 -50.94 66.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.5 -0.75 . . . . 0.0 109.374 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -64.86 -39.23 93.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.554 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.75 ' HG2' HG22 ' A' ' 8' ' ' THR . 1.5 mtm -56.79 -28.13 60.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.602 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -81.37 -36.09 30.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.599 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.01 -1.12 51.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.912 . . . . 0.0 109.676 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.537 ' CB ' ' HB ' ' A' ' 8' ' ' THR . 4.1 m-85 -108.93 -29.81 8.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.146 -0.971 . . . . 0.0 109.546 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 1.12 HD21 HD12 ' A' ' 11' ' ' LEU . 46.9 mt -71.84 -3.94 25.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.614 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 90' ' ' SER . . . 99.0 21.82 14.78 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 90' ' ' SER . 0.3 OUTLIER 64.73 10.69 6.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -1.119 . . . . 0.0 109.484 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.8 m -86.11 -27.95 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.0 109.406 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.575 ' HB2' ' HB2' ' A' ' 59' ' ' TYR . . . -73.19 172.34 11.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.577 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.687 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.1 t -124.73 178.3 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.39 -0.818 . . . . 0.0 109.112 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.687 ' H ' HG12 ' A' ' 93' ' ' VAL . 5.5 tt0 -124.91 131.7 53.4 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.016 -1.052 . . . . 0.0 109.075 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.749 ' HB2' ' CD2' ' A' ' 62' ' ' HIS . 13.3 m80 -125.98 152.1 46.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.97 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.574 ' HA ' ' CZ ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -109.71 130.53 55.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 110.242 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 64' ' ' TRP . 15.8 mp0 -142.12 163.98 31.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 109.333 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.71 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.2 t -153.66 -160.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 108.972 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.71 ' H ' HG12 ' A' ' 98' ' ' VAL . 40.7 tp60 -78.66 4.53 13.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.718 -1.239 . . . . 0.0 109.772 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.19 22.24 0.58 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.534 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 14.9 m-70 -124.68 -17.07 6.04 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.735 -0.862 . . . . 0.0 109.664 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.6 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.09 30.26 1.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.259 -0.901 . . . . 0.0 109.369 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 105' ' ' THR . 89.1 p -57.3 -127.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.066 -1.021 . . . . 0.0 111.189 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.821 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 41.0 mt-10 -39.92 -24.62 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.9 -1.125 . . . . 0.0 111.469 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.492 ' N ' ' O ' ' A' ' 103' ' ' SER . 0.2 OUTLIER -71.99 -65.03 0.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.768 -1.208 . . . . 0.0 110.43 -179.104 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.567 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -56.4 -50.25 72.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.969 -1.082 . . . . 0.0 108.34 -179.39 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.413 ' HA ' HD21 ' A' ' 114' ' ' LEU . 1.3 ttp85 -61.41 -29.78 70.15 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.491 -0.755 . . . . 0.0 108.979 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.821 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -59.05 -36.08 74.42 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.796 ' HB3' HD13 ' A' ' 18' ' ' ILE . 67.1 m-85 -88.13 -13.06 42.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.549 -0.72 . . . . 0.0 109.089 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.955 ' HB2' HD21 ' A' ' 114' ' ' LEU . 60.3 m-85 -113.26 96.9 6.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.472 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -74.05 83.02 1.76 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.925 . . . . 0.0 109.54 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.519 ' CB ' ' O ' ' A' ' 111' ' ' LYS . 3.0 tt0 78.48 78.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.397 -0.814 . . . . 0.0 109.715 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.783 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 168.61 70.77 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.955 HD21 ' HB2' ' A' ' 110' ' ' PHE . 4.1 mm? -126.37 56.03 1.47 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -1.164 . . . . 0.0 109.841 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 2.3 mt -81.42 165.67 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.052 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.577 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 2.2 m-85 -145.49 107.86 4.41 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.373 -0.829 . . . . 0.0 109.211 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.581 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 26.9 mmtt -79.69 -165.79 0.87 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 108.929 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.569 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 33.3 mm-40 -87.15 158.11 19.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.962 -1.086 . . . . 0.0 109.865 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.545 ' HA2' ' CD2' ' A' ' 40' ' ' TYR . . . -95.34 -165.51 35.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 119' ' ' GLY . . . 43.48 74.32 0.2 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.465 HG11 ' CD ' ' A' ' 24' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.246 -1.15 . . . . 0.0 109.751 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.568 HG22 ' H ' ' A' ' 2' ' ' GLU . 9.9 p . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.568 ' H ' HG22 ' A' ' 1' ' ' VAL . 0.0 OUTLIER 79.77 118.21 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.453 -0.779 . . . . 0.0 109.234 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.88 ' HB2' HG21 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -90.05 -21.33 22.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.519 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 1.2 p -59.84 -12.67 7.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 110.029 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -109.4 -47.79 3.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.977 -1.077 . . . . 0.0 109.827 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -90.32 22.01 3.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 110.094 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.88 HG21 ' HB2' ' A' ' 3' ' ' LEU . 10.3 t -145.38 -63.18 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.089 -1.007 . . . . 0.0 109.823 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.562 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 23.1 p -67.81 -12.9 61.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 109.506 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 10' ' ' LYS . . . -74.24 -19.7 79.77 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 1.6 tptm 175.2 55.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.449 -1.03 . . . . 0.0 109.371 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.745 HD23 HD22 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -43.85 -60.29 1.89 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.43 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -161.63 -91.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.43 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER 74.48 125.98 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.502 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.584 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 23.7 p 48.05 54.35 10.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.362 -0.836 . . . . 0.0 109.631 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 14' ' ' THR . 4.0 m -168.43 101.85 0.53 Allowed Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.416 -0.803 . . . . 0.0 109.324 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.04 109.47 2.84 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.413 2.075 . . . . 0.0 110.433 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.472 ' C ' HG23 ' A' ' 18' ' ' ILE . . . 178.87 -143.81 5.99 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.972 HD12 ' CD1' ' A' ' 47' ' ' LEU . 14.3 pt -157.44 140.6 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -1.172 . . . . 0.0 109.829 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.67 ' NE2' ' CZ2' ' A' ' 21' ' ' TRP . 9.7 tt0 -122.01 109.19 14.28 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.803 HG12 HD12 ' A' ' 47' ' ' LEU . 41.9 mt -85.03 166.73 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.145 -0.972 . . . . 0.0 109.84 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.877 ' CZ2' HG13 ' A' ' 7' ' ' VAL . 6.8 m-90 -130.26 121.95 27.1 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.769 ' HG3' HG22 ' A' ' 31' ' ' VAL . 8.7 mtm180 -79.26 132.54 36.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 110.888 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.828 HD13 ' HB2' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -116.8 23.11 5.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.662 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.504 ' CG ' ' HB ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -54.92 171.07 0.15 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.848 . . . . 0.0 110.193 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.776 ' HB3' HG12 ' A' ' 121' ' ' VAL . 0.7 OUTLIER 42.22 26.86 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.619 ' HE1' ' CB ' ' A' ' 70' ' ' SER . 0.0 OUTLIER 59.28 56.69 3.71 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.45 -0.781 . . . . 0.0 110.256 179.336 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 73.5 mm-40 -146.72 -144.05 0.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.925 -1.109 . . . . 0.0 109.655 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.628 ' CE ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -156.04 146.44 21.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.009 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.556 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -160.37 148.77 13.27 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.086 -1.009 . . . . 0.0 109.604 -179.433 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.556 ' HD2' HG13 ' A' ' 29' ' ' VAL . 36.0 Cg_endo -78.53 125.17 6.74 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.548 2.165 . . . . 0.0 111.174 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.769 HG22 ' HG3' ' A' ' 22' ' ' ARG . 2.9 t -114.69 94.51 37.38 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 35' ' ' SER . 34.7 Cg_endo -76.49 -159.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.598 2.198 . . . . 0.0 110.765 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.578 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -76.07 -34.5 59.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.368 -0.832 . . . . 0.0 110.551 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.96 32.86 0.73 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.077 -1.015 . . . . 0.0 109.932 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.515 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 74.8 m -139.66 -37.58 0.49 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.077 -1.014 . . . . 0.0 109.749 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 33' ' ' THR . 11.0 p90 -55.79 173.16 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.584 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.59 -94.93 0.66 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -90.61 113.13 25.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.358 -1.083 . . . . 0.0 109.414 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -140.77 143.46 34.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 109.983 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.643 ' OH ' HG23 ' A' ' 121' ' ' VAL . 19.0 m-85 -42.34 144.75 0.46 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.884 . . . . 0.0 110.415 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 2.0 pt-20 -90.85 -46.72 8.04 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.301 -0.874 . . . . 0.0 109.626 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.625 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -81.86 72.48 2.78 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.522 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -161.28 -145.01 0.11 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.152 -1.205 . . . . 0.0 109.837 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.56 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 23.7 m -138.61 162.1 35.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.333 -0.854 . . . . 0.0 108.811 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 39' ' ' PHE . 11.3 m-85 -160.28 105.31 1.49 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.927 -1.108 . . . . 0.0 110.357 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 57.3 t -78.95 115.19 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.91 -1.119 . . . . 0.0 108.342 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.972 ' CD1' HD12 ' A' ' 18' ' ' ILE . 2.1 tt -104.59 116.08 31.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.31 -0.869 . . . . 0.0 110.721 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.745 HD22 HD23 ' A' ' 11' ' ' LEU . 19.5 tp -98.68 109.05 21.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.015 -1.053 . . . . 0.0 109.433 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.427 ' OG ' HG22 ' A' ' 18' ' ' ILE . 2.6 t -99.91 128.86 45.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.172 -0.955 . . . . 0.0 109.631 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.417 ' OG1' ' OD2' ' A' ' 12' ' ' ASP . 1.2 m -113.64 150.46 33.13 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.54 ' CG ' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -135.93 166.28 23.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.885 . . . . 0.0 109.479 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.54 ' N ' ' CG ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -104.86 147.51 27.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.425 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.9 p -142.18 -172.71 3.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.485 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.3 -10.42 71.12 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 56' ' ' GLY . 1.2 p -107.5 -53.52 2.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -1.172 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.425 ' N ' ' OG ' ' A' ' 55' ' ' SER . . . -157.32 -122.72 0.72 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.584 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 16.5 m-85 -129.32 156.24 44.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -1.092 . . . . 0.0 109.516 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.1 t -117.07 117.58 30.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.848 . . . . 0.0 108.941 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.546 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 26.2 m-85 -97.59 159.52 14.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.974 . . . . 0.0 110.166 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.739 ' CB ' ' HE1' ' A' ' 95' ' ' HIS . 9.3 m-80 -150.06 90.85 1.71 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 1.036 ' CG2' HG23 ' A' ' 81' ' ' THR . 5.9 mt -77.72 135.21 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 110.415 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.756 ' CD2' ' HB2' ' A' ' 95' ' ' HIS . 56.4 m80 -122.0 161.95 22.02 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 53.7 p90 -138.95 96.02 3.05 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 118.4 -1.32 . . . . 0.0 109.387 176.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.593 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 14.8 t90 -69.61 139.9 53.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -123.01 61.84 1.01 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.239 -0.913 . . . . 0.0 111.014 -178.253 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -53.07 89.72 0.01 OUTLIER Glycine 0 N--CA 1.5 2.967 0 N-CA-C 107.967 -2.053 . . . . 0.0 107.967 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 65' ' ' LEU . 5.2 ttmm -49.5 91.9 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.625 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 12.6 m120 -161.65 -42.05 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.534 ' OG ' ' CG ' ' A' ' 73' ' ' GLU . 24.4 p -65.57 -145.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.456 -0.777 . . . . 0.0 109.299 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.619 ' CB ' ' HE1' ' A' ' 26' ' ' MET . 3.9 p -116.11 170.74 8.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.072 -1.017 . . . . 0.0 109.847 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.509 ' HA ' ' HG2' ' A' ' 74' ' ' GLN . 7.3 tt0 -70.51 -11.58 61.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.412 -0.805 . . . . 0.0 110.403 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -82.34 -51.45 7.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.744 -1.223 . . . . 0.0 109.634 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.608 ' OE1' HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -63.69 -30.08 71.23 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.065 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.615 ' HB2' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -70.23 -33.32 71.51 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.187 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.518 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -79.65 -17.19 76.03 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.56 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -82.23 -36.32 27.3 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.385 -1.068 . . . . 0.0 108.706 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.828 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -69.53 -51.95 30.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.364 -0.835 . . . . 0.0 108.989 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.35 79.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.296 -0.877 . . . . 0.0 109.224 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 75' ' ' GLY . 74.2 mt -56.58 -42.49 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.264 -0.898 . . . . 0.0 109.309 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.655 ' CG ' HD22 ' A' ' 3' ' ' LEU . 3.5 m-85 -63.57 -29.68 70.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.227 -0.921 . . . . 0.0 108.661 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 1.036 HG23 ' CG2' ' A' ' 61' ' ' ILE . 15.9 m -71.49 -23.58 61.83 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 m -86.87 -29.04 22.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.567 -0.708 . . . . 0.0 109.229 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.494 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -73.21 -39.87 65.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.297 -0.877 . . . . 0.0 109.493 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.532 ' SD ' HG21 ' A' ' 61' ' ' ILE . 4.8 ptm -77.06 -27.74 54.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.453 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.596 ' HA ' HD11 ' A' ' 61' ' ' ILE . 7.8 t70 -66.72 -35.17 79.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.195 -0.94 . . . . 0.0 109.372 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -86.65 -23.33 25.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 0.0 109.393 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.494 ' CD1' ' O ' ' A' ' 83' ' ' GLN . 5.0 m-85 -87.3 -12.96 44.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -0.967 . . . . 0.0 109.448 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.564 HD11 HD22 ' A' ' 11' ' ' LEU . 21.1 mt -89.66 10.72 22.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.566 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 97.25 1.54 59.35 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 1.8 m 75.78 3.06 3.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -1.186 . . . . 0.0 109.629 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.401 ' H ' HG22 ' A' ' 91' ' ' VAL . 4.2 m -83.94 -16.5 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.397 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.546 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -70.57 172.75 8.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.553 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.67 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.5 t -124.97 176.91 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.315 -0.865 . . . . 0.0 109.267 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.67 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -125.18 132.47 53.03 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.082 -1.011 . . . . 0.0 109.161 179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.756 ' HB2' ' CD2' ' A' ' 62' ' ' HIS . 9.7 m80 -130.25 153.49 48.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.652 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.535 ' HG3' ' CZ ' ' A' ' 63' ' ' TYR . 23.9 ttp180 -118.06 129.67 55.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 110.153 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.503 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 32.8 mp0 -134.01 164.45 27.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.0 t -157.49 -172.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.282 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.726 ' H ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -75.78 78.46 2.72 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.562 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 134.7 -16.71 4.26 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.496 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 37.9 m-70 -99.94 -16.05 18.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.704 -0.88 . . . . 0.0 108.822 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.593 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.12 22.76 3.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.549 -0.719 . . . . 0.0 109.366 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 105' ' ' THR . 90.9 p -57.99 -130.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.511 -0.743 . . . . 0.0 110.993 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.841 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 49.0 mt-10 -39.82 -24.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.07 -1.019 . . . . 0.0 111.271 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 103' ' ' SER . 7.6 m -70.62 -60.92 1.98 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.853 -1.154 . . . . 0.0 110.354 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.571 ' CG ' ' OE1' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -61.7 -50.2 73.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.805 -1.184 . . . . 0.0 108.582 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -61.95 -26.74 68.38 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.36 -0.837 . . . . 0.0 108.828 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -57.67 -51.74 68.29 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.468 ' HB3' HD13 ' A' ' 18' ' ' ILE . 23.1 m-85 -70.98 -17.1 62.67 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.883 ' CG ' HD21 ' A' ' 114' ' ' LEU . 24.6 m-85 -108.17 93.88 4.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.467 -0.77 . . . . 0.0 109.538 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.499 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -86.17 61.81 7.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.971 . . . . 0.0 109.361 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 111' ' ' LYS . 11.8 mt-30 -163.6 -78.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.775 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 179.82 130.88 1.54 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.883 HD21 ' CG ' ' A' ' 110' ' ' PHE . 44.8 mt -96.56 107.75 20.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 109.977 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.511 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 1.3 mm -79.84 164.9 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.559 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 71.1 m-85 -137.35 133.12 34.51 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.039 -1.038 . . . . 0.0 110.055 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 2.7 mmpt? -117.28 -171.81 2.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.099 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.586 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 36.7 mm-40 -90.7 128.64 36.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.073 -1.017 . . . . 0.0 110.145 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.57 ' HA2' ' CG ' ' A' ' 40' ' ' TYR . . . -58.62 -154.96 0.01 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 55.54 79.58 0.09 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.776 HG12 ' HB3' ' A' ' 25' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.324 -1.103 . . . . 0.0 109.52 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.657 HG22 ' CD ' ' A' ' 27' ' ' GLU . 2.1 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 1' ' ' VAL . 9.8 pt-20 40.25 50.1 2.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.571 -0.705 . . . . 0.0 109.758 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.699 HD22 ' CG ' ' A' ' 80' ' ' TYR . 1.4 pp -43.07 -28.3 0.27 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 109.443 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.511 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 6.9 p -57.03 143.06 39.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 109.947 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 4' ' ' SER . 4.1 ttmt 73.41 -79.5 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.508 -0.745 . . . . 0.0 109.69 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 5' ' ' LYS . 7.8 mttm -45.4 -27.04 0.63 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.931 -1.105 . . . . 0.0 108.952 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.701 HG13 ' CE2' ' A' ' 21' ' ' TRP . 41.5 t -106.86 -33.97 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.541 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 8.0 p -87.28 -153.19 0.21 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.392 -0.817 . . . . 0.0 109.124 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.425 ' O ' ' HD2' ' A' ' 10' ' ' LYS . . . 84.15 -44.83 3.39 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -167.67 61.18 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.219 -1.166 . . . . 0.0 109.125 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.108 HD23 HD22 ' A' ' 48' ' ' LEU . 3.0 mp -41.81 -71.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.416 -0.802 . . . . 0.0 109.661 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.527 ' HB3' ' CB ' ' A' ' 50' ' ' THR . 14.4 m-20 -145.88 75.9 1.44 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.431 ' O ' ' OG1' ' A' ' 14' ' ' THR . 17.0 mmtt -91.47 125.51 36.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.515 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 23.4 p 48.6 57.3 6.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.389 -0.82 . . . . 0.0 109.535 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.3 m -162.64 104.76 1.06 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.46 -0.775 . . . . 0.0 109.243 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.94 130.76 11.59 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.312 2.008 . . . . 0.0 110.377 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.1 172.98 12.8 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.94 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -125.91 145.04 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.853 -1.381 . . . . 0.0 110.488 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -112.42 167.17 10.66 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.987 HD11 ' CZ ' ' A' ' 110' ' ' PHE . 26.1 mt -132.25 161.13 41.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.333 -1.479 . . . . 0.0 110.242 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.782 ' HA ' HG23 ' A' ' 31' ' ' VAL . 7.7 m-90 -120.87 122.77 40.96 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.938 ' HD2' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -79.84 130.26 35.16 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.922 -1.111 . . . . 0.0 110.755 -178.463 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 23' ' ' ILE . 7.9 mm -94.2 25.48 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.642 ' HB2' HG21 ' A' ' 121' ' ' VAL . 19.6 pt-20 -57.19 166.81 1.02 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.709 -0.619 . . . . 0.0 109.861 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.537 ' ND2' ' HG3' ' A' ' 24' ' ' GLU . 14.0 p30 42.66 27.67 0.1 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.476 ' HA ' ' OE2' ' A' ' 73' ' ' GLU . 3.8 mmt 53.64 55.23 8.81 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.499 -0.751 . . . . 0.0 109.622 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.657 ' CD ' HG22 ' A' ' 1' ' ' VAL . 0.9 OUTLIER -160.33 144.88 14.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 0.0 109.445 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.606 ' CE ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -76.54 136.36 39.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.051 -1.031 . . . . 0.0 109.788 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.764 HG12 ' CD ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -147.12 151.76 41.77 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.673 ' HD2' HG13 ' A' ' 29' ' ' VAL . 31.9 Cg_endo -72.99 134.27 21.21 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.362 2.041 . . . . 0.0 111.747 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.938 HG22 ' HD2' ' A' ' 22' ' ' ARG . 2.5 t -120.43 104.9 42.32 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.97 -157.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.557 2.171 . . . . 0.0 110.551 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.558 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -78.55 -25.97 45.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.171 -0.956 . . . . 0.0 109.101 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.36 32.47 0.77 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.275 -0.891 . . . . 0.0 109.854 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.509 ' HB2' ' CG1' ' A' ' 31' ' ' VAL . 17.3 m -155.07 -35.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 0.0 110.011 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.854 ' HB2' HD12 ' A' ' 20' ' ' ILE . 11.9 p90 -60.06 -41.22 91.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.011 -1.056 . . . . 0.0 109.768 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.51 ' N ' ' CG ' ' A' ' 36' ' ' TYR . . . -51.7 -24.29 12.24 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.844 ' HA ' HG22 ' A' ' 115' ' ' ILE . 0.9 OUTLIER -131.87 129.85 40.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.088 -1.242 . . . . 0.0 110.158 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -148.56 128.48 13.5 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.291 -0.881 . . . . 0.0 109.671 179.261 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.688 ' HE2' HG22 ' A' ' 121' ' ' VAL . 8.5 m-30 -47.55 140.1 6.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.489 -0.757 . . . . 0.0 110.6 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 1.6 pt-20 -91.3 29.12 1.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -0.864 . . . . 0.0 109.588 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.617 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -146.21 54.62 0.54 Allowed Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.467 ' CG ' ' O ' ' A' ' 42' ' ' GLY . 1.4 m-20 -162.94 -139.47 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.502 -0.999 . . . . 0.0 109.754 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.583 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 53.7 m -147.44 158.83 44.14 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.583 ' CD1' ' O ' ' A' ' 44' ' ' CYS . 31.4 m-85 -149.48 169.5 20.76 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.075 -1.016 . . . . 0.0 108.982 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.59 HG11 ' CE ' ' A' ' 84' ' ' MET . 44.3 t -132.25 113.08 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.783 HD11 HG13 ' A' ' 18' ' ' ILE . 3.8 tt -103.65 106.37 16.86 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.861 -1.149 . . . . 0.0 110.981 -178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.108 HD22 HD23 ' A' ' 11' ' ' LEU . 19.2 tp -94.37 124.92 38.68 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.782 ' OG ' HG22 ' A' ' 18' ' ' ILE . 8.5 t -115.18 136.22 53.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.096 -1.003 . . . . 0.0 109.788 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.527 ' CB ' ' HB3' ' A' ' 12' ' ' ASP . 1.2 m -130.56 124.26 31.41 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.83 137.59 52.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.525 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.581 ' O ' HG23 ' A' ' 53' ' ' THR . 0.7 OUTLIER -54.91 163.85 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.893 . . . . 0.0 109.437 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -165.4 -172.87 2.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.445 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.79 -29.16 39.75 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.68 -17.7 43.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -1.114 . . . . 0.0 109.42 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.8 -69.06 0.45 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.583 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 14.5 m-85 -160.09 157.16 28.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -1.139 . . . . 0.0 109.528 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.66 112.21 15.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 109.114 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.8 ' CD2' HD22 ' A' ' 88' ' ' LEU . 6.6 m-30 -91.93 153.93 19.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.245 -0.909 . . . . 0.0 109.929 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.617 ' CB ' ' HE1' ' A' ' 95' ' ' HIS . 0.6 OUTLIER -147.7 95.25 2.48 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.979 ' CG2' HG23 ' A' ' 81' ' ' THR . 15.3 mt -83.39 130.36 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.172 -0.955 . . . . 0.0 110.519 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.745 ' CD2' ' HB2' ' A' ' 95' ' ' HIS . 38.3 m80 -115.39 164.17 14.65 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.603 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 48.1 p90 -137.87 96.78 3.28 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.611 -1.236 . . . . 0.0 109.792 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.576 ' CE2' ' OE1' ' A' ' 102' ' ' GLU . 6.7 t90 -72.62 141.41 48.34 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -125.57 65.3 1.17 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.069 -1.019 . . . . 0.0 110.865 -178.642 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -49.49 90.46 0.01 OUTLIER Glycine 0 N--CA 1.499 2.834 0 N-CA-C 108.414 -1.874 . . . . 0.0 108.414 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -39.15 91.48 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.927 0.87 . . . . 0.0 112.683 -177.679 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.617 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 1.2 m120 -162.65 -42.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.489 ' HB2' ' CB ' ' A' ' 73' ' ' GLU . 95.9 p -63.9 -151.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.582 -0.699 . . . . 0.0 109.343 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.432 ' OG ' ' OD1' ' A' ' 72' ' ' ASP . 80.1 p -121.2 176.57 5.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 109.62 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 12.0 tt0 -55.12 -41.39 71.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.549 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.432 ' OD1' ' OG ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -60.29 -43.24 96.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.159 -0.963 . . . . 0.0 109.551 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.489 ' CB ' ' HB2' ' A' ' 69' ' ' SER . 2.7 tp10 -56.33 -36.6 68.92 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.022 -1.049 . . . . 0.0 108.353 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 6.6 tt0 -62.7 -36.16 82.06 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.858 ' O ' HD13 ' A' ' 79' ' ' ILE . . . -80.06 -13.82 81.51 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.577 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -78.72 -54.02 6.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.234 -1.157 . . . . 0.0 109.156 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.505 ' HB2' ' CD1' ' A' ' 23' ' ' ILE . . . -72.45 -26.43 61.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.398 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.3 -48.38 20.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.25 -0.906 . . . . 0.0 109.564 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.858 HD13 ' O ' ' A' ' 75' ' ' GLY . 1.5 mp -65.54 -39.2 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -0.901 . . . . 0.0 108.994 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.699 ' CG ' HD22 ' A' ' 3' ' ' LEU . 3.8 m-85 -61.45 -39.46 90.92 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.053 -1.029 . . . . 0.0 108.331 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.979 HG23 ' CG2' ' A' ' 61' ' ' ILE . 3.0 m -67.12 -24.78 65.96 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.4 m -76.82 -37.02 56.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.454 -0.779 . . . . 0.0 109.379 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 24.2 mm100 -66.76 -36.66 82.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 109.585 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.605 ' SD ' HG11 ' A' ' 7' ' ' VAL . 73.3 mtm -71.72 -34.86 69.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.953 . . . . 0.0 109.602 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.55 -58.64 7.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 109.738 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -64.95 -33.33 75.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.672 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 3.1 m-85 -73.2 -10.49 59.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -1.0 . . . . 0.0 109.692 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.968 HD21 HD22 ' A' ' 11' ' ' LEU . 20.1 mt -89.43 -32.19 17.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 109.545 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 121.93 15.55 4.3 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 0.9 OUTLIER 75.8 -0.29 3.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -1.149 . . . . 0.0 109.683 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.535 HG23 ' CD2' ' A' ' 59' ' ' TYR . 15.6 m -83.42 -9.47 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.411 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.744 ' HB2' HD13 ' A' ' 88' ' ' LEU . . . -90.81 176.72 6.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 0.0 109.548 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.671 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.7 t -133.47 177.45 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.365 -0.835 . . . . 0.0 109.156 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.671 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -125.71 135.18 51.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.986 -1.071 . . . . 0.0 108.972 179.532 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.745 ' HB2' ' CD2' ' A' ' 62' ' ' HIS . 7.5 m80 -132.96 149.0 52.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.128 -0.982 . . . . 0.0 109.379 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.585 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -110.77 136.94 49.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 110.384 -179.378 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.515 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 49.8 mm-40 -142.23 164.41 30.23 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.436 -0.79 . . . . 0.0 108.93 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 99' ' ' GLN . 1.8 t -157.78 -165.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.132 -0.98 . . . . 0.0 109.02 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.695 ' H ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -78.36 75.96 4.87 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 178.795 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.94 -12.17 4.78 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.505 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 10.8 m-70 -98.25 -13.21 20.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.667 -0.902 . . . . 0.0 109.107 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.578 ' OE1' ' CD2' ' A' ' 106' ' ' PHE . 2.0 pt-20 -90.05 30.17 1.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.418 -0.801 . . . . 0.0 109.031 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 102' ' ' GLU . 63.5 p -52.45 -141.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.751 0.786 . . . . 0.0 112.126 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.781 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -38.99 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.915 -1.116 . . . . 0.0 111.057 -178.435 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 103' ' ' SER . 0.8 OUTLIER -67.02 -57.47 6.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.811 -1.181 . . . . 0.0 110.138 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.578 ' CD2' ' OE1' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -66.64 -44.33 82.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.959 -1.088 . . . . 0.0 108.309 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.82 -17.54 64.93 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -71.02 -45.4 63.99 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.431 ' HB3' HD12 ' A' ' 18' ' ' ILE . 18.3 m-85 -76.37 -17.88 59.16 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.462 -0.774 . . . . 0.0 109.466 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.987 ' CZ ' HD11 ' A' ' 20' ' ' ILE . 6.9 m-30 -112.07 96.5 6.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.115 -0.991 . . . . 0.0 109.316 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -67.78 86.28 0.22 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.48 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 111' ' ' LYS . 7.3 mm100 72.65 74.82 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.867 . . . . 0.0 109.586 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.777 ' C ' HD22 ' A' ' 114' ' ' LEU . . . -178.73 62.87 0.08 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.785 HD21 ' HB2' ' A' ' 110' ' ' PHE . 3.8 mm? -120.9 63.01 0.87 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -1.14 . . . . 0.0 109.336 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.844 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -85.85 160.96 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.104 -0.998 . . . . 0.0 109.351 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.544 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 2.0 m-85 -139.75 165.0 28.46 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.605 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -146.98 -156.29 0.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.591 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 1.6 tt0 -91.48 169.41 10.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.968 . . . . 0.0 109.819 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 120' ' ' GLY . . . -99.13 -169.86 30.75 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 47.37 95.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.688 HG22 ' HE2' ' A' ' 40' ' ' TYR . 1.3 t . . . . . 0 C--N 1.305 -1.347 0 O-C-N 121.205 -1.173 . . . . 0.0 109.297 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.421 ' O ' HG12 ' A' ' 1' ' ' VAL . 9.1 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 175.54 94.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.43 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.882 ' O ' HD22 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -74.19 3.32 7.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.216 -0.927 . . . . 0.0 110.484 -179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.571 ' N ' HD13 ' A' ' 3' ' ' LEU . 1.7 p -92.74 150.9 20.36 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.811 -1.18 . . . . 0.0 110.34 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.506 ' HD2' ' HG2' ' A' ' 6' ' ' LYS . 12.0 ttmt 47.19 -86.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.429 0.633 . . . . 0.0 110.917 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 4' ' ' SER . 5.8 mmtt -40.54 -27.51 0.05 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.492 -0.755 . . . . 0.0 110.227 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 3' ' ' LEU . 70.4 t -109.16 -31.85 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.097 -1.002 . . . . 0.0 109.607 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.821 HG21 ' CG ' ' A' ' 87' ' ' TYR . 18.2 p -72.22 -3.52 23.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.883 . . . . 0.0 109.473 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 10' ' ' LYS . . . -70.45 85.03 0.34 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 9' ' ' GLY . 5.3 mtmm 80.65 74.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.677 -0.896 . . . . 0.0 109.601 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 8' ' ' THR . 4.7 mt -89.35 32.65 0.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 0.0 109.124 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER 78.31 61.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.438 -0.789 . . . . 0.0 109.357 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.538 ' O ' HG23 ' A' ' 14' ' ' THR . 4.2 mttm -81.6 -10.39 59.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 109.524 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 27.0 p -157.36 67.45 0.52 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.59 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.404 ' O ' ' OD2' ' A' ' 12' ' ' ASP . 99.2 m -161.9 118.5 1.32 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.384 -0.822 . . . . 0.0 109.169 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.84 87.84 1.44 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.255 1.97 . . . . 0.0 110.206 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.462 ' C ' HG23 ' A' ' 18' ' ' ILE . . . -170.48 -145.08 4.58 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.009 HD12 HD11 ' A' ' 47' ' ' LEU . 14.2 pt -157.24 142.21 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.013 -1.287 . . . . 0.0 110.202 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.726 ' NE2' ' CZ2' ' A' ' 21' ' ' TRP . 3.1 tt0 -121.78 117.25 26.12 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.898 HD11 ' HZ ' ' A' ' 110' ' ' PHE . 1.6 mt -90.88 178.16 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.659 -1.276 . . . . 0.0 110.733 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.786 ' CD1' ' HE2' ' A' ' 28' ' ' MET . 9.5 m-90 -137.38 121.18 17.5 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.532 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 3.7 ptp180 -83.75 128.68 34.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.097 . . . . 0.0 111.908 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.58 HD13 ' HB3' ' A' ' 28' ' ' MET . 1.8 mm -111.45 50.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.636 ' HB2' ' CE2' ' A' ' 40' ' ' TYR . 4.7 pt-20 -92.78 -39.06 11.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.372 -0.83 . . . . 0.0 110.295 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.571 ' CB ' HG21 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -88.35 43.77 1.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 108.517 179.32 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.556 ' HE2' ' OE2' ' A' ' 73' ' ' GLU . 0.9 OUTLIER 50.22 24.48 1.48 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.529 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 3.6 pt-20 -151.94 153.74 34.7 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.786 ' HE2' ' CD1' ' A' ' 21' ' ' TRP . 15.5 ptm -97.41 133.69 41.67 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.744 -1.222 . . . . 0.0 110.746 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -120.73 149.33 50.28 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.572 ' HD2' HG13 ' A' ' 29' ' ' VAL . 32.0 Cg_endo -71.94 87.77 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.272 1.981 . . . . 0.0 112.217 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 22' ' ' ARG . 8.6 t -72.99 112.65 16.26 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.537 -0.727 . . . . 0.0 109.473 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 35.9 Cg_endo -78.41 -159.31 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.396 2.064 . . . . 0.0 110.149 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.576 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -88.14 -21.37 24.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 108.909 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -78.91 4.43 14.18 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.291 -0.881 . . . . 0.0 109.661 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 36' ' ' TYR . 38.7 m -128.18 -37.01 1.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.953 . . . . 0.0 109.787 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -42.81 161.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -0.894 . . . . 0.0 109.718 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.535 ' O ' ' CE1' ' A' ' 39' ' ' PHE . . . 110.82 -62.19 0.29 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.474 ' HB3' ' HD3' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -103.75 106.97 17.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -1.152 . . . . 0.0 109.264 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.585 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -130.93 132.47 45.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.124 -0.985 . . . . 0.0 109.989 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.636 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 9.7 m-30 -40.13 131.2 2.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.591 -0.693 . . . . 0.0 111.445 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 0.8 OUTLIER -90.86 112.09 23.78 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.402 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.603 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . 115.22 45.57 0.62 Allowed Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -155.78 -134.29 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.536 -0.979 . . . . 0.0 108.678 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.529 ' HB2' ' CB ' ' A' ' 23' ' ' ILE . 60.8 m -146.18 137.27 24.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.865 -1.147 . . . . 0.0 109.437 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 26.5 m-85 -140.49 108.13 5.62 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.261 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.508 HG13 ' OG1' ' A' ' 81' ' ' THR . 8.2 t -78.86 126.73 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 108.551 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.009 HD11 HD12 ' A' ' 18' ' ' ILE . 7.4 tt -116.65 117.96 31.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.077 -1.015 . . . . 0.0 110.112 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 59' ' ' TYR . 22.2 tp -100.44 113.82 26.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.935 . . . . 0.0 109.333 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.402 ' HA ' HG22 ' A' ' 18' ' ' ILE . 3.1 t -102.4 130.73 49.25 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.225 -0.922 . . . . 0.0 109.538 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 m -121.2 142.82 49.53 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.09 -173.28 3.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.46 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.727 ' O ' HG23 ' A' ' 53' ' ' THR . 1.0 OUTLIER -109.96 168.87 9.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.487 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 52' ' ' LYS . 5.4 p -162.72 -170.9 2.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.06 -17.85 66.34 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.1 m -102.39 -43.74 5.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -1.153 . . . . 0.0 109.478 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.424 ' O ' ' OG1' ' A' ' 53' ' ' THR . . . -175.36 -128.34 1.1 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.579 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 42.1 m-85 -111.23 150.66 29.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -1.125 . . . . 0.0 109.516 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.55 114.33 27.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.0 109.001 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.572 ' HD1' HG23 ' A' ' 91' ' ' VAL . 12.7 m-85 -91.09 155.63 18.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.164 -0.96 . . . . 0.0 109.841 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.81 ' CB ' ' HE1' ' A' ' 95' ' ' HIS . 1.8 m-20 -147.25 92.64 2.13 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.919 ' CG2' HG23 ' A' ' 81' ' ' THR . 21.5 mt -77.64 134.38 28.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 110.374 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.767 ' CD2' ' HB2' ' A' ' 95' ' ' HIS . 58.0 m80 -120.82 162.53 19.64 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 95' ' ' HIS . 45.9 p90 -137.05 97.69 3.57 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 118.605 -1.238 . . . . 0.0 109.298 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.598 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 7.7 t90 -74.33 137.23 42.7 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.774 HD11 ' CG ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -126.53 64.62 1.26 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -0.885 . . . . 0.0 111.095 -178.03 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.451 ' O ' ' HA2' ' A' ' 42' ' ' GLY . . . -49.48 97.38 0.01 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 107.173 -2.371 . . . . 0.0 107.173 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 65' ' ' LEU . 2.2 tptt -55.27 89.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -176.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.603 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 12.0 m120 -160.98 -37.99 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.8 p -67.43 -146.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 109.432 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.451 ' HB2' ' OD2' ' A' ' 72' ' ' ASP . 3.0 p -114.27 158.67 21.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 109.891 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -50.99 -34.89 31.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.451 ' OD2' ' HB2' ' A' ' 70' ' ' SER . 1.6 p30 -58.18 -46.13 86.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.147 -0.971 . . . . 0.0 109.077 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.556 ' OE2' ' HE2' ' A' ' 26' ' ' MET . 59.7 mm-40 -57.09 -36.17 70.29 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.774 ' CG ' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -63.03 -35.92 81.85 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.577 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.531 ' O ' ' CG1' ' A' ' 79' ' ' ILE . . . -81.79 -12.08 81.91 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.19 -54.14 6.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.15 -1.206 . . . . 0.0 109.286 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.481 ' HB1' HG22 ' A' ' 46' ' ' VAL . . . -73.09 -34.02 65.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -0.905 . . . . 0.0 109.376 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.62 -41.76 65.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 109.776 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.531 ' CG1' ' O ' ' A' ' 75' ' ' GLY . 73.0 mt -69.24 -44.87 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.054 -1.029 . . . . 0.0 109.886 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.594 ' CD2' HD12 ' A' ' 3' ' ' LEU . 2.9 m-85 -68.38 -29.5 68.21 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.919 HG23 ' CG2' ' A' ' 61' ' ' ILE . 13.8 m -69.67 -24.17 63.57 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 79' ' ' ILE . 2.1 m -72.62 -49.01 34.86 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 9.3 mt-30 -59.28 -43.38 92.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.368 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.696 ' CG ' HD23 ' A' ' 3' ' ' LEU . 0.9 OUTLIER -55.06 -37.9 67.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.593 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.98 -41.59 99.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.12 4.58 49.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.196 -0.94 . . . . 0.0 109.704 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.821 ' CG ' HG21 ' A' ' 8' ' ' THR . 0.6 OUTLIER -107.97 -13.98 14.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 0.0 109.581 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.48 HD21 ' HB3' ' A' ' 11' ' ' LEU . 20.5 mt -87.13 -66.54 0.9 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 109.589 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.683 ' O ' HG13 ' A' ' 91' ' ' VAL . . . 171.39 37.27 0.03 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.4 m 49.58 22.42 0.76 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -1.15 . . . . 0.0 109.552 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 89' ' ' GLY . 31.1 m -110.86 -25.96 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.198 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -65.46 172.42 3.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 109.515 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.683 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.4 t -126.53 177.76 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.347 -0.846 . . . . 0.0 109.318 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.683 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -125.33 131.77 52.96 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.067 -1.021 . . . . 0.0 109.036 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.81 ' HE1' ' CB ' ' A' ' 60' ' ' ASN . 11.4 m80 -128.52 152.68 48.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.938 . . . . 0.0 109.522 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.574 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 11.7 ttt-85 -114.62 133.23 56.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.365 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.501 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 50.2 mt-10 -140.33 165.11 28.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.108 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.692 HG12 ' H ' ' A' ' 99' ' ' GLN . 1.7 t -155.42 -161.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.085 -1.009 . . . . 0.0 109.319 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.692 ' H ' HG12 ' A' ' 98' ' ' VAL . 8.9 pt20 -82.09 72.78 9.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.086 -1.009 . . . . 0.0 108.552 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 137.07 -19.6 3.45 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.491 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 19.0 m-70 -87.19 -21.96 25.57 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.702 -0.881 . . . . 0.0 108.789 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.598 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.27 22.4 3.35 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.742 0.782 . . . . 0.0 109.124 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.9 p -57.51 -99.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.283 -0.886 . . . . 0.0 111.336 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.943 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 19.1 pt-20 -62.97 -18.32 63.09 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.092 -1.005 . . . . 0.0 111.103 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 1.6 m -79.63 -61.48 1.98 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.805 -1.185 . . . . 0.0 110.166 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.57 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -58.68 -56.45 22.03 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.954 -1.091 . . . . 0.0 108.173 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -57.2 -31.33 65.35 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.455 -0.778 . . . . 0.0 109.18 179.18 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.943 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -51.79 -54.15 31.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.022 -1.049 . . . . 0.0 108.249 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.584 ' HB3' HD13 ' A' ' 18' ' ' ILE . 19.5 m-85 -64.88 -23.95 67.39 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.898 ' HZ ' HD11 ' A' ' 20' ' ' ILE . 9.2 m-85 -102.89 92.53 4.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.518 -0.739 . . . . 0.0 109.312 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.454 ' O ' ' OE1' ' A' ' 112' ' ' GLN . 28.9 mtmm -82.23 89.69 6.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.522 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.454 ' OE1' ' O ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER 168.58 -74.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 108.761 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 114' ' ' LEU . . . -159.78 -142.12 3.31 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.694 HD21 ' CG ' ' A' ' 110' ' ' PHE . 0.5 OUTLIER 174.94 108.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.504 -0.998 . . . . 0.0 108.921 179.433 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.574 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 5.0 mt -93.69 165.04 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 109.374 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.574 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 4.1 m-85 -142.05 113.13 7.5 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.545 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -79.39 -169.24 1.81 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.294 -0.879 . . . . 0.0 109.662 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.583 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 35.5 tp60 -92.64 148.4 22.1 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.751 -1.218 . . . . 0.0 110.73 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.584 ' HA2' ' CD2' ' A' ' 40' ' ' TYR . . . -66.38 -173.73 5.42 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 59.32 117.35 0.01 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.571 HG21 ' CB ' ' A' ' 25' ' ' ASN . 1.5 t . . . . . 0 C--N 1.303 -1.422 0 O-C-N 121.181 -1.187 . . . . 0.0 109.049 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.974 HG22 ' HG2' ' A' ' 27' ' ' GLU . 16.5 t . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.566 ' N ' HG12 ' A' ' 1' ' ' VAL . 7.5 pt-20 39.15 83.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.646 -0.658 . . . . 0.0 109.959 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.848 HD22 ' CG ' ' A' ' 80' ' ' TYR . 2.4 pt? -85.23 14.28 5.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 p -90.83 5.21 49.34 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.675 -1.266 . . . . 0.0 110.088 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -134.26 -48.12 0.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.061 -1.024 . . . . 0.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 8.9 mmtt -89.69 35.48 0.83 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.905 . . . . 0.0 109.024 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.642 HG12 ' HB3' ' A' ' 11' ' ' LEU . 60.6 t -159.3 -49.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.39 -0.819 . . . . 0.0 109.751 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.726 ' HA ' HD23 ' A' ' 11' ' ' LEU . 44.5 p -61.89 -31.3 71.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.325 -0.86 . . . . 0.0 110.137 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 10' ' ' LYS . . . -45.03 -26.62 1.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.5 ' CG ' ' HE3' ' A' ' 13' ' ' LYS . 0.3 OUTLIER 175.87 70.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.505 -0.997 . . . . 0.0 108.622 179.611 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.044 HD12 ' CD2' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -86.92 19.81 2.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.335 -0.853 . . . . 0.0 110.206 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.77 ' OD2' HD21 ' A' ' 48' ' ' LEU . 3.8 p30 157.7 106.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.621 -0.675 . . . . 0.0 109.287 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HE3' ' CG ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -157.94 123.18 4.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 109.644 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 22.1 p 48.34 56.5 7.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.0 109.628 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.5 m -166.41 106.66 0.68 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.392 -0.817 . . . . 0.0 109.27 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 50' ' ' THR . 34.4 Cg_endo -76.96 128.07 9.75 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.347 2.032 . . . . 0.0 110.263 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 144.73 167.91 12.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.951 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -123.64 143.11 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.075 -1.25 . . . . 0.0 109.764 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.472 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 1.7 pm0 -120.15 -170.39 1.96 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.838 HD11 ' HZ ' ' A' ' 110' ' ' PHE . 2.0 mt -147.37 178.65 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.822 -1.174 . . . . 0.0 110.156 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.669 ' H ' HG22 ' A' ' 20' ' ' ILE . 7.1 m-90 -134.67 122.24 21.96 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.54 ' HD3' HG12 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -82.6 130.02 35.04 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.118 -0.989 . . . . 0.0 112.293 -176.826 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.89 HD13 ' HB2' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -121.18 24.68 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 177.127 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.755 ' HG3' HG21 ' A' ' 121' ' ' VAL . 10.6 pt-20 -63.42 -49.57 73.21 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.223 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.405 ' N ' ' CG ' ' A' ' 24' ' ' GLU . 21.3 p-10 -85.33 42.86 0.97 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.118 -0.989 . . . . 0.0 108.336 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.565 ' HE3' ' CD ' ' A' ' 73' ' ' GLU . 79.4 mmm 48.42 34.63 4.9 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.974 ' HG2' HG22 ' A' ' 1' ' ' VAL . 3.2 tt0 -151.57 131.37 13.24 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.852 ' HG3' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -81.42 139.17 35.41 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.089 -1.007 . . . . 0.0 110.237 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -144.0 147.67 38.94 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.536 ' HD2' HG13 ' A' ' 29' ' ' VAL . 32.0 Cg_endo -72.29 88.32 0.86 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.292 1.995 . . . . 0.0 111.618 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' A' ' 21' ' ' TRP . 20.7 t -66.91 111.97 8.45 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 36.2 Cg_endo -78.89 -159.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.408 2.072 . . . . 0.0 110.414 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.459 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -87.55 -12.67 45.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.876 . . . . 0.0 109.085 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.07 26.76 1.12 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.29 -0.881 . . . . 0.0 109.918 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 36' ' ' TYR . 1.1 m -160.08 -37.35 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.046 -1.034 . . . . 0.0 109.823 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.469 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 1.1 p90 -43.42 130.78 5.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.569 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.2 -72.51 0.44 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.542 ' ND2' HD12 ' A' ' 115' ' ' ILE . 13.6 m-20 -94.09 96.85 9.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -1.188 . . . . 0.0 109.518 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.768 ' HZ ' HD22 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -117.33 129.53 55.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.248 -0.908 . . . . 0.0 109.187 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.624 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 84.6 m-85 -39.75 153.13 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.453 -0.779 . . . . 0.0 110.174 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 9.5 pt-20 -90.84 -32.93 15.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.392 -0.818 . . . . 0.0 110.197 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.607 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -91.69 64.49 2.47 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.047 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.489 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 3.2 m-20 -162.83 -144.89 0.09 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.405 -1.056 . . . . 0.0 109.963 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.5 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 84.4 m -149.54 143.36 25.56 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.603 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 29.0 m-85 -140.35 112.39 7.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.367 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.646 ' CG2' ' HB1' ' A' ' 77' ' ' ALA . 90.6 t -79.2 127.13 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.932 -1.105 . . . . 0.0 108.59 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.812 HD21 HG13 ' A' ' 18' ' ' ILE . 8.9 tt -107.69 162.81 13.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.9 -1.125 . . . . 0.0 109.901 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.044 ' CD2' HD12 ' A' ' 11' ' ' LEU . 13.8 tp -151.32 115.15 4.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.073 -1.017 . . . . 0.0 108.997 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.518 ' HA ' ' HB ' ' A' ' 18' ' ' ILE . 3.5 t -109.78 132.14 54.42 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.007 -1.058 . . . . 0.0 110.319 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 1.3 m -125.95 120.87 31.5 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -125.92 157.67 37.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 109.556 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.03 151.76 40.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.458 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.72 HG21 ' OG ' ' A' ' 58' ' ' SER . 1.4 p -137.51 -171.97 3.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.209 -0.932 . . . . 0.0 109.523 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.0 -12.32 77.1 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 p -108.17 -36.42 6.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -1.107 . . . . 0.0 109.461 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.95 -100.88 0.15 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 5.9 m-85 -131.53 154.54 48.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -1.171 . . . . 0.0 109.515 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.72 ' OG ' HG21 ' A' ' 53' ' ' THR . 52.5 m -126.42 112.87 16.13 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.71 ' CD2' HG23 ' A' ' 91' ' ' VAL . 2.8 m-85 -92.62 154.43 18.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.176 -0.953 . . . . 0.0 110.421 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.539 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 6.5 m-20 -140.16 98.68 3.5 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.971 ' CG2' HG23 ' A' ' 81' ' ' THR . 37.2 mt -89.38 119.25 36.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 110.79 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.571 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 21.1 m-70 -109.01 164.44 12.41 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.596 ' CE1' ' HA ' ' A' ' 96' ' ' ARG . 39.4 p90 -138.67 103.73 4.92 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.114 -1.435 . . . . 0.0 109.702 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.602 ' C ' HD23 ' A' ' 65' ' ' LEU . 2.4 t90 -78.97 130.25 35.35 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.047 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.602 HD23 ' C ' ' A' ' 64' ' ' TRP . 0.1 OUTLIER -122.36 65.8 0.94 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.496 -0.753 . . . . 0.0 110.706 -178.526 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.452 ' HA2' ' HB2' ' A' ' 99' ' ' GLN . . . -51.29 89.63 0.01 OUTLIER Glycine 0 N--CA 1.497 2.746 0 N-CA-C 108.304 -1.918 . . . . 0.0 108.304 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -39.1 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 122.076 0.941 . . . . 0.0 112.255 -177.773 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.607 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 1.5 m120 -162.1 -45.2 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 73' ' ' GLU . 88.5 p -62.86 -148.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.354 -0.841 . . . . 0.0 109.199 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.46 ' OG ' ' OD2' ' A' ' 72' ' ' ASP . 2.5 p -121.86 168.54 11.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -48.46 -29.11 3.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.351 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.46 ' OD2' ' OG ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -68.24 -44.49 75.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.446 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.565 ' CD ' ' HE3' ' A' ' 26' ' ' MET . 0.1 OUTLIER -57.16 -36.53 70.88 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.391 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.55 ' HA ' HD11 ' A' ' 65' ' ' LEU . 24.5 tt0 -64.09 -34.96 79.23 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.506 ' O ' ' CG1' ' A' ' 79' ' ' ILE . . . -79.83 -13.46 82.24 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.38 -54.02 6.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -1.124 . . . . 0.0 109.248 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.89 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -75.15 -39.66 60.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.163 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 74' ' ' GLN . . . -63.1 -49.36 74.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.355 -0.84 . . . . 0.0 109.306 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' A' ' 75' ' ' GLY . 70.5 mt -63.57 -44.13 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.211 -0.931 . . . . 0.0 109.414 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.848 ' CG ' HD22 ' A' ' 3' ' ' LEU . 14.5 m-30 -62.98 -25.36 68.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.245 -0.909 . . . . 0.0 109.033 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.971 HG23 ' CG2' ' A' ' 61' ' ' ILE . 5.9 m -79.14 -23.41 44.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.3 m -88.79 -21.82 23.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.638 -0.664 . . . . 0.0 109.352 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 6.8 mt-30 -83.19 -37.87 23.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.497 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.638 ' CG ' HD13 ' A' ' 61' ' ' ILE . 5.3 ptm -75.75 -29.24 58.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.334 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.617 ' HA ' HD11 ' A' ' 61' ' ' ILE . 67.2 t0 -61.64 -59.64 4.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -0.944 . . . . 0.0 109.698 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.58 -33.8 76.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.136 -0.977 . . . . 0.0 109.476 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 0.5 OUTLIER -69.91 -16.11 63.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 109.59 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.983 ' CD1' HD11 ' A' ' 11' ' ' LEU . 66.7 mt -94.06 22.61 5.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.678 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 86.2 0.59 86.86 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 1.4 p 75.86 7.52 3.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -1.165 . . . . 0.0 109.616 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.71 HG23 ' CD2' ' A' ' 59' ' ' TYR . 15.7 m -83.3 -19.5 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 109.285 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.582 ' HB1' HG13 ' A' ' 61' ' ' ILE . . . -68.38 165.61 18.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.581 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.751 HG12 ' H ' ' A' ' 94' ' ' GLN . 2.5 t -115.86 -177.08 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.376 -0.827 . . . . 0.0 109.125 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.751 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -131.01 138.43 49.66 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.092 -1.005 . . . . 0.0 108.674 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.558 ' CE1' ' HB ' ' A' ' 93' ' ' VAL . 12.2 m80 -135.0 142.77 46.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.088 -1.007 . . . . 0.0 110.179 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.596 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -94.17 117.3 29.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 110.148 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.505 ' HB2' ' HA ' ' A' ' 64' ' ' TRP . 44.5 mm-40 -127.98 158.83 36.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.107 -0.996 . . . . 0.0 109.354 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.725 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.6 t -155.75 -175.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.27 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.725 ' H ' HG12 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -69.77 -1.97 10.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.924 -1.11 . . . . 0.0 110.258 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.69 16.11 1.8 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.553 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 5.6 m80 -120.88 -15.73 8.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.487 -1.008 . . . . 0.0 109.373 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.598 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.37 21.59 3.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 0.0 109.169 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 102' ' ' GLU . 4.3 p -41.75 -106.03 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.545 -0.722 . . . . 0.0 112.177 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -67.97 -31.67 71.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.84 -1.163 . . . . 0.0 111.245 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.69 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -58.82 -59.73 4.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.011 -1.056 . . . . 0.0 110.197 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.561 ' HD2' HD13 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -58.71 -55.62 32.75 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.006 -1.059 . . . . 0.0 108.467 -179.252 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -54.48 -20.64 8.03 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 105' ' ' THR . . . -65.22 -51.99 57.43 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.692 ' HB3' HD12 ' A' ' 18' ' ' ILE . 29.4 m-85 -65.46 -17.19 64.36 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.991 ' CG ' HD21 ' A' ' 114' ' ' LEU . 4.2 m-85 -121.4 100.79 7.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 109.684 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 2.8 pttt -81.27 73.55 8.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.222 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.43 -54.93 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 109.731 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 114' ' ' LEU . . . 156.5 -20.08 0.46 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.991 HD21 ' CG ' ' A' ' 110' ' ' PHE . 23.0 mt 62.77 133.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.295 -1.121 . . . . 0.0 109.895 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.562 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 3.2 mt -116.39 164.9 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 0.0 108.978 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.562 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -141.07 102.28 4.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.36 -0.837 . . . . 0.0 109.151 179.765 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.624 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 3.2 mmtt -79.89 -167.97 1.45 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.893 . . . . 0.0 109.587 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.582 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -91.1 124.4 35.29 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.909 -1.119 . . . . 0.0 110.369 -179.451 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 118' ' ' GLN . . . -56.53 -161.61 0.02 OUTLIER Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 67.04 67.38 2.01 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.755 HG21 ' HG3' ' A' ' 24' ' ' GLU . 1.4 t . . . . . 0 C--N 1.303 -1.447 0 O-C-N 121.316 -1.108 . . . . 0.0 109.648 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.962 HG12 ' OE1' ' A' ' 2' ' ' GLU . 1.5 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.962 ' OE1' HG12 ' A' ' 1' ' ' VAL . 15.4 pm0 36.83 51.47 0.94 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.778 -0.576 . . . . 0.0 110.326 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.092 HD22 ' CD2' ' A' ' 80' ' ' TYR . 2.1 pt? -43.33 -31.31 0.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.877 . . . . 0.0 109.412 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.532 ' HA ' ' CG2' ' A' ' 8' ' ' THR . 4.1 t -62.31 87.22 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -0.849 . . . . 0.0 109.935 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.528 ' HG2' ' N ' ' A' ' 6' ' ' LYS . 5.2 ttmm 168.81 -90.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.528 ' N ' ' HG2' ' A' ' 5' ' ' LYS . 1.0 OUTLIER -74.83 -6.62 50.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.202 -0.936 . . . . 0.0 108.94 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.971 HG12 ' CD2' ' A' ' 11' ' ' LEU . 37.4 t -106.9 -72.59 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.833 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 4' ' ' SER . 66.6 p -47.98 -29.66 3.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.678 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 8' ' ' THR . . . -41.81 -47.71 5.06 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.554 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 4.0 mtmt -141.61 -54.39 0.46 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -1.162 . . . . 0.0 109.586 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.069 HD12 ' CD2' ' A' ' 88' ' ' LEU . 55.2 mt 82.22 -42.55 0.13 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.756 -0.59 . . . . 0.0 109.955 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.491 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -170.98 -83.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.939 -1.1 . . . . 0.0 109.605 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER 73.87 124.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.925 . . . . 0.0 109.358 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 22.5 p 48.45 57.02 6.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.442 -0.786 . . . . 0.0 109.521 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.5 m -157.13 101.58 1.92 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.522 -0.736 . . . . 0.0 109.232 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.04 83.66 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.398 2.065 . . . . 0.0 110.502 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.47 -146.3 4.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.868 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -159.24 145.69 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.051 -1.264 . . . . 0.0 109.674 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.708 ' NE2' ' CZ2' ' A' ' 21' ' ' TRP . 8.5 tt0 -122.76 143.58 49.73 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.641 HG22 ' H ' ' A' ' 21' ' ' TRP . 1.5 mt -114.76 175.28 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.745 -1.222 . . . . 0.0 109.537 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.708 ' CZ2' ' NE2' ' A' ' 19' ' ' GLN . 7.3 m-90 -134.81 117.47 15.97 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.55 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -79.51 128.37 33.28 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 -178.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.652 ' CG2' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -101.56 31.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-O 123.075 1.417 . . . . 0.0 107.325 179.098 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.508 ' O ' ' ND2' ' A' ' 25' ' ' ASN . 1.5 pt-20 -54.96 168.44 0.3 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.647 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' CG ' ' A' ' 27' ' ' GLU . 8.0 p30 42.68 27.68 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.634 ' H ' ' HE3' ' A' ' 26' ' ' MET . 0.0 OUTLIER 50.2 56.8 7.36 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.639 -0.663 . . . . 0.0 109.749 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 28' ' ' MET . 10.0 mm-40 -139.51 -99.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.982 -1.074 . . . . 0.0 110.111 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.59 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 4.1 mmm 163.04 140.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.099 -1.001 . . . . 0.0 109.205 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 1.0 OUTLIER -158.95 146.75 13.47 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.125 -0.984 . . . . 0.0 109.488 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.565 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 35.5 Cg_endo -77.45 87.45 1.51 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.842 2.361 . . . . 0.0 111.658 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.55 HG23 ' H ' ' A' ' 22' ' ' ARG . 42.3 t -69.92 113.08 14.86 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.475 ' HG2' ' HG2' ' A' ' 34' ' ' LYS . 34.9 Cg_endo -76.67 -159.91 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.481 2.121 . . . . 0.0 110.827 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -88.61 -16.46 32.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.322 -0.862 . . . . 0.0 109.261 -179.678 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 32' ' ' PRO . 8.9 ptmt -90.38 17.66 7.02 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 110.052 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.1 m -143.2 5.27 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.936 -1.103 . . . . 0.0 110.566 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.567 ' CD1' ' O ' ' A' ' 33' ' ' THR . 30.1 p90 -90.45 146.59 24.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.784 -1.197 . . . . 0.0 109.646 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.424 ' C ' ' OD1' ' A' ' 38' ' ' ASN . . . 136.33 -27.42 2.99 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.566 ' ND2' HD12 ' A' ' 115' ' ' ILE . 0.7 OUTLIER -139.47 106.4 5.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -1.159 . . . . 0.0 109.491 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -119.83 126.89 52.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.108 -0.995 . . . . 0.0 109.67 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.598 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 6.9 m-30 -48.56 121.81 4.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.432 -0.792 . . . . 0.0 109.563 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.598 ' HA ' ' CH2' ' A' ' 64' ' ' TRP . 1.7 pt-20 -64.17 -7.81 10.3 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.104 -0.998 . . . . 0.0 110.297 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.643 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -111.43 57.23 0.43 Allowed Glycine 0 N--CA 1.485 1.901 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.498 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.503 ' OD1' ' HB2' ' A' ' 40' ' ' TYR . 4.3 m-20 -162.34 -143.96 0.09 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.299 -1.118 . . . . 0.0 109.99 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.59 ' HB3' ' HB2' ' A' ' 77' ' ' ALA . 6.3 m -145.54 139.12 26.53 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.494 ' HB3' ' CG2' ' A' ' 20' ' ' ILE . 21.2 m-85 -137.04 106.94 6.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.054 -1.029 . . . . 0.0 110.04 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.576 HG13 ' OG1' ' A' ' 81' ' ' THR . 87.5 t -78.83 128.54 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.102 -0.999 . . . . 0.0 108.857 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.697 HD11 HG13 ' A' ' 18' ' ' ILE . 3.7 tt -107.33 160.88 15.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.019 -1.05 . . . . 0.0 109.895 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.549 ' CD2' ' HB3' ' A' ' 11' ' ' LEU . 20.3 tp -151.18 92.48 1.8 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.999 -1.063 . . . . 0.0 109.519 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.566 ' CB ' ' HB ' ' A' ' 18' ' ' ILE . 3.0 t -96.3 131.0 43.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 110.126 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.468 ' OG1' ' CD2' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -107.07 152.69 23.67 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -138.01 137.58 38.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.106 -0.996 . . . . 0.0 109.642 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.562 ' O ' HG23 ' A' ' 53' ' ' THR . 0.0 OUTLIER -76.98 163.64 26.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.368 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 52' ' ' LYS . 23.6 p -158.55 -177.77 6.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.538 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.36 19.29 36.58 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.7 t -140.91 -50.39 0.44 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -1.145 . . . . 0.0 109.559 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.37 -102.17 0.19 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 3.4 m-85 -152.43 -172.19 4.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -1.15 . . . . 0.0 109.5 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.6 t -149.03 102.92 3.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.844 . . . . 0.0 108.99 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.593 ' CD2' HD22 ' A' ' 88' ' ' LEU . 52.9 m-85 -85.23 159.34 20.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 0.0 110.181 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.658 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 6.2 m-20 -141.36 100.18 3.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.966 ' CG2' HG23 ' A' ' 81' ' ' THR . 47.5 mt -92.51 114.26 29.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.091 -1.005 . . . . 0.0 110.419 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.651 ' CE1' ' CE2' ' A' ' 109' ' ' TYR . 13.8 m-70 -107.91 170.1 8.2 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.545 -0.722 . . . . 0.0 109.272 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.578 ' CE1' ' HA ' ' A' ' 96' ' ' ARG . 53.4 p90 -141.41 107.1 5.09 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.4 -1.32 . . . . 0.0 109.923 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.598 ' CH2' ' HA ' ' A' ' 41' ' ' GLU . 3.0 t90 -82.28 136.46 35.04 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -124.05 63.47 1.07 Allowed 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.329 -178.193 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 68' ' ' ASN . . . -46.49 93.68 0.01 OUTLIER Glycine 0 N--CA 1.498 2.768 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.586 ' N ' ' O ' ' A' ' 65' ' ' LEU . 7.3 tppt? -39.47 84.56 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.643 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 7.7 m120 -163.0 -43.21 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.528 ' HB2' ' CB ' ' A' ' 73' ' ' GLU . 1.4 p -50.29 -178.84 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.755 -0.591 . . . . 0.0 109.483 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.46 ' OG ' ' OD1' ' A' ' 72' ' ' ASP . 1.0 OUTLIER -95.72 -169.0 1.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.553 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.522 ' O ' ' CG ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -70.72 -39.86 73.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 9.3 p-10 -74.34 -24.57 59.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.004 -1.06 . . . . 0.0 109.298 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.528 ' CB ' ' HB2' ' A' ' 69' ' ' SER . 29.5 mt-10 -69.03 -43.03 75.57 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.699 ' HB2' HD11 ' A' ' 65' ' ' LEU . 4.0 pt20 -66.19 -30.35 70.8 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.63 ' O ' HD13 ' A' ' 79' ' ' ILE . . . -83.7 -12.42 77.68 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -83.8 -41.67 17.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.16 -1.2 . . . . 0.0 108.718 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.59 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . . . -72.66 -50.74 22.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.855 . . . . 0.0 108.774 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.53 86.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 109.039 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.63 HD13 ' O ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -63.52 -42.62 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.303 -0.873 . . . . 0.0 108.647 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 1.092 ' CD2' HD22 ' A' ' 3' ' ' LEU . 5.0 m-85 -62.08 -24.23 66.98 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.966 HG23 ' CG2' ' A' ' 61' ' ' ILE . 1.8 m -82.38 -26.31 32.99 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.1 m -70.54 -46.14 64.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.504 -0.747 . . . . 0.0 109.081 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 1.8 mt-30 -68.94 -42.56 76.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.345 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.67 ' O ' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -55.35 -36.0 65.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 109.404 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.487 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.9 t0 -77.4 -36.86 52.96 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.0 109.507 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -86.44 6.21 31.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.57 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 1.9 m-85 -121.0 -17.09 7.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 109.582 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 1.069 ' CD2' HD12 ' A' ' 11' ' ' LEU . 7.0 mt -87.58 4.93 41.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 109.598 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.749 ' O ' HG13 ' A' ' 91' ' ' VAL . . . 96.73 33.63 6.04 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 p 47.02 24.25 0.36 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 0.0 109.627 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.749 HG13 ' O ' ' A' ' 89' ' ' GLY . 14.8 m -100.98 -15.78 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 0.0 109.282 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.547 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -79.98 167.85 19.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.274 -0.891 . . . . 0.0 109.626 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.764 HG12 ' H ' ' A' ' 94' ' ' GLN . 2.8 t -116.16 -176.92 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.452 -0.78 . . . . 0.0 109.099 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.764 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -129.62 142.09 50.81 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.896 -1.127 . . . . 0.0 109.013 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.658 ' CE1' ' OD1' ' A' ' 60' ' ' ASN . 6.1 m80 -143.32 150.19 38.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.067 -1.02 . . . . 0.0 109.882 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.578 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 3.4 ttp180 -108.13 138.3 44.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 110.201 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.512 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 10.5 mm-40 -145.66 161.75 39.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.36 -0.838 . . . . 0.0 109.188 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.754 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.2 t -156.58 -166.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 108.873 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.754 ' H ' HG12 ' A' ' 98' ' ' VAL . 14.2 pt20 -74.12 1.82 10.3 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.837 -1.164 . . . . 0.0 110.127 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.78 19.49 1.27 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.567 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 2.8 m80 -123.93 -9.88 7.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.571 -0.959 . . . . 0.0 109.398 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.656 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 1.2 pp20? -90.39 15.19 11.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.392 -0.817 . . . . 0.0 109.726 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 102' ' ' GLU . 24.5 p -39.72 -109.53 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -75.52 -25.66 57.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.719 -1.238 . . . . 0.0 111.152 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.736 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 4.6 m -64.16 -48.83 74.46 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.823 -1.173 . . . . 0.0 109.501 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.656 ' HB2' ' HB2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -67.56 -57.29 6.73 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.584 ' N ' HD21 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -45.91 -28.04 1.03 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 105' ' ' THR . . . -60.66 -55.22 35.87 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.651 ' CE2' ' CE1' ' A' ' 62' ' ' HIS . 69.6 m-85 -74.33 -3.65 31.53 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.56 ' CG ' HD11 ' A' ' 114' ' ' LEU . 44.9 m-85 -119.15 91.34 3.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.711 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.57 34.17 0.9 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.642 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.31 -71.78 0.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.114 -0.991 . . . . 0.0 109.696 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -173.0 125.85 1.19 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.584 HD21 ' N ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -90.78 125.09 35.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.381 -1.07 . . . . 0.0 110.121 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.566 HD12 ' ND2' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -129.35 166.99 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.558 ' CD1' ' O ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -149.65 112.4 4.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.084 -1.01 . . . . 0.0 109.56 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -96.15 -159.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.424 -0.797 . . . . 0.0 109.801 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -91.07 167.19 12.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.248 -0.907 . . . . 0.0 109.607 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.494 ' HA2' ' OD1' ' A' ' 43' ' ' ASP . . . -80.5 -163.89 29.83 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 62.19 139.52 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 C--N 1.305 -1.344 0 O-C-N 121.219 -1.165 . . . . 0.0 108.673 179.897 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 2' ' ' GLU . 1.3 t . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.475 ' H ' HG12 ' A' ' 1' ' ' VAL . 1.5 pt-20 -44.41 126.25 5.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.479 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.727 HD13 ' HB3' ' A' ' 80' ' ' TYR . 0.7 OUTLIER -85.06 14.71 4.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.575 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 5.9 p -92.51 152.22 19.77 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.668 -1.27 . . . . 0.0 109.902 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 4' ' ' SER . 0.1 OUTLIER 80.5 -69.69 0.09 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.71 . . . . 0.0 110.742 178.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.522 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 13.8 ttmt -81.98 16.44 1.9 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.05 -1.031 . . . . 0.0 110.663 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.626 ' HB ' ' O ' ' A' ' 3' ' ' LEU . 51.6 t -158.69 -59.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.917 -1.115 . . . . 0.0 109.825 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.667 ' HA ' HD12 ' A' ' 11' ' ' LEU . 77.4 p -60.55 -13.32 13.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 109.813 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.79 -20.45 6.03 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.537 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 1.7 pttm -170.99 -33.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -1.141 . . . . 0.0 109.772 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.787 HD21 ' SD ' ' A' ' 84' ' ' MET . 0.2 OUTLIER 69.56 -0.4 2.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.39 -0.819 . . . . 0.0 110.093 -179.671 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 11' ' ' LEU . 32.3 m-20 58.63 135.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.109 -0.994 . . . . 0.0 110.201 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.732 ' O ' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -56.59 -19.27 15.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.044 -1.035 . . . . 0.0 108.587 179.235 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 13' ' ' LYS . 13.8 t 44.99 18.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.916 -0.49 . . . . 0.0 111.925 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.629 HG23 ' HD2' ' A' ' 16' ' ' PRO . 0.5 OUTLIER 47.62 -177.17 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.015 -1.053 . . . . 0.0 108.599 179.435 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HD2' HG23 ' A' ' 15' ' ' THR . 34.9 Cg_endo -80.32 90.11 1.26 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.908 1.739 . . . . 0.0 110.32 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.528 ' O ' ' CG2' ' A' ' 18' ' ' ILE . . . -164.3 -120.89 0.54 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.908 HD12 HD11 ' A' ' 47' ' ' LEU . 19.9 pt -160.5 -165.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -1.188 . . . . 0.0 110.232 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.492 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 2.5 mt-30 -170.78 172.95 5.48 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.728 HD11 ' CZ ' ' A' ' 110' ' ' PHE . 18.5 mt -145.88 168.15 7.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.401 -1.437 . . . . 0.0 110.352 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.636 ' HA ' HG23 ' A' ' 31' ' ' VAL . 7.4 m-90 -133.97 118.83 18.31 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.773 ' HG3' HG22 ' A' ' 31' ' ' VAL . 14.4 mtm180 -79.15 121.2 24.72 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.219 -0.926 . . . . 0.0 110.921 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.636 ' CG2' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -101.98 27.48 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.123 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.537 ' HB2' ' CG2' ' A' ' 121' ' ' VAL . 1.3 pt-20 -58.62 179.13 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.375 -0.828 . . . . 0.0 109.421 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' CG ' ' A' ' 27' ' ' GLU . 8.4 p30 42.14 27.47 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.463 ' N ' ' O ' ' A' ' 24' ' ' GLU . 26.9 mmm 54.71 55.27 8.08 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.489 -0.757 . . . . 0.0 109.765 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 70.1 mm-40 -153.47 -134.36 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.117 -0.99 . . . . 0.0 109.356 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.57 ' HE2' ' CD1' ' A' ' 21' ' ' TRP . 3.1 ttt -160.04 149.74 18.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.898 -1.126 . . . . 0.0 109.316 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.561 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -160.16 149.36 14.07 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.099 -1.0 . . . . 0.0 109.587 -179.559 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HD2' HG13 ' A' ' 29' ' ' VAL . 34.6 Cg_endo -76.43 125.88 8.67 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.534 2.156 . . . . 0.0 111.109 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.773 HG22 ' HG3' ' A' ' 22' ' ' ARG . 5.8 t -111.24 105.61 57.02 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.63 -158.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.44 2.093 . . . . 0.0 110.4 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.561 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -81.86 -18.91 42.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 108.952 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.16 32.33 0.76 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.345 -0.847 . . . . 0.0 109.706 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.525 ' HB3' HG13 ' A' ' 31' ' ' VAL . 1.7 m -155.07 -38.8 0.09 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.95 . . . . 0.0 109.624 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.563 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -45.55 129.47 8.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.469 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.34 -77.09 0.39 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.507 ' HA ' HG22 ' A' ' 115' ' ' ILE . 4.4 m-80 -89.1 106.79 18.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -1.165 . . . . 0.0 109.673 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.701 ' HZ ' HD22 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -135.92 137.08 41.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.233 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.68 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 7.2 m-30 -42.33 151.95 0.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.285 -0.885 . . . . 0.0 109.508 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.557 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 12.1 pt-20 -90.93 -37.98 13.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.171 -0.956 . . . . 0.0 109.784 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.626 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -85.69 66.46 3.75 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.193 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -162.91 -150.28 0.16 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.025 -1.28 . . . . 0.0 110.31 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.497 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 34.6 m -139.0 148.1 43.01 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 28.2 m-85 -145.36 109.23 4.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.015 -1.053 . . . . 0.0 109.717 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.605 HG13 ' OG1' ' A' ' 81' ' ' THR . 98.8 t -79.37 122.6 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.999 -1.063 . . . . 0.0 108.549 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.908 HD11 HD12 ' A' ' 18' ' ' ILE . 6.6 tt -108.1 123.5 48.8 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.256 -0.903 . . . . 0.0 110.168 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.579 ' CD2' HD23 ' A' ' 11' ' ' LEU . 24.0 tp -104.55 100.24 9.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.846 -1.159 . . . . 0.0 109.864 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.491 ' OG ' HG22 ' A' ' 18' ' ' ILE . 10.8 t -83.41 127.21 33.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 108.757 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.655 ' CG2' ' CE1' ' A' ' 57' ' ' PHE . 1.2 m -123.02 114.32 20.24 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -116.6 126.59 53.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.269 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.89 ' O ' HG23 ' A' ' 53' ' ' THR . 11.4 pttm -51.52 -176.86 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.329 -0.857 . . . . 0.0 109.325 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -178.72 153.47 0.68 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.444 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 53' ' ' THR . . . -44.2 -26.83 0.99 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.17 -40.49 14.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -1.092 . . . . 0.0 109.41 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.72 -70.29 0.2 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.655 ' CE1' ' CG2' ' A' ' 50' ' ' THR . 0.1 OUTLIER -139.81 175.63 9.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -1.138 . . . . 0.0 111.196 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.66 89.34 1.68 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.589 ' CE1' ' HB3' ' A' ' 57' ' ' PHE . 6.5 m-85 -78.74 157.2 28.57 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.135 0.969 . . . . 0.0 111.32 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.806 ' CB ' ' HE1' ' A' ' 95' ' ' HIS . 7.7 m-80 -151.54 87.6 1.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 1.034 ' CG2' HG23 ' A' ' 81' ' ' THR . 10.3 mt -71.2 140.71 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.295 -0.878 . . . . 0.0 110.4 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.735 ' CD2' ' HB2' ' A' ' 95' ' ' HIS . 66.3 m80 -125.99 160.18 30.72 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 95' ' ' HIS . 50.6 p90 -134.85 96.18 3.48 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 117.979 -1.489 . . . . 0.0 109.887 177.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.599 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 6.0 t90 -74.18 131.74 41.54 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.613 HD11 ' CG ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -121.55 60.96 0.94 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.287 -0.883 . . . . 0.0 111.039 -178.078 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -49.07 90.46 0.01 OUTLIER Glycine 0 N--CA 1.498 2.786 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.59 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -38.43 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.13 0.967 . . . . 0.0 112.61 -177.432 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.626 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 1.5 m120 -162.61 -45.73 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.486 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 96.3 p -59.34 -156.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.517 -0.739 . . . . 0.0 109.276 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 p -109.34 160.7 15.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -45.44 19.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 109.381 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -57.92 -41.74 83.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.141 -0.974 . . . . 0.0 109.361 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.486 ' HG2' ' HB2' ' A' ' 69' ' ' SER . 3.9 tp10 -54.54 -39.77 68.01 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.613 ' CG ' HD11 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -60.43 -37.69 81.71 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.761 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.605 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -70.67 -23.57 77.65 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 77' ' ' ALA . . . -75.71 -67.21 0.69 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.313 -1.11 . . . . 0.0 109.192 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -45.35 -38.09 5.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 0.0 109.301 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.64 -39.91 73.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.665 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.605 HD12 ' O ' ' A' ' 75' ' ' GLY . 17.9 mt -60.83 -48.69 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 0.0 109.5 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.727 ' HB3' HD13 ' A' ' 3' ' ' LEU . 25.5 m-85 -56.92 -42.46 80.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.042 -1.036 . . . . 0.0 108.968 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 1.034 HG23 ' CG2' ' A' ' 61' ' ' ILE . 6.4 m -68.72 -23.65 64.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.485 -0.76 . . . . 0.0 109.141 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.3 m -78.57 -23.59 45.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.452 -0.78 . . . . 0.0 109.46 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 1.2 mt-30 -89.91 -34.5 16.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.671 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.803 ' HB2' HD13 ' A' ' 61' ' ' ILE . 2.4 mtt -63.14 -47.05 84.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.696 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.671 ' N ' HD11 ' A' ' 61' ' ' ILE . 3.1 t70 -50.73 -54.98 18.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.721 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.69 -12.21 59.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.717 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 4.1 m-30 -97.23 -2.92 41.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.609 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.689 HD21 HD22 ' A' ' 11' ' ' LEU . 3.9 mt -108.43 8.23 27.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.55 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 105.59 3.1 40.52 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 1.3 p 75.38 -0.09 3.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -1.174 . . . . 0.0 109.644 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.536 HG23 ' CD2' ' A' ' 59' ' ' TYR . 4.7 m -87.23 15.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.114 -0.991 . . . . 0.0 109.389 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.584 ' HB3' ' HA ' ' A' ' 85' ' ' ASP . . . -100.03 179.33 4.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.586 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.655 HG12 ' H ' ' A' ' 94' ' ' GLN . 4.6 t -135.24 175.86 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.12 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.655 ' H ' HG12 ' A' ' 93' ' ' VAL . 50.4 tt0 -124.91 131.04 53.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.972 -1.08 . . . . 0.0 109.504 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.806 ' HE1' ' CB ' ' A' ' 60' ' ' ASN . 8.8 m80 -130.21 150.02 51.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.8 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.578 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 8.6 ptm180 -109.79 136.02 49.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.369 -0.832 . . . . 0.0 109.801 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.497 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 7.4 mm-40 -139.77 166.21 25.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.263 -0.898 . . . . 0.0 109.595 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.71 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.7 t -155.58 -176.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.354 -0.841 . . . . 0.0 109.2 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.71 ' H ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -67.63 -4.52 12.18 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.966 -1.084 . . . . 0.0 110.335 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.08 14.38 3.06 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.538 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 24.2 m80 -123.01 -20.96 5.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.57 -0.959 . . . . 0.0 109.725 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.599 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.1 OUTLIER -90.28 8.85 31.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.341 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 107' ' ' ARG . 1.0 OUTLIER -56.79 -63.03 1.34 Allowed 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.162 -0.961 . . . . 0.0 111.225 -178.644 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.662 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 3.6 mt-10 -76.5 -55.6 5.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.967 -1.083 . . . . 0.0 111.748 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -61.26 -52.64 63.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.97 -1.082 . . . . 0.0 111.113 -178.238 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.568 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -64.98 -55.0 21.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.968 -1.082 . . . . 0.0 108.914 -178.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' A' ' 103' ' ' SER . 2.3 ttm180 -61.51 -17.26 53.9 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.179 -0.951 . . . . 0.0 108.661 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.662 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -66.14 -59.81 3.41 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.906 ' HB3' HD13 ' A' ' 18' ' ' ILE . 9.2 m-85 -63.43 -16.19 59.83 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 1.064 ' CG ' HD21 ' A' ' 114' ' ' LEU . 43.7 m-85 -108.22 99.51 8.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.474 -0.766 . . . . 0.0 109.536 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -74.77 1.59 12.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.286 -0.883 . . . . 0.0 109.702 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.78 -81.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.066 -1.021 . . . . 0.0 109.822 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' A' ' 114' ' ' LEU . . . 178.04 -29.99 0.07 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 1.064 HD21 ' CG ' ' A' ' 110' ' ' PHE . 33.3 mt 81.75 109.33 0.07 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.589 -0.948 . . . . 0.0 110.284 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.563 HG23 ' N ' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -91.03 172.15 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.654 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.563 ' N ' HG23 ' A' ' 115' ' ' ILE . 1.4 m-85 -150.04 124.88 9.85 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.024 -1.047 . . . . 0.0 109.981 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.68 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -106.4 -164.89 1.04 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.471 -0.768 . . . . 0.0 109.31 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.579 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 1.6 tp60 -91.56 163.03 14.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.879 -1.138 . . . . 0.0 110.165 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 120' ' ' GLY . . . -76.56 -153.68 5.16 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 52.69 101.46 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.537 ' CG2' ' HB2' ' A' ' 24' ' ' GLU . 1.5 t . . . . . 0 C--N 1.304 -1.384 0 O-C-N 121.17 -1.194 . . . . 0.0 109.253 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 2' ' ' GLU . 29.1 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 2' ' ' GLU . 18.0 pt-20 32.98 93.99 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.428 0.632 . . . . 0.0 110.462 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.639 HD23 ' N ' ' A' ' 3' ' ' LEU . 2.6 pt? -53.8 -33.25 55.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 109.505 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.624 ' HA ' HG23 ' A' ' 8' ' ' THR . 10.7 t -44.53 146.08 0.77 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 4' ' ' SER . 10.9 tttt 80.24 -71.84 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.63 -0.669 . . . . 0.0 109.96 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -84.73 15.76 3.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 109.985 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.526 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 12.0 t -150.56 -65.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.016 -1.052 . . . . 0.0 109.716 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.655 ' HA ' HD21 ' A' ' 11' ' ' LEU . 70.3 p -50.01 -23.19 1.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.4 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 10' ' ' LYS . . . -89.58 33.11 4.49 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.487 ' O ' ' CG ' ' A' ' 10' ' ' LYS . 2.4 tttm 169.28 70.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -1.069 . . . . 0.0 109.17 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.655 HD21 ' HA ' ' A' ' 8' ' ' THR . 4.3 mm? -94.47 74.0 3.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.375 -0.828 . . . . 0.0 109.414 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 13' ' ' LYS . 6.2 t70 62.16 -91.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 109.376 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER 62.37 124.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.954 . . . . 0.0 109.631 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.596 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 22.4 p 48.36 56.99 6.67 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.349 -0.844 . . . . 0.0 109.604 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.436 ' HB ' ' CG ' ' A' ' 12' ' ' ASP . 21.1 m -167.48 102.34 0.6 Allowed Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.417 -0.802 . . . . 0.0 109.414 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.95 99.8 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.423 2.082 . . . . 0.0 110.277 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.455 ' O ' ' CG2' ' A' ' 18' ' ' ILE . . . 179.54 -139.14 3.73 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.018 HD12 HD11 ' A' ' 47' ' ' LEU . 12.3 pt -157.41 142.46 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.049 -1.265 . . . . 0.0 110.1 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -122.24 114.44 20.83 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.588 HD11 ' CE1' ' A' ' 110' ' ' PHE . 2.9 mt -92.49 164.04 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.757 -1.214 . . . . 0.0 109.67 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.681 ' CB ' ' HE3' ' A' ' 28' ' ' MET . 8.3 m-90 -122.01 126.42 48.48 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.596 ' HA ' ' CD1' ' A' ' 45' ' ' TYR . 0.9 OUTLIER -79.23 132.66 36.57 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.177 0.989 . . . . 0.0 111.74 -176.695 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' A' ' 44' ' ' CYS . 2.2 mm -127.27 44.26 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.547 ' HB2' ' CD2' ' A' ' 40' ' ' TYR . 3.2 pm0 -99.81 -40.12 7.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 0.0 110.049 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.521 ' OD1' ' CG ' ' A' ' 27' ' ' GLU . 3.0 p30 -81.97 10.08 7.15 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.132 -0.98 . . . . 0.0 108.677 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.517 ' CE ' ' OG ' ' A' ' 70' ' ' SER . 53.9 mmm 73.08 29.0 1.83 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.521 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 47.6 mt-10 -150.79 103.02 3.04 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.681 ' HE3' ' CB ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -42.29 138.02 1.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 110.173 -179.219 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -139.71 149.37 59.26 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HD2' HG13 ' A' ' 29' ' ' VAL . 35.7 Cg_endo -78.68 82.61 2.44 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.225 1.95 . . . . 0.0 111.737 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.572 ' CG2' ' N ' ' A' ' 22' ' ' ARG . 2.8 t -69.9 112.93 14.01 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.18 -0.95 . . . . 0.0 109.887 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.488 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 36.2 Cg_endo -78.7 -158.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.486 2.124 . . . . 0.0 110.044 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.572 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -90.0 -16.29 30.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.083 -1.01 . . . . 0.0 109.152 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.488 ' HG3' ' HG2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -75.39 -20.31 59.02 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -0.873 . . . . 0.0 109.874 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.0 m -122.96 13.12 9.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.12 -0.988 . . . . 0.0 109.734 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.58 ' CG ' ' O ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -85.05 49.88 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.985 . . . . 0.0 109.914 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.568 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . -137.65 -82.71 0.11 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.542 ' HA ' HG22 ' A' ' 115' ' ' ILE . 4.2 m-80 -81.46 123.96 29.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -1.135 . . . . 0.0 109.58 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.695 ' CZ ' HD22 ' A' ' 114' ' ' LEU . 2.7 p90 -160.24 141.08 12.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.013 . . . . 0.0 110.087 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.691 ' CE2' HG23 ' A' ' 121' ' ' VAL . 5.4 m-30 -39.6 142.9 0.26 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.355 -0.841 . . . . 0.0 110.767 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 15.7 pt-20 -90.66 -38.86 12.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 109.363 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.589 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -83.43 70.97 3.08 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.484 ' OD1' ' HB3' ' A' ' 40' ' ' TYR . 4.9 m-20 -160.66 -132.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.719 -0.871 . . . . 0.0 109.122 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.58 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 57.9 m -156.66 148.77 23.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.988 -1.07 . . . . 0.0 108.599 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.649 ' CZ ' ' HB2' ' A' ' 39' ' ' PHE . 17.2 m-85 -147.57 111.06 4.94 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.353 -0.842 . . . . 0.0 109.575 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.789 HG13 ' OG1' ' A' ' 81' ' ' THR . 4.0 t -79.59 112.21 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.994 -1.066 . . . . 0.0 108.152 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.018 HD11 HD12 ' A' ' 18' ' ' ILE . 7.3 tt -102.97 114.59 29.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.83 -1.168 . . . . 0.0 110.331 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.642 HD11 ' HB3' ' A' ' 59' ' ' TYR . 16.5 tp -99.99 109.89 22.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.237 -0.914 . . . . 0.0 109.195 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 t -97.12 134.28 40.67 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.39 -0.819 . . . . 0.0 109.641 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.53 ' OG1' ' CD1' ' A' ' 59' ' ' TYR . 1.2 m -120.52 135.95 54.92 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.14 155.42 37.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.627 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.511 ' O ' ' CG2' ' A' ' 53' ' ' THR . 0.0 OUTLIER -91.42 155.63 18.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 109.458 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 52' ' ' LYS . 68.9 p -158.83 175.61 13.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 0.0 109.449 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.38 -22.01 71.48 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.13 -52.99 5.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -1.173 . . . . 0.0 109.477 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.06 -97.28 0.11 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.596 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 18.2 m-85 -145.35 156.23 43.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -1.143 . . . . 0.0 109.526 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.0 m -121.89 99.53 6.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.871 . . . . 0.0 108.914 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 1.014 ' CD2' HD22 ' A' ' 88' ' ' LEU . 17.3 m-30 -81.77 158.23 24.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 110.209 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.753 ' CB ' ' HE1' ' A' ' 95' ' ' HIS . 8.0 m-20 -150.43 90.38 1.65 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.996 ' CG2' HG23 ' A' ' 81' ' ' THR . 11.7 mt -77.51 135.52 26.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.231 -0.918 . . . . 0.0 110.291 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.531 ' ND1' ' HB2' ' A' ' 95' ' ' HIS . 55.9 m-70 -122.48 159.56 27.39 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.622 ' CZ ' ' HA ' ' A' ' 96' ' ' ARG . 49.4 p90 -135.52 93.26 2.94 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.92 -1.512 . . . . 0.0 110.099 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.74 ' C ' HD23 ' A' ' 65' ' ' LEU . 5.7 t90 -73.91 119.17 17.75 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.789 HD13 ' HB2' ' A' ' 74' ' ' GLN . 0.2 OUTLIER -110.33 77.41 1.05 Allowed 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.568 -0.707 . . . . 0.0 111.158 -177.284 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' A' ' 99' ' ' GLN . . . -65.7 86.88 0.1 OUTLIER Glycine 0 N--CA 1.494 2.559 0 N-CA-C 107.751 -2.14 . . . . 0.0 107.751 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.478 ' O ' ' OD1' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -52.68 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.798 0.808 . . . . 0.0 112.617 -177.536 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.589 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 10.1 m120 -160.29 -39.1 0.05 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 70' ' ' SER . 11.7 p -71.72 -145.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 109.297 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.517 ' OG ' ' CE ' ' A' ' 26' ' ' MET . 16.8 p -88.62 142.41 27.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 0.0 109.956 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.505 ' CG ' ' OE1' ' A' ' 74' ' ' GLN . 5.5 tt0 -50.78 -46.92 59.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.299 -0.875 . . . . 0.0 109.018 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.93 -38.5 67.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.217 -0.927 . . . . 0.0 109.026 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.537 ' HG3' HG22 ' A' ' 23' ' ' ILE . 1.4 tp10 -56.84 -38.58 72.85 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.789 ' HB2' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -62.45 -35.89 80.7 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.651 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -80.19 -13.64 81.63 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -79.86 -44.25 20.83 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.299 -1.118 . . . . 0.0 108.706 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.12 -44.52 75.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 108.979 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.2 -48.94 71.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.424 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.651 HD12 ' O ' ' A' ' 75' ' ' GLY . 64.6 mt -55.5 -43.97 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.96 . . . . 0.0 109.474 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.568 ' CD2' ' SD ' ' A' ' 28' ' ' MET . 4.5 m-85 -63.35 -32.09 73.42 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.102 -0.999 . . . . 0.0 108.731 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.996 HG23 ' CG2' ' A' ' 61' ' ' ILE . 8.7 m -66.92 -24.8 66.13 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.5 m -84.48 -29.96 25.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.531 -0.73 . . . . 0.0 109.166 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.509 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 1.9 mt-30 -71.45 -38.03 71.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 109.514 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.586 ' HG3' HD13 ' A' ' 61' ' ' ILE . 4.2 ptm -82.38 -33.11 28.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.46 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.53 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 9.2 t0 -59.7 -28.89 67.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 0.0 109.299 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -90.08 -36.83 14.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.872 . . . . 0.0 109.454 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.509 ' CD1' ' O ' ' A' ' 83' ' ' GLN . 5.6 m-85 -71.33 -8.45 53.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 109.565 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 1.014 HD22 ' CD2' ' A' ' 59' ' ' TYR . 20.3 mt -84.98 -14.17 48.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.539 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 90' ' ' SER . . . 100.67 18.22 21.36 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 89' ' ' GLY . 0.3 OUTLIER 73.29 6.77 5.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -1.108 . . . . 0.0 109.606 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.4 m -85.07 -14.95 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.122 -0.986 . . . . 0.0 109.464 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.899 ' HB2' HD13 ' A' ' 88' ' ' LEU . . . -90.14 172.87 8.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 109.546 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.649 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.5 t -128.38 176.14 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 109.312 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.649 ' H ' HG12 ' A' ' 93' ' ' VAL . 33.2 tt0 -122.82 133.48 54.44 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.096 -1.002 . . . . 0.0 109.006 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.753 ' HE1' ' CB ' ' A' ' 60' ' ' ASN . 13.2 m80 -126.83 141.74 51.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.125 -0.984 . . . . 0.0 110.145 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -89.34 120.02 30.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 109.792 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.603 ' HB2' ' HA ' ' A' ' 64' ' ' TRP . 26.9 mt-10 -127.74 156.72 41.98 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.276 -0.89 . . . . 0.0 108.845 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.697 HG12 ' H ' ' A' ' 99' ' ' GLN . 3.0 t -160.11 -179.27 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.301 -0.875 . . . . 0.0 108.874 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.697 ' H ' HG12 ' A' ' 98' ' ' VAL . 28.8 tt0 -73.69 -3.27 27.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.938 -1.101 . . . . 0.0 109.198 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.56 6.21 3.85 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.629 ' CG ' ' CG2' ' A' ' 98' ' ' VAL . 10.9 m170 -109.45 -89.97 0.47 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.397 -1.061 . . . . 0.0 108.766 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -83.5 44.44 0.97 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.446 -0.784 . . . . 0.0 110.269 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -80.62 -61.5 1.95 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 108.698 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.516 ' N ' ' OG ' ' A' ' 103' ' ' SER . 28.2 tt0 -64.46 -47.27 79.67 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.754 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 40.8 m -49.57 -46.51 48.98 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.602 ' HB2' ' O ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -49.73 -65.14 0.61 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.611 ' CA ' HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -42.51 -35.01 0.94 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 105' ' ' THR . . . -52.13 -56.51 14.02 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.867 ' HB3' HD13 ' A' ' 18' ' ' ILE . 97.1 m-85 -56.41 -28.34 59.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.902 . . . . 0.0 108.576 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.635 ' CD2' HD11 ' A' ' 114' ' ' LEU . 87.6 m-85 -88.02 90.38 8.36 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -74.06 -0.14 15.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.438 -0.789 . . . . 0.0 109.923 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -96.85 -85.46 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.109 -0.994 . . . . 0.0 109.594 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -164.22 123.07 1.14 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.695 HD22 ' CZ ' ' A' ' 39' ' ' PHE . 4.4 mt -92.15 145.28 24.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -1.159 . . . . 0.0 110.067 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.542 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -140.29 169.79 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.709 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.571 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 1.0 OUTLIER -147.45 139.34 24.19 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.926 -1.109 . . . . 0.0 110.137 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.425 ' HB2' ' HD1' ' A' ' 40' ' ' TYR . 2.0 mptp? -114.71 -168.25 1.35 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.512 -0.742 . . . . 0.0 109.235 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.583 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 1.1 pm0 -90.92 163.41 14.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.015 -1.053 . . . . 0.0 110.561 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.629 ' HA2' ' CD2' ' A' ' 40' ' ' TYR . . . -93.28 178.67 38.75 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.22 52.8 1.55 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.691 HG23 ' CE2' ' A' ' 40' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.132 -1.216 . . . . 0.0 109.103 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.548 HG22 ' H ' ' A' ' 2' ' ' GLU . 9.7 p . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 80' ' ' TYR . 14.6 pt-20 -43.28 123.21 2.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.349 -0.844 . . . . 0.0 109.639 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.763 HD12 ' HB ' ' A' ' 8' ' ' THR . 1.7 pt? -43.78 133.78 4.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.102 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.604 ' O ' HG22 ' A' ' 8' ' ' THR . 74.4 m -89.23 -176.26 5.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 110.146 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.548 ' CB ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -72.2 -31.26 65.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.372 -0.83 . . . . 0.0 109.147 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -76.93 -28.68 55.33 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 3' ' ' LEU . 1.8 t -70.8 -62.29 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.763 ' HB ' HD12 ' A' ' 3' ' ' LEU . 0.7 OUTLIER -90.32 12.56 17.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.275 -0.891 . . . . 0.0 109.494 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 5' ' ' LYS . . . -70.56 -105.29 0.04 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 11' ' ' LEU . 10.6 mttm -65.23 -29.28 70.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -1.098 . . . . 0.0 109.431 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.893 ' HB3' HD23 ' A' ' 48' ' ' LEU . 4.0 mt 44.34 57.13 4.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.403 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER 68.15 137.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.297 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.448 ' O ' ' OG1' ' A' ' 14' ' ' THR . 26.1 mmtt -142.04 149.7 40.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.659 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 80.5 p 50.09 58.04 5.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.476 -0.765 . . . . 0.0 109.768 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.7 m -171.64 120.82 0.47 Allowed Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.468 -0.77 . . . . 0.0 109.092 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.0 128.18 9.79 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.31 2.007 . . . . 0.0 110.348 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 147.19 169.5 14.71 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.775 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -123.8 155.47 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.011 -1.287 . . . . 0.0 110.159 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.532 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 74.7 mt-30 -115.17 158.3 22.43 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.797 HD11 ' CZ ' ' A' ' 110' ' ' PHE . 4.0 mt -129.02 153.52 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.763 -1.21 . . . . 0.0 110.369 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.869 ' HA ' HG23 ' A' ' 31' ' ' VAL . 9.2 m-90 -115.42 132.54 56.59 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.727 ' CD ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -90.22 128.03 36.28 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.832 -1.167 . . . . 0.0 111.84 -177.351 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.646 HD13 ' HA ' ' A' ' 28' ' ' MET . 5.0 mm -99.69 56.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 177.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.512 ' O ' ' HA3' ' A' ' 120' ' ' GLY . 0.0 OUTLIER -48.44 -106.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.347 -177.804 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.561 ' O ' ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -45.43 -77.69 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.917 -1.114 . . . . 0.0 108.3 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.587 ' CE ' ' CB ' ' A' ' 69' ' ' SER . 13.2 mmt -163.29 36.85 0.09 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 74.8 mt-10 -141.4 145.42 35.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.343 -0.848 . . . . 0.0 109.367 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.945 ' HE3' HG21 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -73.46 139.01 45.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.253 -0.904 . . . . 0.0 110.238 -179.574 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.928 HG13 ' HD2' ' A' ' 30' ' ' PRO . 1.9 t -138.43 154.96 74.0 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.928 ' HD2' HG13 ' A' ' 29' ' ' VAL . 35.1 Cg_endo -77.37 125.52 7.79 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.316 2.011 . . . . 0.0 111.668 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.869 HG23 ' HA ' ' A' ' 21' ' ' TRP . 1.4 t -118.33 97.8 50.97 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.6 -154.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.676 2.25 . . . . 0.0 110.113 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.596 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -77.51 2.88 14.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.104 -0.997 . . . . 0.0 109.322 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -66.0 -35.44 80.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.142 -0.973 . . . . 0.0 110.307 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.13 68.39 0.38 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.945 -1.097 . . . . 0.0 110.38 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.596 ' CD2' ' HA ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -90.47 39.57 0.98 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.046 -1.034 . . . . 0.0 109.86 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.486 ' HA2' ' CE2' ' A' ' 39' ' ' PHE . . . -144.6 -50.48 0.03 OUTLIER Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.206 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.555 ' HA ' HG22 ' A' ' 115' ' ' ILE . 1.7 m-80 -79.73 93.92 5.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.093 -1.239 . . . . 0.0 109.57 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.72 ' HZ ' HD13 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -129.76 128.83 43.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.508 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.652 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 64.5 m-85 -39.14 124.78 1.52 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.56 -0.713 . . . . 0.0 110.613 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.619 ' HA ' ' CH2' ' A' ' 64' ' ' TRP . 2.7 pt-20 -80.63 -0.14 36.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.281 -0.887 . . . . 0.0 109.303 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.579 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -124.61 54.97 0.72 Allowed Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.477 ' HA ' ' OE1' ' A' ' 73' ' ' GLU . 7.9 m-20 -160.15 -123.99 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.296 -1.12 . . . . 0.0 109.186 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.614 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 92.0 m -153.28 155.42 36.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.88 -1.137 . . . . 0.0 109.568 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.659 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 31.0 m-85 -155.03 116.62 4.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.359 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.945 HG21 ' HE3' ' A' ' 28' ' ' MET . 47.9 t -78.08 160.44 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.695 -1.253 . . . . 0.0 108.141 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.807 ' O ' HD23 ' A' ' 47' ' ' LEU . 7.2 tt -153.76 106.48 2.88 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.496 -1.378 . . . . 0.0 110.12 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.893 HD23 ' HB3' ' A' ' 11' ' ' LEU . 13.1 tp -95.99 109.15 21.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.597 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.766 ' OG ' HG22 ' A' ' 18' ' ' ILE . 12.9 t -98.89 133.5 43.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.334 -0.854 . . . . 0.0 109.644 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.2 m -122.17 142.31 50.54 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.502 ' HG2' ' N ' ' A' ' 52' ' ' LYS . 7.6 ttt180 -142.82 147.78 36.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 109.494 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.56 ' O ' HG23 ' A' ' 53' ' ' THR . 0.0 OUTLIER -80.99 163.41 23.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.979 . . . . 0.0 109.608 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 52' ' ' LYS . 1.5 p -157.97 -168.58 2.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.293 -0.879 . . . . 0.0 109.489 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.22 -41.0 32.53 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 56' ' ' GLY . 1.1 p -79.84 -59.15 2.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -1.184 . . . . 0.0 109.469 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.513 ' N ' ' OG ' ' A' ' 55' ' ' SER . . . -157.09 -129.2 1.11 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.566 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 5.0 m-30 -103.31 -169.72 1.69 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -1.159 . . . . 0.0 109.243 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.486 ' HA ' ' CG2' ' A' ' 91' ' ' VAL . 69.5 m -149.94 107.38 3.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.192 -0.943 . . . . 0.0 109.295 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.707 ' HB3' HD11 ' A' ' 48' ' ' LEU . 48.1 m-85 -89.16 158.09 18.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.207 -0.933 . . . . 0.0 109.805 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.657 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 6.8 m-20 -154.85 92.73 1.49 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.968 ' CG2' HG23 ' A' ' 81' ' ' THR . 9.9 mt -80.83 132.26 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.164 -0.96 . . . . 0.0 110.642 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.757 ' CD2' ' HB2' ' A' ' 95' ' ' HIS . 58.1 m80 -119.57 162.35 19.08 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.832 ' CE2' HD11 ' A' ' 65' ' ' LEU . 49.5 p90 -136.7 94.08 2.94 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.339 -1.345 . . . . 0.0 109.674 176.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 1.083 ' O ' HD23 ' A' ' 65' ' ' LEU . 3.4 t90 -70.2 140.52 52.52 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.083 HD23 ' O ' ' A' ' 64' ' ' TRP . 8.1 mt -138.77 77.32 1.62 Allowed 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 118.532 -1.267 . . . . 0.0 111.144 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 41' ' ' GLU . . . -54.81 90.04 0.01 OUTLIER Glycine 0 C--N 1.275 -2.85 0 N-CA-C 106.9 -2.48 . . . . 0.0 106.9 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.732 ' HE3' HG11 ' A' ' 98' ' ' VAL . 9.5 ptpt -51.45 98.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.379 1.085 . . . . 0.0 112.185 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.579 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 13.7 m120 -160.15 -41.22 0.05 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.587 ' CB ' ' CE ' ' A' ' 26' ' ' MET . 81.9 p -67.22 -144.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.522 -0.736 . . . . 0.0 109.036 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.445 ' OG ' ' OD2' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -115.74 163.0 16.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.024 -1.048 . . . . 0.0 109.777 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -49.83 -32.07 13.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.25 -0.906 . . . . 0.0 109.156 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 3.0 p30 -60.35 -45.53 93.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.144 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 15.2 tt0 -56.91 -37.11 70.98 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 1.008 ' HG2' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -62.24 -35.85 80.21 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.795 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.641 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -81.65 -12.98 80.87 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.58 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -77.5 -52.6 8.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.294 -1.121 . . . . 0.0 108.955 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.568 ' CB ' ' HB3' ' A' ' 44' ' ' CYS . . . -75.88 -38.82 57.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.913 . . . . 0.0 109.1 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.83 94.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.301 -0.874 . . . . 0.0 109.229 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.641 HD12 ' O ' ' A' ' 75' ' ' GLY . 65.4 mt -71.6 -43.67 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.248 -0.908 . . . . 0.0 109.266 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.638 ' CD2' ' CB ' ' A' ' 28' ' ' MET . 3.4 m-85 -57.97 -35.47 71.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.122 -0.986 . . . . 0.0 108.867 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.968 HG23 ' CG2' ' A' ' 61' ' ' ILE . 18.1 m -67.51 -38.77 84.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.403 -0.811 . . . . 0.0 108.856 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.9 m -59.83 -42.86 94.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.844 . . . . 0.0 109.06 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.476 ' OE1' HD21 ' A' ' 3' ' ' LEU . 12.1 mt-30 -67.16 -28.47 68.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.264 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.536 ' HG2' HD12 ' A' ' 88' ' ' LEU . 17.8 ttm -63.08 -45.39 92.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.201 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.54 -15.28 25.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 108.994 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.18 -63.66 1.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.327 -0.858 . . . . 0.0 109.066 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.548 ' CE1' ' CB ' ' A' ' 5' ' ' LYS . 4.7 m-85 -53.93 -20.35 5.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 108.969 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.851 HD21 ' CD1' ' A' ' 11' ' ' LEU . 51.7 mt -90.15 -62.64 1.42 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -0.842 . . . . 0.0 109.196 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 57.22 62.3 6.51 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.3 p -143.64 -143.14 0.14 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.259 -1.142 . . . . 0.0 109.297 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.486 ' CG2' ' HA ' ' A' ' 58' ' ' SER . 11.6 m -92.18 15.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -52.23 173.01 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.693 -0.63 . . . . 0.0 109.826 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.9 t -147.63 177.09 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.524 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.672 ' H ' HG12 ' A' ' 93' ' ' VAL . 68.4 mt-30 -124.43 136.16 53.83 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.111 -0.993 . . . . 0.0 108.877 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.757 ' HB2' ' CD2' ' A' ' 62' ' ' HIS . 9.6 m80 -131.96 150.75 52.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.978 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.573 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 8.6 ttm180 -108.78 124.66 50.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.311 -0.868 . . . . 0.0 109.8 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.492 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 66.6 mm-40 -131.97 163.66 27.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.139 -0.975 . . . . 0.0 109.709 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.732 HG11 ' HE3' ' A' ' 67' ' ' LYS . 2.9 t -156.14 -176.95 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 108.977 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.707 ' H ' HG12 ' A' ' 98' ' ' VAL . 12.3 pt20 -66.23 -5.8 11.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.929 -1.107 . . . . 0.0 110.266 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.88 15.46 3.54 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.56 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 20.5 m-70 -122.57 -19.32 6.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.575 -0.956 . . . . 0.0 109.638 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.629 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.27 24.05 2.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.89 . . . . 0.0 109.508 -179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 102' ' ' GLU . 6.1 p -45.01 -106.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.494 -0.754 . . . . 0.0 111.863 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.812 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 40.6 mt-10 -71.39 -19.05 62.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.843 -1.16 . . . . 0.0 110.948 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.496 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 3.6 m -69.6 -50.9 40.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.897 -1.127 . . . . 0.0 109.605 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.558 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.3 OUTLIER -67.85 -57.26 6.56 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.89 -24.87 25.45 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.17 -0.956 . . . . 0.0 108.628 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.812 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -61.26 -58.36 8.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.38 -0.825 . . . . 0.0 108.823 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -68.33 -8.65 41.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -0.892 . . . . 0.0 109.236 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.797 ' CZ ' HD11 ' A' ' 20' ' ' ILE . 1.1 m-85 -113.47 96.73 6.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.557 ' O ' ' NE2' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -88.56 60.39 5.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 109.697 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.557 ' NE2' ' O ' ' A' ' 111' ' ' LYS . 83.9 mm-40 -153.34 -87.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.181 -0.949 . . . . 0.0 109.553 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.613 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -139.16 -113.47 1.12 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.72 HD13 ' HZ ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER 141.72 86.46 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.576 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -95.04 171.05 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 0.0 108.964 179.772 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.576 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -151.89 129.77 11.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.265 -0.897 . . . . 0.0 109.602 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.652 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -100.17 168.03 10.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.712 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 119' ' ' GLY . 10.6 pt20 -92.52 153.39 19.1 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.769 -1.207 . . . . 0.0 111.372 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.599 ' O ' ' CD1' ' A' ' 40' ' ' TYR . . . 52.1 164.62 0.01 OUTLIER Glycine 0 N--CA 1.498 2.807 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.57 ' O ' ' CE1' ' A' ' 40' ' ' TYR . . . -60.91 -123.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 121' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.263 -1.139 . . . . 0.0 109.253 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.945 HG13 ' HB3' ' A' ' 27' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 1' ' ' VAL . 1.5 mm-40 43.48 59.13 3.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.304 -0.872 . . . . 0.0 109.519 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.126 HD13 ' N ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -64.15 -13.89 51.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 109.695 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . 1.126 ' N ' HD13 ' A' ' 3' ' ' LEU . 0.4 OUTLIER -78.21 168.33 20.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 109.791 -179.581 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 4' ' ' SER . 3.8 ttmm 81.39 -69.43 0.08 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.76 -0.588 . . . . 0.0 109.896 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -83.83 12.51 5.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.083 -1.011 . . . . 0.0 110.115 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.559 HG11 ' CZ2' ' A' ' 21' ' ' TRP . 35.0 t -145.52 -77.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.014 -1.054 . . . . 0.0 109.696 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.563 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 77.0 p -39.96 -28.08 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.471 -0.768 . . . . 0.0 109.952 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 7' ' ' VAL . . . -41.98 -59.64 2.84 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 3.3 mtmt -132.58 -29.08 1.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.178 -1.189 . . . . 0.0 110.218 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.999 HD22 HD21 ' A' ' 88' ' ' LEU . 3.1 mp 65.61 9.84 6.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.098 -1.001 . . . . 0.0 109.17 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 62.65 128.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.872 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.733 ' C ' HG22 ' A' ' 14' ' ' THR . 6.0 mmtt -96.43 169.02 10.2 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.733 HG22 ' C ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER 173.96 -83.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.592 -1.317 . . . . 0.0 111.218 -178.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.628 ' OG1' ' HD2' ' A' ' 16' ' ' PRO . 0.6 OUTLIER -161.97 -175.08 0.45 Allowed Pre-proline 0 C--N 1.284 -2.244 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.364 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.628 ' HD2' ' OG1' ' A' ' 15' ' ' THR . 33.3 Cg_endo -76.91 110.3 3.01 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.677 1.585 . . . . 0.0 111.28 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 49' ' ' SER . . . -161.47 -155.68 7.99 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.71 HG13 HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -160.92 154.56 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.734 -1.451 . . . . 0.0 110.523 179.489 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.513 ' N ' HG12 ' A' ' 18' ' ' ILE . 4.9 mp0 -133.82 -168.01 2.04 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.637 ' O ' HG23 ' A' ' 31' ' ' VAL . 55.9 mt -156.07 164.73 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.621 -1.3 . . . . 0.0 110.318 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.75 ' HA ' HG23 ' A' ' 31' ' ' VAL . 15.0 m-90 -124.48 119.0 27.9 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.58 ' HA ' ' CD2' ' A' ' 45' ' ' TYR . 29.8 ttp-105 -80.78 108.85 14.78 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.169 -0.957 . . . . 0.0 112.189 -176.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.799 HD11 ' SD ' ' A' ' 28' ' ' MET . 0.9 OUTLIER -86.57 93.45 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 176.733 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 26' ' ' MET . 1.4 pm0 -56.62 80.02 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.623 ' C ' ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER 41.22 13.64 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.694 -0.629 . . . . 0.0 111.415 -179.149 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.754 ' HE3' ' HA ' ' A' ' 26' ' ' MET . 0.0 OUTLIER -157.75 -76.72 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.271 -1.518 . . . . 0.0 111.142 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.945 ' HB3' HG13 ' A' ' 1' ' ' VAL . 0.4 OUTLIER -89.53 -147.06 0.17 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.167 -0.958 . . . . 0.0 110.776 -177.725 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.799 ' SD ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -144.14 146.62 32.88 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.559 0.695 . . . . 0.0 109.913 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.905 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -140.45 158.82 65.37 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.905 ' HD2' HG13 ' A' ' 29' ' ' VAL . 33.7 Cg_endo -75.33 137.9 21.59 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.32 2.014 . . . . 0.0 111.165 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.75 HG23 ' HA ' ' A' ' 21' ' ' TRP . 2.5 t -123.62 98.44 40.47 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 35' ' ' SER . 34.7 Cg_endo -76.57 -157.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.441 2.094 . . . . 0.0 110.177 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.522 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -83.06 -22.41 33.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.096 -1.002 . . . . 0.0 109.111 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -86.35 1.17 52.1 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.338 -0.851 . . . . 0.0 109.879 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.47 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -131.22 -25.53 2.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.153 -0.967 . . . . 0.0 110.373 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.683 ' CD2' ' CE2' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -68.95 -5.84 23.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.946 -1.096 . . . . 0.0 109.81 -179.57 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.512 ' N ' ' CD1' ' A' ' 36' ' ' TYR . . . -85.67 -4.46 85.27 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.507 ' HB3' ' CG2' ' A' ' 115' ' ' ILE . 17.0 m-80 -153.59 103.06 2.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.133 -1.216 . . . . 0.0 109.57 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.62 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -123.46 131.73 53.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.059 -1.026 . . . . 0.0 109.598 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.625 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 6.6 m-30 -39.53 152.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.544 -0.723 . . . . 0.0 110.148 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 12.4 pt-20 -89.67 -45.09 9.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 109.237 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.631 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -82.58 69.93 3.26 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 25' ' ' ASN . 10.9 m-20 -164.97 -166.39 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.91 -1.347 . . . . 0.0 111.1 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.563 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 1.7 m -127.37 156.87 41.34 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.62 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 30.9 m-85 -147.26 167.97 22.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.172 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.645 HG13 ' OG1' ' A' ' 81' ' ' THR . 99.3 t -132.45 113.31 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.71 HD11 HG13 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -90.13 155.15 19.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.174 -178.943 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.7 HD21 HD23 ' A' ' 11' ' ' LEU . 27.4 tp -146.5 85.9 1.66 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.564 ' CB ' ' HB ' ' A' ' 18' ' ' ILE . 1.0 OUTLIER -87.5 117.38 26.26 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 122.173 0.987 . . . . 0.0 109.872 -179.216 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.647 HG21 ' CD2' ' A' ' 57' ' ' PHE . 1.4 m -98.04 158.41 15.56 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.521 ' HG3' ' CB ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -160.56 117.62 2.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.915 -1.116 . . . . 0.0 109.867 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.848 ' O ' HG23 ' A' ' 53' ' ' THR . 3.0 pttm -46.78 172.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 0.0 109.268 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.848 HG23 ' O ' ' A' ' 52' ' ' LYS . 1.4 p -167.69 172.95 8.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.44 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.9 -18.8 41.48 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 m -99.5 -52.23 3.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -1.111 . . . . 0.0 109.365 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 52' ' ' LYS . . . -176.08 -100.35 0.13 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.647 ' CD2' HG21 ' A' ' 50' ' ' THR . 0.9 OUTLIER -117.93 158.63 24.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -1.114 . . . . 0.0 110.033 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.521 ' CB ' ' HG3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -130.89 123.58 29.29 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.166 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.816 ' CD2' HD22 ' A' ' 88' ' ' LEU . 7.3 m-85 -105.04 153.52 21.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.856 -1.153 . . . . 0.0 111.753 -177.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.544 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 6.2 m-20 -137.6 95.41 3.06 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 1.016 ' CG2' HG23 ' A' ' 81' ' ' THR . 10.9 mt -87.75 122.71 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 111.156 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.738 ' CD2' ' HB2' ' A' ' 95' ' ' HIS . 14.2 m80 -110.47 169.17 8.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.514 -0.741 . . . . 0.0 109.168 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 95' ' ' HIS . 50.2 p90 -139.23 109.4 6.44 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.817 -1.153 . . . . 0.0 109.044 176.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.553 ' C ' HD23 ' A' ' 65' ' ' LEU . 7.0 t90 -86.05 135.72 33.52 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.279 0.561 . . . . 0.0 109.612 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.903 HD11 ' CG ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -120.02 61.57 0.85 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.93 -178.618 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -51.69 89.81 0.01 OUTLIER Glycine 0 N--CA 1.498 2.767 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 178.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 65' ' ' LEU . 1.5 tppt? -39.02 91.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.091 0.948 . . . . 0.0 112.611 -177.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.631 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 1.5 m120 -162.76 -45.69 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 73' ' ' GLU . 14.2 p -61.21 -157.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.507 -0.745 . . . . 0.0 109.272 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.4 p -106.39 161.83 14.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 0.2 OUTLIER -50.32 -49.98 52.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.879 . . . . 0.0 109.43 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -54.45 -39.65 67.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.123 -0.986 . . . . 0.0 108.913 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.479 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -55.52 -39.25 70.29 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.238 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.903 ' CG ' HD11 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -59.78 -38.02 80.67 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.457 ' O ' HG13 ' A' ' 79' ' ' ILE . . . -69.55 -25.2 75.75 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.762 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -73.19 -59.38 2.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -1.129 . . . . 0.0 109.229 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . . . -49.45 -37.53 26.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 0.0 108.945 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.33 -34.68 68.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.334 -0.854 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.762 HD12 ' HA ' ' A' ' 76' ' ' ALA . 15.4 mt -63.44 -49.12 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.867 . . . . 0.0 109.425 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.673 ' HB3' ' HE2' ' A' ' 28' ' ' MET . 27.2 m-85 -58.47 -41.09 84.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.053 -1.029 . . . . 0.0 108.639 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 1.016 HG23 ' CG2' ' A' ' 61' ' ' ILE . 8.9 m -69.6 -22.34 63.51 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.431 -0.793 . . . . 0.0 108.897 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.8 m -86.44 -18.39 31.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.631 -0.668 . . . . 0.0 109.317 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 1.0 OUTLIER -89.85 -35.48 15.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.554 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.889 ' O ' HD12 ' A' ' 88' ' ' LEU . 5.2 ptm -82.32 -12.26 58.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.952 . . . . 0.0 109.482 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' A' ' 92' ' ' ALA . 9.4 t0 -79.91 -37.24 35.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.328 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -89.77 -29.04 18.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 109.257 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.509 ' HB3' ' HB ' ' A' ' 8' ' ' THR . 1.9 m-85 -76.21 -29.67 57.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.237 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.999 HD21 HD22 ' A' ' 11' ' ' LEU . 6.6 mt -72.06 -3.05 20.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.428 -0.795 . . . . 0.0 109.785 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.81 24.73 7.97 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 56.35 17.75 3.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -1.149 . . . . 0.0 109.322 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.568 HG23 ' CD2' ' A' ' 59' ' ' TYR . 11.7 m -96.64 -14.64 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.896 . . . . 0.0 109.255 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.547 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -77.04 164.53 25.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.316 -0.865 . . . . 0.0 109.427 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.738 HG12 ' H ' ' A' ' 94' ' ' GLN . 2.5 t -113.5 -178.53 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.494 -0.754 . . . . 0.0 109.176 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.738 ' H ' HG12 ' A' ' 93' ' ' VAL . 10.8 tt0 -132.64 136.41 46.47 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.135 -0.978 . . . . 0.0 109.054 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.738 ' HB2' ' CD2' ' A' ' 62' ' ' HIS . 6.9 m80 -137.84 153.6 49.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.405 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.568 ' HA ' ' CE2' ' A' ' 63' ' ' TYR . 16.1 ptm180 -111.78 143.97 41.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.671 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.495 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 40.2 mm-40 -150.68 164.19 36.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.408 -0.808 . . . . 0.0 109.05 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.746 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.3 t -154.52 -169.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 0.0 109.012 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.746 ' H ' HG12 ' A' ' 98' ' ' VAL . 9.0 pt20 -72.76 0.92 9.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.844 -1.16 . . . . 0.0 110.282 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.6 19.57 1.15 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.244 -1.943 . . . . 0.0 108.244 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.544 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 17.6 m80 -125.09 -14.78 6.5 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.715 -0.873 . . . . 0.0 109.789 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.552 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.25 29.34 1.26 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.727 -179.451 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 102' ' ' GLU . 77.6 p -55.99 -131.63 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.368 -0.832 . . . . 0.0 111.138 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.457 ' HG2' ' N ' ' A' ' 105' ' ' THR . 0.1 OUTLIER -40.01 -24.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.769 -1.207 . . . . 0.0 111.068 -178.915 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.551 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 1.8 m -66.94 -63.78 0.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.843 -1.161 . . . . 0.0 110.592 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.519 ' HB2' ' HB2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -57.14 -47.16 81.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.756 -1.215 . . . . 0.0 108.227 -179.13 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 110' ' ' PHE . 10.6 mtm180 -59.46 -28.06 66.64 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 105' ' ' THR . . . -59.84 -44.47 94.07 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.622 ' OH ' ' CE1' ' A' ' 62' ' ' HIS . 63.6 m-85 -76.53 -12.79 60.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.817 ' CB ' HD21 ' A' ' 114' ' ' LEU . 20.4 m-85 -126.09 105.65 9.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.648 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 112' ' ' GLN . 5.1 ptmt -90.13 26.4 1.89 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 110.112 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.485 ' CB ' ' O ' ' A' ' 111' ' ' LYS . 1.1 pt20 165.2 83.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.892 -1.13 . . . . 0.0 110.469 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 114' ' ' LEU . . . 167.03 -122.89 1.09 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.817 HD21 ' CB ' ' A' ' 110' ' ' PHE . 0.2 OUTLIER 65.76 49.8 1.66 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.557 -0.966 . . . . 0.0 110.888 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.507 ' CG2' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -87.5 167.18 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 177.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.578 ' CZ ' ' O ' ' A' ' 114' ' ' LEU . 2.9 m-85 -143.66 122.73 12.86 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.823 -1.173 . . . . 0.0 110.353 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.625 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 1.9 mttm -102.62 -163.94 1.04 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.462 -0.773 . . . . 0.0 108.972 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.578 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -90.26 161.47 15.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.92 -1.112 . . . . 0.0 110.14 -179.658 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 120' ' ' GLY . . . -67.88 -161.88 1.9 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 58.73 112.5 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.529 ' HB ' ' CB ' ' A' ' 24' ' ' GLU . 4.2 p . . . . . 0 C--N 1.303 -1.431 0 O-C-N 121.265 -1.138 . . . . 0.0 108.676 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 11.0 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.483 ' HA ' ' CE1' ' A' ' 80' ' ' TYR . 1.9 mt-10 64.64 66.08 0.61 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.347 -0.846 . . . . 0.0 109.521 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.113 HD21 ' CG ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -44.83 -41.16 6.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 3.2 t -42.54 150.56 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.378 -0.826 . . . . 0.0 109.616 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 4' ' ' SER . 14.1 ttpt 80.49 -72.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.586 -0.697 . . . . 0.0 109.775 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.495 ' C ' HG23 ' A' ' 7' ' ' VAL . 70.2 mmtt -88.33 14.53 9.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.079 -1.013 . . . . 0.0 109.851 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.686 HG11 ' HE1' ' A' ' 21' ' ' TRP . 21.8 t -157.2 -74.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.058 -1.026 . . . . 0.0 109.618 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.657 ' HA ' HD21 ' A' ' 11' ' ' LEU . 2.3 m -49.3 -23.16 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 0.0 109.476 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 10' ' ' LYS . . . -89.38 32.89 4.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER 164.12 47.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -1.135 . . . . 0.0 109.464 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.762 HD12 ' HG ' ' A' ' 88' ' ' LEU . 38.2 mt -68.96 -147.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 0.0 109.208 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -83.84 119.6 25.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.961 . . . . 0.0 109.385 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.672 ' O ' HG23 ' A' ' 14' ' ' THR . 5.1 mmmt -122.97 -11.99 8.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 0.0 109.62 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 13' ' ' LYS . 18.4 p -160.8 69.99 0.38 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 109.544 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 15' ' ' THR . 5.9 t -175.33 124.2 0.35 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.371 -0.831 . . . . 0.0 109.176 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.7 105.99 2.12 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.25 1.967 . . . . 0.0 110.514 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 173.33 176.76 42.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.859 HG22 ' HA ' ' A' ' 49' ' ' SER . 3.9 pt -124.49 134.45 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -1.208 . . . . 0.0 109.922 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 5.8 tt0 -112.93 140.77 47.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.311 -0.868 . . . . 0.0 108.732 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.665 HD11 ' CZ ' ' A' ' 110' ' ' PHE . 2.2 mt -115.06 -178.91 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.803 -1.186 . . . . 0.0 109.679 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.686 ' HE1' HG11 ' A' ' 7' ' ' VAL . 10.6 m-90 -141.45 119.39 11.93 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.649 ' H ' HG23 ' A' ' 31' ' ' VAL . 2.5 ptt180 -78.9 128.07 32.84 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.122 -0.986 . . . . 0.0 110.147 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 23' ' ' ILE . 5.8 mm -96.49 43.89 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.54 ' HG2' ' N ' ' A' ' 25' ' ' ASN . 31.1 tt0 -70.29 168.04 16.75 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.335 0.588 . . . . 0.0 110.108 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.54 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 8.2 p30 47.18 24.6 0.43 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -0.796 . . . . 0.0 109.141 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.736 ' HE3' ' HG2' ' A' ' 73' ' ' GLU . 24.4 mmm 57.75 50.54 10.52 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.413 -0.805 . . . . 0.0 109.491 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.514 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 53.8 mm-40 -148.24 -111.22 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.316 -0.865 . . . . 0.0 109.108 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.725 ' HE2' HD22 ' A' ' 3' ' ' LEU . 2.8 ttt 178.88 153.91 0.4 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.787 -1.196 . . . . 0.0 109.861 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -160.26 147.57 12.52 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.559 ' HD2' HG13 ' A' ' 29' ' ' VAL . 33.4 Cg_endo -74.04 94.73 0.89 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.563 2.175 . . . . 0.0 111.869 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.649 HG23 ' H ' ' A' ' 22' ' ' ARG . 60.0 t -76.58 112.75 23.64 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 36.3 Cg_endo -78.78 -161.8 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.448 2.099 . . . . 0.0 110.601 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.475 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -88.28 -3.72 58.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.315 -0.865 . . . . 0.0 109.054 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -87.52 8.29 25.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 109.74 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.4 m -159.99 21.07 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.157 -0.964 . . . . 0.0 110.076 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.564 ' CD2' ' O ' ' A' ' 36' ' ' TYR . 19.4 p90 -90.0 32.64 0.9 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.015 -1.053 . . . . 0.0 109.334 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.31 -10.07 5.73 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.475 ' CB ' ' HB ' ' A' ' 115' ' ' ILE . 5.5 m-80 -148.02 100.92 3.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.192 -1.181 . . . . 0.0 109.889 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.689 ' HZ ' HD13 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -115.19 131.57 56.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.305 -0.872 . . . . 0.0 109.06 179.633 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.638 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 6.7 m-30 -39.42 155.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.451 -0.781 . . . . 0.0 109.943 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 10.4 pt-20 -91.0 -46.32 8.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.474 -0.766 . . . . 0.0 110.161 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.606 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -83.01 67.38 3.76 Favored Glycine 0 N--CA 1.483 1.793 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.057 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.514 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -162.92 -148.11 0.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.916 -1.344 . . . . 0.0 110.299 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.531 ' CB ' HG13 ' A' ' 23' ' ' ILE . 14.2 m -144.28 139.8 28.82 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.609 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 30.1 m-85 -137.18 109.64 7.41 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.983 -1.073 . . . . 0.0 109.878 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.698 HG13 ' OG1' ' A' ' 81' ' ' THR . 25.0 t -78.5 131.21 34.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.176 -0.953 . . . . 0.0 108.462 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.787 HD23 ' N ' ' A' ' 48' ' ' LEU . 8.3 tt -111.57 163.43 14.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.15 -0.968 . . . . 0.0 109.469 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.787 ' N ' HD23 ' A' ' 47' ' ' LEU . 20.3 tp -153.65 92.11 1.54 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.978 -1.077 . . . . 0.0 109.263 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.859 ' HA ' HG22 ' A' ' 18' ' ' ILE . 5.3 t -81.26 148.82 29.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.904 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 m -140.23 117.05 10.98 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -112.91 175.44 5.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.514 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.96 157.31 18.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.908 . . . . 0.0 109.429 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.1 p -146.8 -170.39 3.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.449 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.96 10.17 61.12 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 p -133.73 -54.69 0.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -1.111 . . . . 0.0 109.422 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.53 -135.11 1.85 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.57 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 88.2 m-85 -120.24 144.32 47.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -1.1 . . . . 0.0 109.66 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 68.8 m -101.09 106.82 18.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.282 -0.886 . . . . 0.0 108.705 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.643 ' CD2' HG23 ' A' ' 91' ' ' VAL . 6.3 m-85 -84.64 156.36 21.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.205 -0.935 . . . . 0.0 110.339 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.624 ' HB3' ' HE1' ' A' ' 62' ' ' HIS . 5.8 m-20 -143.68 102.61 3.95 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 1.017 ' CG2' HG23 ' A' ' 81' ' ' THR . 7.7 mt -92.36 112.3 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.255 -0.903 . . . . 0.0 110.461 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.738 ' CD2' ' HB2' ' A' ' 95' ' ' HIS . 11.4 m80 -105.1 166.98 10.01 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.607 -0.683 . . . . 0.0 109.534 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.575 ' CZ ' ' HA ' ' A' ' 96' ' ' ARG . 43.5 p90 -138.04 106.62 5.87 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.401 -1.32 . . . . 0.0 109.856 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.591 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 4.8 t90 -82.38 131.57 35.22 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -119.28 65.21 0.79 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.357 -0.839 . . . . 0.0 110.753 -178.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 68' ' ' ASN . . . -49.53 91.08 0.01 OUTLIER Glycine 0 N--CA 1.498 2.796 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -37.74 88.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 122.081 0.943 . . . . 0.0 112.414 -177.362 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.606 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 1.5 m120 -162.75 -43.65 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.549 ' HB2' ' HE3' ' A' ' 26' ' ' MET . 14.1 p -60.32 168.64 1.95 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.632 -0.667 . . . . 0.0 109.458 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.452 ' OG ' ' OE1' ' A' ' 73' ' ' GLU . 1.5 p -73.87 168.89 18.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.939 . . . . 0.0 109.445 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.3 -51.22 63.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.546 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 2.1 p30 -55.3 -39.32 69.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.127 -0.983 . . . . 0.0 109.511 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.736 ' HG2' ' HE3' ' A' ' 26' ' ' MET . 3.0 mp0 -56.5 -38.66 72.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 108.656 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.496 ' OE1' HD12 ' A' ' 65' ' ' LEU . 53.6 mt-30 -64.17 -33.52 75.97 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.629 ' O ' HD13 ' A' ' 79' ' ' ILE . . . -83.05 -10.91 82.1 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.73 -44.36 13.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.999 -1.295 . . . . 0.0 108.939 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.45 -45.41 59.69 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.328 -0.858 . . . . 0.0 109.029 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.16 93.29 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.629 HD13 ' O ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -65.53 -41.35 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.198 -0.939 . . . . 0.0 108.994 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 1.113 ' CG ' HD21 ' A' ' 3' ' ' LEU . 11.3 m-85 -61.45 -29.43 69.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.973 -1.079 . . . . 0.0 108.53 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 1.017 HG23 ' CG2' ' A' ' 61' ' ' ILE . 2.6 m -75.52 -25.5 57.28 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.0 m -81.16 -27.14 35.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.532 -0.73 . . . . 0.0 109.22 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 0.9 OUTLIER -78.04 -36.57 48.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.608 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.522 ' HG3' ' CD1' ' A' ' 61' ' ' ILE . 5.4 ptm -82.23 -8.14 59.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 109.593 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.604 ' OD1' HD12 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -75.48 -41.57 55.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.381 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -90.03 -29.25 18.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.313 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.507 ' HB3' HG22 ' A' ' 8' ' ' THR . 0.3 OUTLIER -70.22 -32.26 70.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 109.55 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.784 HD12 HD11 ' A' ' 61' ' ' ILE . 14.7 mt -66.19 -22.4 66.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.601 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 90' ' ' SER . . . 121.12 14.61 4.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 89' ' ' GLY . 6.3 t 72.19 3.95 4.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -1.188 . . . . 0.0 109.588 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.643 HG23 ' CD2' ' A' ' 59' ' ' TYR . 17.9 m -87.7 -19.73 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.541 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -77.15 170.13 17.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.237 -0.914 . . . . 0.0 109.608 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.764 HG12 ' H ' ' A' ' 94' ' ' GLN . 2.9 t -121.94 -177.36 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.089 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.764 ' H ' HG12 ' A' ' 93' ' ' VAL . 73.1 mt-30 -128.22 140.07 52.11 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.007 -1.058 . . . . 0.0 108.864 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.738 ' HB2' ' CD2' ' A' ' 62' ' ' HIS . 4.7 m80 -141.63 151.08 42.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.029 -1.044 . . . . 0.0 109.69 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.575 ' HA ' ' CZ ' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -109.67 140.95 42.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.341 -0.849 . . . . 0.0 110.362 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.491 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 60.5 mm-40 -148.41 163.68 36.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.407 -0.808 . . . . 0.0 109.122 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.736 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.7 t -155.38 -175.17 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.098 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.736 ' H ' HG12 ' A' ' 98' ' ' VAL . 38.5 tt0 -69.75 -1.99 10.74 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.934 -1.103 . . . . 0.0 110.195 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.53 16.12 2.04 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.561 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 57.5 m80 -122.45 -16.42 7.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.484 -1.01 . . . . 0.0 109.591 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.591 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.1 24.29 2.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.905 . . . . 0.0 109.363 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 102' ' ' GLU . 3.5 p -48.63 -107.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.417 -0.802 . . . . 0.0 111.459 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.818 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 22.4 mt-10 -67.2 -17.45 64.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.916 -1.115 . . . . 0.0 110.909 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.505 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 4.3 m -72.17 -54.95 8.15 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.937 -1.102 . . . . 0.0 109.756 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.546 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -63.63 -57.5 9.88 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.27 -30.15 36.89 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.228 -0.92 . . . . 0.0 108.806 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.818 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -58.1 -45.0 87.95 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -0.828 . . . . 0.0 108.809 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.471 ' HB3' HD13 ' A' ' 18' ' ' ILE . 34.2 m-85 -76.7 -14.16 59.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -0.816 . . . . 0.0 109.41 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.842 ' CB ' HD21 ' A' ' 114' ' ' LEU . 2.3 m-85 -117.03 96.99 5.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.408 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 23.0 ttpt -83.75 73.1 10.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.135 -0.978 . . . . 0.0 109.415 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 111' ' ' LYS . 4.8 mt-30 -171.33 -80.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.129 -0.982 . . . . 0.0 109.804 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.403 ' C ' HD23 ' A' ' 114' ' ' LEU . . . 179.95 131.49 1.65 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.842 HD21 ' CB ' ' A' ' 110' ' ' PHE . 10.5 mt -103.49 135.75 44.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -1.107 . . . . 0.0 110.007 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.562 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 2.6 mt -107.57 165.42 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 108.836 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.564 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -141.45 102.42 4.2 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.367 -0.833 . . . . 0.0 109.147 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.638 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 5.1 mmmt -82.28 -155.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 109.664 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.585 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -92.18 -179.9 5.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.551 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 120' ' ' GLY . . . -113.19 -169.67 17.38 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 119' ' ' GLY . . . 43.23 84.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.607 ' O ' HG13 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -88.62 12.98 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -1.208 . . . . 0.0 109.222 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.39 -23.34 40.51 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.49 -0.756 . . . . 0.0 109.434 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.7 m 45.85 25.48 0.3 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -0.872 . . . . 0.0 109.489 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -121.57 12.36 9.51 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.0 mmt -112.18 -154.37 0.54 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.404 -1.056 . . . . 0.0 109.407 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.9 mttt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.433 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.755 ' O ' HG12 ' A' ' 1' ' ' VAL . 65.1 t . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 173.87 60.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.191 -0.943 . . . . 0.0 109.484 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.074 HD13 ' N ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -63.48 -11.3 22.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.519 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . 1.074 ' N ' HD13 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -74.73 151.18 39.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.962 . . . . 0.0 109.587 -179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 4' ' ' SER . 17.7 tttm 80.2 -72.57 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.471 -0.768 . . . . 0.0 109.764 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.77 -10.73 29.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 109.757 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.97 HG12 ' CD2' ' A' ' 11' ' ' LEU . 5.2 t -123.93 -71.23 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.101 -0.999 . . . . 0.0 109.519 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.75 HG22 ' HG2' ' A' ' 84' ' ' MET . 19.2 p -50.23 -21.89 1.53 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.668 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.468 ' O ' ' HG2' ' A' ' 10' ' ' LYS . . . -42.75 -42.05 4.65 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 9' ' ' GLY . 12.6 mttt -155.29 -37.96 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.138 -1.213 . . . . 0.0 109.805 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.12 HD12 HD21 ' A' ' 88' ' ' LEU . 51.0 mt 64.2 -144.84 0.28 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.123 -0.986 . . . . 0.0 109.138 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.505 ' O ' ' CE2' ' A' ' 59' ' ' TYR . 2.3 m-20 -88.21 97.81 11.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.113 -0.992 . . . . 0.0 109.549 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.672 ' O ' HG23 ' A' ' 14' ' ' THR . 10.5 mttt -100.83 -4.71 27.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.945 . . . . 0.0 109.641 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 13' ' ' LYS . 19.9 p -160.15 49.59 0.28 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.94 . . . . 0.0 109.499 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.3 m -151.01 105.41 3.0 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.379 -0.826 . . . . 0.0 109.116 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.35 86.76 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.402 2.068 . . . . 0.0 110.343 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.457 ' C ' HG23 ' A' ' 18' ' ' ILE . . . -170.29 -132.76 1.5 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.034 HD12 HD11 ' A' ' 47' ' ' LEU . 18.3 pt -156.81 137.83 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.078 -1.248 . . . . 0.0 110.119 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.705 ' NE2' ' CZ2' ' A' ' 21' ' ' TRP . 6.9 tt0 -119.62 113.9 21.4 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.685 HG22 ' H ' ' A' ' 21' ' ' TRP . 3.8 mt -90.03 175.88 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.799 -1.188 . . . . 0.0 109.942 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.861 ' HB3' ' HE3' ' A' ' 28' ' ' MET . 10.7 m-90 -137.04 119.18 15.49 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.699 ' H ' HG23 ' A' ' 31' ' ' VAL . 8.0 ttp180 -79.15 130.23 35.28 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.14 -0.975 . . . . 0.0 110.921 -177.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 23' ' ' ILE . 3.3 mm -95.08 37.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.612 ' O ' ' ND2' ' A' ' 25' ' ' ASN . 1.3 tt0 -47.31 149.45 1.04 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.395 0.617 . . . . 0.0 110.703 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.612 ' ND2' ' O ' ' A' ' 24' ' ' GLU . 7.5 p30 44.33 27.47 0.22 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.445 -0.785 . . . . 0.0 109.072 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.726 ' HE3' ' HB2' ' A' ' 69' ' ' SER . 3.4 mmm 64.1 51.55 2.19 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.464 -0.773 . . . . 0.0 109.322 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 9.7 mt-10 -153.73 122.65 6.41 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.861 ' HE3' ' HB3' ' A' ' 21' ' ' TRP . 2.1 mtp -56.63 145.06 29.74 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.177 -0.952 . . . . 0.0 110.339 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.598 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -149.64 149.98 29.71 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HD2' HG13 ' A' ' 29' ' ' VAL . 32.3 Cg_endo -72.98 113.86 3.89 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.229 1.953 . . . . 0.0 111.857 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.703 HG13 ' HB3' ' A' ' 35' ' ' SER . 41.4 t -111.3 92.28 15.6 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.521 ' HG2' ' CD ' ' A' ' 34' ' ' LYS . 35.0 Cg_endo -77.12 -156.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.717 2.278 . . . . 0.0 110.202 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.574 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -75.83 -23.53 55.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.094 -1.004 . . . . 0.0 108.945 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.521 ' CD ' ' HG2' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -81.85 8.01 11.36 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.206 -0.934 . . . . 0.0 109.613 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.703 ' HB3' HG13 ' A' ' 31' ' ' VAL . 2.5 m -128.25 -45.36 1.38 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.745 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -45.05 158.31 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.438 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 115' ' ' ILE . . . 112.88 -47.84 1.0 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.43 94.15 4.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -1.209 . . . . 0.0 109.885 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.901 ' HZ ' HD13 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -113.04 121.03 43.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.302 -0.874 . . . . 0.0 109.797 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.581 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 7.0 m-30 -39.33 131.9 1.53 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 110.607 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 2.9 pt-20 -90.66 56.68 3.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.217 -0.927 . . . . 0.0 109.01 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.603 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -176.89 47.92 0.11 Allowed Glycine 0 N--CA 1.484 1.876 0 N-CA-C 108.914 -1.675 . . . . 0.0 108.914 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.468 ' CG ' ' O ' ' A' ' 42' ' ' GLY . 2.4 m-20 -162.16 -129.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.654 -0.909 . . . . 0.0 109.608 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.536 ' CB ' HG13 ' A' ' 23' ' ' ILE . 1.8 m -149.14 144.7 26.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.05 -1.031 . . . . 0.0 108.927 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.592 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 26.0 m-85 -142.65 111.25 6.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.097 -1.002 . . . . 0.0 109.727 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.677 HG13 ' OG1' ' A' ' 81' ' ' THR . 11.3 t -79.73 123.03 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.958 -1.089 . . . . 0.0 108.961 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.034 HD11 HD12 ' A' ' 18' ' ' ILE . 8.2 tt -112.94 122.24 47.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.956 -1.09 . . . . 0.0 110.061 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 59' ' ' TYR . 23.2 tp -107.13 109.86 21.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.069 -1.02 . . . . 0.0 109.705 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.505 ' OG ' HG22 ' A' ' 18' ' ' ILE . 3.2 t -98.19 133.9 41.98 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.18 -0.95 . . . . 0.0 109.272 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.2 m -129.21 142.57 50.82 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.519 ' HG2' ' N ' ' A' ' 52' ' ' LYS . 9.1 ttp180 -140.14 157.12 46.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.892 . . . . 0.0 109.534 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.519 ' N ' ' HG2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -74.12 159.92 31.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.37 -172.74 4.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 109.463 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.73 -35.97 8.13 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t -82.74 -25.24 33.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -1.146 . . . . 0.0 109.488 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.67 -117.61 0.76 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 2.2 m-30 -115.07 169.08 9.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -1.116 . . . . 0.0 109.579 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -133.87 107.85 8.09 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.59 ' HB3' HD11 ' A' ' 48' ' ' LEU . 23.2 m-85 -92.55 169.01 10.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.104 -0.997 . . . . 0.0 110.374 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.713 ' HB3' ' CE1' ' A' ' 95' ' ' HIS . 46.9 m-80 -158.89 88.25 0.89 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.961 ' CG2' HG23 ' A' ' 81' ' ' THR . 21.0 mt -76.67 137.12 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.203 -0.936 . . . . 0.0 110.264 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.749 ' CD2' ' HB2' ' A' ' 95' ' ' HIS . 67.1 m80 -123.79 159.39 29.62 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 95' ' ' HIS . 37.4 p90 -133.38 98.64 4.29 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.345 -1.342 . . . . 0.0 109.196 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.6 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 5.6 t90 -77.07 132.77 39.07 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.076 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -116.83 65.01 0.72 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.456 -0.778 . . . . 0.0 110.844 -178.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -45.24 91.42 0.01 OUTLIER Glycine 0 N--CA 1.5 2.94 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.615 ' O ' ' ND2' ' A' ' 68' ' ' ASN . 1.0 OUTLIER -39.44 91.38 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.928 0.87 . . . . 0.0 113.204 -177.376 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 67' ' ' LYS . 0.3 OUTLIER -162.66 -44.22 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.549 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.726 ' HB2' ' HE3' ' A' ' 26' ' ' MET . 25.2 p -63.93 -153.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.481 -0.762 . . . . 0.0 109.499 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.08 -173.88 2.82 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.302 -0.873 . . . . 0.0 109.428 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -61.01 -32.0 71.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.886 . . . . 0.0 109.604 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -68.09 -44.09 77.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 0.0 109.556 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.712 ' HG2' ' HE3' ' A' ' 26' ' ' MET . 0.8 OUTLIER -57.98 -36.94 73.34 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.953 -1.092 . . . . 0.0 108.395 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.528 ' CG ' HD11 ' A' ' 65' ' ' LEU . 4.5 tt0 -64.82 -32.55 74.3 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.653 ' O ' HD13 ' A' ' 79' ' ' ILE . . . -83.64 -10.92 80.76 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.85 -52.53 5.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.84 -1.388 . . . . 0.0 109.295 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 23' ' ' ILE . . . -71.83 -36.53 70.23 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.183 -0.948 . . . . 0.0 108.807 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.14 -38.52 75.52 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.398 -0.814 . . . . 0.0 109.368 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.653 HD13 ' O ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -66.89 -45.21 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 109.072 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.867 ' CD2' HD12 ' A' ' 3' ' ' LEU . 3.2 m-85 -59.93 -31.71 70.1 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.839 -1.163 . . . . 0.0 108.471 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.961 HG23 ' CG2' ' A' ' 61' ' ' ILE . 3.1 m -74.29 -27.04 60.54 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 79' ' ' ILE . 4.5 m -63.88 -50.94 66.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.5 -0.75 . . . . 0.0 109.374 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -64.86 -39.23 93.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.554 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.75 ' HG2' HG22 ' A' ' 8' ' ' THR . 1.5 mtm -56.79 -28.13 60.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.602 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -81.37 -36.09 30.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.599 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.01 -1.12 51.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.912 . . . . 0.0 109.676 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.537 ' CB ' ' HB ' ' A' ' 8' ' ' THR . 4.1 m-85 -108.93 -29.81 8.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.146 -0.971 . . . . 0.0 109.546 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 1.12 HD21 HD12 ' A' ' 11' ' ' LEU . 46.9 mt -71.84 -3.94 25.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.614 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 90' ' ' SER . . . 99.0 21.82 14.78 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 90' ' ' SER . 0.3 OUTLIER 64.73 10.69 6.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -1.119 . . . . 0.0 109.484 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.8 m -86.11 -27.95 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.0 109.406 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.575 ' HB2' ' HB2' ' A' ' 59' ' ' TYR . . . -73.19 172.34 11.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.577 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.687 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.1 t -124.73 178.3 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.39 -0.818 . . . . 0.0 109.112 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.687 ' H ' HG12 ' A' ' 93' ' ' VAL . 5.5 tt0 -124.91 131.7 53.4 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.016 -1.052 . . . . 0.0 109.075 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.749 ' HB2' ' CD2' ' A' ' 62' ' ' HIS . 13.3 m80 -125.98 152.1 46.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.97 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.574 ' HA ' ' CZ ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -109.71 130.53 55.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 110.242 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 64' ' ' TRP . 15.8 mp0 -142.12 163.98 31.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 109.333 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.71 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.2 t -153.66 -160.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 108.972 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.71 ' H ' HG12 ' A' ' 98' ' ' VAL . 40.7 tp60 -78.66 4.53 13.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.718 -1.239 . . . . 0.0 109.772 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.19 22.24 0.58 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.534 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 14.9 m-70 -124.68 -17.07 6.04 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.735 -0.862 . . . . 0.0 109.664 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.6 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.09 30.26 1.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.259 -0.901 . . . . 0.0 109.369 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 105' ' ' THR . 89.1 p -57.3 -127.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.066 -1.021 . . . . 0.0 111.189 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.821 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 41.0 mt-10 -39.92 -24.62 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.9 -1.125 . . . . 0.0 111.469 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.492 ' N ' ' O ' ' A' ' 103' ' ' SER . 0.2 OUTLIER -71.99 -65.03 0.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.768 -1.208 . . . . 0.0 110.43 -179.104 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.567 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -56.4 -50.25 72.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.969 -1.082 . . . . 0.0 108.34 -179.39 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.413 ' HA ' HD21 ' A' ' 114' ' ' LEU . 1.3 ttp85 -61.41 -29.78 70.15 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.491 -0.755 . . . . 0.0 108.979 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.821 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -59.05 -36.08 74.42 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.796 ' HB3' HD13 ' A' ' 18' ' ' ILE . 67.1 m-85 -88.13 -13.06 42.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.549 -0.72 . . . . 0.0 109.089 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.955 ' HB2' HD21 ' A' ' 114' ' ' LEU . 60.3 m-85 -113.26 96.9 6.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.472 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -74.05 83.02 1.76 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.925 . . . . 0.0 109.54 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.519 ' CB ' ' O ' ' A' ' 111' ' ' LYS . 3.0 tt0 78.48 78.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.397 -0.814 . . . . 0.0 109.715 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.783 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 168.61 70.77 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.955 HD21 ' HB2' ' A' ' 110' ' ' PHE . 4.1 mm? -126.37 56.03 1.47 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -1.164 . . . . 0.0 109.841 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 2.3 mt -81.42 165.67 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.052 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.577 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 2.2 m-85 -145.49 107.86 4.41 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.373 -0.829 . . . . 0.0 109.211 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.581 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 26.9 mmtt -79.69 -165.79 0.87 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 108.929 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.569 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 33.3 mm-40 -87.15 158.11 19.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.962 -1.086 . . . . 0.0 109.865 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.545 ' HA2' ' CD2' ' A' ' 40' ' ' TYR . . . -95.34 -165.51 35.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 119' ' ' GLY . . . 43.48 74.32 0.2 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.465 HG11 ' CD ' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -84.17 7.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -1.15 . . . . 0.0 109.751 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 125' ' ' MET . . . -74.56 -71.09 0.36 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.651 -0.656 . . . . 0.0 109.583 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER 68.58 9.36 7.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.367 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -167.33 26.84 0.15 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.428 ' HB2' ' HB1' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -150.23 -68.04 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -1.155 . . . . 0.0 109.408 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 125' ' ' MET . 20.1 pttt . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.441 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.568 HG22 ' H ' ' A' ' 2' ' ' GLU . 9.9 p . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.568 ' H ' HG22 ' A' ' 1' ' ' VAL . 0.0 OUTLIER 79.77 118.21 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.453 -0.779 . . . . 0.0 109.234 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.88 ' HB2' HG21 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -90.05 -21.33 22.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.519 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 1.2 p -59.84 -12.67 7.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 110.029 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -109.4 -47.79 3.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.977 -1.077 . . . . 0.0 109.827 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -90.32 22.01 3.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 110.094 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.88 HG21 ' HB2' ' A' ' 3' ' ' LEU . 10.3 t -145.38 -63.18 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.089 -1.007 . . . . 0.0 109.823 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.562 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 23.1 p -67.81 -12.9 61.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 109.506 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 10' ' ' LYS . . . -74.24 -19.7 79.77 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 1.6 tptm 175.2 55.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.449 -1.03 . . . . 0.0 109.371 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.745 HD23 HD22 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -43.85 -60.29 1.89 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.43 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -161.63 -91.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.43 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER 74.48 125.98 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.502 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.584 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 23.7 p 48.05 54.35 10.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.362 -0.836 . . . . 0.0 109.631 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 14' ' ' THR . 4.0 m -168.43 101.85 0.53 Allowed Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.416 -0.803 . . . . 0.0 109.324 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.04 109.47 2.84 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.413 2.075 . . . . 0.0 110.433 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.472 ' C ' HG23 ' A' ' 18' ' ' ILE . . . 178.87 -143.81 5.99 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.972 HD12 ' CD1' ' A' ' 47' ' ' LEU . 14.3 pt -157.44 140.6 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -1.172 . . . . 0.0 109.829 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.67 ' NE2' ' CZ2' ' A' ' 21' ' ' TRP . 9.7 tt0 -122.01 109.19 14.28 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.803 HG12 HD12 ' A' ' 47' ' ' LEU . 41.9 mt -85.03 166.73 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.145 -0.972 . . . . 0.0 109.84 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.877 ' CZ2' HG13 ' A' ' 7' ' ' VAL . 6.8 m-90 -130.26 121.95 27.1 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.769 ' HG3' HG22 ' A' ' 31' ' ' VAL . 8.7 mtm180 -79.26 132.54 36.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 110.888 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.828 HD13 ' HB2' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -116.8 23.11 5.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.662 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.504 ' CG ' ' HB ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -54.92 171.07 0.15 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.848 . . . . 0.0 110.193 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.776 ' HB3' HG12 ' A' ' 121' ' ' VAL . 0.7 OUTLIER 42.22 26.86 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.619 ' HE1' ' CB ' ' A' ' 70' ' ' SER . 0.0 OUTLIER 59.28 56.69 3.71 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.45 -0.781 . . . . 0.0 110.256 179.336 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 73.5 mm-40 -146.72 -144.05 0.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.925 -1.109 . . . . 0.0 109.655 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.628 ' CE ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -156.04 146.44 21.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.009 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.556 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -160.37 148.77 13.27 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.086 -1.009 . . . . 0.0 109.604 -179.433 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.556 ' HD2' HG13 ' A' ' 29' ' ' VAL . 36.0 Cg_endo -78.53 125.17 6.74 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.548 2.165 . . . . 0.0 111.174 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.769 HG22 ' HG3' ' A' ' 22' ' ' ARG . 2.9 t -114.69 94.51 37.38 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 35' ' ' SER . 34.7 Cg_endo -76.49 -159.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.598 2.198 . . . . 0.0 110.765 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.578 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -76.07 -34.5 59.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.368 -0.832 . . . . 0.0 110.551 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.96 32.86 0.73 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.077 -1.015 . . . . 0.0 109.932 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.515 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 74.8 m -139.66 -37.58 0.49 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.077 -1.014 . . . . 0.0 109.749 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 33' ' ' THR . 11.0 p90 -55.79 173.16 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.584 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.59 -94.93 0.66 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -90.61 113.13 25.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.358 -1.083 . . . . 0.0 109.414 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -140.77 143.46 34.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 109.983 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.643 ' OH ' HG23 ' A' ' 121' ' ' VAL . 19.0 m-85 -42.34 144.75 0.46 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.884 . . . . 0.0 110.415 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 2.0 pt-20 -90.85 -46.72 8.04 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.301 -0.874 . . . . 0.0 109.626 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.625 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -81.86 72.48 2.78 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.522 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -161.28 -145.01 0.11 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.152 -1.205 . . . . 0.0 109.837 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.56 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 23.7 m -138.61 162.1 35.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.333 -0.854 . . . . 0.0 108.811 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 39' ' ' PHE . 11.3 m-85 -160.28 105.31 1.49 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.927 -1.108 . . . . 0.0 110.357 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 57.3 t -78.95 115.19 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.91 -1.119 . . . . 0.0 108.342 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.972 ' CD1' HD12 ' A' ' 18' ' ' ILE . 2.1 tt -104.59 116.08 31.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.31 -0.869 . . . . 0.0 110.721 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.745 HD22 HD23 ' A' ' 11' ' ' LEU . 19.5 tp -98.68 109.05 21.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.015 -1.053 . . . . 0.0 109.433 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.427 ' OG ' HG22 ' A' ' 18' ' ' ILE . 2.6 t -99.91 128.86 45.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.172 -0.955 . . . . 0.0 109.631 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.417 ' OG1' ' OD2' ' A' ' 12' ' ' ASP . 1.2 m -113.64 150.46 33.13 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.54 ' CG ' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -135.93 166.28 23.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.885 . . . . 0.0 109.479 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.54 ' N ' ' CG ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -104.86 147.51 27.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.425 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.9 p -142.18 -172.71 3.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.485 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.3 -10.42 71.12 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 56' ' ' GLY . 1.2 p -107.5 -53.52 2.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -1.172 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.425 ' N ' ' OG ' ' A' ' 55' ' ' SER . . . -157.32 -122.72 0.72 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.584 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 16.5 m-85 -129.32 156.24 44.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -1.092 . . . . 0.0 109.516 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.1 t -117.07 117.58 30.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.848 . . . . 0.0 108.941 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.546 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 26.2 m-85 -97.59 159.52 14.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.974 . . . . 0.0 110.166 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.739 ' CB ' ' HE1' ' A' ' 95' ' ' HIS . 9.3 m-80 -150.06 90.85 1.71 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 1.036 ' CG2' HG23 ' A' ' 81' ' ' THR . 5.9 mt -77.72 135.21 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 110.415 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.756 ' CD2' ' HB2' ' A' ' 95' ' ' HIS . 56.4 m80 -122.0 161.95 22.02 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 53.7 p90 -138.95 96.02 3.05 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 118.4 -1.32 . . . . 0.0 109.387 176.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.593 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 14.8 t90 -69.61 139.9 53.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -123.01 61.84 1.01 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.239 -0.913 . . . . 0.0 111.014 -178.253 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -53.07 89.72 0.01 OUTLIER Glycine 0 N--CA 1.5 2.967 0 N-CA-C 107.967 -2.053 . . . . 0.0 107.967 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 65' ' ' LEU . 5.2 ttmm -49.5 91.9 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.625 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 12.6 m120 -161.65 -42.05 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.534 ' OG ' ' CG ' ' A' ' 73' ' ' GLU . 24.4 p -65.57 -145.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.456 -0.777 . . . . 0.0 109.299 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.619 ' CB ' ' HE1' ' A' ' 26' ' ' MET . 3.9 p -116.11 170.74 8.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.072 -1.017 . . . . 0.0 109.847 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.509 ' HA ' ' HG2' ' A' ' 74' ' ' GLN . 7.3 tt0 -70.51 -11.58 61.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.412 -0.805 . . . . 0.0 110.403 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -82.34 -51.45 7.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.744 -1.223 . . . . 0.0 109.634 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.608 ' OE1' HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -63.69 -30.08 71.23 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.065 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.615 ' HB2' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -70.23 -33.32 71.51 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.187 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.518 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -79.65 -17.19 76.03 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.56 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -82.23 -36.32 27.3 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.385 -1.068 . . . . 0.0 108.706 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.828 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -69.53 -51.95 30.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.364 -0.835 . . . . 0.0 108.989 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.35 79.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.296 -0.877 . . . . 0.0 109.224 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 75' ' ' GLY . 74.2 mt -56.58 -42.49 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.264 -0.898 . . . . 0.0 109.309 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.655 ' CG ' HD22 ' A' ' 3' ' ' LEU . 3.5 m-85 -63.57 -29.68 70.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.227 -0.921 . . . . 0.0 108.661 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 1.036 HG23 ' CG2' ' A' ' 61' ' ' ILE . 15.9 m -71.49 -23.58 61.83 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 m -86.87 -29.04 22.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.567 -0.708 . . . . 0.0 109.229 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.494 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -73.21 -39.87 65.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.297 -0.877 . . . . 0.0 109.493 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.532 ' SD ' HG21 ' A' ' 61' ' ' ILE . 4.8 ptm -77.06 -27.74 54.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.453 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.596 ' HA ' HD11 ' A' ' 61' ' ' ILE . 7.8 t70 -66.72 -35.17 79.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.195 -0.94 . . . . 0.0 109.372 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -86.65 -23.33 25.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 0.0 109.393 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.494 ' CD1' ' O ' ' A' ' 83' ' ' GLN . 5.0 m-85 -87.3 -12.96 44.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -0.967 . . . . 0.0 109.448 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.564 HD11 HD22 ' A' ' 11' ' ' LEU . 21.1 mt -89.66 10.72 22.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.566 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 97.25 1.54 59.35 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 1.8 m 75.78 3.06 3.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -1.186 . . . . 0.0 109.629 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.401 ' H ' HG22 ' A' ' 91' ' ' VAL . 4.2 m -83.94 -16.5 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.397 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.546 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -70.57 172.75 8.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.553 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.67 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.5 t -124.97 176.91 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.315 -0.865 . . . . 0.0 109.267 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.67 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -125.18 132.47 53.03 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.082 -1.011 . . . . 0.0 109.161 179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.756 ' HB2' ' CD2' ' A' ' 62' ' ' HIS . 9.7 m80 -130.25 153.49 48.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.652 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.535 ' HG3' ' CZ ' ' A' ' 63' ' ' TYR . 23.9 ttp180 -118.06 129.67 55.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 110.153 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.503 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 32.8 mp0 -134.01 164.45 27.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.0 t -157.49 -172.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.282 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.726 ' H ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -75.78 78.46 2.72 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.562 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 134.7 -16.71 4.26 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.496 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 37.9 m-70 -99.94 -16.05 18.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.704 -0.88 . . . . 0.0 108.822 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.593 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.12 22.76 3.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.549 -0.719 . . . . 0.0 109.366 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 105' ' ' THR . 90.9 p -57.99 -130.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.511 -0.743 . . . . 0.0 110.993 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.841 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 49.0 mt-10 -39.82 -24.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.07 -1.019 . . . . 0.0 111.271 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 103' ' ' SER . 7.6 m -70.62 -60.92 1.98 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.853 -1.154 . . . . 0.0 110.354 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.571 ' CG ' ' OE1' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -61.7 -50.2 73.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.805 -1.184 . . . . 0.0 108.582 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -61.95 -26.74 68.38 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.36 -0.837 . . . . 0.0 108.828 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -57.67 -51.74 68.29 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.468 ' HB3' HD13 ' A' ' 18' ' ' ILE . 23.1 m-85 -70.98 -17.1 62.67 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.883 ' CG ' HD21 ' A' ' 114' ' ' LEU . 24.6 m-85 -108.17 93.88 4.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.467 -0.77 . . . . 0.0 109.538 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.499 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -86.17 61.81 7.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.971 . . . . 0.0 109.361 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 111' ' ' LYS . 11.8 mt-30 -163.6 -78.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.775 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 179.82 130.88 1.54 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.883 HD21 ' CG ' ' A' ' 110' ' ' PHE . 44.8 mt -96.56 107.75 20.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 109.977 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.511 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 1.3 mm -79.84 164.9 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.559 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 71.1 m-85 -137.35 133.12 34.51 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.039 -1.038 . . . . 0.0 110.055 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 2.7 mmpt? -117.28 -171.81 2.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.099 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.586 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 36.7 mm-40 -90.7 128.64 36.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.073 -1.017 . . . . 0.0 110.145 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.57 ' HA2' ' CG ' ' A' ' 40' ' ' TYR . . . -58.62 -154.96 0.01 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 55.54 79.58 0.09 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.776 HG12 ' HB3' ' A' ' 25' ' ' ASN . 0.4 OUTLIER -86.21 10.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.324 -1.103 . . . . 0.0 109.52 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 123' ' ' SER . . . -79.12 -76.72 0.19 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.7 -0.625 . . . . 0.0 109.535 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER 167.67 -29.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.39 -69.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.405 ' O ' ' C ' ' A' ' 126' ' ' LYS . 5.5 mmt -121.59 -150.49 0.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -1.144 . . . . 0.0 109.462 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.412 ' C ' ' HD2' ' A' ' 126' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.491 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.657 HG22 ' CD ' ' A' ' 27' ' ' GLU . 2.1 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 1' ' ' VAL . 9.8 pt-20 40.25 50.1 2.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.571 -0.705 . . . . 0.0 109.758 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.699 HD22 ' CG ' ' A' ' 80' ' ' TYR . 1.4 pp -43.07 -28.3 0.27 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 109.443 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.511 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 6.9 p -57.03 143.06 39.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 109.947 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 4' ' ' SER . 4.1 ttmt 73.41 -79.5 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.508 -0.745 . . . . 0.0 109.69 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 5' ' ' LYS . 7.8 mttm -45.4 -27.04 0.63 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.931 -1.105 . . . . 0.0 108.952 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.701 HG13 ' CE2' ' A' ' 21' ' ' TRP . 41.5 t -106.86 -33.97 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.541 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 8.0 p -87.28 -153.19 0.21 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.392 -0.817 . . . . 0.0 109.124 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.425 ' O ' ' HD2' ' A' ' 10' ' ' LYS . . . 84.15 -44.83 3.39 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -167.67 61.18 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.219 -1.166 . . . . 0.0 109.125 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.108 HD23 HD22 ' A' ' 48' ' ' LEU . 3.0 mp -41.81 -71.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.416 -0.802 . . . . 0.0 109.661 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.527 ' HB3' ' CB ' ' A' ' 50' ' ' THR . 14.4 m-20 -145.88 75.9 1.44 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.431 ' O ' ' OG1' ' A' ' 14' ' ' THR . 17.0 mmtt -91.47 125.51 36.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.515 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 23.4 p 48.6 57.3 6.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.389 -0.82 . . . . 0.0 109.535 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.3 m -162.64 104.76 1.06 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.46 -0.775 . . . . 0.0 109.243 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.94 130.76 11.59 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.312 2.008 . . . . 0.0 110.377 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.1 172.98 12.8 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.94 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -125.91 145.04 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.853 -1.381 . . . . 0.0 110.488 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -112.42 167.17 10.66 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.987 HD11 ' CZ ' ' A' ' 110' ' ' PHE . 26.1 mt -132.25 161.13 41.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.333 -1.479 . . . . 0.0 110.242 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.782 ' HA ' HG23 ' A' ' 31' ' ' VAL . 7.7 m-90 -120.87 122.77 40.96 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.938 ' HD2' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -79.84 130.26 35.16 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.922 -1.111 . . . . 0.0 110.755 -178.463 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 23' ' ' ILE . 7.9 mm -94.2 25.48 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.642 ' HB2' HG21 ' A' ' 121' ' ' VAL . 19.6 pt-20 -57.19 166.81 1.02 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.709 -0.619 . . . . 0.0 109.861 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.537 ' ND2' ' HG3' ' A' ' 24' ' ' GLU . 14.0 p30 42.66 27.67 0.1 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.476 ' HA ' ' OE2' ' A' ' 73' ' ' GLU . 3.8 mmt 53.64 55.23 8.81 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.499 -0.751 . . . . 0.0 109.622 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.657 ' CD ' HG22 ' A' ' 1' ' ' VAL . 0.9 OUTLIER -160.33 144.88 14.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 0.0 109.445 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.606 ' CE ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -76.54 136.36 39.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.051 -1.031 . . . . 0.0 109.788 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.764 HG12 ' CD ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -147.12 151.76 41.77 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.673 ' HD2' HG13 ' A' ' 29' ' ' VAL . 31.9 Cg_endo -72.99 134.27 21.21 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.362 2.041 . . . . 0.0 111.747 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.938 HG22 ' HD2' ' A' ' 22' ' ' ARG . 2.5 t -120.43 104.9 42.32 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.97 -157.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.557 2.171 . . . . 0.0 110.551 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.558 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -78.55 -25.97 45.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.171 -0.956 . . . . 0.0 109.101 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.36 32.47 0.77 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.275 -0.891 . . . . 0.0 109.854 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.509 ' HB2' ' CG1' ' A' ' 31' ' ' VAL . 17.3 m -155.07 -35.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 0.0 110.011 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.854 ' HB2' HD12 ' A' ' 20' ' ' ILE . 11.9 p90 -60.06 -41.22 91.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.011 -1.056 . . . . 0.0 109.768 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.51 ' N ' ' CG ' ' A' ' 36' ' ' TYR . . . -51.7 -24.29 12.24 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.844 ' HA ' HG22 ' A' ' 115' ' ' ILE . 0.9 OUTLIER -131.87 129.85 40.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.088 -1.242 . . . . 0.0 110.158 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -148.56 128.48 13.5 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.291 -0.881 . . . . 0.0 109.671 179.261 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.688 ' HE2' HG22 ' A' ' 121' ' ' VAL . 8.5 m-30 -47.55 140.1 6.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.489 -0.757 . . . . 0.0 110.6 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 1.6 pt-20 -91.3 29.12 1.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -0.864 . . . . 0.0 109.588 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.617 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -146.21 54.62 0.54 Allowed Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.467 ' CG ' ' O ' ' A' ' 42' ' ' GLY . 1.4 m-20 -162.94 -139.47 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.502 -0.999 . . . . 0.0 109.754 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.583 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 53.7 m -147.44 158.83 44.14 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.583 ' CD1' ' O ' ' A' ' 44' ' ' CYS . 31.4 m-85 -149.48 169.5 20.76 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.075 -1.016 . . . . 0.0 108.982 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.59 HG11 ' CE ' ' A' ' 84' ' ' MET . 44.3 t -132.25 113.08 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.783 HD11 HG13 ' A' ' 18' ' ' ILE . 3.8 tt -103.65 106.37 16.86 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.861 -1.149 . . . . 0.0 110.981 -178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.108 HD22 HD23 ' A' ' 11' ' ' LEU . 19.2 tp -94.37 124.92 38.68 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.782 ' OG ' HG22 ' A' ' 18' ' ' ILE . 8.5 t -115.18 136.22 53.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.096 -1.003 . . . . 0.0 109.788 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.527 ' CB ' ' HB3' ' A' ' 12' ' ' ASP . 1.2 m -130.56 124.26 31.41 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.83 137.59 52.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.525 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.581 ' O ' HG23 ' A' ' 53' ' ' THR . 0.7 OUTLIER -54.91 163.85 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.893 . . . . 0.0 109.437 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -165.4 -172.87 2.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.445 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.79 -29.16 39.75 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.68 -17.7 43.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -1.114 . . . . 0.0 109.42 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.8 -69.06 0.45 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.583 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 14.5 m-85 -160.09 157.16 28.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -1.139 . . . . 0.0 109.528 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.66 112.21 15.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 109.114 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.8 ' CD2' HD22 ' A' ' 88' ' ' LEU . 6.6 m-30 -91.93 153.93 19.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.245 -0.909 . . . . 0.0 109.929 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.617 ' CB ' ' HE1' ' A' ' 95' ' ' HIS . 0.6 OUTLIER -147.7 95.25 2.48 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.979 ' CG2' HG23 ' A' ' 81' ' ' THR . 15.3 mt -83.39 130.36 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.172 -0.955 . . . . 0.0 110.519 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.745 ' CD2' ' HB2' ' A' ' 95' ' ' HIS . 38.3 m80 -115.39 164.17 14.65 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.603 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 48.1 p90 -137.87 96.78 3.28 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.611 -1.236 . . . . 0.0 109.792 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.576 ' CE2' ' OE1' ' A' ' 102' ' ' GLU . 6.7 t90 -72.62 141.41 48.34 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -125.57 65.3 1.17 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.069 -1.019 . . . . 0.0 110.865 -178.642 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -49.49 90.46 0.01 OUTLIER Glycine 0 N--CA 1.499 2.834 0 N-CA-C 108.414 -1.874 . . . . 0.0 108.414 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -39.15 91.48 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.927 0.87 . . . . 0.0 112.683 -177.679 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.617 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 1.2 m120 -162.65 -42.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.489 ' HB2' ' CB ' ' A' ' 73' ' ' GLU . 95.9 p -63.9 -151.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.582 -0.699 . . . . 0.0 109.343 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.432 ' OG ' ' OD1' ' A' ' 72' ' ' ASP . 80.1 p -121.2 176.57 5.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 109.62 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 12.0 tt0 -55.12 -41.39 71.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.549 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.432 ' OD1' ' OG ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -60.29 -43.24 96.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.159 -0.963 . . . . 0.0 109.551 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.489 ' CB ' ' HB2' ' A' ' 69' ' ' SER . 2.7 tp10 -56.33 -36.6 68.92 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.022 -1.049 . . . . 0.0 108.353 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 6.6 tt0 -62.7 -36.16 82.06 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.858 ' O ' HD13 ' A' ' 79' ' ' ILE . . . -80.06 -13.82 81.51 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.577 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -78.72 -54.02 6.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.234 -1.157 . . . . 0.0 109.156 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.505 ' HB2' ' CD1' ' A' ' 23' ' ' ILE . . . -72.45 -26.43 61.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.398 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.3 -48.38 20.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.25 -0.906 . . . . 0.0 109.564 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.858 HD13 ' O ' ' A' ' 75' ' ' GLY . 1.5 mp -65.54 -39.2 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -0.901 . . . . 0.0 108.994 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.699 ' CG ' HD22 ' A' ' 3' ' ' LEU . 3.8 m-85 -61.45 -39.46 90.92 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.053 -1.029 . . . . 0.0 108.331 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.979 HG23 ' CG2' ' A' ' 61' ' ' ILE . 3.0 m -67.12 -24.78 65.96 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.4 m -76.82 -37.02 56.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.454 -0.779 . . . . 0.0 109.379 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 24.2 mm100 -66.76 -36.66 82.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 109.585 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.605 ' SD ' HG11 ' A' ' 7' ' ' VAL . 73.3 mtm -71.72 -34.86 69.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.953 . . . . 0.0 109.602 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.55 -58.64 7.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 109.738 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -64.95 -33.33 75.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.672 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 3.1 m-85 -73.2 -10.49 59.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -1.0 . . . . 0.0 109.692 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.968 HD21 HD22 ' A' ' 11' ' ' LEU . 20.1 mt -89.43 -32.19 17.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 109.545 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 121.93 15.55 4.3 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 0.9 OUTLIER 75.8 -0.29 3.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -1.149 . . . . 0.0 109.683 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.535 HG23 ' CD2' ' A' ' 59' ' ' TYR . 15.6 m -83.42 -9.47 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.411 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.744 ' HB2' HD13 ' A' ' 88' ' ' LEU . . . -90.81 176.72 6.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 0.0 109.548 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.671 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.7 t -133.47 177.45 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.365 -0.835 . . . . 0.0 109.156 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.671 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -125.71 135.18 51.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.986 -1.071 . . . . 0.0 108.972 179.532 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.745 ' HB2' ' CD2' ' A' ' 62' ' ' HIS . 7.5 m80 -132.96 149.0 52.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.128 -0.982 . . . . 0.0 109.379 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.585 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -110.77 136.94 49.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 110.384 -179.378 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.515 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 49.8 mm-40 -142.23 164.41 30.23 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.436 -0.79 . . . . 0.0 108.93 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 99' ' ' GLN . 1.8 t -157.78 -165.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.132 -0.98 . . . . 0.0 109.02 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.695 ' H ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -78.36 75.96 4.87 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 178.795 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.94 -12.17 4.78 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.505 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 10.8 m-70 -98.25 -13.21 20.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.667 -0.902 . . . . 0.0 109.107 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.578 ' OE1' ' CD2' ' A' ' 106' ' ' PHE . 2.0 pt-20 -90.05 30.17 1.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.418 -0.801 . . . . 0.0 109.031 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 102' ' ' GLU . 63.5 p -52.45 -141.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.751 0.786 . . . . 0.0 112.126 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.781 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -38.99 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.915 -1.116 . . . . 0.0 111.057 -178.435 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 103' ' ' SER . 0.8 OUTLIER -67.02 -57.47 6.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.811 -1.181 . . . . 0.0 110.138 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.578 ' CD2' ' OE1' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -66.64 -44.33 82.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.959 -1.088 . . . . 0.0 108.309 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.82 -17.54 64.93 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -71.02 -45.4 63.99 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.431 ' HB3' HD12 ' A' ' 18' ' ' ILE . 18.3 m-85 -76.37 -17.88 59.16 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.462 -0.774 . . . . 0.0 109.466 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.987 ' CZ ' HD11 ' A' ' 20' ' ' ILE . 6.9 m-30 -112.07 96.5 6.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.115 -0.991 . . . . 0.0 109.316 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -67.78 86.28 0.22 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.48 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 111' ' ' LYS . 7.3 mm100 72.65 74.82 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.867 . . . . 0.0 109.586 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.777 ' C ' HD22 ' A' ' 114' ' ' LEU . . . -178.73 62.87 0.08 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.785 HD21 ' HB2' ' A' ' 110' ' ' PHE . 3.8 mm? -120.9 63.01 0.87 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -1.14 . . . . 0.0 109.336 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.844 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -85.85 160.96 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.104 -0.998 . . . . 0.0 109.351 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.544 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 2.0 m-85 -139.75 165.0 28.46 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.605 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -146.98 -156.29 0.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.591 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 1.6 tt0 -91.48 169.41 10.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.968 . . . . 0.0 109.819 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 120' ' ' GLY . . . -99.13 -169.86 30.75 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 47.37 95.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.688 HG22 ' HE2' ' A' ' 40' ' ' TYR . 1.3 t -90.45 103.93 14.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.205 -1.173 . . . . 0.0 109.297 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 121' ' ' VAL . . . -39.82 -81.37 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.693 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.2 p 46.1 25.82 0.37 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.502 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.07 -82.69 1.47 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.37 154.61 17.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -1.167 . . . . 0.0 109.432 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.8 mttt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.489 179.899 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.421 ' O ' HG12 ' A' ' 1' ' ' VAL . 9.1 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 175.54 94.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.43 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.882 ' O ' HD22 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -74.19 3.32 7.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.216 -0.927 . . . . 0.0 110.484 -179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.571 ' N ' HD13 ' A' ' 3' ' ' LEU . 1.7 p -92.74 150.9 20.36 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.811 -1.18 . . . . 0.0 110.34 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.506 ' HD2' ' HG2' ' A' ' 6' ' ' LYS . 12.0 ttmt 47.19 -86.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.429 0.633 . . . . 0.0 110.917 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 4' ' ' SER . 5.8 mmtt -40.54 -27.51 0.05 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.492 -0.755 . . . . 0.0 110.227 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 3' ' ' LEU . 70.4 t -109.16 -31.85 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.097 -1.002 . . . . 0.0 109.607 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.821 HG21 ' CG ' ' A' ' 87' ' ' TYR . 18.2 p -72.22 -3.52 23.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.883 . . . . 0.0 109.473 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 10' ' ' LYS . . . -70.45 85.03 0.34 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 9' ' ' GLY . 5.3 mtmm 80.65 74.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.677 -0.896 . . . . 0.0 109.601 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 8' ' ' THR . 4.7 mt -89.35 32.65 0.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 0.0 109.124 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER 78.31 61.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.438 -0.789 . . . . 0.0 109.357 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.538 ' O ' HG23 ' A' ' 14' ' ' THR . 4.2 mttm -81.6 -10.39 59.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 109.524 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 27.0 p -157.36 67.45 0.52 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.59 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.404 ' O ' ' OD2' ' A' ' 12' ' ' ASP . 99.2 m -161.9 118.5 1.32 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.384 -0.822 . . . . 0.0 109.169 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.84 87.84 1.44 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.255 1.97 . . . . 0.0 110.206 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.462 ' C ' HG23 ' A' ' 18' ' ' ILE . . . -170.48 -145.08 4.58 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.009 HD12 HD11 ' A' ' 47' ' ' LEU . 14.2 pt -157.24 142.21 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.013 -1.287 . . . . 0.0 110.202 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.726 ' NE2' ' CZ2' ' A' ' 21' ' ' TRP . 3.1 tt0 -121.78 117.25 26.12 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.898 HD11 ' HZ ' ' A' ' 110' ' ' PHE . 1.6 mt -90.88 178.16 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.659 -1.276 . . . . 0.0 110.733 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.786 ' CD1' ' HE2' ' A' ' 28' ' ' MET . 9.5 m-90 -137.38 121.18 17.5 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.532 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 3.7 ptp180 -83.75 128.68 34.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.097 . . . . 0.0 111.908 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.58 HD13 ' HB3' ' A' ' 28' ' ' MET . 1.8 mm -111.45 50.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.636 ' HB2' ' CE2' ' A' ' 40' ' ' TYR . 4.7 pt-20 -92.78 -39.06 11.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.372 -0.83 . . . . 0.0 110.295 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.571 ' CB ' HG21 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -88.35 43.77 1.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 108.517 179.32 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.556 ' HE2' ' OE2' ' A' ' 73' ' ' GLU . 0.9 OUTLIER 50.22 24.48 1.48 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.529 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 3.6 pt-20 -151.94 153.74 34.7 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.786 ' HE2' ' CD1' ' A' ' 21' ' ' TRP . 15.5 ptm -97.41 133.69 41.67 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.744 -1.222 . . . . 0.0 110.746 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -120.73 149.33 50.28 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.572 ' HD2' HG13 ' A' ' 29' ' ' VAL . 32.0 Cg_endo -71.94 87.77 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.272 1.981 . . . . 0.0 112.217 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 22' ' ' ARG . 8.6 t -72.99 112.65 16.26 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.537 -0.727 . . . . 0.0 109.473 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 35.9 Cg_endo -78.41 -159.31 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.396 2.064 . . . . 0.0 110.149 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.576 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -88.14 -21.37 24.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 108.909 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -78.91 4.43 14.18 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.291 -0.881 . . . . 0.0 109.661 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 36' ' ' TYR . 38.7 m -128.18 -37.01 1.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.953 . . . . 0.0 109.787 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -42.81 161.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -0.894 . . . . 0.0 109.718 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.535 ' O ' ' CE1' ' A' ' 39' ' ' PHE . . . 110.82 -62.19 0.29 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.474 ' HB3' ' HD3' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -103.75 106.97 17.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -1.152 . . . . 0.0 109.264 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.585 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -130.93 132.47 45.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.124 -0.985 . . . . 0.0 109.989 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.636 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 9.7 m-30 -40.13 131.2 2.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.591 -0.693 . . . . 0.0 111.445 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 0.8 OUTLIER -90.86 112.09 23.78 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.402 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.603 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . 115.22 45.57 0.62 Allowed Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -155.78 -134.29 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.536 -0.979 . . . . 0.0 108.678 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.529 ' HB2' ' CB ' ' A' ' 23' ' ' ILE . 60.8 m -146.18 137.27 24.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.865 -1.147 . . . . 0.0 109.437 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 26.5 m-85 -140.49 108.13 5.62 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.261 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.508 HG13 ' OG1' ' A' ' 81' ' ' THR . 8.2 t -78.86 126.73 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 108.551 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.009 HD11 HD12 ' A' ' 18' ' ' ILE . 7.4 tt -116.65 117.96 31.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.077 -1.015 . . . . 0.0 110.112 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 59' ' ' TYR . 22.2 tp -100.44 113.82 26.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.935 . . . . 0.0 109.333 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.402 ' HA ' HG22 ' A' ' 18' ' ' ILE . 3.1 t -102.4 130.73 49.25 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.225 -0.922 . . . . 0.0 109.538 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 m -121.2 142.82 49.53 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.09 -173.28 3.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.46 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.727 ' O ' HG23 ' A' ' 53' ' ' THR . 1.0 OUTLIER -109.96 168.87 9.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.487 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 52' ' ' LYS . 5.4 p -162.72 -170.9 2.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.06 -17.85 66.34 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.1 m -102.39 -43.74 5.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -1.153 . . . . 0.0 109.478 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.424 ' O ' ' OG1' ' A' ' 53' ' ' THR . . . -175.36 -128.34 1.1 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.579 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 42.1 m-85 -111.23 150.66 29.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -1.125 . . . . 0.0 109.516 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.55 114.33 27.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.0 109.001 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.572 ' HD1' HG23 ' A' ' 91' ' ' VAL . 12.7 m-85 -91.09 155.63 18.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.164 -0.96 . . . . 0.0 109.841 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.81 ' CB ' ' HE1' ' A' ' 95' ' ' HIS . 1.8 m-20 -147.25 92.64 2.13 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.919 ' CG2' HG23 ' A' ' 81' ' ' THR . 21.5 mt -77.64 134.38 28.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 110.374 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.767 ' CD2' ' HB2' ' A' ' 95' ' ' HIS . 58.0 m80 -120.82 162.53 19.64 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 95' ' ' HIS . 45.9 p90 -137.05 97.69 3.57 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 118.605 -1.238 . . . . 0.0 109.298 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.598 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 7.7 t90 -74.33 137.23 42.7 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.774 HD11 ' CG ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -126.53 64.62 1.26 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -0.885 . . . . 0.0 111.095 -178.03 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.451 ' O ' ' HA2' ' A' ' 42' ' ' GLY . . . -49.48 97.38 0.01 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 107.173 -2.371 . . . . 0.0 107.173 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 65' ' ' LEU . 2.2 tptt -55.27 89.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -176.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.603 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 12.0 m120 -160.98 -37.99 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.8 p -67.43 -146.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 109.432 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.451 ' HB2' ' OD2' ' A' ' 72' ' ' ASP . 3.0 p -114.27 158.67 21.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 109.891 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -50.99 -34.89 31.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.451 ' OD2' ' HB2' ' A' ' 70' ' ' SER . 1.6 p30 -58.18 -46.13 86.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.147 -0.971 . . . . 0.0 109.077 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.556 ' OE2' ' HE2' ' A' ' 26' ' ' MET . 59.7 mm-40 -57.09 -36.17 70.29 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.774 ' CG ' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -63.03 -35.92 81.85 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.577 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.531 ' O ' ' CG1' ' A' ' 79' ' ' ILE . . . -81.79 -12.08 81.91 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.19 -54.14 6.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.15 -1.206 . . . . 0.0 109.286 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.481 ' HB1' HG22 ' A' ' 46' ' ' VAL . . . -73.09 -34.02 65.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -0.905 . . . . 0.0 109.376 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.62 -41.76 65.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 109.776 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.531 ' CG1' ' O ' ' A' ' 75' ' ' GLY . 73.0 mt -69.24 -44.87 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.054 -1.029 . . . . 0.0 109.886 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.594 ' CD2' HD12 ' A' ' 3' ' ' LEU . 2.9 m-85 -68.38 -29.5 68.21 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.919 HG23 ' CG2' ' A' ' 61' ' ' ILE . 13.8 m -69.67 -24.17 63.57 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 79' ' ' ILE . 2.1 m -72.62 -49.01 34.86 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 9.3 mt-30 -59.28 -43.38 92.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.368 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.696 ' CG ' HD23 ' A' ' 3' ' ' LEU . 0.9 OUTLIER -55.06 -37.9 67.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.593 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.98 -41.59 99.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.12 4.58 49.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.196 -0.94 . . . . 0.0 109.704 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.821 ' CG ' HG21 ' A' ' 8' ' ' THR . 0.6 OUTLIER -107.97 -13.98 14.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 0.0 109.581 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.48 HD21 ' HB3' ' A' ' 11' ' ' LEU . 20.5 mt -87.13 -66.54 0.9 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 109.589 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.683 ' O ' HG13 ' A' ' 91' ' ' VAL . . . 171.39 37.27 0.03 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.4 m 49.58 22.42 0.76 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -1.15 . . . . 0.0 109.552 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 89' ' ' GLY . 31.1 m -110.86 -25.96 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.198 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -65.46 172.42 3.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 109.515 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.683 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.4 t -126.53 177.76 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.347 -0.846 . . . . 0.0 109.318 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.683 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -125.33 131.77 52.96 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.067 -1.021 . . . . 0.0 109.036 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.81 ' HE1' ' CB ' ' A' ' 60' ' ' ASN . 11.4 m80 -128.52 152.68 48.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.938 . . . . 0.0 109.522 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.574 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 11.7 ttt-85 -114.62 133.23 56.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.365 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.501 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 50.2 mt-10 -140.33 165.11 28.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.108 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.692 HG12 ' H ' ' A' ' 99' ' ' GLN . 1.7 t -155.42 -161.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.085 -1.009 . . . . 0.0 109.319 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.692 ' H ' HG12 ' A' ' 98' ' ' VAL . 8.9 pt20 -82.09 72.78 9.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.086 -1.009 . . . . 0.0 108.552 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 137.07 -19.6 3.45 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.491 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 19.0 m-70 -87.19 -21.96 25.57 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.702 -0.881 . . . . 0.0 108.789 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.598 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.27 22.4 3.35 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.742 0.782 . . . . 0.0 109.124 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.9 p -57.51 -99.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.283 -0.886 . . . . 0.0 111.336 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.943 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 19.1 pt-20 -62.97 -18.32 63.09 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.092 -1.005 . . . . 0.0 111.103 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 1.6 m -79.63 -61.48 1.98 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.805 -1.185 . . . . 0.0 110.166 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.57 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -58.68 -56.45 22.03 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.954 -1.091 . . . . 0.0 108.173 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -57.2 -31.33 65.35 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.455 -0.778 . . . . 0.0 109.18 179.18 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.943 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -51.79 -54.15 31.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.022 -1.049 . . . . 0.0 108.249 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.584 ' HB3' HD13 ' A' ' 18' ' ' ILE . 19.5 m-85 -64.88 -23.95 67.39 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.898 ' HZ ' HD11 ' A' ' 20' ' ' ILE . 9.2 m-85 -102.89 92.53 4.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.518 -0.739 . . . . 0.0 109.312 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.454 ' O ' ' OE1' ' A' ' 112' ' ' GLN . 28.9 mtmm -82.23 89.69 6.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.522 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.454 ' OE1' ' O ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER 168.58 -74.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 108.761 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 114' ' ' LEU . . . -159.78 -142.12 3.31 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.694 HD21 ' CG ' ' A' ' 110' ' ' PHE . 0.5 OUTLIER 174.94 108.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.504 -0.998 . . . . 0.0 108.921 179.433 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.574 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 5.0 mt -93.69 165.04 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 109.374 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.574 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 4.1 m-85 -142.05 113.13 7.5 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.545 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -79.39 -169.24 1.81 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.294 -0.879 . . . . 0.0 109.662 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.583 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 35.5 tp60 -92.64 148.4 22.1 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.751 -1.218 . . . . 0.0 110.73 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.584 ' HA2' ' CD2' ' A' ' 40' ' ' TYR . . . -66.38 -173.73 5.42 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 59.32 117.35 0.01 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.571 HG21 ' CB ' ' A' ' 25' ' ' ASN . 1.5 t -90.75 -141.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.181 -1.187 . . . . 0.0 109.049 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 123' ' ' SER . . . -84.23 -71.86 0.49 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.95 . . . . 0.0 109.386 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 122' ' ' ALA . 1.0 OUTLIER 75.89 14.48 2.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 109.424 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 53.73 55.07 27.23 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -135.48 -69.31 0.5 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -1.139 . . . . 0.0 109.416 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tttm . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.465 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.974 HG22 ' HG2' ' A' ' 27' ' ' GLU . 16.5 t . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.566 ' N ' HG12 ' A' ' 1' ' ' VAL . 7.5 pt-20 39.15 83.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.646 -0.658 . . . . 0.0 109.959 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.848 HD22 ' CG ' ' A' ' 80' ' ' TYR . 2.4 pt? -85.23 14.28 5.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 p -90.83 5.21 49.34 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.675 -1.266 . . . . 0.0 110.088 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -134.26 -48.12 0.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.061 -1.024 . . . . 0.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 8.9 mmtt -89.69 35.48 0.83 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.905 . . . . 0.0 109.024 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.642 HG12 ' HB3' ' A' ' 11' ' ' LEU . 60.6 t -159.3 -49.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.39 -0.819 . . . . 0.0 109.751 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.726 ' HA ' HD23 ' A' ' 11' ' ' LEU . 44.5 p -61.89 -31.3 71.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.325 -0.86 . . . . 0.0 110.137 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 10' ' ' LYS . . . -45.03 -26.62 1.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.5 ' CG ' ' HE3' ' A' ' 13' ' ' LYS . 0.3 OUTLIER 175.87 70.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.505 -0.997 . . . . 0.0 108.622 179.611 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.044 HD12 ' CD2' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -86.92 19.81 2.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.335 -0.853 . . . . 0.0 110.206 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.77 ' OD2' HD21 ' A' ' 48' ' ' LEU . 3.8 p30 157.7 106.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.621 -0.675 . . . . 0.0 109.287 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HE3' ' CG ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -157.94 123.18 4.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 109.644 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 22.1 p 48.34 56.5 7.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.0 109.628 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.5 m -166.41 106.66 0.68 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.392 -0.817 . . . . 0.0 109.27 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 50' ' ' THR . 34.4 Cg_endo -76.96 128.07 9.75 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.347 2.032 . . . . 0.0 110.263 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 144.73 167.91 12.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.951 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -123.64 143.11 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.075 -1.25 . . . . 0.0 109.764 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.472 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 1.7 pm0 -120.15 -170.39 1.96 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.838 HD11 ' HZ ' ' A' ' 110' ' ' PHE . 2.0 mt -147.37 178.65 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.822 -1.174 . . . . 0.0 110.156 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.669 ' H ' HG22 ' A' ' 20' ' ' ILE . 7.1 m-90 -134.67 122.24 21.96 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.54 ' HD3' HG12 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -82.6 130.02 35.04 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.118 -0.989 . . . . 0.0 112.293 -176.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.89 HD13 ' HB2' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -121.18 24.68 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 177.127 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.755 ' HG3' HG21 ' A' ' 121' ' ' VAL . 10.6 pt-20 -63.42 -49.57 73.21 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.223 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.405 ' N ' ' CG ' ' A' ' 24' ' ' GLU . 21.3 p-10 -85.33 42.86 0.97 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.118 -0.989 . . . . 0.0 108.336 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.565 ' HE3' ' CD ' ' A' ' 73' ' ' GLU . 79.4 mmm 48.42 34.63 4.9 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.974 ' HG2' HG22 ' A' ' 1' ' ' VAL . 3.2 tt0 -151.57 131.37 13.24 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.852 ' HG3' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -81.42 139.17 35.41 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.089 -1.007 . . . . 0.0 110.237 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -144.0 147.67 38.94 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.536 ' HD2' HG13 ' A' ' 29' ' ' VAL . 32.0 Cg_endo -72.29 88.32 0.86 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.292 1.995 . . . . 0.0 111.618 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' A' ' 21' ' ' TRP . 20.7 t -66.91 111.97 8.45 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 36.2 Cg_endo -78.89 -159.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.408 2.072 . . . . 0.0 110.414 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.459 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -87.55 -12.67 45.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.876 . . . . 0.0 109.085 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.07 26.76 1.12 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.29 -0.881 . . . . 0.0 109.918 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 36' ' ' TYR . 1.1 m -160.08 -37.35 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.046 -1.034 . . . . 0.0 109.823 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.469 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 1.1 p90 -43.42 130.78 5.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.569 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.2 -72.51 0.44 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.542 ' ND2' HD12 ' A' ' 115' ' ' ILE . 13.6 m-20 -94.09 96.85 9.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -1.188 . . . . 0.0 109.518 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.768 ' HZ ' HD22 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -117.33 129.53 55.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.248 -0.908 . . . . 0.0 109.187 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.624 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 84.6 m-85 -39.75 153.13 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.453 -0.779 . . . . 0.0 110.174 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 9.5 pt-20 -90.84 -32.93 15.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.392 -0.818 . . . . 0.0 110.197 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.607 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -91.69 64.49 2.47 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.047 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.489 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 3.2 m-20 -162.83 -144.89 0.09 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.405 -1.056 . . . . 0.0 109.963 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.5 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 84.4 m -149.54 143.36 25.56 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.603 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 29.0 m-85 -140.35 112.39 7.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.367 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.646 ' CG2' ' HB1' ' A' ' 77' ' ' ALA . 90.6 t -79.2 127.13 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.932 -1.105 . . . . 0.0 108.59 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.812 HD21 HG13 ' A' ' 18' ' ' ILE . 8.9 tt -107.69 162.81 13.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.9 -1.125 . . . . 0.0 109.901 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.044 ' CD2' HD12 ' A' ' 11' ' ' LEU . 13.8 tp -151.32 115.15 4.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.073 -1.017 . . . . 0.0 108.997 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.518 ' HA ' ' HB ' ' A' ' 18' ' ' ILE . 3.5 t -109.78 132.14 54.42 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.007 -1.058 . . . . 0.0 110.319 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 1.3 m -125.95 120.87 31.5 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -125.92 157.67 37.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 109.556 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.03 151.76 40.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.458 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.72 HG21 ' OG ' ' A' ' 58' ' ' SER . 1.4 p -137.51 -171.97 3.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.209 -0.932 . . . . 0.0 109.523 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.0 -12.32 77.1 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 p -108.17 -36.42 6.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -1.107 . . . . 0.0 109.461 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.95 -100.88 0.15 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 5.9 m-85 -131.53 154.54 48.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -1.171 . . . . 0.0 109.515 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.72 ' OG ' HG21 ' A' ' 53' ' ' THR . 52.5 m -126.42 112.87 16.13 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.71 ' CD2' HG23 ' A' ' 91' ' ' VAL . 2.8 m-85 -92.62 154.43 18.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.176 -0.953 . . . . 0.0 110.421 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.539 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 6.5 m-20 -140.16 98.68 3.5 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.971 ' CG2' HG23 ' A' ' 81' ' ' THR . 37.2 mt -89.38 119.25 36.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 110.79 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.571 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 21.1 m-70 -109.01 164.44 12.41 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.596 ' CE1' ' HA ' ' A' ' 96' ' ' ARG . 39.4 p90 -138.67 103.73 4.92 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.114 -1.435 . . . . 0.0 109.702 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.602 ' C ' HD23 ' A' ' 65' ' ' LEU . 2.4 t90 -78.97 130.25 35.35 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.047 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.602 HD23 ' C ' ' A' ' 64' ' ' TRP . 0.1 OUTLIER -122.36 65.8 0.94 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.496 -0.753 . . . . 0.0 110.706 -178.526 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.452 ' HA2' ' HB2' ' A' ' 99' ' ' GLN . . . -51.29 89.63 0.01 OUTLIER Glycine 0 N--CA 1.497 2.746 0 N-CA-C 108.304 -1.918 . . . . 0.0 108.304 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -39.1 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 122.076 0.941 . . . . 0.0 112.255 -177.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.607 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 1.5 m120 -162.1 -45.2 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 73' ' ' GLU . 88.5 p -62.86 -148.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.354 -0.841 . . . . 0.0 109.199 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.46 ' OG ' ' OD2' ' A' ' 72' ' ' ASP . 2.5 p -121.86 168.54 11.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -48.46 -29.11 3.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.351 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.46 ' OD2' ' OG ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -68.24 -44.49 75.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.446 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.565 ' CD ' ' HE3' ' A' ' 26' ' ' MET . 0.1 OUTLIER -57.16 -36.53 70.88 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.391 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.55 ' HA ' HD11 ' A' ' 65' ' ' LEU . 24.5 tt0 -64.09 -34.96 79.23 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.506 ' O ' ' CG1' ' A' ' 79' ' ' ILE . . . -79.83 -13.46 82.24 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.38 -54.02 6.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -1.124 . . . . 0.0 109.248 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.89 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -75.15 -39.66 60.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.163 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 74' ' ' GLN . . . -63.1 -49.36 74.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.355 -0.84 . . . . 0.0 109.306 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' A' ' 75' ' ' GLY . 70.5 mt -63.57 -44.13 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.211 -0.931 . . . . 0.0 109.414 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.848 ' CG ' HD22 ' A' ' 3' ' ' LEU . 14.5 m-30 -62.98 -25.36 68.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.245 -0.909 . . . . 0.0 109.033 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.971 HG23 ' CG2' ' A' ' 61' ' ' ILE . 5.9 m -79.14 -23.41 44.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.3 m -88.79 -21.82 23.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.638 -0.664 . . . . 0.0 109.352 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 6.8 mt-30 -83.19 -37.87 23.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.497 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.638 ' CG ' HD13 ' A' ' 61' ' ' ILE . 5.3 ptm -75.75 -29.24 58.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.334 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.617 ' HA ' HD11 ' A' ' 61' ' ' ILE . 67.2 t0 -61.64 -59.64 4.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -0.944 . . . . 0.0 109.698 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.58 -33.8 76.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.136 -0.977 . . . . 0.0 109.476 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 0.5 OUTLIER -69.91 -16.11 63.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 109.59 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.983 ' CD1' HD11 ' A' ' 11' ' ' LEU . 66.7 mt -94.06 22.61 5.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.678 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 86.2 0.59 86.86 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 1.4 p 75.86 7.52 3.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -1.165 . . . . 0.0 109.616 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.71 HG23 ' CD2' ' A' ' 59' ' ' TYR . 15.7 m -83.3 -19.5 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 109.285 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.582 ' HB1' HG13 ' A' ' 61' ' ' ILE . . . -68.38 165.61 18.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.581 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.751 HG12 ' H ' ' A' ' 94' ' ' GLN . 2.5 t -115.86 -177.08 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.376 -0.827 . . . . 0.0 109.125 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.751 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -131.01 138.43 49.66 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.092 -1.005 . . . . 0.0 108.674 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.558 ' CE1' ' HB ' ' A' ' 93' ' ' VAL . 12.2 m80 -135.0 142.77 46.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.088 -1.007 . . . . 0.0 110.179 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.596 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -94.17 117.3 29.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 110.148 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.505 ' HB2' ' HA ' ' A' ' 64' ' ' TRP . 44.5 mm-40 -127.98 158.83 36.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.107 -0.996 . . . . 0.0 109.354 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.725 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.6 t -155.75 -175.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.27 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.725 ' H ' HG12 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -69.77 -1.97 10.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.924 -1.11 . . . . 0.0 110.258 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.69 16.11 1.8 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.553 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 5.6 m80 -120.88 -15.73 8.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.487 -1.008 . . . . 0.0 109.373 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.598 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.37 21.59 3.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 0.0 109.169 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 102' ' ' GLU . 4.3 p -41.75 -106.03 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.545 -0.722 . . . . 0.0 112.177 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -67.97 -31.67 71.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.84 -1.163 . . . . 0.0 111.245 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.69 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -58.82 -59.73 4.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.011 -1.056 . . . . 0.0 110.197 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.561 ' HD2' HD13 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -58.71 -55.62 32.75 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.006 -1.059 . . . . 0.0 108.467 -179.252 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -54.48 -20.64 8.03 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 105' ' ' THR . . . -65.22 -51.99 57.43 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.692 ' HB3' HD12 ' A' ' 18' ' ' ILE . 29.4 m-85 -65.46 -17.19 64.36 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.991 ' CG ' HD21 ' A' ' 114' ' ' LEU . 4.2 m-85 -121.4 100.79 7.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 109.684 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 2.8 pttt -81.27 73.55 8.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.222 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.43 -54.93 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 109.731 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 114' ' ' LEU . . . 156.5 -20.08 0.46 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.991 HD21 ' CG ' ' A' ' 110' ' ' PHE . 23.0 mt 62.77 133.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.295 -1.121 . . . . 0.0 109.895 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.562 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 3.2 mt -116.39 164.9 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 0.0 108.978 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.562 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -141.07 102.28 4.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.36 -0.837 . . . . 0.0 109.151 179.765 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.624 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 3.2 mmtt -79.89 -167.97 1.45 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.893 . . . . 0.0 109.587 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.582 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -91.1 124.4 35.29 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.909 -1.119 . . . . 0.0 110.369 -179.451 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 118' ' ' GLN . . . -56.53 -161.61 0.02 OUTLIER Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 67.04 67.38 2.01 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.755 HG21 ' HG3' ' A' ' 24' ' ' GLU . 1.4 t -90.79 102.72 13.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.316 -1.108 . . . . 0.0 109.648 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 121' ' ' VAL . . . -40.98 -79.49 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.321 0.581 . . . . 0.0 109.798 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 172.65 -29.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.335 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' A' ' 125' ' ' MET . . . 103.82 -38.9 3.01 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.529 ' CG ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER 172.59 -79.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -1.112 . . . . 0.0 109.402 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 125' ' ' MET . 8.9 mttp . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.453 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.962 HG12 ' OE1' ' A' ' 2' ' ' GLU . 1.5 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.962 ' OE1' HG12 ' A' ' 1' ' ' VAL . 15.4 pm0 36.83 51.47 0.94 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.778 -0.576 . . . . 0.0 110.326 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.092 HD22 ' CD2' ' A' ' 80' ' ' TYR . 2.1 pt? -43.33 -31.31 0.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.877 . . . . 0.0 109.412 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.532 ' HA ' ' CG2' ' A' ' 8' ' ' THR . 4.1 t -62.31 87.22 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -0.849 . . . . 0.0 109.935 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.528 ' HG2' ' N ' ' A' ' 6' ' ' LYS . 5.2 ttmm 168.81 -90.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.528 ' N ' ' HG2' ' A' ' 5' ' ' LYS . 1.0 OUTLIER -74.83 -6.62 50.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.202 -0.936 . . . . 0.0 108.94 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.971 HG12 ' CD2' ' A' ' 11' ' ' LEU . 37.4 t -106.9 -72.59 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.833 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 4' ' ' SER . 66.6 p -47.98 -29.66 3.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.678 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 8' ' ' THR . . . -41.81 -47.71 5.06 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.554 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 4.0 mtmt -141.61 -54.39 0.46 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -1.162 . . . . 0.0 109.586 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.069 HD12 ' CD2' ' A' ' 88' ' ' LEU . 55.2 mt 82.22 -42.55 0.13 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.756 -0.59 . . . . 0.0 109.955 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.491 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -170.98 -83.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.939 -1.1 . . . . 0.0 109.605 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER 73.87 124.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.925 . . . . 0.0 109.358 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 22.5 p 48.45 57.02 6.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.442 -0.786 . . . . 0.0 109.521 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.5 m -157.13 101.58 1.92 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.522 -0.736 . . . . 0.0 109.232 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.04 83.66 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.398 2.065 . . . . 0.0 110.502 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.47 -146.3 4.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.868 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -159.24 145.69 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.051 -1.264 . . . . 0.0 109.674 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.708 ' NE2' ' CZ2' ' A' ' 21' ' ' TRP . 8.5 tt0 -122.76 143.58 49.73 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.641 HG22 ' H ' ' A' ' 21' ' ' TRP . 1.5 mt -114.76 175.28 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.745 -1.222 . . . . 0.0 109.537 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.708 ' CZ2' ' NE2' ' A' ' 19' ' ' GLN . 7.3 m-90 -134.81 117.47 15.97 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.55 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -79.51 128.37 33.28 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 -178.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.652 ' CG2' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -101.56 31.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-O 123.075 1.417 . . . . 0.0 107.325 179.098 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.508 ' O ' ' ND2' ' A' ' 25' ' ' ASN . 1.5 pt-20 -54.96 168.44 0.3 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.647 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' CG ' ' A' ' 27' ' ' GLU . 8.0 p30 42.68 27.68 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.634 ' H ' ' HE3' ' A' ' 26' ' ' MET . 0.0 OUTLIER 50.2 56.8 7.36 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.639 -0.663 . . . . 0.0 109.749 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 28' ' ' MET . 10.0 mm-40 -139.51 -99.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.982 -1.074 . . . . 0.0 110.111 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.59 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 4.1 mmm 163.04 140.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.099 -1.001 . . . . 0.0 109.205 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 1.0 OUTLIER -158.95 146.75 13.47 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.125 -0.984 . . . . 0.0 109.488 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.565 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 35.5 Cg_endo -77.45 87.45 1.51 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.842 2.361 . . . . 0.0 111.658 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.55 HG23 ' H ' ' A' ' 22' ' ' ARG . 42.3 t -69.92 113.08 14.86 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.475 ' HG2' ' HG2' ' A' ' 34' ' ' LYS . 34.9 Cg_endo -76.67 -159.91 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.481 2.121 . . . . 0.0 110.827 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -88.61 -16.46 32.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.322 -0.862 . . . . 0.0 109.261 -179.678 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 32' ' ' PRO . 8.9 ptmt -90.38 17.66 7.02 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 110.052 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.1 m -143.2 5.27 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.936 -1.103 . . . . 0.0 110.566 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.567 ' CD1' ' O ' ' A' ' 33' ' ' THR . 30.1 p90 -90.45 146.59 24.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.784 -1.197 . . . . 0.0 109.646 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.424 ' C ' ' OD1' ' A' ' 38' ' ' ASN . . . 136.33 -27.42 2.99 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.566 ' ND2' HD12 ' A' ' 115' ' ' ILE . 0.7 OUTLIER -139.47 106.4 5.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -1.159 . . . . 0.0 109.491 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -119.83 126.89 52.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.108 -0.995 . . . . 0.0 109.67 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.598 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 6.9 m-30 -48.56 121.81 4.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.432 -0.792 . . . . 0.0 109.563 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.598 ' HA ' ' CH2' ' A' ' 64' ' ' TRP . 1.7 pt-20 -64.17 -7.81 10.3 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.104 -0.998 . . . . 0.0 110.297 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.643 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -111.43 57.23 0.43 Allowed Glycine 0 N--CA 1.485 1.901 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.498 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.503 ' OD1' ' HB2' ' A' ' 40' ' ' TYR . 4.3 m-20 -162.34 -143.96 0.09 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.299 -1.118 . . . . 0.0 109.99 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.59 ' HB3' ' HB2' ' A' ' 77' ' ' ALA . 6.3 m -145.54 139.12 26.53 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.494 ' HB3' ' CG2' ' A' ' 20' ' ' ILE . 21.2 m-85 -137.04 106.94 6.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.054 -1.029 . . . . 0.0 110.04 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.576 HG13 ' OG1' ' A' ' 81' ' ' THR . 87.5 t -78.83 128.54 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.102 -0.999 . . . . 0.0 108.857 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.697 HD11 HG13 ' A' ' 18' ' ' ILE . 3.7 tt -107.33 160.88 15.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.019 -1.05 . . . . 0.0 109.895 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.549 ' CD2' ' HB3' ' A' ' 11' ' ' LEU . 20.3 tp -151.18 92.48 1.8 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.999 -1.063 . . . . 0.0 109.519 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.566 ' CB ' ' HB ' ' A' ' 18' ' ' ILE . 3.0 t -96.3 131.0 43.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 110.126 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.468 ' OG1' ' CD2' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -107.07 152.69 23.67 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -138.01 137.58 38.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.106 -0.996 . . . . 0.0 109.642 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.562 ' O ' HG23 ' A' ' 53' ' ' THR . 0.0 OUTLIER -76.98 163.64 26.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.368 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 52' ' ' LYS . 23.6 p -158.55 -177.77 6.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.538 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.36 19.29 36.58 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.7 t -140.91 -50.39 0.44 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -1.145 . . . . 0.0 109.559 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.37 -102.17 0.19 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 3.4 m-85 -152.43 -172.19 4.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -1.15 . . . . 0.0 109.5 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.6 t -149.03 102.92 3.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.844 . . . . 0.0 108.99 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.593 ' CD2' HD22 ' A' ' 88' ' ' LEU . 52.9 m-85 -85.23 159.34 20.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 0.0 110.181 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.658 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 6.2 m-20 -141.36 100.18 3.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.966 ' CG2' HG23 ' A' ' 81' ' ' THR . 47.5 mt -92.51 114.26 29.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.091 -1.005 . . . . 0.0 110.419 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.651 ' CE1' ' CE2' ' A' ' 109' ' ' TYR . 13.8 m-70 -107.91 170.1 8.2 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.545 -0.722 . . . . 0.0 109.272 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.578 ' CE1' ' HA ' ' A' ' 96' ' ' ARG . 53.4 p90 -141.41 107.1 5.09 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.4 -1.32 . . . . 0.0 109.923 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.598 ' CH2' ' HA ' ' A' ' 41' ' ' GLU . 3.0 t90 -82.28 136.46 35.04 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -124.05 63.47 1.07 Allowed 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.329 -178.193 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 68' ' ' ASN . . . -46.49 93.68 0.01 OUTLIER Glycine 0 N--CA 1.498 2.768 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.586 ' N ' ' O ' ' A' ' 65' ' ' LEU . 7.3 tppt? -39.47 84.56 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.643 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 7.7 m120 -163.0 -43.21 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.528 ' HB2' ' CB ' ' A' ' 73' ' ' GLU . 1.4 p -50.29 -178.84 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.755 -0.591 . . . . 0.0 109.483 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.46 ' OG ' ' OD1' ' A' ' 72' ' ' ASP . 1.0 OUTLIER -95.72 -169.0 1.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.553 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.522 ' O ' ' CG ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -70.72 -39.86 73.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 9.3 p-10 -74.34 -24.57 59.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.004 -1.06 . . . . 0.0 109.298 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.528 ' CB ' ' HB2' ' A' ' 69' ' ' SER . 29.5 mt-10 -69.03 -43.03 75.57 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.699 ' HB2' HD11 ' A' ' 65' ' ' LEU . 4.0 pt20 -66.19 -30.35 70.8 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.63 ' O ' HD13 ' A' ' 79' ' ' ILE . . . -83.7 -12.42 77.68 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -83.8 -41.67 17.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.16 -1.2 . . . . 0.0 108.718 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.59 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . . . -72.66 -50.74 22.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.855 . . . . 0.0 108.774 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.53 86.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 109.039 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.63 HD13 ' O ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -63.52 -42.62 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.303 -0.873 . . . . 0.0 108.647 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 1.092 ' CD2' HD22 ' A' ' 3' ' ' LEU . 5.0 m-85 -62.08 -24.23 66.98 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.966 HG23 ' CG2' ' A' ' 61' ' ' ILE . 1.8 m -82.38 -26.31 32.99 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.1 m -70.54 -46.14 64.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.504 -0.747 . . . . 0.0 109.081 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 1.8 mt-30 -68.94 -42.56 76.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.345 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.67 ' O ' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -55.35 -36.0 65.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 109.404 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.487 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.9 t0 -77.4 -36.86 52.96 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.0 109.507 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -86.44 6.21 31.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.57 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 1.9 m-85 -121.0 -17.09 7.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 109.582 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 1.069 ' CD2' HD12 ' A' ' 11' ' ' LEU . 7.0 mt -87.58 4.93 41.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 109.598 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.749 ' O ' HG13 ' A' ' 91' ' ' VAL . . . 96.73 33.63 6.04 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 p 47.02 24.25 0.36 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 0.0 109.627 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.749 HG13 ' O ' ' A' ' 89' ' ' GLY . 14.8 m -100.98 -15.78 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 0.0 109.282 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.547 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -79.98 167.85 19.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.274 -0.891 . . . . 0.0 109.626 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.764 HG12 ' H ' ' A' ' 94' ' ' GLN . 2.8 t -116.16 -176.92 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.452 -0.78 . . . . 0.0 109.099 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.764 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -129.62 142.09 50.81 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.896 -1.127 . . . . 0.0 109.013 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.658 ' CE1' ' OD1' ' A' ' 60' ' ' ASN . 6.1 m80 -143.32 150.19 38.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.067 -1.02 . . . . 0.0 109.882 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.578 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 3.4 ttp180 -108.13 138.3 44.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 110.201 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.512 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 10.5 mm-40 -145.66 161.75 39.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.36 -0.838 . . . . 0.0 109.188 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.754 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.2 t -156.58 -166.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 108.873 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.754 ' H ' HG12 ' A' ' 98' ' ' VAL . 14.2 pt20 -74.12 1.82 10.3 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.837 -1.164 . . . . 0.0 110.127 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.78 19.49 1.27 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.567 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 2.8 m80 -123.93 -9.88 7.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.571 -0.959 . . . . 0.0 109.398 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.656 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 1.2 pp20? -90.39 15.19 11.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.392 -0.817 . . . . 0.0 109.726 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 102' ' ' GLU . 24.5 p -39.72 -109.53 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -75.52 -25.66 57.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.719 -1.238 . . . . 0.0 111.152 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.736 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 4.6 m -64.16 -48.83 74.46 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.823 -1.173 . . . . 0.0 109.501 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.656 ' HB2' ' HB2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -67.56 -57.29 6.73 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.584 ' N ' HD21 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -45.91 -28.04 1.03 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 105' ' ' THR . . . -60.66 -55.22 35.87 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.651 ' CE2' ' CE1' ' A' ' 62' ' ' HIS . 69.6 m-85 -74.33 -3.65 31.53 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.56 ' CG ' HD11 ' A' ' 114' ' ' LEU . 44.9 m-85 -119.15 91.34 3.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.711 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.57 34.17 0.9 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.642 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.31 -71.78 0.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.114 -0.991 . . . . 0.0 109.696 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -173.0 125.85 1.19 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.584 HD21 ' N ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -90.78 125.09 35.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.381 -1.07 . . . . 0.0 110.121 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.566 HD12 ' ND2' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -129.35 166.99 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.558 ' CD1' ' O ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -149.65 112.4 4.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.084 -1.01 . . . . 0.0 109.56 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -96.15 -159.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.424 -0.797 . . . . 0.0 109.801 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -91.07 167.19 12.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.248 -0.907 . . . . 0.0 109.607 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.494 ' HA2' ' OD1' ' A' ' 43' ' ' ASP . . . -80.5 -163.89 29.83 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 62.19 139.52 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.824 HG13 ' N ' ' A' ' 122' ' ' ALA . 2.9 p -90.44 -145.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.219 -1.165 . . . . 0.0 108.673 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.824 ' N ' HG13 ' A' ' 121' ' ' VAL . . . -46.3 -86.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 0.0 109.537 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 122' ' ' ALA . 1.0 OUTLIER 165.04 -41.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.935 . . . . 0.0 109.539 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' A' ' 126' ' ' LYS . . . -112.15 -57.52 0.45 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 39.5 mmm -49.53 144.51 5.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -1.123 . . . . 0.0 109.549 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.484 ' CG ' ' OXT' ' A' ' 126' ' ' LYS . 2.2 ptmt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.497 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 2' ' ' GLU . 1.3 t . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.475 ' H ' HG12 ' A' ' 1' ' ' VAL . 1.5 pt-20 -44.41 126.25 5.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.479 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.727 HD13 ' HB3' ' A' ' 80' ' ' TYR . 0.7 OUTLIER -85.06 14.71 4.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.575 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 5.9 p -92.51 152.22 19.77 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.668 -1.27 . . . . 0.0 109.902 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 4' ' ' SER . 0.1 OUTLIER 80.5 -69.69 0.09 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.71 . . . . 0.0 110.742 178.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.522 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 13.8 ttmt -81.98 16.44 1.9 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.05 -1.031 . . . . 0.0 110.663 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.626 ' HB ' ' O ' ' A' ' 3' ' ' LEU . 51.6 t -158.69 -59.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.917 -1.115 . . . . 0.0 109.825 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.667 ' HA ' HD12 ' A' ' 11' ' ' LEU . 77.4 p -60.55 -13.32 13.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 109.813 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.79 -20.45 6.03 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.537 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 1.7 pttm -170.99 -33.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -1.141 . . . . 0.0 109.772 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.787 HD21 ' SD ' ' A' ' 84' ' ' MET . 0.2 OUTLIER 69.56 -0.4 2.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.39 -0.819 . . . . 0.0 110.093 -179.671 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 11' ' ' LEU . 32.3 m-20 58.63 135.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.109 -0.994 . . . . 0.0 110.201 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.732 ' O ' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -56.59 -19.27 15.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.044 -1.035 . . . . 0.0 108.587 179.235 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 13' ' ' LYS . 13.8 t 44.99 18.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.916 -0.49 . . . . 0.0 111.925 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.629 HG23 ' HD2' ' A' ' 16' ' ' PRO . 0.5 OUTLIER 47.62 -177.17 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.015 -1.053 . . . . 0.0 108.599 179.435 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HD2' HG23 ' A' ' 15' ' ' THR . 34.9 Cg_endo -80.32 90.11 1.26 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.908 1.739 . . . . 0.0 110.32 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.528 ' O ' ' CG2' ' A' ' 18' ' ' ILE . . . -164.3 -120.89 0.54 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.908 HD12 HD11 ' A' ' 47' ' ' LEU . 19.9 pt -160.5 -165.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -1.188 . . . . 0.0 110.232 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.492 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 2.5 mt-30 -170.78 172.95 5.48 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.728 HD11 ' CZ ' ' A' ' 110' ' ' PHE . 18.5 mt -145.88 168.15 7.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.401 -1.437 . . . . 0.0 110.352 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.636 ' HA ' HG23 ' A' ' 31' ' ' VAL . 7.4 m-90 -133.97 118.83 18.31 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.773 ' HG3' HG22 ' A' ' 31' ' ' VAL . 14.4 mtm180 -79.15 121.2 24.72 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.219 -0.926 . . . . 0.0 110.921 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.636 ' CG2' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -101.98 27.48 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.123 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.537 ' HB2' ' CG2' ' A' ' 121' ' ' VAL . 1.3 pt-20 -58.62 179.13 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.375 -0.828 . . . . 0.0 109.421 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' CG ' ' A' ' 27' ' ' GLU . 8.4 p30 42.14 27.47 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.463 ' N ' ' O ' ' A' ' 24' ' ' GLU . 26.9 mmm 54.71 55.27 8.08 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.489 -0.757 . . . . 0.0 109.765 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 70.1 mm-40 -153.47 -134.36 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.117 -0.99 . . . . 0.0 109.356 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.57 ' HE2' ' CD1' ' A' ' 21' ' ' TRP . 3.1 ttt -160.04 149.74 18.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.898 -1.126 . . . . 0.0 109.316 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.561 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -160.16 149.36 14.07 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.099 -1.0 . . . . 0.0 109.587 -179.559 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HD2' HG13 ' A' ' 29' ' ' VAL . 34.6 Cg_endo -76.43 125.88 8.67 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.534 2.156 . . . . 0.0 111.109 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.773 HG22 ' HG3' ' A' ' 22' ' ' ARG . 5.8 t -111.24 105.61 57.02 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.63 -158.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.44 2.093 . . . . 0.0 110.4 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.561 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -81.86 -18.91 42.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 108.952 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.16 32.33 0.76 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.345 -0.847 . . . . 0.0 109.706 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.525 ' HB3' HG13 ' A' ' 31' ' ' VAL . 1.7 m -155.07 -38.8 0.09 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.95 . . . . 0.0 109.624 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.563 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -45.55 129.47 8.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.469 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.34 -77.09 0.39 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.507 ' HA ' HG22 ' A' ' 115' ' ' ILE . 4.4 m-80 -89.1 106.79 18.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -1.165 . . . . 0.0 109.673 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.701 ' HZ ' HD22 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -135.92 137.08 41.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.233 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.68 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 7.2 m-30 -42.33 151.95 0.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.285 -0.885 . . . . 0.0 109.508 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.557 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 12.1 pt-20 -90.93 -37.98 13.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.171 -0.956 . . . . 0.0 109.784 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.626 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -85.69 66.46 3.75 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.193 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -162.91 -150.28 0.16 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.025 -1.28 . . . . 0.0 110.31 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.497 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 34.6 m -139.0 148.1 43.01 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 28.2 m-85 -145.36 109.23 4.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.015 -1.053 . . . . 0.0 109.717 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.605 HG13 ' OG1' ' A' ' 81' ' ' THR . 98.8 t -79.37 122.6 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.999 -1.063 . . . . 0.0 108.549 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.908 HD11 HD12 ' A' ' 18' ' ' ILE . 6.6 tt -108.1 123.5 48.8 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.256 -0.903 . . . . 0.0 110.168 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.579 ' CD2' HD23 ' A' ' 11' ' ' LEU . 24.0 tp -104.55 100.24 9.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.846 -1.159 . . . . 0.0 109.864 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.491 ' OG ' HG22 ' A' ' 18' ' ' ILE . 10.8 t -83.41 127.21 33.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 108.757 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.655 ' CG2' ' CE1' ' A' ' 57' ' ' PHE . 1.2 m -123.02 114.32 20.24 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -116.6 126.59 53.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.269 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.89 ' O ' HG23 ' A' ' 53' ' ' THR . 11.4 pttm -51.52 -176.86 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.329 -0.857 . . . . 0.0 109.325 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -178.72 153.47 0.68 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.444 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 53' ' ' THR . . . -44.2 -26.83 0.99 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.17 -40.49 14.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -1.092 . . . . 0.0 109.41 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.72 -70.29 0.2 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.655 ' CE1' ' CG2' ' A' ' 50' ' ' THR . 0.1 OUTLIER -139.81 175.63 9.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -1.138 . . . . 0.0 111.196 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.66 89.34 1.68 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.589 ' CE1' ' HB3' ' A' ' 57' ' ' PHE . 6.5 m-85 -78.74 157.2 28.57 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.135 0.969 . . . . 0.0 111.32 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.806 ' CB ' ' HE1' ' A' ' 95' ' ' HIS . 7.7 m-80 -151.54 87.6 1.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 1.034 ' CG2' HG23 ' A' ' 81' ' ' THR . 10.3 mt -71.2 140.71 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.295 -0.878 . . . . 0.0 110.4 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.735 ' CD2' ' HB2' ' A' ' 95' ' ' HIS . 66.3 m80 -125.99 160.18 30.72 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 95' ' ' HIS . 50.6 p90 -134.85 96.18 3.48 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 117.979 -1.489 . . . . 0.0 109.887 177.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.599 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 6.0 t90 -74.18 131.74 41.54 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.613 HD11 ' CG ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -121.55 60.96 0.94 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.287 -0.883 . . . . 0.0 111.039 -178.078 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -49.07 90.46 0.01 OUTLIER Glycine 0 N--CA 1.498 2.786 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.59 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -38.43 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.13 0.967 . . . . 0.0 112.61 -177.432 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.626 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 1.5 m120 -162.61 -45.73 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.486 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 96.3 p -59.34 -156.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.517 -0.739 . . . . 0.0 109.276 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 p -109.34 160.7 15.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -45.44 19.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 109.381 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -57.92 -41.74 83.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.141 -0.974 . . . . 0.0 109.361 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.486 ' HG2' ' HB2' ' A' ' 69' ' ' SER . 3.9 tp10 -54.54 -39.77 68.01 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.613 ' CG ' HD11 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -60.43 -37.69 81.71 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.761 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.605 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -70.67 -23.57 77.65 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 77' ' ' ALA . . . -75.71 -67.21 0.69 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.313 -1.11 . . . . 0.0 109.192 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -45.35 -38.09 5.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 0.0 109.301 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.64 -39.91 73.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.665 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.605 HD12 ' O ' ' A' ' 75' ' ' GLY . 17.9 mt -60.83 -48.69 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 0.0 109.5 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.727 ' HB3' HD13 ' A' ' 3' ' ' LEU . 25.5 m-85 -56.92 -42.46 80.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.042 -1.036 . . . . 0.0 108.968 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 1.034 HG23 ' CG2' ' A' ' 61' ' ' ILE . 6.4 m -68.72 -23.65 64.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.485 -0.76 . . . . 0.0 109.141 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.3 m -78.57 -23.59 45.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.452 -0.78 . . . . 0.0 109.46 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 1.2 mt-30 -89.91 -34.5 16.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.671 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.803 ' HB2' HD13 ' A' ' 61' ' ' ILE . 2.4 mtt -63.14 -47.05 84.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.696 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.671 ' N ' HD11 ' A' ' 61' ' ' ILE . 3.1 t70 -50.73 -54.98 18.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.721 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.69 -12.21 59.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.717 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 4.1 m-30 -97.23 -2.92 41.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.609 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.689 HD21 HD22 ' A' ' 11' ' ' LEU . 3.9 mt -108.43 8.23 27.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.55 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 105.59 3.1 40.52 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 1.3 p 75.38 -0.09 3.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -1.174 . . . . 0.0 109.644 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.536 HG23 ' CD2' ' A' ' 59' ' ' TYR . 4.7 m -87.23 15.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.114 -0.991 . . . . 0.0 109.389 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.584 ' HB3' ' HA ' ' A' ' 85' ' ' ASP . . . -100.03 179.33 4.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.586 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.655 HG12 ' H ' ' A' ' 94' ' ' GLN . 4.6 t -135.24 175.86 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.12 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.655 ' H ' HG12 ' A' ' 93' ' ' VAL . 50.4 tt0 -124.91 131.04 53.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.972 -1.08 . . . . 0.0 109.504 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.806 ' HE1' ' CB ' ' A' ' 60' ' ' ASN . 8.8 m80 -130.21 150.02 51.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.8 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.578 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 8.6 ptm180 -109.79 136.02 49.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.369 -0.832 . . . . 0.0 109.801 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.497 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 7.4 mm-40 -139.77 166.21 25.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.263 -0.898 . . . . 0.0 109.595 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.71 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.7 t -155.58 -176.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.354 -0.841 . . . . 0.0 109.2 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.71 ' H ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -67.63 -4.52 12.18 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.966 -1.084 . . . . 0.0 110.335 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.08 14.38 3.06 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.538 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 24.2 m80 -123.01 -20.96 5.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.57 -0.959 . . . . 0.0 109.725 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.599 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.1 OUTLIER -90.28 8.85 31.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.341 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 107' ' ' ARG . 1.0 OUTLIER -56.79 -63.03 1.34 Allowed 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.162 -0.961 . . . . 0.0 111.225 -178.644 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.662 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 3.6 mt-10 -76.5 -55.6 5.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.967 -1.083 . . . . 0.0 111.748 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -61.26 -52.64 63.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.97 -1.082 . . . . 0.0 111.113 -178.238 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.568 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -64.98 -55.0 21.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.968 -1.082 . . . . 0.0 108.914 -178.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' A' ' 103' ' ' SER . 2.3 ttm180 -61.51 -17.26 53.9 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.179 -0.951 . . . . 0.0 108.661 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.662 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -66.14 -59.81 3.41 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.906 ' HB3' HD13 ' A' ' 18' ' ' ILE . 9.2 m-85 -63.43 -16.19 59.83 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 1.064 ' CG ' HD21 ' A' ' 114' ' ' LEU . 43.7 m-85 -108.22 99.51 8.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.474 -0.766 . . . . 0.0 109.536 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -74.77 1.59 12.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.286 -0.883 . . . . 0.0 109.702 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.78 -81.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.066 -1.021 . . . . 0.0 109.822 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' A' ' 114' ' ' LEU . . . 178.04 -29.99 0.07 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 1.064 HD21 ' CG ' ' A' ' 110' ' ' PHE . 33.3 mt 81.75 109.33 0.07 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.589 -0.948 . . . . 0.0 110.284 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.563 HG23 ' N ' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -91.03 172.15 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.654 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.563 ' N ' HG23 ' A' ' 115' ' ' ILE . 1.4 m-85 -150.04 124.88 9.85 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.024 -1.047 . . . . 0.0 109.981 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.68 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -106.4 -164.89 1.04 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.471 -0.768 . . . . 0.0 109.31 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.579 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 1.6 tp60 -91.56 163.03 14.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.879 -1.138 . . . . 0.0 110.165 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 120' ' ' GLY . . . -76.56 -153.68 5.16 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 52.69 101.46 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.537 ' CG2' ' HB2' ' A' ' 24' ' ' GLU . 1.5 t -90.27 -141.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.17 -1.194 . . . . 0.0 109.253 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.39 -33.21 73.84 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.334 -0.854 . . . . 0.0 109.52 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.9 m -104.02 36.85 2.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.86 . . . . 0.0 109.402 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -107.87 -54.66 0.63 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.26 167.63 19.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -1.151 . . . . 0.0 109.49 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.6 mttm . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.416 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 2' ' ' GLU . 29.1 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 2' ' ' GLU . 18.0 pt-20 32.98 93.99 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.428 0.632 . . . . 0.0 110.462 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.639 HD23 ' N ' ' A' ' 3' ' ' LEU . 2.6 pt? -53.8 -33.25 55.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 109.505 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.624 ' HA ' HG23 ' A' ' 8' ' ' THR . 10.7 t -44.53 146.08 0.77 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 4' ' ' SER . 10.9 tttt 80.24 -71.84 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.63 -0.669 . . . . 0.0 109.96 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -84.73 15.76 3.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 109.985 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.526 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 12.0 t -150.56 -65.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.016 -1.052 . . . . 0.0 109.716 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.655 ' HA ' HD21 ' A' ' 11' ' ' LEU . 70.3 p -50.01 -23.19 1.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.4 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 10' ' ' LYS . . . -89.58 33.11 4.49 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.487 ' O ' ' CG ' ' A' ' 10' ' ' LYS . 2.4 tttm 169.28 70.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -1.069 . . . . 0.0 109.17 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.655 HD21 ' HA ' ' A' ' 8' ' ' THR . 4.3 mm? -94.47 74.0 3.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.375 -0.828 . . . . 0.0 109.414 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 13' ' ' LYS . 6.2 t70 62.16 -91.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 109.376 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER 62.37 124.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.954 . . . . 0.0 109.631 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.596 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 22.4 p 48.36 56.99 6.67 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.349 -0.844 . . . . 0.0 109.604 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.436 ' HB ' ' CG ' ' A' ' 12' ' ' ASP . 21.1 m -167.48 102.34 0.6 Allowed Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.417 -0.802 . . . . 0.0 109.414 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.95 99.8 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.423 2.082 . . . . 0.0 110.277 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.455 ' O ' ' CG2' ' A' ' 18' ' ' ILE . . . 179.54 -139.14 3.73 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.018 HD12 HD11 ' A' ' 47' ' ' LEU . 12.3 pt -157.41 142.46 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.049 -1.265 . . . . 0.0 110.1 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -122.24 114.44 20.83 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.588 HD11 ' CE1' ' A' ' 110' ' ' PHE . 2.9 mt -92.49 164.04 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.757 -1.214 . . . . 0.0 109.67 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.681 ' CB ' ' HE3' ' A' ' 28' ' ' MET . 8.3 m-90 -122.01 126.42 48.48 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.596 ' HA ' ' CD1' ' A' ' 45' ' ' TYR . 0.9 OUTLIER -79.23 132.66 36.57 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.177 0.989 . . . . 0.0 111.74 -176.695 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' A' ' 44' ' ' CYS . 2.2 mm -127.27 44.26 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.547 ' HB2' ' CD2' ' A' ' 40' ' ' TYR . 3.2 pm0 -99.81 -40.12 7.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 0.0 110.049 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.521 ' OD1' ' CG ' ' A' ' 27' ' ' GLU . 3.0 p30 -81.97 10.08 7.15 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.132 -0.98 . . . . 0.0 108.677 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.517 ' CE ' ' OG ' ' A' ' 70' ' ' SER . 53.9 mmm 73.08 29.0 1.83 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.521 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 47.6 mt-10 -150.79 103.02 3.04 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.681 ' HE3' ' CB ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -42.29 138.02 1.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 110.173 -179.219 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -139.71 149.37 59.26 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HD2' HG13 ' A' ' 29' ' ' VAL . 35.7 Cg_endo -78.68 82.61 2.44 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.225 1.95 . . . . 0.0 111.737 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.572 ' CG2' ' N ' ' A' ' 22' ' ' ARG . 2.8 t -69.9 112.93 14.01 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.18 -0.95 . . . . 0.0 109.887 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.488 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 36.2 Cg_endo -78.7 -158.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.486 2.124 . . . . 0.0 110.044 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.572 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -90.0 -16.29 30.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.083 -1.01 . . . . 0.0 109.152 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.488 ' HG3' ' HG2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -75.39 -20.31 59.02 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -0.873 . . . . 0.0 109.874 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.0 m -122.96 13.12 9.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.12 -0.988 . . . . 0.0 109.734 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.58 ' CG ' ' O ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -85.05 49.88 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.985 . . . . 0.0 109.914 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.568 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . -137.65 -82.71 0.11 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.542 ' HA ' HG22 ' A' ' 115' ' ' ILE . 4.2 m-80 -81.46 123.96 29.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -1.135 . . . . 0.0 109.58 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.695 ' CZ ' HD22 ' A' ' 114' ' ' LEU . 2.7 p90 -160.24 141.08 12.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.013 . . . . 0.0 110.087 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.691 ' CE2' HG23 ' A' ' 121' ' ' VAL . 5.4 m-30 -39.6 142.9 0.26 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.355 -0.841 . . . . 0.0 110.767 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 15.7 pt-20 -90.66 -38.86 12.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 109.363 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.589 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -83.43 70.97 3.08 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.484 ' OD1' ' HB3' ' A' ' 40' ' ' TYR . 4.9 m-20 -160.66 -132.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.719 -0.871 . . . . 0.0 109.122 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.58 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 57.9 m -156.66 148.77 23.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.988 -1.07 . . . . 0.0 108.599 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.649 ' CZ ' ' HB2' ' A' ' 39' ' ' PHE . 17.2 m-85 -147.57 111.06 4.94 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.353 -0.842 . . . . 0.0 109.575 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.789 HG13 ' OG1' ' A' ' 81' ' ' THR . 4.0 t -79.59 112.21 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.994 -1.066 . . . . 0.0 108.152 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.018 HD11 HD12 ' A' ' 18' ' ' ILE . 7.3 tt -102.97 114.59 29.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.83 -1.168 . . . . 0.0 110.331 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.642 HD11 ' HB3' ' A' ' 59' ' ' TYR . 16.5 tp -99.99 109.89 22.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.237 -0.914 . . . . 0.0 109.195 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 t -97.12 134.28 40.67 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.39 -0.819 . . . . 0.0 109.641 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.53 ' OG1' ' CD1' ' A' ' 59' ' ' TYR . 1.2 m -120.52 135.95 54.92 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.14 155.42 37.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.627 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.511 ' O ' ' CG2' ' A' ' 53' ' ' THR . 0.0 OUTLIER -91.42 155.63 18.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 109.458 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 52' ' ' LYS . 68.9 p -158.83 175.61 13.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 0.0 109.449 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.38 -22.01 71.48 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.13 -52.99 5.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -1.173 . . . . 0.0 109.477 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.06 -97.28 0.11 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.596 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 18.2 m-85 -145.35 156.23 43.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -1.143 . . . . 0.0 109.526 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.0 m -121.89 99.53 6.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.871 . . . . 0.0 108.914 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 1.014 ' CD2' HD22 ' A' ' 88' ' ' LEU . 17.3 m-30 -81.77 158.23 24.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 110.209 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.753 ' CB ' ' HE1' ' A' ' 95' ' ' HIS . 8.0 m-20 -150.43 90.38 1.65 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.996 ' CG2' HG23 ' A' ' 81' ' ' THR . 11.7 mt -77.51 135.52 26.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.231 -0.918 . . . . 0.0 110.291 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.531 ' ND1' ' HB2' ' A' ' 95' ' ' HIS . 55.9 m-70 -122.48 159.56 27.39 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.622 ' CZ ' ' HA ' ' A' ' 96' ' ' ARG . 49.4 p90 -135.52 93.26 2.94 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.92 -1.512 . . . . 0.0 110.099 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.74 ' C ' HD23 ' A' ' 65' ' ' LEU . 5.7 t90 -73.91 119.17 17.75 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.789 HD13 ' HB2' ' A' ' 74' ' ' GLN . 0.2 OUTLIER -110.33 77.41 1.05 Allowed 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.568 -0.707 . . . . 0.0 111.158 -177.284 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' A' ' 99' ' ' GLN . . . -65.7 86.88 0.1 OUTLIER Glycine 0 N--CA 1.494 2.559 0 N-CA-C 107.751 -2.14 . . . . 0.0 107.751 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.478 ' O ' ' OD1' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -52.68 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.798 0.808 . . . . 0.0 112.617 -177.536 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.589 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 10.1 m120 -160.29 -39.1 0.05 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 70' ' ' SER . 11.7 p -71.72 -145.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 109.297 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.517 ' OG ' ' CE ' ' A' ' 26' ' ' MET . 16.8 p -88.62 142.41 27.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 0.0 109.956 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.505 ' CG ' ' OE1' ' A' ' 74' ' ' GLN . 5.5 tt0 -50.78 -46.92 59.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.299 -0.875 . . . . 0.0 109.018 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.93 -38.5 67.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.217 -0.927 . . . . 0.0 109.026 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.537 ' HG3' HG22 ' A' ' 23' ' ' ILE . 1.4 tp10 -56.84 -38.58 72.85 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.789 ' HB2' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -62.45 -35.89 80.7 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.651 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -80.19 -13.64 81.63 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -79.86 -44.25 20.83 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.299 -1.118 . . . . 0.0 108.706 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.12 -44.52 75.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 108.979 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.2 -48.94 71.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.424 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.651 HD12 ' O ' ' A' ' 75' ' ' GLY . 64.6 mt -55.5 -43.97 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.96 . . . . 0.0 109.474 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.568 ' CD2' ' SD ' ' A' ' 28' ' ' MET . 4.5 m-85 -63.35 -32.09 73.42 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.102 -0.999 . . . . 0.0 108.731 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.996 HG23 ' CG2' ' A' ' 61' ' ' ILE . 8.7 m -66.92 -24.8 66.13 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.5 m -84.48 -29.96 25.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.531 -0.73 . . . . 0.0 109.166 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.509 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 1.9 mt-30 -71.45 -38.03 71.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 109.514 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.586 ' HG3' HD13 ' A' ' 61' ' ' ILE . 4.2 ptm -82.38 -33.11 28.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.46 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.53 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 9.2 t0 -59.7 -28.89 67.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 0.0 109.299 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -90.08 -36.83 14.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.872 . . . . 0.0 109.454 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.509 ' CD1' ' O ' ' A' ' 83' ' ' GLN . 5.6 m-85 -71.33 -8.45 53.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 109.565 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 1.014 HD22 ' CD2' ' A' ' 59' ' ' TYR . 20.3 mt -84.98 -14.17 48.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.539 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 90' ' ' SER . . . 100.67 18.22 21.36 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 89' ' ' GLY . 0.3 OUTLIER 73.29 6.77 5.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -1.108 . . . . 0.0 109.606 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.4 m -85.07 -14.95 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.122 -0.986 . . . . 0.0 109.464 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.899 ' HB2' HD13 ' A' ' 88' ' ' LEU . . . -90.14 172.87 8.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 109.546 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.649 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.5 t -128.38 176.14 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 109.312 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.649 ' H ' HG12 ' A' ' 93' ' ' VAL . 33.2 tt0 -122.82 133.48 54.44 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.096 -1.002 . . . . 0.0 109.006 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.753 ' HE1' ' CB ' ' A' ' 60' ' ' ASN . 13.2 m80 -126.83 141.74 51.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.125 -0.984 . . . . 0.0 110.145 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -89.34 120.02 30.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 109.792 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.603 ' HB2' ' HA ' ' A' ' 64' ' ' TRP . 26.9 mt-10 -127.74 156.72 41.98 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.276 -0.89 . . . . 0.0 108.845 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.697 HG12 ' H ' ' A' ' 99' ' ' GLN . 3.0 t -160.11 -179.27 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.301 -0.875 . . . . 0.0 108.874 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.697 ' H ' HG12 ' A' ' 98' ' ' VAL . 28.8 tt0 -73.69 -3.27 27.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.938 -1.101 . . . . 0.0 109.198 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.56 6.21 3.85 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.629 ' CG ' ' CG2' ' A' ' 98' ' ' VAL . 10.9 m170 -109.45 -89.97 0.47 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.397 -1.061 . . . . 0.0 108.766 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -83.5 44.44 0.97 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.446 -0.784 . . . . 0.0 110.269 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -80.62 -61.5 1.95 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 108.698 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.516 ' N ' ' OG ' ' A' ' 103' ' ' SER . 28.2 tt0 -64.46 -47.27 79.67 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.754 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 40.8 m -49.57 -46.51 48.98 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.602 ' HB2' ' O ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -49.73 -65.14 0.61 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.611 ' CA ' HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -42.51 -35.01 0.94 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 105' ' ' THR . . . -52.13 -56.51 14.02 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.867 ' HB3' HD13 ' A' ' 18' ' ' ILE . 97.1 m-85 -56.41 -28.34 59.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.902 . . . . 0.0 108.576 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.635 ' CD2' HD11 ' A' ' 114' ' ' LEU . 87.6 m-85 -88.02 90.38 8.36 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -74.06 -0.14 15.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.438 -0.789 . . . . 0.0 109.923 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -96.85 -85.46 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.109 -0.994 . . . . 0.0 109.594 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -164.22 123.07 1.14 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.695 HD22 ' CZ ' ' A' ' 39' ' ' PHE . 4.4 mt -92.15 145.28 24.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -1.159 . . . . 0.0 110.067 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.542 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -140.29 169.79 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.709 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.571 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 1.0 OUTLIER -147.45 139.34 24.19 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.926 -1.109 . . . . 0.0 110.137 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.425 ' HB2' ' HD1' ' A' ' 40' ' ' TYR . 2.0 mptp? -114.71 -168.25 1.35 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.512 -0.742 . . . . 0.0 109.235 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.583 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 1.1 pm0 -90.92 163.41 14.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.015 -1.053 . . . . 0.0 110.561 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.629 ' HA2' ' CD2' ' A' ' 40' ' ' TYR . . . -93.28 178.67 38.75 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.22 52.8 1.55 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.691 HG23 ' CE2' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -90.01 10.08 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.132 -1.216 . . . . 0.0 109.103 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.24 -23.42 21.24 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.179 -0.95 . . . . 0.0 109.484 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 86.6 p -119.93 32.02 6.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.325 -0.859 . . . . 0.0 109.507 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.22 -80.38 1.46 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.5 mtt -84.48 144.51 28.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -1.137 . . . . 0.0 109.471 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.51 -179.958 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.548 HG22 ' H ' ' A' ' 2' ' ' GLU . 9.7 p . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 80' ' ' TYR . 14.6 pt-20 -43.28 123.21 2.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.349 -0.844 . . . . 0.0 109.639 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.763 HD12 ' HB ' ' A' ' 8' ' ' THR . 1.7 pt? -43.78 133.78 4.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.102 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.604 ' O ' HG22 ' A' ' 8' ' ' THR . 74.4 m -89.23 -176.26 5.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 110.146 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.548 ' CB ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -72.2 -31.26 65.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.372 -0.83 . . . . 0.0 109.147 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -76.93 -28.68 55.33 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 3' ' ' LEU . 1.8 t -70.8 -62.29 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.763 ' HB ' HD12 ' A' ' 3' ' ' LEU . 0.7 OUTLIER -90.32 12.56 17.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.275 -0.891 . . . . 0.0 109.494 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 5' ' ' LYS . . . -70.56 -105.29 0.04 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 11' ' ' LEU . 10.6 mttm -65.23 -29.28 70.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -1.098 . . . . 0.0 109.431 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.893 ' HB3' HD23 ' A' ' 48' ' ' LEU . 4.0 mt 44.34 57.13 4.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.403 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER 68.15 137.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.297 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.448 ' O ' ' OG1' ' A' ' 14' ' ' THR . 26.1 mmtt -142.04 149.7 40.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.659 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 80.5 p 50.09 58.04 5.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.476 -0.765 . . . . 0.0 109.768 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.7 m -171.64 120.82 0.47 Allowed Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.468 -0.77 . . . . 0.0 109.092 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.0 128.18 9.79 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.31 2.007 . . . . 0.0 110.348 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 147.19 169.5 14.71 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.775 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -123.8 155.47 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.011 -1.287 . . . . 0.0 110.159 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.532 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 74.7 mt-30 -115.17 158.3 22.43 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.797 HD11 ' CZ ' ' A' ' 110' ' ' PHE . 4.0 mt -129.02 153.52 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.763 -1.21 . . . . 0.0 110.369 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.869 ' HA ' HG23 ' A' ' 31' ' ' VAL . 9.2 m-90 -115.42 132.54 56.59 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.727 ' CD ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -90.22 128.03 36.28 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.832 -1.167 . . . . 0.0 111.84 -177.351 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.646 HD13 ' HA ' ' A' ' 28' ' ' MET . 5.0 mm -99.69 56.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 177.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.512 ' O ' ' HA3' ' A' ' 120' ' ' GLY . 0.0 OUTLIER -48.44 -106.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.347 -177.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.561 ' O ' ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -45.43 -77.69 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.917 -1.114 . . . . 0.0 108.3 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.587 ' CE ' ' CB ' ' A' ' 69' ' ' SER . 13.2 mmt -163.29 36.85 0.09 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 74.8 mt-10 -141.4 145.42 35.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.343 -0.848 . . . . 0.0 109.367 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.945 ' HE3' HG21 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -73.46 139.01 45.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.253 -0.904 . . . . 0.0 110.238 -179.574 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.928 HG13 ' HD2' ' A' ' 30' ' ' PRO . 1.9 t -138.43 154.96 74.0 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.928 ' HD2' HG13 ' A' ' 29' ' ' VAL . 35.1 Cg_endo -77.37 125.52 7.79 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.316 2.011 . . . . 0.0 111.668 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.869 HG23 ' HA ' ' A' ' 21' ' ' TRP . 1.4 t -118.33 97.8 50.97 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.6 -154.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.676 2.25 . . . . 0.0 110.113 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.596 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -77.51 2.88 14.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.104 -0.997 . . . . 0.0 109.322 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -66.0 -35.44 80.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.142 -0.973 . . . . 0.0 110.307 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.13 68.39 0.38 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.945 -1.097 . . . . 0.0 110.38 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.596 ' CD2' ' HA ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -90.47 39.57 0.98 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.046 -1.034 . . . . 0.0 109.86 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.486 ' HA2' ' CE2' ' A' ' 39' ' ' PHE . . . -144.6 -50.48 0.03 OUTLIER Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.206 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.555 ' HA ' HG22 ' A' ' 115' ' ' ILE . 1.7 m-80 -79.73 93.92 5.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.093 -1.239 . . . . 0.0 109.57 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.72 ' HZ ' HD13 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -129.76 128.83 43.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.508 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.652 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 64.5 m-85 -39.14 124.78 1.52 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.56 -0.713 . . . . 0.0 110.613 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.619 ' HA ' ' CH2' ' A' ' 64' ' ' TRP . 2.7 pt-20 -80.63 -0.14 36.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.281 -0.887 . . . . 0.0 109.303 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.579 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -124.61 54.97 0.72 Allowed Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.477 ' HA ' ' OE1' ' A' ' 73' ' ' GLU . 7.9 m-20 -160.15 -123.99 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.296 -1.12 . . . . 0.0 109.186 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.614 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 92.0 m -153.28 155.42 36.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.88 -1.137 . . . . 0.0 109.568 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.659 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 31.0 m-85 -155.03 116.62 4.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.359 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.945 HG21 ' HE3' ' A' ' 28' ' ' MET . 47.9 t -78.08 160.44 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.695 -1.253 . . . . 0.0 108.141 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.807 ' O ' HD23 ' A' ' 47' ' ' LEU . 7.2 tt -153.76 106.48 2.88 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.496 -1.378 . . . . 0.0 110.12 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.893 HD23 ' HB3' ' A' ' 11' ' ' LEU . 13.1 tp -95.99 109.15 21.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.597 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.766 ' OG ' HG22 ' A' ' 18' ' ' ILE . 12.9 t -98.89 133.5 43.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.334 -0.854 . . . . 0.0 109.644 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.2 m -122.17 142.31 50.54 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.502 ' HG2' ' N ' ' A' ' 52' ' ' LYS . 7.6 ttt180 -142.82 147.78 36.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 109.494 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.56 ' O ' HG23 ' A' ' 53' ' ' THR . 0.0 OUTLIER -80.99 163.41 23.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.979 . . . . 0.0 109.608 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 52' ' ' LYS . 1.5 p -157.97 -168.58 2.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.293 -0.879 . . . . 0.0 109.489 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.22 -41.0 32.53 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 56' ' ' GLY . 1.1 p -79.84 -59.15 2.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -1.184 . . . . 0.0 109.469 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.513 ' N ' ' OG ' ' A' ' 55' ' ' SER . . . -157.09 -129.2 1.11 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.566 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 5.0 m-30 -103.31 -169.72 1.69 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -1.159 . . . . 0.0 109.243 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.486 ' HA ' ' CG2' ' A' ' 91' ' ' VAL . 69.5 m -149.94 107.38 3.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.192 -0.943 . . . . 0.0 109.295 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.707 ' HB3' HD11 ' A' ' 48' ' ' LEU . 48.1 m-85 -89.16 158.09 18.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.207 -0.933 . . . . 0.0 109.805 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.657 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 6.8 m-20 -154.85 92.73 1.49 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.968 ' CG2' HG23 ' A' ' 81' ' ' THR . 9.9 mt -80.83 132.26 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.164 -0.96 . . . . 0.0 110.642 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.757 ' CD2' ' HB2' ' A' ' 95' ' ' HIS . 58.1 m80 -119.57 162.35 19.08 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.832 ' CE2' HD11 ' A' ' 65' ' ' LEU . 49.5 p90 -136.7 94.08 2.94 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.339 -1.345 . . . . 0.0 109.674 176.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 1.083 ' O ' HD23 ' A' ' 65' ' ' LEU . 3.4 t90 -70.2 140.52 52.52 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.083 HD23 ' O ' ' A' ' 64' ' ' TRP . 8.1 mt -138.77 77.32 1.62 Allowed 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 118.532 -1.267 . . . . 0.0 111.144 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 41' ' ' GLU . . . -54.81 90.04 0.01 OUTLIER Glycine 0 C--N 1.275 -2.85 0 N-CA-C 106.9 -2.48 . . . . 0.0 106.9 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.732 ' HE3' HG11 ' A' ' 98' ' ' VAL . 9.5 ptpt -51.45 98.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.379 1.085 . . . . 0.0 112.185 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.579 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 13.7 m120 -160.15 -41.22 0.05 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.587 ' CB ' ' CE ' ' A' ' 26' ' ' MET . 81.9 p -67.22 -144.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.522 -0.736 . . . . 0.0 109.036 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.445 ' OG ' ' OD2' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -115.74 163.0 16.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.024 -1.048 . . . . 0.0 109.777 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -49.83 -32.07 13.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.25 -0.906 . . . . 0.0 109.156 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 3.0 p30 -60.35 -45.53 93.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.144 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 15.2 tt0 -56.91 -37.11 70.98 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 1.008 ' HG2' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -62.24 -35.85 80.21 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.795 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.641 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -81.65 -12.98 80.87 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.58 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -77.5 -52.6 8.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.294 -1.121 . . . . 0.0 108.955 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.568 ' CB ' ' HB3' ' A' ' 44' ' ' CYS . . . -75.88 -38.82 57.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.913 . . . . 0.0 109.1 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.83 94.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.301 -0.874 . . . . 0.0 109.229 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.641 HD12 ' O ' ' A' ' 75' ' ' GLY . 65.4 mt -71.6 -43.67 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.248 -0.908 . . . . 0.0 109.266 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.638 ' CD2' ' CB ' ' A' ' 28' ' ' MET . 3.4 m-85 -57.97 -35.47 71.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.122 -0.986 . . . . 0.0 108.867 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.968 HG23 ' CG2' ' A' ' 61' ' ' ILE . 18.1 m -67.51 -38.77 84.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.403 -0.811 . . . . 0.0 108.856 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.9 m -59.83 -42.86 94.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.844 . . . . 0.0 109.06 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.476 ' OE1' HD21 ' A' ' 3' ' ' LEU . 12.1 mt-30 -67.16 -28.47 68.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.264 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.536 ' HG2' HD12 ' A' ' 88' ' ' LEU . 17.8 ttm -63.08 -45.39 92.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.201 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.54 -15.28 25.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 108.994 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.18 -63.66 1.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.327 -0.858 . . . . 0.0 109.066 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.548 ' CE1' ' CB ' ' A' ' 5' ' ' LYS . 4.7 m-85 -53.93 -20.35 5.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 108.969 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.851 HD21 ' CD1' ' A' ' 11' ' ' LEU . 51.7 mt -90.15 -62.64 1.42 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -0.842 . . . . 0.0 109.196 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 57.22 62.3 6.51 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.3 p -143.64 -143.14 0.14 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.259 -1.142 . . . . 0.0 109.297 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.486 ' CG2' ' HA ' ' A' ' 58' ' ' SER . 11.6 m -92.18 15.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -52.23 173.01 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.693 -0.63 . . . . 0.0 109.826 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.9 t -147.63 177.09 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.524 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.672 ' H ' HG12 ' A' ' 93' ' ' VAL . 68.4 mt-30 -124.43 136.16 53.83 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.111 -0.993 . . . . 0.0 108.877 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.757 ' HB2' ' CD2' ' A' ' 62' ' ' HIS . 9.6 m80 -131.96 150.75 52.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.978 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.573 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 8.6 ttm180 -108.78 124.66 50.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.311 -0.868 . . . . 0.0 109.8 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.492 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 66.6 mm-40 -131.97 163.66 27.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.139 -0.975 . . . . 0.0 109.709 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.732 HG11 ' HE3' ' A' ' 67' ' ' LYS . 2.9 t -156.14 -176.95 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 108.977 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.707 ' H ' HG12 ' A' ' 98' ' ' VAL . 12.3 pt20 -66.23 -5.8 11.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.929 -1.107 . . . . 0.0 110.266 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.88 15.46 3.54 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.56 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 20.5 m-70 -122.57 -19.32 6.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.575 -0.956 . . . . 0.0 109.638 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.629 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.27 24.05 2.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.89 . . . . 0.0 109.508 -179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 102' ' ' GLU . 6.1 p -45.01 -106.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.494 -0.754 . . . . 0.0 111.863 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.812 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 40.6 mt-10 -71.39 -19.05 62.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.843 -1.16 . . . . 0.0 110.948 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.496 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 3.6 m -69.6 -50.9 40.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.897 -1.127 . . . . 0.0 109.605 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.558 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.3 OUTLIER -67.85 -57.26 6.56 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.89 -24.87 25.45 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.17 -0.956 . . . . 0.0 108.628 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.812 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -61.26 -58.36 8.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.38 -0.825 . . . . 0.0 108.823 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -68.33 -8.65 41.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -0.892 . . . . 0.0 109.236 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.797 ' CZ ' HD11 ' A' ' 20' ' ' ILE . 1.1 m-85 -113.47 96.73 6.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.557 ' O ' ' NE2' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -88.56 60.39 5.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 109.697 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.557 ' NE2' ' O ' ' A' ' 111' ' ' LYS . 83.9 mm-40 -153.34 -87.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.181 -0.949 . . . . 0.0 109.553 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.613 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -139.16 -113.47 1.12 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.72 HD13 ' HZ ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER 141.72 86.46 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.576 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -95.04 171.05 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 0.0 108.964 179.772 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.576 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -151.89 129.77 11.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.265 -0.897 . . . . 0.0 109.602 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.652 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -100.17 168.03 10.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.712 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 119' ' ' GLY . 10.6 pt20 -92.52 153.39 19.1 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.769 -1.207 . . . . 0.0 111.372 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.599 ' O ' ' CD1' ' A' ' 40' ' ' TYR . . . 52.1 164.62 0.01 OUTLIER Glycine 0 N--CA 1.498 2.807 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.57 ' O ' ' CE1' ' A' ' 40' ' ' TYR . . . -60.91 -123.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -90.28 12.99 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -1.139 . . . . 0.0 109.253 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.11 0.6 18.25 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.556 -0.715 . . . . 0.0 109.607 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.64 -21.24 2.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -0.952 . . . . 0.0 109.516 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -43.78 -43.38 6.62 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.89 -173.9 3.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -1.158 . . . . 0.0 109.436 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.1 pttm . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.448 180.0 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.945 HG13 ' HB3' ' A' ' 27' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 1' ' ' VAL . 1.5 mm-40 43.48 59.13 3.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.304 -0.872 . . . . 0.0 109.519 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.126 HD13 ' N ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -64.15 -13.89 51.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 109.695 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . 1.126 ' N ' HD13 ' A' ' 3' ' ' LEU . 0.4 OUTLIER -78.21 168.33 20.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 109.791 -179.581 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 4' ' ' SER . 3.8 ttmm 81.39 -69.43 0.08 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.76 -0.588 . . . . 0.0 109.896 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -83.83 12.51 5.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.083 -1.011 . . . . 0.0 110.115 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.559 HG11 ' CZ2' ' A' ' 21' ' ' TRP . 35.0 t -145.52 -77.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.014 -1.054 . . . . 0.0 109.696 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.563 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 77.0 p -39.96 -28.08 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.471 -0.768 . . . . 0.0 109.952 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 7' ' ' VAL . . . -41.98 -59.64 2.84 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 3.3 mtmt -132.58 -29.08 1.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.178 -1.189 . . . . 0.0 110.218 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.999 HD22 HD21 ' A' ' 88' ' ' LEU . 3.1 mp 65.61 9.84 6.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.098 -1.001 . . . . 0.0 109.17 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 62.65 128.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.872 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.733 ' C ' HG22 ' A' ' 14' ' ' THR . 6.0 mmtt -96.43 169.02 10.2 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.733 HG22 ' C ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER 173.96 -83.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.592 -1.317 . . . . 0.0 111.218 -178.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.628 ' OG1' ' HD2' ' A' ' 16' ' ' PRO . 0.6 OUTLIER -161.97 -175.08 0.45 Allowed Pre-proline 0 C--N 1.284 -2.244 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.364 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.628 ' HD2' ' OG1' ' A' ' 15' ' ' THR . 33.3 Cg_endo -76.91 110.3 3.01 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.677 1.585 . . . . 0.0 111.28 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 49' ' ' SER . . . -161.47 -155.68 7.99 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.71 HG13 HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -160.92 154.56 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.734 -1.451 . . . . 0.0 110.523 179.489 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.513 ' N ' HG12 ' A' ' 18' ' ' ILE . 4.9 mp0 -133.82 -168.01 2.04 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.637 ' O ' HG23 ' A' ' 31' ' ' VAL . 55.9 mt -156.07 164.73 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.621 -1.3 . . . . 0.0 110.318 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.75 ' HA ' HG23 ' A' ' 31' ' ' VAL . 15.0 m-90 -124.48 119.0 27.9 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.58 ' HA ' ' CD2' ' A' ' 45' ' ' TYR . 29.8 ttp-105 -80.78 108.85 14.78 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.169 -0.957 . . . . 0.0 112.189 -176.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.799 HD11 ' SD ' ' A' ' 28' ' ' MET . 0.9 OUTLIER -86.57 93.45 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 176.733 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 26' ' ' MET . 1.4 pm0 -56.62 80.02 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.623 ' C ' ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER 41.22 13.64 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.694 -0.629 . . . . 0.0 111.415 -179.149 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.754 ' HE3' ' HA ' ' A' ' 26' ' ' MET . 0.0 OUTLIER -157.75 -76.72 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.271 -1.518 . . . . 0.0 111.142 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.945 ' HB3' HG13 ' A' ' 1' ' ' VAL . 0.4 OUTLIER -89.53 -147.06 0.17 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.167 -0.958 . . . . 0.0 110.776 -177.725 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.799 ' SD ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -144.14 146.62 32.88 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.559 0.695 . . . . 0.0 109.913 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.905 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -140.45 158.82 65.37 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.905 ' HD2' HG13 ' A' ' 29' ' ' VAL . 33.7 Cg_endo -75.33 137.9 21.59 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.32 2.014 . . . . 0.0 111.165 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.75 HG23 ' HA ' ' A' ' 21' ' ' TRP . 2.5 t -123.62 98.44 40.47 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 35' ' ' SER . 34.7 Cg_endo -76.57 -157.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.441 2.094 . . . . 0.0 110.177 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.522 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -83.06 -22.41 33.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.096 -1.002 . . . . 0.0 109.111 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -86.35 1.17 52.1 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.338 -0.851 . . . . 0.0 109.879 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.47 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -131.22 -25.53 2.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.153 -0.967 . . . . 0.0 110.373 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.683 ' CD2' ' CE2' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -68.95 -5.84 23.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.946 -1.096 . . . . 0.0 109.81 -179.57 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.512 ' N ' ' CD1' ' A' ' 36' ' ' TYR . . . -85.67 -4.46 85.27 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.507 ' HB3' ' CG2' ' A' ' 115' ' ' ILE . 17.0 m-80 -153.59 103.06 2.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.133 -1.216 . . . . 0.0 109.57 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.62 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -123.46 131.73 53.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.059 -1.026 . . . . 0.0 109.598 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.625 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 6.6 m-30 -39.53 152.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.544 -0.723 . . . . 0.0 110.148 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 12.4 pt-20 -89.67 -45.09 9.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 109.237 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.631 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -82.58 69.93 3.26 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 25' ' ' ASN . 10.9 m-20 -164.97 -166.39 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.91 -1.347 . . . . 0.0 111.1 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.563 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 1.7 m -127.37 156.87 41.34 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.62 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 30.9 m-85 -147.26 167.97 22.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.172 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.645 HG13 ' OG1' ' A' ' 81' ' ' THR . 99.3 t -132.45 113.31 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.71 HD11 HG13 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -90.13 155.15 19.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.174 -178.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.7 HD21 HD23 ' A' ' 11' ' ' LEU . 27.4 tp -146.5 85.9 1.66 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.564 ' CB ' ' HB ' ' A' ' 18' ' ' ILE . 1.0 OUTLIER -87.5 117.38 26.26 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 122.173 0.987 . . . . 0.0 109.872 -179.216 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.647 HG21 ' CD2' ' A' ' 57' ' ' PHE . 1.4 m -98.04 158.41 15.56 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.521 ' HG3' ' CB ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -160.56 117.62 2.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.915 -1.116 . . . . 0.0 109.867 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.848 ' O ' HG23 ' A' ' 53' ' ' THR . 3.0 pttm -46.78 172.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 0.0 109.268 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.848 HG23 ' O ' ' A' ' 52' ' ' LYS . 1.4 p -167.69 172.95 8.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.44 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.9 -18.8 41.48 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 m -99.5 -52.23 3.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -1.111 . . . . 0.0 109.365 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 52' ' ' LYS . . . -176.08 -100.35 0.13 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.647 ' CD2' HG21 ' A' ' 50' ' ' THR . 0.9 OUTLIER -117.93 158.63 24.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -1.114 . . . . 0.0 110.033 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.521 ' CB ' ' HG3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -130.89 123.58 29.29 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.166 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.816 ' CD2' HD22 ' A' ' 88' ' ' LEU . 7.3 m-85 -105.04 153.52 21.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.856 -1.153 . . . . 0.0 111.753 -177.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.544 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 6.2 m-20 -137.6 95.41 3.06 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 1.016 ' CG2' HG23 ' A' ' 81' ' ' THR . 10.9 mt -87.75 122.71 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 111.156 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.738 ' CD2' ' HB2' ' A' ' 95' ' ' HIS . 14.2 m80 -110.47 169.17 8.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.514 -0.741 . . . . 0.0 109.168 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 95' ' ' HIS . 50.2 p90 -139.23 109.4 6.44 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.817 -1.153 . . . . 0.0 109.044 176.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.553 ' C ' HD23 ' A' ' 65' ' ' LEU . 7.0 t90 -86.05 135.72 33.52 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.279 0.561 . . . . 0.0 109.612 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.903 HD11 ' CG ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -120.02 61.57 0.85 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.93 -178.618 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -51.69 89.81 0.01 OUTLIER Glycine 0 N--CA 1.498 2.767 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 178.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 65' ' ' LEU . 1.5 tppt? -39.02 91.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.091 0.948 . . . . 0.0 112.611 -177.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.631 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 1.5 m120 -162.76 -45.69 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 73' ' ' GLU . 14.2 p -61.21 -157.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.507 -0.745 . . . . 0.0 109.272 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.4 p -106.39 161.83 14.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 0.2 OUTLIER -50.32 -49.98 52.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.879 . . . . 0.0 109.43 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -54.45 -39.65 67.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.123 -0.986 . . . . 0.0 108.913 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.479 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -55.52 -39.25 70.29 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.238 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.903 ' CG ' HD11 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -59.78 -38.02 80.67 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.457 ' O ' HG13 ' A' ' 79' ' ' ILE . . . -69.55 -25.2 75.75 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.762 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -73.19 -59.38 2.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -1.129 . . . . 0.0 109.229 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . . . -49.45 -37.53 26.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 0.0 108.945 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.33 -34.68 68.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.334 -0.854 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.762 HD12 ' HA ' ' A' ' 76' ' ' ALA . 15.4 mt -63.44 -49.12 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.867 . . . . 0.0 109.425 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.673 ' HB3' ' HE2' ' A' ' 28' ' ' MET . 27.2 m-85 -58.47 -41.09 84.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.053 -1.029 . . . . 0.0 108.639 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 1.016 HG23 ' CG2' ' A' ' 61' ' ' ILE . 8.9 m -69.6 -22.34 63.51 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.431 -0.793 . . . . 0.0 108.897 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.8 m -86.44 -18.39 31.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.631 -0.668 . . . . 0.0 109.317 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 1.0 OUTLIER -89.85 -35.48 15.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.554 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.889 ' O ' HD12 ' A' ' 88' ' ' LEU . 5.2 ptm -82.32 -12.26 58.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.952 . . . . 0.0 109.482 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' A' ' 92' ' ' ALA . 9.4 t0 -79.91 -37.24 35.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.328 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -89.77 -29.04 18.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 109.257 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.509 ' HB3' ' HB ' ' A' ' 8' ' ' THR . 1.9 m-85 -76.21 -29.67 57.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.237 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.999 HD21 HD22 ' A' ' 11' ' ' LEU . 6.6 mt -72.06 -3.05 20.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.428 -0.795 . . . . 0.0 109.785 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.81 24.73 7.97 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 56.35 17.75 3.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -1.149 . . . . 0.0 109.322 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.568 HG23 ' CD2' ' A' ' 59' ' ' TYR . 11.7 m -96.64 -14.64 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.896 . . . . 0.0 109.255 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.547 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -77.04 164.53 25.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.316 -0.865 . . . . 0.0 109.427 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.738 HG12 ' H ' ' A' ' 94' ' ' GLN . 2.5 t -113.5 -178.53 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.494 -0.754 . . . . 0.0 109.176 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.738 ' H ' HG12 ' A' ' 93' ' ' VAL . 10.8 tt0 -132.64 136.41 46.47 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.135 -0.978 . . . . 0.0 109.054 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.738 ' HB2' ' CD2' ' A' ' 62' ' ' HIS . 6.9 m80 -137.84 153.6 49.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.405 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.568 ' HA ' ' CE2' ' A' ' 63' ' ' TYR . 16.1 ptm180 -111.78 143.97 41.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.671 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.495 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 40.2 mm-40 -150.68 164.19 36.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.408 -0.808 . . . . 0.0 109.05 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.746 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.3 t -154.52 -169.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 0.0 109.012 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.746 ' H ' HG12 ' A' ' 98' ' ' VAL . 9.0 pt20 -72.76 0.92 9.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.844 -1.16 . . . . 0.0 110.282 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.6 19.57 1.15 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.244 -1.943 . . . . 0.0 108.244 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.544 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 17.6 m80 -125.09 -14.78 6.5 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.715 -0.873 . . . . 0.0 109.789 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.552 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.25 29.34 1.26 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.727 -179.451 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 102' ' ' GLU . 77.6 p -55.99 -131.63 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.368 -0.832 . . . . 0.0 111.138 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.457 ' HG2' ' N ' ' A' ' 105' ' ' THR . 0.1 OUTLIER -40.01 -24.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.769 -1.207 . . . . 0.0 111.068 -178.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.551 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 1.8 m -66.94 -63.78 0.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.843 -1.161 . . . . 0.0 110.592 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.519 ' HB2' ' HB2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -57.14 -47.16 81.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.756 -1.215 . . . . 0.0 108.227 -179.13 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 110' ' ' PHE . 10.6 mtm180 -59.46 -28.06 66.64 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 105' ' ' THR . . . -59.84 -44.47 94.07 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.622 ' OH ' ' CE1' ' A' ' 62' ' ' HIS . 63.6 m-85 -76.53 -12.79 60.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.817 ' CB ' HD21 ' A' ' 114' ' ' LEU . 20.4 m-85 -126.09 105.65 9.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.648 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 112' ' ' GLN . 5.1 ptmt -90.13 26.4 1.89 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 110.112 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.485 ' CB ' ' O ' ' A' ' 111' ' ' LYS . 1.1 pt20 165.2 83.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.892 -1.13 . . . . 0.0 110.469 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 114' ' ' LEU . . . 167.03 -122.89 1.09 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.817 HD21 ' CB ' ' A' ' 110' ' ' PHE . 0.2 OUTLIER 65.76 49.8 1.66 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.557 -0.966 . . . . 0.0 110.888 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.507 ' CG2' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -87.5 167.18 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 177.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.578 ' CZ ' ' O ' ' A' ' 114' ' ' LEU . 2.9 m-85 -143.66 122.73 12.86 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.823 -1.173 . . . . 0.0 110.353 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.625 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 1.9 mttm -102.62 -163.94 1.04 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.462 -0.773 . . . . 0.0 108.972 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.578 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -90.26 161.47 15.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.92 -1.112 . . . . 0.0 110.14 -179.658 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 120' ' ' GLY . . . -67.88 -161.88 1.9 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 58.73 112.5 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.721 HG13 ' N ' ' A' ' 122' ' ' ALA . 4.2 p -90.46 -147.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.265 -1.138 . . . . 0.0 108.676 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.721 ' N ' HG13 ' A' ' 121' ' ' VAL . . . -77.88 4.01 13.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.87 -1.144 . . . . 0.0 109.963 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.423 ' H ' HG13 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -44.92 -49.63 10.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 0.0 109.474 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 126' ' ' LYS . . . 142.81 -60.91 0.53 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.14 -90.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -1.159 . . . . 0.0 109.45 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.508 ' N ' ' O ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.507 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 11.0 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.483 ' HA ' ' CE1' ' A' ' 80' ' ' TYR . 1.9 mt-10 64.64 66.08 0.61 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.347 -0.846 . . . . 0.0 109.521 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.113 HD21 ' CG ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -44.83 -41.16 6.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 3.2 t -42.54 150.56 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.378 -0.826 . . . . 0.0 109.616 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 4' ' ' SER . 14.1 ttpt 80.49 -72.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.586 -0.697 . . . . 0.0 109.775 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.495 ' C ' HG23 ' A' ' 7' ' ' VAL . 70.2 mmtt -88.33 14.53 9.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.079 -1.013 . . . . 0.0 109.851 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.686 HG11 ' HE1' ' A' ' 21' ' ' TRP . 21.8 t -157.2 -74.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.058 -1.026 . . . . 0.0 109.618 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.657 ' HA ' HD21 ' A' ' 11' ' ' LEU . 2.3 m -49.3 -23.16 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 0.0 109.476 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 10' ' ' LYS . . . -89.38 32.89 4.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER 164.12 47.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -1.135 . . . . 0.0 109.464 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.762 HD12 ' HG ' ' A' ' 88' ' ' LEU . 38.2 mt -68.96 -147.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 0.0 109.208 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -83.84 119.6 25.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.961 . . . . 0.0 109.385 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.672 ' O ' HG23 ' A' ' 14' ' ' THR . 5.1 mmmt -122.97 -11.99 8.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 0.0 109.62 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 13' ' ' LYS . 18.4 p -160.8 69.99 0.38 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 109.544 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 15' ' ' THR . 5.9 t -175.33 124.2 0.35 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.371 -0.831 . . . . 0.0 109.176 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.7 105.99 2.12 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.25 1.967 . . . . 0.0 110.514 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 173.33 176.76 42.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.859 HG22 ' HA ' ' A' ' 49' ' ' SER . 3.9 pt -124.49 134.45 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -1.208 . . . . 0.0 109.922 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.446 ' NE2' ' CH2' ' A' ' 21' ' ' TRP . 1.5 tt0 -112.93 140.77 47.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.311 -0.868 . . . . 0.0 108.732 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.665 HD11 ' CZ ' ' A' ' 110' ' ' PHE . 2.2 mt -115.06 -178.91 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.803 -1.186 . . . . 0.0 109.679 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.686 ' HE1' HG11 ' A' ' 7' ' ' VAL . 10.6 m-90 -141.45 119.39 11.93 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.649 ' H ' HG23 ' A' ' 31' ' ' VAL . 2.5 ptt180 -78.9 128.07 32.84 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.122 -0.986 . . . . 0.0 110.147 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 23' ' ' ILE . 5.8 mm -96.49 43.89 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.54 ' HG2' ' N ' ' A' ' 25' ' ' ASN . 31.1 tt0 -70.29 168.04 16.75 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.335 0.588 . . . . 0.0 110.108 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.54 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 8.2 p30 47.18 24.6 0.43 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -0.796 . . . . 0.0 109.141 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.736 ' HE3' ' HG2' ' A' ' 73' ' ' GLU . 24.4 mmm 57.75 50.54 10.52 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.413 -0.805 . . . . 0.0 109.491 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.514 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 53.8 mm-40 -148.24 -111.22 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.316 -0.865 . . . . 0.0 109.108 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.725 ' HE2' HD22 ' A' ' 3' ' ' LEU . 2.8 ttt 178.88 153.91 0.4 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.787 -1.196 . . . . 0.0 109.861 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -160.26 147.57 12.52 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.559 ' HD2' HG13 ' A' ' 29' ' ' VAL . 33.4 Cg_endo -74.04 94.73 0.89 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.563 2.175 . . . . 0.0 111.869 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.649 HG23 ' H ' ' A' ' 22' ' ' ARG . 60.0 t -76.58 112.75 23.64 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 36.3 Cg_endo -78.78 -161.8 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.448 2.099 . . . . 0.0 110.601 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.475 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -88.28 -3.72 58.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.315 -0.865 . . . . 0.0 109.054 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -87.52 8.29 25.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 109.74 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.4 m -159.99 21.07 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.157 -0.964 . . . . 0.0 110.076 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.564 ' CD2' ' O ' ' A' ' 36' ' ' TYR . 19.4 p90 -90.0 32.64 0.9 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.015 -1.053 . . . . 0.0 109.334 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.31 -10.07 5.73 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.475 ' CB ' ' HB ' ' A' ' 115' ' ' ILE . 5.5 m-80 -148.02 100.92 3.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.192 -1.181 . . . . 0.0 109.889 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.689 ' HZ ' HD13 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -115.19 131.57 56.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.305 -0.872 . . . . 0.0 109.06 179.633 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.638 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 6.7 m-30 -39.42 155.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.451 -0.781 . . . . 0.0 109.943 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 10.4 pt-20 -91.0 -46.32 8.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.474 -0.766 . . . . 0.0 110.161 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.606 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -83.01 67.38 3.76 Favored Glycine 0 N--CA 1.483 1.793 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.057 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.514 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -162.92 -148.11 0.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.916 -1.344 . . . . 0.0 110.299 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.531 ' CB ' HG13 ' A' ' 23' ' ' ILE . 14.2 m -144.28 139.8 28.82 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.609 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 30.1 m-85 -137.18 109.64 7.41 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.983 -1.073 . . . . 0.0 109.878 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.698 HG13 ' OG1' ' A' ' 81' ' ' THR . 25.0 t -78.5 131.21 34.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.176 -0.953 . . . . 0.0 108.462 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.787 HD23 ' N ' ' A' ' 48' ' ' LEU . 8.3 tt -111.57 163.43 14.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.15 -0.968 . . . . 0.0 109.469 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.787 ' N ' HD23 ' A' ' 47' ' ' LEU . 20.3 tp -153.65 92.11 1.54 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.978 -1.077 . . . . 0.0 109.263 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.859 ' HA ' HG22 ' A' ' 18' ' ' ILE . 5.3 t -81.26 148.82 29.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.904 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 m -140.23 117.05 10.98 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -112.91 175.44 5.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.514 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.96 157.31 18.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.908 . . . . 0.0 109.429 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.1 p -146.8 -170.39 3.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.449 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.96 10.17 61.12 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 p -133.73 -54.69 0.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -1.111 . . . . 0.0 109.422 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.53 -135.11 1.85 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.57 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 88.2 m-85 -120.24 144.32 47.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -1.1 . . . . 0.0 109.66 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 68.8 m -101.09 106.82 18.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.282 -0.886 . . . . 0.0 108.705 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.643 ' CD2' HG23 ' A' ' 91' ' ' VAL . 6.3 m-85 -84.64 156.36 21.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.205 -0.935 . . . . 0.0 110.339 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.476 ' OD1' ' CG2' ' A' ' 93' ' ' VAL . 5.8 m-20 -143.68 102.61 3.95 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 1.017 ' CG2' HG23 ' A' ' 81' ' ' THR . 7.7 mt -92.36 112.3 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.255 -0.903 . . . . 0.0 110.461 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.708 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 15.1 m-70 -105.1 166.98 10.01 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.607 -0.683 . . . . 0.0 109.534 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.575 ' CZ ' ' HA ' ' A' ' 96' ' ' ARG . 43.5 p90 -138.04 106.62 5.87 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.401 -1.32 . . . . 0.0 109.856 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.591 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 4.8 t90 -82.38 131.57 35.22 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -119.28 65.21 0.79 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.357 -0.839 . . . . 0.0 110.753 -178.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 68' ' ' ASN . . . -49.53 91.08 0.01 OUTLIER Glycine 0 N--CA 1.498 2.796 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -37.74 88.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 122.081 0.943 . . . . 0.0 112.414 -177.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.606 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 2.7 m-80 -162.75 -43.65 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.549 ' HB2' ' HE3' ' A' ' 26' ' ' MET . 14.1 p -60.32 168.64 1.95 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.632 -0.667 . . . . 0.0 109.458 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.452 ' OG ' ' OE1' ' A' ' 73' ' ' GLU . 1.5 p -73.87 168.89 18.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.939 . . . . 0.0 109.445 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.3 -51.22 63.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.546 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 2.1 p30 -55.3 -39.32 69.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.127 -0.983 . . . . 0.0 109.511 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.736 ' HG2' ' HE3' ' A' ' 26' ' ' MET . 3.0 mp0 -56.5 -38.66 72.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 108.656 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.496 ' OE1' HD12 ' A' ' 65' ' ' LEU . 53.6 mt-30 -64.17 -33.52 75.97 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.629 ' O ' HD13 ' A' ' 79' ' ' ILE . . . -83.05 -10.91 82.1 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.73 -44.36 13.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.999 -1.295 . . . . 0.0 108.939 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.45 -45.41 59.69 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.328 -0.858 . . . . 0.0 109.029 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.16 93.29 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.629 HD13 ' O ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -65.53 -41.35 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.198 -0.939 . . . . 0.0 108.994 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 1.113 ' CG ' HD21 ' A' ' 3' ' ' LEU . 11.3 m-85 -61.45 -29.43 69.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.973 -1.079 . . . . 0.0 108.53 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 1.017 HG23 ' CG2' ' A' ' 61' ' ' ILE . 2.6 m -75.52 -25.5 57.28 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.0 m -81.16 -27.14 35.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.532 -0.73 . . . . 0.0 109.22 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 0.9 OUTLIER -78.04 -36.57 48.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.608 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.522 ' HG3' ' CD1' ' A' ' 61' ' ' ILE . 5.4 ptm -82.23 -8.14 59.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 109.593 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.604 ' OD1' HD12 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -75.48 -41.57 55.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.381 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -90.03 -29.25 18.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.313 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.507 ' HB3' HG22 ' A' ' 8' ' ' THR . 0.3 OUTLIER -70.22 -32.26 70.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 109.55 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.784 HD12 HD11 ' A' ' 61' ' ' ILE . 14.7 mt -66.19 -22.4 66.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.601 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 90' ' ' SER . . . 121.12 14.61 4.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 89' ' ' GLY . 6.3 t 72.19 3.95 4.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -1.188 . . . . 0.0 109.588 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.643 HG23 ' CD2' ' A' ' 59' ' ' TYR . 17.9 m -87.7 -19.73 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.541 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -77.15 170.13 17.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.237 -0.914 . . . . 0.0 109.608 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.764 HG12 ' H ' ' A' ' 94' ' ' GLN . 2.9 t -121.94 -177.36 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.089 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.764 ' H ' HG12 ' A' ' 93' ' ' VAL . 16.0 mt-30 -128.22 140.07 52.11 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.007 -1.058 . . . . 0.0 108.864 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.708 ' CD2' ' CD2' ' A' ' 62' ' ' HIS . 7.0 m-70 -141.63 151.08 42.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.029 -1.044 . . . . 0.0 109.69 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.575 ' HA ' ' CZ ' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -109.67 140.95 42.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.341 -0.849 . . . . 0.0 110.362 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.491 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 60.5 mm-40 -148.41 163.68 36.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.407 -0.808 . . . . 0.0 109.122 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.736 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.7 t -155.38 -175.17 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.098 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.736 ' H ' HG12 ' A' ' 98' ' ' VAL . 38.5 tt0 -69.75 -1.99 10.74 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.934 -1.103 . . . . 0.0 110.195 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.53 16.12 2.04 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.561 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 39.4 m-70 -122.45 -16.42 7.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.484 -1.01 . . . . 0.0 109.591 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.591 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.1 24.29 2.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.905 . . . . 0.0 109.363 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 102' ' ' GLU . 3.5 p -48.63 -107.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.417 -0.802 . . . . 0.0 111.459 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.818 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 22.4 mt-10 -67.2 -17.45 64.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.916 -1.115 . . . . 0.0 110.909 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.505 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 4.3 m -72.17 -54.95 8.15 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.937 -1.102 . . . . 0.0 109.756 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.546 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -63.63 -57.5 9.88 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.27 -30.15 36.89 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.228 -0.92 . . . . 0.0 108.806 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.818 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -58.1 -45.0 87.95 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -0.828 . . . . 0.0 108.809 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.473 ' CE2' ' CE1' ' A' ' 62' ' ' HIS . 34.2 m-85 -76.7 -14.16 59.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -0.816 . . . . 0.0 109.41 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.842 ' CB ' HD21 ' A' ' 114' ' ' LEU . 2.3 m-85 -117.03 96.99 5.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.408 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 23.0 ttpt -83.75 73.1 10.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.135 -0.978 . . . . 0.0 109.415 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 111' ' ' LYS . 4.8 mt-30 -171.33 -80.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.129 -0.982 . . . . 0.0 109.804 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.403 ' C ' HD23 ' A' ' 114' ' ' LEU . . . 179.95 131.49 1.65 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.842 HD21 ' CB ' ' A' ' 110' ' ' PHE . 10.5 mt -103.49 135.75 44.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -1.107 . . . . 0.0 110.007 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.562 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 2.6 mt -107.57 165.42 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 108.836 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.564 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -141.45 102.42 4.2 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.367 -0.833 . . . . 0.0 109.147 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.638 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 5.1 mmmt -82.28 -155.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 109.664 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.585 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -92.18 -179.9 5.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.551 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 120' ' ' GLY . . . -113.19 -169.67 17.38 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 119' ' ' GLY . . . 43.23 84.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.607 ' O ' HG13 ' A' ' 121' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.147 -1.208 . . . . 0.0 109.222 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.755 ' O ' HG12 ' A' ' 1' ' ' VAL . 65.1 t . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 173.87 60.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.191 -0.943 . . . . 0.0 109.484 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.074 HD13 ' N ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -63.48 -11.3 22.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.519 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 1.074 ' N ' HD13 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -74.73 151.18 39.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.962 . . . . 0.0 109.587 -179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 4' ' ' SER . 17.7 tttm 80.2 -72.57 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.471 -0.768 . . . . 0.0 109.764 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.77 -10.73 29.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 109.757 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.97 HG12 ' CD2' ' A' ' 11' ' ' LEU . 5.2 t -123.93 -71.23 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.101 -0.999 . . . . 0.0 109.519 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.75 HG22 ' HG2' ' A' ' 84' ' ' MET . 19.2 p -50.23 -21.89 1.53 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.668 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.468 ' O ' ' HG2' ' A' ' 10' ' ' LYS . . . -42.75 -42.05 4.65 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 9' ' ' GLY . 12.6 mttt -155.29 -37.96 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.138 -1.213 . . . . 0.0 109.805 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.12 HD12 HD21 ' A' ' 88' ' ' LEU . 51.0 mt 64.2 -144.84 0.28 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.123 -0.986 . . . . 0.0 109.138 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.505 ' O ' ' CE2' ' A' ' 59' ' ' TYR . 2.3 m-20 -88.21 97.81 11.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.113 -0.992 . . . . 0.0 109.549 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.672 ' O ' HG23 ' A' ' 14' ' ' THR . 10.5 mttt -100.83 -4.71 27.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.945 . . . . 0.0 109.641 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 13' ' ' LYS . 19.9 p -160.15 49.59 0.28 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.94 . . . . 0.0 109.499 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.3 m -151.01 105.41 3.0 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.379 -0.826 . . . . 0.0 109.116 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.35 86.76 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.402 2.068 . . . . 0.0 110.343 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.457 ' C ' HG23 ' A' ' 18' ' ' ILE . . . -170.29 -132.76 1.5 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.034 HD12 HD11 ' A' ' 47' ' ' LEU . 18.3 pt -156.81 137.83 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.078 -1.248 . . . . 0.0 110.119 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.58 ' O ' ' CZ3' ' A' ' 21' ' ' TRP . 1.4 tt0 -119.62 113.9 21.4 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.685 HG22 ' H ' ' A' ' 21' ' ' TRP . 3.8 mt -90.03 175.88 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.799 -1.188 . . . . 0.0 109.942 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.861 ' HB3' ' HE3' ' A' ' 28' ' ' MET . 10.7 m-90 -137.04 119.18 15.49 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.699 ' H ' HG23 ' A' ' 31' ' ' VAL . 8.0 ttp180 -79.15 130.23 35.28 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.14 -0.975 . . . . 0.0 110.921 -177.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 23' ' ' ILE . 3.3 mm -95.08 37.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.511 ' HG2' ' N ' ' A' ' 25' ' ' ASN . 1.3 tt0 -47.31 149.45 1.04 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.395 0.617 . . . . 0.0 110.703 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.511 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 2.4 p-10 44.33 27.47 0.22 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.445 -0.785 . . . . 0.0 109.072 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.726 ' HE3' ' HB2' ' A' ' 69' ' ' SER . 3.4 mmm 64.1 51.55 2.19 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.464 -0.773 . . . . 0.0 109.322 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 9.7 mt-10 -153.73 122.65 6.41 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.861 ' HE3' ' HB3' ' A' ' 21' ' ' TRP . 2.1 mtp -56.63 145.06 29.74 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.177 -0.952 . . . . 0.0 110.339 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.598 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -149.64 149.98 29.71 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HD2' HG13 ' A' ' 29' ' ' VAL . 32.3 Cg_endo -72.98 113.86 3.89 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.229 1.953 . . . . 0.0 111.857 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.703 HG13 ' HB3' ' A' ' 35' ' ' SER . 41.4 t -111.3 92.28 15.6 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.521 ' HG2' ' CD ' ' A' ' 34' ' ' LYS . 35.0 Cg_endo -77.12 -156.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.717 2.278 . . . . 0.0 110.202 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.574 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -75.83 -23.53 55.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.094 -1.004 . . . . 0.0 108.945 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.521 ' CD ' ' HG2' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -81.85 8.01 11.36 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.206 -0.934 . . . . 0.0 109.613 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.703 ' HB3' HG13 ' A' ' 31' ' ' VAL . 2.5 m -128.25 -45.36 1.38 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.745 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -45.05 158.31 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.438 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 115' ' ' ILE . . . 112.88 -47.84 1.0 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.43 94.15 4.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -1.209 . . . . 0.0 109.885 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.901 ' HZ ' HD13 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -113.04 121.03 43.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.302 -0.874 . . . . 0.0 109.797 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.581 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 7.0 m-30 -39.33 131.9 1.53 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 110.607 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 2.9 pt-20 -90.66 56.68 3.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.217 -0.927 . . . . 0.0 109.01 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.603 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -176.89 47.92 0.11 Allowed Glycine 0 N--CA 1.484 1.876 0 N-CA-C 108.914 -1.675 . . . . 0.0 108.914 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.468 ' CG ' ' O ' ' A' ' 42' ' ' GLY . 2.4 m-20 -162.16 -129.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.654 -0.909 . . . . 0.0 109.608 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.536 ' CB ' HG13 ' A' ' 23' ' ' ILE . 1.8 m -149.14 144.7 26.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.05 -1.031 . . . . 0.0 108.927 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.592 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 26.0 m-85 -142.65 111.25 6.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.097 -1.002 . . . . 0.0 109.727 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.677 HG13 ' OG1' ' A' ' 81' ' ' THR . 11.3 t -79.73 123.03 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.958 -1.089 . . . . 0.0 108.961 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.034 HD11 HD12 ' A' ' 18' ' ' ILE . 8.2 tt -112.94 122.24 47.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.956 -1.09 . . . . 0.0 110.061 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 59' ' ' TYR . 23.2 tp -107.13 109.86 21.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.069 -1.02 . . . . 0.0 109.705 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.505 ' OG ' HG22 ' A' ' 18' ' ' ILE . 3.2 t -98.19 133.9 41.98 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.18 -0.95 . . . . 0.0 109.272 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.2 m -129.21 142.57 50.82 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.519 ' HG2' ' N ' ' A' ' 52' ' ' LYS . 9.1 ttp180 -140.14 157.12 46.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.892 . . . . 0.0 109.534 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.519 ' N ' ' HG2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -74.12 159.92 31.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.37 -172.74 4.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 109.463 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.73 -35.97 8.13 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t -82.74 -25.24 33.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -1.146 . . . . 0.0 109.488 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.67 -117.61 0.76 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 2.2 m-30 -115.07 169.08 9.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -1.116 . . . . 0.0 109.579 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -133.87 107.85 8.09 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.59 ' HB3' HD11 ' A' ' 48' ' ' LEU . 23.2 m-85 -92.55 169.01 10.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.104 -0.997 . . . . 0.0 110.374 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.513 ' HB3' ' NE2' ' A' ' 95' ' ' HIS . 14.2 m120 -158.89 88.25 0.89 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.961 ' CG2' HG23 ' A' ' 81' ' ' THR . 21.0 mt -76.67 137.12 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.203 -0.936 . . . . 0.0 110.264 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.686 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 53.3 m-70 -123.79 159.39 29.62 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 95' ' ' HIS . 37.4 p90 -133.38 98.64 4.29 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.345 -1.342 . . . . 0.0 109.196 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.6 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 5.6 t90 -77.07 132.77 39.07 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.076 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -116.83 65.01 0.72 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.456 -0.778 . . . . 0.0 110.844 -178.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -45.24 91.42 0.01 OUTLIER Glycine 0 N--CA 1.5 2.94 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.611 ' N ' ' O ' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -39.44 91.38 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.928 0.87 . . . . 0.0 113.204 -177.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.603 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 3.1 m-20 -162.66 -44.22 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.726 ' HB2' ' HE3' ' A' ' 26' ' ' MET . 25.2 p -63.93 -153.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.481 -0.762 . . . . 0.0 109.499 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.08 -173.88 2.82 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.302 -0.873 . . . . 0.0 109.428 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -61.01 -32.0 71.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.886 . . . . 0.0 109.604 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -68.09 -44.09 77.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 0.0 109.556 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.712 ' HG2' ' HE3' ' A' ' 26' ' ' MET . 0.8 OUTLIER -57.98 -36.94 73.34 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.953 -1.092 . . . . 0.0 108.395 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.528 ' CG ' HD11 ' A' ' 65' ' ' LEU . 4.5 tt0 -64.82 -32.55 74.3 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.653 ' O ' HD13 ' A' ' 79' ' ' ILE . . . -83.64 -10.92 80.76 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.85 -52.53 5.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.84 -1.388 . . . . 0.0 109.295 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 23' ' ' ILE . . . -71.83 -36.53 70.23 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.183 -0.948 . . . . 0.0 108.807 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.14 -38.52 75.52 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.398 -0.814 . . . . 0.0 109.368 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.653 HD13 ' O ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -66.89 -45.21 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 109.072 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.867 ' CD2' HD12 ' A' ' 3' ' ' LEU . 3.2 m-85 -59.93 -31.71 70.1 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.839 -1.163 . . . . 0.0 108.471 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.961 HG23 ' CG2' ' A' ' 61' ' ' ILE . 3.1 m -74.29 -27.04 60.54 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 79' ' ' ILE . 4.5 m -63.88 -50.94 66.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.5 -0.75 . . . . 0.0 109.374 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -64.86 -39.23 93.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.554 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.75 ' HG2' HG22 ' A' ' 8' ' ' THR . 1.5 mtm -56.79 -28.13 60.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.602 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -81.37 -36.09 30.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.599 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.01 -1.12 51.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.912 . . . . 0.0 109.676 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.537 ' CB ' ' HB ' ' A' ' 8' ' ' THR . 4.1 m-85 -108.93 -29.81 8.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.146 -0.971 . . . . 0.0 109.546 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 1.12 HD21 HD12 ' A' ' 11' ' ' LEU . 46.9 mt -71.84 -3.94 25.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.614 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 90' ' ' SER . . . 99.0 21.82 14.78 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 90' ' ' SER . 0.3 OUTLIER 64.73 10.69 6.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -1.119 . . . . 0.0 109.484 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.8 m -86.11 -27.95 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.0 109.406 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.575 ' HB2' ' HB2' ' A' ' 59' ' ' TYR . . . -73.19 172.34 11.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.577 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.687 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.1 t -124.73 178.3 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.39 -0.818 . . . . 0.0 109.112 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.687 ' H ' HG12 ' A' ' 93' ' ' VAL . 5.5 tt0 -124.91 131.7 53.4 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.016 -1.052 . . . . 0.0 109.075 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.686 ' CD2' ' CE1' ' A' ' 62' ' ' HIS . 28.9 m-70 -125.98 152.1 46.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.97 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.574 ' HA ' ' CZ ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -109.71 130.53 55.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 110.242 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 64' ' ' TRP . 15.8 mp0 -142.12 163.98 31.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 109.333 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.71 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.2 t -153.66 -160.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 108.972 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.71 ' H ' HG12 ' A' ' 98' ' ' VAL . 40.7 tp60 -78.66 4.53 13.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.718 -1.239 . . . . 0.0 109.772 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.19 22.24 0.58 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.534 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 14.9 m-70 -124.68 -17.07 6.04 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.735 -0.862 . . . . 0.0 109.664 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.6 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.09 30.26 1.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.259 -0.901 . . . . 0.0 109.369 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 105' ' ' THR . 89.1 p -57.3 -127.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.066 -1.021 . . . . 0.0 111.189 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.821 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 41.0 mt-10 -39.92 -24.62 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.9 -1.125 . . . . 0.0 111.469 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.492 ' N ' ' O ' ' A' ' 103' ' ' SER . 0.2 OUTLIER -71.99 -65.03 0.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.768 -1.208 . . . . 0.0 110.43 -179.104 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.567 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -56.4 -50.25 72.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.969 -1.082 . . . . 0.0 108.34 -179.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.413 ' HA ' HD21 ' A' ' 114' ' ' LEU . 1.3 ttp85 -61.41 -29.78 70.15 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.491 -0.755 . . . . 0.0 108.979 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.821 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -59.05 -36.08 74.42 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.796 ' HB3' HD13 ' A' ' 18' ' ' ILE . 67.1 m-85 -88.13 -13.06 42.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.549 -0.72 . . . . 0.0 109.089 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.955 ' HB2' HD21 ' A' ' 114' ' ' LEU . 60.3 m-85 -113.26 96.9 6.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.472 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -74.05 83.02 1.76 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.925 . . . . 0.0 109.54 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.519 ' CB ' ' O ' ' A' ' 111' ' ' LYS . 3.0 tt0 78.48 78.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.397 -0.814 . . . . 0.0 109.715 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.783 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 168.61 70.77 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.955 HD21 ' HB2' ' A' ' 110' ' ' PHE . 4.1 mm? -126.37 56.03 1.47 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -1.164 . . . . 0.0 109.841 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 2.3 mt -81.42 165.67 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.052 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.577 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 2.2 m-85 -145.49 107.86 4.41 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.373 -0.829 . . . . 0.0 109.211 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.581 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 26.9 mmtt -79.69 -165.79 0.87 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 108.929 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.569 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 33.3 mm-40 -87.15 158.11 19.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.962 -1.086 . . . . 0.0 109.865 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.545 ' HA2' ' CD2' ' A' ' 40' ' ' TYR . . . -95.34 -165.51 35.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 119' ' ' GLY . . . 43.48 74.32 0.2 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.465 HG11 ' CD ' ' A' ' 24' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.246 -1.15 . . . . 0.0 109.751 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.568 HG22 ' H ' ' A' ' 2' ' ' GLU . 9.9 p . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.568 ' H ' HG22 ' A' ' 1' ' ' VAL . 0.0 OUTLIER 79.77 118.21 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.453 -0.779 . . . . 0.0 109.234 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.88 ' HB2' HG21 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -90.05 -21.33 22.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.519 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 1.2 p -59.84 -12.67 7.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 110.029 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -109.4 -47.79 3.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.977 -1.077 . . . . 0.0 109.827 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -90.32 22.01 3.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 110.094 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.88 HG21 ' HB2' ' A' ' 3' ' ' LEU . 10.3 t -145.38 -63.18 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.089 -1.007 . . . . 0.0 109.823 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.562 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 23.1 p -67.81 -12.9 61.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 109.506 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 10' ' ' LYS . . . -74.24 -19.7 79.77 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 1.6 tptm 175.2 55.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.449 -1.03 . . . . 0.0 109.371 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.745 HD23 HD22 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -43.85 -60.29 1.89 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.43 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -161.63 -91.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.43 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER 74.48 125.98 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.502 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.584 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 23.7 p 48.05 54.35 10.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.362 -0.836 . . . . 0.0 109.631 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 14' ' ' THR . 4.0 m -168.43 101.85 0.53 Allowed Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.416 -0.803 . . . . 0.0 109.324 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.04 109.47 2.84 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.413 2.075 . . . . 0.0 110.433 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.472 ' C ' HG23 ' A' ' 18' ' ' ILE . . . 178.87 -143.81 5.99 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.972 HD12 ' CD1' ' A' ' 47' ' ' LEU . 14.3 pt -157.44 140.6 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -1.172 . . . . 0.0 109.829 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.557 ' NE2' ' CZ2' ' A' ' 21' ' ' TRP . 2.0 tt0 -122.01 109.19 14.28 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.803 HG12 HD12 ' A' ' 47' ' ' LEU . 41.9 mt -85.03 166.73 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.145 -0.972 . . . . 0.0 109.84 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.877 ' CZ2' HG13 ' A' ' 7' ' ' VAL . 6.8 m-90 -130.26 121.95 27.1 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.769 ' HG3' HG22 ' A' ' 31' ' ' VAL . 8.7 mtm180 -79.26 132.54 36.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 110.888 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.828 HD13 ' HB2' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -116.8 23.11 5.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.662 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.504 ' CG ' ' HB ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -54.92 171.07 0.15 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.848 . . . . 0.0 110.193 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.776 ' HB3' HG12 ' A' ' 121' ' ' VAL . 0.7 OUTLIER 42.22 26.86 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.619 ' HE1' ' CB ' ' A' ' 70' ' ' SER . 0.0 OUTLIER 59.28 56.69 3.71 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.45 -0.781 . . . . 0.0 110.256 179.336 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 73.5 mm-40 -146.72 -144.05 0.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.925 -1.109 . . . . 0.0 109.655 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.628 ' CE ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -156.04 146.44 21.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.009 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.556 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -160.37 148.77 13.27 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.086 -1.009 . . . . 0.0 109.604 -179.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.556 ' HD2' HG13 ' A' ' 29' ' ' VAL . 36.0 Cg_endo -78.53 125.17 6.74 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.548 2.165 . . . . 0.0 111.174 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.769 HG22 ' HG3' ' A' ' 22' ' ' ARG . 2.9 t -114.69 94.51 37.38 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 35' ' ' SER . 34.7 Cg_endo -76.49 -159.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.598 2.198 . . . . 0.0 110.765 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.578 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -76.07 -34.5 59.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.368 -0.832 . . . . 0.0 110.551 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.96 32.86 0.73 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.077 -1.015 . . . . 0.0 109.932 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.515 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 74.8 m -139.66 -37.58 0.49 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.077 -1.014 . . . . 0.0 109.749 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 33' ' ' THR . 11.0 p90 -55.79 173.16 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.584 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.59 -94.93 0.66 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -90.61 113.13 25.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.358 -1.083 . . . . 0.0 109.414 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -140.77 143.46 34.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 109.983 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.643 ' OH ' HG23 ' A' ' 121' ' ' VAL . 19.0 m-85 -42.34 144.75 0.46 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.884 . . . . 0.0 110.415 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 2.0 pt-20 -90.85 -46.72 8.04 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.301 -0.874 . . . . 0.0 109.626 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.625 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -81.86 72.48 2.78 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.522 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -161.28 -145.01 0.11 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.152 -1.205 . . . . 0.0 109.837 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.56 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 23.7 m -138.61 162.1 35.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.333 -0.854 . . . . 0.0 108.811 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 39' ' ' PHE . 11.3 m-85 -160.28 105.31 1.49 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.927 -1.108 . . . . 0.0 110.357 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 57.3 t -78.95 115.19 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.91 -1.119 . . . . 0.0 108.342 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.972 ' CD1' HD12 ' A' ' 18' ' ' ILE . 2.1 tt -104.59 116.08 31.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.31 -0.869 . . . . 0.0 110.721 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.745 HD22 HD23 ' A' ' 11' ' ' LEU . 19.5 tp -98.68 109.05 21.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.015 -1.053 . . . . 0.0 109.433 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.427 ' OG ' HG22 ' A' ' 18' ' ' ILE . 2.6 t -99.91 128.86 45.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.172 -0.955 . . . . 0.0 109.631 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.417 ' OG1' ' OD2' ' A' ' 12' ' ' ASP . 1.2 m -113.64 150.46 33.13 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.54 ' CG ' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -135.93 166.28 23.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.885 . . . . 0.0 109.479 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.54 ' N ' ' CG ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -104.86 147.51 27.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.425 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.9 p -142.18 -172.71 3.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.485 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.3 -10.42 71.12 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 56' ' ' GLY . 1.2 p -107.5 -53.52 2.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -1.172 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.425 ' N ' ' OG ' ' A' ' 55' ' ' SER . . . -157.32 -122.72 0.72 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.584 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 16.5 m-85 -129.32 156.24 44.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -1.092 . . . . 0.0 109.516 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.1 t -117.07 117.58 30.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.848 . . . . 0.0 108.941 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.546 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 26.2 m-85 -97.59 159.52 14.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.974 . . . . 0.0 110.166 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.549 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 9.3 m-80 -150.06 90.85 1.71 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 1.036 ' CG2' HG23 ' A' ' 81' ' ' THR . 5.9 mt -77.72 135.21 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 110.415 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.642 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 41.7 m-70 -122.0 161.95 22.02 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 53.7 p90 -138.95 96.02 3.05 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 118.4 -1.32 . . . . 0.0 109.387 176.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.593 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 14.8 t90 -69.61 139.9 53.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -123.01 61.84 1.01 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.239 -0.913 . . . . 0.0 111.014 -178.253 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -53.07 89.72 0.01 OUTLIER Glycine 0 N--CA 1.5 2.967 0 N-CA-C 107.967 -2.053 . . . . 0.0 107.967 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 65' ' ' LEU . 5.2 ttmm -49.5 91.9 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.625 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 12.6 m120 -161.65 -42.05 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.534 ' OG ' ' CG ' ' A' ' 73' ' ' GLU . 24.4 p -65.57 -145.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.456 -0.777 . . . . 0.0 109.299 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.619 ' CB ' ' HE1' ' A' ' 26' ' ' MET . 3.9 p -116.11 170.74 8.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.072 -1.017 . . . . 0.0 109.847 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.509 ' HA ' ' HG2' ' A' ' 74' ' ' GLN . 7.3 tt0 -70.51 -11.58 61.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.412 -0.805 . . . . 0.0 110.403 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -82.34 -51.45 7.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.744 -1.223 . . . . 0.0 109.634 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.608 ' OE1' HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -63.69 -30.08 71.23 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.615 ' HB2' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -70.23 -33.32 71.51 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.187 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.518 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -79.65 -17.19 76.03 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.56 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -82.23 -36.32 27.3 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.385 -1.068 . . . . 0.0 108.706 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.828 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -69.53 -51.95 30.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.364 -0.835 . . . . 0.0 108.989 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.35 79.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.296 -0.877 . . . . 0.0 109.224 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 75' ' ' GLY . 74.2 mt -56.58 -42.49 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.264 -0.898 . . . . 0.0 109.309 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.655 ' CG ' HD22 ' A' ' 3' ' ' LEU . 3.5 m-85 -63.57 -29.68 70.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.227 -0.921 . . . . 0.0 108.661 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 1.036 HG23 ' CG2' ' A' ' 61' ' ' ILE . 15.9 m -71.49 -23.58 61.83 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 m -86.87 -29.04 22.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.567 -0.708 . . . . 0.0 109.229 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.494 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -73.21 -39.87 65.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.297 -0.877 . . . . 0.0 109.493 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.532 ' SD ' HG21 ' A' ' 61' ' ' ILE . 4.8 ptm -77.06 -27.74 54.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.453 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.596 ' HA ' HD11 ' A' ' 61' ' ' ILE . 7.8 t70 -66.72 -35.17 79.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.195 -0.94 . . . . 0.0 109.372 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -86.65 -23.33 25.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 0.0 109.393 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.494 ' CD1' ' O ' ' A' ' 83' ' ' GLN . 5.0 m-85 -87.3 -12.96 44.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -0.967 . . . . 0.0 109.448 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.564 HD11 HD22 ' A' ' 11' ' ' LEU . 21.1 mt -89.66 10.72 22.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.566 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 97.25 1.54 59.35 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 1.8 m 75.78 3.06 3.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -1.186 . . . . 0.0 109.629 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.401 ' H ' HG22 ' A' ' 91' ' ' VAL . 4.2 m -83.94 -16.5 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.397 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.546 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -70.57 172.75 8.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.553 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.67 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.5 t -124.97 176.91 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.315 -0.865 . . . . 0.0 109.267 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.67 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -125.18 132.47 53.03 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.082 -1.011 . . . . 0.0 109.161 179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.642 ' CD2' ' CE1' ' A' ' 62' ' ' HIS . 19.3 m-70 -130.25 153.49 48.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.652 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.535 ' HG3' ' CZ ' ' A' ' 63' ' ' TYR . 23.9 ttp180 -118.06 129.67 55.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 110.153 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.503 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 32.8 mp0 -134.01 164.45 27.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.0 t -157.49 -172.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.282 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.726 ' H ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -75.78 78.46 2.72 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 134.7 -16.71 4.26 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.496 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 37.9 m-70 -99.94 -16.05 18.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.704 -0.88 . . . . 0.0 108.822 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.593 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.12 22.76 3.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.549 -0.719 . . . . 0.0 109.366 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 105' ' ' THR . 90.9 p -57.99 -130.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.511 -0.743 . . . . 0.0 110.993 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.841 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 49.0 mt-10 -39.82 -24.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.07 -1.019 . . . . 0.0 111.271 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 103' ' ' SER . 7.6 m -70.62 -60.92 1.98 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.853 -1.154 . . . . 0.0 110.354 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.571 ' CG ' ' OE1' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -61.7 -50.2 73.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.805 -1.184 . . . . 0.0 108.582 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -61.95 -26.74 68.38 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.36 -0.837 . . . . 0.0 108.828 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -57.67 -51.74 68.29 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.468 ' HB3' HD13 ' A' ' 18' ' ' ILE . 23.1 m-85 -70.98 -17.1 62.67 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.883 ' CG ' HD21 ' A' ' 114' ' ' LEU . 24.6 m-85 -108.17 93.88 4.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.467 -0.77 . . . . 0.0 109.538 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.499 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -86.17 61.81 7.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.971 . . . . 0.0 109.361 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 111' ' ' LYS . 11.8 mt-30 -163.6 -78.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.775 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 179.82 130.88 1.54 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.883 HD21 ' CG ' ' A' ' 110' ' ' PHE . 44.8 mt -96.56 107.75 20.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 109.977 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.511 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 1.3 mm -79.84 164.9 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.559 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 71.1 m-85 -137.35 133.12 34.51 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.039 -1.038 . . . . 0.0 110.055 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 2.7 mmpt? -117.28 -171.81 2.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.099 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.586 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 8.1 mm100 -90.7 128.64 36.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.073 -1.017 . . . . 0.0 110.145 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.57 ' HA2' ' CG ' ' A' ' 40' ' ' TYR . . . -58.62 -154.96 0.01 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 55.54 79.58 0.09 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.776 HG12 ' HB3' ' A' ' 25' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.324 -1.103 . . . . 0.0 109.52 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.657 HG22 ' CD ' ' A' ' 27' ' ' GLU . 2.1 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 1' ' ' VAL . 9.8 pt-20 40.25 50.1 2.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.571 -0.705 . . . . 0.0 109.758 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.699 HD22 ' CG ' ' A' ' 80' ' ' TYR . 1.4 pp -43.07 -28.3 0.27 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 109.443 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.511 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 6.9 p -57.03 143.06 39.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 109.947 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 4' ' ' SER . 4.1 ttmt 73.41 -79.5 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.508 -0.745 . . . . 0.0 109.69 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 5' ' ' LYS . 7.8 mttm -45.4 -27.04 0.63 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.931 -1.105 . . . . 0.0 108.952 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.701 HG13 ' CE2' ' A' ' 21' ' ' TRP . 41.5 t -106.86 -33.97 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.541 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 8.0 p -87.28 -153.19 0.21 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.392 -0.817 . . . . 0.0 109.124 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.425 ' O ' ' HD2' ' A' ' 10' ' ' LYS . . . 84.15 -44.83 3.39 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -167.67 61.18 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.219 -1.166 . . . . 0.0 109.125 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.108 HD23 HD22 ' A' ' 48' ' ' LEU . 3.0 mp -41.81 -71.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.416 -0.802 . . . . 0.0 109.661 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.527 ' HB3' ' CB ' ' A' ' 50' ' ' THR . 14.4 m-20 -145.88 75.9 1.44 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.431 ' O ' ' OG1' ' A' ' 14' ' ' THR . 17.0 mmtt -91.47 125.51 36.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.515 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 23.4 p 48.6 57.3 6.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.389 -0.82 . . . . 0.0 109.535 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.3 m -162.64 104.76 1.06 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.46 -0.775 . . . . 0.0 109.243 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.94 130.76 11.59 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.312 2.008 . . . . 0.0 110.377 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.1 172.98 12.8 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.94 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -125.91 145.04 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.853 -1.381 . . . . 0.0 110.488 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -112.42 167.17 10.66 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.987 HD11 ' CZ ' ' A' ' 110' ' ' PHE . 26.1 mt -132.25 161.13 41.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.333 -1.479 . . . . 0.0 110.242 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.782 ' HA ' HG23 ' A' ' 31' ' ' VAL . 7.7 m-90 -120.87 122.77 40.96 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.938 ' HD2' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -79.84 130.26 35.16 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.922 -1.111 . . . . 0.0 110.755 -178.463 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 23' ' ' ILE . 7.9 mm -94.2 25.48 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.642 ' HB2' HG21 ' A' ' 121' ' ' VAL . 19.6 pt-20 -57.19 166.81 1.02 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.709 -0.619 . . . . 0.0 109.861 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.537 ' ND2' ' HG3' ' A' ' 24' ' ' GLU . 14.0 p30 42.66 27.67 0.1 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.476 ' HA ' ' OE2' ' A' ' 73' ' ' GLU . 3.8 mmt 53.64 55.23 8.81 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.499 -0.751 . . . . 0.0 109.622 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.657 ' CD ' HG22 ' A' ' 1' ' ' VAL . 0.9 OUTLIER -160.33 144.88 14.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 0.0 109.445 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.606 ' CE ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -76.54 136.36 39.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.051 -1.031 . . . . 0.0 109.788 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.764 HG12 ' CD ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -147.12 151.76 41.77 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.673 ' HD2' HG13 ' A' ' 29' ' ' VAL . 31.9 Cg_endo -72.99 134.27 21.21 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.362 2.041 . . . . 0.0 111.747 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.938 HG22 ' HD2' ' A' ' 22' ' ' ARG . 2.5 t -120.43 104.9 42.32 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.97 -157.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.557 2.171 . . . . 0.0 110.551 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.558 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -78.55 -25.97 45.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.171 -0.956 . . . . 0.0 109.101 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.36 32.47 0.77 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.275 -0.891 . . . . 0.0 109.854 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.509 ' HB2' ' CG1' ' A' ' 31' ' ' VAL . 17.3 m -155.07 -35.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 0.0 110.011 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.854 ' HB2' HD12 ' A' ' 20' ' ' ILE . 11.9 p90 -60.06 -41.22 91.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.011 -1.056 . . . . 0.0 109.768 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.51 ' N ' ' CG ' ' A' ' 36' ' ' TYR . . . -51.7 -24.29 12.24 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.844 ' HA ' HG22 ' A' ' 115' ' ' ILE . 0.9 OUTLIER -131.87 129.85 40.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.088 -1.242 . . . . 0.0 110.158 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -148.56 128.48 13.5 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.291 -0.881 . . . . 0.0 109.671 179.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.688 ' HE2' HG22 ' A' ' 121' ' ' VAL . 8.5 m-30 -47.55 140.1 6.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.489 -0.757 . . . . 0.0 110.6 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 1.6 pt-20 -91.3 29.12 1.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -0.864 . . . . 0.0 109.588 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.617 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -146.21 54.62 0.54 Allowed Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.467 ' CG ' ' O ' ' A' ' 42' ' ' GLY . 1.4 m-20 -162.94 -139.47 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.502 -0.999 . . . . 0.0 109.754 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.583 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 53.7 m -147.44 158.83 44.14 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.583 ' CD1' ' O ' ' A' ' 44' ' ' CYS . 31.4 m-85 -149.48 169.5 20.76 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.075 -1.016 . . . . 0.0 108.982 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.59 HG11 ' CE ' ' A' ' 84' ' ' MET . 44.3 t -132.25 113.08 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.783 HD11 HG13 ' A' ' 18' ' ' ILE . 3.8 tt -103.65 106.37 16.86 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.861 -1.149 . . . . 0.0 110.981 -178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.108 HD22 HD23 ' A' ' 11' ' ' LEU . 19.2 tp -94.37 124.92 38.68 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.782 ' OG ' HG22 ' A' ' 18' ' ' ILE . 8.5 t -115.18 136.22 53.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.096 -1.003 . . . . 0.0 109.788 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.527 ' CB ' ' HB3' ' A' ' 12' ' ' ASP . 1.2 m -130.56 124.26 31.41 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.83 137.59 52.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.525 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.581 ' O ' HG23 ' A' ' 53' ' ' THR . 0.7 OUTLIER -54.91 163.85 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.893 . . . . 0.0 109.437 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -165.4 -172.87 2.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.445 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.79 -29.16 39.75 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.68 -17.7 43.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -1.114 . . . . 0.0 109.42 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.8 -69.06 0.45 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.583 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 14.5 m-85 -160.09 157.16 28.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -1.139 . . . . 0.0 109.528 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.66 112.21 15.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 109.114 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.8 ' CD2' HD22 ' A' ' 88' ' ' LEU . 6.6 m-30 -91.93 153.93 19.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.245 -0.909 . . . . 0.0 109.929 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.504 ' ND2' ' CE1' ' A' ' 95' ' ' HIS . 1.9 m-20 -147.7 95.25 2.48 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.979 ' CG2' HG23 ' A' ' 81' ' ' THR . 15.3 mt -83.39 130.36 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.172 -0.955 . . . . 0.0 110.519 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.595 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 28.3 m-70 -115.39 164.17 14.65 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.603 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 48.1 p90 -137.87 96.78 3.28 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.611 -1.236 . . . . 0.0 109.792 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.576 ' CE2' ' OE1' ' A' ' 102' ' ' GLU . 6.7 t90 -72.62 141.41 48.34 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -125.57 65.3 1.17 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.069 -1.019 . . . . 0.0 110.865 -178.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -49.49 90.46 0.01 OUTLIER Glycine 0 N--CA 1.499 2.834 0 N-CA-C 108.414 -1.874 . . . . 0.0 108.414 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -39.15 91.48 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.927 0.87 . . . . 0.0 112.683 -177.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.617 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 1.2 m120 -162.65 -42.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.489 ' HB2' ' CB ' ' A' ' 73' ' ' GLU . 95.9 p -63.9 -151.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.582 -0.699 . . . . 0.0 109.343 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.432 ' OG ' ' OD1' ' A' ' 72' ' ' ASP . 80.1 p -121.2 176.57 5.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 109.62 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 12.0 tt0 -55.12 -41.39 71.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.549 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.432 ' OD1' ' OG ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -60.29 -43.24 96.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.159 -0.963 . . . . 0.0 109.551 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.489 ' CB ' ' HB2' ' A' ' 69' ' ' SER . 2.7 tp10 -56.33 -36.6 68.92 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.022 -1.049 . . . . 0.0 108.353 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 6.6 tt0 -62.7 -36.16 82.06 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.858 ' O ' HD13 ' A' ' 79' ' ' ILE . . . -80.06 -13.82 81.51 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.577 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -78.72 -54.02 6.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.234 -1.157 . . . . 0.0 109.156 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.505 ' HB2' ' CD1' ' A' ' 23' ' ' ILE . . . -72.45 -26.43 61.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.398 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.3 -48.38 20.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.25 -0.906 . . . . 0.0 109.564 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.858 HD13 ' O ' ' A' ' 75' ' ' GLY . 1.5 mp -65.54 -39.2 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -0.901 . . . . 0.0 108.994 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.699 ' CG ' HD22 ' A' ' 3' ' ' LEU . 3.8 m-85 -61.45 -39.46 90.92 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.053 -1.029 . . . . 0.0 108.331 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.979 HG23 ' CG2' ' A' ' 61' ' ' ILE . 3.0 m -67.12 -24.78 65.96 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.4 m -76.82 -37.02 56.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.454 -0.779 . . . . 0.0 109.379 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 24.2 mm100 -66.76 -36.66 82.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 109.585 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.605 ' SD ' HG11 ' A' ' 7' ' ' VAL . 73.3 mtm -71.72 -34.86 69.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.953 . . . . 0.0 109.602 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.55 -58.64 7.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 109.738 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -64.95 -33.33 75.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.672 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 3.1 m-85 -73.2 -10.49 59.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -1.0 . . . . 0.0 109.692 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.968 HD21 HD22 ' A' ' 11' ' ' LEU . 20.1 mt -89.43 -32.19 17.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 109.545 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 121.93 15.55 4.3 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 0.9 OUTLIER 75.8 -0.29 3.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -1.149 . . . . 0.0 109.683 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.535 HG23 ' CD2' ' A' ' 59' ' ' TYR . 15.6 m -83.42 -9.47 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.411 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.744 ' HB2' HD13 ' A' ' 88' ' ' LEU . . . -90.81 176.72 6.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 0.0 109.548 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.671 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.7 t -133.47 177.45 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.365 -0.835 . . . . 0.0 109.156 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.671 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -125.71 135.18 51.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.986 -1.071 . . . . 0.0 108.972 179.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.595 ' CD2' ' CD2' ' A' ' 62' ' ' HIS . 12.6 m-70 -132.96 149.0 52.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.128 -0.982 . . . . 0.0 109.379 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.585 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -110.77 136.94 49.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 110.384 -179.378 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.515 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 49.8 mm-40 -142.23 164.41 30.23 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.436 -0.79 . . . . 0.0 108.93 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 99' ' ' GLN . 1.8 t -157.78 -165.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.132 -0.98 . . . . 0.0 109.02 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.695 ' H ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -78.36 75.96 4.87 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 178.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.94 -12.17 4.78 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.505 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 10.8 m-70 -98.25 -13.21 20.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.667 -0.902 . . . . 0.0 109.107 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.578 ' OE1' ' CD2' ' A' ' 106' ' ' PHE . 2.0 pt-20 -90.05 30.17 1.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.418 -0.801 . . . . 0.0 109.031 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 102' ' ' GLU . 63.5 p -52.45 -141.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.751 0.786 . . . . 0.0 112.126 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.781 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -38.99 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.915 -1.116 . . . . 0.0 111.057 -178.435 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 103' ' ' SER . 0.8 OUTLIER -67.02 -57.47 6.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.811 -1.181 . . . . 0.0 110.138 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.578 ' CD2' ' OE1' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -66.64 -44.33 82.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.959 -1.088 . . . . 0.0 108.309 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.82 -17.54 64.93 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -71.02 -45.4 63.99 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.431 ' HB3' HD12 ' A' ' 18' ' ' ILE . 18.3 m-85 -76.37 -17.88 59.16 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.462 -0.774 . . . . 0.0 109.466 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.987 ' CZ ' HD11 ' A' ' 20' ' ' ILE . 6.9 m-30 -112.07 96.5 6.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.115 -0.991 . . . . 0.0 109.316 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -67.78 86.28 0.22 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.48 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 111' ' ' LYS . 7.3 mm100 72.65 74.82 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.867 . . . . 0.0 109.586 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.777 ' C ' HD22 ' A' ' 114' ' ' LEU . . . -178.73 62.87 0.08 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.785 HD21 ' HB2' ' A' ' 110' ' ' PHE . 3.8 mm? -120.9 63.01 0.87 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -1.14 . . . . 0.0 109.336 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.844 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -85.85 160.96 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.104 -0.998 . . . . 0.0 109.351 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.544 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 2.0 m-85 -139.75 165.0 28.46 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.605 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -146.98 -156.29 0.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.591 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -91.48 169.41 10.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.968 . . . . 0.0 109.819 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 120' ' ' GLY . . . -99.13 -169.86 30.75 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 47.37 95.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.688 HG22 ' HE2' ' A' ' 40' ' ' TYR . 1.3 t . . . . . 0 C--N 1.305 -1.347 0 O-C-N 121.205 -1.173 . . . . 0.0 109.297 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.421 ' O ' HG12 ' A' ' 1' ' ' VAL . 9.1 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 175.54 94.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.43 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.882 ' O ' HD22 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -74.19 3.32 7.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.216 -0.927 . . . . 0.0 110.484 -179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.571 ' N ' HD13 ' A' ' 3' ' ' LEU . 1.7 p -92.74 150.9 20.36 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.811 -1.18 . . . . 0.0 110.34 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.506 ' HD2' ' HG2' ' A' ' 6' ' ' LYS . 12.0 ttmt 47.19 -86.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.429 0.633 . . . . 0.0 110.917 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 4' ' ' SER . 5.8 mmtt -40.54 -27.51 0.05 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.492 -0.755 . . . . 0.0 110.227 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 3' ' ' LEU . 70.4 t -109.16 -31.85 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.097 -1.002 . . . . 0.0 109.607 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.821 HG21 ' CG ' ' A' ' 87' ' ' TYR . 18.2 p -72.22 -3.52 23.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.883 . . . . 0.0 109.473 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 10' ' ' LYS . . . -70.45 85.03 0.34 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 9' ' ' GLY . 5.3 mtmm 80.65 74.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.677 -0.896 . . . . 0.0 109.601 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 8' ' ' THR . 4.7 mt -89.35 32.65 0.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 0.0 109.124 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER 78.31 61.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.438 -0.789 . . . . 0.0 109.357 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.538 ' O ' HG23 ' A' ' 14' ' ' THR . 4.2 mttm -81.6 -10.39 59.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 109.524 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 27.0 p -157.36 67.45 0.52 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.59 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.404 ' O ' ' OD2' ' A' ' 12' ' ' ASP . 99.2 m -161.9 118.5 1.32 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.384 -0.822 . . . . 0.0 109.169 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.84 87.84 1.44 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.255 1.97 . . . . 0.0 110.206 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.462 ' C ' HG23 ' A' ' 18' ' ' ILE . . . -170.48 -145.08 4.58 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.009 HD12 HD11 ' A' ' 47' ' ' LEU . 14.2 pt -157.24 142.21 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.013 -1.287 . . . . 0.0 110.202 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.61 ' NE2' ' CH2' ' A' ' 21' ' ' TRP . 0.4 OUTLIER -121.78 117.25 26.12 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.485 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.898 HD11 ' HZ ' ' A' ' 110' ' ' PHE . 1.6 mt -90.88 178.16 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.659 -1.276 . . . . 0.0 110.733 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.786 ' CD1' ' HE2' ' A' ' 28' ' ' MET . 9.5 m-90 -137.38 121.18 17.5 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.532 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 3.7 ptp180 -83.75 128.68 34.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.097 . . . . 0.0 111.908 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.58 HD13 ' HB3' ' A' ' 28' ' ' MET . 1.8 mm -111.45 50.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.636 ' HB2' ' CE2' ' A' ' 40' ' ' TYR . 4.7 pt-20 -92.78 -39.06 11.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.372 -0.83 . . . . 0.0 110.295 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.571 ' CB ' HG21 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -88.35 43.77 1.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 108.517 179.32 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.556 ' HE2' ' OE2' ' A' ' 73' ' ' GLU . 0.9 OUTLIER 50.22 24.48 1.48 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.529 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 3.6 pt-20 -151.94 153.74 34.7 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.786 ' HE2' ' CD1' ' A' ' 21' ' ' TRP . 15.5 ptm -97.41 133.69 41.67 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.744 -1.222 . . . . 0.0 110.746 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -120.73 149.33 50.28 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.572 ' HD2' HG13 ' A' ' 29' ' ' VAL . 32.0 Cg_endo -71.94 87.77 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.272 1.981 . . . . 0.0 112.217 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 22' ' ' ARG . 8.6 t -72.99 112.65 16.26 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.537 -0.727 . . . . 0.0 109.473 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 35.9 Cg_endo -78.41 -159.31 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.396 2.064 . . . . 0.0 110.149 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.576 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -88.14 -21.37 24.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 108.909 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -78.91 4.43 14.18 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.291 -0.881 . . . . 0.0 109.661 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 36' ' ' TYR . 38.7 m -128.18 -37.01 1.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.953 . . . . 0.0 109.787 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -42.81 161.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -0.894 . . . . 0.0 109.718 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.535 ' O ' ' CE1' ' A' ' 39' ' ' PHE . . . 110.82 -62.19 0.29 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.552 ' N ' ' ND2' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -103.75 106.97 17.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -1.152 . . . . 0.0 109.264 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.585 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -130.93 132.47 45.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.124 -0.985 . . . . 0.0 109.989 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.636 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 9.7 m-30 -40.13 131.2 2.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.591 -0.693 . . . . 0.0 111.445 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 0.8 OUTLIER -90.86 112.09 23.78 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.603 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . 115.22 45.57 0.62 Allowed Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -155.78 -134.29 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.536 -0.979 . . . . 0.0 108.678 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.529 ' HB2' ' CB ' ' A' ' 23' ' ' ILE . 60.8 m -146.18 137.27 24.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.865 -1.147 . . . . 0.0 109.437 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 26.5 m-85 -140.49 108.13 5.62 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.261 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.508 HG13 ' OG1' ' A' ' 81' ' ' THR . 8.2 t -78.86 126.73 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 108.551 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.009 HD11 HD12 ' A' ' 18' ' ' ILE . 7.4 tt -116.65 117.96 31.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.077 -1.015 . . . . 0.0 110.112 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 59' ' ' TYR . 22.2 tp -100.44 113.82 26.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.935 . . . . 0.0 109.333 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.402 ' HA ' HG22 ' A' ' 18' ' ' ILE . 3.1 t -102.4 130.73 49.25 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.225 -0.922 . . . . 0.0 109.538 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 m -121.2 142.82 49.53 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.09 -173.28 3.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.46 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.727 ' O ' HG23 ' A' ' 53' ' ' THR . 1.0 OUTLIER -109.96 168.87 9.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.487 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 52' ' ' LYS . 5.4 p -162.72 -170.9 2.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.06 -17.85 66.34 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.1 m -102.39 -43.74 5.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -1.153 . . . . 0.0 109.478 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.424 ' O ' ' OG1' ' A' ' 53' ' ' THR . . . -175.36 -128.34 1.1 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.579 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 42.1 m-85 -111.23 150.66 29.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -1.125 . . . . 0.0 109.516 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.55 114.33 27.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.0 109.001 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.572 ' HD1' HG23 ' A' ' 91' ' ' VAL . 12.7 m-85 -91.09 155.63 18.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.164 -0.96 . . . . 0.0 109.841 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.59 ' ND2' ' CE1' ' A' ' 95' ' ' HIS . 1.8 m-20 -147.25 92.64 2.13 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.919 ' CG2' HG23 ' A' ' 81' ' ' THR . 21.5 mt -77.64 134.38 28.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 110.374 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.616 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 42.9 m-70 -120.82 162.53 19.64 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 95' ' ' HIS . 45.9 p90 -137.05 97.69 3.57 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 118.605 -1.238 . . . . 0.0 109.298 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.598 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 7.7 t90 -74.33 137.23 42.7 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.774 HD11 ' CG ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -126.53 64.62 1.26 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -0.885 . . . . 0.0 111.095 -178.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.451 ' O ' ' HA2' ' A' ' 42' ' ' GLY . . . -49.48 97.38 0.01 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 107.173 -2.371 . . . . 0.0 107.173 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 65' ' ' LEU . 2.2 tptt -55.27 89.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -176.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.603 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 12.0 m120 -160.98 -37.99 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.8 p -67.43 -146.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 109.432 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.451 ' HB2' ' OD2' ' A' ' 72' ' ' ASP . 3.0 p -114.27 158.67 21.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 109.891 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -50.99 -34.89 31.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.451 ' OD2' ' HB2' ' A' ' 70' ' ' SER . 1.6 p30 -58.18 -46.13 86.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.147 -0.971 . . . . 0.0 109.077 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.556 ' OE2' ' HE2' ' A' ' 26' ' ' MET . 59.7 mm-40 -57.09 -36.17 70.29 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.774 ' CG ' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -63.03 -35.92 81.85 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.531 ' O ' ' CG1' ' A' ' 79' ' ' ILE . . . -81.79 -12.08 81.91 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.19 -54.14 6.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.15 -1.206 . . . . 0.0 109.286 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.481 ' HB1' HG22 ' A' ' 46' ' ' VAL . . . -73.09 -34.02 65.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -0.905 . . . . 0.0 109.376 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.62 -41.76 65.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 109.776 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.531 ' CG1' ' O ' ' A' ' 75' ' ' GLY . 73.0 mt -69.24 -44.87 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.054 -1.029 . . . . 0.0 109.886 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.594 ' CD2' HD12 ' A' ' 3' ' ' LEU . 2.9 m-85 -68.38 -29.5 68.21 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.919 HG23 ' CG2' ' A' ' 61' ' ' ILE . 13.8 m -69.67 -24.17 63.57 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 79' ' ' ILE . 2.1 m -72.62 -49.01 34.86 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 9.3 mt-30 -59.28 -43.38 92.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.368 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.696 ' CG ' HD23 ' A' ' 3' ' ' LEU . 0.9 OUTLIER -55.06 -37.9 67.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.593 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.98 -41.59 99.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.12 4.58 49.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.196 -0.94 . . . . 0.0 109.704 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.821 ' CG ' HG21 ' A' ' 8' ' ' THR . 0.6 OUTLIER -107.97 -13.98 14.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 0.0 109.581 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.48 HD21 ' HB3' ' A' ' 11' ' ' LEU . 20.5 mt -87.13 -66.54 0.9 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 109.589 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.683 ' O ' HG13 ' A' ' 91' ' ' VAL . . . 171.39 37.27 0.03 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.4 m 49.58 22.42 0.76 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -1.15 . . . . 0.0 109.552 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 89' ' ' GLY . 31.1 m -110.86 -25.96 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.198 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -65.46 172.42 3.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 109.515 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.683 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.4 t -126.53 177.76 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.347 -0.846 . . . . 0.0 109.318 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.683 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -125.33 131.77 52.96 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.067 -1.021 . . . . 0.0 109.036 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.616 ' CD2' ' CE1' ' A' ' 62' ' ' HIS . 22.1 m-70 -128.52 152.68 48.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.938 . . . . 0.0 109.522 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.574 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 11.7 ttt-85 -114.62 133.23 56.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.365 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.501 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 50.2 mt-10 -140.33 165.11 28.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.108 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.692 HG12 ' H ' ' A' ' 99' ' ' GLN . 1.7 t -155.42 -161.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.085 -1.009 . . . . 0.0 109.319 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.692 ' H ' HG12 ' A' ' 98' ' ' VAL . 8.9 pt20 -82.09 72.78 9.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.086 -1.009 . . . . 0.0 108.552 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 137.07 -19.6 3.45 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.491 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 19.0 m-70 -87.19 -21.96 25.57 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.702 -0.881 . . . . 0.0 108.789 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.598 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.27 22.4 3.35 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.742 0.782 . . . . 0.0 109.124 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.9 p -57.51 -99.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.283 -0.886 . . . . 0.0 111.336 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.943 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 19.1 pt-20 -62.97 -18.32 63.09 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.092 -1.005 . . . . 0.0 111.103 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 1.6 m -79.63 -61.48 1.98 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.805 -1.185 . . . . 0.0 110.166 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.57 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -58.68 -56.45 22.03 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.954 -1.091 . . . . 0.0 108.173 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -57.2 -31.33 65.35 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.455 -0.778 . . . . 0.0 109.18 179.18 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.943 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -51.79 -54.15 31.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.022 -1.049 . . . . 0.0 108.249 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.584 ' HB3' HD13 ' A' ' 18' ' ' ILE . 19.5 m-85 -64.88 -23.95 67.39 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.898 ' HZ ' HD11 ' A' ' 20' ' ' ILE . 9.2 m-85 -102.89 92.53 4.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.518 -0.739 . . . . 0.0 109.312 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.454 ' O ' ' OE1' ' A' ' 112' ' ' GLN . 28.9 mtmm -82.23 89.69 6.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.522 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.454 ' OE1' ' O ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER 168.58 -74.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 108.761 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 114' ' ' LEU . . . -159.78 -142.12 3.31 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.694 HD21 ' CG ' ' A' ' 110' ' ' PHE . 0.5 OUTLIER 174.94 108.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.504 -0.998 . . . . 0.0 108.921 179.433 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.574 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 5.0 mt -93.69 165.04 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 109.374 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.574 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 4.1 m-85 -142.05 113.13 7.5 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.545 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -79.39 -169.24 1.81 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.294 -0.879 . . . . 0.0 109.662 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.583 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 35.5 tp60 -92.64 148.4 22.1 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.751 -1.218 . . . . 0.0 110.73 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.584 ' HA2' ' CD2' ' A' ' 40' ' ' TYR . . . -66.38 -173.73 5.42 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 59.32 117.35 0.01 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.571 HG21 ' CB ' ' A' ' 25' ' ' ASN . 1.5 t . . . . . 0 C--N 1.303 -1.422 0 O-C-N 121.181 -1.187 . . . . 0.0 109.049 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.974 HG22 ' HG2' ' A' ' 27' ' ' GLU . 16.5 t . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.566 ' N ' HG12 ' A' ' 1' ' ' VAL . 7.5 pt-20 39.15 83.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.646 -0.658 . . . . 0.0 109.959 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.848 HD22 ' CG ' ' A' ' 80' ' ' TYR . 2.4 pt? -85.23 14.28 5.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 p -90.83 5.21 49.34 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.675 -1.266 . . . . 0.0 110.088 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -134.26 -48.12 0.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.061 -1.024 . . . . 0.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 8.9 mmtt -89.69 35.48 0.83 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.905 . . . . 0.0 109.024 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.642 HG12 ' HB3' ' A' ' 11' ' ' LEU . 60.6 t -159.3 -49.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.39 -0.819 . . . . 0.0 109.751 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.726 ' HA ' HD23 ' A' ' 11' ' ' LEU . 44.5 p -61.89 -31.3 71.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.325 -0.86 . . . . 0.0 110.137 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 10' ' ' LYS . . . -45.03 -26.62 1.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.5 ' CG ' ' HE3' ' A' ' 13' ' ' LYS . 0.3 OUTLIER 175.87 70.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.505 -0.997 . . . . 0.0 108.622 179.611 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.044 HD12 ' CD2' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -86.92 19.81 2.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.335 -0.853 . . . . 0.0 110.206 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.77 ' OD2' HD21 ' A' ' 48' ' ' LEU . 3.8 p30 157.7 106.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.621 -0.675 . . . . 0.0 109.287 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HE3' ' CG ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -157.94 123.18 4.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 109.644 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 22.1 p 48.34 56.5 7.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.0 109.628 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.5 m -166.41 106.66 0.68 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.392 -0.817 . . . . 0.0 109.27 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 50' ' ' THR . 34.4 Cg_endo -76.96 128.07 9.75 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.347 2.032 . . . . 0.0 110.263 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 144.73 167.91 12.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.951 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -123.64 143.11 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.075 -1.25 . . . . 0.0 109.764 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.472 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 1.7 pm0 -120.15 -170.39 1.96 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.838 HD11 ' HZ ' ' A' ' 110' ' ' PHE . 2.0 mt -147.37 178.65 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.822 -1.174 . . . . 0.0 110.156 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.669 ' H ' HG22 ' A' ' 20' ' ' ILE . 7.1 m-90 -134.67 122.24 21.96 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.54 ' HD3' HG12 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -82.6 130.02 35.04 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.118 -0.989 . . . . 0.0 112.293 -176.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.89 HD13 ' HB2' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -121.18 24.68 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 177.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.755 ' HG3' HG21 ' A' ' 121' ' ' VAL . 10.6 pt-20 -63.42 -49.57 73.21 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.223 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.405 ' N ' ' CG ' ' A' ' 24' ' ' GLU . 21.3 p-10 -85.33 42.86 0.97 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.118 -0.989 . . . . 0.0 108.336 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.565 ' HE3' ' CD ' ' A' ' 73' ' ' GLU . 79.4 mmm 48.42 34.63 4.9 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.974 ' HG2' HG22 ' A' ' 1' ' ' VAL . 3.2 tt0 -151.57 131.37 13.24 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.852 ' HG3' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -81.42 139.17 35.41 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.089 -1.007 . . . . 0.0 110.237 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -144.0 147.67 38.94 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.536 ' HD2' HG13 ' A' ' 29' ' ' VAL . 32.0 Cg_endo -72.29 88.32 0.86 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.292 1.995 . . . . 0.0 111.618 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' A' ' 21' ' ' TRP . 20.7 t -66.91 111.97 8.45 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 36.2 Cg_endo -78.89 -159.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.408 2.072 . . . . 0.0 110.414 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.459 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -87.55 -12.67 45.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.876 . . . . 0.0 109.085 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.07 26.76 1.12 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.29 -0.881 . . . . 0.0 109.918 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 36' ' ' TYR . 1.1 m -160.08 -37.35 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.046 -1.034 . . . . 0.0 109.823 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.469 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 1.1 p90 -43.42 130.78 5.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.569 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.2 -72.51 0.44 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.542 ' ND2' HD12 ' A' ' 115' ' ' ILE . 13.6 m-20 -94.09 96.85 9.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -1.188 . . . . 0.0 109.518 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.768 ' HZ ' HD22 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -117.33 129.53 55.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.248 -0.908 . . . . 0.0 109.187 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.624 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 84.6 m-85 -39.75 153.13 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.453 -0.779 . . . . 0.0 110.174 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 9.5 pt-20 -90.84 -32.93 15.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.392 -0.818 . . . . 0.0 110.197 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.607 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -91.69 64.49 2.47 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.047 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.489 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 3.2 m-20 -162.83 -144.89 0.09 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.405 -1.056 . . . . 0.0 109.963 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.5 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 84.4 m -149.54 143.36 25.56 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.603 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 29.0 m-85 -140.35 112.39 7.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.367 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.646 ' CG2' ' HB1' ' A' ' 77' ' ' ALA . 90.6 t -79.2 127.13 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.932 -1.105 . . . . 0.0 108.59 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.812 HD21 HG13 ' A' ' 18' ' ' ILE . 8.9 tt -107.69 162.81 13.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.9 -1.125 . . . . 0.0 109.901 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.044 ' CD2' HD12 ' A' ' 11' ' ' LEU . 13.8 tp -151.32 115.15 4.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.073 -1.017 . . . . 0.0 108.997 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.518 ' HA ' ' HB ' ' A' ' 18' ' ' ILE . 3.5 t -109.78 132.14 54.42 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.007 -1.058 . . . . 0.0 110.319 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 1.3 m -125.95 120.87 31.5 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -125.92 157.67 37.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 109.556 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.03 151.76 40.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.458 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.72 HG21 ' OG ' ' A' ' 58' ' ' SER . 1.4 p -137.51 -171.97 3.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.209 -0.932 . . . . 0.0 109.523 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.0 -12.32 77.1 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 p -108.17 -36.42 6.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -1.107 . . . . 0.0 109.461 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.95 -100.88 0.15 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 5.9 m-85 -131.53 154.54 48.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -1.171 . . . . 0.0 109.515 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.72 ' OG ' HG21 ' A' ' 53' ' ' THR . 52.5 m -126.42 112.87 16.13 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.71 ' CD2' HG23 ' A' ' 91' ' ' VAL . 2.8 m-85 -92.62 154.43 18.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.176 -0.953 . . . . 0.0 110.421 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.467 ' OD1' ' HB ' ' A' ' 93' ' ' VAL . 6.5 m-20 -140.16 98.68 3.5 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.971 ' CG2' HG23 ' A' ' 81' ' ' THR . 37.2 mt -89.38 119.25 36.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 110.79 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.69 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 21.1 m-70 -109.01 164.44 12.41 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.596 ' CE1' ' HA ' ' A' ' 96' ' ' ARG . 39.4 p90 -138.67 103.73 4.92 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.114 -1.435 . . . . 0.0 109.702 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.602 ' C ' HD23 ' A' ' 65' ' ' LEU . 2.4 t90 -78.97 130.25 35.35 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.047 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.602 HD23 ' C ' ' A' ' 64' ' ' TRP . 0.1 OUTLIER -122.36 65.8 0.94 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.496 -0.753 . . . . 0.0 110.706 -178.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.452 ' HA2' ' HB2' ' A' ' 99' ' ' GLN . . . -51.29 89.63 0.01 OUTLIER Glycine 0 N--CA 1.497 2.746 0 N-CA-C 108.304 -1.918 . . . . 0.0 108.304 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -39.1 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 122.076 0.941 . . . . 0.0 112.255 -177.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.607 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 2.4 m-80 -162.1 -45.2 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 73' ' ' GLU . 88.5 p -62.86 -148.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.354 -0.841 . . . . 0.0 109.199 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.46 ' OG ' ' OD2' ' A' ' 72' ' ' ASP . 2.5 p -121.86 168.54 11.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -48.46 -29.11 3.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.351 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.46 ' OD2' ' OG ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -68.24 -44.49 75.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.446 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.565 ' CD ' ' HE3' ' A' ' 26' ' ' MET . 0.1 OUTLIER -57.16 -36.53 70.88 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.55 ' HA ' HD11 ' A' ' 65' ' ' LEU . 3.8 tt0 -64.09 -34.96 79.23 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.506 ' O ' ' CG1' ' A' ' 79' ' ' ILE . . . -79.83 -13.46 82.24 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.38 -54.02 6.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -1.124 . . . . 0.0 109.248 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.89 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -75.15 -39.66 60.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.163 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 74' ' ' GLN . . . -63.1 -49.36 74.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.355 -0.84 . . . . 0.0 109.306 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' A' ' 75' ' ' GLY . 70.5 mt -63.57 -44.13 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.211 -0.931 . . . . 0.0 109.414 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.848 ' CG ' HD22 ' A' ' 3' ' ' LEU . 14.5 m-30 -62.98 -25.36 68.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.245 -0.909 . . . . 0.0 109.033 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.971 HG23 ' CG2' ' A' ' 61' ' ' ILE . 5.9 m -79.14 -23.41 44.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.3 m -88.79 -21.82 23.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.638 -0.664 . . . . 0.0 109.352 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 6.8 mt-30 -83.19 -37.87 23.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.497 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.638 ' CG ' HD13 ' A' ' 61' ' ' ILE . 5.3 ptm -75.75 -29.24 58.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.334 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.617 ' HA ' HD11 ' A' ' 61' ' ' ILE . 67.2 t0 -61.64 -59.64 4.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -0.944 . . . . 0.0 109.698 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.58 -33.8 76.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.136 -0.977 . . . . 0.0 109.476 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 0.5 OUTLIER -69.91 -16.11 63.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 109.59 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.983 ' CD1' HD11 ' A' ' 11' ' ' LEU . 66.7 mt -94.06 22.61 5.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.678 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 86.2 0.59 86.86 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 1.4 p 75.86 7.52 3.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -1.165 . . . . 0.0 109.616 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.71 HG23 ' CD2' ' A' ' 59' ' ' TYR . 15.7 m -83.3 -19.5 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 109.285 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.582 ' HB1' HG13 ' A' ' 61' ' ' ILE . . . -68.38 165.61 18.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.581 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.751 HG12 ' H ' ' A' ' 94' ' ' GLN . 2.5 t -115.86 -177.08 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.376 -0.827 . . . . 0.0 109.125 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.751 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -131.01 138.43 49.66 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.092 -1.005 . . . . 0.0 108.674 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.69 ' CD2' ' CD2' ' A' ' 62' ' ' HIS . 19.0 m-70 -135.0 142.77 46.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.088 -1.007 . . . . 0.0 110.179 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.596 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -94.17 117.3 29.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 110.148 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.505 ' HB2' ' HA ' ' A' ' 64' ' ' TRP . 44.5 mm-40 -127.98 158.83 36.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.107 -0.996 . . . . 0.0 109.354 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.725 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.6 t -155.75 -175.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.27 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.725 ' H ' HG12 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -69.77 -1.97 10.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.924 -1.11 . . . . 0.0 110.258 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.69 16.11 1.8 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.586 ' CD2' ' HB ' ' A' ' 98' ' ' VAL . 13.1 m-70 -120.88 -15.73 8.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.487 -1.008 . . . . 0.0 109.373 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.598 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.37 21.59 3.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 0.0 109.169 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 102' ' ' GLU . 4.3 p -41.75 -106.03 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.545 -0.722 . . . . 0.0 112.177 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -67.97 -31.67 71.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.84 -1.163 . . . . 0.0 111.245 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.69 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -58.82 -59.73 4.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.011 -1.056 . . . . 0.0 110.197 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.561 ' HD2' HD13 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -58.71 -55.62 32.75 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.006 -1.059 . . . . 0.0 108.467 -179.252 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -54.48 -20.64 8.03 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 105' ' ' THR . . . -65.22 -51.99 57.43 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.692 ' HB3' HD12 ' A' ' 18' ' ' ILE . 29.4 m-85 -65.46 -17.19 64.36 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.991 ' CG ' HD21 ' A' ' 114' ' ' LEU . 4.2 m-85 -121.4 100.79 7.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 109.684 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 2.8 pttt -81.27 73.55 8.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.222 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.43 -54.93 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 109.731 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 114' ' ' LEU . . . 156.5 -20.08 0.46 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.991 HD21 ' CG ' ' A' ' 110' ' ' PHE . 23.0 mt 62.77 133.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.295 -1.121 . . . . 0.0 109.895 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.562 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 3.2 mt -116.39 164.9 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 0.0 108.978 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.562 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -141.07 102.28 4.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.36 -0.837 . . . . 0.0 109.151 179.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.624 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 3.2 mmtt -79.89 -167.97 1.45 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.893 . . . . 0.0 109.587 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.582 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -91.1 124.4 35.29 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.909 -1.119 . . . . 0.0 110.369 -179.451 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 118' ' ' GLN . . . -56.53 -161.61 0.02 OUTLIER Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 67.04 67.38 2.01 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.755 HG21 ' HG3' ' A' ' 24' ' ' GLU . 1.4 t . . . . . 0 C--N 1.303 -1.447 0 O-C-N 121.316 -1.108 . . . . 0.0 109.648 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.962 HG12 ' OE1' ' A' ' 2' ' ' GLU . 1.5 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.962 ' OE1' HG12 ' A' ' 1' ' ' VAL . 15.4 pm0 36.83 51.47 0.94 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.778 -0.576 . . . . 0.0 110.326 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.092 HD22 ' CD2' ' A' ' 80' ' ' TYR . 2.1 pt? -43.33 -31.31 0.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.877 . . . . 0.0 109.412 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.532 ' HA ' ' CG2' ' A' ' 8' ' ' THR . 4.1 t -62.31 87.22 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -0.849 . . . . 0.0 109.935 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.528 ' HG2' ' N ' ' A' ' 6' ' ' LYS . 5.2 ttmm 168.81 -90.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.528 ' N ' ' HG2' ' A' ' 5' ' ' LYS . 1.0 OUTLIER -74.83 -6.62 50.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.202 -0.936 . . . . 0.0 108.94 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.971 HG12 ' CD2' ' A' ' 11' ' ' LEU . 37.4 t -106.9 -72.59 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.833 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 4' ' ' SER . 66.6 p -47.98 -29.66 3.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.678 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 8' ' ' THR . . . -41.81 -47.71 5.06 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.554 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 4.0 mtmt -141.61 -54.39 0.46 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -1.162 . . . . 0.0 109.586 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.069 HD12 ' CD2' ' A' ' 88' ' ' LEU . 55.2 mt 82.22 -42.55 0.13 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.756 -0.59 . . . . 0.0 109.955 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.491 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -170.98 -83.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.939 -1.1 . . . . 0.0 109.605 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER 73.87 124.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.925 . . . . 0.0 109.358 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 22.5 p 48.45 57.02 6.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.442 -0.786 . . . . 0.0 109.521 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.5 m -157.13 101.58 1.92 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.522 -0.736 . . . . 0.0 109.232 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.04 83.66 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.398 2.065 . . . . 0.0 110.502 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.47 -146.3 4.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.868 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -159.24 145.69 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.051 -1.264 . . . . 0.0 109.674 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.633 ' NE2' ' CH2' ' A' ' 21' ' ' TRP . 1.6 tt0 -122.76 143.58 49.73 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.641 HG22 ' H ' ' A' ' 21' ' ' TRP . 1.5 mt -114.76 175.28 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.745 -1.222 . . . . 0.0 109.537 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.641 ' H ' HG22 ' A' ' 20' ' ' ILE . 7.3 m-90 -134.81 117.47 15.97 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.55 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -79.51 128.37 33.28 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 -178.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.652 ' CG2' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -101.56 31.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-O 123.075 1.417 . . . . 0.0 107.325 179.098 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.508 ' O ' ' ND2' ' A' ' 25' ' ' ASN . 1.5 pt-20 -54.96 168.44 0.3 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.647 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' CG ' ' A' ' 27' ' ' GLU . 8.0 p30 42.68 27.68 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.634 ' H ' ' HE3' ' A' ' 26' ' ' MET . 0.0 OUTLIER 50.2 56.8 7.36 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.639 -0.663 . . . . 0.0 109.749 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 28' ' ' MET . 10.0 mm-40 -139.51 -99.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.982 -1.074 . . . . 0.0 110.111 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.59 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 4.1 mmm 163.04 140.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.099 -1.001 . . . . 0.0 109.205 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 1.0 OUTLIER -158.95 146.75 13.47 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.125 -0.984 . . . . 0.0 109.488 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.565 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 35.5 Cg_endo -77.45 87.45 1.51 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.842 2.361 . . . . 0.0 111.658 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.55 HG23 ' H ' ' A' ' 22' ' ' ARG . 42.3 t -69.92 113.08 14.86 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.475 ' HG2' ' HG2' ' A' ' 34' ' ' LYS . 34.9 Cg_endo -76.67 -159.91 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.481 2.121 . . . . 0.0 110.827 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -88.61 -16.46 32.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.322 -0.862 . . . . 0.0 109.261 -179.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 32' ' ' PRO . 8.9 ptmt -90.38 17.66 7.02 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 110.052 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.1 m -143.2 5.27 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.936 -1.103 . . . . 0.0 110.566 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.567 ' CD1' ' O ' ' A' ' 33' ' ' THR . 30.1 p90 -90.45 146.59 24.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.784 -1.197 . . . . 0.0 109.646 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.424 ' C ' ' OD1' ' A' ' 38' ' ' ASN . . . 136.33 -27.42 2.99 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.566 ' ND2' HD12 ' A' ' 115' ' ' ILE . 0.7 OUTLIER -139.47 106.4 5.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -1.159 . . . . 0.0 109.491 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -119.83 126.89 52.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.108 -0.995 . . . . 0.0 109.67 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.598 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 6.9 m-30 -48.56 121.81 4.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.432 -0.792 . . . . 0.0 109.563 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.598 ' HA ' ' CH2' ' A' ' 64' ' ' TRP . 1.7 pt-20 -64.17 -7.81 10.3 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.104 -0.998 . . . . 0.0 110.297 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.643 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -111.43 57.23 0.43 Allowed Glycine 0 N--CA 1.485 1.901 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.498 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.503 ' OD1' ' HB2' ' A' ' 40' ' ' TYR . 4.3 m-20 -162.34 -143.96 0.09 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.299 -1.118 . . . . 0.0 109.99 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.59 ' HB3' ' HB2' ' A' ' 77' ' ' ALA . 6.3 m -145.54 139.12 26.53 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.494 ' HB3' ' CG2' ' A' ' 20' ' ' ILE . 21.2 m-85 -137.04 106.94 6.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.054 -1.029 . . . . 0.0 110.04 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.576 HG13 ' OG1' ' A' ' 81' ' ' THR . 87.5 t -78.83 128.54 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.102 -0.999 . . . . 0.0 108.857 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.697 HD11 HG13 ' A' ' 18' ' ' ILE . 3.7 tt -107.33 160.88 15.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.019 -1.05 . . . . 0.0 109.895 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.549 ' CD2' ' HB3' ' A' ' 11' ' ' LEU . 20.3 tp -151.18 92.48 1.8 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.999 -1.063 . . . . 0.0 109.519 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.566 ' CB ' ' HB ' ' A' ' 18' ' ' ILE . 3.0 t -96.3 131.0 43.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 110.126 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.468 ' OG1' ' CD2' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -107.07 152.69 23.67 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -138.01 137.58 38.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.106 -0.996 . . . . 0.0 109.642 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.562 ' O ' HG23 ' A' ' 53' ' ' THR . 0.0 OUTLIER -76.98 163.64 26.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.368 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 52' ' ' LYS . 23.6 p -158.55 -177.77 6.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.538 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.36 19.29 36.58 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.7 t -140.91 -50.39 0.44 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -1.145 . . . . 0.0 109.559 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.37 -102.17 0.19 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 3.4 m-85 -152.43 -172.19 4.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -1.15 . . . . 0.0 109.5 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.6 t -149.03 102.92 3.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.844 . . . . 0.0 108.99 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.593 ' CD2' HD22 ' A' ' 88' ' ' LEU . 52.9 m-85 -85.23 159.34 20.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 0.0 110.181 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.469 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 6.2 m-20 -141.36 100.18 3.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.966 ' CG2' HG23 ' A' ' 81' ' ' THR . 47.5 mt -92.51 114.26 29.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.091 -1.005 . . . . 0.0 110.419 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.698 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 13.8 m-70 -107.91 170.1 8.2 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.545 -0.722 . . . . 0.0 109.272 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.578 ' CE1' ' HA ' ' A' ' 96' ' ' ARG . 53.4 p90 -141.41 107.1 5.09 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.4 -1.32 . . . . 0.0 109.923 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.598 ' CH2' ' HA ' ' A' ' 41' ' ' GLU . 3.0 t90 -82.28 136.46 35.04 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -124.05 63.47 1.07 Allowed 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.329 -178.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 68' ' ' ASN . . . -46.49 93.68 0.01 OUTLIER Glycine 0 N--CA 1.498 2.768 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.586 ' N ' ' O ' ' A' ' 65' ' ' LEU . 7.3 tppt? -39.47 84.56 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.643 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 7.7 m120 -163.0 -43.21 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.528 ' HB2' ' CB ' ' A' ' 73' ' ' GLU . 1.4 p -50.29 -178.84 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.755 -0.591 . . . . 0.0 109.483 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.46 ' OG ' ' OD1' ' A' ' 72' ' ' ASP . 1.0 OUTLIER -95.72 -169.0 1.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.553 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.522 ' O ' ' CG ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -70.72 -39.86 73.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 9.3 p-10 -74.34 -24.57 59.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.004 -1.06 . . . . 0.0 109.298 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.528 ' CB ' ' HB2' ' A' ' 69' ' ' SER . 29.5 mt-10 -69.03 -43.03 75.57 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.699 ' HB2' HD11 ' A' ' 65' ' ' LEU . 4.0 pt20 -66.19 -30.35 70.8 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.63 ' O ' HD13 ' A' ' 79' ' ' ILE . . . -83.7 -12.42 77.68 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -83.8 -41.67 17.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.16 -1.2 . . . . 0.0 108.718 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.59 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . . . -72.66 -50.74 22.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.855 . . . . 0.0 108.774 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.53 86.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 109.039 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.63 HD13 ' O ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -63.52 -42.62 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.303 -0.873 . . . . 0.0 108.647 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 1.092 ' CD2' HD22 ' A' ' 3' ' ' LEU . 5.0 m-85 -62.08 -24.23 66.98 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.966 HG23 ' CG2' ' A' ' 61' ' ' ILE . 1.8 m -82.38 -26.31 32.99 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.1 m -70.54 -46.14 64.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.504 -0.747 . . . . 0.0 109.081 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 1.8 mt-30 -68.94 -42.56 76.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.345 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.67 ' O ' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -55.35 -36.0 65.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 109.404 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.487 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.9 t0 -77.4 -36.86 52.96 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.0 109.507 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -86.44 6.21 31.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.57 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 1.9 m-85 -121.0 -17.09 7.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 109.582 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 1.069 ' CD2' HD12 ' A' ' 11' ' ' LEU . 7.0 mt -87.58 4.93 41.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 109.598 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.749 ' O ' HG13 ' A' ' 91' ' ' VAL . . . 96.73 33.63 6.04 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 p 47.02 24.25 0.36 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 0.0 109.627 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.749 HG13 ' O ' ' A' ' 89' ' ' GLY . 14.8 m -100.98 -15.78 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 0.0 109.282 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.547 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -79.98 167.85 19.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.274 -0.891 . . . . 0.0 109.626 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.764 HG12 ' H ' ' A' ' 94' ' ' GLN . 2.8 t -116.16 -176.92 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.452 -0.78 . . . . 0.0 109.099 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.764 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -129.62 142.09 50.81 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.896 -1.127 . . . . 0.0 109.013 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.698 ' CD2' ' CD2' ' A' ' 62' ' ' HIS . 9.0 m-70 -143.32 150.19 38.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.067 -1.02 . . . . 0.0 109.882 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.578 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 3.4 ttp180 -108.13 138.3 44.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 110.201 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.512 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 10.5 mm-40 -145.66 161.75 39.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.36 -0.838 . . . . 0.0 109.188 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.754 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.2 t -156.58 -166.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 108.873 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.754 ' H ' HG12 ' A' ' 98' ' ' VAL . 14.2 pt20 -74.12 1.82 10.3 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.837 -1.164 . . . . 0.0 110.127 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.78 19.49 1.27 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.567 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 11.9 m-70 -123.93 -9.88 7.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.571 -0.959 . . . . 0.0 109.398 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.656 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 1.2 pp20? -90.39 15.19 11.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.392 -0.817 . . . . 0.0 109.726 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 102' ' ' GLU . 24.5 p -39.72 -109.53 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -75.52 -25.66 57.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.719 -1.238 . . . . 0.0 111.152 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.736 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 4.6 m -64.16 -48.83 74.46 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.823 -1.173 . . . . 0.0 109.501 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.656 ' HB2' ' HB2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -67.56 -57.29 6.73 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.584 ' N ' HD21 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -45.91 -28.04 1.03 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 105' ' ' THR . . . -60.66 -55.22 35.87 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.651 ' CE2' ' CE1' ' A' ' 62' ' ' HIS . 69.6 m-85 -74.33 -3.65 31.53 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.56 ' CG ' HD11 ' A' ' 114' ' ' LEU . 44.9 m-85 -119.15 91.34 3.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.711 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.57 34.17 0.9 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.642 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.31 -71.78 0.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.114 -0.991 . . . . 0.0 109.696 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -173.0 125.85 1.19 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.584 HD21 ' N ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -90.78 125.09 35.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.381 -1.07 . . . . 0.0 110.121 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.566 HD12 ' ND2' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -129.35 166.99 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.558 ' CD1' ' O ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -149.65 112.4 4.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.084 -1.01 . . . . 0.0 109.56 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -96.15 -159.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.424 -0.797 . . . . 0.0 109.801 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -91.07 167.19 12.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.248 -0.907 . . . . 0.0 109.607 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.494 ' HA2' ' OD1' ' A' ' 43' ' ' ASP . . . -80.5 -163.89 29.83 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 62.19 139.52 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 C--N 1.305 -1.344 0 O-C-N 121.219 -1.165 . . . . 0.0 108.673 179.897 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 2' ' ' GLU . 1.3 t . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.475 ' H ' HG12 ' A' ' 1' ' ' VAL . 1.5 pt-20 -44.41 126.25 5.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.479 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.727 HD13 ' HB3' ' A' ' 80' ' ' TYR . 0.7 OUTLIER -85.06 14.71 4.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.575 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 5.9 p -92.51 152.22 19.77 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.668 -1.27 . . . . 0.0 109.902 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 4' ' ' SER . 0.1 OUTLIER 80.5 -69.69 0.09 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.71 . . . . 0.0 110.742 178.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.522 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 13.8 ttmt -81.98 16.44 1.9 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.05 -1.031 . . . . 0.0 110.663 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.626 ' HB ' ' O ' ' A' ' 3' ' ' LEU . 51.6 t -158.69 -59.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.917 -1.115 . . . . 0.0 109.825 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.667 ' HA ' HD12 ' A' ' 11' ' ' LEU . 77.4 p -60.55 -13.32 13.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 109.813 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.79 -20.45 6.03 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.537 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 1.7 pttm -170.99 -33.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -1.141 . . . . 0.0 109.772 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.787 HD21 ' SD ' ' A' ' 84' ' ' MET . 0.2 OUTLIER 69.56 -0.4 2.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.39 -0.819 . . . . 0.0 110.093 -179.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 11' ' ' LEU . 32.3 m-20 58.63 135.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.109 -0.994 . . . . 0.0 110.201 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.732 ' O ' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -56.59 -19.27 15.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.044 -1.035 . . . . 0.0 108.587 179.235 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 13' ' ' LYS . 13.8 t 44.99 18.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.916 -0.49 . . . . 0.0 111.925 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.629 HG23 ' HD2' ' A' ' 16' ' ' PRO . 0.5 OUTLIER 47.62 -177.17 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.015 -1.053 . . . . 0.0 108.599 179.435 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HD2' HG23 ' A' ' 15' ' ' THR . 34.9 Cg_endo -80.32 90.11 1.26 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.908 1.739 . . . . 0.0 110.32 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.528 ' O ' ' CG2' ' A' ' 18' ' ' ILE . . . -164.3 -120.89 0.54 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.908 HD12 HD11 ' A' ' 47' ' ' LEU . 19.9 pt -160.5 -165.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -1.188 . . . . 0.0 110.232 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.492 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 2.5 mt-30 -170.78 172.95 5.48 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.728 HD11 ' CZ ' ' A' ' 110' ' ' PHE . 18.5 mt -145.88 168.15 7.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.401 -1.437 . . . . 0.0 110.352 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.636 ' HA ' HG23 ' A' ' 31' ' ' VAL . 7.4 m-90 -133.97 118.83 18.31 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.773 ' HG3' HG22 ' A' ' 31' ' ' VAL . 14.4 mtm180 -79.15 121.2 24.72 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.219 -0.926 . . . . 0.0 110.921 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.636 ' CG2' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -101.98 27.48 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.123 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.537 ' HB2' ' CG2' ' A' ' 121' ' ' VAL . 1.3 pt-20 -58.62 179.13 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.375 -0.828 . . . . 0.0 109.421 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' CG ' ' A' ' 27' ' ' GLU . 8.4 p30 42.14 27.47 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.463 ' N ' ' O ' ' A' ' 24' ' ' GLU . 26.9 mmm 54.71 55.27 8.08 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.489 -0.757 . . . . 0.0 109.765 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 70.1 mm-40 -153.47 -134.36 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.117 -0.99 . . . . 0.0 109.356 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.57 ' HE2' ' CD1' ' A' ' 21' ' ' TRP . 3.1 ttt -160.04 149.74 18.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.898 -1.126 . . . . 0.0 109.316 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.561 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -160.16 149.36 14.07 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.099 -1.0 . . . . 0.0 109.587 -179.559 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HD2' HG13 ' A' ' 29' ' ' VAL . 34.6 Cg_endo -76.43 125.88 8.67 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.534 2.156 . . . . 0.0 111.109 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.773 HG22 ' HG3' ' A' ' 22' ' ' ARG . 5.8 t -111.24 105.61 57.02 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.63 -158.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.44 2.093 . . . . 0.0 110.4 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.561 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -81.86 -18.91 42.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 108.952 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.16 32.33 0.76 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.345 -0.847 . . . . 0.0 109.706 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.525 ' HB3' HG13 ' A' ' 31' ' ' VAL . 1.7 m -155.07 -38.8 0.09 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.95 . . . . 0.0 109.624 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.563 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -45.55 129.47 8.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.469 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.34 -77.09 0.39 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.507 ' HA ' HG22 ' A' ' 115' ' ' ILE . 4.4 m-80 -89.1 106.79 18.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -1.165 . . . . 0.0 109.673 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.701 ' HZ ' HD22 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -135.92 137.08 41.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.233 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.68 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 7.2 m-30 -42.33 151.95 0.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.285 -0.885 . . . . 0.0 109.508 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.557 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 12.1 pt-20 -90.93 -37.98 13.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.171 -0.956 . . . . 0.0 109.784 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.626 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -85.69 66.46 3.75 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.193 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -162.91 -150.28 0.16 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.025 -1.28 . . . . 0.0 110.31 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.497 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 34.6 m -139.0 148.1 43.01 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 28.2 m-85 -145.36 109.23 4.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.015 -1.053 . . . . 0.0 109.717 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.605 HG13 ' OG1' ' A' ' 81' ' ' THR . 98.8 t -79.37 122.6 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.999 -1.063 . . . . 0.0 108.549 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.908 HD11 HD12 ' A' ' 18' ' ' ILE . 6.6 tt -108.1 123.5 48.8 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.256 -0.903 . . . . 0.0 110.168 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.579 ' CD2' HD23 ' A' ' 11' ' ' LEU . 24.0 tp -104.55 100.24 9.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.846 -1.159 . . . . 0.0 109.864 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.491 ' OG ' HG22 ' A' ' 18' ' ' ILE . 10.8 t -83.41 127.21 33.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 108.757 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.655 ' CG2' ' CE1' ' A' ' 57' ' ' PHE . 1.2 m -123.02 114.32 20.24 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -116.6 126.59 53.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.269 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.89 ' O ' HG23 ' A' ' 53' ' ' THR . 11.4 pttm -51.52 -176.86 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.329 -0.857 . . . . 0.0 109.325 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -178.72 153.47 0.68 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.444 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 53' ' ' THR . . . -44.2 -26.83 0.99 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.17 -40.49 14.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -1.092 . . . . 0.0 109.41 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.72 -70.29 0.2 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.655 ' CE1' ' CG2' ' A' ' 50' ' ' THR . 0.1 OUTLIER -139.81 175.63 9.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -1.138 . . . . 0.0 111.196 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.66 89.34 1.68 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.589 ' CE1' ' HB3' ' A' ' 57' ' ' PHE . 6.5 m-85 -78.74 157.2 28.57 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.135 0.969 . . . . 0.0 111.32 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.572 ' O ' ' CD2' ' A' ' 62' ' ' HIS . 7.7 m-80 -151.54 87.6 1.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 1.034 ' CG2' HG23 ' A' ' 81' ' ' THR . 10.3 mt -71.2 140.71 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.295 -0.878 . . . . 0.0 110.4 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.648 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 55.4 m-70 -125.99 160.18 30.72 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 95' ' ' HIS . 50.6 p90 -134.85 96.18 3.48 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 117.979 -1.489 . . . . 0.0 109.887 177.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.599 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 6.0 t90 -74.18 131.74 41.54 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.613 HD11 ' CG ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -121.55 60.96 0.94 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.287 -0.883 . . . . 0.0 111.039 -178.078 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -49.07 90.46 0.01 OUTLIER Glycine 0 N--CA 1.498 2.786 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.59 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -38.43 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.13 0.967 . . . . 0.0 112.61 -177.432 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.626 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 2.7 m-80 -162.61 -45.73 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.486 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 96.3 p -59.34 -156.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.517 -0.739 . . . . 0.0 109.276 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 p -109.34 160.7 15.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -45.44 19.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 109.381 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -57.92 -41.74 83.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.141 -0.974 . . . . 0.0 109.361 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.486 ' HG2' ' HB2' ' A' ' 69' ' ' SER . 3.9 tp10 -54.54 -39.77 68.01 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.613 ' CG ' HD11 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -60.43 -37.69 81.71 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.605 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -70.67 -23.57 77.65 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 77' ' ' ALA . . . -75.71 -67.21 0.69 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.313 -1.11 . . . . 0.0 109.192 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -45.35 -38.09 5.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 0.0 109.301 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.64 -39.91 73.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.665 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.605 HD12 ' O ' ' A' ' 75' ' ' GLY . 17.9 mt -60.83 -48.69 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 0.0 109.5 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.727 ' HB3' HD13 ' A' ' 3' ' ' LEU . 25.5 m-85 -56.92 -42.46 80.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.042 -1.036 . . . . 0.0 108.968 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 1.034 HG23 ' CG2' ' A' ' 61' ' ' ILE . 6.4 m -68.72 -23.65 64.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.485 -0.76 . . . . 0.0 109.141 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.3 m -78.57 -23.59 45.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.452 -0.78 . . . . 0.0 109.46 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 5.1 mt-30 -89.91 -34.5 16.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.671 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.803 ' HB2' HD13 ' A' ' 61' ' ' ILE . 2.4 mtt -63.14 -47.05 84.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.696 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.671 ' N ' HD11 ' A' ' 61' ' ' ILE . 3.1 t70 -50.73 -54.98 18.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.721 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.69 -12.21 59.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.717 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 4.1 m-30 -97.23 -2.92 41.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.609 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.689 HD21 HD22 ' A' ' 11' ' ' LEU . 3.9 mt -108.43 8.23 27.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.55 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 105.59 3.1 40.52 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 1.3 p 75.38 -0.09 3.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -1.174 . . . . 0.0 109.644 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.536 HG23 ' CD2' ' A' ' 59' ' ' TYR . 4.7 m -87.23 15.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.114 -0.991 . . . . 0.0 109.389 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.584 ' HB3' ' HA ' ' A' ' 85' ' ' ASP . . . -100.03 179.33 4.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.586 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.655 HG12 ' H ' ' A' ' 94' ' ' GLN . 4.6 t -135.24 175.86 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.12 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.655 ' H ' HG12 ' A' ' 93' ' ' VAL . 50.4 tt0 -124.91 131.04 53.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.972 -1.08 . . . . 0.0 109.504 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.648 ' CD2' ' CE1' ' A' ' 62' ' ' HIS . 20.2 m-70 -130.21 150.02 51.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.8 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.578 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 8.6 ptm180 -109.79 136.02 49.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.369 -0.832 . . . . 0.0 109.801 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.497 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 7.4 mm-40 -139.77 166.21 25.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.263 -0.898 . . . . 0.0 109.595 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.71 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.7 t -155.58 -176.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.354 -0.841 . . . . 0.0 109.2 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.71 ' H ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -67.63 -4.52 12.18 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.966 -1.084 . . . . 0.0 110.335 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.08 14.38 3.06 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.538 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 51.8 m-70 -123.01 -20.96 5.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.57 -0.959 . . . . 0.0 109.725 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.599 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.1 OUTLIER -90.28 8.85 31.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.341 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 107' ' ' ARG . 1.0 OUTLIER -56.79 -63.03 1.34 Allowed 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.162 -0.961 . . . . 0.0 111.225 -178.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.662 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 3.6 mt-10 -76.5 -55.6 5.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.967 -1.083 . . . . 0.0 111.748 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -61.26 -52.64 63.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.97 -1.082 . . . . 0.0 111.113 -178.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.568 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -64.98 -55.0 21.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.968 -1.082 . . . . 0.0 108.914 -178.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' A' ' 103' ' ' SER . 2.3 ttm180 -61.51 -17.26 53.9 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.179 -0.951 . . . . 0.0 108.661 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.662 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -66.14 -59.81 3.41 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.906 ' HB3' HD13 ' A' ' 18' ' ' ILE . 9.2 m-85 -63.43 -16.19 59.83 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 1.064 ' CG ' HD21 ' A' ' 114' ' ' LEU . 43.7 m-85 -108.22 99.51 8.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.474 -0.766 . . . . 0.0 109.536 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -74.77 1.59 12.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.286 -0.883 . . . . 0.0 109.702 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.78 -81.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.066 -1.021 . . . . 0.0 109.822 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' A' ' 114' ' ' LEU . . . 178.04 -29.99 0.07 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 1.064 HD21 ' CG ' ' A' ' 110' ' ' PHE . 33.3 mt 81.75 109.33 0.07 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.589 -0.948 . . . . 0.0 110.284 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.563 HG23 ' N ' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -91.03 172.15 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.563 ' N ' HG23 ' A' ' 115' ' ' ILE . 1.4 m-85 -150.04 124.88 9.85 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.024 -1.047 . . . . 0.0 109.981 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.68 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -106.4 -164.89 1.04 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.471 -0.768 . . . . 0.0 109.31 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.579 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 1.6 tp60 -91.56 163.03 14.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.879 -1.138 . . . . 0.0 110.165 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 120' ' ' GLY . . . -76.56 -153.68 5.16 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 52.69 101.46 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.537 ' CG2' ' HB2' ' A' ' 24' ' ' GLU . 1.5 t . . . . . 0 C--N 1.304 -1.384 0 O-C-N 121.17 -1.194 . . . . 0.0 109.253 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 2' ' ' GLU . 29.1 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 2' ' ' GLU . 18.0 pt-20 32.98 93.99 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.428 0.632 . . . . 0.0 110.462 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.639 HD23 ' N ' ' A' ' 3' ' ' LEU . 2.6 pt? -53.8 -33.25 55.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 109.505 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.624 ' HA ' HG23 ' A' ' 8' ' ' THR . 10.7 t -44.53 146.08 0.77 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 4' ' ' SER . 10.9 tttt 80.24 -71.84 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.63 -0.669 . . . . 0.0 109.96 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -84.73 15.76 3.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 109.985 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.526 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 12.0 t -150.56 -65.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.016 -1.052 . . . . 0.0 109.716 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.655 ' HA ' HD21 ' A' ' 11' ' ' LEU . 70.3 p -50.01 -23.19 1.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.4 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 10' ' ' LYS . . . -89.58 33.11 4.49 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.487 ' O ' ' CG ' ' A' ' 10' ' ' LYS . 2.4 tttm 169.28 70.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -1.069 . . . . 0.0 109.17 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.655 HD21 ' HA ' ' A' ' 8' ' ' THR . 4.3 mm? -94.47 74.0 3.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.375 -0.828 . . . . 0.0 109.414 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 13' ' ' LYS . 6.2 t70 62.16 -91.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 109.376 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER 62.37 124.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.954 . . . . 0.0 109.631 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.596 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 22.4 p 48.36 56.99 6.67 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.349 -0.844 . . . . 0.0 109.604 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.436 ' HB ' ' CG ' ' A' ' 12' ' ' ASP . 21.1 m -167.48 102.34 0.6 Allowed Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.417 -0.802 . . . . 0.0 109.414 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.95 99.8 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.423 2.082 . . . . 0.0 110.277 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.455 ' O ' ' CG2' ' A' ' 18' ' ' ILE . . . 179.54 -139.14 3.73 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.018 HD12 HD11 ' A' ' 47' ' ' LEU . 12.3 pt -157.41 142.46 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.049 -1.265 . . . . 0.0 110.1 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.447 ' NE2' ' CZ2' ' A' ' 21' ' ' TRP . 1.1 tt0 -122.24 114.44 20.83 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.588 HD11 ' CE1' ' A' ' 110' ' ' PHE . 2.9 mt -92.49 164.04 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.757 -1.214 . . . . 0.0 109.67 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.681 ' CB ' ' HE3' ' A' ' 28' ' ' MET . 8.3 m-90 -122.01 126.42 48.48 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.596 ' HA ' ' CD1' ' A' ' 45' ' ' TYR . 0.9 OUTLIER -79.23 132.66 36.57 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.177 0.989 . . . . 0.0 111.74 -176.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' A' ' 44' ' ' CYS . 2.2 mm -127.27 44.26 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.547 ' HB2' ' CD2' ' A' ' 40' ' ' TYR . 3.2 pm0 -99.81 -40.12 7.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 0.0 110.049 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.521 ' OD1' ' CG ' ' A' ' 27' ' ' GLU . 3.0 p30 -81.97 10.08 7.15 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.132 -0.98 . . . . 0.0 108.677 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.517 ' CE ' ' OG ' ' A' ' 70' ' ' SER . 53.9 mmm 73.08 29.0 1.83 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.521 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 47.6 mt-10 -150.79 103.02 3.04 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.681 ' HE3' ' CB ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -42.29 138.02 1.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 110.173 -179.219 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -139.71 149.37 59.26 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HD2' HG13 ' A' ' 29' ' ' VAL . 35.7 Cg_endo -78.68 82.61 2.44 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.225 1.95 . . . . 0.0 111.737 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.572 ' CG2' ' N ' ' A' ' 22' ' ' ARG . 2.8 t -69.9 112.93 14.01 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.18 -0.95 . . . . 0.0 109.887 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.488 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 36.2 Cg_endo -78.7 -158.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.486 2.124 . . . . 0.0 110.044 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.572 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -90.0 -16.29 30.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.083 -1.01 . . . . 0.0 109.152 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.488 ' HG3' ' HG2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -75.39 -20.31 59.02 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -0.873 . . . . 0.0 109.874 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.0 m -122.96 13.12 9.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.12 -0.988 . . . . 0.0 109.734 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.58 ' CG ' ' O ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -85.05 49.88 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.985 . . . . 0.0 109.914 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.568 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . -137.65 -82.71 0.11 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.542 ' HA ' HG22 ' A' ' 115' ' ' ILE . 4.2 m-80 -81.46 123.96 29.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -1.135 . . . . 0.0 109.58 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.695 ' CZ ' HD22 ' A' ' 114' ' ' LEU . 2.7 p90 -160.24 141.08 12.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.013 . . . . 0.0 110.087 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.691 ' CE2' HG23 ' A' ' 121' ' ' VAL . 5.4 m-30 -39.6 142.9 0.26 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.355 -0.841 . . . . 0.0 110.767 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 15.7 pt-20 -90.66 -38.86 12.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 109.363 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.589 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -83.43 70.97 3.08 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.484 ' OD1' ' HB3' ' A' ' 40' ' ' TYR . 4.9 m-20 -160.66 -132.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.719 -0.871 . . . . 0.0 109.122 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.58 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 57.9 m -156.66 148.77 23.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.988 -1.07 . . . . 0.0 108.599 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.649 ' CZ ' ' HB2' ' A' ' 39' ' ' PHE . 17.2 m-85 -147.57 111.06 4.94 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.353 -0.842 . . . . 0.0 109.575 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.789 HG13 ' OG1' ' A' ' 81' ' ' THR . 4.0 t -79.59 112.21 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.994 -1.066 . . . . 0.0 108.152 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.018 HD11 HD12 ' A' ' 18' ' ' ILE . 7.3 tt -102.97 114.59 29.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.83 -1.168 . . . . 0.0 110.331 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.642 HD11 ' HB3' ' A' ' 59' ' ' TYR . 16.5 tp -99.99 109.89 22.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.237 -0.914 . . . . 0.0 109.195 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 t -97.12 134.28 40.67 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.39 -0.819 . . . . 0.0 109.641 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.53 ' OG1' ' CD1' ' A' ' 59' ' ' TYR . 1.2 m -120.52 135.95 54.92 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.14 155.42 37.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.627 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.511 ' O ' ' CG2' ' A' ' 53' ' ' THR . 0.0 OUTLIER -91.42 155.63 18.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 109.458 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 52' ' ' LYS . 68.9 p -158.83 175.61 13.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 0.0 109.449 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.38 -22.01 71.48 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.13 -52.99 5.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -1.173 . . . . 0.0 109.477 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.06 -97.28 0.11 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.596 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 18.2 m-85 -145.35 156.23 43.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -1.143 . . . . 0.0 109.526 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.0 m -121.89 99.53 6.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.871 . . . . 0.0 108.914 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 1.014 ' CD2' HD22 ' A' ' 88' ' ' LEU . 17.3 m-30 -81.77 158.23 24.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 110.209 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.558 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 8.0 m-20 -150.43 90.38 1.65 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.996 ' CG2' HG23 ' A' ' 81' ' ' THR . 11.7 mt -77.51 135.52 26.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.231 -0.918 . . . . 0.0 110.291 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.682 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 55.9 m-70 -122.48 159.56 27.39 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.622 ' CZ ' ' HA ' ' A' ' 96' ' ' ARG . 49.4 p90 -135.52 93.26 2.94 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.92 -1.512 . . . . 0.0 110.099 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.74 ' C ' HD23 ' A' ' 65' ' ' LEU . 5.7 t90 -73.91 119.17 17.75 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.789 HD13 ' HB2' ' A' ' 74' ' ' GLN . 0.2 OUTLIER -110.33 77.41 1.05 Allowed 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.568 -0.707 . . . . 0.0 111.158 -177.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' A' ' 99' ' ' GLN . . . -65.7 86.88 0.1 OUTLIER Glycine 0 N--CA 1.494 2.559 0 N-CA-C 107.751 -2.14 . . . . 0.0 107.751 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.478 ' O ' ' OD1' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -52.68 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.798 0.808 . . . . 0.0 112.617 -177.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.589 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 10.1 m120 -160.29 -39.1 0.05 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 70' ' ' SER . 11.7 p -71.72 -145.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 109.297 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.517 ' OG ' ' CE ' ' A' ' 26' ' ' MET . 16.8 p -88.62 142.41 27.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 0.0 109.956 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.505 ' CG ' ' OE1' ' A' ' 74' ' ' GLN . 5.5 tt0 -50.78 -46.92 59.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.299 -0.875 . . . . 0.0 109.018 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.93 -38.5 67.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.217 -0.927 . . . . 0.0 109.026 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.537 ' HG3' HG22 ' A' ' 23' ' ' ILE . 1.4 tp10 -56.84 -38.58 72.85 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.789 ' HB2' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -62.45 -35.89 80.7 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.651 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -80.19 -13.64 81.63 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -79.86 -44.25 20.83 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.299 -1.118 . . . . 0.0 108.706 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.12 -44.52 75.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 108.979 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.2 -48.94 71.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.424 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.651 HD12 ' O ' ' A' ' 75' ' ' GLY . 64.6 mt -55.5 -43.97 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.96 . . . . 0.0 109.474 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.568 ' CD2' ' SD ' ' A' ' 28' ' ' MET . 4.5 m-85 -63.35 -32.09 73.42 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.102 -0.999 . . . . 0.0 108.731 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.996 HG23 ' CG2' ' A' ' 61' ' ' ILE . 8.7 m -66.92 -24.8 66.13 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.5 m -84.48 -29.96 25.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.531 -0.73 . . . . 0.0 109.166 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.509 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 1.9 mt-30 -71.45 -38.03 71.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 109.514 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.586 ' HG3' HD13 ' A' ' 61' ' ' ILE . 4.2 ptm -82.38 -33.11 28.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.46 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.53 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 9.2 t0 -59.7 -28.89 67.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 0.0 109.299 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -90.08 -36.83 14.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.872 . . . . 0.0 109.454 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.509 ' CD1' ' O ' ' A' ' 83' ' ' GLN . 5.6 m-85 -71.33 -8.45 53.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 109.565 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 1.014 HD22 ' CD2' ' A' ' 59' ' ' TYR . 20.3 mt -84.98 -14.17 48.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.539 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 90' ' ' SER . . . 100.67 18.22 21.36 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 89' ' ' GLY . 0.3 OUTLIER 73.29 6.77 5.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -1.108 . . . . 0.0 109.606 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.4 m -85.07 -14.95 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.122 -0.986 . . . . 0.0 109.464 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.899 ' HB2' HD13 ' A' ' 88' ' ' LEU . . . -90.14 172.87 8.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 109.546 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.649 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.5 t -128.38 176.14 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 109.312 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.649 ' H ' HG12 ' A' ' 93' ' ' VAL . 33.2 tt0 -122.82 133.48 54.44 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.096 -1.002 . . . . 0.0 109.006 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.682 ' CD2' ' CE1' ' A' ' 62' ' ' HIS . 29.1 m-70 -126.83 141.74 51.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.125 -0.984 . . . . 0.0 110.145 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -89.34 120.02 30.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 109.792 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.603 ' HB2' ' HA ' ' A' ' 64' ' ' TRP . 26.9 mt-10 -127.74 156.72 41.98 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.276 -0.89 . . . . 0.0 108.845 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.697 HG12 ' H ' ' A' ' 99' ' ' GLN . 3.0 t -160.11 -179.27 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.301 -0.875 . . . . 0.0 108.874 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.697 ' H ' HG12 ' A' ' 98' ' ' VAL . 28.8 tt0 -73.69 -3.27 27.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.938 -1.101 . . . . 0.0 109.198 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.56 6.21 3.85 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.629 ' CG ' ' CG2' ' A' ' 98' ' ' VAL . 10.9 m170 -109.45 -89.97 0.47 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.397 -1.061 . . . . 0.0 108.766 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -83.5 44.44 0.97 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.446 -0.784 . . . . 0.0 110.269 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -80.62 -61.5 1.95 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 108.698 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.516 ' N ' ' OG ' ' A' ' 103' ' ' SER . 28.2 tt0 -64.46 -47.27 79.67 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.754 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 40.8 m -49.57 -46.51 48.98 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.602 ' HB2' ' O ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -49.73 -65.14 0.61 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.611 ' CA ' HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -42.51 -35.01 0.94 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 105' ' ' THR . . . -52.13 -56.51 14.02 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.867 ' HB3' HD13 ' A' ' 18' ' ' ILE . 97.1 m-85 -56.41 -28.34 59.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.902 . . . . 0.0 108.576 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.635 ' CD2' HD11 ' A' ' 114' ' ' LEU . 87.6 m-85 -88.02 90.38 8.36 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -74.06 -0.14 15.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.438 -0.789 . . . . 0.0 109.923 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -96.85 -85.46 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.109 -0.994 . . . . 0.0 109.594 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -164.22 123.07 1.14 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.695 HD22 ' CZ ' ' A' ' 39' ' ' PHE . 4.4 mt -92.15 145.28 24.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -1.159 . . . . 0.0 110.067 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.542 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -140.29 169.79 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.571 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 1.0 OUTLIER -147.45 139.34 24.19 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.926 -1.109 . . . . 0.0 110.137 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.425 ' HB2' ' HD1' ' A' ' 40' ' ' TYR . 2.0 mptp? -114.71 -168.25 1.35 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.512 -0.742 . . . . 0.0 109.235 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.583 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 1.1 pm0 -90.92 163.41 14.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.015 -1.053 . . . . 0.0 110.561 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.629 ' HA2' ' CD2' ' A' ' 40' ' ' TYR . . . -93.28 178.67 38.75 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.22 52.8 1.55 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.691 HG23 ' CE2' ' A' ' 40' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.132 -1.216 . . . . 0.0 109.103 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.548 HG22 ' H ' ' A' ' 2' ' ' GLU . 9.7 p . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 80' ' ' TYR . 14.6 pt-20 -43.28 123.21 2.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.349 -0.844 . . . . 0.0 109.639 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.763 HD12 ' HB ' ' A' ' 8' ' ' THR . 1.7 pt? -43.78 133.78 4.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.102 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.604 ' O ' HG22 ' A' ' 8' ' ' THR . 74.4 m -89.23 -176.26 5.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 110.146 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.548 ' CB ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -72.2 -31.26 65.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.372 -0.83 . . . . 0.0 109.147 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -76.93 -28.68 55.33 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 3' ' ' LEU . 1.8 t -70.8 -62.29 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.763 ' HB ' HD12 ' A' ' 3' ' ' LEU . 0.7 OUTLIER -90.32 12.56 17.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.275 -0.891 . . . . 0.0 109.494 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 5' ' ' LYS . . . -70.56 -105.29 0.04 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 11' ' ' LEU . 10.6 mttm -65.23 -29.28 70.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -1.098 . . . . 0.0 109.431 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.893 ' HB3' HD23 ' A' ' 48' ' ' LEU . 4.0 mt 44.34 57.13 4.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.403 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.467 ' HB2' ' NE2' ' A' ' 19' ' ' GLN . 0.3 OUTLIER 68.15 137.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.297 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.448 ' O ' ' OG1' ' A' ' 14' ' ' THR . 26.1 mmtt -142.04 149.7 40.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.659 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 80.5 p 50.09 58.04 5.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.476 -0.765 . . . . 0.0 109.768 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.7 m -171.64 120.82 0.47 Allowed Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.468 -0.77 . . . . 0.0 109.092 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.0 128.18 9.79 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.31 2.007 . . . . 0.0 110.348 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 147.19 169.5 14.71 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.775 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -123.8 155.47 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.011 -1.287 . . . . 0.0 110.159 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.532 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 16.5 mt-30 -115.17 158.3 22.43 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.797 HD11 ' CZ ' ' A' ' 110' ' ' PHE . 4.0 mt -129.02 153.52 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.763 -1.21 . . . . 0.0 110.369 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.869 ' HA ' HG23 ' A' ' 31' ' ' VAL . 9.2 m-90 -115.42 132.54 56.59 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.727 ' CD ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -90.22 128.03 36.28 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.832 -1.167 . . . . 0.0 111.84 -177.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.646 HD13 ' HA ' ' A' ' 28' ' ' MET . 5.0 mm -99.69 56.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 177.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.512 ' O ' ' HA3' ' A' ' 120' ' ' GLY . 0.0 OUTLIER -48.44 -106.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.347 -177.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.561 ' O ' ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -45.43 -77.69 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.917 -1.114 . . . . 0.0 108.3 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.587 ' CE ' ' CB ' ' A' ' 69' ' ' SER . 13.2 mmt -163.29 36.85 0.09 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 74.8 mt-10 -141.4 145.42 35.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.343 -0.848 . . . . 0.0 109.367 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.945 ' HE3' HG21 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -73.46 139.01 45.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.253 -0.904 . . . . 0.0 110.238 -179.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.928 HG13 ' HD2' ' A' ' 30' ' ' PRO . 1.9 t -138.43 154.96 74.0 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.928 ' HD2' HG13 ' A' ' 29' ' ' VAL . 35.1 Cg_endo -77.37 125.52 7.79 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.316 2.011 . . . . 0.0 111.668 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.869 HG23 ' HA ' ' A' ' 21' ' ' TRP . 1.4 t -118.33 97.8 50.97 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.6 -154.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.676 2.25 . . . . 0.0 110.113 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.596 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -77.51 2.88 14.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.104 -0.997 . . . . 0.0 109.322 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -66.0 -35.44 80.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.142 -0.973 . . . . 0.0 110.307 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.13 68.39 0.38 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.945 -1.097 . . . . 0.0 110.38 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.596 ' CD2' ' HA ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -90.47 39.57 0.98 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.046 -1.034 . . . . 0.0 109.86 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.486 ' HA2' ' CE2' ' A' ' 39' ' ' PHE . . . -144.6 -50.48 0.03 OUTLIER Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.206 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.555 ' HA ' HG22 ' A' ' 115' ' ' ILE . 1.7 m-80 -79.73 93.92 5.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.093 -1.239 . . . . 0.0 109.57 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.72 ' HZ ' HD13 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -129.76 128.83 43.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.508 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.652 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 64.5 m-85 -39.14 124.78 1.52 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.56 -0.713 . . . . 0.0 110.613 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.619 ' HA ' ' CH2' ' A' ' 64' ' ' TRP . 2.7 pt-20 -80.63 -0.14 36.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.281 -0.887 . . . . 0.0 109.303 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.579 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -124.61 54.97 0.72 Allowed Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.477 ' HA ' ' OE1' ' A' ' 73' ' ' GLU . 7.9 m-20 -160.15 -123.99 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.296 -1.12 . . . . 0.0 109.186 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.614 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 92.0 m -153.28 155.42 36.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.88 -1.137 . . . . 0.0 109.568 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.659 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 31.0 m-85 -155.03 116.62 4.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.359 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.945 HG21 ' HE3' ' A' ' 28' ' ' MET . 47.9 t -78.08 160.44 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.695 -1.253 . . . . 0.0 108.141 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.807 ' O ' HD23 ' A' ' 47' ' ' LEU . 7.2 tt -153.76 106.48 2.88 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.496 -1.378 . . . . 0.0 110.12 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.893 HD23 ' HB3' ' A' ' 11' ' ' LEU . 13.1 tp -95.99 109.15 21.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.597 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.766 ' OG ' HG22 ' A' ' 18' ' ' ILE . 12.9 t -98.89 133.5 43.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.334 -0.854 . . . . 0.0 109.644 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.2 m -122.17 142.31 50.54 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.502 ' HG2' ' N ' ' A' ' 52' ' ' LYS . 7.6 ttt180 -142.82 147.78 36.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 109.494 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.56 ' O ' HG23 ' A' ' 53' ' ' THR . 0.0 OUTLIER -80.99 163.41 23.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.979 . . . . 0.0 109.608 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 52' ' ' LYS . 1.5 p -157.97 -168.58 2.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.293 -0.879 . . . . 0.0 109.489 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.22 -41.0 32.53 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 56' ' ' GLY . 1.1 p -79.84 -59.15 2.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -1.184 . . . . 0.0 109.469 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.513 ' N ' ' OG ' ' A' ' 55' ' ' SER . . . -157.09 -129.2 1.11 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.566 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 5.0 m-30 -103.31 -169.72 1.69 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -1.159 . . . . 0.0 109.243 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.486 ' HA ' ' CG2' ' A' ' 91' ' ' VAL . 69.5 m -149.94 107.38 3.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.192 -0.943 . . . . 0.0 109.295 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.707 ' HB3' HD11 ' A' ' 48' ' ' LEU . 48.1 m-85 -89.16 158.09 18.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.207 -0.933 . . . . 0.0 109.805 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.577 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 6.8 m-20 -154.85 92.73 1.49 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.968 ' CG2' HG23 ' A' ' 81' ' ' THR . 9.9 mt -80.83 132.26 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.164 -0.96 . . . . 0.0 110.642 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.576 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 42.7 m-70 -119.57 162.35 19.08 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.832 ' CE2' HD11 ' A' ' 65' ' ' LEU . 49.5 p90 -136.7 94.08 2.94 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.339 -1.345 . . . . 0.0 109.674 176.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 1.083 ' O ' HD23 ' A' ' 65' ' ' LEU . 3.4 t90 -70.2 140.52 52.52 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.083 HD23 ' O ' ' A' ' 64' ' ' TRP . 8.1 mt -138.77 77.32 1.62 Allowed 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 118.532 -1.267 . . . . 0.0 111.144 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 41' ' ' GLU . . . -54.81 90.04 0.01 OUTLIER Glycine 0 C--N 1.275 -2.85 0 N-CA-C 106.9 -2.48 . . . . 0.0 106.9 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.732 ' HE3' HG11 ' A' ' 98' ' ' VAL . 9.5 ptpt -51.45 98.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.379 1.085 . . . . 0.0 112.185 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.579 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 13.7 m120 -160.15 -41.22 0.05 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.587 ' CB ' ' CE ' ' A' ' 26' ' ' MET . 81.9 p -67.22 -144.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.522 -0.736 . . . . 0.0 109.036 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.445 ' OG ' ' OD2' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -115.74 163.0 16.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.024 -1.048 . . . . 0.0 109.777 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -49.83 -32.07 13.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.25 -0.906 . . . . 0.0 109.156 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 3.0 p30 -60.35 -45.53 93.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.144 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 15.2 tt0 -56.91 -37.11 70.98 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 1.008 ' HG2' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -62.24 -35.85 80.21 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.641 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -81.65 -12.98 80.87 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.58 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -77.5 -52.6 8.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.294 -1.121 . . . . 0.0 108.955 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.568 ' CB ' ' HB3' ' A' ' 44' ' ' CYS . . . -75.88 -38.82 57.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.913 . . . . 0.0 109.1 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.83 94.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.301 -0.874 . . . . 0.0 109.229 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.641 HD12 ' O ' ' A' ' 75' ' ' GLY . 65.4 mt -71.6 -43.67 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.248 -0.908 . . . . 0.0 109.266 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.638 ' CD2' ' CB ' ' A' ' 28' ' ' MET . 3.4 m-85 -57.97 -35.47 71.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.122 -0.986 . . . . 0.0 108.867 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.968 HG23 ' CG2' ' A' ' 61' ' ' ILE . 18.1 m -67.51 -38.77 84.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.403 -0.811 . . . . 0.0 108.856 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.9 m -59.83 -42.86 94.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.844 . . . . 0.0 109.06 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.476 ' OE1' HD21 ' A' ' 3' ' ' LEU . 12.1 mt-30 -67.16 -28.47 68.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.264 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.536 ' HG2' HD12 ' A' ' 88' ' ' LEU . 17.8 ttm -63.08 -45.39 92.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.201 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.54 -15.28 25.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 108.994 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.18 -63.66 1.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.327 -0.858 . . . . 0.0 109.066 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.548 ' CE1' ' CB ' ' A' ' 5' ' ' LYS . 4.7 m-85 -53.93 -20.35 5.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 108.969 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.851 HD21 ' CD1' ' A' ' 11' ' ' LEU . 51.7 mt -90.15 -62.64 1.42 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -0.842 . . . . 0.0 109.196 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 57.22 62.3 6.51 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.3 p -143.64 -143.14 0.14 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.259 -1.142 . . . . 0.0 109.297 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.486 ' CG2' ' HA ' ' A' ' 58' ' ' SER . 11.6 m -92.18 15.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -52.23 173.01 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.693 -0.63 . . . . 0.0 109.826 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.9 t -147.63 177.09 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.524 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.672 ' H ' HG12 ' A' ' 93' ' ' VAL . 26.1 mt-30 -124.43 136.16 53.83 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.111 -0.993 . . . . 0.0 108.877 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.59 ' O ' ' CD1' ' A' ' 63' ' ' TYR . 18.0 m-70 -131.96 150.75 52.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.978 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.573 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 8.6 ttm180 -108.78 124.66 50.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.311 -0.868 . . . . 0.0 109.8 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.492 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 66.6 mm-40 -131.97 163.66 27.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.139 -0.975 . . . . 0.0 109.709 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.732 HG11 ' HE3' ' A' ' 67' ' ' LYS . 2.9 t -156.14 -176.95 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 108.977 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.707 ' H ' HG12 ' A' ' 98' ' ' VAL . 12.3 pt20 -66.23 -5.8 11.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.929 -1.107 . . . . 0.0 110.266 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.88 15.46 3.54 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.56 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 20.5 m-70 -122.57 -19.32 6.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.575 -0.956 . . . . 0.0 109.638 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.629 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.27 24.05 2.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.89 . . . . 0.0 109.508 -179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 102' ' ' GLU . 6.1 p -45.01 -106.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.494 -0.754 . . . . 0.0 111.863 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.812 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 40.6 mt-10 -71.39 -19.05 62.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.843 -1.16 . . . . 0.0 110.948 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.496 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 3.6 m -69.6 -50.9 40.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.897 -1.127 . . . . 0.0 109.605 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.558 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.3 OUTLIER -67.85 -57.26 6.56 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.89 -24.87 25.45 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.17 -0.956 . . . . 0.0 108.628 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.812 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -61.26 -58.36 8.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.38 -0.825 . . . . 0.0 108.823 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -68.33 -8.65 41.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -0.892 . . . . 0.0 109.236 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.797 ' CZ ' HD11 ' A' ' 20' ' ' ILE . 1.1 m-85 -113.47 96.73 6.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -88.56 60.39 5.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 109.697 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 111' ' ' LYS . 28.2 mm100 -153.34 -87.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.181 -0.949 . . . . 0.0 109.553 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.613 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -139.16 -113.47 1.12 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.72 HD13 ' HZ ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER 141.72 86.46 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.576 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -95.04 171.05 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 0.0 108.964 179.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.576 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -151.89 129.77 11.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.265 -0.897 . . . . 0.0 109.602 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.652 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -100.17 168.03 10.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.712 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 119' ' ' GLY . 10.6 pt20 -92.52 153.39 19.1 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.769 -1.207 . . . . 0.0 111.372 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.599 ' O ' ' CD1' ' A' ' 40' ' ' TYR . . . 52.1 164.62 0.01 OUTLIER Glycine 0 N--CA 1.498 2.807 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.57 ' O ' ' CE1' ' A' ' 40' ' ' TYR . . . -60.91 -123.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 121' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.263 -1.139 . . . . 0.0 109.253 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.945 HG13 ' HB3' ' A' ' 27' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 1' ' ' VAL . 1.5 mm-40 43.48 59.13 3.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.304 -0.872 . . . . 0.0 109.519 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.126 HD13 ' N ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -64.15 -13.89 51.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 109.695 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 1.126 ' N ' HD13 ' A' ' 3' ' ' LEU . 0.4 OUTLIER -78.21 168.33 20.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 109.791 -179.581 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 4' ' ' SER . 3.8 ttmm 81.39 -69.43 0.08 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.76 -0.588 . . . . 0.0 109.896 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -83.83 12.51 5.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.083 -1.011 . . . . 0.0 110.115 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.559 HG11 ' CZ2' ' A' ' 21' ' ' TRP . 35.0 t -145.52 -77.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.014 -1.054 . . . . 0.0 109.696 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.563 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 77.0 p -39.96 -28.08 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.471 -0.768 . . . . 0.0 109.952 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 7' ' ' VAL . . . -41.98 -59.64 2.84 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 3.3 mtmt -132.58 -29.08 1.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.178 -1.189 . . . . 0.0 110.218 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.999 HD22 HD21 ' A' ' 88' ' ' LEU . 3.1 mp 65.61 9.84 6.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.098 -1.001 . . . . 0.0 109.17 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 62.65 128.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.872 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.733 ' C ' HG22 ' A' ' 14' ' ' THR . 6.0 mmtt -96.43 169.02 10.2 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.733 HG22 ' C ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER 173.96 -83.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.592 -1.317 . . . . 0.0 111.218 -178.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.628 ' OG1' ' HD2' ' A' ' 16' ' ' PRO . 0.6 OUTLIER -161.97 -175.08 0.45 Allowed Pre-proline 0 C--N 1.284 -2.244 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.364 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.628 ' HD2' ' OG1' ' A' ' 15' ' ' THR . 33.3 Cg_endo -76.91 110.3 3.01 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.677 1.585 . . . . 0.0 111.28 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 49' ' ' SER . . . -161.47 -155.68 7.99 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.71 HG13 HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -160.92 154.56 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.734 -1.451 . . . . 0.0 110.523 179.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.513 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -133.82 -168.01 2.04 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.637 ' O ' HG23 ' A' ' 31' ' ' VAL . 55.9 mt -156.07 164.73 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.621 -1.3 . . . . 0.0 110.318 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.75 ' HA ' HG23 ' A' ' 31' ' ' VAL . 15.0 m-90 -124.48 119.0 27.9 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.58 ' HA ' ' CD2' ' A' ' 45' ' ' TYR . 29.8 ttp-105 -80.78 108.85 14.78 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.169 -0.957 . . . . 0.0 112.189 -176.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.799 HD11 ' SD ' ' A' ' 28' ' ' MET . 0.9 OUTLIER -86.57 93.45 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 176.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 26' ' ' MET . 1.4 pm0 -56.62 80.02 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.623 ' C ' ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER 41.22 13.64 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.694 -0.629 . . . . 0.0 111.415 -179.149 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.754 ' HE3' ' HA ' ' A' ' 26' ' ' MET . 0.0 OUTLIER -157.75 -76.72 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.271 -1.518 . . . . 0.0 111.142 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.945 ' HB3' HG13 ' A' ' 1' ' ' VAL . 0.4 OUTLIER -89.53 -147.06 0.17 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.167 -0.958 . . . . 0.0 110.776 -177.725 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.799 ' SD ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -144.14 146.62 32.88 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.559 0.695 . . . . 0.0 109.913 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.905 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -140.45 158.82 65.37 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.905 ' HD2' HG13 ' A' ' 29' ' ' VAL . 33.7 Cg_endo -75.33 137.9 21.59 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.32 2.014 . . . . 0.0 111.165 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.75 HG23 ' HA ' ' A' ' 21' ' ' TRP . 2.5 t -123.62 98.44 40.47 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 35' ' ' SER . 34.7 Cg_endo -76.57 -157.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.441 2.094 . . . . 0.0 110.177 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.522 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -83.06 -22.41 33.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.096 -1.002 . . . . 0.0 109.111 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -86.35 1.17 52.1 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.338 -0.851 . . . . 0.0 109.879 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.47 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -131.22 -25.53 2.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.153 -0.967 . . . . 0.0 110.373 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.683 ' CD2' ' CE2' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -68.95 -5.84 23.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.946 -1.096 . . . . 0.0 109.81 -179.57 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.512 ' N ' ' CD1' ' A' ' 36' ' ' TYR . . . -85.67 -4.46 85.27 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.507 ' HB3' ' CG2' ' A' ' 115' ' ' ILE . 17.0 m-80 -153.59 103.06 2.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.133 -1.216 . . . . 0.0 109.57 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.62 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -123.46 131.73 53.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.059 -1.026 . . . . 0.0 109.598 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.625 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 6.6 m-30 -39.53 152.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.544 -0.723 . . . . 0.0 110.148 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 12.4 pt-20 -89.67 -45.09 9.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 109.237 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.631 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -82.58 69.93 3.26 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 25' ' ' ASN . 10.9 m-20 -164.97 -166.39 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.91 -1.347 . . . . 0.0 111.1 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.563 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 1.7 m -127.37 156.87 41.34 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.62 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 30.9 m-85 -147.26 167.97 22.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.172 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.645 HG13 ' OG1' ' A' ' 81' ' ' THR . 99.3 t -132.45 113.31 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.71 HD11 HG13 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -90.13 155.15 19.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.174 -178.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.7 HD21 HD23 ' A' ' 11' ' ' LEU . 27.4 tp -146.5 85.9 1.66 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.564 ' CB ' ' HB ' ' A' ' 18' ' ' ILE . 1.0 OUTLIER -87.5 117.38 26.26 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 122.173 0.987 . . . . 0.0 109.872 -179.216 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.647 HG21 ' CD2' ' A' ' 57' ' ' PHE . 1.4 m -98.04 158.41 15.56 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.521 ' HG3' ' CB ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -160.56 117.62 2.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.915 -1.116 . . . . 0.0 109.867 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.848 ' O ' HG23 ' A' ' 53' ' ' THR . 3.0 pttm -46.78 172.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 0.0 109.268 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.848 HG23 ' O ' ' A' ' 52' ' ' LYS . 1.4 p -167.69 172.95 8.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.44 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.9 -18.8 41.48 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 m -99.5 -52.23 3.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -1.111 . . . . 0.0 109.365 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 52' ' ' LYS . . . -176.08 -100.35 0.13 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.647 ' CD2' HG21 ' A' ' 50' ' ' THR . 0.9 OUTLIER -117.93 158.63 24.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -1.114 . . . . 0.0 110.033 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.521 ' CB ' ' HG3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -130.89 123.58 29.29 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.166 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.816 ' CD2' HD22 ' A' ' 88' ' ' LEU . 7.3 m-85 -105.04 153.52 21.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.856 -1.153 . . . . 0.0 111.753 -177.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.501 ' OD1' ' CG2' ' A' ' 93' ' ' VAL . 6.2 m-20 -137.6 95.41 3.06 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 1.016 ' CG2' HG23 ' A' ' 81' ' ' THR . 10.9 mt -87.75 122.71 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 111.156 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.706 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 16.4 m-70 -110.47 169.17 8.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.514 -0.741 . . . . 0.0 109.168 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 95' ' ' HIS . 50.2 p90 -139.23 109.4 6.44 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.817 -1.153 . . . . 0.0 109.044 176.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.553 ' C ' HD23 ' A' ' 65' ' ' LEU . 7.0 t90 -86.05 135.72 33.52 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.279 0.561 . . . . 0.0 109.612 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.903 HD11 ' CG ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -120.02 61.57 0.85 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.93 -178.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -51.69 89.81 0.01 OUTLIER Glycine 0 N--CA 1.498 2.767 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 178.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 65' ' ' LEU . 1.5 tppt? -39.02 91.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.091 0.948 . . . . 0.0 112.611 -177.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.631 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 2.7 m-80 -162.76 -45.69 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 73' ' ' GLU . 14.2 p -61.21 -157.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.507 -0.745 . . . . 0.0 109.272 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.4 p -106.39 161.83 14.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 0.2 OUTLIER -50.32 -49.98 52.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.879 . . . . 0.0 109.43 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -54.45 -39.65 67.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.123 -0.986 . . . . 0.0 108.913 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.479 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -55.52 -39.25 70.29 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.238 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.903 ' CG ' HD11 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -59.78 -38.02 80.67 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.457 ' O ' HG13 ' A' ' 79' ' ' ILE . . . -69.55 -25.2 75.75 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.762 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -73.19 -59.38 2.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -1.129 . . . . 0.0 109.229 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . . . -49.45 -37.53 26.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 0.0 108.945 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.33 -34.68 68.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.334 -0.854 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.762 HD12 ' HA ' ' A' ' 76' ' ' ALA . 15.4 mt -63.44 -49.12 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.867 . . . . 0.0 109.425 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.673 ' HB3' ' HE2' ' A' ' 28' ' ' MET . 27.2 m-85 -58.47 -41.09 84.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.053 -1.029 . . . . 0.0 108.639 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 1.016 HG23 ' CG2' ' A' ' 61' ' ' ILE . 8.9 m -69.6 -22.34 63.51 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.431 -0.793 . . . . 0.0 108.897 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.8 m -86.44 -18.39 31.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.631 -0.668 . . . . 0.0 109.317 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 1.0 OUTLIER -89.85 -35.48 15.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.554 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.889 ' O ' HD12 ' A' ' 88' ' ' LEU . 5.2 ptm -82.32 -12.26 58.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.952 . . . . 0.0 109.482 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' A' ' 92' ' ' ALA . 9.4 t0 -79.91 -37.24 35.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.328 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -89.77 -29.04 18.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 109.257 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.509 ' HB3' ' HB ' ' A' ' 8' ' ' THR . 1.9 m-85 -76.21 -29.67 57.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.237 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.999 HD21 HD22 ' A' ' 11' ' ' LEU . 6.6 mt -72.06 -3.05 20.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.428 -0.795 . . . . 0.0 109.785 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.81 24.73 7.97 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 56.35 17.75 3.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -1.149 . . . . 0.0 109.322 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.568 HG23 ' CD2' ' A' ' 59' ' ' TYR . 11.7 m -96.64 -14.64 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.896 . . . . 0.0 109.255 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.547 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -77.04 164.53 25.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.316 -0.865 . . . . 0.0 109.427 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.738 HG12 ' H ' ' A' ' 94' ' ' GLN . 2.5 t -113.5 -178.53 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.494 -0.754 . . . . 0.0 109.176 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.738 ' H ' HG12 ' A' ' 93' ' ' VAL . 10.8 tt0 -132.64 136.41 46.47 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.135 -0.978 . . . . 0.0 109.054 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.706 ' CD2' ' CD2' ' A' ' 62' ' ' HIS . 10.1 m-70 -137.84 153.6 49.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.405 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.568 ' HA ' ' CE2' ' A' ' 63' ' ' TYR . 16.1 ptm180 -111.78 143.97 41.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.671 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.495 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 40.2 mm-40 -150.68 164.19 36.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.408 -0.808 . . . . 0.0 109.05 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.746 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.3 t -154.52 -169.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 0.0 109.012 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.746 ' H ' HG12 ' A' ' 98' ' ' VAL . 3.3 pt20 -72.76 0.92 9.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.844 -1.16 . . . . 0.0 110.282 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.6 19.57 1.15 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.244 -1.943 . . . . 0.0 108.244 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.544 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 46.0 m-70 -125.09 -14.78 6.5 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.715 -0.873 . . . . 0.0 109.789 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.552 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.25 29.34 1.26 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.727 -179.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 102' ' ' GLU . 77.6 p -55.99 -131.63 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.368 -0.832 . . . . 0.0 111.138 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.457 ' HG2' ' N ' ' A' ' 105' ' ' THR . 0.1 OUTLIER -40.01 -24.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.769 -1.207 . . . . 0.0 111.068 -178.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.551 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 1.8 m -66.94 -63.78 0.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.843 -1.161 . . . . 0.0 110.592 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.519 ' HB2' ' HB2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -57.14 -47.16 81.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.756 -1.215 . . . . 0.0 108.227 -179.13 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 110' ' ' PHE . 10.6 mtm180 -59.46 -28.06 66.64 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 105' ' ' THR . . . -59.84 -44.47 94.07 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.571 ' OH ' ' CE1' ' A' ' 62' ' ' HIS . 63.6 m-85 -76.53 -12.79 60.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.817 ' CB ' HD21 ' A' ' 114' ' ' LEU . 20.4 m-85 -126.09 105.65 9.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.648 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 112' ' ' GLN . 5.1 ptmt -90.13 26.4 1.89 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 110.112 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.485 ' CB ' ' O ' ' A' ' 111' ' ' LYS . 1.1 pt20 165.2 83.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.892 -1.13 . . . . 0.0 110.469 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 114' ' ' LEU . . . 167.03 -122.89 1.09 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.817 HD21 ' CB ' ' A' ' 110' ' ' PHE . 0.2 OUTLIER 65.76 49.8 1.66 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.557 -0.966 . . . . 0.0 110.888 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.507 ' CG2' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -87.5 167.18 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 177.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.578 ' CZ ' ' O ' ' A' ' 114' ' ' LEU . 2.9 m-85 -143.66 122.73 12.86 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.823 -1.173 . . . . 0.0 110.353 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.625 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 1.9 mttm -102.62 -163.94 1.04 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.462 -0.773 . . . . 0.0 108.972 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.578 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -90.26 161.47 15.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.92 -1.112 . . . . 0.0 110.14 -179.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 120' ' ' GLY . . . -67.88 -161.88 1.9 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 58.73 112.5 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.529 ' HB ' ' CB ' ' A' ' 24' ' ' GLU . 4.2 p . . . . . 0 C--N 1.303 -1.431 0 O-C-N 121.265 -1.138 . . . . 0.0 108.676 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 11.0 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.483 ' HA ' ' CE1' ' A' ' 80' ' ' TYR . 1.9 mt-10 64.64 66.08 0.61 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.347 -0.846 . . . . 0.0 109.521 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.113 HD21 ' CG ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -44.83 -41.16 6.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 3.2 t -42.54 150.56 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.378 -0.826 . . . . 0.0 109.616 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 4' ' ' SER . 14.1 ttpt 80.49 -72.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.586 -0.697 . . . . 0.0 109.775 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.495 ' C ' HG23 ' A' ' 7' ' ' VAL . 70.2 mmtt -88.33 14.53 9.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.079 -1.013 . . . . 0.0 109.851 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.686 HG11 ' HE1' ' A' ' 21' ' ' TRP . 21.8 t -157.2 -74.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.058 -1.026 . . . . 0.0 109.618 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.657 ' HA ' HD21 ' A' ' 11' ' ' LEU . 2.3 m -49.3 -23.16 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 0.0 109.476 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 10' ' ' LYS . . . -89.38 32.89 4.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER 164.12 47.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -1.135 . . . . 0.0 109.464 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.762 HD12 ' HG ' ' A' ' 88' ' ' LEU . 38.2 mt -68.96 -147.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 0.0 109.208 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -83.84 119.6 25.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.961 . . . . 0.0 109.385 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.672 ' O ' HG23 ' A' ' 14' ' ' THR . 5.1 mmmt -122.97 -11.99 8.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 0.0 109.62 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 13' ' ' LYS . 18.4 p -160.8 69.99 0.38 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 109.544 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 15' ' ' THR . 5.9 t -175.33 124.2 0.35 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.371 -0.831 . . . . 0.0 109.176 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.7 105.99 2.12 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.25 1.967 . . . . 0.0 110.514 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 173.33 176.76 42.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.859 HG22 ' HA ' ' A' ' 49' ' ' SER . 3.9 pt -124.49 134.45 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -1.208 . . . . 0.0 109.922 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.446 ' NE2' ' CH2' ' A' ' 21' ' ' TRP . 1.5 tt0 -112.93 140.77 47.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.311 -0.868 . . . . 0.0 108.732 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.665 HD11 ' CZ ' ' A' ' 110' ' ' PHE . 2.2 mt -115.06 -178.91 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.803 -1.186 . . . . 0.0 109.679 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.686 ' HE1' HG11 ' A' ' 7' ' ' VAL . 10.6 m-90 -141.45 119.39 11.93 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.649 ' H ' HG23 ' A' ' 31' ' ' VAL . 2.5 ptt180 -78.9 128.07 32.84 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.122 -0.986 . . . . 0.0 110.147 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 23' ' ' ILE . 5.8 mm -96.49 43.89 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.54 ' HG2' ' N ' ' A' ' 25' ' ' ASN . 31.1 tt0 -70.29 168.04 16.75 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.335 0.588 . . . . 0.0 110.108 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.54 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 8.2 p30 47.18 24.6 0.43 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -0.796 . . . . 0.0 109.141 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.736 ' HE3' ' HG2' ' A' ' 73' ' ' GLU . 24.4 mmm 57.75 50.54 10.52 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.413 -0.805 . . . . 0.0 109.491 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.514 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 53.8 mm-40 -148.24 -111.22 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.316 -0.865 . . . . 0.0 109.108 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.725 ' HE2' HD22 ' A' ' 3' ' ' LEU . 2.8 ttt 178.88 153.91 0.4 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.787 -1.196 . . . . 0.0 109.861 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -160.26 147.57 12.52 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.559 ' HD2' HG13 ' A' ' 29' ' ' VAL . 33.4 Cg_endo -74.04 94.73 0.89 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.563 2.175 . . . . 0.0 111.869 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.649 HG23 ' H ' ' A' ' 22' ' ' ARG . 60.0 t -76.58 112.75 23.64 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 36.3 Cg_endo -78.78 -161.8 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.448 2.099 . . . . 0.0 110.601 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.475 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -88.28 -3.72 58.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.315 -0.865 . . . . 0.0 109.054 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -87.52 8.29 25.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 109.74 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.4 m -159.99 21.07 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.157 -0.964 . . . . 0.0 110.076 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.564 ' CD2' ' O ' ' A' ' 36' ' ' TYR . 19.4 p90 -90.0 32.64 0.9 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.015 -1.053 . . . . 0.0 109.334 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.31 -10.07 5.73 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.475 ' CB ' ' HB ' ' A' ' 115' ' ' ILE . 5.5 m-80 -148.02 100.92 3.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.192 -1.181 . . . . 0.0 109.889 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.689 ' HZ ' HD13 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -115.19 131.57 56.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.305 -0.872 . . . . 0.0 109.06 179.633 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.638 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 6.7 m-30 -39.42 155.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.451 -0.781 . . . . 0.0 109.943 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 10.4 pt-20 -91.0 -46.32 8.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.474 -0.766 . . . . 0.0 110.161 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.606 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -83.01 67.38 3.76 Favored Glycine 0 N--CA 1.483 1.793 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.057 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.514 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -162.92 -148.11 0.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.916 -1.344 . . . . 0.0 110.299 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.531 ' CB ' HG13 ' A' ' 23' ' ' ILE . 14.2 m -144.28 139.8 28.82 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.609 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 30.1 m-85 -137.18 109.64 7.41 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.983 -1.073 . . . . 0.0 109.878 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.698 HG13 ' OG1' ' A' ' 81' ' ' THR . 25.0 t -78.5 131.21 34.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.176 -0.953 . . . . 0.0 108.462 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.787 HD23 ' N ' ' A' ' 48' ' ' LEU . 8.3 tt -111.57 163.43 14.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.15 -0.968 . . . . 0.0 109.469 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.787 ' N ' HD23 ' A' ' 47' ' ' LEU . 20.3 tp -153.65 92.11 1.54 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.978 -1.077 . . . . 0.0 109.263 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.859 ' HA ' HG22 ' A' ' 18' ' ' ILE . 5.3 t -81.26 148.82 29.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.904 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 m -140.23 117.05 10.98 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -112.91 175.44 5.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.514 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.96 157.31 18.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.908 . . . . 0.0 109.429 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.1 p -146.8 -170.39 3.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.449 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.96 10.17 61.12 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 p -133.73 -54.69 0.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -1.111 . . . . 0.0 109.422 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.53 -135.11 1.85 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.57 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 88.2 m-85 -120.24 144.32 47.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -1.1 . . . . 0.0 109.66 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 68.8 m -101.09 106.82 18.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.282 -0.886 . . . . 0.0 108.705 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.643 ' CD2' HG23 ' A' ' 91' ' ' VAL . 6.3 m-85 -84.64 156.36 21.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.205 -0.935 . . . . 0.0 110.339 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.476 ' OD1' ' CG2' ' A' ' 93' ' ' VAL . 5.8 m-20 -143.68 102.61 3.95 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 1.017 ' CG2' HG23 ' A' ' 81' ' ' THR . 7.7 mt -92.36 112.3 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.255 -0.903 . . . . 0.0 110.461 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.708 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 15.1 m-70 -105.1 166.98 10.01 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.607 -0.683 . . . . 0.0 109.534 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.575 ' CZ ' ' HA ' ' A' ' 96' ' ' ARG . 43.5 p90 -138.04 106.62 5.87 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.401 -1.32 . . . . 0.0 109.856 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.591 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 4.8 t90 -82.38 131.57 35.22 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -119.28 65.21 0.79 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.357 -0.839 . . . . 0.0 110.753 -178.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 68' ' ' ASN . . . -49.53 91.08 0.01 OUTLIER Glycine 0 N--CA 1.498 2.796 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -37.74 88.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 122.081 0.943 . . . . 0.0 112.414 -177.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.606 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 2.7 m-80 -162.75 -43.65 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.549 ' HB2' ' HE3' ' A' ' 26' ' ' MET . 14.1 p -60.32 168.64 1.95 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.632 -0.667 . . . . 0.0 109.458 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.452 ' OG ' ' OE1' ' A' ' 73' ' ' GLU . 1.5 p -73.87 168.89 18.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.939 . . . . 0.0 109.445 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.3 -51.22 63.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.546 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 2.1 p30 -55.3 -39.32 69.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.127 -0.983 . . . . 0.0 109.511 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.736 ' HG2' ' HE3' ' A' ' 26' ' ' MET . 3.0 mp0 -56.5 -38.66 72.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 108.656 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.496 ' OE1' HD12 ' A' ' 65' ' ' LEU . 53.6 mt-30 -64.17 -33.52 75.97 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.629 ' O ' HD13 ' A' ' 79' ' ' ILE . . . -83.05 -10.91 82.1 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.73 -44.36 13.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.999 -1.295 . . . . 0.0 108.939 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.45 -45.41 59.69 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.328 -0.858 . . . . 0.0 109.029 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.16 93.29 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.629 HD13 ' O ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -65.53 -41.35 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.198 -0.939 . . . . 0.0 108.994 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 1.113 ' CG ' HD21 ' A' ' 3' ' ' LEU . 11.3 m-85 -61.45 -29.43 69.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.973 -1.079 . . . . 0.0 108.53 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 1.017 HG23 ' CG2' ' A' ' 61' ' ' ILE . 2.6 m -75.52 -25.5 57.28 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.0 m -81.16 -27.14 35.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.532 -0.73 . . . . 0.0 109.22 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 0.9 OUTLIER -78.04 -36.57 48.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.608 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.522 ' HG3' ' CD1' ' A' ' 61' ' ' ILE . 5.4 ptm -82.23 -8.14 59.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 109.593 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.604 ' OD1' HD12 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -75.48 -41.57 55.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.381 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -90.03 -29.25 18.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.313 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.507 ' HB3' HG22 ' A' ' 8' ' ' THR . 0.3 OUTLIER -70.22 -32.26 70.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 109.55 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.784 HD12 HD11 ' A' ' 61' ' ' ILE . 14.7 mt -66.19 -22.4 66.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.601 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 90' ' ' SER . . . 121.12 14.61 4.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 89' ' ' GLY . 6.3 t 72.19 3.95 4.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -1.188 . . . . 0.0 109.588 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.643 HG23 ' CD2' ' A' ' 59' ' ' TYR . 17.9 m -87.7 -19.73 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.541 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -77.15 170.13 17.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.237 -0.914 . . . . 0.0 109.608 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.764 HG12 ' H ' ' A' ' 94' ' ' GLN . 2.9 t -121.94 -177.36 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.089 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.764 ' H ' HG12 ' A' ' 93' ' ' VAL . 16.0 mt-30 -128.22 140.07 52.11 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.007 -1.058 . . . . 0.0 108.864 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.708 ' CD2' ' CD2' ' A' ' 62' ' ' HIS . 7.0 m-70 -141.63 151.08 42.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.029 -1.044 . . . . 0.0 109.69 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.575 ' HA ' ' CZ ' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -109.67 140.95 42.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.341 -0.849 . . . . 0.0 110.362 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.491 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 60.5 mm-40 -148.41 163.68 36.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.407 -0.808 . . . . 0.0 109.122 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.736 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.7 t -155.38 -175.17 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.098 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.736 ' H ' HG12 ' A' ' 98' ' ' VAL . 38.5 tt0 -69.75 -1.99 10.74 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.934 -1.103 . . . . 0.0 110.195 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.53 16.12 2.04 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.561 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 39.4 m-70 -122.45 -16.42 7.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.484 -1.01 . . . . 0.0 109.591 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.591 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.1 24.29 2.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.905 . . . . 0.0 109.363 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 102' ' ' GLU . 3.5 p -48.63 -107.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.417 -0.802 . . . . 0.0 111.459 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.818 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 22.4 mt-10 -67.2 -17.45 64.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.916 -1.115 . . . . 0.0 110.909 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.505 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 4.3 m -72.17 -54.95 8.15 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.937 -1.102 . . . . 0.0 109.756 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.546 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -63.63 -57.5 9.88 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.27 -30.15 36.89 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.228 -0.92 . . . . 0.0 108.806 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.818 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -58.1 -45.0 87.95 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -0.828 . . . . 0.0 108.809 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.473 ' CE2' ' CE1' ' A' ' 62' ' ' HIS . 34.2 m-85 -76.7 -14.16 59.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -0.816 . . . . 0.0 109.41 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.842 ' CB ' HD21 ' A' ' 114' ' ' LEU . 2.3 m-85 -117.03 96.99 5.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.408 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 23.0 ttpt -83.75 73.1 10.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.135 -0.978 . . . . 0.0 109.415 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 111' ' ' LYS . 4.8 mt-30 -171.33 -80.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.129 -0.982 . . . . 0.0 109.804 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.403 ' C ' HD23 ' A' ' 114' ' ' LEU . . . 179.95 131.49 1.65 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.842 HD21 ' CB ' ' A' ' 110' ' ' PHE . 10.5 mt -103.49 135.75 44.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -1.107 . . . . 0.0 110.007 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.562 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 2.6 mt -107.57 165.42 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 108.836 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.564 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -141.45 102.42 4.2 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.367 -0.833 . . . . 0.0 109.147 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.638 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 5.1 mmmt -82.28 -155.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 109.664 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.585 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -92.18 -179.9 5.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.551 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 120' ' ' GLY . . . -113.19 -169.67 17.38 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 119' ' ' GLY . . . 43.23 84.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.607 ' O ' HG13 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -88.62 12.98 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -1.208 . . . . 0.0 109.222 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.39 -23.34 40.51 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.49 -0.756 . . . . 0.0 109.434 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.7 m 45.85 25.48 0.3 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -0.872 . . . . 0.0 109.489 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -121.57 12.36 9.51 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.0 mmt -112.18 -154.37 0.54 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.404 -1.056 . . . . 0.0 109.407 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.9 mttt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.433 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.755 ' O ' HG12 ' A' ' 1' ' ' VAL . 65.1 t . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 173.87 60.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.191 -0.943 . . . . 0.0 109.484 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.074 HD13 ' N ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -63.48 -11.3 22.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.519 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 1.074 ' N ' HD13 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -74.73 151.18 39.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.962 . . . . 0.0 109.587 -179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 4' ' ' SER . 17.7 tttm 80.2 -72.57 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.471 -0.768 . . . . 0.0 109.764 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.77 -10.73 29.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 109.757 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.97 HG12 ' CD2' ' A' ' 11' ' ' LEU . 5.2 t -123.93 -71.23 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.101 -0.999 . . . . 0.0 109.519 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.75 HG22 ' HG2' ' A' ' 84' ' ' MET . 19.2 p -50.23 -21.89 1.53 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.668 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.468 ' O ' ' HG2' ' A' ' 10' ' ' LYS . . . -42.75 -42.05 4.65 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 9' ' ' GLY . 12.6 mttt -155.29 -37.96 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.138 -1.213 . . . . 0.0 109.805 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.12 HD12 HD21 ' A' ' 88' ' ' LEU . 51.0 mt 64.2 -144.84 0.28 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.123 -0.986 . . . . 0.0 109.138 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.505 ' O ' ' CE2' ' A' ' 59' ' ' TYR . 2.3 m-20 -88.21 97.81 11.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.113 -0.992 . . . . 0.0 109.549 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.672 ' O ' HG23 ' A' ' 14' ' ' THR . 10.5 mttt -100.83 -4.71 27.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.945 . . . . 0.0 109.641 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 13' ' ' LYS . 19.9 p -160.15 49.59 0.28 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.94 . . . . 0.0 109.499 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.3 m -151.01 105.41 3.0 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.379 -0.826 . . . . 0.0 109.116 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.35 86.76 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.402 2.068 . . . . 0.0 110.343 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.457 ' C ' HG23 ' A' ' 18' ' ' ILE . . . -170.29 -132.76 1.5 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.034 HD12 HD11 ' A' ' 47' ' ' LEU . 18.3 pt -156.81 137.83 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.078 -1.248 . . . . 0.0 110.119 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.58 ' O ' ' CZ3' ' A' ' 21' ' ' TRP . 1.4 tt0 -119.62 113.9 21.4 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.685 HG22 ' H ' ' A' ' 21' ' ' TRP . 3.8 mt -90.03 175.88 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.799 -1.188 . . . . 0.0 109.942 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.861 ' HB3' ' HE3' ' A' ' 28' ' ' MET . 10.7 m-90 -137.04 119.18 15.49 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.699 ' H ' HG23 ' A' ' 31' ' ' VAL . 8.0 ttp180 -79.15 130.23 35.28 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.14 -0.975 . . . . 0.0 110.921 -177.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 23' ' ' ILE . 3.3 mm -95.08 37.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.511 ' HG2' ' N ' ' A' ' 25' ' ' ASN . 1.3 tt0 -47.31 149.45 1.04 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.395 0.617 . . . . 0.0 110.703 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.511 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 2.4 p-10 44.33 27.47 0.22 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.445 -0.785 . . . . 0.0 109.072 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.726 ' HE3' ' HB2' ' A' ' 69' ' ' SER . 3.4 mmm 64.1 51.55 2.19 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.464 -0.773 . . . . 0.0 109.322 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 9.7 mt-10 -153.73 122.65 6.41 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.861 ' HE3' ' HB3' ' A' ' 21' ' ' TRP . 2.1 mtp -56.63 145.06 29.74 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.177 -0.952 . . . . 0.0 110.339 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.598 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -149.64 149.98 29.71 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HD2' HG13 ' A' ' 29' ' ' VAL . 32.3 Cg_endo -72.98 113.86 3.89 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.229 1.953 . . . . 0.0 111.857 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.703 HG13 ' HB3' ' A' ' 35' ' ' SER . 41.4 t -111.3 92.28 15.6 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.521 ' HG2' ' CD ' ' A' ' 34' ' ' LYS . 35.0 Cg_endo -77.12 -156.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.717 2.278 . . . . 0.0 110.202 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.574 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -75.83 -23.53 55.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.094 -1.004 . . . . 0.0 108.945 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.521 ' CD ' ' HG2' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -81.85 8.01 11.36 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.206 -0.934 . . . . 0.0 109.613 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.703 ' HB3' HG13 ' A' ' 31' ' ' VAL . 2.5 m -128.25 -45.36 1.38 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.745 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -45.05 158.31 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.438 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 115' ' ' ILE . . . 112.88 -47.84 1.0 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.43 94.15 4.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -1.209 . . . . 0.0 109.885 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.901 ' HZ ' HD13 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -113.04 121.03 43.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.302 -0.874 . . . . 0.0 109.797 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.581 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 7.0 m-30 -39.33 131.9 1.53 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 110.607 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 2.9 pt-20 -90.66 56.68 3.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.217 -0.927 . . . . 0.0 109.01 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.603 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -176.89 47.92 0.11 Allowed Glycine 0 N--CA 1.484 1.876 0 N-CA-C 108.914 -1.675 . . . . 0.0 108.914 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.468 ' CG ' ' O ' ' A' ' 42' ' ' GLY . 2.4 m-20 -162.16 -129.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.654 -0.909 . . . . 0.0 109.608 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.536 ' CB ' HG13 ' A' ' 23' ' ' ILE . 1.8 m -149.14 144.7 26.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.05 -1.031 . . . . 0.0 108.927 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.592 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 26.0 m-85 -142.65 111.25 6.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.097 -1.002 . . . . 0.0 109.727 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.677 HG13 ' OG1' ' A' ' 81' ' ' THR . 11.3 t -79.73 123.03 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.958 -1.089 . . . . 0.0 108.961 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.034 HD11 HD12 ' A' ' 18' ' ' ILE . 8.2 tt -112.94 122.24 47.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.956 -1.09 . . . . 0.0 110.061 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 59' ' ' TYR . 23.2 tp -107.13 109.86 21.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.069 -1.02 . . . . 0.0 109.705 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.505 ' OG ' HG22 ' A' ' 18' ' ' ILE . 3.2 t -98.19 133.9 41.98 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.18 -0.95 . . . . 0.0 109.272 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.2 m -129.21 142.57 50.82 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.519 ' HG2' ' N ' ' A' ' 52' ' ' LYS . 9.1 ttp180 -140.14 157.12 46.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.892 . . . . 0.0 109.534 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.519 ' N ' ' HG2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -74.12 159.92 31.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.37 -172.74 4.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 109.463 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.73 -35.97 8.13 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t -82.74 -25.24 33.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -1.146 . . . . 0.0 109.488 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.67 -117.61 0.76 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 2.2 m-30 -115.07 169.08 9.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -1.116 . . . . 0.0 109.579 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -133.87 107.85 8.09 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.59 ' HB3' HD11 ' A' ' 48' ' ' LEU . 23.2 m-85 -92.55 169.01 10.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.104 -0.997 . . . . 0.0 110.374 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.513 ' HB3' ' NE2' ' A' ' 95' ' ' HIS . 14.2 m120 -158.89 88.25 0.89 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.961 ' CG2' HG23 ' A' ' 81' ' ' THR . 21.0 mt -76.67 137.12 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.203 -0.936 . . . . 0.0 110.264 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.686 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 53.3 m-70 -123.79 159.39 29.62 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 95' ' ' HIS . 37.4 p90 -133.38 98.64 4.29 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.345 -1.342 . . . . 0.0 109.196 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.6 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 5.6 t90 -77.07 132.77 39.07 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.076 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -116.83 65.01 0.72 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.456 -0.778 . . . . 0.0 110.844 -178.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -45.24 91.42 0.01 OUTLIER Glycine 0 N--CA 1.5 2.94 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.611 ' N ' ' O ' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -39.44 91.38 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.928 0.87 . . . . 0.0 113.204 -177.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.603 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 3.1 m-20 -162.66 -44.22 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.726 ' HB2' ' HE3' ' A' ' 26' ' ' MET . 25.2 p -63.93 -153.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.481 -0.762 . . . . 0.0 109.499 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.08 -173.88 2.82 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.302 -0.873 . . . . 0.0 109.428 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -61.01 -32.0 71.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.886 . . . . 0.0 109.604 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -68.09 -44.09 77.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 0.0 109.556 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.712 ' HG2' ' HE3' ' A' ' 26' ' ' MET . 0.8 OUTLIER -57.98 -36.94 73.34 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.953 -1.092 . . . . 0.0 108.395 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.528 ' CG ' HD11 ' A' ' 65' ' ' LEU . 4.5 tt0 -64.82 -32.55 74.3 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.653 ' O ' HD13 ' A' ' 79' ' ' ILE . . . -83.64 -10.92 80.76 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.85 -52.53 5.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.84 -1.388 . . . . 0.0 109.295 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 23' ' ' ILE . . . -71.83 -36.53 70.23 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.183 -0.948 . . . . 0.0 108.807 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.14 -38.52 75.52 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.398 -0.814 . . . . 0.0 109.368 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.653 HD13 ' O ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -66.89 -45.21 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 109.072 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.867 ' CD2' HD12 ' A' ' 3' ' ' LEU . 3.2 m-85 -59.93 -31.71 70.1 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.839 -1.163 . . . . 0.0 108.471 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.961 HG23 ' CG2' ' A' ' 61' ' ' ILE . 3.1 m -74.29 -27.04 60.54 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 79' ' ' ILE . 4.5 m -63.88 -50.94 66.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.5 -0.75 . . . . 0.0 109.374 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -64.86 -39.23 93.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.554 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.75 ' HG2' HG22 ' A' ' 8' ' ' THR . 1.5 mtm -56.79 -28.13 60.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.602 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -81.37 -36.09 30.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.599 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.01 -1.12 51.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.912 . . . . 0.0 109.676 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.537 ' CB ' ' HB ' ' A' ' 8' ' ' THR . 4.1 m-85 -108.93 -29.81 8.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.146 -0.971 . . . . 0.0 109.546 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 1.12 HD21 HD12 ' A' ' 11' ' ' LEU . 46.9 mt -71.84 -3.94 25.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.614 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 90' ' ' SER . . . 99.0 21.82 14.78 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 90' ' ' SER . 0.3 OUTLIER 64.73 10.69 6.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -1.119 . . . . 0.0 109.484 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.8 m -86.11 -27.95 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.0 109.406 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.575 ' HB2' ' HB2' ' A' ' 59' ' ' TYR . . . -73.19 172.34 11.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.577 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.687 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.1 t -124.73 178.3 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.39 -0.818 . . . . 0.0 109.112 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.687 ' H ' HG12 ' A' ' 93' ' ' VAL . 5.5 tt0 -124.91 131.7 53.4 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.016 -1.052 . . . . 0.0 109.075 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.686 ' CD2' ' CE1' ' A' ' 62' ' ' HIS . 28.9 m-70 -125.98 152.1 46.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.97 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.574 ' HA ' ' CZ ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -109.71 130.53 55.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 110.242 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 64' ' ' TRP . 15.8 mp0 -142.12 163.98 31.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 109.333 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.71 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.2 t -153.66 -160.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 108.972 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.71 ' H ' HG12 ' A' ' 98' ' ' VAL . 40.7 tp60 -78.66 4.53 13.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.718 -1.239 . . . . 0.0 109.772 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.19 22.24 0.58 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.534 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 14.9 m-70 -124.68 -17.07 6.04 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.735 -0.862 . . . . 0.0 109.664 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.6 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.09 30.26 1.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.259 -0.901 . . . . 0.0 109.369 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 105' ' ' THR . 89.1 p -57.3 -127.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.066 -1.021 . . . . 0.0 111.189 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.821 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 41.0 mt-10 -39.92 -24.62 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.9 -1.125 . . . . 0.0 111.469 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.492 ' N ' ' O ' ' A' ' 103' ' ' SER . 0.2 OUTLIER -71.99 -65.03 0.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.768 -1.208 . . . . 0.0 110.43 -179.104 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.567 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -56.4 -50.25 72.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.969 -1.082 . . . . 0.0 108.34 -179.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.413 ' HA ' HD21 ' A' ' 114' ' ' LEU . 1.3 ttp85 -61.41 -29.78 70.15 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.491 -0.755 . . . . 0.0 108.979 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.821 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -59.05 -36.08 74.42 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.796 ' HB3' HD13 ' A' ' 18' ' ' ILE . 67.1 m-85 -88.13 -13.06 42.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.549 -0.72 . . . . 0.0 109.089 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.955 ' HB2' HD21 ' A' ' 114' ' ' LEU . 60.3 m-85 -113.26 96.9 6.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.472 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -74.05 83.02 1.76 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.925 . . . . 0.0 109.54 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.519 ' CB ' ' O ' ' A' ' 111' ' ' LYS . 3.0 tt0 78.48 78.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.397 -0.814 . . . . 0.0 109.715 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.783 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 168.61 70.77 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.955 HD21 ' HB2' ' A' ' 110' ' ' PHE . 4.1 mm? -126.37 56.03 1.47 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -1.164 . . . . 0.0 109.841 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 2.3 mt -81.42 165.67 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.052 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.577 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 2.2 m-85 -145.49 107.86 4.41 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.373 -0.829 . . . . 0.0 109.211 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.581 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 26.9 mmtt -79.69 -165.79 0.87 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 108.929 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.569 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 33.3 mm-40 -87.15 158.11 19.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.962 -1.086 . . . . 0.0 109.865 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.545 ' HA2' ' CD2' ' A' ' 40' ' ' TYR . . . -95.34 -165.51 35.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 119' ' ' GLY . . . 43.48 74.32 0.2 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.465 HG11 ' CD ' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -84.17 7.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -1.15 . . . . 0.0 109.751 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 125' ' ' MET . . . -74.56 -71.09 0.36 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.651 -0.656 . . . . 0.0 109.583 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER 68.58 9.36 7.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.367 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -167.33 26.84 0.15 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.428 ' HB2' ' HB1' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -150.23 -68.04 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -1.155 . . . . 0.0 109.408 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 125' ' ' MET . 20.1 pttt . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.441 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.568 HG22 ' H ' ' A' ' 2' ' ' GLU . 9.9 p . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.568 ' H ' HG22 ' A' ' 1' ' ' VAL . 0.0 OUTLIER 79.77 118.21 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.453 -0.779 . . . . 0.0 109.234 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.88 ' HB2' HG21 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -90.05 -21.33 22.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.519 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 1.2 p -59.84 -12.67 7.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 110.029 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -109.4 -47.79 3.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.977 -1.077 . . . . 0.0 109.827 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -90.32 22.01 3.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 110.094 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.88 HG21 ' HB2' ' A' ' 3' ' ' LEU . 10.3 t -145.38 -63.18 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.089 -1.007 . . . . 0.0 109.823 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.562 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 23.1 p -67.81 -12.9 61.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 109.506 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 10' ' ' LYS . . . -74.24 -19.7 79.77 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 1.6 tptm 175.2 55.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.449 -1.03 . . . . 0.0 109.371 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.745 HD23 HD22 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -43.85 -60.29 1.89 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.43 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -161.63 -91.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.43 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER 74.48 125.98 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.502 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.584 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 23.7 p 48.05 54.35 10.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.362 -0.836 . . . . 0.0 109.631 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 14' ' ' THR . 4.0 m -168.43 101.85 0.53 Allowed Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.416 -0.803 . . . . 0.0 109.324 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.04 109.47 2.84 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.413 2.075 . . . . 0.0 110.433 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.472 ' C ' HG23 ' A' ' 18' ' ' ILE . . . 178.87 -143.81 5.99 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.972 HD12 ' CD1' ' A' ' 47' ' ' LEU . 14.3 pt -157.44 140.6 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -1.172 . . . . 0.0 109.829 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.557 ' NE2' ' CZ2' ' A' ' 21' ' ' TRP . 2.0 tt0 -122.01 109.19 14.28 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.803 HG12 HD12 ' A' ' 47' ' ' LEU . 41.9 mt -85.03 166.73 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.145 -0.972 . . . . 0.0 109.84 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.877 ' CZ2' HG13 ' A' ' 7' ' ' VAL . 6.8 m-90 -130.26 121.95 27.1 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.769 ' HG3' HG22 ' A' ' 31' ' ' VAL . 8.7 mtm180 -79.26 132.54 36.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 110.888 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.828 HD13 ' HB2' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -116.8 23.11 5.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.662 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.504 ' CG ' ' HB ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -54.92 171.07 0.15 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.848 . . . . 0.0 110.193 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.776 ' HB3' HG12 ' A' ' 121' ' ' VAL . 0.7 OUTLIER 42.22 26.86 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.619 ' HE1' ' CB ' ' A' ' 70' ' ' SER . 0.0 OUTLIER 59.28 56.69 3.71 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.45 -0.781 . . . . 0.0 110.256 179.336 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 73.5 mm-40 -146.72 -144.05 0.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.925 -1.109 . . . . 0.0 109.655 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.628 ' CE ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -156.04 146.44 21.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.009 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.556 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -160.37 148.77 13.27 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.086 -1.009 . . . . 0.0 109.604 -179.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.556 ' HD2' HG13 ' A' ' 29' ' ' VAL . 36.0 Cg_endo -78.53 125.17 6.74 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.548 2.165 . . . . 0.0 111.174 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.769 HG22 ' HG3' ' A' ' 22' ' ' ARG . 2.9 t -114.69 94.51 37.38 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 35' ' ' SER . 34.7 Cg_endo -76.49 -159.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.598 2.198 . . . . 0.0 110.765 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.578 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -76.07 -34.5 59.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.368 -0.832 . . . . 0.0 110.551 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.96 32.86 0.73 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.077 -1.015 . . . . 0.0 109.932 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.515 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 74.8 m -139.66 -37.58 0.49 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.077 -1.014 . . . . 0.0 109.749 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 33' ' ' THR . 11.0 p90 -55.79 173.16 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.584 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.59 -94.93 0.66 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -90.61 113.13 25.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.358 -1.083 . . . . 0.0 109.414 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -140.77 143.46 34.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 109.983 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.643 ' OH ' HG23 ' A' ' 121' ' ' VAL . 19.0 m-85 -42.34 144.75 0.46 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.884 . . . . 0.0 110.415 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 2.0 pt-20 -90.85 -46.72 8.04 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.301 -0.874 . . . . 0.0 109.626 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.625 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -81.86 72.48 2.78 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.522 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -161.28 -145.01 0.11 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.152 -1.205 . . . . 0.0 109.837 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.56 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 23.7 m -138.61 162.1 35.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.333 -0.854 . . . . 0.0 108.811 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 39' ' ' PHE . 11.3 m-85 -160.28 105.31 1.49 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.927 -1.108 . . . . 0.0 110.357 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 57.3 t -78.95 115.19 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.91 -1.119 . . . . 0.0 108.342 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.972 ' CD1' HD12 ' A' ' 18' ' ' ILE . 2.1 tt -104.59 116.08 31.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.31 -0.869 . . . . 0.0 110.721 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.745 HD22 HD23 ' A' ' 11' ' ' LEU . 19.5 tp -98.68 109.05 21.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.015 -1.053 . . . . 0.0 109.433 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.427 ' OG ' HG22 ' A' ' 18' ' ' ILE . 2.6 t -99.91 128.86 45.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.172 -0.955 . . . . 0.0 109.631 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.417 ' OG1' ' OD2' ' A' ' 12' ' ' ASP . 1.2 m -113.64 150.46 33.13 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.54 ' CG ' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -135.93 166.28 23.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.885 . . . . 0.0 109.479 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.54 ' N ' ' CG ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -104.86 147.51 27.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.425 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.9 p -142.18 -172.71 3.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.485 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.3 -10.42 71.12 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 56' ' ' GLY . 1.2 p -107.5 -53.52 2.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -1.172 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.425 ' N ' ' OG ' ' A' ' 55' ' ' SER . . . -157.32 -122.72 0.72 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.584 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 16.5 m-85 -129.32 156.24 44.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -1.092 . . . . 0.0 109.516 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.1 t -117.07 117.58 30.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.848 . . . . 0.0 108.941 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.546 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 26.2 m-85 -97.59 159.52 14.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.974 . . . . 0.0 110.166 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.549 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 9.3 m-80 -150.06 90.85 1.71 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 1.036 ' CG2' HG23 ' A' ' 81' ' ' THR . 5.9 mt -77.72 135.21 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 110.415 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.642 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 41.7 m-70 -122.0 161.95 22.02 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 53.7 p90 -138.95 96.02 3.05 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 118.4 -1.32 . . . . 0.0 109.387 176.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.593 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 14.8 t90 -69.61 139.9 53.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -123.01 61.84 1.01 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.239 -0.913 . . . . 0.0 111.014 -178.253 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -53.07 89.72 0.01 OUTLIER Glycine 0 N--CA 1.5 2.967 0 N-CA-C 107.967 -2.053 . . . . 0.0 107.967 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 65' ' ' LEU . 5.2 ttmm -49.5 91.9 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.625 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 12.6 m120 -161.65 -42.05 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.534 ' OG ' ' CG ' ' A' ' 73' ' ' GLU . 24.4 p -65.57 -145.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.456 -0.777 . . . . 0.0 109.299 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.619 ' CB ' ' HE1' ' A' ' 26' ' ' MET . 3.9 p -116.11 170.74 8.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.072 -1.017 . . . . 0.0 109.847 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.509 ' HA ' ' HG2' ' A' ' 74' ' ' GLN . 7.3 tt0 -70.51 -11.58 61.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.412 -0.805 . . . . 0.0 110.403 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -82.34 -51.45 7.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.744 -1.223 . . . . 0.0 109.634 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.608 ' OE1' HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -63.69 -30.08 71.23 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.615 ' HB2' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -70.23 -33.32 71.51 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.187 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.518 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -79.65 -17.19 76.03 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.56 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -82.23 -36.32 27.3 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.385 -1.068 . . . . 0.0 108.706 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.828 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -69.53 -51.95 30.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.364 -0.835 . . . . 0.0 108.989 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.35 79.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.296 -0.877 . . . . 0.0 109.224 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 75' ' ' GLY . 74.2 mt -56.58 -42.49 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.264 -0.898 . . . . 0.0 109.309 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.655 ' CG ' HD22 ' A' ' 3' ' ' LEU . 3.5 m-85 -63.57 -29.68 70.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.227 -0.921 . . . . 0.0 108.661 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 1.036 HG23 ' CG2' ' A' ' 61' ' ' ILE . 15.9 m -71.49 -23.58 61.83 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 m -86.87 -29.04 22.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.567 -0.708 . . . . 0.0 109.229 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.494 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -73.21 -39.87 65.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.297 -0.877 . . . . 0.0 109.493 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.532 ' SD ' HG21 ' A' ' 61' ' ' ILE . 4.8 ptm -77.06 -27.74 54.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.453 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.596 ' HA ' HD11 ' A' ' 61' ' ' ILE . 7.8 t70 -66.72 -35.17 79.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.195 -0.94 . . . . 0.0 109.372 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -86.65 -23.33 25.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 0.0 109.393 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.494 ' CD1' ' O ' ' A' ' 83' ' ' GLN . 5.0 m-85 -87.3 -12.96 44.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -0.967 . . . . 0.0 109.448 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.564 HD11 HD22 ' A' ' 11' ' ' LEU . 21.1 mt -89.66 10.72 22.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.566 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 97.25 1.54 59.35 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 1.8 m 75.78 3.06 3.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -1.186 . . . . 0.0 109.629 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.401 ' H ' HG22 ' A' ' 91' ' ' VAL . 4.2 m -83.94 -16.5 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.397 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.546 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -70.57 172.75 8.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.553 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.67 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.5 t -124.97 176.91 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.315 -0.865 . . . . 0.0 109.267 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.67 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -125.18 132.47 53.03 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.082 -1.011 . . . . 0.0 109.161 179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.642 ' CD2' ' CE1' ' A' ' 62' ' ' HIS . 19.3 m-70 -130.25 153.49 48.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.652 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.535 ' HG3' ' CZ ' ' A' ' 63' ' ' TYR . 23.9 ttp180 -118.06 129.67 55.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 110.153 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.503 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 32.8 mp0 -134.01 164.45 27.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.0 t -157.49 -172.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.282 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.726 ' H ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -75.78 78.46 2.72 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 134.7 -16.71 4.26 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.496 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 37.9 m-70 -99.94 -16.05 18.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.704 -0.88 . . . . 0.0 108.822 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.593 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.12 22.76 3.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.549 -0.719 . . . . 0.0 109.366 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 105' ' ' THR . 90.9 p -57.99 -130.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.511 -0.743 . . . . 0.0 110.993 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.841 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 49.0 mt-10 -39.82 -24.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.07 -1.019 . . . . 0.0 111.271 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 103' ' ' SER . 7.6 m -70.62 -60.92 1.98 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.853 -1.154 . . . . 0.0 110.354 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.571 ' CG ' ' OE1' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -61.7 -50.2 73.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.805 -1.184 . . . . 0.0 108.582 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -61.95 -26.74 68.38 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.36 -0.837 . . . . 0.0 108.828 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -57.67 -51.74 68.29 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.468 ' HB3' HD13 ' A' ' 18' ' ' ILE . 23.1 m-85 -70.98 -17.1 62.67 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.883 ' CG ' HD21 ' A' ' 114' ' ' LEU . 24.6 m-85 -108.17 93.88 4.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.467 -0.77 . . . . 0.0 109.538 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.499 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -86.17 61.81 7.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.971 . . . . 0.0 109.361 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 111' ' ' LYS . 11.8 mt-30 -163.6 -78.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.775 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 179.82 130.88 1.54 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.883 HD21 ' CG ' ' A' ' 110' ' ' PHE . 44.8 mt -96.56 107.75 20.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 109.977 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.511 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 1.3 mm -79.84 164.9 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.559 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 71.1 m-85 -137.35 133.12 34.51 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.039 -1.038 . . . . 0.0 110.055 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 2.7 mmpt? -117.28 -171.81 2.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.099 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.586 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 8.1 mm100 -90.7 128.64 36.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.073 -1.017 . . . . 0.0 110.145 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.57 ' HA2' ' CG ' ' A' ' 40' ' ' TYR . . . -58.62 -154.96 0.01 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 55.54 79.58 0.09 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.776 HG12 ' HB3' ' A' ' 25' ' ' ASN . 0.4 OUTLIER -86.21 10.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.324 -1.103 . . . . 0.0 109.52 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 123' ' ' SER . . . -79.12 -76.72 0.19 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.7 -0.625 . . . . 0.0 109.535 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER 167.67 -29.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.39 -69.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.405 ' O ' ' C ' ' A' ' 126' ' ' LYS . 5.5 mmt -121.59 -150.49 0.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -1.144 . . . . 0.0 109.462 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.412 ' C ' ' HD2' ' A' ' 126' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.491 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.657 HG22 ' CD ' ' A' ' 27' ' ' GLU . 2.1 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 1' ' ' VAL . 9.8 pt-20 40.25 50.1 2.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.571 -0.705 . . . . 0.0 109.758 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.699 HD22 ' CG ' ' A' ' 80' ' ' TYR . 1.4 pp -43.07 -28.3 0.27 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 109.443 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.511 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 6.9 p -57.03 143.06 39.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 109.947 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 4' ' ' SER . 4.1 ttmt 73.41 -79.5 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.508 -0.745 . . . . 0.0 109.69 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 5' ' ' LYS . 7.8 mttm -45.4 -27.04 0.63 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.931 -1.105 . . . . 0.0 108.952 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.701 HG13 ' CE2' ' A' ' 21' ' ' TRP . 41.5 t -106.86 -33.97 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.541 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 8.0 p -87.28 -153.19 0.21 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.392 -0.817 . . . . 0.0 109.124 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.425 ' O ' ' HD2' ' A' ' 10' ' ' LYS . . . 84.15 -44.83 3.39 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -167.67 61.18 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.219 -1.166 . . . . 0.0 109.125 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.108 HD23 HD22 ' A' ' 48' ' ' LEU . 3.0 mp -41.81 -71.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.416 -0.802 . . . . 0.0 109.661 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.527 ' HB3' ' CB ' ' A' ' 50' ' ' THR . 14.4 m-20 -145.88 75.9 1.44 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.431 ' O ' ' OG1' ' A' ' 14' ' ' THR . 17.0 mmtt -91.47 125.51 36.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.515 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 23.4 p 48.6 57.3 6.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.389 -0.82 . . . . 0.0 109.535 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.3 m -162.64 104.76 1.06 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.46 -0.775 . . . . 0.0 109.243 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.94 130.76 11.59 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.312 2.008 . . . . 0.0 110.377 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.1 172.98 12.8 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.94 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -125.91 145.04 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.853 -1.381 . . . . 0.0 110.488 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -112.42 167.17 10.66 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.987 HD11 ' CZ ' ' A' ' 110' ' ' PHE . 26.1 mt -132.25 161.13 41.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.333 -1.479 . . . . 0.0 110.242 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.782 ' HA ' HG23 ' A' ' 31' ' ' VAL . 7.7 m-90 -120.87 122.77 40.96 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.938 ' HD2' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -79.84 130.26 35.16 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.922 -1.111 . . . . 0.0 110.755 -178.463 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 23' ' ' ILE . 7.9 mm -94.2 25.48 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.642 ' HB2' HG21 ' A' ' 121' ' ' VAL . 19.6 pt-20 -57.19 166.81 1.02 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.709 -0.619 . . . . 0.0 109.861 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.537 ' ND2' ' HG3' ' A' ' 24' ' ' GLU . 14.0 p30 42.66 27.67 0.1 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.476 ' HA ' ' OE2' ' A' ' 73' ' ' GLU . 3.8 mmt 53.64 55.23 8.81 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.499 -0.751 . . . . 0.0 109.622 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.657 ' CD ' HG22 ' A' ' 1' ' ' VAL . 0.9 OUTLIER -160.33 144.88 14.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 0.0 109.445 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.606 ' CE ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -76.54 136.36 39.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.051 -1.031 . . . . 0.0 109.788 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.764 HG12 ' CD ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -147.12 151.76 41.77 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.673 ' HD2' HG13 ' A' ' 29' ' ' VAL . 31.9 Cg_endo -72.99 134.27 21.21 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.362 2.041 . . . . 0.0 111.747 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.938 HG22 ' HD2' ' A' ' 22' ' ' ARG . 2.5 t -120.43 104.9 42.32 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.97 -157.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.557 2.171 . . . . 0.0 110.551 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.558 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -78.55 -25.97 45.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.171 -0.956 . . . . 0.0 109.101 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.36 32.47 0.77 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.275 -0.891 . . . . 0.0 109.854 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.509 ' HB2' ' CG1' ' A' ' 31' ' ' VAL . 17.3 m -155.07 -35.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 0.0 110.011 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.854 ' HB2' HD12 ' A' ' 20' ' ' ILE . 11.9 p90 -60.06 -41.22 91.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.011 -1.056 . . . . 0.0 109.768 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.51 ' N ' ' CG ' ' A' ' 36' ' ' TYR . . . -51.7 -24.29 12.24 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.844 ' HA ' HG22 ' A' ' 115' ' ' ILE . 0.9 OUTLIER -131.87 129.85 40.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.088 -1.242 . . . . 0.0 110.158 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -148.56 128.48 13.5 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.291 -0.881 . . . . 0.0 109.671 179.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.688 ' HE2' HG22 ' A' ' 121' ' ' VAL . 8.5 m-30 -47.55 140.1 6.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.489 -0.757 . . . . 0.0 110.6 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 1.6 pt-20 -91.3 29.12 1.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -0.864 . . . . 0.0 109.588 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.617 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -146.21 54.62 0.54 Allowed Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.467 ' CG ' ' O ' ' A' ' 42' ' ' GLY . 1.4 m-20 -162.94 -139.47 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.502 -0.999 . . . . 0.0 109.754 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.583 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 53.7 m -147.44 158.83 44.14 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.583 ' CD1' ' O ' ' A' ' 44' ' ' CYS . 31.4 m-85 -149.48 169.5 20.76 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.075 -1.016 . . . . 0.0 108.982 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.59 HG11 ' CE ' ' A' ' 84' ' ' MET . 44.3 t -132.25 113.08 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.783 HD11 HG13 ' A' ' 18' ' ' ILE . 3.8 tt -103.65 106.37 16.86 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.861 -1.149 . . . . 0.0 110.981 -178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.108 HD22 HD23 ' A' ' 11' ' ' LEU . 19.2 tp -94.37 124.92 38.68 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.782 ' OG ' HG22 ' A' ' 18' ' ' ILE . 8.5 t -115.18 136.22 53.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.096 -1.003 . . . . 0.0 109.788 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.527 ' CB ' ' HB3' ' A' ' 12' ' ' ASP . 1.2 m -130.56 124.26 31.41 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.83 137.59 52.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.525 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.581 ' O ' HG23 ' A' ' 53' ' ' THR . 0.7 OUTLIER -54.91 163.85 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.893 . . . . 0.0 109.437 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -165.4 -172.87 2.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.445 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.79 -29.16 39.75 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.68 -17.7 43.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -1.114 . . . . 0.0 109.42 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.8 -69.06 0.45 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.583 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 14.5 m-85 -160.09 157.16 28.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -1.139 . . . . 0.0 109.528 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.66 112.21 15.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 109.114 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.8 ' CD2' HD22 ' A' ' 88' ' ' LEU . 6.6 m-30 -91.93 153.93 19.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.245 -0.909 . . . . 0.0 109.929 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.504 ' ND2' ' CE1' ' A' ' 95' ' ' HIS . 1.9 m-20 -147.7 95.25 2.48 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.979 ' CG2' HG23 ' A' ' 81' ' ' THR . 15.3 mt -83.39 130.36 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.172 -0.955 . . . . 0.0 110.519 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.595 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 28.3 m-70 -115.39 164.17 14.65 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.603 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 48.1 p90 -137.87 96.78 3.28 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.611 -1.236 . . . . 0.0 109.792 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.576 ' CE2' ' OE1' ' A' ' 102' ' ' GLU . 6.7 t90 -72.62 141.41 48.34 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -125.57 65.3 1.17 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.069 -1.019 . . . . 0.0 110.865 -178.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -49.49 90.46 0.01 OUTLIER Glycine 0 N--CA 1.499 2.834 0 N-CA-C 108.414 -1.874 . . . . 0.0 108.414 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -39.15 91.48 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.927 0.87 . . . . 0.0 112.683 -177.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.617 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 1.2 m120 -162.65 -42.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.489 ' HB2' ' CB ' ' A' ' 73' ' ' GLU . 95.9 p -63.9 -151.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.582 -0.699 . . . . 0.0 109.343 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.432 ' OG ' ' OD1' ' A' ' 72' ' ' ASP . 80.1 p -121.2 176.57 5.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 109.62 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 12.0 tt0 -55.12 -41.39 71.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.549 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.432 ' OD1' ' OG ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -60.29 -43.24 96.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.159 -0.963 . . . . 0.0 109.551 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.489 ' CB ' ' HB2' ' A' ' 69' ' ' SER . 2.7 tp10 -56.33 -36.6 68.92 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.022 -1.049 . . . . 0.0 108.353 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 6.6 tt0 -62.7 -36.16 82.06 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.858 ' O ' HD13 ' A' ' 79' ' ' ILE . . . -80.06 -13.82 81.51 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.577 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -78.72 -54.02 6.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.234 -1.157 . . . . 0.0 109.156 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.505 ' HB2' ' CD1' ' A' ' 23' ' ' ILE . . . -72.45 -26.43 61.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.398 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.3 -48.38 20.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.25 -0.906 . . . . 0.0 109.564 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.858 HD13 ' O ' ' A' ' 75' ' ' GLY . 1.5 mp -65.54 -39.2 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -0.901 . . . . 0.0 108.994 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.699 ' CG ' HD22 ' A' ' 3' ' ' LEU . 3.8 m-85 -61.45 -39.46 90.92 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.053 -1.029 . . . . 0.0 108.331 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.979 HG23 ' CG2' ' A' ' 61' ' ' ILE . 3.0 m -67.12 -24.78 65.96 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.4 m -76.82 -37.02 56.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.454 -0.779 . . . . 0.0 109.379 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 24.2 mm100 -66.76 -36.66 82.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 109.585 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.605 ' SD ' HG11 ' A' ' 7' ' ' VAL . 73.3 mtm -71.72 -34.86 69.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.953 . . . . 0.0 109.602 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.55 -58.64 7.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 109.738 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -64.95 -33.33 75.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.672 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 3.1 m-85 -73.2 -10.49 59.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -1.0 . . . . 0.0 109.692 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.968 HD21 HD22 ' A' ' 11' ' ' LEU . 20.1 mt -89.43 -32.19 17.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 109.545 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 121.93 15.55 4.3 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 0.9 OUTLIER 75.8 -0.29 3.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -1.149 . . . . 0.0 109.683 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.535 HG23 ' CD2' ' A' ' 59' ' ' TYR . 15.6 m -83.42 -9.47 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.411 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.744 ' HB2' HD13 ' A' ' 88' ' ' LEU . . . -90.81 176.72 6.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 0.0 109.548 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.671 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.7 t -133.47 177.45 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.365 -0.835 . . . . 0.0 109.156 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.671 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -125.71 135.18 51.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.986 -1.071 . . . . 0.0 108.972 179.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.595 ' CD2' ' CD2' ' A' ' 62' ' ' HIS . 12.6 m-70 -132.96 149.0 52.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.128 -0.982 . . . . 0.0 109.379 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.585 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -110.77 136.94 49.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 110.384 -179.378 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.515 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 49.8 mm-40 -142.23 164.41 30.23 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.436 -0.79 . . . . 0.0 108.93 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 99' ' ' GLN . 1.8 t -157.78 -165.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.132 -0.98 . . . . 0.0 109.02 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.695 ' H ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -78.36 75.96 4.87 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 178.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.94 -12.17 4.78 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.505 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 10.8 m-70 -98.25 -13.21 20.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.667 -0.902 . . . . 0.0 109.107 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.578 ' OE1' ' CD2' ' A' ' 106' ' ' PHE . 2.0 pt-20 -90.05 30.17 1.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.418 -0.801 . . . . 0.0 109.031 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 102' ' ' GLU . 63.5 p -52.45 -141.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.751 0.786 . . . . 0.0 112.126 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.781 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -38.99 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.915 -1.116 . . . . 0.0 111.057 -178.435 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 103' ' ' SER . 0.8 OUTLIER -67.02 -57.47 6.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.811 -1.181 . . . . 0.0 110.138 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.578 ' CD2' ' OE1' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -66.64 -44.33 82.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.959 -1.088 . . . . 0.0 108.309 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.82 -17.54 64.93 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -71.02 -45.4 63.99 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.431 ' HB3' HD12 ' A' ' 18' ' ' ILE . 18.3 m-85 -76.37 -17.88 59.16 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.462 -0.774 . . . . 0.0 109.466 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.987 ' CZ ' HD11 ' A' ' 20' ' ' ILE . 6.9 m-30 -112.07 96.5 6.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.115 -0.991 . . . . 0.0 109.316 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -67.78 86.28 0.22 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.48 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 111' ' ' LYS . 7.3 mm100 72.65 74.82 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.867 . . . . 0.0 109.586 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.777 ' C ' HD22 ' A' ' 114' ' ' LEU . . . -178.73 62.87 0.08 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.785 HD21 ' HB2' ' A' ' 110' ' ' PHE . 3.8 mm? -120.9 63.01 0.87 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -1.14 . . . . 0.0 109.336 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.844 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -85.85 160.96 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.104 -0.998 . . . . 0.0 109.351 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.544 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 2.0 m-85 -139.75 165.0 28.46 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.605 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -146.98 -156.29 0.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.591 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -91.48 169.41 10.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.968 . . . . 0.0 109.819 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 120' ' ' GLY . . . -99.13 -169.86 30.75 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 47.37 95.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.688 HG22 ' HE2' ' A' ' 40' ' ' TYR . 1.3 t -90.45 103.93 14.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.205 -1.173 . . . . 0.0 109.297 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 121' ' ' VAL . . . -39.82 -81.37 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.693 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.2 p 46.1 25.82 0.37 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.502 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.07 -82.69 1.47 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.37 154.61 17.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -1.167 . . . . 0.0 109.432 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.8 mttt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.489 179.899 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.421 ' O ' HG12 ' A' ' 1' ' ' VAL . 9.1 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 175.54 94.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.43 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.882 ' O ' HD22 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -74.19 3.32 7.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.216 -0.927 . . . . 0.0 110.484 -179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.571 ' N ' HD13 ' A' ' 3' ' ' LEU . 1.7 p -92.74 150.9 20.36 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.811 -1.18 . . . . 0.0 110.34 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.506 ' HD2' ' HG2' ' A' ' 6' ' ' LYS . 12.0 ttmt 47.19 -86.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.429 0.633 . . . . 0.0 110.917 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 4' ' ' SER . 5.8 mmtt -40.54 -27.51 0.05 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.492 -0.755 . . . . 0.0 110.227 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 3' ' ' LEU . 70.4 t -109.16 -31.85 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.097 -1.002 . . . . 0.0 109.607 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.821 HG21 ' CG ' ' A' ' 87' ' ' TYR . 18.2 p -72.22 -3.52 23.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.883 . . . . 0.0 109.473 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 10' ' ' LYS . . . -70.45 85.03 0.34 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 9' ' ' GLY . 5.3 mtmm 80.65 74.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.677 -0.896 . . . . 0.0 109.601 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 8' ' ' THR . 4.7 mt -89.35 32.65 0.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 0.0 109.124 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER 78.31 61.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.438 -0.789 . . . . 0.0 109.357 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.538 ' O ' HG23 ' A' ' 14' ' ' THR . 4.2 mttm -81.6 -10.39 59.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 109.524 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 27.0 p -157.36 67.45 0.52 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.59 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.404 ' O ' ' OD2' ' A' ' 12' ' ' ASP . 99.2 m -161.9 118.5 1.32 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.384 -0.822 . . . . 0.0 109.169 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.84 87.84 1.44 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.255 1.97 . . . . 0.0 110.206 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.462 ' C ' HG23 ' A' ' 18' ' ' ILE . . . -170.48 -145.08 4.58 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.009 HD12 HD11 ' A' ' 47' ' ' LEU . 14.2 pt -157.24 142.21 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.013 -1.287 . . . . 0.0 110.202 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.61 ' NE2' ' CH2' ' A' ' 21' ' ' TRP . 0.4 OUTLIER -121.78 117.25 26.12 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.485 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.898 HD11 ' HZ ' ' A' ' 110' ' ' PHE . 1.6 mt -90.88 178.16 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.659 -1.276 . . . . 0.0 110.733 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.786 ' CD1' ' HE2' ' A' ' 28' ' ' MET . 9.5 m-90 -137.38 121.18 17.5 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.532 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 3.7 ptp180 -83.75 128.68 34.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.097 . . . . 0.0 111.908 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.58 HD13 ' HB3' ' A' ' 28' ' ' MET . 1.8 mm -111.45 50.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.636 ' HB2' ' CE2' ' A' ' 40' ' ' TYR . 4.7 pt-20 -92.78 -39.06 11.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.372 -0.83 . . . . 0.0 110.295 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.571 ' CB ' HG21 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -88.35 43.77 1.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 108.517 179.32 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.556 ' HE2' ' OE2' ' A' ' 73' ' ' GLU . 0.9 OUTLIER 50.22 24.48 1.48 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.529 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 3.6 pt-20 -151.94 153.74 34.7 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.786 ' HE2' ' CD1' ' A' ' 21' ' ' TRP . 15.5 ptm -97.41 133.69 41.67 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.744 -1.222 . . . . 0.0 110.746 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -120.73 149.33 50.28 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.572 ' HD2' HG13 ' A' ' 29' ' ' VAL . 32.0 Cg_endo -71.94 87.77 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.272 1.981 . . . . 0.0 112.217 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 22' ' ' ARG . 8.6 t -72.99 112.65 16.26 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.537 -0.727 . . . . 0.0 109.473 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 35.9 Cg_endo -78.41 -159.31 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.396 2.064 . . . . 0.0 110.149 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.576 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -88.14 -21.37 24.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 108.909 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -78.91 4.43 14.18 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.291 -0.881 . . . . 0.0 109.661 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 36' ' ' TYR . 38.7 m -128.18 -37.01 1.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.953 . . . . 0.0 109.787 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -42.81 161.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -0.894 . . . . 0.0 109.718 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.535 ' O ' ' CE1' ' A' ' 39' ' ' PHE . . . 110.82 -62.19 0.29 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.552 ' N ' ' ND2' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -103.75 106.97 17.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -1.152 . . . . 0.0 109.264 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.585 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -130.93 132.47 45.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.124 -0.985 . . . . 0.0 109.989 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.636 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 9.7 m-30 -40.13 131.2 2.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.591 -0.693 . . . . 0.0 111.445 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 0.8 OUTLIER -90.86 112.09 23.78 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.603 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . 115.22 45.57 0.62 Allowed Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -155.78 -134.29 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.536 -0.979 . . . . 0.0 108.678 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.529 ' HB2' ' CB ' ' A' ' 23' ' ' ILE . 60.8 m -146.18 137.27 24.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.865 -1.147 . . . . 0.0 109.437 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 26.5 m-85 -140.49 108.13 5.62 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.261 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.508 HG13 ' OG1' ' A' ' 81' ' ' THR . 8.2 t -78.86 126.73 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 108.551 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.009 HD11 HD12 ' A' ' 18' ' ' ILE . 7.4 tt -116.65 117.96 31.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.077 -1.015 . . . . 0.0 110.112 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 59' ' ' TYR . 22.2 tp -100.44 113.82 26.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.935 . . . . 0.0 109.333 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.402 ' HA ' HG22 ' A' ' 18' ' ' ILE . 3.1 t -102.4 130.73 49.25 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.225 -0.922 . . . . 0.0 109.538 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 m -121.2 142.82 49.53 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.09 -173.28 3.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.46 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.727 ' O ' HG23 ' A' ' 53' ' ' THR . 1.0 OUTLIER -109.96 168.87 9.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.487 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 52' ' ' LYS . 5.4 p -162.72 -170.9 2.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.06 -17.85 66.34 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.1 m -102.39 -43.74 5.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -1.153 . . . . 0.0 109.478 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.424 ' O ' ' OG1' ' A' ' 53' ' ' THR . . . -175.36 -128.34 1.1 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.579 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 42.1 m-85 -111.23 150.66 29.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -1.125 . . . . 0.0 109.516 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.55 114.33 27.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.0 109.001 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.572 ' HD1' HG23 ' A' ' 91' ' ' VAL . 12.7 m-85 -91.09 155.63 18.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.164 -0.96 . . . . 0.0 109.841 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.59 ' ND2' ' CE1' ' A' ' 95' ' ' HIS . 1.8 m-20 -147.25 92.64 2.13 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.919 ' CG2' HG23 ' A' ' 81' ' ' THR . 21.5 mt -77.64 134.38 28.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 110.374 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.616 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 42.9 m-70 -120.82 162.53 19.64 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 95' ' ' HIS . 45.9 p90 -137.05 97.69 3.57 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 118.605 -1.238 . . . . 0.0 109.298 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.598 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 7.7 t90 -74.33 137.23 42.7 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.774 HD11 ' CG ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -126.53 64.62 1.26 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -0.885 . . . . 0.0 111.095 -178.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.451 ' O ' ' HA2' ' A' ' 42' ' ' GLY . . . -49.48 97.38 0.01 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 107.173 -2.371 . . . . 0.0 107.173 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 65' ' ' LEU . 2.2 tptt -55.27 89.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -176.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.603 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 12.0 m120 -160.98 -37.99 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.8 p -67.43 -146.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 109.432 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.451 ' HB2' ' OD2' ' A' ' 72' ' ' ASP . 3.0 p -114.27 158.67 21.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 109.891 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -50.99 -34.89 31.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.451 ' OD2' ' HB2' ' A' ' 70' ' ' SER . 1.6 p30 -58.18 -46.13 86.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.147 -0.971 . . . . 0.0 109.077 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.556 ' OE2' ' HE2' ' A' ' 26' ' ' MET . 59.7 mm-40 -57.09 -36.17 70.29 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.774 ' CG ' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -63.03 -35.92 81.85 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.531 ' O ' ' CG1' ' A' ' 79' ' ' ILE . . . -81.79 -12.08 81.91 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.19 -54.14 6.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.15 -1.206 . . . . 0.0 109.286 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.481 ' HB1' HG22 ' A' ' 46' ' ' VAL . . . -73.09 -34.02 65.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -0.905 . . . . 0.0 109.376 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.62 -41.76 65.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 109.776 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.531 ' CG1' ' O ' ' A' ' 75' ' ' GLY . 73.0 mt -69.24 -44.87 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.054 -1.029 . . . . 0.0 109.886 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.594 ' CD2' HD12 ' A' ' 3' ' ' LEU . 2.9 m-85 -68.38 -29.5 68.21 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.919 HG23 ' CG2' ' A' ' 61' ' ' ILE . 13.8 m -69.67 -24.17 63.57 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 79' ' ' ILE . 2.1 m -72.62 -49.01 34.86 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 9.3 mt-30 -59.28 -43.38 92.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.368 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.696 ' CG ' HD23 ' A' ' 3' ' ' LEU . 0.9 OUTLIER -55.06 -37.9 67.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.593 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.98 -41.59 99.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.12 4.58 49.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.196 -0.94 . . . . 0.0 109.704 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.821 ' CG ' HG21 ' A' ' 8' ' ' THR . 0.6 OUTLIER -107.97 -13.98 14.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 0.0 109.581 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.48 HD21 ' HB3' ' A' ' 11' ' ' LEU . 20.5 mt -87.13 -66.54 0.9 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 109.589 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.683 ' O ' HG13 ' A' ' 91' ' ' VAL . . . 171.39 37.27 0.03 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.4 m 49.58 22.42 0.76 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -1.15 . . . . 0.0 109.552 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 89' ' ' GLY . 31.1 m -110.86 -25.96 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.198 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -65.46 172.42 3.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 109.515 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.683 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.4 t -126.53 177.76 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.347 -0.846 . . . . 0.0 109.318 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.683 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -125.33 131.77 52.96 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.067 -1.021 . . . . 0.0 109.036 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.616 ' CD2' ' CE1' ' A' ' 62' ' ' HIS . 22.1 m-70 -128.52 152.68 48.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.938 . . . . 0.0 109.522 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.574 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 11.7 ttt-85 -114.62 133.23 56.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.365 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.501 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 50.2 mt-10 -140.33 165.11 28.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.108 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.692 HG12 ' H ' ' A' ' 99' ' ' GLN . 1.7 t -155.42 -161.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.085 -1.009 . . . . 0.0 109.319 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.692 ' H ' HG12 ' A' ' 98' ' ' VAL . 8.9 pt20 -82.09 72.78 9.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.086 -1.009 . . . . 0.0 108.552 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 137.07 -19.6 3.45 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.491 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 19.0 m-70 -87.19 -21.96 25.57 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.702 -0.881 . . . . 0.0 108.789 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.598 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.27 22.4 3.35 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.742 0.782 . . . . 0.0 109.124 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.9 p -57.51 -99.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.283 -0.886 . . . . 0.0 111.336 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.943 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 19.1 pt-20 -62.97 -18.32 63.09 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.092 -1.005 . . . . 0.0 111.103 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 1.6 m -79.63 -61.48 1.98 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.805 -1.185 . . . . 0.0 110.166 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.57 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -58.68 -56.45 22.03 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.954 -1.091 . . . . 0.0 108.173 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -57.2 -31.33 65.35 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.455 -0.778 . . . . 0.0 109.18 179.18 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.943 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -51.79 -54.15 31.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.022 -1.049 . . . . 0.0 108.249 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.584 ' HB3' HD13 ' A' ' 18' ' ' ILE . 19.5 m-85 -64.88 -23.95 67.39 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.898 ' HZ ' HD11 ' A' ' 20' ' ' ILE . 9.2 m-85 -102.89 92.53 4.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.518 -0.739 . . . . 0.0 109.312 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.454 ' O ' ' OE1' ' A' ' 112' ' ' GLN . 28.9 mtmm -82.23 89.69 6.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.522 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.454 ' OE1' ' O ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER 168.58 -74.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 108.761 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 114' ' ' LEU . . . -159.78 -142.12 3.31 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.694 HD21 ' CG ' ' A' ' 110' ' ' PHE . 0.5 OUTLIER 174.94 108.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.504 -0.998 . . . . 0.0 108.921 179.433 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.574 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 5.0 mt -93.69 165.04 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 109.374 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.574 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 4.1 m-85 -142.05 113.13 7.5 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.545 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -79.39 -169.24 1.81 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.294 -0.879 . . . . 0.0 109.662 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.583 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 35.5 tp60 -92.64 148.4 22.1 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.751 -1.218 . . . . 0.0 110.73 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.584 ' HA2' ' CD2' ' A' ' 40' ' ' TYR . . . -66.38 -173.73 5.42 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 59.32 117.35 0.01 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.571 HG21 ' CB ' ' A' ' 25' ' ' ASN . 1.5 t -90.75 -141.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.181 -1.187 . . . . 0.0 109.049 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 123' ' ' SER . . . -84.23 -71.86 0.49 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.95 . . . . 0.0 109.386 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 122' ' ' ALA . 1.0 OUTLIER 75.89 14.48 2.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 109.424 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 53.73 55.07 27.23 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -135.48 -69.31 0.5 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -1.139 . . . . 0.0 109.416 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tttm . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.465 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.974 HG22 ' HG2' ' A' ' 27' ' ' GLU . 16.5 t . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.566 ' N ' HG12 ' A' ' 1' ' ' VAL . 7.5 pt-20 39.15 83.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.646 -0.658 . . . . 0.0 109.959 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.848 HD22 ' CG ' ' A' ' 80' ' ' TYR . 2.4 pt? -85.23 14.28 5.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 p -90.83 5.21 49.34 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.675 -1.266 . . . . 0.0 110.088 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -134.26 -48.12 0.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.061 -1.024 . . . . 0.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 8.9 mmtt -89.69 35.48 0.83 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.905 . . . . 0.0 109.024 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.642 HG12 ' HB3' ' A' ' 11' ' ' LEU . 60.6 t -159.3 -49.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.39 -0.819 . . . . 0.0 109.751 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.726 ' HA ' HD23 ' A' ' 11' ' ' LEU . 44.5 p -61.89 -31.3 71.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.325 -0.86 . . . . 0.0 110.137 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 10' ' ' LYS . . . -45.03 -26.62 1.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.5 ' CG ' ' HE3' ' A' ' 13' ' ' LYS . 0.3 OUTLIER 175.87 70.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.505 -0.997 . . . . 0.0 108.622 179.611 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.044 HD12 ' CD2' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -86.92 19.81 2.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.335 -0.853 . . . . 0.0 110.206 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.77 ' OD2' HD21 ' A' ' 48' ' ' LEU . 3.8 p30 157.7 106.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.621 -0.675 . . . . 0.0 109.287 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HE3' ' CG ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -157.94 123.18 4.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 109.644 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 22.1 p 48.34 56.5 7.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.0 109.628 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.5 m -166.41 106.66 0.68 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.392 -0.817 . . . . 0.0 109.27 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 50' ' ' THR . 34.4 Cg_endo -76.96 128.07 9.75 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.347 2.032 . . . . 0.0 110.263 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 144.73 167.91 12.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.951 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -123.64 143.11 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.075 -1.25 . . . . 0.0 109.764 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.472 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 1.7 pm0 -120.15 -170.39 1.96 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.838 HD11 ' HZ ' ' A' ' 110' ' ' PHE . 2.0 mt -147.37 178.65 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.822 -1.174 . . . . 0.0 110.156 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.669 ' H ' HG22 ' A' ' 20' ' ' ILE . 7.1 m-90 -134.67 122.24 21.96 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.54 ' HD3' HG12 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -82.6 130.02 35.04 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.118 -0.989 . . . . 0.0 112.293 -176.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.89 HD13 ' HB2' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -121.18 24.68 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 177.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.755 ' HG3' HG21 ' A' ' 121' ' ' VAL . 10.6 pt-20 -63.42 -49.57 73.21 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.223 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.405 ' N ' ' CG ' ' A' ' 24' ' ' GLU . 21.3 p-10 -85.33 42.86 0.97 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.118 -0.989 . . . . 0.0 108.336 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.565 ' HE3' ' CD ' ' A' ' 73' ' ' GLU . 79.4 mmm 48.42 34.63 4.9 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.974 ' HG2' HG22 ' A' ' 1' ' ' VAL . 3.2 tt0 -151.57 131.37 13.24 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.852 ' HG3' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -81.42 139.17 35.41 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.089 -1.007 . . . . 0.0 110.237 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -144.0 147.67 38.94 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.536 ' HD2' HG13 ' A' ' 29' ' ' VAL . 32.0 Cg_endo -72.29 88.32 0.86 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.292 1.995 . . . . 0.0 111.618 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' A' ' 21' ' ' TRP . 20.7 t -66.91 111.97 8.45 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 36.2 Cg_endo -78.89 -159.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.408 2.072 . . . . 0.0 110.414 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.459 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -87.55 -12.67 45.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.876 . . . . 0.0 109.085 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.07 26.76 1.12 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.29 -0.881 . . . . 0.0 109.918 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 36' ' ' TYR . 1.1 m -160.08 -37.35 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.046 -1.034 . . . . 0.0 109.823 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.469 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 1.1 p90 -43.42 130.78 5.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.569 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.2 -72.51 0.44 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.542 ' ND2' HD12 ' A' ' 115' ' ' ILE . 13.6 m-20 -94.09 96.85 9.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -1.188 . . . . 0.0 109.518 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.768 ' HZ ' HD22 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -117.33 129.53 55.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.248 -0.908 . . . . 0.0 109.187 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.624 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 84.6 m-85 -39.75 153.13 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.453 -0.779 . . . . 0.0 110.174 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 9.5 pt-20 -90.84 -32.93 15.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.392 -0.818 . . . . 0.0 110.197 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.607 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -91.69 64.49 2.47 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.047 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.489 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 3.2 m-20 -162.83 -144.89 0.09 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.405 -1.056 . . . . 0.0 109.963 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.5 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 84.4 m -149.54 143.36 25.56 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.603 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 29.0 m-85 -140.35 112.39 7.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.367 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.646 ' CG2' ' HB1' ' A' ' 77' ' ' ALA . 90.6 t -79.2 127.13 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.932 -1.105 . . . . 0.0 108.59 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.812 HD21 HG13 ' A' ' 18' ' ' ILE . 8.9 tt -107.69 162.81 13.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.9 -1.125 . . . . 0.0 109.901 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.044 ' CD2' HD12 ' A' ' 11' ' ' LEU . 13.8 tp -151.32 115.15 4.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.073 -1.017 . . . . 0.0 108.997 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.518 ' HA ' ' HB ' ' A' ' 18' ' ' ILE . 3.5 t -109.78 132.14 54.42 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.007 -1.058 . . . . 0.0 110.319 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 1.3 m -125.95 120.87 31.5 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -125.92 157.67 37.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 109.556 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.03 151.76 40.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.458 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.72 HG21 ' OG ' ' A' ' 58' ' ' SER . 1.4 p -137.51 -171.97 3.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.209 -0.932 . . . . 0.0 109.523 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.0 -12.32 77.1 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 p -108.17 -36.42 6.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -1.107 . . . . 0.0 109.461 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.95 -100.88 0.15 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 5.9 m-85 -131.53 154.54 48.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -1.171 . . . . 0.0 109.515 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.72 ' OG ' HG21 ' A' ' 53' ' ' THR . 52.5 m -126.42 112.87 16.13 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.71 ' CD2' HG23 ' A' ' 91' ' ' VAL . 2.8 m-85 -92.62 154.43 18.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.176 -0.953 . . . . 0.0 110.421 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.467 ' OD1' ' HB ' ' A' ' 93' ' ' VAL . 6.5 m-20 -140.16 98.68 3.5 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.971 ' CG2' HG23 ' A' ' 81' ' ' THR . 37.2 mt -89.38 119.25 36.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 110.79 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.69 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 21.1 m-70 -109.01 164.44 12.41 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.596 ' CE1' ' HA ' ' A' ' 96' ' ' ARG . 39.4 p90 -138.67 103.73 4.92 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.114 -1.435 . . . . 0.0 109.702 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.602 ' C ' HD23 ' A' ' 65' ' ' LEU . 2.4 t90 -78.97 130.25 35.35 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.047 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.602 HD23 ' C ' ' A' ' 64' ' ' TRP . 0.1 OUTLIER -122.36 65.8 0.94 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.496 -0.753 . . . . 0.0 110.706 -178.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.452 ' HA2' ' HB2' ' A' ' 99' ' ' GLN . . . -51.29 89.63 0.01 OUTLIER Glycine 0 N--CA 1.497 2.746 0 N-CA-C 108.304 -1.918 . . . . 0.0 108.304 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -39.1 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 122.076 0.941 . . . . 0.0 112.255 -177.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.607 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 2.4 m-80 -162.1 -45.2 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 73' ' ' GLU . 88.5 p -62.86 -148.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.354 -0.841 . . . . 0.0 109.199 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.46 ' OG ' ' OD2' ' A' ' 72' ' ' ASP . 2.5 p -121.86 168.54 11.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -48.46 -29.11 3.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.351 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.46 ' OD2' ' OG ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -68.24 -44.49 75.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.446 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.565 ' CD ' ' HE3' ' A' ' 26' ' ' MET . 0.1 OUTLIER -57.16 -36.53 70.88 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.55 ' HA ' HD11 ' A' ' 65' ' ' LEU . 3.8 tt0 -64.09 -34.96 79.23 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.506 ' O ' ' CG1' ' A' ' 79' ' ' ILE . . . -79.83 -13.46 82.24 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.38 -54.02 6.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -1.124 . . . . 0.0 109.248 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.89 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -75.15 -39.66 60.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.163 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 74' ' ' GLN . . . -63.1 -49.36 74.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.355 -0.84 . . . . 0.0 109.306 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' A' ' 75' ' ' GLY . 70.5 mt -63.57 -44.13 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.211 -0.931 . . . . 0.0 109.414 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.848 ' CG ' HD22 ' A' ' 3' ' ' LEU . 14.5 m-30 -62.98 -25.36 68.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.245 -0.909 . . . . 0.0 109.033 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.971 HG23 ' CG2' ' A' ' 61' ' ' ILE . 5.9 m -79.14 -23.41 44.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.3 m -88.79 -21.82 23.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.638 -0.664 . . . . 0.0 109.352 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 6.8 mt-30 -83.19 -37.87 23.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.497 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.638 ' CG ' HD13 ' A' ' 61' ' ' ILE . 5.3 ptm -75.75 -29.24 58.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.334 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.617 ' HA ' HD11 ' A' ' 61' ' ' ILE . 67.2 t0 -61.64 -59.64 4.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -0.944 . . . . 0.0 109.698 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.58 -33.8 76.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.136 -0.977 . . . . 0.0 109.476 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 0.5 OUTLIER -69.91 -16.11 63.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 109.59 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.983 ' CD1' HD11 ' A' ' 11' ' ' LEU . 66.7 mt -94.06 22.61 5.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.678 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 86.2 0.59 86.86 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 1.4 p 75.86 7.52 3.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -1.165 . . . . 0.0 109.616 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.71 HG23 ' CD2' ' A' ' 59' ' ' TYR . 15.7 m -83.3 -19.5 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 109.285 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.582 ' HB1' HG13 ' A' ' 61' ' ' ILE . . . -68.38 165.61 18.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.581 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.751 HG12 ' H ' ' A' ' 94' ' ' GLN . 2.5 t -115.86 -177.08 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.376 -0.827 . . . . 0.0 109.125 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.751 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -131.01 138.43 49.66 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.092 -1.005 . . . . 0.0 108.674 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.69 ' CD2' ' CD2' ' A' ' 62' ' ' HIS . 19.0 m-70 -135.0 142.77 46.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.088 -1.007 . . . . 0.0 110.179 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.596 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -94.17 117.3 29.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 110.148 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.505 ' HB2' ' HA ' ' A' ' 64' ' ' TRP . 44.5 mm-40 -127.98 158.83 36.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.107 -0.996 . . . . 0.0 109.354 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.725 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.6 t -155.75 -175.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.27 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.725 ' H ' HG12 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -69.77 -1.97 10.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.924 -1.11 . . . . 0.0 110.258 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.69 16.11 1.8 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.586 ' CD2' ' HB ' ' A' ' 98' ' ' VAL . 13.1 m-70 -120.88 -15.73 8.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.487 -1.008 . . . . 0.0 109.373 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.598 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.37 21.59 3.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 0.0 109.169 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 102' ' ' GLU . 4.3 p -41.75 -106.03 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.545 -0.722 . . . . 0.0 112.177 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -67.97 -31.67 71.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.84 -1.163 . . . . 0.0 111.245 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.69 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -58.82 -59.73 4.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.011 -1.056 . . . . 0.0 110.197 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.561 ' HD2' HD13 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -58.71 -55.62 32.75 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.006 -1.059 . . . . 0.0 108.467 -179.252 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -54.48 -20.64 8.03 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 105' ' ' THR . . . -65.22 -51.99 57.43 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.692 ' HB3' HD12 ' A' ' 18' ' ' ILE . 29.4 m-85 -65.46 -17.19 64.36 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.991 ' CG ' HD21 ' A' ' 114' ' ' LEU . 4.2 m-85 -121.4 100.79 7.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 109.684 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 2.8 pttt -81.27 73.55 8.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.222 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.43 -54.93 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 109.731 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 114' ' ' LEU . . . 156.5 -20.08 0.46 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.991 HD21 ' CG ' ' A' ' 110' ' ' PHE . 23.0 mt 62.77 133.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.295 -1.121 . . . . 0.0 109.895 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.562 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 3.2 mt -116.39 164.9 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 0.0 108.978 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.562 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -141.07 102.28 4.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.36 -0.837 . . . . 0.0 109.151 179.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.624 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 3.2 mmtt -79.89 -167.97 1.45 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.893 . . . . 0.0 109.587 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.582 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -91.1 124.4 35.29 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.909 -1.119 . . . . 0.0 110.369 -179.451 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 118' ' ' GLN . . . -56.53 -161.61 0.02 OUTLIER Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 67.04 67.38 2.01 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.755 HG21 ' HG3' ' A' ' 24' ' ' GLU . 1.4 t -90.79 102.72 13.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.316 -1.108 . . . . 0.0 109.648 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 121' ' ' VAL . . . -40.98 -79.49 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.321 0.581 . . . . 0.0 109.798 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 172.65 -29.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.335 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' A' ' 125' ' ' MET . . . 103.82 -38.9 3.01 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.529 ' CG ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER 172.59 -79.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -1.112 . . . . 0.0 109.402 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 125' ' ' MET . 8.9 mttp . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.453 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.962 HG12 ' OE1' ' A' ' 2' ' ' GLU . 1.5 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.962 ' OE1' HG12 ' A' ' 1' ' ' VAL . 15.4 pm0 36.83 51.47 0.94 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.778 -0.576 . . . . 0.0 110.326 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.092 HD22 ' CD2' ' A' ' 80' ' ' TYR . 2.1 pt? -43.33 -31.31 0.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.877 . . . . 0.0 109.412 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.532 ' HA ' ' CG2' ' A' ' 8' ' ' THR . 4.1 t -62.31 87.22 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -0.849 . . . . 0.0 109.935 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.528 ' HG2' ' N ' ' A' ' 6' ' ' LYS . 5.2 ttmm 168.81 -90.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.528 ' N ' ' HG2' ' A' ' 5' ' ' LYS . 1.0 OUTLIER -74.83 -6.62 50.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.202 -0.936 . . . . 0.0 108.94 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.971 HG12 ' CD2' ' A' ' 11' ' ' LEU . 37.4 t -106.9 -72.59 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.833 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 4' ' ' SER . 66.6 p -47.98 -29.66 3.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.678 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 8' ' ' THR . . . -41.81 -47.71 5.06 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.554 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 4.0 mtmt -141.61 -54.39 0.46 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -1.162 . . . . 0.0 109.586 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.069 HD12 ' CD2' ' A' ' 88' ' ' LEU . 55.2 mt 82.22 -42.55 0.13 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.756 -0.59 . . . . 0.0 109.955 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.491 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -170.98 -83.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.939 -1.1 . . . . 0.0 109.605 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER 73.87 124.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.925 . . . . 0.0 109.358 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 22.5 p 48.45 57.02 6.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.442 -0.786 . . . . 0.0 109.521 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.5 m -157.13 101.58 1.92 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.522 -0.736 . . . . 0.0 109.232 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.04 83.66 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.398 2.065 . . . . 0.0 110.502 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.47 -146.3 4.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.868 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -159.24 145.69 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.051 -1.264 . . . . 0.0 109.674 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.633 ' NE2' ' CH2' ' A' ' 21' ' ' TRP . 1.6 tt0 -122.76 143.58 49.73 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.641 HG22 ' H ' ' A' ' 21' ' ' TRP . 1.5 mt -114.76 175.28 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.745 -1.222 . . . . 0.0 109.537 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.641 ' H ' HG22 ' A' ' 20' ' ' ILE . 7.3 m-90 -134.81 117.47 15.97 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.55 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -79.51 128.37 33.28 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 -178.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.652 ' CG2' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -101.56 31.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-O 123.075 1.417 . . . . 0.0 107.325 179.098 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.508 ' O ' ' ND2' ' A' ' 25' ' ' ASN . 1.5 pt-20 -54.96 168.44 0.3 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.647 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' CG ' ' A' ' 27' ' ' GLU . 8.0 p30 42.68 27.68 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.634 ' H ' ' HE3' ' A' ' 26' ' ' MET . 0.0 OUTLIER 50.2 56.8 7.36 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.639 -0.663 . . . . 0.0 109.749 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 28' ' ' MET . 10.0 mm-40 -139.51 -99.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.982 -1.074 . . . . 0.0 110.111 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.59 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 4.1 mmm 163.04 140.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.099 -1.001 . . . . 0.0 109.205 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 1.0 OUTLIER -158.95 146.75 13.47 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.125 -0.984 . . . . 0.0 109.488 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.565 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 35.5 Cg_endo -77.45 87.45 1.51 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.842 2.361 . . . . 0.0 111.658 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.55 HG23 ' H ' ' A' ' 22' ' ' ARG . 42.3 t -69.92 113.08 14.86 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.475 ' HG2' ' HG2' ' A' ' 34' ' ' LYS . 34.9 Cg_endo -76.67 -159.91 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.481 2.121 . . . . 0.0 110.827 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -88.61 -16.46 32.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.322 -0.862 . . . . 0.0 109.261 -179.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 32' ' ' PRO . 8.9 ptmt -90.38 17.66 7.02 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 110.052 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.1 m -143.2 5.27 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.936 -1.103 . . . . 0.0 110.566 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.567 ' CD1' ' O ' ' A' ' 33' ' ' THR . 30.1 p90 -90.45 146.59 24.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.784 -1.197 . . . . 0.0 109.646 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.424 ' C ' ' OD1' ' A' ' 38' ' ' ASN . . . 136.33 -27.42 2.99 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.566 ' ND2' HD12 ' A' ' 115' ' ' ILE . 0.7 OUTLIER -139.47 106.4 5.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -1.159 . . . . 0.0 109.491 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -119.83 126.89 52.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.108 -0.995 . . . . 0.0 109.67 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.598 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 6.9 m-30 -48.56 121.81 4.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.432 -0.792 . . . . 0.0 109.563 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.598 ' HA ' ' CH2' ' A' ' 64' ' ' TRP . 1.7 pt-20 -64.17 -7.81 10.3 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.104 -0.998 . . . . 0.0 110.297 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.643 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -111.43 57.23 0.43 Allowed Glycine 0 N--CA 1.485 1.901 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.498 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.503 ' OD1' ' HB2' ' A' ' 40' ' ' TYR . 4.3 m-20 -162.34 -143.96 0.09 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.299 -1.118 . . . . 0.0 109.99 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.59 ' HB3' ' HB2' ' A' ' 77' ' ' ALA . 6.3 m -145.54 139.12 26.53 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.494 ' HB3' ' CG2' ' A' ' 20' ' ' ILE . 21.2 m-85 -137.04 106.94 6.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.054 -1.029 . . . . 0.0 110.04 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.576 HG13 ' OG1' ' A' ' 81' ' ' THR . 87.5 t -78.83 128.54 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.102 -0.999 . . . . 0.0 108.857 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.697 HD11 HG13 ' A' ' 18' ' ' ILE . 3.7 tt -107.33 160.88 15.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.019 -1.05 . . . . 0.0 109.895 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.549 ' CD2' ' HB3' ' A' ' 11' ' ' LEU . 20.3 tp -151.18 92.48 1.8 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.999 -1.063 . . . . 0.0 109.519 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.566 ' CB ' ' HB ' ' A' ' 18' ' ' ILE . 3.0 t -96.3 131.0 43.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 110.126 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.468 ' OG1' ' CD2' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -107.07 152.69 23.67 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -138.01 137.58 38.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.106 -0.996 . . . . 0.0 109.642 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.562 ' O ' HG23 ' A' ' 53' ' ' THR . 0.0 OUTLIER -76.98 163.64 26.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.368 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 52' ' ' LYS . 23.6 p -158.55 -177.77 6.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.538 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.36 19.29 36.58 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.7 t -140.91 -50.39 0.44 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -1.145 . . . . 0.0 109.559 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.37 -102.17 0.19 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 3.4 m-85 -152.43 -172.19 4.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -1.15 . . . . 0.0 109.5 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.6 t -149.03 102.92 3.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.844 . . . . 0.0 108.99 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.593 ' CD2' HD22 ' A' ' 88' ' ' LEU . 52.9 m-85 -85.23 159.34 20.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 0.0 110.181 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.469 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 6.2 m-20 -141.36 100.18 3.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.966 ' CG2' HG23 ' A' ' 81' ' ' THR . 47.5 mt -92.51 114.26 29.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.091 -1.005 . . . . 0.0 110.419 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.698 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 13.8 m-70 -107.91 170.1 8.2 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.545 -0.722 . . . . 0.0 109.272 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.578 ' CE1' ' HA ' ' A' ' 96' ' ' ARG . 53.4 p90 -141.41 107.1 5.09 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.4 -1.32 . . . . 0.0 109.923 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.598 ' CH2' ' HA ' ' A' ' 41' ' ' GLU . 3.0 t90 -82.28 136.46 35.04 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -124.05 63.47 1.07 Allowed 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.329 -178.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 68' ' ' ASN . . . -46.49 93.68 0.01 OUTLIER Glycine 0 N--CA 1.498 2.768 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.586 ' N ' ' O ' ' A' ' 65' ' ' LEU . 7.3 tppt? -39.47 84.56 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.643 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 7.7 m120 -163.0 -43.21 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.528 ' HB2' ' CB ' ' A' ' 73' ' ' GLU . 1.4 p -50.29 -178.84 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.755 -0.591 . . . . 0.0 109.483 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.46 ' OG ' ' OD1' ' A' ' 72' ' ' ASP . 1.0 OUTLIER -95.72 -169.0 1.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.553 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.522 ' O ' ' CG ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -70.72 -39.86 73.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 9.3 p-10 -74.34 -24.57 59.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.004 -1.06 . . . . 0.0 109.298 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.528 ' CB ' ' HB2' ' A' ' 69' ' ' SER . 29.5 mt-10 -69.03 -43.03 75.57 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.699 ' HB2' HD11 ' A' ' 65' ' ' LEU . 4.0 pt20 -66.19 -30.35 70.8 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.63 ' O ' HD13 ' A' ' 79' ' ' ILE . . . -83.7 -12.42 77.68 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -83.8 -41.67 17.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.16 -1.2 . . . . 0.0 108.718 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.59 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . . . -72.66 -50.74 22.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.855 . . . . 0.0 108.774 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.53 86.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 109.039 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.63 HD13 ' O ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -63.52 -42.62 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.303 -0.873 . . . . 0.0 108.647 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 1.092 ' CD2' HD22 ' A' ' 3' ' ' LEU . 5.0 m-85 -62.08 -24.23 66.98 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.966 HG23 ' CG2' ' A' ' 61' ' ' ILE . 1.8 m -82.38 -26.31 32.99 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.1 m -70.54 -46.14 64.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.504 -0.747 . . . . 0.0 109.081 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 1.8 mt-30 -68.94 -42.56 76.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.345 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.67 ' O ' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -55.35 -36.0 65.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 109.404 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.487 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.9 t0 -77.4 -36.86 52.96 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.0 109.507 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -86.44 6.21 31.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.57 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 1.9 m-85 -121.0 -17.09 7.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 109.582 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 1.069 ' CD2' HD12 ' A' ' 11' ' ' LEU . 7.0 mt -87.58 4.93 41.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 109.598 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.749 ' O ' HG13 ' A' ' 91' ' ' VAL . . . 96.73 33.63 6.04 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 p 47.02 24.25 0.36 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 0.0 109.627 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.749 HG13 ' O ' ' A' ' 89' ' ' GLY . 14.8 m -100.98 -15.78 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 0.0 109.282 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.547 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -79.98 167.85 19.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.274 -0.891 . . . . 0.0 109.626 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.764 HG12 ' H ' ' A' ' 94' ' ' GLN . 2.8 t -116.16 -176.92 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.452 -0.78 . . . . 0.0 109.099 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.764 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -129.62 142.09 50.81 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.896 -1.127 . . . . 0.0 109.013 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.698 ' CD2' ' CD2' ' A' ' 62' ' ' HIS . 9.0 m-70 -143.32 150.19 38.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.067 -1.02 . . . . 0.0 109.882 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.578 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 3.4 ttp180 -108.13 138.3 44.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 110.201 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.512 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 10.5 mm-40 -145.66 161.75 39.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.36 -0.838 . . . . 0.0 109.188 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.754 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.2 t -156.58 -166.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 108.873 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.754 ' H ' HG12 ' A' ' 98' ' ' VAL . 14.2 pt20 -74.12 1.82 10.3 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.837 -1.164 . . . . 0.0 110.127 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.78 19.49 1.27 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.567 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 11.9 m-70 -123.93 -9.88 7.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.571 -0.959 . . . . 0.0 109.398 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.656 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 1.2 pp20? -90.39 15.19 11.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.392 -0.817 . . . . 0.0 109.726 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 102' ' ' GLU . 24.5 p -39.72 -109.53 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -75.52 -25.66 57.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.719 -1.238 . . . . 0.0 111.152 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.736 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 4.6 m -64.16 -48.83 74.46 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.823 -1.173 . . . . 0.0 109.501 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.656 ' HB2' ' HB2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -67.56 -57.29 6.73 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.584 ' N ' HD21 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -45.91 -28.04 1.03 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 105' ' ' THR . . . -60.66 -55.22 35.87 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.651 ' CE2' ' CE1' ' A' ' 62' ' ' HIS . 69.6 m-85 -74.33 -3.65 31.53 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.56 ' CG ' HD11 ' A' ' 114' ' ' LEU . 44.9 m-85 -119.15 91.34 3.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.711 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.57 34.17 0.9 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.642 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.31 -71.78 0.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.114 -0.991 . . . . 0.0 109.696 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -173.0 125.85 1.19 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.584 HD21 ' N ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -90.78 125.09 35.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.381 -1.07 . . . . 0.0 110.121 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.566 HD12 ' ND2' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -129.35 166.99 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.558 ' CD1' ' O ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -149.65 112.4 4.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.084 -1.01 . . . . 0.0 109.56 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -96.15 -159.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.424 -0.797 . . . . 0.0 109.801 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -91.07 167.19 12.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.248 -0.907 . . . . 0.0 109.607 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.494 ' HA2' ' OD1' ' A' ' 43' ' ' ASP . . . -80.5 -163.89 29.83 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 62.19 139.52 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.824 HG13 ' N ' ' A' ' 122' ' ' ALA . 2.9 p -90.44 -145.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.219 -1.165 . . . . 0.0 108.673 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.824 ' N ' HG13 ' A' ' 121' ' ' VAL . . . -46.3 -86.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 0.0 109.537 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 122' ' ' ALA . 1.0 OUTLIER 165.04 -41.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.935 . . . . 0.0 109.539 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' A' ' 126' ' ' LYS . . . -112.15 -57.52 0.45 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 39.5 mmm -49.53 144.51 5.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -1.123 . . . . 0.0 109.549 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.484 ' CG ' ' OXT' ' A' ' 126' ' ' LYS . 2.2 ptmt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.497 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 2' ' ' GLU . 1.3 t . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.475 ' H ' HG12 ' A' ' 1' ' ' VAL . 1.5 pt-20 -44.41 126.25 5.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.479 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.727 HD13 ' HB3' ' A' ' 80' ' ' TYR . 0.7 OUTLIER -85.06 14.71 4.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.575 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 5.9 p -92.51 152.22 19.77 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.668 -1.27 . . . . 0.0 109.902 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 4' ' ' SER . 0.1 OUTLIER 80.5 -69.69 0.09 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.71 . . . . 0.0 110.742 178.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.522 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 13.8 ttmt -81.98 16.44 1.9 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.05 -1.031 . . . . 0.0 110.663 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.626 ' HB ' ' O ' ' A' ' 3' ' ' LEU . 51.6 t -158.69 -59.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.917 -1.115 . . . . 0.0 109.825 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.667 ' HA ' HD12 ' A' ' 11' ' ' LEU . 77.4 p -60.55 -13.32 13.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 109.813 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.79 -20.45 6.03 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.537 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 1.7 pttm -170.99 -33.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -1.141 . . . . 0.0 109.772 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.787 HD21 ' SD ' ' A' ' 84' ' ' MET . 0.2 OUTLIER 69.56 -0.4 2.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.39 -0.819 . . . . 0.0 110.093 -179.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 11' ' ' LEU . 32.3 m-20 58.63 135.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.109 -0.994 . . . . 0.0 110.201 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.732 ' O ' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -56.59 -19.27 15.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.044 -1.035 . . . . 0.0 108.587 179.235 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 13' ' ' LYS . 13.8 t 44.99 18.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.916 -0.49 . . . . 0.0 111.925 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.629 HG23 ' HD2' ' A' ' 16' ' ' PRO . 0.5 OUTLIER 47.62 -177.17 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.015 -1.053 . . . . 0.0 108.599 179.435 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HD2' HG23 ' A' ' 15' ' ' THR . 34.9 Cg_endo -80.32 90.11 1.26 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.908 1.739 . . . . 0.0 110.32 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.528 ' O ' ' CG2' ' A' ' 18' ' ' ILE . . . -164.3 -120.89 0.54 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.908 HD12 HD11 ' A' ' 47' ' ' LEU . 19.9 pt -160.5 -165.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -1.188 . . . . 0.0 110.232 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.492 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 2.5 mt-30 -170.78 172.95 5.48 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.728 HD11 ' CZ ' ' A' ' 110' ' ' PHE . 18.5 mt -145.88 168.15 7.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.401 -1.437 . . . . 0.0 110.352 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.636 ' HA ' HG23 ' A' ' 31' ' ' VAL . 7.4 m-90 -133.97 118.83 18.31 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.773 ' HG3' HG22 ' A' ' 31' ' ' VAL . 14.4 mtm180 -79.15 121.2 24.72 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.219 -0.926 . . . . 0.0 110.921 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.636 ' CG2' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -101.98 27.48 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.123 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.537 ' HB2' ' CG2' ' A' ' 121' ' ' VAL . 1.3 pt-20 -58.62 179.13 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.375 -0.828 . . . . 0.0 109.421 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' CG ' ' A' ' 27' ' ' GLU . 8.4 p30 42.14 27.47 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.463 ' N ' ' O ' ' A' ' 24' ' ' GLU . 26.9 mmm 54.71 55.27 8.08 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.489 -0.757 . . . . 0.0 109.765 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 70.1 mm-40 -153.47 -134.36 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.117 -0.99 . . . . 0.0 109.356 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.57 ' HE2' ' CD1' ' A' ' 21' ' ' TRP . 3.1 ttt -160.04 149.74 18.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.898 -1.126 . . . . 0.0 109.316 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.561 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -160.16 149.36 14.07 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.099 -1.0 . . . . 0.0 109.587 -179.559 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HD2' HG13 ' A' ' 29' ' ' VAL . 34.6 Cg_endo -76.43 125.88 8.67 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.534 2.156 . . . . 0.0 111.109 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.773 HG22 ' HG3' ' A' ' 22' ' ' ARG . 5.8 t -111.24 105.61 57.02 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.63 -158.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.44 2.093 . . . . 0.0 110.4 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.561 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -81.86 -18.91 42.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 108.952 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.16 32.33 0.76 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.345 -0.847 . . . . 0.0 109.706 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.525 ' HB3' HG13 ' A' ' 31' ' ' VAL . 1.7 m -155.07 -38.8 0.09 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.95 . . . . 0.0 109.624 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.563 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -45.55 129.47 8.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.469 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.34 -77.09 0.39 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.507 ' HA ' HG22 ' A' ' 115' ' ' ILE . 4.4 m-80 -89.1 106.79 18.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -1.165 . . . . 0.0 109.673 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.701 ' HZ ' HD22 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -135.92 137.08 41.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.233 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.68 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 7.2 m-30 -42.33 151.95 0.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.285 -0.885 . . . . 0.0 109.508 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.557 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 12.1 pt-20 -90.93 -37.98 13.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.171 -0.956 . . . . 0.0 109.784 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.626 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -85.69 66.46 3.75 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.193 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -162.91 -150.28 0.16 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.025 -1.28 . . . . 0.0 110.31 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.497 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 34.6 m -139.0 148.1 43.01 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 28.2 m-85 -145.36 109.23 4.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.015 -1.053 . . . . 0.0 109.717 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.605 HG13 ' OG1' ' A' ' 81' ' ' THR . 98.8 t -79.37 122.6 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.999 -1.063 . . . . 0.0 108.549 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.908 HD11 HD12 ' A' ' 18' ' ' ILE . 6.6 tt -108.1 123.5 48.8 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.256 -0.903 . . . . 0.0 110.168 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.579 ' CD2' HD23 ' A' ' 11' ' ' LEU . 24.0 tp -104.55 100.24 9.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.846 -1.159 . . . . 0.0 109.864 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.491 ' OG ' HG22 ' A' ' 18' ' ' ILE . 10.8 t -83.41 127.21 33.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 108.757 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.655 ' CG2' ' CE1' ' A' ' 57' ' ' PHE . 1.2 m -123.02 114.32 20.24 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -116.6 126.59 53.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.269 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.89 ' O ' HG23 ' A' ' 53' ' ' THR . 11.4 pttm -51.52 -176.86 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.329 -0.857 . . . . 0.0 109.325 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -178.72 153.47 0.68 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.444 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 53' ' ' THR . . . -44.2 -26.83 0.99 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.17 -40.49 14.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -1.092 . . . . 0.0 109.41 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.72 -70.29 0.2 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.655 ' CE1' ' CG2' ' A' ' 50' ' ' THR . 0.1 OUTLIER -139.81 175.63 9.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -1.138 . . . . 0.0 111.196 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.66 89.34 1.68 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.589 ' CE1' ' HB3' ' A' ' 57' ' ' PHE . 6.5 m-85 -78.74 157.2 28.57 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.135 0.969 . . . . 0.0 111.32 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.572 ' O ' ' CD2' ' A' ' 62' ' ' HIS . 7.7 m-80 -151.54 87.6 1.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 1.034 ' CG2' HG23 ' A' ' 81' ' ' THR . 10.3 mt -71.2 140.71 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.295 -0.878 . . . . 0.0 110.4 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.648 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 55.4 m-70 -125.99 160.18 30.72 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 95' ' ' HIS . 50.6 p90 -134.85 96.18 3.48 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 117.979 -1.489 . . . . 0.0 109.887 177.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.599 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 6.0 t90 -74.18 131.74 41.54 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.613 HD11 ' CG ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -121.55 60.96 0.94 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.287 -0.883 . . . . 0.0 111.039 -178.078 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -49.07 90.46 0.01 OUTLIER Glycine 0 N--CA 1.498 2.786 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.59 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -38.43 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.13 0.967 . . . . 0.0 112.61 -177.432 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.626 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 2.7 m-80 -162.61 -45.73 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.486 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 96.3 p -59.34 -156.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.517 -0.739 . . . . 0.0 109.276 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 p -109.34 160.7 15.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -45.44 19.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 109.381 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -57.92 -41.74 83.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.141 -0.974 . . . . 0.0 109.361 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.486 ' HG2' ' HB2' ' A' ' 69' ' ' SER . 3.9 tp10 -54.54 -39.77 68.01 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.613 ' CG ' HD11 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -60.43 -37.69 81.71 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.605 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -70.67 -23.57 77.65 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 77' ' ' ALA . . . -75.71 -67.21 0.69 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.313 -1.11 . . . . 0.0 109.192 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -45.35 -38.09 5.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 0.0 109.301 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.64 -39.91 73.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.665 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.605 HD12 ' O ' ' A' ' 75' ' ' GLY . 17.9 mt -60.83 -48.69 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 0.0 109.5 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.727 ' HB3' HD13 ' A' ' 3' ' ' LEU . 25.5 m-85 -56.92 -42.46 80.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.042 -1.036 . . . . 0.0 108.968 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 1.034 HG23 ' CG2' ' A' ' 61' ' ' ILE . 6.4 m -68.72 -23.65 64.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.485 -0.76 . . . . 0.0 109.141 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.3 m -78.57 -23.59 45.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.452 -0.78 . . . . 0.0 109.46 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 5.1 mt-30 -89.91 -34.5 16.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.671 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.803 ' HB2' HD13 ' A' ' 61' ' ' ILE . 2.4 mtt -63.14 -47.05 84.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.696 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.671 ' N ' HD11 ' A' ' 61' ' ' ILE . 3.1 t70 -50.73 -54.98 18.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.721 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.69 -12.21 59.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.717 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 4.1 m-30 -97.23 -2.92 41.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.609 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.689 HD21 HD22 ' A' ' 11' ' ' LEU . 3.9 mt -108.43 8.23 27.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.55 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 105.59 3.1 40.52 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 1.3 p 75.38 -0.09 3.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -1.174 . . . . 0.0 109.644 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.536 HG23 ' CD2' ' A' ' 59' ' ' TYR . 4.7 m -87.23 15.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.114 -0.991 . . . . 0.0 109.389 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.584 ' HB3' ' HA ' ' A' ' 85' ' ' ASP . . . -100.03 179.33 4.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.586 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.655 HG12 ' H ' ' A' ' 94' ' ' GLN . 4.6 t -135.24 175.86 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.12 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.655 ' H ' HG12 ' A' ' 93' ' ' VAL . 50.4 tt0 -124.91 131.04 53.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.972 -1.08 . . . . 0.0 109.504 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.648 ' CD2' ' CE1' ' A' ' 62' ' ' HIS . 20.2 m-70 -130.21 150.02 51.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.8 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.578 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 8.6 ptm180 -109.79 136.02 49.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.369 -0.832 . . . . 0.0 109.801 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.497 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 7.4 mm-40 -139.77 166.21 25.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.263 -0.898 . . . . 0.0 109.595 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.71 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.7 t -155.58 -176.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.354 -0.841 . . . . 0.0 109.2 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.71 ' H ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -67.63 -4.52 12.18 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.966 -1.084 . . . . 0.0 110.335 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.08 14.38 3.06 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.538 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 51.8 m-70 -123.01 -20.96 5.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.57 -0.959 . . . . 0.0 109.725 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.599 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.1 OUTLIER -90.28 8.85 31.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.341 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 107' ' ' ARG . 1.0 OUTLIER -56.79 -63.03 1.34 Allowed 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.162 -0.961 . . . . 0.0 111.225 -178.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.662 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 3.6 mt-10 -76.5 -55.6 5.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.967 -1.083 . . . . 0.0 111.748 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -61.26 -52.64 63.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.97 -1.082 . . . . 0.0 111.113 -178.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.568 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -64.98 -55.0 21.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.968 -1.082 . . . . 0.0 108.914 -178.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' A' ' 103' ' ' SER . 2.3 ttm180 -61.51 -17.26 53.9 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.179 -0.951 . . . . 0.0 108.661 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.662 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -66.14 -59.81 3.41 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.906 ' HB3' HD13 ' A' ' 18' ' ' ILE . 9.2 m-85 -63.43 -16.19 59.83 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 1.064 ' CG ' HD21 ' A' ' 114' ' ' LEU . 43.7 m-85 -108.22 99.51 8.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.474 -0.766 . . . . 0.0 109.536 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -74.77 1.59 12.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.286 -0.883 . . . . 0.0 109.702 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.78 -81.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.066 -1.021 . . . . 0.0 109.822 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' A' ' 114' ' ' LEU . . . 178.04 -29.99 0.07 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 1.064 HD21 ' CG ' ' A' ' 110' ' ' PHE . 33.3 mt 81.75 109.33 0.07 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.589 -0.948 . . . . 0.0 110.284 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.563 HG23 ' N ' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -91.03 172.15 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.563 ' N ' HG23 ' A' ' 115' ' ' ILE . 1.4 m-85 -150.04 124.88 9.85 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.024 -1.047 . . . . 0.0 109.981 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.68 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -106.4 -164.89 1.04 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.471 -0.768 . . . . 0.0 109.31 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.579 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 1.6 tp60 -91.56 163.03 14.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.879 -1.138 . . . . 0.0 110.165 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 120' ' ' GLY . . . -76.56 -153.68 5.16 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 52.69 101.46 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.537 ' CG2' ' HB2' ' A' ' 24' ' ' GLU . 1.5 t -90.27 -141.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.17 -1.194 . . . . 0.0 109.253 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.39 -33.21 73.84 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.334 -0.854 . . . . 0.0 109.52 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.9 m -104.02 36.85 2.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.86 . . . . 0.0 109.402 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -107.87 -54.66 0.63 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.26 167.63 19.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -1.151 . . . . 0.0 109.49 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.6 mttm . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.416 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 2' ' ' GLU . 29.1 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 2' ' ' GLU . 18.0 pt-20 32.98 93.99 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.428 0.632 . . . . 0.0 110.462 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.639 HD23 ' N ' ' A' ' 3' ' ' LEU . 2.6 pt? -53.8 -33.25 55.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 109.505 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.624 ' HA ' HG23 ' A' ' 8' ' ' THR . 10.7 t -44.53 146.08 0.77 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 4' ' ' SER . 10.9 tttt 80.24 -71.84 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.63 -0.669 . . . . 0.0 109.96 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -84.73 15.76 3.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 109.985 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.526 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 12.0 t -150.56 -65.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.016 -1.052 . . . . 0.0 109.716 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.655 ' HA ' HD21 ' A' ' 11' ' ' LEU . 70.3 p -50.01 -23.19 1.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.4 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 10' ' ' LYS . . . -89.58 33.11 4.49 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.487 ' O ' ' CG ' ' A' ' 10' ' ' LYS . 2.4 tttm 169.28 70.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -1.069 . . . . 0.0 109.17 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.655 HD21 ' HA ' ' A' ' 8' ' ' THR . 4.3 mm? -94.47 74.0 3.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.375 -0.828 . . . . 0.0 109.414 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 13' ' ' LYS . 6.2 t70 62.16 -91.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 109.376 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER 62.37 124.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.954 . . . . 0.0 109.631 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.596 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 22.4 p 48.36 56.99 6.67 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.349 -0.844 . . . . 0.0 109.604 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.436 ' HB ' ' CG ' ' A' ' 12' ' ' ASP . 21.1 m -167.48 102.34 0.6 Allowed Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.417 -0.802 . . . . 0.0 109.414 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.95 99.8 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.423 2.082 . . . . 0.0 110.277 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.455 ' O ' ' CG2' ' A' ' 18' ' ' ILE . . . 179.54 -139.14 3.73 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.018 HD12 HD11 ' A' ' 47' ' ' LEU . 12.3 pt -157.41 142.46 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.049 -1.265 . . . . 0.0 110.1 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.447 ' NE2' ' CZ2' ' A' ' 21' ' ' TRP . 1.1 tt0 -122.24 114.44 20.83 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.588 HD11 ' CE1' ' A' ' 110' ' ' PHE . 2.9 mt -92.49 164.04 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.757 -1.214 . . . . 0.0 109.67 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.681 ' CB ' ' HE3' ' A' ' 28' ' ' MET . 8.3 m-90 -122.01 126.42 48.48 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.596 ' HA ' ' CD1' ' A' ' 45' ' ' TYR . 0.9 OUTLIER -79.23 132.66 36.57 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.177 0.989 . . . . 0.0 111.74 -176.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' A' ' 44' ' ' CYS . 2.2 mm -127.27 44.26 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.547 ' HB2' ' CD2' ' A' ' 40' ' ' TYR . 3.2 pm0 -99.81 -40.12 7.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 0.0 110.049 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.521 ' OD1' ' CG ' ' A' ' 27' ' ' GLU . 3.0 p30 -81.97 10.08 7.15 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.132 -0.98 . . . . 0.0 108.677 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.517 ' CE ' ' OG ' ' A' ' 70' ' ' SER . 53.9 mmm 73.08 29.0 1.83 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.521 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 47.6 mt-10 -150.79 103.02 3.04 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.681 ' HE3' ' CB ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -42.29 138.02 1.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 110.173 -179.219 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -139.71 149.37 59.26 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HD2' HG13 ' A' ' 29' ' ' VAL . 35.7 Cg_endo -78.68 82.61 2.44 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.225 1.95 . . . . 0.0 111.737 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.572 ' CG2' ' N ' ' A' ' 22' ' ' ARG . 2.8 t -69.9 112.93 14.01 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.18 -0.95 . . . . 0.0 109.887 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.488 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 36.2 Cg_endo -78.7 -158.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.486 2.124 . . . . 0.0 110.044 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.572 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -90.0 -16.29 30.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.083 -1.01 . . . . 0.0 109.152 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.488 ' HG3' ' HG2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -75.39 -20.31 59.02 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -0.873 . . . . 0.0 109.874 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.0 m -122.96 13.12 9.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.12 -0.988 . . . . 0.0 109.734 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.58 ' CG ' ' O ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -85.05 49.88 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.985 . . . . 0.0 109.914 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.568 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . -137.65 -82.71 0.11 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.542 ' HA ' HG22 ' A' ' 115' ' ' ILE . 4.2 m-80 -81.46 123.96 29.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -1.135 . . . . 0.0 109.58 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.695 ' CZ ' HD22 ' A' ' 114' ' ' LEU . 2.7 p90 -160.24 141.08 12.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.013 . . . . 0.0 110.087 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.691 ' CE2' HG23 ' A' ' 121' ' ' VAL . 5.4 m-30 -39.6 142.9 0.26 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.355 -0.841 . . . . 0.0 110.767 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 15.7 pt-20 -90.66 -38.86 12.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 109.363 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.589 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -83.43 70.97 3.08 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.484 ' OD1' ' HB3' ' A' ' 40' ' ' TYR . 4.9 m-20 -160.66 -132.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.719 -0.871 . . . . 0.0 109.122 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.58 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 57.9 m -156.66 148.77 23.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.988 -1.07 . . . . 0.0 108.599 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.649 ' CZ ' ' HB2' ' A' ' 39' ' ' PHE . 17.2 m-85 -147.57 111.06 4.94 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.353 -0.842 . . . . 0.0 109.575 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.789 HG13 ' OG1' ' A' ' 81' ' ' THR . 4.0 t -79.59 112.21 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.994 -1.066 . . . . 0.0 108.152 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.018 HD11 HD12 ' A' ' 18' ' ' ILE . 7.3 tt -102.97 114.59 29.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.83 -1.168 . . . . 0.0 110.331 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.642 HD11 ' HB3' ' A' ' 59' ' ' TYR . 16.5 tp -99.99 109.89 22.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.237 -0.914 . . . . 0.0 109.195 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 t -97.12 134.28 40.67 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.39 -0.819 . . . . 0.0 109.641 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.53 ' OG1' ' CD1' ' A' ' 59' ' ' TYR . 1.2 m -120.52 135.95 54.92 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.14 155.42 37.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.627 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.511 ' O ' ' CG2' ' A' ' 53' ' ' THR . 0.0 OUTLIER -91.42 155.63 18.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 109.458 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 52' ' ' LYS . 68.9 p -158.83 175.61 13.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 0.0 109.449 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.38 -22.01 71.48 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.13 -52.99 5.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -1.173 . . . . 0.0 109.477 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.06 -97.28 0.11 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.596 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 18.2 m-85 -145.35 156.23 43.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -1.143 . . . . 0.0 109.526 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.0 m -121.89 99.53 6.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.871 . . . . 0.0 108.914 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 1.014 ' CD2' HD22 ' A' ' 88' ' ' LEU . 17.3 m-30 -81.77 158.23 24.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 110.209 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.558 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 8.0 m-20 -150.43 90.38 1.65 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.996 ' CG2' HG23 ' A' ' 81' ' ' THR . 11.7 mt -77.51 135.52 26.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.231 -0.918 . . . . 0.0 110.291 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.682 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 55.9 m-70 -122.48 159.56 27.39 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.622 ' CZ ' ' HA ' ' A' ' 96' ' ' ARG . 49.4 p90 -135.52 93.26 2.94 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.92 -1.512 . . . . 0.0 110.099 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.74 ' C ' HD23 ' A' ' 65' ' ' LEU . 5.7 t90 -73.91 119.17 17.75 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.789 HD13 ' HB2' ' A' ' 74' ' ' GLN . 0.2 OUTLIER -110.33 77.41 1.05 Allowed 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.568 -0.707 . . . . 0.0 111.158 -177.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' A' ' 99' ' ' GLN . . . -65.7 86.88 0.1 OUTLIER Glycine 0 N--CA 1.494 2.559 0 N-CA-C 107.751 -2.14 . . . . 0.0 107.751 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.478 ' O ' ' OD1' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -52.68 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.798 0.808 . . . . 0.0 112.617 -177.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.589 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 10.1 m120 -160.29 -39.1 0.05 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 70' ' ' SER . 11.7 p -71.72 -145.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 109.297 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.517 ' OG ' ' CE ' ' A' ' 26' ' ' MET . 16.8 p -88.62 142.41 27.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 0.0 109.956 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.505 ' CG ' ' OE1' ' A' ' 74' ' ' GLN . 5.5 tt0 -50.78 -46.92 59.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.299 -0.875 . . . . 0.0 109.018 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.93 -38.5 67.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.217 -0.927 . . . . 0.0 109.026 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.537 ' HG3' HG22 ' A' ' 23' ' ' ILE . 1.4 tp10 -56.84 -38.58 72.85 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.789 ' HB2' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -62.45 -35.89 80.7 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.651 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -80.19 -13.64 81.63 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -79.86 -44.25 20.83 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.299 -1.118 . . . . 0.0 108.706 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.12 -44.52 75.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 108.979 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.2 -48.94 71.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.424 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.651 HD12 ' O ' ' A' ' 75' ' ' GLY . 64.6 mt -55.5 -43.97 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.96 . . . . 0.0 109.474 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.568 ' CD2' ' SD ' ' A' ' 28' ' ' MET . 4.5 m-85 -63.35 -32.09 73.42 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.102 -0.999 . . . . 0.0 108.731 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.996 HG23 ' CG2' ' A' ' 61' ' ' ILE . 8.7 m -66.92 -24.8 66.13 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.5 m -84.48 -29.96 25.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.531 -0.73 . . . . 0.0 109.166 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.509 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 1.9 mt-30 -71.45 -38.03 71.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 109.514 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.586 ' HG3' HD13 ' A' ' 61' ' ' ILE . 4.2 ptm -82.38 -33.11 28.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.46 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.53 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 9.2 t0 -59.7 -28.89 67.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 0.0 109.299 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -90.08 -36.83 14.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.872 . . . . 0.0 109.454 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.509 ' CD1' ' O ' ' A' ' 83' ' ' GLN . 5.6 m-85 -71.33 -8.45 53.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 109.565 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 1.014 HD22 ' CD2' ' A' ' 59' ' ' TYR . 20.3 mt -84.98 -14.17 48.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.539 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 90' ' ' SER . . . 100.67 18.22 21.36 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 89' ' ' GLY . 0.3 OUTLIER 73.29 6.77 5.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -1.108 . . . . 0.0 109.606 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.4 m -85.07 -14.95 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.122 -0.986 . . . . 0.0 109.464 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.899 ' HB2' HD13 ' A' ' 88' ' ' LEU . . . -90.14 172.87 8.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 109.546 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.649 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.5 t -128.38 176.14 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 109.312 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.649 ' H ' HG12 ' A' ' 93' ' ' VAL . 33.2 tt0 -122.82 133.48 54.44 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.096 -1.002 . . . . 0.0 109.006 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.682 ' CD2' ' CE1' ' A' ' 62' ' ' HIS . 29.1 m-70 -126.83 141.74 51.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.125 -0.984 . . . . 0.0 110.145 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -89.34 120.02 30.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 109.792 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.603 ' HB2' ' HA ' ' A' ' 64' ' ' TRP . 26.9 mt-10 -127.74 156.72 41.98 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.276 -0.89 . . . . 0.0 108.845 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.697 HG12 ' H ' ' A' ' 99' ' ' GLN . 3.0 t -160.11 -179.27 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.301 -0.875 . . . . 0.0 108.874 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.697 ' H ' HG12 ' A' ' 98' ' ' VAL . 28.8 tt0 -73.69 -3.27 27.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.938 -1.101 . . . . 0.0 109.198 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.56 6.21 3.85 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.629 ' CG ' ' CG2' ' A' ' 98' ' ' VAL . 10.9 m170 -109.45 -89.97 0.47 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.397 -1.061 . . . . 0.0 108.766 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -83.5 44.44 0.97 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.446 -0.784 . . . . 0.0 110.269 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -80.62 -61.5 1.95 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 108.698 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.516 ' N ' ' OG ' ' A' ' 103' ' ' SER . 28.2 tt0 -64.46 -47.27 79.67 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.754 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 40.8 m -49.57 -46.51 48.98 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.602 ' HB2' ' O ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -49.73 -65.14 0.61 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.611 ' CA ' HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -42.51 -35.01 0.94 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 105' ' ' THR . . . -52.13 -56.51 14.02 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.867 ' HB3' HD13 ' A' ' 18' ' ' ILE . 97.1 m-85 -56.41 -28.34 59.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.902 . . . . 0.0 108.576 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.635 ' CD2' HD11 ' A' ' 114' ' ' LEU . 87.6 m-85 -88.02 90.38 8.36 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -74.06 -0.14 15.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.438 -0.789 . . . . 0.0 109.923 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -96.85 -85.46 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.109 -0.994 . . . . 0.0 109.594 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -164.22 123.07 1.14 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.695 HD22 ' CZ ' ' A' ' 39' ' ' PHE . 4.4 mt -92.15 145.28 24.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -1.159 . . . . 0.0 110.067 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.542 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -140.29 169.79 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.571 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 1.0 OUTLIER -147.45 139.34 24.19 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.926 -1.109 . . . . 0.0 110.137 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.425 ' HB2' ' HD1' ' A' ' 40' ' ' TYR . 2.0 mptp? -114.71 -168.25 1.35 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.512 -0.742 . . . . 0.0 109.235 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.583 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 1.1 pm0 -90.92 163.41 14.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.015 -1.053 . . . . 0.0 110.561 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.629 ' HA2' ' CD2' ' A' ' 40' ' ' TYR . . . -93.28 178.67 38.75 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.22 52.8 1.55 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.691 HG23 ' CE2' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -90.01 10.08 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.132 -1.216 . . . . 0.0 109.103 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.24 -23.42 21.24 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.179 -0.95 . . . . 0.0 109.484 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 86.6 p -119.93 32.02 6.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.325 -0.859 . . . . 0.0 109.507 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.22 -80.38 1.46 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.5 mtt -84.48 144.51 28.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -1.137 . . . . 0.0 109.471 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.51 -179.958 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.548 HG22 ' H ' ' A' ' 2' ' ' GLU . 9.7 p . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 80' ' ' TYR . 14.6 pt-20 -43.28 123.21 2.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.349 -0.844 . . . . 0.0 109.639 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.763 HD12 ' HB ' ' A' ' 8' ' ' THR . 1.7 pt? -43.78 133.78 4.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.102 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.604 ' O ' HG22 ' A' ' 8' ' ' THR . 74.4 m -89.23 -176.26 5.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 110.146 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.548 ' CB ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -72.2 -31.26 65.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.372 -0.83 . . . . 0.0 109.147 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -76.93 -28.68 55.33 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 3' ' ' LEU . 1.8 t -70.8 -62.29 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.763 ' HB ' HD12 ' A' ' 3' ' ' LEU . 0.7 OUTLIER -90.32 12.56 17.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.275 -0.891 . . . . 0.0 109.494 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 5' ' ' LYS . . . -70.56 -105.29 0.04 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 11' ' ' LEU . 10.6 mttm -65.23 -29.28 70.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -1.098 . . . . 0.0 109.431 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.893 ' HB3' HD23 ' A' ' 48' ' ' LEU . 4.0 mt 44.34 57.13 4.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.403 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.467 ' HB2' ' NE2' ' A' ' 19' ' ' GLN . 0.3 OUTLIER 68.15 137.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.297 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.448 ' O ' ' OG1' ' A' ' 14' ' ' THR . 26.1 mmtt -142.04 149.7 40.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.659 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 80.5 p 50.09 58.04 5.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.476 -0.765 . . . . 0.0 109.768 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.7 m -171.64 120.82 0.47 Allowed Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.468 -0.77 . . . . 0.0 109.092 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.0 128.18 9.79 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.31 2.007 . . . . 0.0 110.348 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 147.19 169.5 14.71 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.775 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -123.8 155.47 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.011 -1.287 . . . . 0.0 110.159 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.532 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 16.5 mt-30 -115.17 158.3 22.43 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.797 HD11 ' CZ ' ' A' ' 110' ' ' PHE . 4.0 mt -129.02 153.52 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.763 -1.21 . . . . 0.0 110.369 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.869 ' HA ' HG23 ' A' ' 31' ' ' VAL . 9.2 m-90 -115.42 132.54 56.59 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.727 ' CD ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -90.22 128.03 36.28 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.832 -1.167 . . . . 0.0 111.84 -177.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.646 HD13 ' HA ' ' A' ' 28' ' ' MET . 5.0 mm -99.69 56.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 177.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.512 ' O ' ' HA3' ' A' ' 120' ' ' GLY . 0.0 OUTLIER -48.44 -106.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.347 -177.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.561 ' O ' ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -45.43 -77.69 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.917 -1.114 . . . . 0.0 108.3 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.587 ' CE ' ' CB ' ' A' ' 69' ' ' SER . 13.2 mmt -163.29 36.85 0.09 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 74.8 mt-10 -141.4 145.42 35.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.343 -0.848 . . . . 0.0 109.367 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.945 ' HE3' HG21 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -73.46 139.01 45.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.253 -0.904 . . . . 0.0 110.238 -179.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.928 HG13 ' HD2' ' A' ' 30' ' ' PRO . 1.9 t -138.43 154.96 74.0 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.928 ' HD2' HG13 ' A' ' 29' ' ' VAL . 35.1 Cg_endo -77.37 125.52 7.79 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.316 2.011 . . . . 0.0 111.668 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.869 HG23 ' HA ' ' A' ' 21' ' ' TRP . 1.4 t -118.33 97.8 50.97 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.6 -154.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.676 2.25 . . . . 0.0 110.113 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.596 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -77.51 2.88 14.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.104 -0.997 . . . . 0.0 109.322 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -66.0 -35.44 80.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.142 -0.973 . . . . 0.0 110.307 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.13 68.39 0.38 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.945 -1.097 . . . . 0.0 110.38 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.596 ' CD2' ' HA ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -90.47 39.57 0.98 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.046 -1.034 . . . . 0.0 109.86 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.486 ' HA2' ' CE2' ' A' ' 39' ' ' PHE . . . -144.6 -50.48 0.03 OUTLIER Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.206 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.555 ' HA ' HG22 ' A' ' 115' ' ' ILE . 1.7 m-80 -79.73 93.92 5.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.093 -1.239 . . . . 0.0 109.57 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.72 ' HZ ' HD13 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -129.76 128.83 43.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.508 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.652 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 64.5 m-85 -39.14 124.78 1.52 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.56 -0.713 . . . . 0.0 110.613 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.619 ' HA ' ' CH2' ' A' ' 64' ' ' TRP . 2.7 pt-20 -80.63 -0.14 36.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.281 -0.887 . . . . 0.0 109.303 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.579 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -124.61 54.97 0.72 Allowed Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.477 ' HA ' ' OE1' ' A' ' 73' ' ' GLU . 7.9 m-20 -160.15 -123.99 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.296 -1.12 . . . . 0.0 109.186 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.614 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 92.0 m -153.28 155.42 36.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.88 -1.137 . . . . 0.0 109.568 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.659 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 31.0 m-85 -155.03 116.62 4.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.359 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.945 HG21 ' HE3' ' A' ' 28' ' ' MET . 47.9 t -78.08 160.44 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.695 -1.253 . . . . 0.0 108.141 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.807 ' O ' HD23 ' A' ' 47' ' ' LEU . 7.2 tt -153.76 106.48 2.88 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.496 -1.378 . . . . 0.0 110.12 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.893 HD23 ' HB3' ' A' ' 11' ' ' LEU . 13.1 tp -95.99 109.15 21.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.597 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.766 ' OG ' HG22 ' A' ' 18' ' ' ILE . 12.9 t -98.89 133.5 43.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.334 -0.854 . . . . 0.0 109.644 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.2 m -122.17 142.31 50.54 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.502 ' HG2' ' N ' ' A' ' 52' ' ' LYS . 7.6 ttt180 -142.82 147.78 36.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 109.494 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.56 ' O ' HG23 ' A' ' 53' ' ' THR . 0.0 OUTLIER -80.99 163.41 23.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.979 . . . . 0.0 109.608 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 52' ' ' LYS . 1.5 p -157.97 -168.58 2.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.293 -0.879 . . . . 0.0 109.489 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.22 -41.0 32.53 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 56' ' ' GLY . 1.1 p -79.84 -59.15 2.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -1.184 . . . . 0.0 109.469 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.513 ' N ' ' OG ' ' A' ' 55' ' ' SER . . . -157.09 -129.2 1.11 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.566 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 5.0 m-30 -103.31 -169.72 1.69 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -1.159 . . . . 0.0 109.243 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.486 ' HA ' ' CG2' ' A' ' 91' ' ' VAL . 69.5 m -149.94 107.38 3.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.192 -0.943 . . . . 0.0 109.295 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.707 ' HB3' HD11 ' A' ' 48' ' ' LEU . 48.1 m-85 -89.16 158.09 18.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.207 -0.933 . . . . 0.0 109.805 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.577 ' OD1' ' CE1' ' A' ' 95' ' ' HIS . 6.8 m-20 -154.85 92.73 1.49 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.968 ' CG2' HG23 ' A' ' 81' ' ' THR . 9.9 mt -80.83 132.26 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.164 -0.96 . . . . 0.0 110.642 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.576 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 42.7 m-70 -119.57 162.35 19.08 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.832 ' CE2' HD11 ' A' ' 65' ' ' LEU . 49.5 p90 -136.7 94.08 2.94 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.339 -1.345 . . . . 0.0 109.674 176.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 1.083 ' O ' HD23 ' A' ' 65' ' ' LEU . 3.4 t90 -70.2 140.52 52.52 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.083 HD23 ' O ' ' A' ' 64' ' ' TRP . 8.1 mt -138.77 77.32 1.62 Allowed 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 118.532 -1.267 . . . . 0.0 111.144 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 41' ' ' GLU . . . -54.81 90.04 0.01 OUTLIER Glycine 0 C--N 1.275 -2.85 0 N-CA-C 106.9 -2.48 . . . . 0.0 106.9 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.732 ' HE3' HG11 ' A' ' 98' ' ' VAL . 9.5 ptpt -51.45 98.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.379 1.085 . . . . 0.0 112.185 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.579 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 13.7 m120 -160.15 -41.22 0.05 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.587 ' CB ' ' CE ' ' A' ' 26' ' ' MET . 81.9 p -67.22 -144.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.522 -0.736 . . . . 0.0 109.036 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.445 ' OG ' ' OD2' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -115.74 163.0 16.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.024 -1.048 . . . . 0.0 109.777 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -49.83 -32.07 13.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.25 -0.906 . . . . 0.0 109.156 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 3.0 p30 -60.35 -45.53 93.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.144 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 15.2 tt0 -56.91 -37.11 70.98 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 1.008 ' HG2' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -62.24 -35.85 80.21 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.641 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -81.65 -12.98 80.87 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.58 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -77.5 -52.6 8.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.294 -1.121 . . . . 0.0 108.955 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.568 ' CB ' ' HB3' ' A' ' 44' ' ' CYS . . . -75.88 -38.82 57.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.913 . . . . 0.0 109.1 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.83 94.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.301 -0.874 . . . . 0.0 109.229 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.641 HD12 ' O ' ' A' ' 75' ' ' GLY . 65.4 mt -71.6 -43.67 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.248 -0.908 . . . . 0.0 109.266 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.638 ' CD2' ' CB ' ' A' ' 28' ' ' MET . 3.4 m-85 -57.97 -35.47 71.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.122 -0.986 . . . . 0.0 108.867 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.968 HG23 ' CG2' ' A' ' 61' ' ' ILE . 18.1 m -67.51 -38.77 84.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.403 -0.811 . . . . 0.0 108.856 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.9 m -59.83 -42.86 94.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.844 . . . . 0.0 109.06 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.476 ' OE1' HD21 ' A' ' 3' ' ' LEU . 12.1 mt-30 -67.16 -28.47 68.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.264 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.536 ' HG2' HD12 ' A' ' 88' ' ' LEU . 17.8 ttm -63.08 -45.39 92.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.201 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.54 -15.28 25.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 108.994 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.18 -63.66 1.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.327 -0.858 . . . . 0.0 109.066 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.548 ' CE1' ' CB ' ' A' ' 5' ' ' LYS . 4.7 m-85 -53.93 -20.35 5.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 108.969 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.851 HD21 ' CD1' ' A' ' 11' ' ' LEU . 51.7 mt -90.15 -62.64 1.42 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -0.842 . . . . 0.0 109.196 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 57.22 62.3 6.51 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.3 p -143.64 -143.14 0.14 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.259 -1.142 . . . . 0.0 109.297 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.486 ' CG2' ' HA ' ' A' ' 58' ' ' SER . 11.6 m -92.18 15.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -52.23 173.01 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.693 -0.63 . . . . 0.0 109.826 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.9 t -147.63 177.09 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.524 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.672 ' H ' HG12 ' A' ' 93' ' ' VAL . 26.1 mt-30 -124.43 136.16 53.83 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.111 -0.993 . . . . 0.0 108.877 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.59 ' O ' ' CD1' ' A' ' 63' ' ' TYR . 18.0 m-70 -131.96 150.75 52.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.978 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.573 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 8.6 ttm180 -108.78 124.66 50.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.311 -0.868 . . . . 0.0 109.8 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.492 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 66.6 mm-40 -131.97 163.66 27.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.139 -0.975 . . . . 0.0 109.709 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.732 HG11 ' HE3' ' A' ' 67' ' ' LYS . 2.9 t -156.14 -176.95 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 108.977 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.707 ' H ' HG12 ' A' ' 98' ' ' VAL . 12.3 pt20 -66.23 -5.8 11.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.929 -1.107 . . . . 0.0 110.266 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.88 15.46 3.54 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.56 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 20.5 m-70 -122.57 -19.32 6.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.575 -0.956 . . . . 0.0 109.638 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.629 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.27 24.05 2.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.89 . . . . 0.0 109.508 -179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 102' ' ' GLU . 6.1 p -45.01 -106.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.494 -0.754 . . . . 0.0 111.863 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.812 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 40.6 mt-10 -71.39 -19.05 62.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.843 -1.16 . . . . 0.0 110.948 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.496 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 3.6 m -69.6 -50.9 40.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.897 -1.127 . . . . 0.0 109.605 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.558 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.3 OUTLIER -67.85 -57.26 6.56 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.89 -24.87 25.45 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.17 -0.956 . . . . 0.0 108.628 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.812 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -61.26 -58.36 8.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.38 -0.825 . . . . 0.0 108.823 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -68.33 -8.65 41.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -0.892 . . . . 0.0 109.236 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.797 ' CZ ' HD11 ' A' ' 20' ' ' ILE . 1.1 m-85 -113.47 96.73 6.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -88.56 60.39 5.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 109.697 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 111' ' ' LYS . 28.2 mm100 -153.34 -87.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.181 -0.949 . . . . 0.0 109.553 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.613 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -139.16 -113.47 1.12 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.72 HD13 ' HZ ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER 141.72 86.46 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.576 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -95.04 171.05 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 0.0 108.964 179.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.576 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -151.89 129.77 11.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.265 -0.897 . . . . 0.0 109.602 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.652 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -100.17 168.03 10.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.712 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 119' ' ' GLY . 10.6 pt20 -92.52 153.39 19.1 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.769 -1.207 . . . . 0.0 111.372 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.599 ' O ' ' CD1' ' A' ' 40' ' ' TYR . . . 52.1 164.62 0.01 OUTLIER Glycine 0 N--CA 1.498 2.807 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.57 ' O ' ' CE1' ' A' ' 40' ' ' TYR . . . -60.91 -123.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -90.28 12.99 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -1.139 . . . . 0.0 109.253 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.11 0.6 18.25 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.556 -0.715 . . . . 0.0 109.607 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.64 -21.24 2.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -0.952 . . . . 0.0 109.516 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -43.78 -43.38 6.62 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.89 -173.9 3.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -1.158 . . . . 0.0 109.436 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.1 pttm . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.448 180.0 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.945 HG13 ' HB3' ' A' ' 27' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 1' ' ' VAL . 1.5 mm-40 43.48 59.13 3.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.304 -0.872 . . . . 0.0 109.519 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.126 HD13 ' N ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -64.15 -13.89 51.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 109.695 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 1.126 ' N ' HD13 ' A' ' 3' ' ' LEU . 0.4 OUTLIER -78.21 168.33 20.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 109.791 -179.581 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 4' ' ' SER . 3.8 ttmm 81.39 -69.43 0.08 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.76 -0.588 . . . . 0.0 109.896 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -83.83 12.51 5.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.083 -1.011 . . . . 0.0 110.115 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.559 HG11 ' CZ2' ' A' ' 21' ' ' TRP . 35.0 t -145.52 -77.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.014 -1.054 . . . . 0.0 109.696 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.563 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 77.0 p -39.96 -28.08 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.471 -0.768 . . . . 0.0 109.952 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 7' ' ' VAL . . . -41.98 -59.64 2.84 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 3.3 mtmt -132.58 -29.08 1.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.178 -1.189 . . . . 0.0 110.218 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.999 HD22 HD21 ' A' ' 88' ' ' LEU . 3.1 mp 65.61 9.84 6.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.098 -1.001 . . . . 0.0 109.17 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 62.65 128.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.872 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.733 ' C ' HG22 ' A' ' 14' ' ' THR . 6.0 mmtt -96.43 169.02 10.2 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.733 HG22 ' C ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER 173.96 -83.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.592 -1.317 . . . . 0.0 111.218 -178.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.628 ' OG1' ' HD2' ' A' ' 16' ' ' PRO . 0.6 OUTLIER -161.97 -175.08 0.45 Allowed Pre-proline 0 C--N 1.284 -2.244 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.364 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.628 ' HD2' ' OG1' ' A' ' 15' ' ' THR . 33.3 Cg_endo -76.91 110.3 3.01 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.677 1.585 . . . . 0.0 111.28 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 49' ' ' SER . . . -161.47 -155.68 7.99 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.71 HG13 HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -160.92 154.56 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.734 -1.451 . . . . 0.0 110.523 179.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.513 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -133.82 -168.01 2.04 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.637 ' O ' HG23 ' A' ' 31' ' ' VAL . 55.9 mt -156.07 164.73 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.621 -1.3 . . . . 0.0 110.318 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.75 ' HA ' HG23 ' A' ' 31' ' ' VAL . 15.0 m-90 -124.48 119.0 27.9 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.58 ' HA ' ' CD2' ' A' ' 45' ' ' TYR . 29.8 ttp-105 -80.78 108.85 14.78 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.169 -0.957 . . . . 0.0 112.189 -176.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.799 HD11 ' SD ' ' A' ' 28' ' ' MET . 0.9 OUTLIER -86.57 93.45 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 176.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 26' ' ' MET . 1.4 pm0 -56.62 80.02 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.623 ' C ' ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER 41.22 13.64 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.694 -0.629 . . . . 0.0 111.415 -179.149 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.754 ' HE3' ' HA ' ' A' ' 26' ' ' MET . 0.0 OUTLIER -157.75 -76.72 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.271 -1.518 . . . . 0.0 111.142 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.945 ' HB3' HG13 ' A' ' 1' ' ' VAL . 0.4 OUTLIER -89.53 -147.06 0.17 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.167 -0.958 . . . . 0.0 110.776 -177.725 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.799 ' SD ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -144.14 146.62 32.88 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.559 0.695 . . . . 0.0 109.913 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.905 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -140.45 158.82 65.37 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.905 ' HD2' HG13 ' A' ' 29' ' ' VAL . 33.7 Cg_endo -75.33 137.9 21.59 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.32 2.014 . . . . 0.0 111.165 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.75 HG23 ' HA ' ' A' ' 21' ' ' TRP . 2.5 t -123.62 98.44 40.47 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 35' ' ' SER . 34.7 Cg_endo -76.57 -157.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.441 2.094 . . . . 0.0 110.177 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.522 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -83.06 -22.41 33.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.096 -1.002 . . . . 0.0 109.111 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -86.35 1.17 52.1 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.338 -0.851 . . . . 0.0 109.879 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.47 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -131.22 -25.53 2.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.153 -0.967 . . . . 0.0 110.373 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.683 ' CD2' ' CE2' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -68.95 -5.84 23.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.946 -1.096 . . . . 0.0 109.81 -179.57 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.512 ' N ' ' CD1' ' A' ' 36' ' ' TYR . . . -85.67 -4.46 85.27 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.507 ' HB3' ' CG2' ' A' ' 115' ' ' ILE . 17.0 m-80 -153.59 103.06 2.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.133 -1.216 . . . . 0.0 109.57 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.62 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -123.46 131.73 53.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.059 -1.026 . . . . 0.0 109.598 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.625 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 6.6 m-30 -39.53 152.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.544 -0.723 . . . . 0.0 110.148 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 12.4 pt-20 -89.67 -45.09 9.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 109.237 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.631 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -82.58 69.93 3.26 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 25' ' ' ASN . 10.9 m-20 -164.97 -166.39 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.91 -1.347 . . . . 0.0 111.1 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.563 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 1.7 m -127.37 156.87 41.34 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.62 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 30.9 m-85 -147.26 167.97 22.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.172 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.645 HG13 ' OG1' ' A' ' 81' ' ' THR . 99.3 t -132.45 113.31 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.71 HD11 HG13 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -90.13 155.15 19.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.174 -178.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.7 HD21 HD23 ' A' ' 11' ' ' LEU . 27.4 tp -146.5 85.9 1.66 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.564 ' CB ' ' HB ' ' A' ' 18' ' ' ILE . 1.0 OUTLIER -87.5 117.38 26.26 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 122.173 0.987 . . . . 0.0 109.872 -179.216 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.647 HG21 ' CD2' ' A' ' 57' ' ' PHE . 1.4 m -98.04 158.41 15.56 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.521 ' HG3' ' CB ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -160.56 117.62 2.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.915 -1.116 . . . . 0.0 109.867 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.848 ' O ' HG23 ' A' ' 53' ' ' THR . 3.0 pttm -46.78 172.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 0.0 109.268 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.848 HG23 ' O ' ' A' ' 52' ' ' LYS . 1.4 p -167.69 172.95 8.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.44 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.9 -18.8 41.48 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 m -99.5 -52.23 3.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -1.111 . . . . 0.0 109.365 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 52' ' ' LYS . . . -176.08 -100.35 0.13 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.647 ' CD2' HG21 ' A' ' 50' ' ' THR . 0.9 OUTLIER -117.93 158.63 24.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -1.114 . . . . 0.0 110.033 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.521 ' CB ' ' HG3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -130.89 123.58 29.29 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.166 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.816 ' CD2' HD22 ' A' ' 88' ' ' LEU . 7.3 m-85 -105.04 153.52 21.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.856 -1.153 . . . . 0.0 111.753 -177.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.501 ' OD1' ' CG2' ' A' ' 93' ' ' VAL . 6.2 m-20 -137.6 95.41 3.06 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 1.016 ' CG2' HG23 ' A' ' 81' ' ' THR . 10.9 mt -87.75 122.71 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 111.156 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.706 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 16.4 m-70 -110.47 169.17 8.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.514 -0.741 . . . . 0.0 109.168 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 95' ' ' HIS . 50.2 p90 -139.23 109.4 6.44 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.817 -1.153 . . . . 0.0 109.044 176.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.553 ' C ' HD23 ' A' ' 65' ' ' LEU . 7.0 t90 -86.05 135.72 33.52 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.279 0.561 . . . . 0.0 109.612 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.903 HD11 ' CG ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -120.02 61.57 0.85 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.93 -178.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 43' ' ' ASP . . . -51.69 89.81 0.01 OUTLIER Glycine 0 N--CA 1.498 2.767 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 178.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 65' ' ' LEU . 1.5 tppt? -39.02 91.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.091 0.948 . . . . 0.0 112.611 -177.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.631 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 2.7 m-80 -162.76 -45.69 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 73' ' ' GLU . 14.2 p -61.21 -157.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.507 -0.745 . . . . 0.0 109.272 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.4 p -106.39 161.83 14.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 0.2 OUTLIER -50.32 -49.98 52.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.879 . . . . 0.0 109.43 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -54.45 -39.65 67.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.123 -0.986 . . . . 0.0 108.913 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.479 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -55.52 -39.25 70.29 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.238 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.903 ' CG ' HD11 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -59.78 -38.02 80.67 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.457 ' O ' HG13 ' A' ' 79' ' ' ILE . . . -69.55 -25.2 75.75 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.762 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -73.19 -59.38 2.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -1.129 . . . . 0.0 109.229 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . . . -49.45 -37.53 26.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 0.0 108.945 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.33 -34.68 68.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.334 -0.854 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.762 HD12 ' HA ' ' A' ' 76' ' ' ALA . 15.4 mt -63.44 -49.12 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.867 . . . . 0.0 109.425 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.673 ' HB3' ' HE2' ' A' ' 28' ' ' MET . 27.2 m-85 -58.47 -41.09 84.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.053 -1.029 . . . . 0.0 108.639 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 1.016 HG23 ' CG2' ' A' ' 61' ' ' ILE . 8.9 m -69.6 -22.34 63.51 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.431 -0.793 . . . . 0.0 108.897 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.8 m -86.44 -18.39 31.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.631 -0.668 . . . . 0.0 109.317 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 1.0 OUTLIER -89.85 -35.48 15.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.554 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.889 ' O ' HD12 ' A' ' 88' ' ' LEU . 5.2 ptm -82.32 -12.26 58.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.952 . . . . 0.0 109.482 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' A' ' 92' ' ' ALA . 9.4 t0 -79.91 -37.24 35.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.328 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -89.77 -29.04 18.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 109.257 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.509 ' HB3' ' HB ' ' A' ' 8' ' ' THR . 1.9 m-85 -76.21 -29.67 57.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.237 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.999 HD21 HD22 ' A' ' 11' ' ' LEU . 6.6 mt -72.06 -3.05 20.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.428 -0.795 . . . . 0.0 109.785 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.81 24.73 7.97 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 56.35 17.75 3.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -1.149 . . . . 0.0 109.322 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.568 HG23 ' CD2' ' A' ' 59' ' ' TYR . 11.7 m -96.64 -14.64 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.896 . . . . 0.0 109.255 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.547 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -77.04 164.53 25.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.316 -0.865 . . . . 0.0 109.427 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.738 HG12 ' H ' ' A' ' 94' ' ' GLN . 2.5 t -113.5 -178.53 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.494 -0.754 . . . . 0.0 109.176 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.738 ' H ' HG12 ' A' ' 93' ' ' VAL . 10.8 tt0 -132.64 136.41 46.47 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.135 -0.978 . . . . 0.0 109.054 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.706 ' CD2' ' CD2' ' A' ' 62' ' ' HIS . 10.1 m-70 -137.84 153.6 49.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.405 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.568 ' HA ' ' CE2' ' A' ' 63' ' ' TYR . 16.1 ptm180 -111.78 143.97 41.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.671 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.495 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 40.2 mm-40 -150.68 164.19 36.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.408 -0.808 . . . . 0.0 109.05 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.746 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.3 t -154.52 -169.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 0.0 109.012 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.746 ' H ' HG12 ' A' ' 98' ' ' VAL . 3.3 pt20 -72.76 0.92 9.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.844 -1.16 . . . . 0.0 110.282 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.6 19.57 1.15 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.244 -1.943 . . . . 0.0 108.244 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.544 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 46.0 m-70 -125.09 -14.78 6.5 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.715 -0.873 . . . . 0.0 109.789 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.552 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.25 29.34 1.26 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.727 -179.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 102' ' ' GLU . 77.6 p -55.99 -131.63 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.368 -0.832 . . . . 0.0 111.138 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.457 ' HG2' ' N ' ' A' ' 105' ' ' THR . 0.1 OUTLIER -40.01 -24.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.769 -1.207 . . . . 0.0 111.068 -178.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.551 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 1.8 m -66.94 -63.78 0.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.843 -1.161 . . . . 0.0 110.592 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.519 ' HB2' ' HB2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -57.14 -47.16 81.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.756 -1.215 . . . . 0.0 108.227 -179.13 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 110' ' ' PHE . 10.6 mtm180 -59.46 -28.06 66.64 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 105' ' ' THR . . . -59.84 -44.47 94.07 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.571 ' OH ' ' CE1' ' A' ' 62' ' ' HIS . 63.6 m-85 -76.53 -12.79 60.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.817 ' CB ' HD21 ' A' ' 114' ' ' LEU . 20.4 m-85 -126.09 105.65 9.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.648 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 112' ' ' GLN . 5.1 ptmt -90.13 26.4 1.89 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 110.112 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.485 ' CB ' ' O ' ' A' ' 111' ' ' LYS . 1.1 pt20 165.2 83.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.892 -1.13 . . . . 0.0 110.469 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 114' ' ' LEU . . . 167.03 -122.89 1.09 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.817 HD21 ' CB ' ' A' ' 110' ' ' PHE . 0.2 OUTLIER 65.76 49.8 1.66 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.557 -0.966 . . . . 0.0 110.888 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.507 ' CG2' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -87.5 167.18 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 177.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.578 ' CZ ' ' O ' ' A' ' 114' ' ' LEU . 2.9 m-85 -143.66 122.73 12.86 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.823 -1.173 . . . . 0.0 110.353 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.625 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 1.9 mttm -102.62 -163.94 1.04 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.462 -0.773 . . . . 0.0 108.972 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.578 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -90.26 161.47 15.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.92 -1.112 . . . . 0.0 110.14 -179.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 120' ' ' GLY . . . -67.88 -161.88 1.9 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 119' ' ' GLY . . . 58.73 112.5 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.721 HG13 ' N ' ' A' ' 122' ' ' ALA . 4.2 p -90.46 -147.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.265 -1.138 . . . . 0.0 108.676 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.721 ' N ' HG13 ' A' ' 121' ' ' VAL . . . -77.88 4.01 13.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.87 -1.144 . . . . 0.0 109.963 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.423 ' H ' HG13 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -44.92 -49.63 10.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 0.0 109.474 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 126' ' ' LYS . . . 142.81 -60.91 0.53 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.14 -90.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -1.159 . . . . 0.0 109.45 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.508 ' N ' ' O ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.507 -179.981 . . . . . . . . 2 2 . 1 stop_ save_